(function(){const n=document.createElement("link").relList;if(n&&n.supports&&n.supports("modulepreload"))return;for(const a of document.querySelectorAll('link[rel="modulepreload"]'))r(a);new MutationObserver(a=>{for(const o of a)if(o.type==="childList")for(const d of o.addedNodes)d.tagName==="LINK"&&d.rel==="modulepreload"&&r(d)}).observe(document,{childList:!0,subtree:!0});function s(a){const o={};return a.integrity&&(o.integrity=a.integrity),a.referrerPolicy&&(o.referrerPolicy=a.referrerPolicy),a.crossOrigin==="use-credentials"?o.credentials="include":a.crossOrigin==="anonymous"?o.credentials="omit":o.credentials="same-origin",o}function r(a){if(a.ep)return;a.ep=!0;const o=s(a);fetch(a.href,o)}})();function Vf(t){return t&&t.__esModule&&Object.prototype.hasOwnProperty.call(t,"default")?t.default:t}var Gf={exports:{}},ya={},Uf={exports:{}},B={};/**
 * @license React
 * react.production.min.js
 *
 * Copyright (c) Facebook, Inc. and its affiliates.
 *
 * This source code is licensed under the MIT license found in the
 * LICENSE file in the root directory of this source tree.
 */var _s=Symbol.for("react.element"),n0=Symbol.for("react.portal"),i0=Symbol.for("react.fragment"),s0=Symbol.for("react.strict_mode"),r0=Symbol.for("react.profiler"),a0=Symbol.for("react.provider"),o0=Symbol.for("react.context"),l0=Symbol.for("react.forward_ref"),c0=Symbol.for("react.suspense"),d0=Symbol.for("react.memo"),u0=Symbol.for("react.lazy"),Wd=Symbol.iterator;function h0(t){return t===null||typeof t!="object"?null:(t=Wd&&t[Wd]||t["@@iterator"],typeof t=="function"?t:null)}var qf={isMounted:function(){return!1},enqueueForceUpdate:function(){},enqueueReplaceState:function(){},enqueueSetState:function(){}},Wf=Object.assign,Qf={};function Ri(t,n,s){this.props=t,this.context=n,this.refs=Qf,this.updater=s||qf}Ri.prototype.isReactComponent={};Ri.prototype.setState=function(t,n){if(typeof t!="object"&&typeof t!="function"&&t!=null)throw Error("setState(...): takes an object of state variables to update or a function which returns an object of state variables.");this.updater.enqueueSetState(this,t,n,"setState")};Ri.prototype.forceUpdate=function(t){this.updater.enqueueForceUpdate(this,t,"forceUpdate")};function Yf(){}Yf.prototype=Ri.prototype;function Jl(t,n,s){this.props=t,this.context=n,this.refs=Qf,this.updater=s||qf}var ec=Jl.prototype=new Yf;ec.constructor=Jl;Wf(ec,Ri.prototype);ec.isPureReactComponent=!0;var Qd=Array.isArray,Kf=Object.prototype.hasOwnProperty,tc={current:null},Xf={key:!0,ref:!0,__self:!0,__source:!0};function Zf(t,n,s){var r,a={},o=null,d=null;if(n!=null)for(r in n.ref!==void 0&&(d=n.ref),n.key!==void 0&&(o=""+n.key),n)Kf.call(n,r)&&!Xf.hasOwnProperty(r)&&(a[r]=n[r]);var u=arguments.length-2;if(u===1)a.children=s;else if(1<u){for(var h=Array(u),p=0;p<u;p++)h[p]=arguments[p+2];a.children=h}if(t&&t.defaultProps)for(r in u=t.defaultProps,u)a[r]===void 0&&(a[r]=u[r]);return{$$typeof:_s,type:t,key:o,ref:d,props:a,_owner:tc.current}}function f0(t,n){return{$$typeof:_s,type:t.type,key:n,ref:t.ref,props:t.props,_owner:t._owner}}function nc(t){return typeof t=="object"&&t!==null&&t.$$typeof===_s}function p0(t){var n={"=":"=0",":":"=2"};return"$"+t.replace(/[=:]/g,function(s){return n[s]})}var Yd=/\/+/g;function so(t,n){return typeof t=="object"&&t!==null&&t.key!=null?p0(""+t.key):n.toString(36)}function kr(t,n,s,r,a){var o=typeof t;(o==="undefined"||o==="boolean")&&(t=null);var d=!1;if(t===null)d=!0;else switch(o){case"string":case"number":d=!0;break;case"object":switch(t.$$typeof){case _s:case n0:d=!0}}if(d)return d=t,a=a(d),t=r===""?"."+so(d,0):r,Qd(a)?(s="",t!=null&&(s=t.replace(Yd,"$&/")+"/"),kr(a,n,s,"",function(p){return p})):a!=null&&(nc(a)&&(a=f0(a,s+(!a.key||d&&d.key===a.key?"":(""+a.key).replace(Yd,"$&/")+"/")+t)),n.push(a)),1;if(d=0,r=r===""?".":r+":",Qd(t))for(var u=0;u<t.length;u++){o=t[u];var h=r+so(o,u);d+=kr(o,n,s,h,a)}else if(h=h0(t),typeof h=="function")for(t=h.call(t),u=0;!(o=t.next()).done;)o=o.value,h=r+so(o,u++),d+=kr(o,n,s,h,a);else if(o==="object")throw n=String(t),Error("Objects are not valid as a React child (found: "+(n==="[object Object]"?"object with keys {"+Object.keys(t).join(", ")+"}":n)+"). If you meant to render a collection of children, use an array instead.");return d}function Zs(t,n,s){if(t==null)return t;var r=[],a=0;return kr(t,r,"","",function(o){return n.call(s,o,a++)}),r}function m0(t){if(t._status===-1){var n=t._result;n=n(),n.then(function(s){(t._status===0||t._status===-1)&&(t._status=1,t._result=s)},function(s){(t._status===0||t._status===-1)&&(t._status=2,t._result=s)}),t._status===-1&&(t._status=0,t._result=n)}if(t._status===1)return t._result.default;throw t._result}var Ie={current:null},Pr={transition:null},g0={ReactCurrentDispatcher:Ie,ReactCurrentBatchConfig:Pr,ReactCurrentOwner:tc};function Jf(){throw Error("act(...) is not supported in production builds of React.")}B.Children={map:Zs,forEach:function(t,n,s){Zs(t,function(){n.apply(this,arguments)},s)},count:function(t){var n=0;return Zs(t,function(){n++}),n},toArray:function(t){return Zs(t,function(n){return n})||[]},only:function(t){if(!nc(t))throw Error("React.Children.only expected to receive a single React element child.");return t}};B.Component=Ri;B.Fragment=i0;B.Profiler=r0;B.PureComponent=Jl;B.StrictMode=s0;B.Suspense=c0;B.__SECRET_INTERNALS_DO_NOT_USE_OR_YOU_WILL_BE_FIRED=g0;B.act=Jf;B.cloneElement=function(t,n,s){if(t==null)throw Error("React.cloneElement(...): The argument must be a React element, but you passed "+t+".");var r=Wf({},t.props),a=t.key,o=t.ref,d=t._owner;if(n!=null){if(n.ref!==void 0&&(o=n.ref,d=tc.current),n.key!==void 0&&(a=""+n.key),t.type&&t.type.defaultProps)var u=t.type.defaultProps;for(h in n)Kf.call(n,h)&&!Xf.hasOwnProperty(h)&&(r[h]=n[h]===void 0&&u!==void 0?u[h]:n[h])}var h=arguments.length-2;if(h===1)r.children=s;else if(1<h){u=Array(h);for(var p=0;p<h;p++)u[p]=arguments[p+2];r.children=u}return{$$typeof:_s,type:t.type,key:a,ref:o,props:r,_owner:d}};B.createContext=function(t){return t={$$typeof:o0,_currentValue:t,_currentValue2:t,_threadCount:0,Provider:null,Consumer:null,_defaultValue:null,_globalName:null},t.Provider={$$typeof:a0,_context:t},t.Consumer=t};B.createElement=Zf;B.createFactory=function(t){var n=Zf.bind(null,t);return n.type=t,n};B.createRef=function(){return{current:null}};B.forwardRef=function(t){return{$$typeof:l0,render:t}};B.isValidElement=nc;B.lazy=function(t){return{$$typeof:u0,_payload:{_status:-1,_result:t},_init:m0}};B.memo=function(t,n){return{$$typeof:d0,type:t,compare:n===void 0?null:n}};B.startTransition=function(t){var n=Pr.transition;Pr.transition={};try{t()}finally{Pr.transition=n}};B.unstable_act=Jf;B.useCallback=function(t,n){return Ie.current.useCallback(t,n)};B.useContext=function(t){return Ie.current.useContext(t)};B.useDebugValue=function(){};B.useDeferredValue=function(t){return Ie.current.useDeferredValue(t)};B.useEffect=function(t,n){return Ie.current.useEffect(t,n)};B.useId=function(){return Ie.current.useId()};B.useImperativeHandle=function(t,n,s){return Ie.current.useImperativeHandle(t,n,s)};B.useInsertionEffect=function(t,n){return Ie.current.useInsertionEffect(t,n)};B.useLayoutEffect=function(t,n){return Ie.current.useLayoutEffect(t,n)};B.useMemo=function(t,n){return Ie.current.useMemo(t,n)};B.useReducer=function(t,n,s){return Ie.current.useReducer(t,n,s)};B.useRef=function(t){return Ie.current.useRef(t)};B.useState=function(t){return Ie.current.useState(t)};B.useSyncExternalStore=function(t,n,s){return Ie.current.useSyncExternalStore(t,n,s)};B.useTransition=function(){return Ie.current.useTransition()};B.version="18.3.1";Uf.exports=B;var v=Uf.exports;const x0=Vf(v);/**
 * @license React
 * react-jsx-runtime.production.min.js
 *
 * Copyright (c) Facebook, Inc. and its affiliates.
 *
 * This source code is licensed under the MIT license found in the
 * LICENSE file in the root directory of this source tree.
 */var v0=v,y0=Symbol.for("react.element"),j0=Symbol.for("react.fragment"),w0=Object.prototype.hasOwnProperty,b0=v0.__SECRET_INTERNALS_DO_NOT_USE_OR_YOU_WILL_BE_FIRED.ReactCurrentOwner,S0={key:!0,ref:!0,__self:!0,__source:!0};function ep(t,n,s){var r,a={},o=null,d=null;s!==void 0&&(o=""+s),n.key!==void 0&&(o=""+n.key),n.ref!==void 0&&(d=n.ref);for(r in n)w0.call(n,r)&&!S0.hasOwnProperty(r)&&(a[r]=n[r]);if(t&&t.defaultProps)for(r in n=t.defaultProps,n)a[r]===void 0&&(a[r]=n[r]);return{$$typeof:y0,type:t,key:o,ref:d,props:a,_owner:b0.current}}ya.Fragment=j0;ya.jsx=ep;ya.jsxs=ep;Gf.exports=ya;var e=Gf.exports,tp={exports:{}},_e={},np={exports:{}},ip={};/**
 * @license React
 * scheduler.production.min.js
 *
 * Copyright (c) Facebook, Inc. and its affiliates.
 *
 * This source code is licensed under the MIT license found in the
 * LICENSE file in the root directory of this source tree.
 */(function(t){function n(A,O){var $=A.length;A.push(O);e:for(;0<$;){var X=$-1>>>1,re=A[X];if(0<a(re,O))A[X]=O,A[$]=re,$=X;else break e}}function s(A){return A.length===0?null:A[0]}function r(A){if(A.length===0)return null;var O=A[0],$=A.pop();if($!==O){A[0]=$;e:for(var X=0,re=A.length,Nn=re>>>1;X<Nn;){var wt=2*(X+1)-1,Li=A[wt],bt=wt+1,_n=A[bt];if(0>a(Li,$))bt<re&&0>a(_n,Li)?(A[X]=_n,A[bt]=$,X=bt):(A[X]=Li,A[wt]=$,X=wt);else if(bt<re&&0>a(_n,$))A[X]=_n,A[bt]=$,X=bt;else break e}}return O}function a(A,O){var $=A.sortIndex-O.sortIndex;return $!==0?$:A.id-O.id}if(typeof performance=="object"&&typeof performance.now=="function"){var o=performance;t.unstable_now=function(){return o.now()}}else{var d=Date,u=d.now();t.unstable_now=function(){return d.now()-u}}var h=[],p=[],m=1,g=null,x=3,j=!1,I=!1,S=!1,T=typeof setTimeout=="function"?setTimeout:null,w=typeof clearTimeout=="function"?clearTimeout:null,y=typeof setImmediate<"u"?setImmediate:null;typeof navigator<"u"&&navigator.scheduling!==void 0&&navigator.scheduling.isInputPending!==void 0&&navigator.scheduling.isInputPending.bind(navigator.scheduling);function b(A){for(var O=s(p);O!==null;){if(O.callback===null)r(p);else if(O.startTime<=A)r(p),O.sortIndex=O.expirationTime,n(h,O);else break;O=s(p)}}function C(A){if(S=!1,b(A),!I)if(s(h)!==null)I=!0,Xe(R);else{var O=s(p);O!==null&&jt(C,O.startTime-A)}}function R(A,O){I=!1,S&&(S=!1,w(P),P=-1),j=!0;var $=x;try{for(b(O),g=s(h);g!==null&&(!(g.expirationTime>O)||A&&!q());){var X=g.callback;if(typeof X=="function"){g.callback=null,x=g.priorityLevel;var re=X(g.expirationTime<=O);O=t.unstable_now(),typeof re=="function"?g.callback=re:g===s(h)&&r(h),b(O)}else r(h);g=s(h)}if(g!==null)var Nn=!0;else{var wt=s(p);wt!==null&&jt(C,wt.startTime-O),Nn=!1}return Nn}finally{g=null,x=$,j=!1}}var D=!1,k=null,P=-1,z=5,_=-1;function q(){return!(t.unstable_now()-_<z)}function oe(){if(k!==null){var A=t.unstable_now();_=A;var O=!0;try{O=k(!0,A)}finally{O?ge():(D=!1,k=null)}}else D=!1}var ge;if(typeof y=="function")ge=function(){y(oe)};else if(typeof MessageChannel<"u"){var Ye=new MessageChannel,Ke=Ye.port2;Ye.port1.onmessage=oe,ge=function(){Ke.postMessage(null)}}else ge=function(){T(oe,0)};function Xe(A){k=A,D||(D=!0,ge())}function jt(A,O){P=T(function(){A(t.unstable_now())},O)}t.unstable_IdlePriority=5,t.unstable_ImmediatePriority=1,t.unstable_LowPriority=4,t.unstable_NormalPriority=3,t.unstable_Profiling=null,t.unstable_UserBlockingPriority=2,t.unstable_cancelCallback=function(A){A.callback=null},t.unstable_continueExecution=function(){I||j||(I=!0,Xe(R))},t.unstable_forceFrameRate=function(A){0>A||125<A?console.error("forceFrameRate takes a positive int between 0 and 125, forcing frame rates higher than 125 fps is not supported"):z=0<A?Math.floor(1e3/A):5},t.unstable_getCurrentPriorityLevel=function(){return x},t.unstable_getFirstCallbackNode=function(){return s(h)},t.unstable_next=function(A){switch(x){case 1:case 2:case 3:var O=3;break;default:O=x}var $=x;x=O;try{return A()}finally{x=$}},t.unstable_pauseExecution=function(){},t.unstable_requestPaint=function(){},t.unstable_runWithPriority=function(A,O){switch(A){case 1:case 2:case 3:case 4:case 5:break;default:A=3}var $=x;x=A;try{return O()}finally{x=$}},t.unstable_scheduleCallback=function(A,O,$){var X=t.unstable_now();switch(typeof $=="object"&&$!==null?($=$.delay,$=typeof $=="number"&&0<$?X+$:X):$=X,A){case 1:var re=-1;break;case 2:re=250;break;case 5:re=1073741823;break;case 4:re=1e4;break;default:re=5e3}return re=$+re,A={id:m++,callback:O,priorityLevel:A,startTime:$,expirationTime:re,sortIndex:-1},$>X?(A.sortIndex=$,n(p,A),s(h)===null&&A===s(p)&&(S?(w(P),P=-1):S=!0,jt(C,$-X))):(A.sortIndex=re,n(h,A),I||j||(I=!0,Xe(R))),A},t.unstable_shouldYield=q,t.unstable_wrapCallback=function(A){var O=x;return function(){var $=x;x=O;try{return A.apply(this,arguments)}finally{x=$}}}})(ip);np.exports=ip;var I0=np.exports;/**
 * @license React
 * react-dom.production.min.js
 *
 * Copyright (c) Facebook, Inc. and its affiliates.
 *
 * This source code is licensed under the MIT license found in the
 * LICENSE file in the root directory of this source tree.
 */var C0=v,Ne=I0;function M(t){for(var n="https://reactjs.org/docs/error-decoder.html?invariant="+t,s=1;s<arguments.length;s++)n+="&args[]="+encodeURIComponent(arguments[s]);return"Minified React error #"+t+"; visit "+n+" for the full message or use the non-minified dev environment for full errors and additional helpful warnings."}var sp=new Set,xs={};function En(t,n){pi(t,n),pi(t+"Capture",n)}function pi(t,n){for(xs[t]=n,t=0;t<n.length;t++)sp.add(n[t])}var Pt=!(typeof window>"u"||typeof window.document>"u"||typeof window.document.createElement>"u"),Yo=Object.prototype.hasOwnProperty,T0=/^[:A-Z_a-z\u00C0-\u00D6\u00D8-\u00F6\u00F8-\u02FF\u0370-\u037D\u037F-\u1FFF\u200C-\u200D\u2070-\u218F\u2C00-\u2FEF\u3001-\uD7FF\uF900-\uFDCF\uFDF0-\uFFFD][:A-Z_a-z\u00C0-\u00D6\u00D8-\u00F6\u00F8-\u02FF\u0370-\u037D\u037F-\u1FFF\u200C-\u200D\u2070-\u218F\u2C00-\u2FEF\u3001-\uD7FF\uF900-\uFDCF\uFDF0-\uFFFD\-.0-9\u00B7\u0300-\u036F\u203F-\u2040]*$/,Kd={},Xd={};function R0(t){return Yo.call(Xd,t)?!0:Yo.call(Kd,t)?!1:T0.test(t)?Xd[t]=!0:(Kd[t]=!0,!1)}function k0(t,n,s,r){if(s!==null&&s.type===0)return!1;switch(typeof n){case"function":case"symbol":return!0;case"boolean":return r?!1:s!==null?!s.acceptsBooleans:(t=t.toLowerCase().slice(0,5),t!=="data-"&&t!=="aria-");default:return!1}}function P0(t,n,s,r){if(n===null||typeof n>"u"||k0(t,n,s,r))return!0;if(r)return!1;if(s!==null)switch(s.type){case 3:return!n;case 4:return n===!1;case 5:return isNaN(n);case 6:return isNaN(n)||1>n}return!1}function Ce(t,n,s,r,a,o,d){this.acceptsBooleans=n===2||n===3||n===4,this.attributeName=r,this.attributeNamespace=a,this.mustUseProperty=s,this.propertyName=t,this.type=n,this.sanitizeURL=o,this.removeEmptyString=d}var me={};"children dangerouslySetInnerHTML defaultValue defaultChecked innerHTML suppressContentEditableWarning suppressHydrationWarning style".split(" ").forEach(function(t){me[t]=new Ce(t,0,!1,t,null,!1,!1)});[["acceptCharset","accept-charset"],["className","class"],["htmlFor","for"],["httpEquiv","http-equiv"]].forEach(function(t){var n=t[0];me[n]=new Ce(n,1,!1,t[1],null,!1,!1)});["contentEditable","draggable","spellCheck","value"].forEach(function(t){me[t]=new Ce(t,2,!1,t.toLowerCase(),null,!1,!1)});["autoReverse","externalResourcesRequired","focusable","preserveAlpha"].forEach(function(t){me[t]=new Ce(t,2,!1,t,null,!1,!1)});"allowFullScreen async autoFocus autoPlay controls default defer disabled disablePictureInPicture disableRemotePlayback formNoValidate hidden loop noModule noValidate open playsInline readOnly required reversed scoped seamless itemScope".split(" ").forEach(function(t){me[t]=new Ce(t,3,!1,t.toLowerCase(),null,!1,!1)});["checked","multiple","muted","selected"].forEach(function(t){me[t]=new Ce(t,3,!0,t,null,!1,!1)});["capture","download"].forEach(function(t){me[t]=new Ce(t,4,!1,t,null,!1,!1)});["cols","rows","size","span"].forEach(function(t){me[t]=new Ce(t,6,!1,t,null,!1,!1)});["rowSpan","start"].forEach(function(t){me[t]=new Ce(t,5,!1,t.toLowerCase(),null,!1,!1)});var ic=/[\-:]([a-z])/g;function sc(t){return t[1].toUpperCase()}"accent-height alignment-baseline arabic-form baseline-shift cap-height clip-path clip-rule color-interpolation color-interpolation-filters color-profile color-rendering dominant-baseline enable-background fill-opacity fill-rule flood-color flood-opacity font-family font-size font-size-adjust font-stretch font-style font-variant font-weight glyph-name glyph-orientation-horizontal glyph-orientation-vertical horiz-adv-x horiz-origin-x image-rendering letter-spacing lighting-color marker-end marker-mid marker-start overline-position overline-thickness paint-order panose-1 pointer-events rendering-intent shape-rendering stop-color stop-opacity strikethrough-position strikethrough-thickness stroke-dasharray stroke-dashoffset stroke-linecap stroke-linejoin stroke-miterlimit stroke-opacity stroke-width text-anchor text-decoration text-rendering underline-position underline-thickness unicode-bidi unicode-range units-per-em v-alphabetic v-hanging v-ideographic v-mathematical vector-effect vert-adv-y vert-origin-x vert-origin-y word-spacing writing-mode xmlns:xlink x-height".split(" ").forEach(function(t){var n=t.replace(ic,sc);me[n]=new Ce(n,1,!1,t,null,!1,!1)});"xlink:actuate xlink:arcrole xlink:role xlink:show xlink:title xlink:type".split(" ").forEach(function(t){var n=t.replace(ic,sc);me[n]=new Ce(n,1,!1,t,"http://www.w3.org/1999/xlink",!1,!1)});["xml:base","xml:lang","xml:space"].forEach(function(t){var n=t.replace(ic,sc);me[n]=new Ce(n,1,!1,t,"http://www.w3.org/XML/1998/namespace",!1,!1)});["tabIndex","crossOrigin"].forEach(function(t){me[t]=new Ce(t,1,!1,t.toLowerCase(),null,!1,!1)});me.xlinkHref=new Ce("xlinkHref",1,!1,"xlink:href","http://www.w3.org/1999/xlink",!0,!1);["src","href","action","formAction"].forEach(function(t){me[t]=new Ce(t,1,!1,t.toLowerCase(),null,!0,!0)});function rc(t,n,s,r){var a=me.hasOwnProperty(n)?me[n]:null;(a!==null?a.type!==0:r||!(2<n.length)||n[0]!=="o"&&n[0]!=="O"||n[1]!=="n"&&n[1]!=="N")&&(P0(n,s,a,r)&&(s=null),r||a===null?R0(n)&&(s===null?t.removeAttribute(n):t.setAttribute(n,""+s)):a.mustUseProperty?t[a.propertyName]=s===null?a.type===3?!1:"":s:(n=a.attributeName,r=a.attributeNamespace,s===null?t.removeAttribute(n):(a=a.type,s=a===3||a===4&&s===!0?"":""+s,r?t.setAttributeNS(r,n,s):t.setAttribute(n,s))))}var zt=C0.__SECRET_INTERNALS_DO_NOT_USE_OR_YOU_WILL_BE_FIRED,Js=Symbol.for("react.element"),Yn=Symbol.for("react.portal"),Kn=Symbol.for("react.fragment"),ac=Symbol.for("react.strict_mode"),Ko=Symbol.for("react.profiler"),rp=Symbol.for("react.provider"),ap=Symbol.for("react.context"),oc=Symbol.for("react.forward_ref"),Xo=Symbol.for("react.suspense"),Zo=Symbol.for("react.suspense_list"),lc=Symbol.for("react.memo"),Vt=Symbol.for("react.lazy"),op=Symbol.for("react.offscreen"),Zd=Symbol.iterator;function Oi(t){return t===null||typeof t!="object"?null:(t=Zd&&t[Zd]||t["@@iterator"],typeof t=="function"?t:null)}var te=Object.assign,ro;function ns(t){if(ro===void 0)try{throw Error()}catch(s){var n=s.stack.trim().match(/\n( *(at )?)/);ro=n&&n[1]||""}return`
`+ro+t}var ao=!1;function oo(t,n){if(!t||ao)return"";ao=!0;var s=Error.prepareStackTrace;Error.prepareStackTrace=void 0;try{if(n)if(n=function(){throw Error()},Object.defineProperty(n.prototype,"props",{set:function(){throw Error()}}),typeof Reflect=="object"&&Reflect.construct){try{Reflect.construct(n,[])}catch(p){var r=p}Reflect.construct(t,[],n)}else{try{n.call()}catch(p){r=p}t.call(n.prototype)}else{try{throw Error()}catch(p){r=p}t()}}catch(p){if(p&&r&&typeof p.stack=="string"){for(var a=p.stack.split(`
`),o=r.stack.split(`
`),d=a.length-1,u=o.length-1;1<=d&&0<=u&&a[d]!==o[u];)u--;for(;1<=d&&0<=u;d--,u--)if(a[d]!==o[u]){if(d!==1||u!==1)do if(d--,u--,0>u||a[d]!==o[u]){var h=`
`+a[d].replace(" at new "," at ");return t.displayName&&h.includes("<anonymous>")&&(h=h.replace("<anonymous>",t.displayName)),h}while(1<=d&&0<=u);break}}}finally{ao=!1,Error.prepareStackTrace=s}return(t=t?t.displayName||t.name:"")?ns(t):""}function E0(t){switch(t.tag){case 5:return ns(t.type);case 16:return ns("Lazy");case 13:return ns("Suspense");case 19:return ns("SuspenseList");case 0:case 2:case 15:return t=oo(t.type,!1),t;case 11:return t=oo(t.type.render,!1),t;case 1:return t=oo(t.type,!0),t;default:return""}}function Jo(t){if(t==null)return null;if(typeof t=="function")return t.displayName||t.name||null;if(typeof t=="string")return t;switch(t){case Kn:return"Fragment";case Yn:return"Portal";case Ko:return"Profiler";case ac:return"StrictMode";case Xo:return"Suspense";case Zo:return"SuspenseList"}if(typeof t=="object")switch(t.$$typeof){case ap:return(t.displayName||"Context")+".Consumer";case rp:return(t._context.displayName||"Context")+".Provider";case oc:var n=t.render;return t=t.displayName,t||(t=n.displayName||n.name||"",t=t!==""?"ForwardRef("+t+")":"ForwardRef"),t;case lc:return n=t.displayName||null,n!==null?n:Jo(t.type)||"Memo";case Vt:n=t._payload,t=t._init;try{return Jo(t(n))}catch{}}return null}function D0(t){var n=t.type;switch(t.tag){case 24:return"Cache";case 9:return(n.displayName||"Context")+".Consumer";case 10:return(n._context.displayName||"Context")+".Provider";case 18:return"DehydratedFragment";case 11:return t=n.render,t=t.displayName||t.name||"",n.displayName||(t!==""?"ForwardRef("+t+")":"ForwardRef");case 7:return"Fragment";case 5:return n;case 4:return"Portal";case 3:return"Root";case 6:return"Text";case 16:return Jo(n);case 8:return n===ac?"StrictMode":"Mode";case 22:return"Offscreen";case 12:return"Profiler";case 21:return"Scope";case 13:return"Suspense";case 19:return"SuspenseList";case 25:return"TracingMarker";case 1:case 0:case 17:case 2:case 14:case 15:if(typeof n=="function")return n.displayName||n.name||null;if(typeof n=="string")return n}return null}function sn(t){switch(typeof t){case"boolean":case"number":case"string":case"undefined":return t;case"object":return t;default:return""}}function lp(t){var n=t.type;return(t=t.nodeName)&&t.toLowerCase()==="input"&&(n==="checkbox"||n==="radio")}function M0(t){var n=lp(t)?"checked":"value",s=Object.getOwnPropertyDescriptor(t.constructor.prototype,n),r=""+t[n];if(!t.hasOwnProperty(n)&&typeof s<"u"&&typeof s.get=="function"&&typeof s.set=="function"){var a=s.get,o=s.set;return Object.defineProperty(t,n,{configurable:!0,get:function(){return a.call(this)},set:function(d){r=""+d,o.call(this,d)}}),Object.defineProperty(t,n,{enumerable:s.enumerable}),{getValue:function(){return r},setValue:function(d){r=""+d},stopTracking:function(){t._valueTracker=null,delete t[n]}}}}function er(t){t._valueTracker||(t._valueTracker=M0(t))}function cp(t){if(!t)return!1;var n=t._valueTracker;if(!n)return!0;var s=n.getValue(),r="";return t&&(r=lp(t)?t.checked?"true":"false":t.value),t=r,t!==s?(n.setValue(t),!0):!1}function Ur(t){if(t=t||(typeof document<"u"?document:void 0),typeof t>"u")return null;try{return t.activeElement||t.body}catch{return t.body}}function el(t,n){var s=n.checked;return te({},n,{defaultChecked:void 0,defaultValue:void 0,value:void 0,checked:s??t._wrapperState.initialChecked})}function Jd(t,n){var s=n.defaultValue==null?"":n.defaultValue,r=n.checked!=null?n.checked:n.defaultChecked;s=sn(n.value!=null?n.value:s),t._wrapperState={initialChecked:r,initialValue:s,controlled:n.type==="checkbox"||n.type==="radio"?n.checked!=null:n.value!=null}}function dp(t,n){n=n.checked,n!=null&&rc(t,"checked",n,!1)}function tl(t,n){dp(t,n);var s=sn(n.value),r=n.type;if(s!=null)r==="number"?(s===0&&t.value===""||t.value!=s)&&(t.value=""+s):t.value!==""+s&&(t.value=""+s);else if(r==="submit"||r==="reset"){t.removeAttribute("value");return}n.hasOwnProperty("value")?nl(t,n.type,s):n.hasOwnProperty("defaultValue")&&nl(t,n.type,sn(n.defaultValue)),n.checked==null&&n.defaultChecked!=null&&(t.defaultChecked=!!n.defaultChecked)}function eu(t,n,s){if(n.hasOwnProperty("value")||n.hasOwnProperty("defaultValue")){var r=n.type;if(!(r!=="submit"&&r!=="reset"||n.value!==void 0&&n.value!==null))return;n=""+t._wrapperState.initialValue,s||n===t.value||(t.value=n),t.defaultValue=n}s=t.name,s!==""&&(t.name=""),t.defaultChecked=!!t._wrapperState.initialChecked,s!==""&&(t.name=s)}function nl(t,n,s){(n!=="number"||Ur(t.ownerDocument)!==t)&&(s==null?t.defaultValue=""+t._wrapperState.initialValue:t.defaultValue!==""+s&&(t.defaultValue=""+s))}var is=Array.isArray;function oi(t,n,s,r){if(t=t.options,n){n={};for(var a=0;a<s.length;a++)n["$"+s[a]]=!0;for(s=0;s<t.length;s++)a=n.hasOwnProperty("$"+t[s].value),t[s].selected!==a&&(t[s].selected=a),a&&r&&(t[s].defaultSelected=!0)}else{for(s=""+sn(s),n=null,a=0;a<t.length;a++){if(t[a].value===s){t[a].selected=!0,r&&(t[a].defaultSelected=!0);return}n!==null||t[a].disabled||(n=t[a])}n!==null&&(n.selected=!0)}}function il(t,n){if(n.dangerouslySetInnerHTML!=null)throw Error(M(91));return te({},n,{value:void 0,defaultValue:void 0,children:""+t._wrapperState.initialValue})}function tu(t,n){var s=n.value;if(s==null){if(s=n.children,n=n.defaultValue,s!=null){if(n!=null)throw Error(M(92));if(is(s)){if(1<s.length)throw Error(M(93));s=s[0]}n=s}n==null&&(n=""),s=n}t._wrapperState={initialValue:sn(s)}}function up(t,n){var s=sn(n.value),r=sn(n.defaultValue);s!=null&&(s=""+s,s!==t.value&&(t.value=s),n.defaultValue==null&&t.defaultValue!==s&&(t.defaultValue=s)),r!=null&&(t.defaultValue=""+r)}function nu(t){var n=t.textContent;n===t._wrapperState.initialValue&&n!==""&&n!==null&&(t.value=n)}function hp(t){switch(t){case"svg":return"http://www.w3.org/2000/svg";case"math":return"http://www.w3.org/1998/Math/MathML";default:return"http://www.w3.org/1999/xhtml"}}function sl(t,n){return t==null||t==="http://www.w3.org/1999/xhtml"?hp(n):t==="http://www.w3.org/2000/svg"&&n==="foreignObject"?"http://www.w3.org/1999/xhtml":t}var tr,fp=function(t){return typeof MSApp<"u"&&MSApp.execUnsafeLocalFunction?function(n,s,r,a){MSApp.execUnsafeLocalFunction(function(){return t(n,s,r,a)})}:t}(function(t,n){if(t.namespaceURI!=="http://www.w3.org/2000/svg"||"innerHTML"in t)t.innerHTML=n;else{for(tr=tr||document.createElement("div"),tr.innerHTML="<svg>"+n.valueOf().toString()+"</svg>",n=tr.firstChild;t.firstChild;)t.removeChild(t.firstChild);for(;n.firstChild;)t.appendChild(n.firstChild)}});function vs(t,n){if(n){var s=t.firstChild;if(s&&s===t.lastChild&&s.nodeType===3){s.nodeValue=n;return}}t.textContent=n}var ls={animationIterationCount:!0,aspectRatio:!0,borderImageOutset:!0,borderImageSlice:!0,borderImageWidth:!0,boxFlex:!0,boxFlexGroup:!0,boxOrdinalGroup:!0,columnCount:!0,columns:!0,flex:!0,flexGrow:!0,flexPositive:!0,flexShrink:!0,flexNegative:!0,flexOrder:!0,gridArea:!0,gridRow:!0,gridRowEnd:!0,gridRowSpan:!0,gridRowStart:!0,gridColumn:!0,gridColumnEnd:!0,gridColumnSpan:!0,gridColumnStart:!0,fontWeight:!0,lineClamp:!0,lineHeight:!0,opacity:!0,order:!0,orphans:!0,tabSize:!0,widows:!0,zIndex:!0,zoom:!0,fillOpacity:!0,floodOpacity:!0,stopOpacity:!0,strokeDasharray:!0,strokeDashoffset:!0,strokeMiterlimit:!0,strokeOpacity:!0,strokeWidth:!0},A0=["Webkit","ms","Moz","O"];Object.keys(ls).forEach(function(t){A0.forEach(function(n){n=n+t.charAt(0).toUpperCase()+t.substring(1),ls[n]=ls[t]})});function pp(t,n,s){return n==null||typeof n=="boolean"||n===""?"":s||typeof n!="number"||n===0||ls.hasOwnProperty(t)&&ls[t]?(""+n).trim():n+"px"}function mp(t,n){t=t.style;for(var s in n)if(n.hasOwnProperty(s)){var r=s.indexOf("--")===0,a=pp(s,n[s],r);s==="float"&&(s="cssFloat"),r?t.setProperty(s,a):t[s]=a}}var z0=te({menuitem:!0},{area:!0,base:!0,br:!0,col:!0,embed:!0,hr:!0,img:!0,input:!0,keygen:!0,link:!0,meta:!0,param:!0,source:!0,track:!0,wbr:!0});function rl(t,n){if(n){if(z0[t]&&(n.children!=null||n.dangerouslySetInnerHTML!=null))throw Error(M(137,t));if(n.dangerouslySetInnerHTML!=null){if(n.children!=null)throw Error(M(60));if(typeof n.dangerouslySetInnerHTML!="object"||!("__html"in n.dangerouslySetInnerHTML))throw Error(M(61))}if(n.style!=null&&typeof n.style!="object")throw Error(M(62))}}function al(t,n){if(t.indexOf("-")===-1)return typeof n.is=="string";switch(t){case"annotation-xml":case"color-profile":case"font-face":case"font-face-src":case"font-face-uri":case"font-face-format":case"font-face-name":case"missing-glyph":return!1;default:return!0}}var ol=null;function cc(t){return t=t.target||t.srcElement||window,t.correspondingUseElement&&(t=t.correspondingUseElement),t.nodeType===3?t.parentNode:t}var ll=null,li=null,ci=null;function iu(t){if(t=Fs(t)){if(typeof ll!="function")throw Error(M(280));var n=t.stateNode;n&&(n=Ia(n),ll(t.stateNode,t.type,n))}}function gp(t){li?ci?ci.push(t):ci=[t]:li=t}function xp(){if(li){var t=li,n=ci;if(ci=li=null,iu(t),n)for(t=0;t<n.length;t++)iu(n[t])}}function vp(t,n){return t(n)}function yp(){}var lo=!1;function jp(t,n,s){if(lo)return t(n,s);lo=!0;try{return vp(t,n,s)}finally{lo=!1,(li!==null||ci!==null)&&(yp(),xp())}}function ys(t,n){var s=t.stateNode;if(s===null)return null;var r=Ia(s);if(r===null)return null;s=r[n];e:switch(n){case"onClick":case"onClickCapture":case"onDoubleClick":case"onDoubleClickCapture":case"onMouseDown":case"onMouseDownCapture":case"onMouseMove":case"onMouseMoveCapture":case"onMouseUp":case"onMouseUpCapture":case"onMouseEnter":(r=!r.disabled)||(t=t.type,r=!(t==="button"||t==="input"||t==="select"||t==="textarea")),t=!r;break e;default:t=!1}if(t)return null;if(s&&typeof s!="function")throw Error(M(231,n,typeof s));return s}var cl=!1;if(Pt)try{var Fi={};Object.defineProperty(Fi,"passive",{get:function(){cl=!0}}),window.addEventListener("test",Fi,Fi),window.removeEventListener("test",Fi,Fi)}catch{cl=!1}function N0(t,n,s,r,a,o,d,u,h){var p=Array.prototype.slice.call(arguments,3);try{n.apply(s,p)}catch(m){this.onError(m)}}var cs=!1,qr=null,Wr=!1,dl=null,_0={onError:function(t){cs=!0,qr=t}};function L0(t,n,s,r,a,o,d,u,h){cs=!1,qr=null,N0.apply(_0,arguments)}function O0(t,n,s,r,a,o,d,u,h){if(L0.apply(this,arguments),cs){if(cs){var p=qr;cs=!1,qr=null}else throw Error(M(198));Wr||(Wr=!0,dl=p)}}function Dn(t){var n=t,s=t;if(t.alternate)for(;n.return;)n=n.return;else{t=n;do n=t,n.flags&4098&&(s=n.return),t=n.return;while(t)}return n.tag===3?s:null}function wp(t){if(t.tag===13){var n=t.memoizedState;if(n===null&&(t=t.alternate,t!==null&&(n=t.memoizedState)),n!==null)return n.dehydrated}return null}function su(t){if(Dn(t)!==t)throw Error(M(188))}function F0(t){var n=t.alternate;if(!n){if(n=Dn(t),n===null)throw Error(M(188));return n!==t?null:t}for(var s=t,r=n;;){var a=s.return;if(a===null)break;var o=a.alternate;if(o===null){if(r=a.return,r!==null){s=r;continue}break}if(a.child===o.child){for(o=a.child;o;){if(o===s)return su(a),t;if(o===r)return su(a),n;o=o.sibling}throw Error(M(188))}if(s.return!==r.return)s=a,r=o;else{for(var d=!1,u=a.child;u;){if(u===s){d=!0,s=a,r=o;break}if(u===r){d=!0,r=a,s=o;break}u=u.sibling}if(!d){for(u=o.child;u;){if(u===s){d=!0,s=o,r=a;break}if(u===r){d=!0,r=o,s=a;break}u=u.sibling}if(!d)throw Error(M(189))}}if(s.alternate!==r)throw Error(M(190))}if(s.tag!==3)throw Error(M(188));return s.stateNode.current===s?t:n}function bp(t){return t=F0(t),t!==null?Sp(t):null}function Sp(t){if(t.tag===5||t.tag===6)return t;for(t=t.child;t!==null;){var n=Sp(t);if(n!==null)return n;t=t.sibling}return null}var Ip=Ne.unstable_scheduleCallback,ru=Ne.unstable_cancelCallback,$0=Ne.unstable_shouldYield,B0=Ne.unstable_requestPaint,ie=Ne.unstable_now,H0=Ne.unstable_getCurrentPriorityLevel,dc=Ne.unstable_ImmediatePriority,Cp=Ne.unstable_UserBlockingPriority,Qr=Ne.unstable_NormalPriority,V0=Ne.unstable_LowPriority,Tp=Ne.unstable_IdlePriority,ja=null,pt=null;function G0(t){if(pt&&typeof pt.onCommitFiberRoot=="function")try{pt.onCommitFiberRoot(ja,t,void 0,(t.current.flags&128)===128)}catch{}}var rt=Math.clz32?Math.clz32:W0,U0=Math.log,q0=Math.LN2;function W0(t){return t>>>=0,t===0?32:31-(U0(t)/q0|0)|0}var nr=64,ir=4194304;function ss(t){switch(t&-t){case 1:return 1;case 2:return 2;case 4:return 4;case 8:return 8;case 16:return 16;case 32:return 32;case 64:case 128:case 256:case 512:case 1024:case 2048:case 4096:case 8192:case 16384:case 32768:case 65536:case 131072:case 262144:case 524288:case 1048576:case 2097152:return t&4194240;case 4194304:case 8388608:case 16777216:case 33554432:case 67108864:return t&130023424;case 134217728:return 134217728;case 268435456:return 268435456;case 536870912:return 536870912;case 1073741824:return 1073741824;default:return t}}function Yr(t,n){var s=t.pendingLanes;if(s===0)return 0;var r=0,a=t.suspendedLanes,o=t.pingedLanes,d=s&268435455;if(d!==0){var u=d&~a;u!==0?r=ss(u):(o&=d,o!==0&&(r=ss(o)))}else d=s&~a,d!==0?r=ss(d):o!==0&&(r=ss(o));if(r===0)return 0;if(n!==0&&n!==r&&!(n&a)&&(a=r&-r,o=n&-n,a>=o||a===16&&(o&4194240)!==0))return n;if(r&4&&(r|=s&16),n=t.entangledLanes,n!==0)for(t=t.entanglements,n&=r;0<n;)s=31-rt(n),a=1<<s,r|=t[s],n&=~a;return r}function Q0(t,n){switch(t){case 1:case 2:case 4:return n+250;case 8:case 16:case 32:case 64:case 128:case 256:case 512:case 1024:case 2048:case 4096:case 8192:case 16384:case 32768:case 65536:case 131072:case 262144:case 524288:case 1048576:case 2097152:return n+5e3;case 4194304:case 8388608:case 16777216:case 33554432:case 67108864:return-1;case 134217728:case 268435456:case 536870912:case 1073741824:return-1;default:return-1}}function Y0(t,n){for(var s=t.suspendedLanes,r=t.pingedLanes,a=t.expirationTimes,o=t.pendingLanes;0<o;){var d=31-rt(o),u=1<<d,h=a[d];h===-1?(!(u&s)||u&r)&&(a[d]=Q0(u,n)):h<=n&&(t.expiredLanes|=u),o&=~u}}function ul(t){return t=t.pendingLanes&-1073741825,t!==0?t:t&1073741824?1073741824:0}function Rp(){var t=nr;return nr<<=1,!(nr&4194240)&&(nr=64),t}function co(t){for(var n=[],s=0;31>s;s++)n.push(t);return n}function Ls(t,n,s){t.pendingLanes|=n,n!==536870912&&(t.suspendedLanes=0,t.pingedLanes=0),t=t.eventTimes,n=31-rt(n),t[n]=s}function K0(t,n){var s=t.pendingLanes&~n;t.pendingLanes=n,t.suspendedLanes=0,t.pingedLanes=0,t.expiredLanes&=n,t.mutableReadLanes&=n,t.entangledLanes&=n,n=t.entanglements;var r=t.eventTimes;for(t=t.expirationTimes;0<s;){var a=31-rt(s),o=1<<a;n[a]=0,r[a]=-1,t[a]=-1,s&=~o}}function uc(t,n){var s=t.entangledLanes|=n;for(t=t.entanglements;s;){var r=31-rt(s),a=1<<r;a&n|t[r]&n&&(t[r]|=n),s&=~a}}var U=0;function kp(t){return t&=-t,1<t?4<t?t&268435455?16:536870912:4:1}var Pp,hc,Ep,Dp,Mp,hl=!1,sr=[],Yt=null,Kt=null,Xt=null,js=new Map,ws=new Map,Ut=[],X0="mousedown mouseup touchcancel touchend touchstart auxclick dblclick pointercancel pointerdown pointerup dragend dragstart drop compositionend compositionstart keydown keypress keyup input textInput copy cut paste click change contextmenu reset submit".split(" ");function au(t,n){switch(t){case"focusin":case"focusout":Yt=null;break;case"dragenter":case"dragleave":Kt=null;break;case"mouseover":case"mouseout":Xt=null;break;case"pointerover":case"pointerout":js.delete(n.pointerId);break;case"gotpointercapture":case"lostpointercapture":ws.delete(n.pointerId)}}function $i(t,n,s,r,a,o){return t===null||t.nativeEvent!==o?(t={blockedOn:n,domEventName:s,eventSystemFlags:r,nativeEvent:o,targetContainers:[a]},n!==null&&(n=Fs(n),n!==null&&hc(n)),t):(t.eventSystemFlags|=r,n=t.targetContainers,a!==null&&n.indexOf(a)===-1&&n.push(a),t)}function Z0(t,n,s,r,a){switch(n){case"focusin":return Yt=$i(Yt,t,n,s,r,a),!0;case"dragenter":return Kt=$i(Kt,t,n,s,r,a),!0;case"mouseover":return Xt=$i(Xt,t,n,s,r,a),!0;case"pointerover":var o=a.pointerId;return js.set(o,$i(js.get(o)||null,t,n,s,r,a)),!0;case"gotpointercapture":return o=a.pointerId,ws.set(o,$i(ws.get(o)||null,t,n,s,r,a)),!0}return!1}function Ap(t){var n=xn(t.target);if(n!==null){var s=Dn(n);if(s!==null){if(n=s.tag,n===13){if(n=wp(s),n!==null){t.blockedOn=n,Mp(t.priority,function(){Ep(s)});return}}else if(n===3&&s.stateNode.current.memoizedState.isDehydrated){t.blockedOn=s.tag===3?s.stateNode.containerInfo:null;return}}}t.blockedOn=null}function Er(t){if(t.blockedOn!==null)return!1;for(var n=t.targetContainers;0<n.length;){var s=fl(t.domEventName,t.eventSystemFlags,n[0],t.nativeEvent);if(s===null){s=t.nativeEvent;var r=new s.constructor(s.type,s);ol=r,s.target.dispatchEvent(r),ol=null}else return n=Fs(s),n!==null&&hc(n),t.blockedOn=s,!1;n.shift()}return!0}function ou(t,n,s){Er(t)&&s.delete(n)}function J0(){hl=!1,Yt!==null&&Er(Yt)&&(Yt=null),Kt!==null&&Er(Kt)&&(Kt=null),Xt!==null&&Er(Xt)&&(Xt=null),js.forEach(ou),ws.forEach(ou)}function Bi(t,n){t.blockedOn===n&&(t.blockedOn=null,hl||(hl=!0,Ne.unstable_scheduleCallback(Ne.unstable_NormalPriority,J0)))}function bs(t){function n(a){return Bi(a,t)}if(0<sr.length){Bi(sr[0],t);for(var s=1;s<sr.length;s++){var r=sr[s];r.blockedOn===t&&(r.blockedOn=null)}}for(Yt!==null&&Bi(Yt,t),Kt!==null&&Bi(Kt,t),Xt!==null&&Bi(Xt,t),js.forEach(n),ws.forEach(n),s=0;s<Ut.length;s++)r=Ut[s],r.blockedOn===t&&(r.blockedOn=null);for(;0<Ut.length&&(s=Ut[0],s.blockedOn===null);)Ap(s),s.blockedOn===null&&Ut.shift()}var di=zt.ReactCurrentBatchConfig,Kr=!0;function ey(t,n,s,r){var a=U,o=di.transition;di.transition=null;try{U=1,fc(t,n,s,r)}finally{U=a,di.transition=o}}function ty(t,n,s,r){var a=U,o=di.transition;di.transition=null;try{U=4,fc(t,n,s,r)}finally{U=a,di.transition=o}}function fc(t,n,s,r){if(Kr){var a=fl(t,n,s,r);if(a===null)jo(t,n,r,Xr,s),au(t,r);else if(Z0(a,t,n,s,r))r.stopPropagation();else if(au(t,r),n&4&&-1<X0.indexOf(t)){for(;a!==null;){var o=Fs(a);if(o!==null&&Pp(o),o=fl(t,n,s,r),o===null&&jo(t,n,r,Xr,s),o===a)break;a=o}a!==null&&r.stopPropagation()}else jo(t,n,r,null,s)}}var Xr=null;function fl(t,n,s,r){if(Xr=null,t=cc(r),t=xn(t),t!==null)if(n=Dn(t),n===null)t=null;else if(s=n.tag,s===13){if(t=wp(n),t!==null)return t;t=null}else if(s===3){if(n.stateNode.current.memoizedState.isDehydrated)return n.tag===3?n.stateNode.containerInfo:null;t=null}else n!==t&&(t=null);return Xr=t,null}function zp(t){switch(t){case"cancel":case"click":case"close":case"contextmenu":case"copy":case"cut":case"auxclick":case"dblclick":case"dragend":case"dragstart":case"drop":case"focusin":case"focusout":case"input":case"invalid":case"keydown":case"keypress":case"keyup":case"mousedown":case"mouseup":case"paste":case"pause":case"play":case"pointercancel":case"pointerdown":case"pointerup":case"ratechange":case"reset":case"resize":case"seeked":case"submit":case"touchcancel":case"touchend":case"touchstart":case"volumechange":case"change":case"selectionchange":case"textInput":case"compositionstart":case"compositionend":case"compositionupdate":case"beforeblur":case"afterblur":case"beforeinput":case"blur":case"fullscreenchange":case"focus":case"hashchange":case"popstate":case"select":case"selectstart":return 1;case"drag":case"dragenter":case"dragexit":case"dragleave":case"dragover":case"mousemove":case"mouseout":case"mouseover":case"pointermove":case"pointerout":case"pointerover":case"scroll":case"toggle":case"touchmove":case"wheel":case"mouseenter":case"mouseleave":case"pointerenter":case"pointerleave":return 4;case"message":switch(H0()){case dc:return 1;case Cp:return 4;case Qr:case V0:return 16;case Tp:return 536870912;default:return 16}default:return 16}}var Wt=null,pc=null,Dr=null;function Np(){if(Dr)return Dr;var t,n=pc,s=n.length,r,a="value"in Wt?Wt.value:Wt.textContent,o=a.length;for(t=0;t<s&&n[t]===a[t];t++);var d=s-t;for(r=1;r<=d&&n[s-r]===a[o-r];r++);return Dr=a.slice(t,1<r?1-r:void 0)}function Mr(t){var n=t.keyCode;return"charCode"in t?(t=t.charCode,t===0&&n===13&&(t=13)):t=n,t===10&&(t=13),32<=t||t===13?t:0}function rr(){return!0}function lu(){return!1}function Le(t){function n(s,r,a,o,d){this._reactName=s,this._targetInst=a,this.type=r,this.nativeEvent=o,this.target=d,this.currentTarget=null;for(var u in t)t.hasOwnProperty(u)&&(s=t[u],this[u]=s?s(o):o[u]);return this.isDefaultPrevented=(o.defaultPrevented!=null?o.defaultPrevented:o.returnValue===!1)?rr:lu,this.isPropagationStopped=lu,this}return te(n.prototype,{preventDefault:function(){this.defaultPrevented=!0;var s=this.nativeEvent;s&&(s.preventDefault?s.preventDefault():typeof s.returnValue!="unknown"&&(s.returnValue=!1),this.isDefaultPrevented=rr)},stopPropagation:function(){var s=this.nativeEvent;s&&(s.stopPropagation?s.stopPropagation():typeof s.cancelBubble!="unknown"&&(s.cancelBubble=!0),this.isPropagationStopped=rr)},persist:function(){},isPersistent:rr}),n}var ki={eventPhase:0,bubbles:0,cancelable:0,timeStamp:function(t){return t.timeStamp||Date.now()},defaultPrevented:0,isTrusted:0},mc=Le(ki),Os=te({},ki,{view:0,detail:0}),ny=Le(Os),uo,ho,Hi,wa=te({},Os,{screenX:0,screenY:0,clientX:0,clientY:0,pageX:0,pageY:0,ctrlKey:0,shiftKey:0,altKey:0,metaKey:0,getModifierState:gc,button:0,buttons:0,relatedTarget:function(t){return t.relatedTarget===void 0?t.fromElement===t.srcElement?t.toElement:t.fromElement:t.relatedTarget},movementX:function(t){return"movementX"in t?t.movementX:(t!==Hi&&(Hi&&t.type==="mousemove"?(uo=t.screenX-Hi.screenX,ho=t.screenY-Hi.screenY):ho=uo=0,Hi=t),uo)},movementY:function(t){return"movementY"in t?t.movementY:ho}}),cu=Le(wa),iy=te({},wa,{dataTransfer:0}),sy=Le(iy),ry=te({},Os,{relatedTarget:0}),fo=Le(ry),ay=te({},ki,{animationName:0,elapsedTime:0,pseudoElement:0}),oy=Le(ay),ly=te({},ki,{clipboardData:function(t){return"clipboardData"in t?t.clipboardData:window.clipboardData}}),cy=Le(ly),dy=te({},ki,{data:0}),du=Le(dy),uy={Esc:"Escape",Spacebar:" ",Left:"ArrowLeft",Up:"ArrowUp",Right:"ArrowRight",Down:"ArrowDown",Del:"Delete",Win:"OS",Menu:"ContextMenu",Apps:"ContextMenu",Scroll:"ScrollLock",MozPrintableKey:"Unidentified"},hy={8:"Backspace",9:"Tab",12:"Clear",13:"Enter",16:"Shift",17:"Control",18:"Alt",19:"Pause",20:"CapsLock",27:"Escape",32:" ",33:"PageUp",34:"PageDown",35:"End",36:"Home",37:"ArrowLeft",38:"ArrowUp",39:"ArrowRight",40:"ArrowDown",45:"Insert",46:"Delete",112:"F1",113:"F2",114:"F3",115:"F4",116:"F5",117:"F6",118:"F7",119:"F8",120:"F9",121:"F10",122:"F11",123:"F12",144:"NumLock",145:"ScrollLock",224:"Meta"},fy={Alt:"altKey",Control:"ctrlKey",Meta:"metaKey",Shift:"shiftKey"};function py(t){var n=this.nativeEvent;return n.getModifierState?n.getModifierState(t):(t=fy[t])?!!n[t]:!1}function gc(){return py}var my=te({},Os,{key:function(t){if(t.key){var n=uy[t.key]||t.key;if(n!=="Unidentified")return n}return t.type==="keypress"?(t=Mr(t),t===13?"Enter":String.fromCharCode(t)):t.type==="keydown"||t.type==="keyup"?hy[t.keyCode]||"Unidentified":""},code:0,location:0,ctrlKey:0,shiftKey:0,altKey:0,metaKey:0,repeat:0,locale:0,getModifierState:gc,charCode:function(t){return t.type==="keypress"?Mr(t):0},keyCode:function(t){return t.type==="keydown"||t.type==="keyup"?t.keyCode:0},which:function(t){return t.type==="keypress"?Mr(t):t.type==="keydown"||t.type==="keyup"?t.keyCode:0}}),gy=Le(my),xy=te({},wa,{pointerId:0,width:0,height:0,pressure:0,tangentialPressure:0,tiltX:0,tiltY:0,twist:0,pointerType:0,isPrimary:0}),uu=Le(xy),vy=te({},Os,{touches:0,targetTouches:0,changedTouches:0,altKey:0,metaKey:0,ctrlKey:0,shiftKey:0,getModifierState:gc}),yy=Le(vy),jy=te({},ki,{propertyName:0,elapsedTime:0,pseudoElement:0}),wy=Le(jy),by=te({},wa,{deltaX:function(t){return"deltaX"in t?t.deltaX:"wheelDeltaX"in t?-t.wheelDeltaX:0},deltaY:function(t){return"deltaY"in t?t.deltaY:"wheelDeltaY"in t?-t.wheelDeltaY:"wheelDelta"in t?-t.wheelDelta:0},deltaZ:0,deltaMode:0}),Sy=Le(by),Iy=[9,13,27,32],xc=Pt&&"CompositionEvent"in window,ds=null;Pt&&"documentMode"in document&&(ds=document.documentMode);var Cy=Pt&&"TextEvent"in window&&!ds,_p=Pt&&(!xc||ds&&8<ds&&11>=ds),hu=" ",fu=!1;function Lp(t,n){switch(t){case"keyup":return Iy.indexOf(n.keyCode)!==-1;case"keydown":return n.keyCode!==229;case"keypress":case"mousedown":case"focusout":return!0;default:return!1}}function Op(t){return t=t.detail,typeof t=="object"&&"data"in t?t.data:null}var Xn=!1;function Ty(t,n){switch(t){case"compositionend":return Op(n);case"keypress":return n.which!==32?null:(fu=!0,hu);case"textInput":return t=n.data,t===hu&&fu?null:t;default:return null}}function Ry(t,n){if(Xn)return t==="compositionend"||!xc&&Lp(t,n)?(t=Np(),Dr=pc=Wt=null,Xn=!1,t):null;switch(t){case"paste":return null;case"keypress":if(!(n.ctrlKey||n.altKey||n.metaKey)||n.ctrlKey&&n.altKey){if(n.char&&1<n.char.length)return n.char;if(n.which)return String.fromCharCode(n.which)}return null;case"compositionend":return _p&&n.locale!=="ko"?null:n.data;default:return null}}var ky={color:!0,date:!0,datetime:!0,"datetime-local":!0,email:!0,month:!0,number:!0,password:!0,range:!0,search:!0,tel:!0,text:!0,time:!0,url:!0,week:!0};function pu(t){var n=t&&t.nodeName&&t.nodeName.toLowerCase();return n==="input"?!!ky[t.type]:n==="textarea"}function Fp(t,n,s,r){gp(r),n=Zr(n,"onChange"),0<n.length&&(s=new mc("onChange","change",null,s,r),t.push({event:s,listeners:n}))}var us=null,Ss=null;function Py(t){Kp(t,0)}function ba(t){var n=ei(t);if(cp(n))return t}function Ey(t,n){if(t==="change")return n}var $p=!1;if(Pt){var po;if(Pt){var mo="oninput"in document;if(!mo){var mu=document.createElement("div");mu.setAttribute("oninput","return;"),mo=typeof mu.oninput=="function"}po=mo}else po=!1;$p=po&&(!document.documentMode||9<document.documentMode)}function gu(){us&&(us.detachEvent("onpropertychange",Bp),Ss=us=null)}function Bp(t){if(t.propertyName==="value"&&ba(Ss)){var n=[];Fp(n,Ss,t,cc(t)),jp(Py,n)}}function Dy(t,n,s){t==="focusin"?(gu(),us=n,Ss=s,us.attachEvent("onpropertychange",Bp)):t==="focusout"&&gu()}function My(t){if(t==="selectionchange"||t==="keyup"||t==="keydown")return ba(Ss)}function Ay(t,n){if(t==="click")return ba(n)}function zy(t,n){if(t==="input"||t==="change")return ba(n)}function Ny(t,n){return t===n&&(t!==0||1/t===1/n)||t!==t&&n!==n}var lt=typeof Object.is=="function"?Object.is:Ny;function Is(t,n){if(lt(t,n))return!0;if(typeof t!="object"||t===null||typeof n!="object"||n===null)return!1;var s=Object.keys(t),r=Object.keys(n);if(s.length!==r.length)return!1;for(r=0;r<s.length;r++){var a=s[r];if(!Yo.call(n,a)||!lt(t[a],n[a]))return!1}return!0}function xu(t){for(;t&&t.firstChild;)t=t.firstChild;return t}function vu(t,n){var s=xu(t);t=0;for(var r;s;){if(s.nodeType===3){if(r=t+s.textContent.length,t<=n&&r>=n)return{node:s,offset:n-t};t=r}e:{for(;s;){if(s.nextSibling){s=s.nextSibling;break e}s=s.parentNode}s=void 0}s=xu(s)}}function Hp(t,n){return t&&n?t===n?!0:t&&t.nodeType===3?!1:n&&n.nodeType===3?Hp(t,n.parentNode):"contains"in t?t.contains(n):t.compareDocumentPosition?!!(t.compareDocumentPosition(n)&16):!1:!1}function Vp(){for(var t=window,n=Ur();n instanceof t.HTMLIFrameElement;){try{var s=typeof n.contentWindow.location.href=="string"}catch{s=!1}if(s)t=n.contentWindow;else break;n=Ur(t.document)}return n}function vc(t){var n=t&&t.nodeName&&t.nodeName.toLowerCase();return n&&(n==="input"&&(t.type==="text"||t.type==="search"||t.type==="tel"||t.type==="url"||t.type==="password")||n==="textarea"||t.contentEditable==="true")}function _y(t){var n=Vp(),s=t.focusedElem,r=t.selectionRange;if(n!==s&&s&&s.ownerDocument&&Hp(s.ownerDocument.documentElement,s)){if(r!==null&&vc(s)){if(n=r.start,t=r.end,t===void 0&&(t=n),"selectionStart"in s)s.selectionStart=n,s.selectionEnd=Math.min(t,s.value.length);else if(t=(n=s.ownerDocument||document)&&n.defaultView||window,t.getSelection){t=t.getSelection();var a=s.textContent.length,o=Math.min(r.start,a);r=r.end===void 0?o:Math.min(r.end,a),!t.extend&&o>r&&(a=r,r=o,o=a),a=vu(s,o);var d=vu(s,r);a&&d&&(t.rangeCount!==1||t.anchorNode!==a.node||t.anchorOffset!==a.offset||t.focusNode!==d.node||t.focusOffset!==d.offset)&&(n=n.createRange(),n.setStart(a.node,a.offset),t.removeAllRanges(),o>r?(t.addRange(n),t.extend(d.node,d.offset)):(n.setEnd(d.node,d.offset),t.addRange(n)))}}for(n=[],t=s;t=t.parentNode;)t.nodeType===1&&n.push({element:t,left:t.scrollLeft,top:t.scrollTop});for(typeof s.focus=="function"&&s.focus(),s=0;s<n.length;s++)t=n[s],t.element.scrollLeft=t.left,t.element.scrollTop=t.top}}var Ly=Pt&&"documentMode"in document&&11>=document.documentMode,Zn=null,pl=null,hs=null,ml=!1;function yu(t,n,s){var r=s.window===s?s.document:s.nodeType===9?s:s.ownerDocument;ml||Zn==null||Zn!==Ur(r)||(r=Zn,"selectionStart"in r&&vc(r)?r={start:r.selectionStart,end:r.selectionEnd}:(r=(r.ownerDocument&&r.ownerDocument.defaultView||window).getSelection(),r={anchorNode:r.anchorNode,anchorOffset:r.anchorOffset,focusNode:r.focusNode,focusOffset:r.focusOffset}),hs&&Is(hs,r)||(hs=r,r=Zr(pl,"onSelect"),0<r.length&&(n=new mc("onSelect","select",null,n,s),t.push({event:n,listeners:r}),n.target=Zn)))}function ar(t,n){var s={};return s[t.toLowerCase()]=n.toLowerCase(),s["Webkit"+t]="webkit"+n,s["Moz"+t]="moz"+n,s}var Jn={animationend:ar("Animation","AnimationEnd"),animationiteration:ar("Animation","AnimationIteration"),animationstart:ar("Animation","AnimationStart"),transitionend:ar("Transition","TransitionEnd")},go={},Gp={};Pt&&(Gp=document.createElement("div").style,"AnimationEvent"in window||(delete Jn.animationend.animation,delete Jn.animationiteration.animation,delete Jn.animationstart.animation),"TransitionEvent"in window||delete Jn.transitionend.transition);function Sa(t){if(go[t])return go[t];if(!Jn[t])return t;var n=Jn[t],s;for(s in n)if(n.hasOwnProperty(s)&&s in Gp)return go[t]=n[s];return t}var Up=Sa("animationend"),qp=Sa("animationiteration"),Wp=Sa("animationstart"),Qp=Sa("transitionend"),Yp=new Map,ju="abort auxClick cancel canPlay canPlayThrough click close contextMenu copy cut drag dragEnd dragEnter dragExit dragLeave dragOver dragStart drop durationChange emptied encrypted ended error gotPointerCapture input invalid keyDown keyPress keyUp load loadedData loadedMetadata loadStart lostPointerCapture mouseDown mouseMove mouseOut mouseOver mouseUp paste pause play playing pointerCancel pointerDown pointerMove pointerOut pointerOver pointerUp progress rateChange reset resize seeked seeking stalled submit suspend timeUpdate touchCancel touchEnd touchStart volumeChange scroll toggle touchMove waiting wheel".split(" ");function on(t,n){Yp.set(t,n),En(n,[t])}for(var xo=0;xo<ju.length;xo++){var vo=ju[xo],Oy=vo.toLowerCase(),Fy=vo[0].toUpperCase()+vo.slice(1);on(Oy,"on"+Fy)}on(Up,"onAnimationEnd");on(qp,"onAnimationIteration");on(Wp,"onAnimationStart");on("dblclick","onDoubleClick");on("focusin","onFocus");on("focusout","onBlur");on(Qp,"onTransitionEnd");pi("onMouseEnter",["mouseout","mouseover"]);pi("onMouseLeave",["mouseout","mouseover"]);pi("onPointerEnter",["pointerout","pointerover"]);pi("onPointerLeave",["pointerout","pointerover"]);En("onChange","change click focusin focusout input keydown keyup selectionchange".split(" "));En("onSelect","focusout contextmenu dragend focusin keydown keyup mousedown mouseup selectionchange".split(" "));En("onBeforeInput",["compositionend","keypress","textInput","paste"]);En("onCompositionEnd","compositionend focusout keydown keypress keyup mousedown".split(" "));En("onCompositionStart","compositionstart focusout keydown keypress keyup mousedown".split(" "));En("onCompositionUpdate","compositionupdate focusout keydown keypress keyup mousedown".split(" "));var rs="abort canplay canplaythrough durationchange emptied encrypted ended error loadeddata loadedmetadata loadstart pause play playing progress ratechange resize seeked seeking stalled suspend timeupdate volumechange waiting".split(" "),$y=new Set("cancel close invalid load scroll toggle".split(" ").concat(rs));function wu(t,n,s){var r=t.type||"unknown-event";t.currentTarget=s,O0(r,n,void 0,t),t.currentTarget=null}function Kp(t,n){n=(n&4)!==0;for(var s=0;s<t.length;s++){var r=t[s],a=r.event;r=r.listeners;e:{var o=void 0;if(n)for(var d=r.length-1;0<=d;d--){var u=r[d],h=u.instance,p=u.currentTarget;if(u=u.listener,h!==o&&a.isPropagationStopped())break e;wu(a,u,p),o=h}else for(d=0;d<r.length;d++){if(u=r[d],h=u.instance,p=u.currentTarget,u=u.listener,h!==o&&a.isPropagationStopped())break e;wu(a,u,p),o=h}}}if(Wr)throw t=dl,Wr=!1,dl=null,t}function Q(t,n){var s=n[jl];s===void 0&&(s=n[jl]=new Set);var r=t+"__bubble";s.has(r)||(Xp(n,t,2,!1),s.add(r))}function yo(t,n,s){var r=0;n&&(r|=4),Xp(s,t,r,n)}var or="_reactListening"+Math.random().toString(36).slice(2);function Cs(t){if(!t[or]){t[or]=!0,sp.forEach(function(s){s!=="selectionchange"&&($y.has(s)||yo(s,!1,t),yo(s,!0,t))});var n=t.nodeType===9?t:t.ownerDocument;n===null||n[or]||(n[or]=!0,yo("selectionchange",!1,n))}}function Xp(t,n,s,r){switch(zp(n)){case 1:var a=ey;break;case 4:a=ty;break;default:a=fc}s=a.bind(null,n,s,t),a=void 0,!cl||n!=="touchstart"&&n!=="touchmove"&&n!=="wheel"||(a=!0),r?a!==void 0?t.addEventListener(n,s,{capture:!0,passive:a}):t.addEventListener(n,s,!0):a!==void 0?t.addEventListener(n,s,{passive:a}):t.addEventListener(n,s,!1)}function jo(t,n,s,r,a){var o=r;if(!(n&1)&&!(n&2)&&r!==null)e:for(;;){if(r===null)return;var d=r.tag;if(d===3||d===4){var u=r.stateNode.containerInfo;if(u===a||u.nodeType===8&&u.parentNode===a)break;if(d===4)for(d=r.return;d!==null;){var h=d.tag;if((h===3||h===4)&&(h=d.stateNode.containerInfo,h===a||h.nodeType===8&&h.parentNode===a))return;d=d.return}for(;u!==null;){if(d=xn(u),d===null)return;if(h=d.tag,h===5||h===6){r=o=d;continue e}u=u.parentNode}}r=r.return}jp(function(){var p=o,m=cc(s),g=[];e:{var x=Yp.get(t);if(x!==void 0){var j=mc,I=t;switch(t){case"keypress":if(Mr(s)===0)break e;case"keydown":case"keyup":j=gy;break;case"focusin":I="focus",j=fo;break;case"focusout":I="blur",j=fo;break;case"beforeblur":case"afterblur":j=fo;break;case"click":if(s.button===2)break e;case"auxclick":case"dblclick":case"mousedown":case"mousemove":case"mouseup":case"mouseout":case"mouseover":case"contextmenu":j=cu;break;case"drag":case"dragend":case"dragenter":case"dragexit":case"dragleave":case"dragover":case"dragstart":case"drop":j=sy;break;case"touchcancel":case"touchend":case"touchmove":case"touchstart":j=yy;break;case Up:case qp:case Wp:j=oy;break;case Qp:j=wy;break;case"scroll":j=ny;break;case"wheel":j=Sy;break;case"copy":case"cut":case"paste":j=cy;break;case"gotpointercapture":case"lostpointercapture":case"pointercancel":case"pointerdown":case"pointermove":case"pointerout":case"pointerover":case"pointerup":j=uu}var S=(n&4)!==0,T=!S&&t==="scroll",w=S?x!==null?x+"Capture":null:x;S=[];for(var y=p,b;y!==null;){b=y;var C=b.stateNode;if(b.tag===5&&C!==null&&(b=C,w!==null&&(C=ys(y,w),C!=null&&S.push(Ts(y,C,b)))),T)break;y=y.return}0<S.length&&(x=new j(x,I,null,s,m),g.push({event:x,listeners:S}))}}if(!(n&7)){e:{if(x=t==="mouseover"||t==="pointerover",j=t==="mouseout"||t==="pointerout",x&&s!==ol&&(I=s.relatedTarget||s.fromElement)&&(xn(I)||I[Et]))break e;if((j||x)&&(x=m.window===m?m:(x=m.ownerDocument)?x.defaultView||x.parentWindow:window,j?(I=s.relatedTarget||s.toElement,j=p,I=I?xn(I):null,I!==null&&(T=Dn(I),I!==T||I.tag!==5&&I.tag!==6)&&(I=null)):(j=null,I=p),j!==I)){if(S=cu,C="onMouseLeave",w="onMouseEnter",y="mouse",(t==="pointerout"||t==="pointerover")&&(S=uu,C="onPointerLeave",w="onPointerEnter",y="pointer"),T=j==null?x:ei(j),b=I==null?x:ei(I),x=new S(C,y+"leave",j,s,m),x.target=T,x.relatedTarget=b,C=null,xn(m)===p&&(S=new S(w,y+"enter",I,s,m),S.target=b,S.relatedTarget=T,C=S),T=C,j&&I)t:{for(S=j,w=I,y=0,b=S;b;b=Ln(b))y++;for(b=0,C=w;C;C=Ln(C))b++;for(;0<y-b;)S=Ln(S),y--;for(;0<b-y;)w=Ln(w),b--;for(;y--;){if(S===w||w!==null&&S===w.alternate)break t;S=Ln(S),w=Ln(w)}S=null}else S=null;j!==null&&bu(g,x,j,S,!1),I!==null&&T!==null&&bu(g,T,I,S,!0)}}e:{if(x=p?ei(p):window,j=x.nodeName&&x.nodeName.toLowerCase(),j==="select"||j==="input"&&x.type==="file")var R=Ey;else if(pu(x))if($p)R=zy;else{R=My;var D=Dy}else(j=x.nodeName)&&j.toLowerCase()==="input"&&(x.type==="checkbox"||x.type==="radio")&&(R=Ay);if(R&&(R=R(t,p))){Fp(g,R,s,m);break e}D&&D(t,x,p),t==="focusout"&&(D=x._wrapperState)&&D.controlled&&x.type==="number"&&nl(x,"number",x.value)}switch(D=p?ei(p):window,t){case"focusin":(pu(D)||D.contentEditable==="true")&&(Zn=D,pl=p,hs=null);break;case"focusout":hs=pl=Zn=null;break;case"mousedown":ml=!0;break;case"contextmenu":case"mouseup":case"dragend":ml=!1,yu(g,s,m);break;case"selectionchange":if(Ly)break;case"keydown":case"keyup":yu(g,s,m)}var k;if(xc)e:{switch(t){case"compositionstart":var P="onCompositionStart";break e;case"compositionend":P="onCompositionEnd";break e;case"compositionupdate":P="onCompositionUpdate";break e}P=void 0}else Xn?Lp(t,s)&&(P="onCompositionEnd"):t==="keydown"&&s.keyCode===229&&(P="onCompositionStart");P&&(_p&&s.locale!=="ko"&&(Xn||P!=="onCompositionStart"?P==="onCompositionEnd"&&Xn&&(k=Np()):(Wt=m,pc="value"in Wt?Wt.value:Wt.textContent,Xn=!0)),D=Zr(p,P),0<D.length&&(P=new du(P,t,null,s,m),g.push({event:P,listeners:D}),k?P.data=k:(k=Op(s),k!==null&&(P.data=k)))),(k=Cy?Ty(t,s):Ry(t,s))&&(p=Zr(p,"onBeforeInput"),0<p.length&&(m=new du("onBeforeInput","beforeinput",null,s,m),g.push({event:m,listeners:p}),m.data=k))}Kp(g,n)})}function Ts(t,n,s){return{instance:t,listener:n,currentTarget:s}}function Zr(t,n){for(var s=n+"Capture",r=[];t!==null;){var a=t,o=a.stateNode;a.tag===5&&o!==null&&(a=o,o=ys(t,s),o!=null&&r.unshift(Ts(t,o,a)),o=ys(t,n),o!=null&&r.push(Ts(t,o,a))),t=t.return}return r}function Ln(t){if(t===null)return null;do t=t.return;while(t&&t.tag!==5);return t||null}function bu(t,n,s,r,a){for(var o=n._reactName,d=[];s!==null&&s!==r;){var u=s,h=u.alternate,p=u.stateNode;if(h!==null&&h===r)break;u.tag===5&&p!==null&&(u=p,a?(h=ys(s,o),h!=null&&d.unshift(Ts(s,h,u))):a||(h=ys(s,o),h!=null&&d.push(Ts(s,h,u)))),s=s.return}d.length!==0&&t.push({event:n,listeners:d})}var By=/\r\n?/g,Hy=/\u0000|\uFFFD/g;function Su(t){return(typeof t=="string"?t:""+t).replace(By,`
`).replace(Hy,"")}function lr(t,n,s){if(n=Su(n),Su(t)!==n&&s)throw Error(M(425))}function Jr(){}var gl=null,xl=null;function vl(t,n){return t==="textarea"||t==="noscript"||typeof n.children=="string"||typeof n.children=="number"||typeof n.dangerouslySetInnerHTML=="object"&&n.dangerouslySetInnerHTML!==null&&n.dangerouslySetInnerHTML.__html!=null}var yl=typeof setTimeout=="function"?setTimeout:void 0,Vy=typeof clearTimeout=="function"?clearTimeout:void 0,Iu=typeof Promise=="function"?Promise:void 0,Gy=typeof queueMicrotask=="function"?queueMicrotask:typeof Iu<"u"?function(t){return Iu.resolve(null).then(t).catch(Uy)}:yl;function Uy(t){setTimeout(function(){throw t})}function wo(t,n){var s=n,r=0;do{var a=s.nextSibling;if(t.removeChild(s),a&&a.nodeType===8)if(s=a.data,s==="/$"){if(r===0){t.removeChild(a),bs(n);return}r--}else s!=="$"&&s!=="$?"&&s!=="$!"||r++;s=a}while(s);bs(n)}function Zt(t){for(;t!=null;t=t.nextSibling){var n=t.nodeType;if(n===1||n===3)break;if(n===8){if(n=t.data,n==="$"||n==="$!"||n==="$?")break;if(n==="/$")return null}}return t}function Cu(t){t=t.previousSibling;for(var n=0;t;){if(t.nodeType===8){var s=t.data;if(s==="$"||s==="$!"||s==="$?"){if(n===0)return t;n--}else s==="/$"&&n++}t=t.previousSibling}return null}var Pi=Math.random().toString(36).slice(2),ht="__reactFiber$"+Pi,Rs="__reactProps$"+Pi,Et="__reactContainer$"+Pi,jl="__reactEvents$"+Pi,qy="__reactListeners$"+Pi,Wy="__reactHandles$"+Pi;function xn(t){var n=t[ht];if(n)return n;for(var s=t.parentNode;s;){if(n=s[Et]||s[ht]){if(s=n.alternate,n.child!==null||s!==null&&s.child!==null)for(t=Cu(t);t!==null;){if(s=t[ht])return s;t=Cu(t)}return n}t=s,s=t.parentNode}return null}function Fs(t){return t=t[ht]||t[Et],!t||t.tag!==5&&t.tag!==6&&t.tag!==13&&t.tag!==3?null:t}function ei(t){if(t.tag===5||t.tag===6)return t.stateNode;throw Error(M(33))}function Ia(t){return t[Rs]||null}var wl=[],ti=-1;function ln(t){return{current:t}}function Y(t){0>ti||(t.current=wl[ti],wl[ti]=null,ti--)}function W(t,n){ti++,wl[ti]=t.current,t.current=n}var rn={},je=ln(rn),ke=ln(!1),Sn=rn;function mi(t,n){var s=t.type.contextTypes;if(!s)return rn;var r=t.stateNode;if(r&&r.__reactInternalMemoizedUnmaskedChildContext===n)return r.__reactInternalMemoizedMaskedChildContext;var a={},o;for(o in s)a[o]=n[o];return r&&(t=t.stateNode,t.__reactInternalMemoizedUnmaskedChildContext=n,t.__reactInternalMemoizedMaskedChildContext=a),a}function Pe(t){return t=t.childContextTypes,t!=null}function ea(){Y(ke),Y(je)}function Tu(t,n,s){if(je.current!==rn)throw Error(M(168));W(je,n),W(ke,s)}function Zp(t,n,s){var r=t.stateNode;if(n=n.childContextTypes,typeof r.getChildContext!="function")return s;r=r.getChildContext();for(var a in r)if(!(a in n))throw Error(M(108,D0(t)||"Unknown",a));return te({},s,r)}function ta(t){return t=(t=t.stateNode)&&t.__reactInternalMemoizedMergedChildContext||rn,Sn=je.current,W(je,t),W(ke,ke.current),!0}function Ru(t,n,s){var r=t.stateNode;if(!r)throw Error(M(169));s?(t=Zp(t,n,Sn),r.__reactInternalMemoizedMergedChildContext=t,Y(ke),Y(je),W(je,t)):Y(ke),W(ke,s)}var It=null,Ca=!1,bo=!1;function Jp(t){It===null?It=[t]:It.push(t)}function Qy(t){Ca=!0,Jp(t)}function cn(){if(!bo&&It!==null){bo=!0;var t=0,n=U;try{var s=It;for(U=1;t<s.length;t++){var r=s[t];do r=r(!0);while(r!==null)}It=null,Ca=!1}catch(a){throw It!==null&&(It=It.slice(t+1)),Ip(dc,cn),a}finally{U=n,bo=!1}}return null}var ni=[],ii=0,na=null,ia=0,Fe=[],$e=0,In=null,Ct=1,Tt="";function hn(t,n){ni[ii++]=ia,ni[ii++]=na,na=t,ia=n}function em(t,n,s){Fe[$e++]=Ct,Fe[$e++]=Tt,Fe[$e++]=In,In=t;var r=Ct;t=Tt;var a=32-rt(r)-1;r&=~(1<<a),s+=1;var o=32-rt(n)+a;if(30<o){var d=a-a%5;o=(r&(1<<d)-1).toString(32),r>>=d,a-=d,Ct=1<<32-rt(n)+a|s<<a|r,Tt=o+t}else Ct=1<<o|s<<a|r,Tt=t}function yc(t){t.return!==null&&(hn(t,1),em(t,1,0))}function jc(t){for(;t===na;)na=ni[--ii],ni[ii]=null,ia=ni[--ii],ni[ii]=null;for(;t===In;)In=Fe[--$e],Fe[$e]=null,Tt=Fe[--$e],Fe[$e]=null,Ct=Fe[--$e],Fe[$e]=null}var ze=null,Ae=null,K=!1,tt=null;function tm(t,n){var s=Ve(5,null,null,0);s.elementType="DELETED",s.stateNode=n,s.return=t,n=t.deletions,n===null?(t.deletions=[s],t.flags|=16):n.push(s)}function ku(t,n){switch(t.tag){case 5:var s=t.type;return n=n.nodeType!==1||s.toLowerCase()!==n.nodeName.toLowerCase()?null:n,n!==null?(t.stateNode=n,ze=t,Ae=Zt(n.firstChild),!0):!1;case 6:return n=t.pendingProps===""||n.nodeType!==3?null:n,n!==null?(t.stateNode=n,ze=t,Ae=null,!0):!1;case 13:return n=n.nodeType!==8?null:n,n!==null?(s=In!==null?{id:Ct,overflow:Tt}:null,t.memoizedState={dehydrated:n,treeContext:s,retryLane:1073741824},s=Ve(18,null,null,0),s.stateNode=n,s.return=t,t.child=s,ze=t,Ae=null,!0):!1;default:return!1}}function bl(t){return(t.mode&1)!==0&&(t.flags&128)===0}function Sl(t){if(K){var n=Ae;if(n){var s=n;if(!ku(t,n)){if(bl(t))throw Error(M(418));n=Zt(s.nextSibling);var r=ze;n&&ku(t,n)?tm(r,s):(t.flags=t.flags&-4097|2,K=!1,ze=t)}}else{if(bl(t))throw Error(M(418));t.flags=t.flags&-4097|2,K=!1,ze=t}}}function Pu(t){for(t=t.return;t!==null&&t.tag!==5&&t.tag!==3&&t.tag!==13;)t=t.return;ze=t}function cr(t){if(t!==ze)return!1;if(!K)return Pu(t),K=!0,!1;var n;if((n=t.tag!==3)&&!(n=t.tag!==5)&&(n=t.type,n=n!=="head"&&n!=="body"&&!vl(t.type,t.memoizedProps)),n&&(n=Ae)){if(bl(t))throw nm(),Error(M(418));for(;n;)tm(t,n),n=Zt(n.nextSibling)}if(Pu(t),t.tag===13){if(t=t.memoizedState,t=t!==null?t.dehydrated:null,!t)throw Error(M(317));e:{for(t=t.nextSibling,n=0;t;){if(t.nodeType===8){var s=t.data;if(s==="/$"){if(n===0){Ae=Zt(t.nextSibling);break e}n--}else s!=="$"&&s!=="$!"&&s!=="$?"||n++}t=t.nextSibling}Ae=null}}else Ae=ze?Zt(t.stateNode.nextSibling):null;return!0}function nm(){for(var t=Ae;t;)t=Zt(t.nextSibling)}function gi(){Ae=ze=null,K=!1}function wc(t){tt===null?tt=[t]:tt.push(t)}var Yy=zt.ReactCurrentBatchConfig;function Vi(t,n,s){if(t=s.ref,t!==null&&typeof t!="function"&&typeof t!="object"){if(s._owner){if(s=s._owner,s){if(s.tag!==1)throw Error(M(309));var r=s.stateNode}if(!r)throw Error(M(147,t));var a=r,o=""+t;return n!==null&&n.ref!==null&&typeof n.ref=="function"&&n.ref._stringRef===o?n.ref:(n=function(d){var u=a.refs;d===null?delete u[o]:u[o]=d},n._stringRef=o,n)}if(typeof t!="string")throw Error(M(284));if(!s._owner)throw Error(M(290,t))}return t}function dr(t,n){throw t=Object.prototype.toString.call(n),Error(M(31,t==="[object Object]"?"object with keys {"+Object.keys(n).join(", ")+"}":t))}function Eu(t){var n=t._init;return n(t._payload)}function im(t){function n(w,y){if(t){var b=w.deletions;b===null?(w.deletions=[y],w.flags|=16):b.push(y)}}function s(w,y){if(!t)return null;for(;y!==null;)n(w,y),y=y.sibling;return null}function r(w,y){for(w=new Map;y!==null;)y.key!==null?w.set(y.key,y):w.set(y.index,y),y=y.sibling;return w}function a(w,y){return w=nn(w,y),w.index=0,w.sibling=null,w}function o(w,y,b){return w.index=b,t?(b=w.alternate,b!==null?(b=b.index,b<y?(w.flags|=2,y):b):(w.flags|=2,y)):(w.flags|=1048576,y)}function d(w){return t&&w.alternate===null&&(w.flags|=2),w}function u(w,y,b,C){return y===null||y.tag!==6?(y=Po(b,w.mode,C),y.return=w,y):(y=a(y,b),y.return=w,y)}function h(w,y,b,C){var R=b.type;return R===Kn?m(w,y,b.props.children,C,b.key):y!==null&&(y.elementType===R||typeof R=="object"&&R!==null&&R.$$typeof===Vt&&Eu(R)===y.type)?(C=a(y,b.props),C.ref=Vi(w,y,b),C.return=w,C):(C=Fr(b.type,b.key,b.props,null,w.mode,C),C.ref=Vi(w,y,b),C.return=w,C)}function p(w,y,b,C){return y===null||y.tag!==4||y.stateNode.containerInfo!==b.containerInfo||y.stateNode.implementation!==b.implementation?(y=Eo(b,w.mode,C),y.return=w,y):(y=a(y,b.children||[]),y.return=w,y)}function m(w,y,b,C,R){return y===null||y.tag!==7?(y=wn(b,w.mode,C,R),y.return=w,y):(y=a(y,b),y.return=w,y)}function g(w,y,b){if(typeof y=="string"&&y!==""||typeof y=="number")return y=Po(""+y,w.mode,b),y.return=w,y;if(typeof y=="object"&&y!==null){switch(y.$$typeof){case Js:return b=Fr(y.type,y.key,y.props,null,w.mode,b),b.ref=Vi(w,null,y),b.return=w,b;case Yn:return y=Eo(y,w.mode,b),y.return=w,y;case Vt:var C=y._init;return g(w,C(y._payload),b)}if(is(y)||Oi(y))return y=wn(y,w.mode,b,null),y.return=w,y;dr(w,y)}return null}function x(w,y,b,C){var R=y!==null?y.key:null;if(typeof b=="string"&&b!==""||typeof b=="number")return R!==null?null:u(w,y,""+b,C);if(typeof b=="object"&&b!==null){switch(b.$$typeof){case Js:return b.key===R?h(w,y,b,C):null;case Yn:return b.key===R?p(w,y,b,C):null;case Vt:return R=b._init,x(w,y,R(b._payload),C)}if(is(b)||Oi(b))return R!==null?null:m(w,y,b,C,null);dr(w,b)}return null}function j(w,y,b,C,R){if(typeof C=="string"&&C!==""||typeof C=="number")return w=w.get(b)||null,u(y,w,""+C,R);if(typeof C=="object"&&C!==null){switch(C.$$typeof){case Js:return w=w.get(C.key===null?b:C.key)||null,h(y,w,C,R);case Yn:return w=w.get(C.key===null?b:C.key)||null,p(y,w,C,R);case Vt:var D=C._init;return j(w,y,b,D(C._payload),R)}if(is(C)||Oi(C))return w=w.get(b)||null,m(y,w,C,R,null);dr(y,C)}return null}function I(w,y,b,C){for(var R=null,D=null,k=y,P=y=0,z=null;k!==null&&P<b.length;P++){k.index>P?(z=k,k=null):z=k.sibling;var _=x(w,k,b[P],C);if(_===null){k===null&&(k=z);break}t&&k&&_.alternate===null&&n(w,k),y=o(_,y,P),D===null?R=_:D.sibling=_,D=_,k=z}if(P===b.length)return s(w,k),K&&hn(w,P),R;if(k===null){for(;P<b.length;P++)k=g(w,b[P],C),k!==null&&(y=o(k,y,P),D===null?R=k:D.sibling=k,D=k);return K&&hn(w,P),R}for(k=r(w,k);P<b.length;P++)z=j(k,w,P,b[P],C),z!==null&&(t&&z.alternate!==null&&k.delete(z.key===null?P:z.key),y=o(z,y,P),D===null?R=z:D.sibling=z,D=z);return t&&k.forEach(function(q){return n(w,q)}),K&&hn(w,P),R}function S(w,y,b,C){var R=Oi(b);if(typeof R!="function")throw Error(M(150));if(b=R.call(b),b==null)throw Error(M(151));for(var D=R=null,k=y,P=y=0,z=null,_=b.next();k!==null&&!_.done;P++,_=b.next()){k.index>P?(z=k,k=null):z=k.sibling;var q=x(w,k,_.value,C);if(q===null){k===null&&(k=z);break}t&&k&&q.alternate===null&&n(w,k),y=o(q,y,P),D===null?R=q:D.sibling=q,D=q,k=z}if(_.done)return s(w,k),K&&hn(w,P),R;if(k===null){for(;!_.done;P++,_=b.next())_=g(w,_.value,C),_!==null&&(y=o(_,y,P),D===null?R=_:D.sibling=_,D=_);return K&&hn(w,P),R}for(k=r(w,k);!_.done;P++,_=b.next())_=j(k,w,P,_.value,C),_!==null&&(t&&_.alternate!==null&&k.delete(_.key===null?P:_.key),y=o(_,y,P),D===null?R=_:D.sibling=_,D=_);return t&&k.forEach(function(oe){return n(w,oe)}),K&&hn(w,P),R}function T(w,y,b,C){if(typeof b=="object"&&b!==null&&b.type===Kn&&b.key===null&&(b=b.props.children),typeof b=="object"&&b!==null){switch(b.$$typeof){case Js:e:{for(var R=b.key,D=y;D!==null;){if(D.key===R){if(R=b.type,R===Kn){if(D.tag===7){s(w,D.sibling),y=a(D,b.props.children),y.return=w,w=y;break e}}else if(D.elementType===R||typeof R=="object"&&R!==null&&R.$$typeof===Vt&&Eu(R)===D.type){s(w,D.sibling),y=a(D,b.props),y.ref=Vi(w,D,b),y.return=w,w=y;break e}s(w,D);break}else n(w,D);D=D.sibling}b.type===Kn?(y=wn(b.props.children,w.mode,C,b.key),y.return=w,w=y):(C=Fr(b.type,b.key,b.props,null,w.mode,C),C.ref=Vi(w,y,b),C.return=w,w=C)}return d(w);case Yn:e:{for(D=b.key;y!==null;){if(y.key===D)if(y.tag===4&&y.stateNode.containerInfo===b.containerInfo&&y.stateNode.implementation===b.implementation){s(w,y.sibling),y=a(y,b.children||[]),y.return=w,w=y;break e}else{s(w,y);break}else n(w,y);y=y.sibling}y=Eo(b,w.mode,C),y.return=w,w=y}return d(w);case Vt:return D=b._init,T(w,y,D(b._payload),C)}if(is(b))return I(w,y,b,C);if(Oi(b))return S(w,y,b,C);dr(w,b)}return typeof b=="string"&&b!==""||typeof b=="number"?(b=""+b,y!==null&&y.tag===6?(s(w,y.sibling),y=a(y,b),y.return=w,w=y):(s(w,y),y=Po(b,w.mode,C),y.return=w,w=y),d(w)):s(w,y)}return T}var xi=im(!0),sm=im(!1),sa=ln(null),ra=null,si=null,bc=null;function Sc(){bc=si=ra=null}function Ic(t){var n=sa.current;Y(sa),t._currentValue=n}function Il(t,n,s){for(;t!==null;){var r=t.alternate;if((t.childLanes&n)!==n?(t.childLanes|=n,r!==null&&(r.childLanes|=n)):r!==null&&(r.childLanes&n)!==n&&(r.childLanes|=n),t===s)break;t=t.return}}function ui(t,n){ra=t,bc=si=null,t=t.dependencies,t!==null&&t.firstContext!==null&&(t.lanes&n&&(Re=!0),t.firstContext=null)}function Ue(t){var n=t._currentValue;if(bc!==t)if(t={context:t,memoizedValue:n,next:null},si===null){if(ra===null)throw Error(M(308));si=t,ra.dependencies={lanes:0,firstContext:t}}else si=si.next=t;return n}var vn=null;function Cc(t){vn===null?vn=[t]:vn.push(t)}function rm(t,n,s,r){var a=n.interleaved;return a===null?(s.next=s,Cc(n)):(s.next=a.next,a.next=s),n.interleaved=s,Dt(t,r)}function Dt(t,n){t.lanes|=n;var s=t.alternate;for(s!==null&&(s.lanes|=n),s=t,t=t.return;t!==null;)t.childLanes|=n,s=t.alternate,s!==null&&(s.childLanes|=n),s=t,t=t.return;return s.tag===3?s.stateNode:null}var Gt=!1;function Tc(t){t.updateQueue={baseState:t.memoizedState,firstBaseUpdate:null,lastBaseUpdate:null,shared:{pending:null,interleaved:null,lanes:0},effects:null}}function am(t,n){t=t.updateQueue,n.updateQueue===t&&(n.updateQueue={baseState:t.baseState,firstBaseUpdate:t.firstBaseUpdate,lastBaseUpdate:t.lastBaseUpdate,shared:t.shared,effects:t.effects})}function Rt(t,n){return{eventTime:t,lane:n,tag:0,payload:null,callback:null,next:null}}function Jt(t,n,s){var r=t.updateQueue;if(r===null)return null;if(r=r.shared,V&2){var a=r.pending;return a===null?n.next=n:(n.next=a.next,a.next=n),r.pending=n,Dt(t,s)}return a=r.interleaved,a===null?(n.next=n,Cc(r)):(n.next=a.next,a.next=n),r.interleaved=n,Dt(t,s)}function Ar(t,n,s){if(n=n.updateQueue,n!==null&&(n=n.shared,(s&4194240)!==0)){var r=n.lanes;r&=t.pendingLanes,s|=r,n.lanes=s,uc(t,s)}}function Du(t,n){var s=t.updateQueue,r=t.alternate;if(r!==null&&(r=r.updateQueue,s===r)){var a=null,o=null;if(s=s.firstBaseUpdate,s!==null){do{var d={eventTime:s.eventTime,lane:s.lane,tag:s.tag,payload:s.payload,callback:s.callback,next:null};o===null?a=o=d:o=o.next=d,s=s.next}while(s!==null);o===null?a=o=n:o=o.next=n}else a=o=n;s={baseState:r.baseState,firstBaseUpdate:a,lastBaseUpdate:o,shared:r.shared,effects:r.effects},t.updateQueue=s;return}t=s.lastBaseUpdate,t===null?s.firstBaseUpdate=n:t.next=n,s.lastBaseUpdate=n}function aa(t,n,s,r){var a=t.updateQueue;Gt=!1;var o=a.firstBaseUpdate,d=a.lastBaseUpdate,u=a.shared.pending;if(u!==null){a.shared.pending=null;var h=u,p=h.next;h.next=null,d===null?o=p:d.next=p,d=h;var m=t.alternate;m!==null&&(m=m.updateQueue,u=m.lastBaseUpdate,u!==d&&(u===null?m.firstBaseUpdate=p:u.next=p,m.lastBaseUpdate=h))}if(o!==null){var g=a.baseState;d=0,m=p=h=null,u=o;do{var x=u.lane,j=u.eventTime;if((r&x)===x){m!==null&&(m=m.next={eventTime:j,lane:0,tag:u.tag,payload:u.payload,callback:u.callback,next:null});e:{var I=t,S=u;switch(x=n,j=s,S.tag){case 1:if(I=S.payload,typeof I=="function"){g=I.call(j,g,x);break e}g=I;break e;case 3:I.flags=I.flags&-65537|128;case 0:if(I=S.payload,x=typeof I=="function"?I.call(j,g,x):I,x==null)break e;g=te({},g,x);break e;case 2:Gt=!0}}u.callback!==null&&u.lane!==0&&(t.flags|=64,x=a.effects,x===null?a.effects=[u]:x.push(u))}else j={eventTime:j,lane:x,tag:u.tag,payload:u.payload,callback:u.callback,next:null},m===null?(p=m=j,h=g):m=m.next=j,d|=x;if(u=u.next,u===null){if(u=a.shared.pending,u===null)break;x=u,u=x.next,x.next=null,a.lastBaseUpdate=x,a.shared.pending=null}}while(!0);if(m===null&&(h=g),a.baseState=h,a.firstBaseUpdate=p,a.lastBaseUpdate=m,n=a.shared.interleaved,n!==null){a=n;do d|=a.lane,a=a.next;while(a!==n)}else o===null&&(a.shared.lanes=0);Tn|=d,t.lanes=d,t.memoizedState=g}}function Mu(t,n,s){if(t=n.effects,n.effects=null,t!==null)for(n=0;n<t.length;n++){var r=t[n],a=r.callback;if(a!==null){if(r.callback=null,r=s,typeof a!="function")throw Error(M(191,a));a.call(r)}}}var $s={},mt=ln($s),ks=ln($s),Ps=ln($s);function yn(t){if(t===$s)throw Error(M(174));return t}function Rc(t,n){switch(W(Ps,n),W(ks,t),W(mt,$s),t=n.nodeType,t){case 9:case 11:n=(n=n.documentElement)?n.namespaceURI:sl(null,"");break;default:t=t===8?n.parentNode:n,n=t.namespaceURI||null,t=t.tagName,n=sl(n,t)}Y(mt),W(mt,n)}function vi(){Y(mt),Y(ks),Y(Ps)}function om(t){yn(Ps.current);var n=yn(mt.current),s=sl(n,t.type);n!==s&&(W(ks,t),W(mt,s))}function kc(t){ks.current===t&&(Y(mt),Y(ks))}var Z=ln(0);function oa(t){for(var n=t;n!==null;){if(n.tag===13){var s=n.memoizedState;if(s!==null&&(s=s.dehydrated,s===null||s.data==="$?"||s.data==="$!"))return n}else if(n.tag===19&&n.memoizedProps.revealOrder!==void 0){if(n.flags&128)return n}else if(n.child!==null){n.child.return=n,n=n.child;continue}if(n===t)break;for(;n.sibling===null;){if(n.return===null||n.return===t)return null;n=n.return}n.sibling.return=n.return,n=n.sibling}return null}var So=[];function Pc(){for(var t=0;t<So.length;t++)So[t]._workInProgressVersionPrimary=null;So.length=0}var zr=zt.ReactCurrentDispatcher,Io=zt.ReactCurrentBatchConfig,Cn=0,J=null,le=null,de=null,la=!1,fs=!1,Es=0,Ky=0;function xe(){throw Error(M(321))}function Ec(t,n){if(n===null)return!1;for(var s=0;s<n.length&&s<t.length;s++)if(!lt(t[s],n[s]))return!1;return!0}function Dc(t,n,s,r,a,o){if(Cn=o,J=n,n.memoizedState=null,n.updateQueue=null,n.lanes=0,zr.current=t===null||t.memoizedState===null?ej:tj,t=s(r,a),fs){o=0;do{if(fs=!1,Es=0,25<=o)throw Error(M(301));o+=1,de=le=null,n.updateQueue=null,zr.current=nj,t=s(r,a)}while(fs)}if(zr.current=ca,n=le!==null&&le.next!==null,Cn=0,de=le=J=null,la=!1,n)throw Error(M(300));return t}function Mc(){var t=Es!==0;return Es=0,t}function dt(){var t={memoizedState:null,baseState:null,baseQueue:null,queue:null,next:null};return de===null?J.memoizedState=de=t:de=de.next=t,de}function qe(){if(le===null){var t=J.alternate;t=t!==null?t.memoizedState:null}else t=le.next;var n=de===null?J.memoizedState:de.next;if(n!==null)de=n,le=t;else{if(t===null)throw Error(M(310));le=t,t={memoizedState:le.memoizedState,baseState:le.baseState,baseQueue:le.baseQueue,queue:le.queue,next:null},de===null?J.memoizedState=de=t:de=de.next=t}return de}function Ds(t,n){return typeof n=="function"?n(t):n}function Co(t){var n=qe(),s=n.queue;if(s===null)throw Error(M(311));s.lastRenderedReducer=t;var r=le,a=r.baseQueue,o=s.pending;if(o!==null){if(a!==null){var d=a.next;a.next=o.next,o.next=d}r.baseQueue=a=o,s.pending=null}if(a!==null){o=a.next,r=r.baseState;var u=d=null,h=null,p=o;do{var m=p.lane;if((Cn&m)===m)h!==null&&(h=h.next={lane:0,action:p.action,hasEagerState:p.hasEagerState,eagerState:p.eagerState,next:null}),r=p.hasEagerState?p.eagerState:t(r,p.action);else{var g={lane:m,action:p.action,hasEagerState:p.hasEagerState,eagerState:p.eagerState,next:null};h===null?(u=h=g,d=r):h=h.next=g,J.lanes|=m,Tn|=m}p=p.next}while(p!==null&&p!==o);h===null?d=r:h.next=u,lt(r,n.memoizedState)||(Re=!0),n.memoizedState=r,n.baseState=d,n.baseQueue=h,s.lastRenderedState=r}if(t=s.interleaved,t!==null){a=t;do o=a.lane,J.lanes|=o,Tn|=o,a=a.next;while(a!==t)}else a===null&&(s.lanes=0);return[n.memoizedState,s.dispatch]}function To(t){var n=qe(),s=n.queue;if(s===null)throw Error(M(311));s.lastRenderedReducer=t;var r=s.dispatch,a=s.pending,o=n.memoizedState;if(a!==null){s.pending=null;var d=a=a.next;do o=t(o,d.action),d=d.next;while(d!==a);lt(o,n.memoizedState)||(Re=!0),n.memoizedState=o,n.baseQueue===null&&(n.baseState=o),s.lastRenderedState=o}return[o,r]}function lm(){}function cm(t,n){var s=J,r=qe(),a=n(),o=!lt(r.memoizedState,a);if(o&&(r.memoizedState=a,Re=!0),r=r.queue,Ac(hm.bind(null,s,r,t),[t]),r.getSnapshot!==n||o||de!==null&&de.memoizedState.tag&1){if(s.flags|=2048,Ms(9,um.bind(null,s,r,a,n),void 0,null),ue===null)throw Error(M(349));Cn&30||dm(s,n,a)}return a}function dm(t,n,s){t.flags|=16384,t={getSnapshot:n,value:s},n=J.updateQueue,n===null?(n={lastEffect:null,stores:null},J.updateQueue=n,n.stores=[t]):(s=n.stores,s===null?n.stores=[t]:s.push(t))}function um(t,n,s,r){n.value=s,n.getSnapshot=r,fm(n)&&pm(t)}function hm(t,n,s){return s(function(){fm(n)&&pm(t)})}function fm(t){var n=t.getSnapshot;t=t.value;try{var s=n();return!lt(t,s)}catch{return!0}}function pm(t){var n=Dt(t,1);n!==null&&at(n,t,1,-1)}function Au(t){var n=dt();return typeof t=="function"&&(t=t()),n.memoizedState=n.baseState=t,t={pending:null,interleaved:null,lanes:0,dispatch:null,lastRenderedReducer:Ds,lastRenderedState:t},n.queue=t,t=t.dispatch=Jy.bind(null,J,t),[n.memoizedState,t]}function Ms(t,n,s,r){return t={tag:t,create:n,destroy:s,deps:r,next:null},n=J.updateQueue,n===null?(n={lastEffect:null,stores:null},J.updateQueue=n,n.lastEffect=t.next=t):(s=n.lastEffect,s===null?n.lastEffect=t.next=t:(r=s.next,s.next=t,t.next=r,n.lastEffect=t)),t}function mm(){return qe().memoizedState}function Nr(t,n,s,r){var a=dt();J.flags|=t,a.memoizedState=Ms(1|n,s,void 0,r===void 0?null:r)}function Ta(t,n,s,r){var a=qe();r=r===void 0?null:r;var o=void 0;if(le!==null){var d=le.memoizedState;if(o=d.destroy,r!==null&&Ec(r,d.deps)){a.memoizedState=Ms(n,s,o,r);return}}J.flags|=t,a.memoizedState=Ms(1|n,s,o,r)}function zu(t,n){return Nr(8390656,8,t,n)}function Ac(t,n){return Ta(2048,8,t,n)}function gm(t,n){return Ta(4,2,t,n)}function xm(t,n){return Ta(4,4,t,n)}function vm(t,n){if(typeof n=="function")return t=t(),n(t),function(){n(null)};if(n!=null)return t=t(),n.current=t,function(){n.current=null}}function ym(t,n,s){return s=s!=null?s.concat([t]):null,Ta(4,4,vm.bind(null,n,t),s)}function zc(){}function jm(t,n){var s=qe();n=n===void 0?null:n;var r=s.memoizedState;return r!==null&&n!==null&&Ec(n,r[1])?r[0]:(s.memoizedState=[t,n],t)}function wm(t,n){var s=qe();n=n===void 0?null:n;var r=s.memoizedState;return r!==null&&n!==null&&Ec(n,r[1])?r[0]:(t=t(),s.memoizedState=[t,n],t)}function bm(t,n,s){return Cn&21?(lt(s,n)||(s=Rp(),J.lanes|=s,Tn|=s,t.baseState=!0),n):(t.baseState&&(t.baseState=!1,Re=!0),t.memoizedState=s)}function Xy(t,n){var s=U;U=s!==0&&4>s?s:4,t(!0);var r=Io.transition;Io.transition={};try{t(!1),n()}finally{U=s,Io.transition=r}}function Sm(){return qe().memoizedState}function Zy(t,n,s){var r=tn(t);if(s={lane:r,action:s,hasEagerState:!1,eagerState:null,next:null},Im(t))Cm(n,s);else if(s=rm(t,n,s,r),s!==null){var a=Se();at(s,t,r,a),Tm(s,n,r)}}function Jy(t,n,s){var r=tn(t),a={lane:r,action:s,hasEagerState:!1,eagerState:null,next:null};if(Im(t))Cm(n,a);else{var o=t.alternate;if(t.lanes===0&&(o===null||o.lanes===0)&&(o=n.lastRenderedReducer,o!==null))try{var d=n.lastRenderedState,u=o(d,s);if(a.hasEagerState=!0,a.eagerState=u,lt(u,d)){var h=n.interleaved;h===null?(a.next=a,Cc(n)):(a.next=h.next,h.next=a),n.interleaved=a;return}}catch{}finally{}s=rm(t,n,a,r),s!==null&&(a=Se(),at(s,t,r,a),Tm(s,n,r))}}function Im(t){var n=t.alternate;return t===J||n!==null&&n===J}function Cm(t,n){fs=la=!0;var s=t.pending;s===null?n.next=n:(n.next=s.next,s.next=n),t.pending=n}function Tm(t,n,s){if(s&4194240){var r=n.lanes;r&=t.pendingLanes,s|=r,n.lanes=s,uc(t,s)}}var ca={readContext:Ue,useCallback:xe,useContext:xe,useEffect:xe,useImperativeHandle:xe,useInsertionEffect:xe,useLayoutEffect:xe,useMemo:xe,useReducer:xe,useRef:xe,useState:xe,useDebugValue:xe,useDeferredValue:xe,useTransition:xe,useMutableSource:xe,useSyncExternalStore:xe,useId:xe,unstable_isNewReconciler:!1},ej={readContext:Ue,useCallback:function(t,n){return dt().memoizedState=[t,n===void 0?null:n],t},useContext:Ue,useEffect:zu,useImperativeHandle:function(t,n,s){return s=s!=null?s.concat([t]):null,Nr(4194308,4,vm.bind(null,n,t),s)},useLayoutEffect:function(t,n){return Nr(4194308,4,t,n)},useInsertionEffect:function(t,n){return Nr(4,2,t,n)},useMemo:function(t,n){var s=dt();return n=n===void 0?null:n,t=t(),s.memoizedState=[t,n],t},useReducer:function(t,n,s){var r=dt();return n=s!==void 0?s(n):n,r.memoizedState=r.baseState=n,t={pending:null,interleaved:null,lanes:0,dispatch:null,lastRenderedReducer:t,lastRenderedState:n},r.queue=t,t=t.dispatch=Zy.bind(null,J,t),[r.memoizedState,t]},useRef:function(t){var n=dt();return t={current:t},n.memoizedState=t},useState:Au,useDebugValue:zc,useDeferredValue:function(t){return dt().memoizedState=t},useTransition:function(){var t=Au(!1),n=t[0];return t=Xy.bind(null,t[1]),dt().memoizedState=t,[n,t]},useMutableSource:function(){},useSyncExternalStore:function(t,n,s){var r=J,a=dt();if(K){if(s===void 0)throw Error(M(407));s=s()}else{if(s=n(),ue===null)throw Error(M(349));Cn&30||dm(r,n,s)}a.memoizedState=s;var o={value:s,getSnapshot:n};return a.queue=o,zu(hm.bind(null,r,o,t),[t]),r.flags|=2048,Ms(9,um.bind(null,r,o,s,n),void 0,null),s},useId:function(){var t=dt(),n=ue.identifierPrefix;if(K){var s=Tt,r=Ct;s=(r&~(1<<32-rt(r)-1)).toString(32)+s,n=":"+n+"R"+s,s=Es++,0<s&&(n+="H"+s.toString(32)),n+=":"}else s=Ky++,n=":"+n+"r"+s.toString(32)+":";return t.memoizedState=n},unstable_isNewReconciler:!1},tj={readContext:Ue,useCallback:jm,useContext:Ue,useEffect:Ac,useImperativeHandle:ym,useInsertionEffect:gm,useLayoutEffect:xm,useMemo:wm,useReducer:Co,useRef:mm,useState:function(){return Co(Ds)},useDebugValue:zc,useDeferredValue:function(t){var n=qe();return bm(n,le.memoizedState,t)},useTransition:function(){var t=Co(Ds)[0],n=qe().memoizedState;return[t,n]},useMutableSource:lm,useSyncExternalStore:cm,useId:Sm,unstable_isNewReconciler:!1},nj={readContext:Ue,useCallback:jm,useContext:Ue,useEffect:Ac,useImperativeHandle:ym,useInsertionEffect:gm,useLayoutEffect:xm,useMemo:wm,useReducer:To,useRef:mm,useState:function(){return To(Ds)},useDebugValue:zc,useDeferredValue:function(t){var n=qe();return le===null?n.memoizedState=t:bm(n,le.memoizedState,t)},useTransition:function(){var t=To(Ds)[0],n=qe().memoizedState;return[t,n]},useMutableSource:lm,useSyncExternalStore:cm,useId:Sm,unstable_isNewReconciler:!1};function Je(t,n){if(t&&t.defaultProps){n=te({},n),t=t.defaultProps;for(var s in t)n[s]===void 0&&(n[s]=t[s]);return n}return n}function Cl(t,n,s,r){n=t.memoizedState,s=s(r,n),s=s==null?n:te({},n,s),t.memoizedState=s,t.lanes===0&&(t.updateQueue.baseState=s)}var Ra={isMounted:function(t){return(t=t._reactInternals)?Dn(t)===t:!1},enqueueSetState:function(t,n,s){t=t._reactInternals;var r=Se(),a=tn(t),o=Rt(r,a);o.payload=n,s!=null&&(o.callback=s),n=Jt(t,o,a),n!==null&&(at(n,t,a,r),Ar(n,t,a))},enqueueReplaceState:function(t,n,s){t=t._reactInternals;var r=Se(),a=tn(t),o=Rt(r,a);o.tag=1,o.payload=n,s!=null&&(o.callback=s),n=Jt(t,o,a),n!==null&&(at(n,t,a,r),Ar(n,t,a))},enqueueForceUpdate:function(t,n){t=t._reactInternals;var s=Se(),r=tn(t),a=Rt(s,r);a.tag=2,n!=null&&(a.callback=n),n=Jt(t,a,r),n!==null&&(at(n,t,r,s),Ar(n,t,r))}};function Nu(t,n,s,r,a,o,d){return t=t.stateNode,typeof t.shouldComponentUpdate=="function"?t.shouldComponentUpdate(r,o,d):n.prototype&&n.prototype.isPureReactComponent?!Is(s,r)||!Is(a,o):!0}function Rm(t,n,s){var r=!1,a=rn,o=n.contextType;return typeof o=="object"&&o!==null?o=Ue(o):(a=Pe(n)?Sn:je.current,r=n.contextTypes,o=(r=r!=null)?mi(t,a):rn),n=new n(s,o),t.memoizedState=n.state!==null&&n.state!==void 0?n.state:null,n.updater=Ra,t.stateNode=n,n._reactInternals=t,r&&(t=t.stateNode,t.__reactInternalMemoizedUnmaskedChildContext=a,t.__reactInternalMemoizedMaskedChildContext=o),n}function _u(t,n,s,r){t=n.state,typeof n.componentWillReceiveProps=="function"&&n.componentWillReceiveProps(s,r),typeof n.UNSAFE_componentWillReceiveProps=="function"&&n.UNSAFE_componentWillReceiveProps(s,r),n.state!==t&&Ra.enqueueReplaceState(n,n.state,null)}function Tl(t,n,s,r){var a=t.stateNode;a.props=s,a.state=t.memoizedState,a.refs={},Tc(t);var o=n.contextType;typeof o=="object"&&o!==null?a.context=Ue(o):(o=Pe(n)?Sn:je.current,a.context=mi(t,o)),a.state=t.memoizedState,o=n.getDerivedStateFromProps,typeof o=="function"&&(Cl(t,n,o,s),a.state=t.memoizedState),typeof n.getDerivedStateFromProps=="function"||typeof a.getSnapshotBeforeUpdate=="function"||typeof a.UNSAFE_componentWillMount!="function"&&typeof a.componentWillMount!="function"||(n=a.state,typeof a.componentWillMount=="function"&&a.componentWillMount(),typeof a.UNSAFE_componentWillMount=="function"&&a.UNSAFE_componentWillMount(),n!==a.state&&Ra.enqueueReplaceState(a,a.state,null),aa(t,s,a,r),a.state=t.memoizedState),typeof a.componentDidMount=="function"&&(t.flags|=4194308)}function yi(t,n){try{var s="",r=n;do s+=E0(r),r=r.return;while(r);var a=s}catch(o){a=`
Error generating stack: `+o.message+`
`+o.stack}return{value:t,source:n,stack:a,digest:null}}function Ro(t,n,s){return{value:t,source:null,stack:s??null,digest:n??null}}function Rl(t,n){try{console.error(n.value)}catch(s){setTimeout(function(){throw s})}}var ij=typeof WeakMap=="function"?WeakMap:Map;function km(t,n,s){s=Rt(-1,s),s.tag=3,s.payload={element:null};var r=n.value;return s.callback=function(){ua||(ua=!0,Ll=r),Rl(t,n)},s}function Pm(t,n,s){s=Rt(-1,s),s.tag=3;var r=t.type.getDerivedStateFromError;if(typeof r=="function"){var a=n.value;s.payload=function(){return r(a)},s.callback=function(){Rl(t,n)}}var o=t.stateNode;return o!==null&&typeof o.componentDidCatch=="function"&&(s.callback=function(){Rl(t,n),typeof r!="function"&&(en===null?en=new Set([this]):en.add(this));var d=n.stack;this.componentDidCatch(n.value,{componentStack:d!==null?d:""})}),s}function Lu(t,n,s){var r=t.pingCache;if(r===null){r=t.pingCache=new ij;var a=new Set;r.set(n,a)}else a=r.get(n),a===void 0&&(a=new Set,r.set(n,a));a.has(s)||(a.add(s),t=xj.bind(null,t,n,s),n.then(t,t))}function Ou(t){do{var n;if((n=t.tag===13)&&(n=t.memoizedState,n=n!==null?n.dehydrated!==null:!0),n)return t;t=t.return}while(t!==null);return null}function Fu(t,n,s,r,a){return t.mode&1?(t.flags|=65536,t.lanes=a,t):(t===n?t.flags|=65536:(t.flags|=128,s.flags|=131072,s.flags&=-52805,s.tag===1&&(s.alternate===null?s.tag=17:(n=Rt(-1,1),n.tag=2,Jt(s,n,1))),s.lanes|=1),t)}var sj=zt.ReactCurrentOwner,Re=!1;function be(t,n,s,r){n.child=t===null?sm(n,null,s,r):xi(n,t.child,s,r)}function $u(t,n,s,r,a){s=s.render;var o=n.ref;return ui(n,a),r=Dc(t,n,s,r,o,a),s=Mc(),t!==null&&!Re?(n.updateQueue=t.updateQueue,n.flags&=-2053,t.lanes&=~a,Mt(t,n,a)):(K&&s&&yc(n),n.flags|=1,be(t,n,r,a),n.child)}function Bu(t,n,s,r,a){if(t===null){var o=s.type;return typeof o=="function"&&!Hc(o)&&o.defaultProps===void 0&&s.compare===null&&s.defaultProps===void 0?(n.tag=15,n.type=o,Em(t,n,o,r,a)):(t=Fr(s.type,null,r,n,n.mode,a),t.ref=n.ref,t.return=n,n.child=t)}if(o=t.child,!(t.lanes&a)){var d=o.memoizedProps;if(s=s.compare,s=s!==null?s:Is,s(d,r)&&t.ref===n.ref)return Mt(t,n,a)}return n.flags|=1,t=nn(o,r),t.ref=n.ref,t.return=n,n.child=t}function Em(t,n,s,r,a){if(t!==null){var o=t.memoizedProps;if(Is(o,r)&&t.ref===n.ref)if(Re=!1,n.pendingProps=r=o,(t.lanes&a)!==0)t.flags&131072&&(Re=!0);else return n.lanes=t.lanes,Mt(t,n,a)}return kl(t,n,s,r,a)}function Dm(t,n,s){var r=n.pendingProps,a=r.children,o=t!==null?t.memoizedState:null;if(r.mode==="hidden")if(!(n.mode&1))n.memoizedState={baseLanes:0,cachePool:null,transitions:null},W(ai,Me),Me|=s;else{if(!(s&1073741824))return t=o!==null?o.baseLanes|s:s,n.lanes=n.childLanes=1073741824,n.memoizedState={baseLanes:t,cachePool:null,transitions:null},n.updateQueue=null,W(ai,Me),Me|=t,null;n.memoizedState={baseLanes:0,cachePool:null,transitions:null},r=o!==null?o.baseLanes:s,W(ai,Me),Me|=r}else o!==null?(r=o.baseLanes|s,n.memoizedState=null):r=s,W(ai,Me),Me|=r;return be(t,n,a,s),n.child}function Mm(t,n){var s=n.ref;(t===null&&s!==null||t!==null&&t.ref!==s)&&(n.flags|=512,n.flags|=2097152)}function kl(t,n,s,r,a){var o=Pe(s)?Sn:je.current;return o=mi(n,o),ui(n,a),s=Dc(t,n,s,r,o,a),r=Mc(),t!==null&&!Re?(n.updateQueue=t.updateQueue,n.flags&=-2053,t.lanes&=~a,Mt(t,n,a)):(K&&r&&yc(n),n.flags|=1,be(t,n,s,a),n.child)}function Hu(t,n,s,r,a){if(Pe(s)){var o=!0;ta(n)}else o=!1;if(ui(n,a),n.stateNode===null)_r(t,n),Rm(n,s,r),Tl(n,s,r,a),r=!0;else if(t===null){var d=n.stateNode,u=n.memoizedProps;d.props=u;var h=d.context,p=s.contextType;typeof p=="object"&&p!==null?p=Ue(p):(p=Pe(s)?Sn:je.current,p=mi(n,p));var m=s.getDerivedStateFromProps,g=typeof m=="function"||typeof d.getSnapshotBeforeUpdate=="function";g||typeof d.UNSAFE_componentWillReceiveProps!="function"&&typeof d.componentWillReceiveProps!="function"||(u!==r||h!==p)&&_u(n,d,r,p),Gt=!1;var x=n.memoizedState;d.state=x,aa(n,r,d,a),h=n.memoizedState,u!==r||x!==h||ke.current||Gt?(typeof m=="function"&&(Cl(n,s,m,r),h=n.memoizedState),(u=Gt||Nu(n,s,u,r,x,h,p))?(g||typeof d.UNSAFE_componentWillMount!="function"&&typeof d.componentWillMount!="function"||(typeof d.componentWillMount=="function"&&d.componentWillMount(),typeof d.UNSAFE_componentWillMount=="function"&&d.UNSAFE_componentWillMount()),typeof d.componentDidMount=="function"&&(n.flags|=4194308)):(typeof d.componentDidMount=="function"&&(n.flags|=4194308),n.memoizedProps=r,n.memoizedState=h),d.props=r,d.state=h,d.context=p,r=u):(typeof d.componentDidMount=="function"&&(n.flags|=4194308),r=!1)}else{d=n.stateNode,am(t,n),u=n.memoizedProps,p=n.type===n.elementType?u:Je(n.type,u),d.props=p,g=n.pendingProps,x=d.context,h=s.contextType,typeof h=="object"&&h!==null?h=Ue(h):(h=Pe(s)?Sn:je.current,h=mi(n,h));var j=s.getDerivedStateFromProps;(m=typeof j=="function"||typeof d.getSnapshotBeforeUpdate=="function")||typeof d.UNSAFE_componentWillReceiveProps!="function"&&typeof d.componentWillReceiveProps!="function"||(u!==g||x!==h)&&_u(n,d,r,h),Gt=!1,x=n.memoizedState,d.state=x,aa(n,r,d,a);var I=n.memoizedState;u!==g||x!==I||ke.current||Gt?(typeof j=="function"&&(Cl(n,s,j,r),I=n.memoizedState),(p=Gt||Nu(n,s,p,r,x,I,h)||!1)?(m||typeof d.UNSAFE_componentWillUpdate!="function"&&typeof d.componentWillUpdate!="function"||(typeof d.componentWillUpdate=="function"&&d.componentWillUpdate(r,I,h),typeof d.UNSAFE_componentWillUpdate=="function"&&d.UNSAFE_componentWillUpdate(r,I,h)),typeof d.componentDidUpdate=="function"&&(n.flags|=4),typeof d.getSnapshotBeforeUpdate=="function"&&(n.flags|=1024)):(typeof d.componentDidUpdate!="function"||u===t.memoizedProps&&x===t.memoizedState||(n.flags|=4),typeof d.getSnapshotBeforeUpdate!="function"||u===t.memoizedProps&&x===t.memoizedState||(n.flags|=1024),n.memoizedProps=r,n.memoizedState=I),d.props=r,d.state=I,d.context=h,r=p):(typeof d.componentDidUpdate!="function"||u===t.memoizedProps&&x===t.memoizedState||(n.flags|=4),typeof d.getSnapshotBeforeUpdate!="function"||u===t.memoizedProps&&x===t.memoizedState||(n.flags|=1024),r=!1)}return Pl(t,n,s,r,o,a)}function Pl(t,n,s,r,a,o){Mm(t,n);var d=(n.flags&128)!==0;if(!r&&!d)return a&&Ru(n,s,!1),Mt(t,n,o);r=n.stateNode,sj.current=n;var u=d&&typeof s.getDerivedStateFromError!="function"?null:r.render();return n.flags|=1,t!==null&&d?(n.child=xi(n,t.child,null,o),n.child=xi(n,null,u,o)):be(t,n,u,o),n.memoizedState=r.state,a&&Ru(n,s,!0),n.child}function Am(t){var n=t.stateNode;n.pendingContext?Tu(t,n.pendingContext,n.pendingContext!==n.context):n.context&&Tu(t,n.context,!1),Rc(t,n.containerInfo)}function Vu(t,n,s,r,a){return gi(),wc(a),n.flags|=256,be(t,n,s,r),n.child}var El={dehydrated:null,treeContext:null,retryLane:0};function Dl(t){return{baseLanes:t,cachePool:null,transitions:null}}function zm(t,n,s){var r=n.pendingProps,a=Z.current,o=!1,d=(n.flags&128)!==0,u;if((u=d)||(u=t!==null&&t.memoizedState===null?!1:(a&2)!==0),u?(o=!0,n.flags&=-129):(t===null||t.memoizedState!==null)&&(a|=1),W(Z,a&1),t===null)return Sl(n),t=n.memoizedState,t!==null&&(t=t.dehydrated,t!==null)?(n.mode&1?t.data==="$!"?n.lanes=8:n.lanes=1073741824:n.lanes=1,null):(d=r.children,t=r.fallback,o?(r=n.mode,o=n.child,d={mode:"hidden",children:d},!(r&1)&&o!==null?(o.childLanes=0,o.pendingProps=d):o=Ea(d,r,0,null),t=wn(t,r,s,null),o.return=n,t.return=n,o.sibling=t,n.child=o,n.child.memoizedState=Dl(s),n.memoizedState=El,t):Nc(n,d));if(a=t.memoizedState,a!==null&&(u=a.dehydrated,u!==null))return rj(t,n,d,r,u,a,s);if(o){o=r.fallback,d=n.mode,a=t.child,u=a.sibling;var h={mode:"hidden",children:r.children};return!(d&1)&&n.child!==a?(r=n.child,r.childLanes=0,r.pendingProps=h,n.deletions=null):(r=nn(a,h),r.subtreeFlags=a.subtreeFlags&14680064),u!==null?o=nn(u,o):(o=wn(o,d,s,null),o.flags|=2),o.return=n,r.return=n,r.sibling=o,n.child=r,r=o,o=n.child,d=t.child.memoizedState,d=d===null?Dl(s):{baseLanes:d.baseLanes|s,cachePool:null,transitions:d.transitions},o.memoizedState=d,o.childLanes=t.childLanes&~s,n.memoizedState=El,r}return o=t.child,t=o.sibling,r=nn(o,{mode:"visible",children:r.children}),!(n.mode&1)&&(r.lanes=s),r.return=n,r.sibling=null,t!==null&&(s=n.deletions,s===null?(n.deletions=[t],n.flags|=16):s.push(t)),n.child=r,n.memoizedState=null,r}function Nc(t,n){return n=Ea({mode:"visible",children:n},t.mode,0,null),n.return=t,t.child=n}function ur(t,n,s,r){return r!==null&&wc(r),xi(n,t.child,null,s),t=Nc(n,n.pendingProps.children),t.flags|=2,n.memoizedState=null,t}function rj(t,n,s,r,a,o,d){if(s)return n.flags&256?(n.flags&=-257,r=Ro(Error(M(422))),ur(t,n,d,r)):n.memoizedState!==null?(n.child=t.child,n.flags|=128,null):(o=r.fallback,a=n.mode,r=Ea({mode:"visible",children:r.children},a,0,null),o=wn(o,a,d,null),o.flags|=2,r.return=n,o.return=n,r.sibling=o,n.child=r,n.mode&1&&xi(n,t.child,null,d),n.child.memoizedState=Dl(d),n.memoizedState=El,o);if(!(n.mode&1))return ur(t,n,d,null);if(a.data==="$!"){if(r=a.nextSibling&&a.nextSibling.dataset,r)var u=r.dgst;return r=u,o=Error(M(419)),r=Ro(o,r,void 0),ur(t,n,d,r)}if(u=(d&t.childLanes)!==0,Re||u){if(r=ue,r!==null){switch(d&-d){case 4:a=2;break;case 16:a=8;break;case 64:case 128:case 256:case 512:case 1024:case 2048:case 4096:case 8192:case 16384:case 32768:case 65536:case 131072:case 262144:case 524288:case 1048576:case 2097152:case 4194304:case 8388608:case 16777216:case 33554432:case 67108864:a=32;break;case 536870912:a=268435456;break;default:a=0}a=a&(r.suspendedLanes|d)?0:a,a!==0&&a!==o.retryLane&&(o.retryLane=a,Dt(t,a),at(r,t,a,-1))}return Bc(),r=Ro(Error(M(421))),ur(t,n,d,r)}return a.data==="$?"?(n.flags|=128,n.child=t.child,n=vj.bind(null,t),a._reactRetry=n,null):(t=o.treeContext,Ae=Zt(a.nextSibling),ze=n,K=!0,tt=null,t!==null&&(Fe[$e++]=Ct,Fe[$e++]=Tt,Fe[$e++]=In,Ct=t.id,Tt=t.overflow,In=n),n=Nc(n,r.children),n.flags|=4096,n)}function Gu(t,n,s){t.lanes|=n;var r=t.alternate;r!==null&&(r.lanes|=n),Il(t.return,n,s)}function ko(t,n,s,r,a){var o=t.memoizedState;o===null?t.memoizedState={isBackwards:n,rendering:null,renderingStartTime:0,last:r,tail:s,tailMode:a}:(o.isBackwards=n,o.rendering=null,o.renderingStartTime=0,o.last=r,o.tail=s,o.tailMode=a)}function Nm(t,n,s){var r=n.pendingProps,a=r.revealOrder,o=r.tail;if(be(t,n,r.children,s),r=Z.current,r&2)r=r&1|2,n.flags|=128;else{if(t!==null&&t.flags&128)e:for(t=n.child;t!==null;){if(t.tag===13)t.memoizedState!==null&&Gu(t,s,n);else if(t.tag===19)Gu(t,s,n);else if(t.child!==null){t.child.return=t,t=t.child;continue}if(t===n)break e;for(;t.sibling===null;){if(t.return===null||t.return===n)break e;t=t.return}t.sibling.return=t.return,t=t.sibling}r&=1}if(W(Z,r),!(n.mode&1))n.memoizedState=null;else switch(a){case"forwards":for(s=n.child,a=null;s!==null;)t=s.alternate,t!==null&&oa(t)===null&&(a=s),s=s.sibling;s=a,s===null?(a=n.child,n.child=null):(a=s.sibling,s.sibling=null),ko(n,!1,a,s,o);break;case"backwards":for(s=null,a=n.child,n.child=null;a!==null;){if(t=a.alternate,t!==null&&oa(t)===null){n.child=a;break}t=a.sibling,a.sibling=s,s=a,a=t}ko(n,!0,s,null,o);break;case"together":ko(n,!1,null,null,void 0);break;default:n.memoizedState=null}return n.child}function _r(t,n){!(n.mode&1)&&t!==null&&(t.alternate=null,n.alternate=null,n.flags|=2)}function Mt(t,n,s){if(t!==null&&(n.dependencies=t.dependencies),Tn|=n.lanes,!(s&n.childLanes))return null;if(t!==null&&n.child!==t.child)throw Error(M(153));if(n.child!==null){for(t=n.child,s=nn(t,t.pendingProps),n.child=s,s.return=n;t.sibling!==null;)t=t.sibling,s=s.sibling=nn(t,t.pendingProps),s.return=n;s.sibling=null}return n.child}function aj(t,n,s){switch(n.tag){case 3:Am(n),gi();break;case 5:om(n);break;case 1:Pe(n.type)&&ta(n);break;case 4:Rc(n,n.stateNode.containerInfo);break;case 10:var r=n.type._context,a=n.memoizedProps.value;W(sa,r._currentValue),r._currentValue=a;break;case 13:if(r=n.memoizedState,r!==null)return r.dehydrated!==null?(W(Z,Z.current&1),n.flags|=128,null):s&n.child.childLanes?zm(t,n,s):(W(Z,Z.current&1),t=Mt(t,n,s),t!==null?t.sibling:null);W(Z,Z.current&1);break;case 19:if(r=(s&n.childLanes)!==0,t.flags&128){if(r)return Nm(t,n,s);n.flags|=128}if(a=n.memoizedState,a!==null&&(a.rendering=null,a.tail=null,a.lastEffect=null),W(Z,Z.current),r)break;return null;case 22:case 23:return n.lanes=0,Dm(t,n,s)}return Mt(t,n,s)}var _m,Ml,Lm,Om;_m=function(t,n){for(var s=n.child;s!==null;){if(s.tag===5||s.tag===6)t.appendChild(s.stateNode);else if(s.tag!==4&&s.child!==null){s.child.return=s,s=s.child;continue}if(s===n)break;for(;s.sibling===null;){if(s.return===null||s.return===n)return;s=s.return}s.sibling.return=s.return,s=s.sibling}};Ml=function(){};Lm=function(t,n,s,r){var a=t.memoizedProps;if(a!==r){t=n.stateNode,yn(mt.current);var o=null;switch(s){case"input":a=el(t,a),r=el(t,r),o=[];break;case"select":a=te({},a,{value:void 0}),r=te({},r,{value:void 0}),o=[];break;case"textarea":a=il(t,a),r=il(t,r),o=[];break;default:typeof a.onClick!="function"&&typeof r.onClick=="function"&&(t.onclick=Jr)}rl(s,r);var d;s=null;for(p in a)if(!r.hasOwnProperty(p)&&a.hasOwnProperty(p)&&a[p]!=null)if(p==="style"){var u=a[p];for(d in u)u.hasOwnProperty(d)&&(s||(s={}),s[d]="")}else p!=="dangerouslySetInnerHTML"&&p!=="children"&&p!=="suppressContentEditableWarning"&&p!=="suppressHydrationWarning"&&p!=="autoFocus"&&(xs.hasOwnProperty(p)?o||(o=[]):(o=o||[]).push(p,null));for(p in r){var h=r[p];if(u=a!=null?a[p]:void 0,r.hasOwnProperty(p)&&h!==u&&(h!=null||u!=null))if(p==="style")if(u){for(d in u)!u.hasOwnProperty(d)||h&&h.hasOwnProperty(d)||(s||(s={}),s[d]="");for(d in h)h.hasOwnProperty(d)&&u[d]!==h[d]&&(s||(s={}),s[d]=h[d])}else s||(o||(o=[]),o.push(p,s)),s=h;else p==="dangerouslySetInnerHTML"?(h=h?h.__html:void 0,u=u?u.__html:void 0,h!=null&&u!==h&&(o=o||[]).push(p,h)):p==="children"?typeof h!="string"&&typeof h!="number"||(o=o||[]).push(p,""+h):p!=="suppressContentEditableWarning"&&p!=="suppressHydrationWarning"&&(xs.hasOwnProperty(p)?(h!=null&&p==="onScroll"&&Q("scroll",t),o||u===h||(o=[])):(o=o||[]).push(p,h))}s&&(o=o||[]).push("style",s);var p=o;(n.updateQueue=p)&&(n.flags|=4)}};Om=function(t,n,s,r){s!==r&&(n.flags|=4)};function Gi(t,n){if(!K)switch(t.tailMode){case"hidden":n=t.tail;for(var s=null;n!==null;)n.alternate!==null&&(s=n),n=n.sibling;s===null?t.tail=null:s.sibling=null;break;case"collapsed":s=t.tail;for(var r=null;s!==null;)s.alternate!==null&&(r=s),s=s.sibling;r===null?n||t.tail===null?t.tail=null:t.tail.sibling=null:r.sibling=null}}function ve(t){var n=t.alternate!==null&&t.alternate.child===t.child,s=0,r=0;if(n)for(var a=t.child;a!==null;)s|=a.lanes|a.childLanes,r|=a.subtreeFlags&14680064,r|=a.flags&14680064,a.return=t,a=a.sibling;else for(a=t.child;a!==null;)s|=a.lanes|a.childLanes,r|=a.subtreeFlags,r|=a.flags,a.return=t,a=a.sibling;return t.subtreeFlags|=r,t.childLanes=s,n}function oj(t,n,s){var r=n.pendingProps;switch(jc(n),n.tag){case 2:case 16:case 15:case 0:case 11:case 7:case 8:case 12:case 9:case 14:return ve(n),null;case 1:return Pe(n.type)&&ea(),ve(n),null;case 3:return r=n.stateNode,vi(),Y(ke),Y(je),Pc(),r.pendingContext&&(r.context=r.pendingContext,r.pendingContext=null),(t===null||t.child===null)&&(cr(n)?n.flags|=4:t===null||t.memoizedState.isDehydrated&&!(n.flags&256)||(n.flags|=1024,tt!==null&&($l(tt),tt=null))),Ml(t,n),ve(n),null;case 5:kc(n);var a=yn(Ps.current);if(s=n.type,t!==null&&n.stateNode!=null)Lm(t,n,s,r,a),t.ref!==n.ref&&(n.flags|=512,n.flags|=2097152);else{if(!r){if(n.stateNode===null)throw Error(M(166));return ve(n),null}if(t=yn(mt.current),cr(n)){r=n.stateNode,s=n.type;var o=n.memoizedProps;switch(r[ht]=n,r[Rs]=o,t=(n.mode&1)!==0,s){case"dialog":Q("cancel",r),Q("close",r);break;case"iframe":case"object":case"embed":Q("load",r);break;case"video":case"audio":for(a=0;a<rs.length;a++)Q(rs[a],r);break;case"source":Q("error",r);break;case"img":case"image":case"link":Q("error",r),Q("load",r);break;case"details":Q("toggle",r);break;case"input":Jd(r,o),Q("invalid",r);break;case"select":r._wrapperState={wasMultiple:!!o.multiple},Q("invalid",r);break;case"textarea":tu(r,o),Q("invalid",r)}rl(s,o),a=null;for(var d in o)if(o.hasOwnProperty(d)){var u=o[d];d==="children"?typeof u=="string"?r.textContent!==u&&(o.suppressHydrationWarning!==!0&&lr(r.textContent,u,t),a=["children",u]):typeof u=="number"&&r.textContent!==""+u&&(o.suppressHydrationWarning!==!0&&lr(r.textContent,u,t),a=["children",""+u]):xs.hasOwnProperty(d)&&u!=null&&d==="onScroll"&&Q("scroll",r)}switch(s){case"input":er(r),eu(r,o,!0);break;case"textarea":er(r),nu(r);break;case"select":case"option":break;default:typeof o.onClick=="function"&&(r.onclick=Jr)}r=a,n.updateQueue=r,r!==null&&(n.flags|=4)}else{d=a.nodeType===9?a:a.ownerDocument,t==="http://www.w3.org/1999/xhtml"&&(t=hp(s)),t==="http://www.w3.org/1999/xhtml"?s==="script"?(t=d.createElement("div"),t.innerHTML="<script><\/script>",t=t.removeChild(t.firstChild)):typeof r.is=="string"?t=d.createElement(s,{is:r.is}):(t=d.createElement(s),s==="select"&&(d=t,r.multiple?d.multiple=!0:r.size&&(d.size=r.size))):t=d.createElementNS(t,s),t[ht]=n,t[Rs]=r,_m(t,n,!1,!1),n.stateNode=t;e:{switch(d=al(s,r),s){case"dialog":Q("cancel",t),Q("close",t),a=r;break;case"iframe":case"object":case"embed":Q("load",t),a=r;break;case"video":case"audio":for(a=0;a<rs.length;a++)Q(rs[a],t);a=r;break;case"source":Q("error",t),a=r;break;case"img":case"image":case"link":Q("error",t),Q("load",t),a=r;break;case"details":Q("toggle",t),a=r;break;case"input":Jd(t,r),a=el(t,r),Q("invalid",t);break;case"option":a=r;break;case"select":t._wrapperState={wasMultiple:!!r.multiple},a=te({},r,{value:void 0}),Q("invalid",t);break;case"textarea":tu(t,r),a=il(t,r),Q("invalid",t);break;default:a=r}rl(s,a),u=a;for(o in u)if(u.hasOwnProperty(o)){var h=u[o];o==="style"?mp(t,h):o==="dangerouslySetInnerHTML"?(h=h?h.__html:void 0,h!=null&&fp(t,h)):o==="children"?typeof h=="string"?(s!=="textarea"||h!=="")&&vs(t,h):typeof h=="number"&&vs(t,""+h):o!=="suppressContentEditableWarning"&&o!=="suppressHydrationWarning"&&o!=="autoFocus"&&(xs.hasOwnProperty(o)?h!=null&&o==="onScroll"&&Q("scroll",t):h!=null&&rc(t,o,h,d))}switch(s){case"input":er(t),eu(t,r,!1);break;case"textarea":er(t),nu(t);break;case"option":r.value!=null&&t.setAttribute("value",""+sn(r.value));break;case"select":t.multiple=!!r.multiple,o=r.value,o!=null?oi(t,!!r.multiple,o,!1):r.defaultValue!=null&&oi(t,!!r.multiple,r.defaultValue,!0);break;default:typeof a.onClick=="function"&&(t.onclick=Jr)}switch(s){case"button":case"input":case"select":case"textarea":r=!!r.autoFocus;break e;case"img":r=!0;break e;default:r=!1}}r&&(n.flags|=4)}n.ref!==null&&(n.flags|=512,n.flags|=2097152)}return ve(n),null;case 6:if(t&&n.stateNode!=null)Om(t,n,t.memoizedProps,r);else{if(typeof r!="string"&&n.stateNode===null)throw Error(M(166));if(s=yn(Ps.current),yn(mt.current),cr(n)){if(r=n.stateNode,s=n.memoizedProps,r[ht]=n,(o=r.nodeValue!==s)&&(t=ze,t!==null))switch(t.tag){case 3:lr(r.nodeValue,s,(t.mode&1)!==0);break;case 5:t.memoizedProps.suppressHydrationWarning!==!0&&lr(r.nodeValue,s,(t.mode&1)!==0)}o&&(n.flags|=4)}else r=(s.nodeType===9?s:s.ownerDocument).createTextNode(r),r[ht]=n,n.stateNode=r}return ve(n),null;case 13:if(Y(Z),r=n.memoizedState,t===null||t.memoizedState!==null&&t.memoizedState.dehydrated!==null){if(K&&Ae!==null&&n.mode&1&&!(n.flags&128))nm(),gi(),n.flags|=98560,o=!1;else if(o=cr(n),r!==null&&r.dehydrated!==null){if(t===null){if(!o)throw Error(M(318));if(o=n.memoizedState,o=o!==null?o.dehydrated:null,!o)throw Error(M(317));o[ht]=n}else gi(),!(n.flags&128)&&(n.memoizedState=null),n.flags|=4;ve(n),o=!1}else tt!==null&&($l(tt),tt=null),o=!0;if(!o)return n.flags&65536?n:null}return n.flags&128?(n.lanes=s,n):(r=r!==null,r!==(t!==null&&t.memoizedState!==null)&&r&&(n.child.flags|=8192,n.mode&1&&(t===null||Z.current&1?ce===0&&(ce=3):Bc())),n.updateQueue!==null&&(n.flags|=4),ve(n),null);case 4:return vi(),Ml(t,n),t===null&&Cs(n.stateNode.containerInfo),ve(n),null;case 10:return Ic(n.type._context),ve(n),null;case 17:return Pe(n.type)&&ea(),ve(n),null;case 19:if(Y(Z),o=n.memoizedState,o===null)return ve(n),null;if(r=(n.flags&128)!==0,d=o.rendering,d===null)if(r)Gi(o,!1);else{if(ce!==0||t!==null&&t.flags&128)for(t=n.child;t!==null;){if(d=oa(t),d!==null){for(n.flags|=128,Gi(o,!1),r=d.updateQueue,r!==null&&(n.updateQueue=r,n.flags|=4),n.subtreeFlags=0,r=s,s=n.child;s!==null;)o=s,t=r,o.flags&=14680066,d=o.alternate,d===null?(o.childLanes=0,o.lanes=t,o.child=null,o.subtreeFlags=0,o.memoizedProps=null,o.memoizedState=null,o.updateQueue=null,o.dependencies=null,o.stateNode=null):(o.childLanes=d.childLanes,o.lanes=d.lanes,o.child=d.child,o.subtreeFlags=0,o.deletions=null,o.memoizedProps=d.memoizedProps,o.memoizedState=d.memoizedState,o.updateQueue=d.updateQueue,o.type=d.type,t=d.dependencies,o.dependencies=t===null?null:{lanes:t.lanes,firstContext:t.firstContext}),s=s.sibling;return W(Z,Z.current&1|2),n.child}t=t.sibling}o.tail!==null&&ie()>ji&&(n.flags|=128,r=!0,Gi(o,!1),n.lanes=4194304)}else{if(!r)if(t=oa(d),t!==null){if(n.flags|=128,r=!0,s=t.updateQueue,s!==null&&(n.updateQueue=s,n.flags|=4),Gi(o,!0),o.tail===null&&o.tailMode==="hidden"&&!d.alternate&&!K)return ve(n),null}else 2*ie()-o.renderingStartTime>ji&&s!==1073741824&&(n.flags|=128,r=!0,Gi(o,!1),n.lanes=4194304);o.isBackwards?(d.sibling=n.child,n.child=d):(s=o.last,s!==null?s.sibling=d:n.child=d,o.last=d)}return o.tail!==null?(n=o.tail,o.rendering=n,o.tail=n.sibling,o.renderingStartTime=ie(),n.sibling=null,s=Z.current,W(Z,r?s&1|2:s&1),n):(ve(n),null);case 22:case 23:return $c(),r=n.memoizedState!==null,t!==null&&t.memoizedState!==null!==r&&(n.flags|=8192),r&&n.mode&1?Me&1073741824&&(ve(n),n.subtreeFlags&6&&(n.flags|=8192)):ve(n),null;case 24:return null;case 25:return null}throw Error(M(156,n.tag))}function lj(t,n){switch(jc(n),n.tag){case 1:return Pe(n.type)&&ea(),t=n.flags,t&65536?(n.flags=t&-65537|128,n):null;case 3:return vi(),Y(ke),Y(je),Pc(),t=n.flags,t&65536&&!(t&128)?(n.flags=t&-65537|128,n):null;case 5:return kc(n),null;case 13:if(Y(Z),t=n.memoizedState,t!==null&&t.dehydrated!==null){if(n.alternate===null)throw Error(M(340));gi()}return t=n.flags,t&65536?(n.flags=t&-65537|128,n):null;case 19:return Y(Z),null;case 4:return vi(),null;case 10:return Ic(n.type._context),null;case 22:case 23:return $c(),null;case 24:return null;default:return null}}var hr=!1,ye=!1,cj=typeof WeakSet=="function"?WeakSet:Set,N=null;function ri(t,n){var s=t.ref;if(s!==null)if(typeof s=="function")try{s(null)}catch(r){ne(t,n,r)}else s.current=null}function Al(t,n,s){try{s()}catch(r){ne(t,n,r)}}var Uu=!1;function dj(t,n){if(gl=Kr,t=Vp(),vc(t)){if("selectionStart"in t)var s={start:t.selectionStart,end:t.selectionEnd};else e:{s=(s=t.ownerDocument)&&s.defaultView||window;var r=s.getSelection&&s.getSelection();if(r&&r.rangeCount!==0){s=r.anchorNode;var a=r.anchorOffset,o=r.focusNode;r=r.focusOffset;try{s.nodeType,o.nodeType}catch{s=null;break e}var d=0,u=-1,h=-1,p=0,m=0,g=t,x=null;t:for(;;){for(var j;g!==s||a!==0&&g.nodeType!==3||(u=d+a),g!==o||r!==0&&g.nodeType!==3||(h=d+r),g.nodeType===3&&(d+=g.nodeValue.length),(j=g.firstChild)!==null;)x=g,g=j;for(;;){if(g===t)break t;if(x===s&&++p===a&&(u=d),x===o&&++m===r&&(h=d),(j=g.nextSibling)!==null)break;g=x,x=g.parentNode}g=j}s=u===-1||h===-1?null:{start:u,end:h}}else s=null}s=s||{start:0,end:0}}else s=null;for(xl={focusedElem:t,selectionRange:s},Kr=!1,N=n;N!==null;)if(n=N,t=n.child,(n.subtreeFlags&1028)!==0&&t!==null)t.return=n,N=t;else for(;N!==null;){n=N;try{var I=n.alternate;if(n.flags&1024)switch(n.tag){case 0:case 11:case 15:break;case 1:if(I!==null){var S=I.memoizedProps,T=I.memoizedState,w=n.stateNode,y=w.getSnapshotBeforeUpdate(n.elementType===n.type?S:Je(n.type,S),T);w.__reactInternalSnapshotBeforeUpdate=y}break;case 3:var b=n.stateNode.containerInfo;b.nodeType===1?b.textContent="":b.nodeType===9&&b.documentElement&&b.removeChild(b.documentElement);break;case 5:case 6:case 4:case 17:break;default:throw Error(M(163))}}catch(C){ne(n,n.return,C)}if(t=n.sibling,t!==null){t.return=n.return,N=t;break}N=n.return}return I=Uu,Uu=!1,I}function ps(t,n,s){var r=n.updateQueue;if(r=r!==null?r.lastEffect:null,r!==null){var a=r=r.next;do{if((a.tag&t)===t){var o=a.destroy;a.destroy=void 0,o!==void 0&&Al(n,s,o)}a=a.next}while(a!==r)}}function ka(t,n){if(n=n.updateQueue,n=n!==null?n.lastEffect:null,n!==null){var s=n=n.next;do{if((s.tag&t)===t){var r=s.create;s.destroy=r()}s=s.next}while(s!==n)}}function zl(t){var n=t.ref;if(n!==null){var s=t.stateNode;switch(t.tag){case 5:t=s;break;default:t=s}typeof n=="function"?n(t):n.current=t}}function Fm(t){var n=t.alternate;n!==null&&(t.alternate=null,Fm(n)),t.child=null,t.deletions=null,t.sibling=null,t.tag===5&&(n=t.stateNode,n!==null&&(delete n[ht],delete n[Rs],delete n[jl],delete n[qy],delete n[Wy])),t.stateNode=null,t.return=null,t.dependencies=null,t.memoizedProps=null,t.memoizedState=null,t.pendingProps=null,t.stateNode=null,t.updateQueue=null}function $m(t){return t.tag===5||t.tag===3||t.tag===4}function qu(t){e:for(;;){for(;t.sibling===null;){if(t.return===null||$m(t.return))return null;t=t.return}for(t.sibling.return=t.return,t=t.sibling;t.tag!==5&&t.tag!==6&&t.tag!==18;){if(t.flags&2||t.child===null||t.tag===4)continue e;t.child.return=t,t=t.child}if(!(t.flags&2))return t.stateNode}}function Nl(t,n,s){var r=t.tag;if(r===5||r===6)t=t.stateNode,n?s.nodeType===8?s.parentNode.insertBefore(t,n):s.insertBefore(t,n):(s.nodeType===8?(n=s.parentNode,n.insertBefore(t,s)):(n=s,n.appendChild(t)),s=s._reactRootContainer,s!=null||n.onclick!==null||(n.onclick=Jr));else if(r!==4&&(t=t.child,t!==null))for(Nl(t,n,s),t=t.sibling;t!==null;)Nl(t,n,s),t=t.sibling}function _l(t,n,s){var r=t.tag;if(r===5||r===6)t=t.stateNode,n?s.insertBefore(t,n):s.appendChild(t);else if(r!==4&&(t=t.child,t!==null))for(_l(t,n,s),t=t.sibling;t!==null;)_l(t,n,s),t=t.sibling}var he=null,et=!1;function $t(t,n,s){for(s=s.child;s!==null;)Bm(t,n,s),s=s.sibling}function Bm(t,n,s){if(pt&&typeof pt.onCommitFiberUnmount=="function")try{pt.onCommitFiberUnmount(ja,s)}catch{}switch(s.tag){case 5:ye||ri(s,n);case 6:var r=he,a=et;he=null,$t(t,n,s),he=r,et=a,he!==null&&(et?(t=he,s=s.stateNode,t.nodeType===8?t.parentNode.removeChild(s):t.removeChild(s)):he.removeChild(s.stateNode));break;case 18:he!==null&&(et?(t=he,s=s.stateNode,t.nodeType===8?wo(t.parentNode,s):t.nodeType===1&&wo(t,s),bs(t)):wo(he,s.stateNode));break;case 4:r=he,a=et,he=s.stateNode.containerInfo,et=!0,$t(t,n,s),he=r,et=a;break;case 0:case 11:case 14:case 15:if(!ye&&(r=s.updateQueue,r!==null&&(r=r.lastEffect,r!==null))){a=r=r.next;do{var o=a,d=o.destroy;o=o.tag,d!==void 0&&(o&2||o&4)&&Al(s,n,d),a=a.next}while(a!==r)}$t(t,n,s);break;case 1:if(!ye&&(ri(s,n),r=s.stateNode,typeof r.componentWillUnmount=="function"))try{r.props=s.memoizedProps,r.state=s.memoizedState,r.componentWillUnmount()}catch(u){ne(s,n,u)}$t(t,n,s);break;case 21:$t(t,n,s);break;case 22:s.mode&1?(ye=(r=ye)||s.memoizedState!==null,$t(t,n,s),ye=r):$t(t,n,s);break;default:$t(t,n,s)}}function Wu(t){var n=t.updateQueue;if(n!==null){t.updateQueue=null;var s=t.stateNode;s===null&&(s=t.stateNode=new cj),n.forEach(function(r){var a=yj.bind(null,t,r);s.has(r)||(s.add(r),r.then(a,a))})}}function Ze(t,n){var s=n.deletions;if(s!==null)for(var r=0;r<s.length;r++){var a=s[r];try{var o=t,d=n,u=d;e:for(;u!==null;){switch(u.tag){case 5:he=u.stateNode,et=!1;break e;case 3:he=u.stateNode.containerInfo,et=!0;break e;case 4:he=u.stateNode.containerInfo,et=!0;break e}u=u.return}if(he===null)throw Error(M(160));Bm(o,d,a),he=null,et=!1;var h=a.alternate;h!==null&&(h.return=null),a.return=null}catch(p){ne(a,n,p)}}if(n.subtreeFlags&12854)for(n=n.child;n!==null;)Hm(n,t),n=n.sibling}function Hm(t,n){var s=t.alternate,r=t.flags;switch(t.tag){case 0:case 11:case 14:case 15:if(Ze(n,t),ct(t),r&4){try{ps(3,t,t.return),ka(3,t)}catch(S){ne(t,t.return,S)}try{ps(5,t,t.return)}catch(S){ne(t,t.return,S)}}break;case 1:Ze(n,t),ct(t),r&512&&s!==null&&ri(s,s.return);break;case 5:if(Ze(n,t),ct(t),r&512&&s!==null&&ri(s,s.return),t.flags&32){var a=t.stateNode;try{vs(a,"")}catch(S){ne(t,t.return,S)}}if(r&4&&(a=t.stateNode,a!=null)){var o=t.memoizedProps,d=s!==null?s.memoizedProps:o,u=t.type,h=t.updateQueue;if(t.updateQueue=null,h!==null)try{u==="input"&&o.type==="radio"&&o.name!=null&&dp(a,o),al(u,d);var p=al(u,o);for(d=0;d<h.length;d+=2){var m=h[d],g=h[d+1];m==="style"?mp(a,g):m==="dangerouslySetInnerHTML"?fp(a,g):m==="children"?vs(a,g):rc(a,m,g,p)}switch(u){case"input":tl(a,o);break;case"textarea":up(a,o);break;case"select":var x=a._wrapperState.wasMultiple;a._wrapperState.wasMultiple=!!o.multiple;var j=o.value;j!=null?oi(a,!!o.multiple,j,!1):x!==!!o.multiple&&(o.defaultValue!=null?oi(a,!!o.multiple,o.defaultValue,!0):oi(a,!!o.multiple,o.multiple?[]:"",!1))}a[Rs]=o}catch(S){ne(t,t.return,S)}}break;case 6:if(Ze(n,t),ct(t),r&4){if(t.stateNode===null)throw Error(M(162));a=t.stateNode,o=t.memoizedProps;try{a.nodeValue=o}catch(S){ne(t,t.return,S)}}break;case 3:if(Ze(n,t),ct(t),r&4&&s!==null&&s.memoizedState.isDehydrated)try{bs(n.containerInfo)}catch(S){ne(t,t.return,S)}break;case 4:Ze(n,t),ct(t);break;case 13:Ze(n,t),ct(t),a=t.child,a.flags&8192&&(o=a.memoizedState!==null,a.stateNode.isHidden=o,!o||a.alternate!==null&&a.alternate.memoizedState!==null||(Oc=ie())),r&4&&Wu(t);break;case 22:if(m=s!==null&&s.memoizedState!==null,t.mode&1?(ye=(p=ye)||m,Ze(n,t),ye=p):Ze(n,t),ct(t),r&8192){if(p=t.memoizedState!==null,(t.stateNode.isHidden=p)&&!m&&t.mode&1)for(N=t,m=t.child;m!==null;){for(g=N=m;N!==null;){switch(x=N,j=x.child,x.tag){case 0:case 11:case 14:case 15:ps(4,x,x.return);break;case 1:ri(x,x.return);var I=x.stateNode;if(typeof I.componentWillUnmount=="function"){r=x,s=x.return;try{n=r,I.props=n.memoizedProps,I.state=n.memoizedState,I.componentWillUnmount()}catch(S){ne(r,s,S)}}break;case 5:ri(x,x.return);break;case 22:if(x.memoizedState!==null){Yu(g);continue}}j!==null?(j.return=x,N=j):Yu(g)}m=m.sibling}e:for(m=null,g=t;;){if(g.tag===5){if(m===null){m=g;try{a=g.stateNode,p?(o=a.style,typeof o.setProperty=="function"?o.setProperty("display","none","important"):o.display="none"):(u=g.stateNode,h=g.memoizedProps.style,d=h!=null&&h.hasOwnProperty("display")?h.display:null,u.style.display=pp("display",d))}catch(S){ne(t,t.return,S)}}}else if(g.tag===6){if(m===null)try{g.stateNode.nodeValue=p?"":g.memoizedProps}catch(S){ne(t,t.return,S)}}else if((g.tag!==22&&g.tag!==23||g.memoizedState===null||g===t)&&g.child!==null){g.child.return=g,g=g.child;continue}if(g===t)break e;for(;g.sibling===null;){if(g.return===null||g.return===t)break e;m===g&&(m=null),g=g.return}m===g&&(m=null),g.sibling.return=g.return,g=g.sibling}}break;case 19:Ze(n,t),ct(t),r&4&&Wu(t);break;case 21:break;default:Ze(n,t),ct(t)}}function ct(t){var n=t.flags;if(n&2){try{e:{for(var s=t.return;s!==null;){if($m(s)){var r=s;break e}s=s.return}throw Error(M(160))}switch(r.tag){case 5:var a=r.stateNode;r.flags&32&&(vs(a,""),r.flags&=-33);var o=qu(t);_l(t,o,a);break;case 3:case 4:var d=r.stateNode.containerInfo,u=qu(t);Nl(t,u,d);break;default:throw Error(M(161))}}catch(h){ne(t,t.return,h)}t.flags&=-3}n&4096&&(t.flags&=-4097)}function uj(t,n,s){N=t,Vm(t)}function Vm(t,n,s){for(var r=(t.mode&1)!==0;N!==null;){var a=N,o=a.child;if(a.tag===22&&r){var d=a.memoizedState!==null||hr;if(!d){var u=a.alternate,h=u!==null&&u.memoizedState!==null||ye;u=hr;var p=ye;if(hr=d,(ye=h)&&!p)for(N=a;N!==null;)d=N,h=d.child,d.tag===22&&d.memoizedState!==null?Ku(a):h!==null?(h.return=d,N=h):Ku(a);for(;o!==null;)N=o,Vm(o),o=o.sibling;N=a,hr=u,ye=p}Qu(t)}else a.subtreeFlags&8772&&o!==null?(o.return=a,N=o):Qu(t)}}function Qu(t){for(;N!==null;){var n=N;if(n.flags&8772){var s=n.alternate;try{if(n.flags&8772)switch(n.tag){case 0:case 11:case 15:ye||ka(5,n);break;case 1:var r=n.stateNode;if(n.flags&4&&!ye)if(s===null)r.componentDidMount();else{var a=n.elementType===n.type?s.memoizedProps:Je(n.type,s.memoizedProps);r.componentDidUpdate(a,s.memoizedState,r.__reactInternalSnapshotBeforeUpdate)}var o=n.updateQueue;o!==null&&Mu(n,o,r);break;case 3:var d=n.updateQueue;if(d!==null){if(s=null,n.child!==null)switch(n.child.tag){case 5:s=n.child.stateNode;break;case 1:s=n.child.stateNode}Mu(n,d,s)}break;case 5:var u=n.stateNode;if(s===null&&n.flags&4){s=u;var h=n.memoizedProps;switch(n.type){case"button":case"input":case"select":case"textarea":h.autoFocus&&s.focus();break;case"img":h.src&&(s.src=h.src)}}break;case 6:break;case 4:break;case 12:break;case 13:if(n.memoizedState===null){var p=n.alternate;if(p!==null){var m=p.memoizedState;if(m!==null){var g=m.dehydrated;g!==null&&bs(g)}}}break;case 19:case 17:case 21:case 22:case 23:case 25:break;default:throw Error(M(163))}ye||n.flags&512&&zl(n)}catch(x){ne(n,n.return,x)}}if(n===t){N=null;break}if(s=n.sibling,s!==null){s.return=n.return,N=s;break}N=n.return}}function Yu(t){for(;N!==null;){var n=N;if(n===t){N=null;break}var s=n.sibling;if(s!==null){s.return=n.return,N=s;break}N=n.return}}function Ku(t){for(;N!==null;){var n=N;try{switch(n.tag){case 0:case 11:case 15:var s=n.return;try{ka(4,n)}catch(h){ne(n,s,h)}break;case 1:var r=n.stateNode;if(typeof r.componentDidMount=="function"){var a=n.return;try{r.componentDidMount()}catch(h){ne(n,a,h)}}var o=n.return;try{zl(n)}catch(h){ne(n,o,h)}break;case 5:var d=n.return;try{zl(n)}catch(h){ne(n,d,h)}}}catch(h){ne(n,n.return,h)}if(n===t){N=null;break}var u=n.sibling;if(u!==null){u.return=n.return,N=u;break}N=n.return}}var hj=Math.ceil,da=zt.ReactCurrentDispatcher,_c=zt.ReactCurrentOwner,Ge=zt.ReactCurrentBatchConfig,V=0,ue=null,ae=null,fe=0,Me=0,ai=ln(0),ce=0,As=null,Tn=0,Pa=0,Lc=0,ms=null,Te=null,Oc=0,ji=1/0,St=null,ua=!1,Ll=null,en=null,fr=!1,Qt=null,ha=0,gs=0,Ol=null,Lr=-1,Or=0;function Se(){return V&6?ie():Lr!==-1?Lr:Lr=ie()}function tn(t){return t.mode&1?V&2&&fe!==0?fe&-fe:Yy.transition!==null?(Or===0&&(Or=Rp()),Or):(t=U,t!==0||(t=window.event,t=t===void 0?16:zp(t.type)),t):1}function at(t,n,s,r){if(50<gs)throw gs=0,Ol=null,Error(M(185));Ls(t,s,r),(!(V&2)||t!==ue)&&(t===ue&&(!(V&2)&&(Pa|=s),ce===4&&qt(t,fe)),Ee(t,r),s===1&&V===0&&!(n.mode&1)&&(ji=ie()+500,Ca&&cn()))}function Ee(t,n){var s=t.callbackNode;Y0(t,n);var r=Yr(t,t===ue?fe:0);if(r===0)s!==null&&ru(s),t.callbackNode=null,t.callbackPriority=0;else if(n=r&-r,t.callbackPriority!==n){if(s!=null&&ru(s),n===1)t.tag===0?Qy(Xu.bind(null,t)):Jp(Xu.bind(null,t)),Gy(function(){!(V&6)&&cn()}),s=null;else{switch(kp(r)){case 1:s=dc;break;case 4:s=Cp;break;case 16:s=Qr;break;case 536870912:s=Tp;break;default:s=Qr}s=Xm(s,Gm.bind(null,t))}t.callbackPriority=n,t.callbackNode=s}}function Gm(t,n){if(Lr=-1,Or=0,V&6)throw Error(M(327));var s=t.callbackNode;if(hi()&&t.callbackNode!==s)return null;var r=Yr(t,t===ue?fe:0);if(r===0)return null;if(r&30||r&t.expiredLanes||n)n=fa(t,r);else{n=r;var a=V;V|=2;var o=qm();(ue!==t||fe!==n)&&(St=null,ji=ie()+500,jn(t,n));do try{mj();break}catch(u){Um(t,u)}while(!0);Sc(),da.current=o,V=a,ae!==null?n=0:(ue=null,fe=0,n=ce)}if(n!==0){if(n===2&&(a=ul(t),a!==0&&(r=a,n=Fl(t,a))),n===1)throw s=As,jn(t,0),qt(t,r),Ee(t,ie()),s;if(n===6)qt(t,r);else{if(a=t.current.alternate,!(r&30)&&!fj(a)&&(n=fa(t,r),n===2&&(o=ul(t),o!==0&&(r=o,n=Fl(t,o))),n===1))throw s=As,jn(t,0),qt(t,r),Ee(t,ie()),s;switch(t.finishedWork=a,t.finishedLanes=r,n){case 0:case 1:throw Error(M(345));case 2:fn(t,Te,St);break;case 3:if(qt(t,r),(r&130023424)===r&&(n=Oc+500-ie(),10<n)){if(Yr(t,0)!==0)break;if(a=t.suspendedLanes,(a&r)!==r){Se(),t.pingedLanes|=t.suspendedLanes&a;break}t.timeoutHandle=yl(fn.bind(null,t,Te,St),n);break}fn(t,Te,St);break;case 4:if(qt(t,r),(r&4194240)===r)break;for(n=t.eventTimes,a=-1;0<r;){var d=31-rt(r);o=1<<d,d=n[d],d>a&&(a=d),r&=~o}if(r=a,r=ie()-r,r=(120>r?120:480>r?480:1080>r?1080:1920>r?1920:3e3>r?3e3:4320>r?4320:1960*hj(r/1960))-r,10<r){t.timeoutHandle=yl(fn.bind(null,t,Te,St),r);break}fn(t,Te,St);break;case 5:fn(t,Te,St);break;default:throw Error(M(329))}}}return Ee(t,ie()),t.callbackNode===s?Gm.bind(null,t):null}function Fl(t,n){var s=ms;return t.current.memoizedState.isDehydrated&&(jn(t,n).flags|=256),t=fa(t,n),t!==2&&(n=Te,Te=s,n!==null&&$l(n)),t}function $l(t){Te===null?Te=t:Te.push.apply(Te,t)}function fj(t){for(var n=t;;){if(n.flags&16384){var s=n.updateQueue;if(s!==null&&(s=s.stores,s!==null))for(var r=0;r<s.length;r++){var a=s[r],o=a.getSnapshot;a=a.value;try{if(!lt(o(),a))return!1}catch{return!1}}}if(s=n.child,n.subtreeFlags&16384&&s!==null)s.return=n,n=s;else{if(n===t)break;for(;n.sibling===null;){if(n.return===null||n.return===t)return!0;n=n.return}n.sibling.return=n.return,n=n.sibling}}return!0}function qt(t,n){for(n&=~Lc,n&=~Pa,t.suspendedLanes|=n,t.pingedLanes&=~n,t=t.expirationTimes;0<n;){var s=31-rt(n),r=1<<s;t[s]=-1,n&=~r}}function Xu(t){if(V&6)throw Error(M(327));hi();var n=Yr(t,0);if(!(n&1))return Ee(t,ie()),null;var s=fa(t,n);if(t.tag!==0&&s===2){var r=ul(t);r!==0&&(n=r,s=Fl(t,r))}if(s===1)throw s=As,jn(t,0),qt(t,n),Ee(t,ie()),s;if(s===6)throw Error(M(345));return t.finishedWork=t.current.alternate,t.finishedLanes=n,fn(t,Te,St),Ee(t,ie()),null}function Fc(t,n){var s=V;V|=1;try{return t(n)}finally{V=s,V===0&&(ji=ie()+500,Ca&&cn())}}function Rn(t){Qt!==null&&Qt.tag===0&&!(V&6)&&hi();var n=V;V|=1;var s=Ge.transition,r=U;try{if(Ge.transition=null,U=1,t)return t()}finally{U=r,Ge.transition=s,V=n,!(V&6)&&cn()}}function $c(){Me=ai.current,Y(ai)}function jn(t,n){t.finishedWork=null,t.finishedLanes=0;var s=t.timeoutHandle;if(s!==-1&&(t.timeoutHandle=-1,Vy(s)),ae!==null)for(s=ae.return;s!==null;){var r=s;switch(jc(r),r.tag){case 1:r=r.type.childContextTypes,r!=null&&ea();break;case 3:vi(),Y(ke),Y(je),Pc();break;case 5:kc(r);break;case 4:vi();break;case 13:Y(Z);break;case 19:Y(Z);break;case 10:Ic(r.type._context);break;case 22:case 23:$c()}s=s.return}if(ue=t,ae=t=nn(t.current,null),fe=Me=n,ce=0,As=null,Lc=Pa=Tn=0,Te=ms=null,vn!==null){for(n=0;n<vn.length;n++)if(s=vn[n],r=s.interleaved,r!==null){s.interleaved=null;var a=r.next,o=s.pending;if(o!==null){var d=o.next;o.next=a,r.next=d}s.pending=r}vn=null}return t}function Um(t,n){do{var s=ae;try{if(Sc(),zr.current=ca,la){for(var r=J.memoizedState;r!==null;){var a=r.queue;a!==null&&(a.pending=null),r=r.next}la=!1}if(Cn=0,de=le=J=null,fs=!1,Es=0,_c.current=null,s===null||s.return===null){ce=1,As=n,ae=null;break}e:{var o=t,d=s.return,u=s,h=n;if(n=fe,u.flags|=32768,h!==null&&typeof h=="object"&&typeof h.then=="function"){var p=h,m=u,g=m.tag;if(!(m.mode&1)&&(g===0||g===11||g===15)){var x=m.alternate;x?(m.updateQueue=x.updateQueue,m.memoizedState=x.memoizedState,m.lanes=x.lanes):(m.updateQueue=null,m.memoizedState=null)}var j=Ou(d);if(j!==null){j.flags&=-257,Fu(j,d,u,o,n),j.mode&1&&Lu(o,p,n),n=j,h=p;var I=n.updateQueue;if(I===null){var S=new Set;S.add(h),n.updateQueue=S}else I.add(h);break e}else{if(!(n&1)){Lu(o,p,n),Bc();break e}h=Error(M(426))}}else if(K&&u.mode&1){var T=Ou(d);if(T!==null){!(T.flags&65536)&&(T.flags|=256),Fu(T,d,u,o,n),wc(yi(h,u));break e}}o=h=yi(h,u),ce!==4&&(ce=2),ms===null?ms=[o]:ms.push(o),o=d;do{switch(o.tag){case 3:o.flags|=65536,n&=-n,o.lanes|=n;var w=km(o,h,n);Du(o,w);break e;case 1:u=h;var y=o.type,b=o.stateNode;if(!(o.flags&128)&&(typeof y.getDerivedStateFromError=="function"||b!==null&&typeof b.componentDidCatch=="function"&&(en===null||!en.has(b)))){o.flags|=65536,n&=-n,o.lanes|=n;var C=Pm(o,u,n);Du(o,C);break e}}o=o.return}while(o!==null)}Qm(s)}catch(R){n=R,ae===s&&s!==null&&(ae=s=s.return);continue}break}while(!0)}function qm(){var t=da.current;return da.current=ca,t===null?ca:t}function Bc(){(ce===0||ce===3||ce===2)&&(ce=4),ue===null||!(Tn&268435455)&&!(Pa&268435455)||qt(ue,fe)}function fa(t,n){var s=V;V|=2;var r=qm();(ue!==t||fe!==n)&&(St=null,jn(t,n));do try{pj();break}catch(a){Um(t,a)}while(!0);if(Sc(),V=s,da.current=r,ae!==null)throw Error(M(261));return ue=null,fe=0,ce}function pj(){for(;ae!==null;)Wm(ae)}function mj(){for(;ae!==null&&!$0();)Wm(ae)}function Wm(t){var n=Km(t.alternate,t,Me);t.memoizedProps=t.pendingProps,n===null?Qm(t):ae=n,_c.current=null}function Qm(t){var n=t;do{var s=n.alternate;if(t=n.return,n.flags&32768){if(s=lj(s,n),s!==null){s.flags&=32767,ae=s;return}if(t!==null)t.flags|=32768,t.subtreeFlags=0,t.deletions=null;else{ce=6,ae=null;return}}else if(s=oj(s,n,Me),s!==null){ae=s;return}if(n=n.sibling,n!==null){ae=n;return}ae=n=t}while(n!==null);ce===0&&(ce=5)}function fn(t,n,s){var r=U,a=Ge.transition;try{Ge.transition=null,U=1,gj(t,n,s,r)}finally{Ge.transition=a,U=r}return null}function gj(t,n,s,r){do hi();while(Qt!==null);if(V&6)throw Error(M(327));s=t.finishedWork;var a=t.finishedLanes;if(s===null)return null;if(t.finishedWork=null,t.finishedLanes=0,s===t.current)throw Error(M(177));t.callbackNode=null,t.callbackPriority=0;var o=s.lanes|s.childLanes;if(K0(t,o),t===ue&&(ae=ue=null,fe=0),!(s.subtreeFlags&2064)&&!(s.flags&2064)||fr||(fr=!0,Xm(Qr,function(){return hi(),null})),o=(s.flags&15990)!==0,s.subtreeFlags&15990||o){o=Ge.transition,Ge.transition=null;var d=U;U=1;var u=V;V|=4,_c.current=null,dj(t,s),Hm(s,t),_y(xl),Kr=!!gl,xl=gl=null,t.current=s,uj(s),B0(),V=u,U=d,Ge.transition=o}else t.current=s;if(fr&&(fr=!1,Qt=t,ha=a),o=t.pendingLanes,o===0&&(en=null),G0(s.stateNode),Ee(t,ie()),n!==null)for(r=t.onRecoverableError,s=0;s<n.length;s++)a=n[s],r(a.value,{componentStack:a.stack,digest:a.digest});if(ua)throw ua=!1,t=Ll,Ll=null,t;return ha&1&&t.tag!==0&&hi(),o=t.pendingLanes,o&1?t===Ol?gs++:(gs=0,Ol=t):gs=0,cn(),null}function hi(){if(Qt!==null){var t=kp(ha),n=Ge.transition,s=U;try{if(Ge.transition=null,U=16>t?16:t,Qt===null)var r=!1;else{if(t=Qt,Qt=null,ha=0,V&6)throw Error(M(331));var a=V;for(V|=4,N=t.current;N!==null;){var o=N,d=o.child;if(N.flags&16){var u=o.deletions;if(u!==null){for(var h=0;h<u.length;h++){var p=u[h];for(N=p;N!==null;){var m=N;switch(m.tag){case 0:case 11:case 15:ps(8,m,o)}var g=m.child;if(g!==null)g.return=m,N=g;else for(;N!==null;){m=N;var x=m.sibling,j=m.return;if(Fm(m),m===p){N=null;break}if(x!==null){x.return=j,N=x;break}N=j}}}var I=o.alternate;if(I!==null){var S=I.child;if(S!==null){I.child=null;do{var T=S.sibling;S.sibling=null,S=T}while(S!==null)}}N=o}}if(o.subtreeFlags&2064&&d!==null)d.return=o,N=d;else e:for(;N!==null;){if(o=N,o.flags&2048)switch(o.tag){case 0:case 11:case 15:ps(9,o,o.return)}var w=o.sibling;if(w!==null){w.return=o.return,N=w;break e}N=o.return}}var y=t.current;for(N=y;N!==null;){d=N;var b=d.child;if(d.subtreeFlags&2064&&b!==null)b.return=d,N=b;else e:for(d=y;N!==null;){if(u=N,u.flags&2048)try{switch(u.tag){case 0:case 11:case 15:ka(9,u)}}catch(R){ne(u,u.return,R)}if(u===d){N=null;break e}var C=u.sibling;if(C!==null){C.return=u.return,N=C;break e}N=u.return}}if(V=a,cn(),pt&&typeof pt.onPostCommitFiberRoot=="function")try{pt.onPostCommitFiberRoot(ja,t)}catch{}r=!0}return r}finally{U=s,Ge.transition=n}}return!1}function Zu(t,n,s){n=yi(s,n),n=km(t,n,1),t=Jt(t,n,1),n=Se(),t!==null&&(Ls(t,1,n),Ee(t,n))}function ne(t,n,s){if(t.tag===3)Zu(t,t,s);else for(;n!==null;){if(n.tag===3){Zu(n,t,s);break}else if(n.tag===1){var r=n.stateNode;if(typeof n.type.getDerivedStateFromError=="function"||typeof r.componentDidCatch=="function"&&(en===null||!en.has(r))){t=yi(s,t),t=Pm(n,t,1),n=Jt(n,t,1),t=Se(),n!==null&&(Ls(n,1,t),Ee(n,t));break}}n=n.return}}function xj(t,n,s){var r=t.pingCache;r!==null&&r.delete(n),n=Se(),t.pingedLanes|=t.suspendedLanes&s,ue===t&&(fe&s)===s&&(ce===4||ce===3&&(fe&130023424)===fe&&500>ie()-Oc?jn(t,0):Lc|=s),Ee(t,n)}function Ym(t,n){n===0&&(t.mode&1?(n=ir,ir<<=1,!(ir&130023424)&&(ir=4194304)):n=1);var s=Se();t=Dt(t,n),t!==null&&(Ls(t,n,s),Ee(t,s))}function vj(t){var n=t.memoizedState,s=0;n!==null&&(s=n.retryLane),Ym(t,s)}function yj(t,n){var s=0;switch(t.tag){case 13:var r=t.stateNode,a=t.memoizedState;a!==null&&(s=a.retryLane);break;case 19:r=t.stateNode;break;default:throw Error(M(314))}r!==null&&r.delete(n),Ym(t,s)}var Km;Km=function(t,n,s){if(t!==null)if(t.memoizedProps!==n.pendingProps||ke.current)Re=!0;else{if(!(t.lanes&s)&&!(n.flags&128))return Re=!1,aj(t,n,s);Re=!!(t.flags&131072)}else Re=!1,K&&n.flags&1048576&&em(n,ia,n.index);switch(n.lanes=0,n.tag){case 2:var r=n.type;_r(t,n),t=n.pendingProps;var a=mi(n,je.current);ui(n,s),a=Dc(null,n,r,t,a,s);var o=Mc();return n.flags|=1,typeof a=="object"&&a!==null&&typeof a.render=="function"&&a.$$typeof===void 0?(n.tag=1,n.memoizedState=null,n.updateQueue=null,Pe(r)?(o=!0,ta(n)):o=!1,n.memoizedState=a.state!==null&&a.state!==void 0?a.state:null,Tc(n),a.updater=Ra,n.stateNode=a,a._reactInternals=n,Tl(n,r,t,s),n=Pl(null,n,r,!0,o,s)):(n.tag=0,K&&o&&yc(n),be(null,n,a,s),n=n.child),n;case 16:r=n.elementType;e:{switch(_r(t,n),t=n.pendingProps,a=r._init,r=a(r._payload),n.type=r,a=n.tag=wj(r),t=Je(r,t),a){case 0:n=kl(null,n,r,t,s);break e;case 1:n=Hu(null,n,r,t,s);break e;case 11:n=$u(null,n,r,t,s);break e;case 14:n=Bu(null,n,r,Je(r.type,t),s);break e}throw Error(M(306,r,""))}return n;case 0:return r=n.type,a=n.pendingProps,a=n.elementType===r?a:Je(r,a),kl(t,n,r,a,s);case 1:return r=n.type,a=n.pendingProps,a=n.elementType===r?a:Je(r,a),Hu(t,n,r,a,s);case 3:e:{if(Am(n),t===null)throw Error(M(387));r=n.pendingProps,o=n.memoizedState,a=o.element,am(t,n),aa(n,r,null,s);var d=n.memoizedState;if(r=d.element,o.isDehydrated)if(o={element:r,isDehydrated:!1,cache:d.cache,pendingSuspenseBoundaries:d.pendingSuspenseBoundaries,transitions:d.transitions},n.updateQueue.baseState=o,n.memoizedState=o,n.flags&256){a=yi(Error(M(423)),n),n=Vu(t,n,r,s,a);break e}else if(r!==a){a=yi(Error(M(424)),n),n=Vu(t,n,r,s,a);break e}else for(Ae=Zt(n.stateNode.containerInfo.firstChild),ze=n,K=!0,tt=null,s=sm(n,null,r,s),n.child=s;s;)s.flags=s.flags&-3|4096,s=s.sibling;else{if(gi(),r===a){n=Mt(t,n,s);break e}be(t,n,r,s)}n=n.child}return n;case 5:return om(n),t===null&&Sl(n),r=n.type,a=n.pendingProps,o=t!==null?t.memoizedProps:null,d=a.children,vl(r,a)?d=null:o!==null&&vl(r,o)&&(n.flags|=32),Mm(t,n),be(t,n,d,s),n.child;case 6:return t===null&&Sl(n),null;case 13:return zm(t,n,s);case 4:return Rc(n,n.stateNode.containerInfo),r=n.pendingProps,t===null?n.child=xi(n,null,r,s):be(t,n,r,s),n.child;case 11:return r=n.type,a=n.pendingProps,a=n.elementType===r?a:Je(r,a),$u(t,n,r,a,s);case 7:return be(t,n,n.pendingProps,s),n.child;case 8:return be(t,n,n.pendingProps.children,s),n.child;case 12:return be(t,n,n.pendingProps.children,s),n.child;case 10:e:{if(r=n.type._context,a=n.pendingProps,o=n.memoizedProps,d=a.value,W(sa,r._currentValue),r._currentValue=d,o!==null)if(lt(o.value,d)){if(o.children===a.children&&!ke.current){n=Mt(t,n,s);break e}}else for(o=n.child,o!==null&&(o.return=n);o!==null;){var u=o.dependencies;if(u!==null){d=o.child;for(var h=u.firstContext;h!==null;){if(h.context===r){if(o.tag===1){h=Rt(-1,s&-s),h.tag=2;var p=o.updateQueue;if(p!==null){p=p.shared;var m=p.pending;m===null?h.next=h:(h.next=m.next,m.next=h),p.pending=h}}o.lanes|=s,h=o.alternate,h!==null&&(h.lanes|=s),Il(o.return,s,n),u.lanes|=s;break}h=h.next}}else if(o.tag===10)d=o.type===n.type?null:o.child;else if(o.tag===18){if(d=o.return,d===null)throw Error(M(341));d.lanes|=s,u=d.alternate,u!==null&&(u.lanes|=s),Il(d,s,n),d=o.sibling}else d=o.child;if(d!==null)d.return=o;else for(d=o;d!==null;){if(d===n){d=null;break}if(o=d.sibling,o!==null){o.return=d.return,d=o;break}d=d.return}o=d}be(t,n,a.children,s),n=n.child}return n;case 9:return a=n.type,r=n.pendingProps.children,ui(n,s),a=Ue(a),r=r(a),n.flags|=1,be(t,n,r,s),n.child;case 14:return r=n.type,a=Je(r,n.pendingProps),a=Je(r.type,a),Bu(t,n,r,a,s);case 15:return Em(t,n,n.type,n.pendingProps,s);case 17:return r=n.type,a=n.pendingProps,a=n.elementType===r?a:Je(r,a),_r(t,n),n.tag=1,Pe(r)?(t=!0,ta(n)):t=!1,ui(n,s),Rm(n,r,a),Tl(n,r,a,s),Pl(null,n,r,!0,t,s);case 19:return Nm(t,n,s);case 22:return Dm(t,n,s)}throw Error(M(156,n.tag))};function Xm(t,n){return Ip(t,n)}function jj(t,n,s,r){this.tag=t,this.key=s,this.sibling=this.child=this.return=this.stateNode=this.type=this.elementType=null,this.index=0,this.ref=null,this.pendingProps=n,this.dependencies=this.memoizedState=this.updateQueue=this.memoizedProps=null,this.mode=r,this.subtreeFlags=this.flags=0,this.deletions=null,this.childLanes=this.lanes=0,this.alternate=null}function Ve(t,n,s,r){return new jj(t,n,s,r)}function Hc(t){return t=t.prototype,!(!t||!t.isReactComponent)}function wj(t){if(typeof t=="function")return Hc(t)?1:0;if(t!=null){if(t=t.$$typeof,t===oc)return 11;if(t===lc)return 14}return 2}function nn(t,n){var s=t.alternate;return s===null?(s=Ve(t.tag,n,t.key,t.mode),s.elementType=t.elementType,s.type=t.type,s.stateNode=t.stateNode,s.alternate=t,t.alternate=s):(s.pendingProps=n,s.type=t.type,s.flags=0,s.subtreeFlags=0,s.deletions=null),s.flags=t.flags&14680064,s.childLanes=t.childLanes,s.lanes=t.lanes,s.child=t.child,s.memoizedProps=t.memoizedProps,s.memoizedState=t.memoizedState,s.updateQueue=t.updateQueue,n=t.dependencies,s.dependencies=n===null?null:{lanes:n.lanes,firstContext:n.firstContext},s.sibling=t.sibling,s.index=t.index,s.ref=t.ref,s}function Fr(t,n,s,r,a,o){var d=2;if(r=t,typeof t=="function")Hc(t)&&(d=1);else if(typeof t=="string")d=5;else e:switch(t){case Kn:return wn(s.children,a,o,n);case ac:d=8,a|=8;break;case Ko:return t=Ve(12,s,n,a|2),t.elementType=Ko,t.lanes=o,t;case Xo:return t=Ve(13,s,n,a),t.elementType=Xo,t.lanes=o,t;case Zo:return t=Ve(19,s,n,a),t.elementType=Zo,t.lanes=o,t;case op:return Ea(s,a,o,n);default:if(typeof t=="object"&&t!==null)switch(t.$$typeof){case rp:d=10;break e;case ap:d=9;break e;case oc:d=11;break e;case lc:d=14;break e;case Vt:d=16,r=null;break e}throw Error(M(130,t==null?t:typeof t,""))}return n=Ve(d,s,n,a),n.elementType=t,n.type=r,n.lanes=o,n}function wn(t,n,s,r){return t=Ve(7,t,r,n),t.lanes=s,t}function Ea(t,n,s,r){return t=Ve(22,t,r,n),t.elementType=op,t.lanes=s,t.stateNode={isHidden:!1},t}function Po(t,n,s){return t=Ve(6,t,null,n),t.lanes=s,t}function Eo(t,n,s){return n=Ve(4,t.children!==null?t.children:[],t.key,n),n.lanes=s,n.stateNode={containerInfo:t.containerInfo,pendingChildren:null,implementation:t.implementation},n}function bj(t,n,s,r,a){this.tag=n,this.containerInfo=t,this.finishedWork=this.pingCache=this.current=this.pendingChildren=null,this.timeoutHandle=-1,this.callbackNode=this.pendingContext=this.context=null,this.callbackPriority=0,this.eventTimes=co(0),this.expirationTimes=co(-1),this.entangledLanes=this.finishedLanes=this.mutableReadLanes=this.expiredLanes=this.pingedLanes=this.suspendedLanes=this.pendingLanes=0,this.entanglements=co(0),this.identifierPrefix=r,this.onRecoverableError=a,this.mutableSourceEagerHydrationData=null}function Vc(t,n,s,r,a,o,d,u,h){return t=new bj(t,n,s,u,h),n===1?(n=1,o===!0&&(n|=8)):n=0,o=Ve(3,null,null,n),t.current=o,o.stateNode=t,o.memoizedState={element:r,isDehydrated:s,cache:null,transitions:null,pendingSuspenseBoundaries:null},Tc(o),t}function Sj(t,n,s){var r=3<arguments.length&&arguments[3]!==void 0?arguments[3]:null;return{$$typeof:Yn,key:r==null?null:""+r,children:t,containerInfo:n,implementation:s}}function Zm(t){if(!t)return rn;t=t._reactInternals;e:{if(Dn(t)!==t||t.tag!==1)throw Error(M(170));var n=t;do{switch(n.tag){case 3:n=n.stateNode.context;break e;case 1:if(Pe(n.type)){n=n.stateNode.__reactInternalMemoizedMergedChildContext;break e}}n=n.return}while(n!==null);throw Error(M(171))}if(t.tag===1){var s=t.type;if(Pe(s))return Zp(t,s,n)}return n}function Jm(t,n,s,r,a,o,d,u,h){return t=Vc(s,r,!0,t,a,o,d,u,h),t.context=Zm(null),s=t.current,r=Se(),a=tn(s),o=Rt(r,a),o.callback=n??null,Jt(s,o,a),t.current.lanes=a,Ls(t,a,r),Ee(t,r),t}function Da(t,n,s,r){var a=n.current,o=Se(),d=tn(a);return s=Zm(s),n.context===null?n.context=s:n.pendingContext=s,n=Rt(o,d),n.payload={element:t},r=r===void 0?null:r,r!==null&&(n.callback=r),t=Jt(a,n,d),t!==null&&(at(t,a,d,o),Ar(t,a,d)),d}function pa(t){if(t=t.current,!t.child)return null;switch(t.child.tag){case 5:return t.child.stateNode;default:return t.child.stateNode}}function Ju(t,n){if(t=t.memoizedState,t!==null&&t.dehydrated!==null){var s=t.retryLane;t.retryLane=s!==0&&s<n?s:n}}function Gc(t,n){Ju(t,n),(t=t.alternate)&&Ju(t,n)}function Ij(){return null}var eg=typeof reportError=="function"?reportError:function(t){console.error(t)};function Uc(t){this._internalRoot=t}Ma.prototype.render=Uc.prototype.render=function(t){var n=this._internalRoot;if(n===null)throw Error(M(409));Da(t,n,null,null)};Ma.prototype.unmount=Uc.prototype.unmount=function(){var t=this._internalRoot;if(t!==null){this._internalRoot=null;var n=t.containerInfo;Rn(function(){Da(null,t,null,null)}),n[Et]=null}};function Ma(t){this._internalRoot=t}Ma.prototype.unstable_scheduleHydration=function(t){if(t){var n=Dp();t={blockedOn:null,target:t,priority:n};for(var s=0;s<Ut.length&&n!==0&&n<Ut[s].priority;s++);Ut.splice(s,0,t),s===0&&Ap(t)}};function qc(t){return!(!t||t.nodeType!==1&&t.nodeType!==9&&t.nodeType!==11)}function Aa(t){return!(!t||t.nodeType!==1&&t.nodeType!==9&&t.nodeType!==11&&(t.nodeType!==8||t.nodeValue!==" react-mount-point-unstable "))}function eh(){}function Cj(t,n,s,r,a){if(a){if(typeof r=="function"){var o=r;r=function(){var p=pa(d);o.call(p)}}var d=Jm(n,r,t,0,null,!1,!1,"",eh);return t._reactRootContainer=d,t[Et]=d.current,Cs(t.nodeType===8?t.parentNode:t),Rn(),d}for(;a=t.lastChild;)t.removeChild(a);if(typeof r=="function"){var u=r;r=function(){var p=pa(h);u.call(p)}}var h=Vc(t,0,!1,null,null,!1,!1,"",eh);return t._reactRootContainer=h,t[Et]=h.current,Cs(t.nodeType===8?t.parentNode:t),Rn(function(){Da(n,h,s,r)}),h}function za(t,n,s,r,a){var o=s._reactRootContainer;if(o){var d=o;if(typeof a=="function"){var u=a;a=function(){var h=pa(d);u.call(h)}}Da(n,d,t,a)}else d=Cj(s,n,t,a,r);return pa(d)}Pp=function(t){switch(t.tag){case 3:var n=t.stateNode;if(n.current.memoizedState.isDehydrated){var s=ss(n.pendingLanes);s!==0&&(uc(n,s|1),Ee(n,ie()),!(V&6)&&(ji=ie()+500,cn()))}break;case 13:Rn(function(){var r=Dt(t,1);if(r!==null){var a=Se();at(r,t,1,a)}}),Gc(t,1)}};hc=function(t){if(t.tag===13){var n=Dt(t,134217728);if(n!==null){var s=Se();at(n,t,134217728,s)}Gc(t,134217728)}};Ep=function(t){if(t.tag===13){var n=tn(t),s=Dt(t,n);if(s!==null){var r=Se();at(s,t,n,r)}Gc(t,n)}};Dp=function(){return U};Mp=function(t,n){var s=U;try{return U=t,n()}finally{U=s}};ll=function(t,n,s){switch(n){case"input":if(tl(t,s),n=s.name,s.type==="radio"&&n!=null){for(s=t;s.parentNode;)s=s.parentNode;for(s=s.querySelectorAll("input[name="+JSON.stringify(""+n)+'][type="radio"]'),n=0;n<s.length;n++){var r=s[n];if(r!==t&&r.form===t.form){var a=Ia(r);if(!a)throw Error(M(90));cp(r),tl(r,a)}}}break;case"textarea":up(t,s);break;case"select":n=s.value,n!=null&&oi(t,!!s.multiple,n,!1)}};vp=Fc;yp=Rn;var Tj={usingClientEntryPoint:!1,Events:[Fs,ei,Ia,gp,xp,Fc]},Ui={findFiberByHostInstance:xn,bundleType:0,version:"18.3.1",rendererPackageName:"react-dom"},Rj={bundleType:Ui.bundleType,version:Ui.version,rendererPackageName:Ui.rendererPackageName,rendererConfig:Ui.rendererConfig,overrideHookState:null,overrideHookStateDeletePath:null,overrideHookStateRenamePath:null,overrideProps:null,overridePropsDeletePath:null,overridePropsRenamePath:null,setErrorHandler:null,setSuspenseHandler:null,scheduleUpdate:null,currentDispatcherRef:zt.ReactCurrentDispatcher,findHostInstanceByFiber:function(t){return t=bp(t),t===null?null:t.stateNode},findFiberByHostInstance:Ui.findFiberByHostInstance||Ij,findHostInstancesForRefresh:null,scheduleRefresh:null,scheduleRoot:null,setRefreshHandler:null,getCurrentFiber:null,reconcilerVersion:"18.3.1-next-f1338f8080-20240426"};if(typeof __REACT_DEVTOOLS_GLOBAL_HOOK__<"u"){var pr=__REACT_DEVTOOLS_GLOBAL_HOOK__;if(!pr.isDisabled&&pr.supportsFiber)try{ja=pr.inject(Rj),pt=pr}catch{}}_e.__SECRET_INTERNALS_DO_NOT_USE_OR_YOU_WILL_BE_FIRED=Tj;_e.createPortal=function(t,n){var s=2<arguments.length&&arguments[2]!==void 0?arguments[2]:null;if(!qc(n))throw Error(M(200));return Sj(t,n,null,s)};_e.createRoot=function(t,n){if(!qc(t))throw Error(M(299));var s=!1,r="",a=eg;return n!=null&&(n.unstable_strictMode===!0&&(s=!0),n.identifierPrefix!==void 0&&(r=n.identifierPrefix),n.onRecoverableError!==void 0&&(a=n.onRecoverableError)),n=Vc(t,1,!1,null,null,s,!1,r,a),t[Et]=n.current,Cs(t.nodeType===8?t.parentNode:t),new Uc(n)};_e.findDOMNode=function(t){if(t==null)return null;if(t.nodeType===1)return t;var n=t._reactInternals;if(n===void 0)throw typeof t.render=="function"?Error(M(188)):(t=Object.keys(t).join(","),Error(M(268,t)));return t=bp(n),t=t===null?null:t.stateNode,t};_e.flushSync=function(t){return Rn(t)};_e.hydrate=function(t,n,s){if(!Aa(n))throw Error(M(200));return za(null,t,n,!0,s)};_e.hydrateRoot=function(t,n,s){if(!qc(t))throw Error(M(405));var r=s!=null&&s.hydratedSources||null,a=!1,o="",d=eg;if(s!=null&&(s.unstable_strictMode===!0&&(a=!0),s.identifierPrefix!==void 0&&(o=s.identifierPrefix),s.onRecoverableError!==void 0&&(d=s.onRecoverableError)),n=Jm(n,null,t,1,s??null,a,!1,o,d),t[Et]=n.current,Cs(t),r)for(t=0;t<r.length;t++)s=r[t],a=s._getVersion,a=a(s._source),n.mutableSourceEagerHydrationData==null?n.mutableSourceEagerHydrationData=[s,a]:n.mutableSourceEagerHydrationData.push(s,a);return new Ma(n)};_e.render=function(t,n,s){if(!Aa(n))throw Error(M(200));return za(null,t,n,!1,s)};_e.unmountComponentAtNode=function(t){if(!Aa(t))throw Error(M(40));return t._reactRootContainer?(Rn(function(){za(null,null,t,!1,function(){t._reactRootContainer=null,t[Et]=null})}),!0):!1};_e.unstable_batchedUpdates=Fc;_e.unstable_renderSubtreeIntoContainer=function(t,n,s,r){if(!Aa(s))throw Error(M(200));if(t==null||t._reactInternals===void 0)throw Error(M(38));return za(t,n,s,!1,r)};_e.version="18.3.1-next-f1338f8080-20240426";function tg(){if(!(typeof __REACT_DEVTOOLS_GLOBAL_HOOK__>"u"||typeof __REACT_DEVTOOLS_GLOBAL_HOOK__.checkDCE!="function"))try{__REACT_DEVTOOLS_GLOBAL_HOOK__.checkDCE(tg)}catch(t){console.error(t)}}tg(),tp.exports=_e;var Wc=tp.exports;const kj=Vf(Wc);var ng,th=Wc;ng=th.createRoot,th.hydrateRoot;var ft=function(){return ft=Object.assign||function(n){for(var s,r=1,a=arguments.length;r<a;r++){s=arguments[r];for(var o in s)Object.prototype.hasOwnProperty.call(s,o)&&(n[o]=s[o])}return n},ft.apply(this,arguments)};function ig(t,n){var s={};for(var r in t)Object.prototype.hasOwnProperty.call(t,r)&&n.indexOf(r)<0&&(s[r]=t[r]);if(t!=null&&typeof Object.getOwnPropertySymbols=="function")for(var a=0,r=Object.getOwnPropertySymbols(t);a<r.length;a++)n.indexOf(r[a])<0&&Object.prototype.propertyIsEnumerable.call(t,r[a])&&(s[r[a]]=t[r[a]]);return s}function Pj(t,n,s){if(s||arguments.length===2)for(var r=0,a=n.length,o;r<a;r++)(o||!(r in n))&&(o||(o=Array.prototype.slice.call(n,0,r)),o[r]=n[r]);return t.concat(o||Array.prototype.slice.call(n))}var $r="right-scroll-bar-position",Br="width-before-scroll-bar",Ej="with-scroll-bars-hidden",Dj="--removed-body-scroll-bar-size";function Do(t,n){return typeof t=="function"?t(n):t&&(t.current=n),t}function Mj(t,n){var s=v.useState(function(){return{value:t,callback:n,facade:{get current(){return s.value},set current(r){var a=s.value;a!==r&&(s.value=r,s.callback(r,a))}}}})[0];return s.callback=n,s.facade}var Aj=typeof window<"u"?v.useLayoutEffect:v.useEffect,nh=new WeakMap;function zj(t,n){var s=Mj(null,function(r){return t.forEach(function(a){return Do(a,r)})});return Aj(function(){var r=nh.get(s);if(r){var a=new Set(r),o=new Set(t),d=s.current;a.forEach(function(u){o.has(u)||Do(u,null)}),o.forEach(function(u){a.has(u)||Do(u,d)})}nh.set(s,t)},[t]),s}function Nj(t){return t}function _j(t,n){n===void 0&&(n=Nj);var s=[],r=!1,a={read:function(){if(r)throw new Error("Sidecar: could not `read` from an `assigned` medium. `read` could be used only with `useMedium`.");return s.length?s[s.length-1]:t},useMedium:function(o){var d=n(o,r);return s.push(d),function(){s=s.filter(function(u){return u!==d})}},assignSyncMedium:function(o){for(r=!0;s.length;){var d=s;s=[],d.forEach(o)}s={push:function(u){return o(u)},filter:function(){return s}}},assignMedium:function(o){r=!0;var d=[];if(s.length){var u=s;s=[],u.forEach(o),d=s}var h=function(){var m=d;d=[],m.forEach(o)},p=function(){return Promise.resolve().then(h)};p(),s={push:function(m){d.push(m),p()},filter:function(m){return d=d.filter(m),s}}}};return a}function Lj(t){t===void 0&&(t={});var n=_j(null);return n.options=ft({async:!0,ssr:!1},t),n}var sg=function(t){var n=t.sideCar,s=ig(t,["sideCar"]);if(!n)throw new Error("Sidecar: please provide `sideCar` property to import the right car");var r=n.read();if(!r)throw new Error("Sidecar medium not found");return v.createElement(r,ft({},s))};sg.isSideCarExport=!0;function Oj(t,n){return t.useMedium(n),sg}var rg=Lj(),Mo=function(){},Na=v.forwardRef(function(t,n){var s=v.useRef(null),r=v.useState({onScrollCapture:Mo,onWheelCapture:Mo,onTouchMoveCapture:Mo}),a=r[0],o=r[1],d=t.forwardProps,u=t.children,h=t.className,p=t.removeScrollBar,m=t.enabled,g=t.shards,x=t.sideCar,j=t.noRelative,I=t.noIsolation,S=t.inert,T=t.allowPinchZoom,w=t.as,y=w===void 0?"div":w,b=t.gapMode,C=ig(t,["forwardProps","children","className","removeScrollBar","enabled","shards","sideCar","noRelative","noIsolation","inert","allowPinchZoom","as","gapMode"]),R=x,D=zj([s,n]),k=ft(ft({},C),a);return v.createElement(v.Fragment,null,m&&v.createElement(R,{sideCar:rg,removeScrollBar:p,shards:g,noRelative:j,noIsolation:I,inert:S,setCallbacks:o,allowPinchZoom:!!T,lockRef:s,gapMode:b}),d?v.cloneElement(v.Children.only(u),ft(ft({},k),{ref:D})):v.createElement(y,ft({},k,{className:h,ref:D}),u))});Na.defaultProps={enabled:!0,removeScrollBar:!0,inert:!1};Na.classNames={fullWidth:Br,zeroRight:$r};var Fj=function(){if(typeof __webpack_nonce__<"u")return __webpack_nonce__};function $j(){if(!document)return null;var t=document.createElement("style");t.type="text/css";var n=Fj();return n&&t.setAttribute("nonce",n),t}function Bj(t,n){t.styleSheet?t.styleSheet.cssText=n:t.appendChild(document.createTextNode(n))}function Hj(t){var n=document.head||document.getElementsByTagName("head")[0];n.appendChild(t)}var Vj=function(){var t=0,n=null;return{add:function(s){t==0&&(n=$j())&&(Bj(n,s),Hj(n)),t++},remove:function(){t--,!t&&n&&(n.parentNode&&n.parentNode.removeChild(n),n=null)}}},Gj=function(){var t=Vj();return function(n,s){v.useEffect(function(){return t.add(n),function(){t.remove()}},[n&&s])}},ag=function(){var t=Gj(),n=function(s){var r=s.styles,a=s.dynamic;return t(r,a),null};return n},Uj={left:0,top:0,right:0,gap:0},Ao=function(t){return parseInt(t||"",10)||0},qj=function(t){var n=window.getComputedStyle(document.body),s=n[t==="padding"?"paddingLeft":"marginLeft"],r=n[t==="padding"?"paddingTop":"marginTop"],a=n[t==="padding"?"paddingRight":"marginRight"];return[Ao(s),Ao(r),Ao(a)]},Wj=function(t){if(t===void 0&&(t="margin"),typeof window>"u")return Uj;var n=qj(t),s=document.documentElement.clientWidth,r=window.innerWidth;return{left:n[0],top:n[1],right:n[2],gap:Math.max(0,r-s+n[2]-n[0])}},Qj=ag(),fi="data-scroll-locked",Yj=function(t,n,s,r){var a=t.left,o=t.top,d=t.right,u=t.gap;return s===void 0&&(s="margin"),`
  .`.concat(Ej,` {
   overflow: hidden `).concat(r,`;
   padding-right: `).concat(u,"px ").concat(r,`;
  }
  body[`).concat(fi,`] {
    overflow: hidden `).concat(r,`;
    overscroll-behavior: contain;
    `).concat([n&&"position: relative ".concat(r,";"),s==="margin"&&`
    padding-left: `.concat(a,`px;
    padding-top: `).concat(o,`px;
    padding-right: `).concat(d,`px;
    margin-left:0;
    margin-top:0;
    margin-right: `).concat(u,"px ").concat(r,`;
    `),s==="padding"&&"padding-right: ".concat(u,"px ").concat(r,";")].filter(Boolean).join(""),`
  }
  
  .`).concat($r,` {
    right: `).concat(u,"px ").concat(r,`;
  }
  
  .`).concat(Br,` {
    margin-right: `).concat(u,"px ").concat(r,`;
  }
  
  .`).concat($r," .").concat($r,` {
    right: 0 `).concat(r,`;
  }
  
  .`).concat(Br," .").concat(Br,` {
    margin-right: 0 `).concat(r,`;
  }
  
  body[`).concat(fi,`] {
    `).concat(Dj,": ").concat(u,`px;
  }
`)},ih=function(){var t=parseInt(document.body.getAttribute(fi)||"0",10);return isFinite(t)?t:0},Kj=function(){v.useEffect(function(){return document.body.setAttribute(fi,(ih()+1).toString()),function(){var t=ih()-1;t<=0?document.body.removeAttribute(fi):document.body.setAttribute(fi,t.toString())}},[])},Xj=function(t){var n=t.noRelative,s=t.noImportant,r=t.gapMode,a=r===void 0?"margin":r;Kj();var o=v.useMemo(function(){return Wj(a)},[a]);return v.createElement(Qj,{styles:Yj(o,!n,a,s?"":"!important")})},Bl=!1;if(typeof window<"u")try{var mr=Object.defineProperty({},"passive",{get:function(){return Bl=!0,!0}});window.addEventListener("test",mr,mr),window.removeEventListener("test",mr,mr)}catch{Bl=!1}var On=Bl?{passive:!1}:!1,Zj=function(t){return t.tagName==="TEXTAREA"},og=function(t,n){if(!(t instanceof Element))return!1;var s=window.getComputedStyle(t);return s[n]!=="hidden"&&!(s.overflowY===s.overflowX&&!Zj(t)&&s[n]==="visible")},Jj=function(t){return og(t,"overflowY")},ew=function(t){return og(t,"overflowX")},sh=function(t,n){var s=n.ownerDocument,r=n;do{typeof ShadowRoot<"u"&&r instanceof ShadowRoot&&(r=r.host);var a=lg(t,r);if(a){var o=cg(t,r),d=o[1],u=o[2];if(d>u)return!0}r=r.parentNode}while(r&&r!==s.body);return!1},tw=function(t){var n=t.scrollTop,s=t.scrollHeight,r=t.clientHeight;return[n,s,r]},nw=function(t){var n=t.scrollLeft,s=t.scrollWidth,r=t.clientWidth;return[n,s,r]},lg=function(t,n){return t==="v"?Jj(n):ew(n)},cg=function(t,n){return t==="v"?tw(n):nw(n)},iw=function(t,n){return t==="h"&&n==="rtl"?-1:1},sw=function(t,n,s,r,a){var o=iw(t,window.getComputedStyle(n).direction),d=o*r,u=s.target,h=n.contains(u),p=!1,m=d>0,g=0,x=0;do{if(!u)break;var j=cg(t,u),I=j[0],S=j[1],T=j[2],w=S-T-o*I;(I||w)&&lg(t,u)&&(g+=w,x+=I);var y=u.parentNode;u=y&&y.nodeType===Node.DOCUMENT_FRAGMENT_NODE?y.host:y}while(!h&&u!==document.body||h&&(n.contains(u)||n===u));return(m&&Math.abs(g)<1||!m&&Math.abs(x)<1)&&(p=!0),p},gr=function(t){return"changedTouches"in t?[t.changedTouches[0].clientX,t.changedTouches[0].clientY]:[0,0]},rh=function(t){return[t.deltaX,t.deltaY]},ah=function(t){return t&&"current"in t?t.current:t},rw=function(t,n){return t[0]===n[0]&&t[1]===n[1]},aw=function(t){return`
  .block-interactivity-`.concat(t,` {pointer-events: none;}
  .allow-interactivity-`).concat(t,` {pointer-events: all;}
`)},ow=0,Fn=[];function lw(t){var n=v.useRef([]),s=v.useRef([0,0]),r=v.useRef(),a=v.useState(ow++)[0],o=v.useState(ag)[0],d=v.useRef(t);v.useEffect(function(){d.current=t},[t]),v.useEffect(function(){if(t.inert){document.body.classList.add("block-interactivity-".concat(a));var S=Pj([t.lockRef.current],(t.shards||[]).map(ah),!0).filter(Boolean);return S.forEach(function(T){return T.classList.add("allow-interactivity-".concat(a))}),function(){document.body.classList.remove("block-interactivity-".concat(a)),S.forEach(function(T){return T.classList.remove("allow-interactivity-".concat(a))})}}},[t.inert,t.lockRef.current,t.shards]);var u=v.useCallback(function(S,T){if("touches"in S&&S.touches.length===2||S.type==="wheel"&&S.ctrlKey)return!d.current.allowPinchZoom;var w=gr(S),y=s.current,b="deltaX"in S?S.deltaX:y[0]-w[0],C="deltaY"in S?S.deltaY:y[1]-w[1],R,D=S.target,k=Math.abs(b)>Math.abs(C)?"h":"v";if("touches"in S&&k==="h"&&D.type==="range")return!1;var P=sh(k,D);if(!P)return!0;if(P?R=k:(R=k==="v"?"h":"v",P=sh(k,D)),!P)return!1;if(!r.current&&"changedTouches"in S&&(b||C)&&(r.current=R),!R)return!0;var z=r.current||R;return sw(z,T,S,z==="h"?b:C)},[]),h=v.useCallback(function(S){var T=S;if(!(!Fn.length||Fn[Fn.length-1]!==o)){var w="deltaY"in T?rh(T):gr(T),y=n.current.filter(function(R){return R.name===T.type&&(R.target===T.target||T.target===R.shadowParent)&&rw(R.delta,w)})[0];if(y&&y.should){T.cancelable&&T.preventDefault();return}if(!y){var b=(d.current.shards||[]).map(ah).filter(Boolean).filter(function(R){return R.contains(T.target)}),C=b.length>0?u(T,b[0]):!d.current.noIsolation;C&&T.cancelable&&T.preventDefault()}}},[]),p=v.useCallback(function(S,T,w,y){var b={name:S,delta:T,target:w,should:y,shadowParent:cw(w)};n.current.push(b),setTimeout(function(){n.current=n.current.filter(function(C){return C!==b})},1)},[]),m=v.useCallback(function(S){s.current=gr(S),r.current=void 0},[]),g=v.useCallback(function(S){p(S.type,rh(S),S.target,u(S,t.lockRef.current))},[]),x=v.useCallback(function(S){p(S.type,gr(S),S.target,u(S,t.lockRef.current))},[]);v.useEffect(function(){return Fn.push(o),t.setCallbacks({onScrollCapture:g,onWheelCapture:g,onTouchMoveCapture:x}),document.addEventListener("wheel",h,On),document.addEventListener("touchmove",h,On),document.addEventListener("touchstart",m,On),function(){Fn=Fn.filter(function(S){return S!==o}),document.removeEventListener("wheel",h,On),document.removeEventListener("touchmove",h,On),document.removeEventListener("touchstart",m,On)}},[]);var j=t.removeScrollBar,I=t.inert;return v.createElement(v.Fragment,null,I?v.createElement(o,{styles:aw(a)}):null,j?v.createElement(Xj,{noRelative:t.noRelative,gapMode:t.gapMode}):null)}function cw(t){for(var n=null;t!==null;)t instanceof ShadowRoot&&(n=t.host,t=t.host),t=t.parentNode;return n}const dw=Oj(rg,lw);var _a=v.forwardRef(function(t,n){return v.createElement(Na,ft({},t,{ref:n,sideCar:dw}))});_a.classNames=Na.classNames;function pe(t){return Object.keys(t)}function zo(t){return t&&typeof t=="object"&&!Array.isArray(t)}function Qc(t,n){const s={...t},r=n;return zo(t)&&zo(n)&&Object.keys(n).forEach(a=>{zo(r[a])&&a in t?s[a]=Qc(s[a],r[a]):s[a]=r[a]}),s}function uw(t){return t.replace(/[A-Z]/g,n=>`-${n.toLowerCase()}`)}function hw(t){var n;return typeof t!="string"||!t.includes("var(--mantine-scale)")?t:(n=t.match(/^calc\((.*?)\)$/))==null?void 0:n[1].split("*")[0].trim()}function Hl(t){const n=hw(t);return typeof n=="number"?n:typeof n=="string"?n.includes("calc")||n.includes("var")?n:n.includes("px")?Number(n.replace("px","")):n.includes("rem")?Number(n.replace("rem",""))*16:n.includes("em")?Number(n.replace("em",""))*16:Number(n):NaN}function No(t){return t==="0rem"?"0rem":`calc(${t} * var(--mantine-scale))`}function dg(t,{shouldScale:n=!1}={}){function s(r){if(r===0||r==="0")return`0${t}`;if(typeof r=="number"){const a=`${r/16}${t}`;return n?No(a):a}if(typeof r=="string"){if(r===""||r.startsWith("calc(")||r.startsWith("clamp(")||r.includes("rgba("))return r;if(r.includes(","))return r.split(",").map(o=>s(o)).join(",");if(r.includes(" "))return r.split(" ").map(o=>s(o)).join(" ");if(r.includes(t))return n?No(r):r;const a=r.replace("px","");if(!Number.isNaN(Number(a))){const o=`${Number(a)/16}${t}`;return n?No(o):o}}return r}return s}const E=dg("rem",{shouldScale:!0}),ma=dg("em");function Yc(t){return Object.keys(t).reduce((n,s)=>(t[s]!==void 0&&(n[s]=t[s]),n),{})}function ug(t){if(typeof t=="number")return!0;if(typeof t=="string"){if(t.startsWith("calc(")||t.startsWith("var(")||t.includes(" ")&&t.trim()!=="")return!0;const n=/^[+-]?[0-9]+(\.[0-9]+)?(px|em|rem|ex|ch|lh|rlh|vw|vh|vmin|vmax|vb|vi|svw|svh|lvw|lvh|dvw|dvh|cm|mm|in|pt|pc|q|cqw|cqh|cqi|cqb|cqmin|cqmax|%)?$/;return t.trim().split(/\s+/).every(r=>n.test(r))}return!1}function fw(t){return Array.isArray(t)||t===null?!1:typeof t=="object"?t.type!==v.Fragment:!1}function Nt(t){const n=v.createContext(null);return[({children:a,value:o})=>e.jsx(n.Provider,{value:o,children:a}),()=>{const a=v.useContext(n);if(a===null)throw new Error(t);return a}]}function pw(t=null){const n=v.createContext(t);return[({children:a,value:o})=>e.jsx(n.Provider,{value:o,children:a}),()=>v.useContext(n)]}function oh(t,n){return s=>{if(typeof s!="string"||s.trim().length===0)throw new Error(n);return`${t}-${s}`}}function Vl(t,n){let s=t;for(;(s=s.parentElement)&&!s.matches(n););return s}function mw(t,n,s){for(let r=t-1;r>=0;r-=1)if(!n[r].disabled)return r;if(s){for(let r=n.length-1;r>-1;r-=1)if(!n[r].disabled)return r}return t}function gw(t,n,s){for(let r=t+1;r<n.length;r+=1)if(!n[r].disabled)return r;if(s){for(let r=0;r<n.length;r+=1)if(!n[r].disabled)return r}return t}function xw(t,n,s){return Vl(t,s)===Vl(n,s)}function vw({parentSelector:t,siblingSelector:n,onKeyDown:s,loop:r=!0,activateOnFocus:a=!1,dir:o="rtl",orientation:d}){return u=>{var I;s==null||s(u);const h=Array.from(((I=Vl(u.currentTarget,t))==null?void 0:I.querySelectorAll(n))||[]).filter(S=>xw(u.currentTarget,S,t)),p=h.findIndex(S=>u.currentTarget===S),m=gw(p,h,r),g=mw(p,h,r),x=o==="rtl"?g:m,j=o==="rtl"?m:g;switch(u.key){case"ArrowRight":{d==="horizontal"&&(u.stopPropagation(),u.preventDefault(),h[x].focus(),a&&h[x].click());break}case"ArrowLeft":{d==="horizontal"&&(u.stopPropagation(),u.preventDefault(),h[j].focus(),a&&h[j].click());break}case"ArrowUp":{d==="vertical"&&(u.stopPropagation(),u.preventDefault(),h[g].focus(),a&&h[g].click());break}case"ArrowDown":{d==="vertical"&&(u.stopPropagation(),u.preventDefault(),h[m].focus(),a&&h[m].click());break}case"Home":{u.stopPropagation(),u.preventDefault(),!h[0].disabled&&h[0].focus();break}case"End":{u.stopPropagation(),u.preventDefault();const S=h.length-1;!h[S].disabled&&h[S].focus();break}}}}const yw={app:100,modal:200,popover:300,overlay:400,max:9999};function Mn(t){return yw[t]}function De(t,n="size",s=!0){if(t!==void 0)return ug(t)?s?E(t):t:`var(--${n}-${t})`}function An(t){return De(t,"mantine-spacing")}function dn(t){return t===void 0?"var(--mantine-radius-default)":De(t,"mantine-radius")}function wi(t){return De(t,"mantine-font-size")}function hg(t){return De(t,"mantine-line-height",!1)}function fg(t){if(t)return De(t,"mantine-shadow",!1)}function Kc(t,n){return t in n?Hl(n[t]):Hl(t)}function lh(t,n){const s=t.map(r=>({value:r,px:Kc(r,n)}));return s.sort((r,a)=>r.px-a.px),s}function jw(t="mantine-"){return`${t}${Math.random().toString(36).slice(2,11)}`}function pn(t){const n=v.useRef(t);return v.useEffect(()=>{n.current=t}),v.useMemo(()=>(...s)=>{var r;return(r=n.current)==null?void 0:r.call(n,...s)},[])}function La(t,n){const s=typeof n=="number"?n:n.delay,r=typeof n=="number"?!1:n.flushOnUnmount,a=pn(t),o=v.useRef(0),d=v.useRef(()=>{}),u=Object.assign(v.useCallback((...h)=>{window.clearTimeout(o.current);const p=()=>{o.current!==0&&(o.current=0,a(...h))};d.current=p,u.flush=p,o.current=window.setTimeout(p,s)},[a,s]),{flush:d.current});return v.useEffect(()=>()=>{window.clearTimeout(o.current),r&&u.flush()},[u,r]),u}function ww(t,n){try{return t.addEventListener("change",n),()=>t.removeEventListener("change",n)}catch{return t.addListener(n),()=>t.removeListener(n)}}function bw(t,n){return typeof window<"u"&&"matchMedia"in window?window.matchMedia(t).matches:!1}function mn(t,n,{getInitialValueInEffect:s}={getInitialValueInEffect:!0}){const[r,a]=v.useState(s?n:bw(t)),o=v.useRef(null);return v.useEffect(()=>{if("matchMedia"in window)return o.current=window.matchMedia(t),a(o.current.matches),ww(o.current,d=>a(d.matches))},[t]),r}const Ei=typeof document<"u"?v.useLayoutEffect:v.useEffect;function pg(t,n){const s=v.useRef(!1);v.useEffect(()=>()=>{s.current=!1},[]),v.useEffect(()=>{if(s.current)return t();s.current=!0},n)}function Sw({opened:t,shouldReturnFocus:n=!0}){const s=v.useRef(null),r=()=>{var a;s.current&&"focus"in s.current&&typeof s.current.focus=="function"&&((a=s.current)==null||a.focus({preventScroll:!0}))};return pg(()=>{let a=-1;const o=d=>{d.key==="Tab"&&window.clearTimeout(a)};return document.addEventListener("keydown",o),t?s.current=document.activeElement:n&&(a=window.setTimeout(r,10)),()=>{window.clearTimeout(a),document.removeEventListener("keydown",o)}},[t,n]),r}const Iw=/input|select|textarea|button|object/,mg="a, input, select, textarea, button, object, [tabindex]";function Cw(t){return t.style.display==="none"}function Tw(t){if(t.getAttribute("aria-hidden")||t.getAttribute("hidden")||t.getAttribute("type")==="hidden")return!1;let s=t;for(;s&&!(s===document.body||s.nodeType===11);){if(Cw(s))return!1;s=s.parentNode}return!0}function gg(t){let n=t.getAttribute("tabindex");return n===null&&(n=void 0),parseInt(n,10)}function Gl(t){const n=t.nodeName.toLowerCase(),s=!Number.isNaN(gg(t));return(Iw.test(n)&&!t.disabled||t instanceof HTMLAnchorElement&&t.href||s)&&Tw(t)}function xg(t){const n=gg(t);return(Number.isNaN(n)||n>=0)&&Gl(t)}function Rw(t){return Array.from(t.querySelectorAll(mg)).filter(xg)}function kw(t,n){const s=Rw(t);if(!s.length){n.preventDefault();return}const r=s[n.shiftKey?0:s.length-1],a=t.getRootNode();let o=r===a.activeElement||t===a.activeElement;const d=a.activeElement;if(d.tagName==="INPUT"&&d.getAttribute("type")==="radio"&&(o=s.filter(m=>m.getAttribute("type")==="radio"&&m.getAttribute("name")===d.getAttribute("name")).includes(r)),!o)return;n.preventDefault();const h=s[n.shiftKey?s.length-1:0];h&&h.focus()}function Pw(t=!0){const n=v.useRef(null),s=a=>{let o=a.querySelector("[data-autofocus]");if(!o){const d=Array.from(a.querySelectorAll(mg));o=d.find(xg)||d.find(Gl)||null,!o&&Gl(a)&&(o=a)}o&&o.focus({preventScroll:!0})},r=v.useCallback(a=>{t&&a!==null&&n.current!==a&&(a?(setTimeout(()=>{a.getRootNode()&&s(a)}),n.current=a):n.current=null)},[t]);return v.useEffect(()=>{if(!t)return;n.current&&setTimeout(()=>s(n.current));const a=o=>{o.key==="Tab"&&n.current&&kw(n.current,o)};return document.addEventListener("keydown",a),()=>document.removeEventListener("keydown",a)},[t]),r}const Ew=x0.useId||(()=>{});function Dw(){const t=Ew();return t?`mantine-${t.replace(/:/g,"")}`:""}function vg(t){const n=Dw(),[s,r]=v.useState(n);return Ei(()=>{r(jw())},[]),typeof t=="string"?t:typeof window>"u"?n:s}function yg(t,n,s){v.useEffect(()=>(window.addEventListener(t,n,s),()=>window.removeEventListener(t,n,s)),[t,n])}function Ul(t,n){if(typeof t=="function")return t(n);typeof t=="object"&&t!==null&&"current"in t&&(t.current=n)}function Mw(...t){const n=new Map;return s=>{if(t.forEach(r=>{const a=Ul(r,s);a&&n.set(r,a)}),n.size>0)return()=>{t.forEach(r=>{const a=n.get(r);a?a():Ul(r,null)}),n.clear()}}}function zn(...t){return v.useCallback(Mw(...t),t)}function Aw({value:t,defaultValue:n,finalValue:s,onChange:r=()=>{}}){const[a,o]=v.useState(n!==void 0?n:s),d=(u,...h)=>{o(u),r==null||r(u,...h)};return t!==void 0?[t,r,!0]:[a,d,!1]}function jg(t,n){return mn("(prefers-reduced-motion: reduce)",t,n)}function wg(t){var n,s,r="";if(typeof t=="string"||typeof t=="number")r+=t;else if(typeof t=="object")if(Array.isArray(t)){var a=t.length;for(n=0;n<a;n++)t[n]&&(s=wg(t[n]))&&(r&&(r+=" "),r+=s)}else for(s in t)t[s]&&(r&&(r+=" "),r+=s);return r}function we(){for(var t,n,s=0,r="",a=arguments.length;s<a;s++)(t=arguments[s])&&(n=wg(t))&&(r&&(r+=" "),r+=n);return r}const zw={};function Nw(t){const n={};return t.forEach(s=>{Object.entries(s).forEach(([r,a])=>{n[r]?n[r]=we(n[r],a):n[r]=a})}),n}function Oa({theme:t,classNames:n,props:s,stylesCtx:r}){const o=(Array.isArray(n)?n:[n]).map(d=>typeof d=="function"?d(t,s,r):d||zw);return Nw(o)}function ga({theme:t,styles:n,props:s,stylesCtx:r}){return(Array.isArray(n)?n:[n]).reduce((o,d)=>typeof d=="function"?{...o,...d(t,s,r)}:{...o,...d},{})}const bg=v.createContext(null);function _t(){const t=v.useContext(bg);if(!t)throw new Error("[@mantine/core] MantineProvider was not found in tree");return t}function _w(){return _t().cssVariablesResolver}function Lw(){return _t().classNamesPrefix}function Xc(){return _t().getStyleNonce}function Ow(){return _t().withStaticClasses}function Fw(){return _t().headless}function $w(){var t;return(t=_t().stylesTransform)==null?void 0:t.sx}function Bw(){var t;return(t=_t().stylesTransform)==null?void 0:t.styles}function Sg(){return _t().env||"default"}function Hw(t){return/^#?([0-9A-F]{3}){1,2}([0-9A-F]{2})?$/i.test(t)}function Vw(t){let n=t.replace("#","");if(n.length===3){const d=n.split("");n=[d[0],d[0],d[1],d[1],d[2],d[2]].join("")}if(n.length===8){const d=parseInt(n.slice(6,8),16)/255;return{r:parseInt(n.slice(0,2),16),g:parseInt(n.slice(2,4),16),b:parseInt(n.slice(4,6),16),a:d}}const s=parseInt(n,16),r=s>>16&255,a=s>>8&255,o=s&255;return{r,g:a,b:o,a:1}}function Gw(t){const[n,s,r,a]=t.replace(/[^0-9,./]/g,"").split(/[/,]/).map(Number);return{r:n,g:s,b:r,a:a===void 0?1:a}}function Uw(t){const n=/^hsla?\(\s*(\d+)\s*,\s*(\d+%)\s*,\s*(\d+%)\s*(,\s*(0?\.\d+|\d+(\.\d+)?))?\s*\)$/i,s=t.match(n);if(!s)return{r:0,g:0,b:0,a:1};const r=parseInt(s[1],10),a=parseInt(s[2],10)/100,o=parseInt(s[3],10)/100,d=s[5]?parseFloat(s[5]):void 0,u=(1-Math.abs(2*o-1))*a,h=r/60,p=u*(1-Math.abs(h%2-1)),m=o-u/2;let g,x,j;return h>=0&&h<1?(g=u,x=p,j=0):h>=1&&h<2?(g=p,x=u,j=0):h>=2&&h<3?(g=0,x=u,j=p):h>=3&&h<4?(g=0,x=p,j=u):h>=4&&h<5?(g=p,x=0,j=u):(g=u,x=0,j=p),{r:Math.round((g+m)*255),g:Math.round((x+m)*255),b:Math.round((j+m)*255),a:d||1}}function Zc(t){return Hw(t)?Vw(t):t.startsWith("rgb")?Gw(t):t.startsWith("hsl")?Uw(t):{r:0,g:0,b:0,a:1}}function xr(t,n){if(t.startsWith("var("))return`color-mix(in srgb, ${t}, black ${n*100}%)`;const{r:s,g:r,b:a,a:o}=Zc(t),d=1-n,u=h=>Math.round(h*d);return`rgba(${u(s)}, ${u(r)}, ${u(a)}, ${o})`}function zs(t,n){return typeof t.primaryShade=="number"?t.primaryShade:n==="dark"?t.primaryShade.dark:t.primaryShade.light}function _o(t){return t<=.03928?t/12.92:((t+.055)/1.055)**2.4}function qw(t){const n=t.match(/oklch\((.*?)%\s/);return n?parseFloat(n[1]):null}function Ww(t){if(t.startsWith("oklch("))return(qw(t)||0)/100;const{r:n,g:s,b:r}=Zc(t),a=n/255,o=s/255,d=r/255,u=_o(a),h=_o(o),p=_o(d);return .2126*u+.7152*h+.0722*p}function qi(t,n=.179){return t.startsWith("var(")?!1:Ww(t)>n}function Bs({color:t,theme:n,colorScheme:s}){if(typeof t!="string")throw new Error(`[@mantine/core] Failed to parse color. Expected color to be a string, instead got ${typeof t}`);if(t==="bright")return{color:t,value:s==="dark"?n.white:n.black,shade:void 0,isThemeColor:!1,isLight:qi(s==="dark"?n.white:n.black,n.luminanceThreshold),variable:"--mantine-color-bright"};if(t==="dimmed")return{color:t,value:s==="dark"?n.colors.dark[2]:n.colors.gray[7],shade:void 0,isThemeColor:!1,isLight:qi(s==="dark"?n.colors.dark[2]:n.colors.gray[6],n.luminanceThreshold),variable:"--mantine-color-dimmed"};if(t==="white"||t==="black")return{color:t,value:t==="white"?n.white:n.black,shade:void 0,isThemeColor:!1,isLight:qi(t==="white"?n.white:n.black,n.luminanceThreshold),variable:`--mantine-color-${t}`};const[r,a]=t.split("."),o=a?Number(a):void 0,d=r in n.colors;if(d){const u=o!==void 0?n.colors[r][o]:n.colors[r][zs(n,s||"light")];return{color:r,value:u,shade:o,isThemeColor:d,isLight:qi(u,n.luminanceThreshold),variable:a?`--mantine-color-${r}-${o}`:`--mantine-color-${r}-filled`}}return{color:t,value:t,isThemeColor:d,isLight:qi(t,n.luminanceThreshold),shade:o,variable:void 0}}function an(t,n){const s=Bs({color:t||n.primaryColor,theme:n});return s.variable?`var(${s.variable})`:t}function ql(t,n){const s={from:(t==null?void 0:t.from)||n.defaultGradient.from,to:(t==null?void 0:t.to)||n.defaultGradient.to,deg:(t==null?void 0:t.deg)??n.defaultGradient.deg??0},r=an(s.from,n),a=an(s.to,n);return`linear-gradient(${s.deg}deg, ${r} 0%, ${a} 100%)`}function ut(t,n){if(typeof t!="string"||n>1||n<0)return"rgba(0, 0, 0, 1)";if(t.startsWith("var(")){const o=(1-n)*100;return`color-mix(in srgb, ${t}, transparent ${o}%)`}if(t.startsWith("oklch"))return t.includes("/")?t.replace(/\/\s*[\d.]+\s*\)/,`/ ${n})`):t.replace(")",` / ${n})`);const{r:s,g:r,b:a}=Zc(t);return`rgba(${s}, ${r}, ${a}, ${n})`}const $n=ut,Qw=({color:t,theme:n,variant:s,gradient:r,autoContrast:a})=>{const o=Bs({color:t,theme:n}),d=typeof a=="boolean"?a:n.autoContrast;if(s==="filled"){const u=d&&o.isLight?"var(--mantine-color-black)":"var(--mantine-color-white)";return o.isThemeColor?o.shade===void 0?{background:`var(--mantine-color-${t}-filled)`,hover:`var(--mantine-color-${t}-filled-hover)`,color:u,border:`${E(1)} solid transparent`}:{background:`var(--mantine-color-${o.color}-${o.shade})`,hover:`var(--mantine-color-${o.color}-${o.shade===9?8:o.shade+1})`,color:u,border:`${E(1)} solid transparent`}:{background:t,hover:xr(t,.1),color:u,border:`${E(1)} solid transparent`}}if(s==="light"){if(o.isThemeColor){if(o.shade===void 0)return{background:`var(--mantine-color-${t}-light)`,hover:`var(--mantine-color-${t}-light-hover)`,color:`var(--mantine-color-${t}-light-color)`,border:`${E(1)} solid transparent`};const u=n.colors[o.color][o.shade];return{background:ut(u,.1),hover:ut(u,.12),color:`var(--mantine-color-${o.color}-${Math.min(o.shade,6)})`,border:`${E(1)} solid transparent`}}return{background:ut(t,.1),hover:ut(t,.12),color:t,border:`${E(1)} solid transparent`}}if(s==="outline")return o.isThemeColor?o.shade===void 0?{background:"transparent",hover:`var(--mantine-color-${t}-outline-hover)`,color:`var(--mantine-color-${t}-outline)`,border:`${E(1)} solid var(--mantine-color-${t}-outline)`}:{background:"transparent",hover:ut(n.colors[o.color][o.shade],.05),color:`var(--mantine-color-${o.color}-${o.shade})`,border:`${E(1)} solid var(--mantine-color-${o.color}-${o.shade})`}:{background:"transparent",hover:ut(t,.05),color:t,border:`${E(1)} solid ${t}`};if(s==="subtle"){if(o.isThemeColor){if(o.shade===void 0)return{background:"transparent",hover:`var(--mantine-color-${t}-light-hover)`,color:`var(--mantine-color-${t}-light-color)`,border:`${E(1)} solid transparent`};const u=n.colors[o.color][o.shade];return{background:"transparent",hover:ut(u,.12),color:`var(--mantine-color-${o.color}-${Math.min(o.shade,6)})`,border:`${E(1)} solid transparent`}}return{background:"transparent",hover:ut(t,.12),color:t,border:`${E(1)} solid transparent`}}return s==="transparent"?o.isThemeColor?o.shade===void 0?{background:"transparent",hover:"transparent",color:`var(--mantine-color-${t}-light-color)`,border:`${E(1)} solid transparent`}:{background:"transparent",hover:"transparent",color:`var(--mantine-color-${o.color}-${Math.min(o.shade,6)})`,border:`${E(1)} solid transparent`}:{background:"transparent",hover:"transparent",color:t,border:`${E(1)} solid transparent`}:s==="white"?o.isThemeColor?o.shade===void 0?{background:"var(--mantine-color-white)",hover:xr(n.white,.01),color:`var(--mantine-color-${t}-filled)`,border:`${E(1)} solid transparent`}:{background:"var(--mantine-color-white)",hover:xr(n.white,.01),color:`var(--mantine-color-${o.color}-${o.shade})`,border:`${E(1)} solid transparent`}:{background:"var(--mantine-color-white)",hover:xr(n.white,.01),color:t,border:`${E(1)} solid transparent`}:s==="gradient"?{background:ql(r,n),hover:ql(r,n),color:"var(--mantine-color-white)",border:"none"}:s==="default"?{background:"var(--mantine-color-default)",hover:"var(--mantine-color-default-hover)",color:"var(--mantine-color-default-color)",border:`${E(1)} solid var(--mantine-color-default-border)`}:{}},Yw={dark:["#C9C9C9","#b8b8b8","#828282","#696969","#424242","#3b3b3b","#2e2e2e","#242424","#1f1f1f","#141414"],gray:["#f8f9fa","#f1f3f5","#e9ecef","#dee2e6","#ced4da","#adb5bd","#868e96","#495057","#343a40","#212529"],red:["#fff5f5","#ffe3e3","#ffc9c9","#ffa8a8","#ff8787","#ff6b6b","#fa5252","#f03e3e","#e03131","#c92a2a"],pink:["#fff0f6","#ffdeeb","#fcc2d7","#faa2c1","#f783ac","#f06595","#e64980","#d6336c","#c2255c","#a61e4d"],grape:["#f8f0fc","#f3d9fa","#eebefa","#e599f7","#da77f2","#cc5de8","#be4bdb","#ae3ec9","#9c36b5","#862e9c"],violet:["#f3f0ff","#e5dbff","#d0bfff","#b197fc","#9775fa","#845ef7","#7950f2","#7048e8","#6741d9","#5f3dc4"],indigo:["#edf2ff","#dbe4ff","#bac8ff","#91a7ff","#748ffc","#5c7cfa","#4c6ef5","#4263eb","#3b5bdb","#364fc7"],blue:["#e7f5ff","#d0ebff","#a5d8ff","#74c0fc","#4dabf7","#339af0","#228be6","#1c7ed6","#1971c2","#1864ab"],cyan:["#e3fafc","#c5f6fa","#99e9f2","#66d9e8","#3bc9db","#22b8cf","#15aabf","#1098ad","#0c8599","#0b7285"],teal:["#e6fcf5","#c3fae8","#96f2d7","#63e6be","#38d9a9","#20c997","#12b886","#0ca678","#099268","#087f5b"],green:["#ebfbee","#d3f9d8","#b2f2bb","#8ce99a","#69db7c","#51cf66","#40c057","#37b24d","#2f9e44","#2b8a3e"],lime:["#f4fce3","#e9fac8","#d8f5a2","#c0eb75","#a9e34b","#94d82d","#82c91e","#74b816","#66a80f","#5c940d"],yellow:["#fff9db","#fff3bf","#ffec99","#ffe066","#ffd43b","#fcc419","#fab005","#f59f00","#f08c00","#e67700"],orange:["#fff4e6","#ffe8cc","#ffd8a8","#ffc078","#ffa94d","#ff922b","#fd7e14","#f76707","#e8590c","#d9480f"]},ch="-apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji",Jc={scale:1,fontSmoothing:!0,focusRing:"auto",white:"#fff",black:"#000",colors:Yw,primaryShade:{light:6,dark:8},primaryColor:"blue",variantColorResolver:Qw,autoContrast:!1,luminanceThreshold:.3,fontFamily:ch,fontFamilyMonospace:"ui-monospace, SFMono-Regular, Menlo, Monaco, Consolas, Liberation Mono, Courier New, monospace",respectReducedMotion:!1,cursorType:"default",defaultGradient:{from:"blue",to:"cyan",deg:45},defaultRadius:"sm",activeClassName:"mantine-active",focusClassName:"",headings:{fontFamily:ch,fontWeight:"700",textWrap:"wrap",sizes:{h1:{fontSize:E(34),lineHeight:"1.3"},h2:{fontSize:E(26),lineHeight:"1.35"},h3:{fontSize:E(22),lineHeight:"1.4"},h4:{fontSize:E(18),lineHeight:"1.45"},h5:{fontSize:E(16),lineHeight:"1.5"},h6:{fontSize:E(14),lineHeight:"1.5"}}},fontSizes:{xs:E(12),sm:E(14),md:E(16),lg:E(18),xl:E(20)},lineHeights:{xs:"1.4",sm:"1.45",md:"1.55",lg:"1.6",xl:"1.65"},radius:{xs:E(2),sm:E(4),md:E(8),lg:E(16),xl:E(32)},spacing:{xs:E(10),sm:E(12),md:E(16),lg:E(20),xl:E(32)},breakpoints:{xs:"36em",sm:"48em",md:"62em",lg:"75em",xl:"88em"},shadows:{xs:`0 ${E(1)} ${E(3)} rgba(0, 0, 0, 0.05), 0 ${E(1)} ${E(2)} rgba(0, 0, 0, 0.1)`,sm:`0 ${E(1)} ${E(3)} rgba(0, 0, 0, 0.05), rgba(0, 0, 0, 0.05) 0 ${E(10)} ${E(15)} ${E(-5)}, rgba(0, 0, 0, 0.04) 0 ${E(7)} ${E(7)} ${E(-5)}`,md:`0 ${E(1)} ${E(3)} rgba(0, 0, 0, 0.05), rgba(0, 0, 0, 0.05) 0 ${E(20)} ${E(25)} ${E(-5)}, rgba(0, 0, 0, 0.04) 0 ${E(10)} ${E(10)} ${E(-5)}`,lg:`0 ${E(1)} ${E(3)} rgba(0, 0, 0, 0.05), rgba(0, 0, 0, 0.05) 0 ${E(28)} ${E(23)} ${E(-7)}, rgba(0, 0, 0, 0.04) 0 ${E(12)} ${E(12)} ${E(-7)}`,xl:`0 ${E(1)} ${E(3)} rgba(0, 0, 0, 0.05), rgba(0, 0, 0, 0.05) 0 ${E(36)} ${E(28)} ${E(-7)}, rgba(0, 0, 0, 0.04) 0 ${E(17)} ${E(17)} ${E(-7)}`},other:{},components:{}};function dh(t){return t==="auto"||t==="dark"||t==="light"}function Kw({key:t="mantine-color-scheme-value"}={}){let n;return{get:s=>{if(typeof window>"u")return s;try{const r=window.localStorage.getItem(t);return dh(r)?r:s}catch{return s}},set:s=>{try{window.localStorage.setItem(t,s)}catch(r){console.warn("[@mantine/core] Local storage color scheme manager was unable to save color scheme.",r)}},subscribe:s=>{n=r=>{r.storageArea===window.localStorage&&r.key===t&&dh(r.newValue)&&s(r.newValue)},window.addEventListener("storage",n)},unsubscribe:()=>{window.removeEventListener("storage",n)},clear:()=>{window.localStorage.removeItem(t)}}}const Xw="[@mantine/core] MantineProvider: Invalid theme.primaryColor, it accepts only key of theme.colors, learn more  https://mantine.dev/theming/colors/#primary-color",uh="[@mantine/core] MantineProvider: Invalid theme.primaryShade, it accepts only 0-9 integers or an object { light: 0-9, dark: 0-9 }";function Lo(t){return t<0||t>9?!1:parseInt(t.toString(),10)===t}function hh(t){if(!(t.primaryColor in t.colors))throw new Error(Xw);if(typeof t.primaryShade=="object"&&(!Lo(t.primaryShade.dark)||!Lo(t.primaryShade.light)))throw new Error(uh);if(typeof t.primaryShade=="number"&&!Lo(t.primaryShade))throw new Error(uh)}function Zw(t,n){var r;if(!n)return hh(t),t;const s=Qc(t,n);return n.fontFamily&&!((r=n.headings)!=null&&r.fontFamily)&&(s.headings.fontFamily=n.fontFamily),hh(s),s}const ed=v.createContext(null),Jw=()=>v.useContext(ed)||Jc;function Oe(){const t=v.useContext(ed);if(!t)throw new Error("@mantine/core: MantineProvider was not found in component tree, make sure you have it in your app");return t}function Ig({theme:t,children:n,inherit:s=!0}){const r=Jw(),a=v.useMemo(()=>Zw(s?r:Jc,t),[t,r,s]);return e.jsx(ed.Provider,{value:a,children:n})}Ig.displayName="@mantine/core/MantineThemeProvider";function eb(){const t=Oe(),n=Xc(),s=pe(t.breakpoints).reduce((r,a)=>{const o=t.breakpoints[a].includes("px"),d=Hl(t.breakpoints[a]),u=o?`${d-.1}px`:ma(d-.1),h=o?`${d}px`:ma(d);return`${r}@media (max-width: ${u}) {.mantine-visible-from-${a} {display: none !important;}}@media (min-width: ${h}) {.mantine-hidden-from-${a} {display: none !important;}}`},"");return e.jsx("style",{"data-mantine-styles":"classes",nonce:n==null?void 0:n(),dangerouslySetInnerHTML:{__html:s}})}function Oo(t){return Object.entries(t).map(([n,s])=>`${n}: ${s};`).join("")}function Wi(t,n){return(Array.isArray(t)?t:[t]).reduce((r,a)=>`${a}{${r}}`,n)}function tb(t,n){const s=Oo(t.variables),r=s?Wi(n,s):"",a=Oo(t.dark),o=Oo(t.light),d=a?Wi(n===":host"?`${n}([data-mantine-color-scheme="dark"])`:`${n}[data-mantine-color-scheme="dark"]`,a):"",u=o?Wi(n===":host"?`${n}([data-mantine-color-scheme="light"])`:`${n}[data-mantine-color-scheme="light"]`,o):"";return`${r}${d}${u}`}function td({color:t,theme:n,autoContrast:s}){return(typeof s=="boolean"?s:n.autoContrast)&&Bs({color:t||n.primaryColor,theme:n}).isLight?"var(--mantine-color-black)":"var(--mantine-color-white)"}function fh(t,n){return td({color:t.colors[t.primaryColor][zs(t,n)],theme:t,autoContrast:null})}function vr({theme:t,color:n,colorScheme:s,name:r=n,withColorValues:a=!0}){if(!t.colors[n])return{};if(s==="light"){const u=zs(t,"light"),h={[`--mantine-color-${r}-text`]:`var(--mantine-color-${r}-filled)`,[`--mantine-color-${r}-filled`]:`var(--mantine-color-${r}-${u})`,[`--mantine-color-${r}-filled-hover`]:`var(--mantine-color-${r}-${u===9?8:u+1})`,[`--mantine-color-${r}-light`]:$n(t.colors[n][u],.1),[`--mantine-color-${r}-light-hover`]:$n(t.colors[n][u],.12),[`--mantine-color-${r}-light-color`]:`var(--mantine-color-${r}-${u})`,[`--mantine-color-${r}-outline`]:`var(--mantine-color-${r}-${u})`,[`--mantine-color-${r}-outline-hover`]:$n(t.colors[n][u],.05)};return a?{[`--mantine-color-${r}-0`]:t.colors[n][0],[`--mantine-color-${r}-1`]:t.colors[n][1],[`--mantine-color-${r}-2`]:t.colors[n][2],[`--mantine-color-${r}-3`]:t.colors[n][3],[`--mantine-color-${r}-4`]:t.colors[n][4],[`--mantine-color-${r}-5`]:t.colors[n][5],[`--mantine-color-${r}-6`]:t.colors[n][6],[`--mantine-color-${r}-7`]:t.colors[n][7],[`--mantine-color-${r}-8`]:t.colors[n][8],[`--mantine-color-${r}-9`]:t.colors[n][9],...h}:h}const o=zs(t,"dark"),d={[`--mantine-color-${r}-text`]:`var(--mantine-color-${r}-4)`,[`--mantine-color-${r}-filled`]:`var(--mantine-color-${r}-${o})`,[`--mantine-color-${r}-filled-hover`]:`var(--mantine-color-${r}-${o===9?8:o+1})`,[`--mantine-color-${r}-light`]:$n(t.colors[n][Math.max(0,o-2)],.15),[`--mantine-color-${r}-light-hover`]:$n(t.colors[n][Math.max(0,o-2)],.2),[`--mantine-color-${r}-light-color`]:`var(--mantine-color-${r}-${Math.max(o-5,0)})`,[`--mantine-color-${r}-outline`]:`var(--mantine-color-${r}-${Math.max(o-4,0)})`,[`--mantine-color-${r}-outline-hover`]:$n(t.colors[n][Math.max(o-4,0)],.05)};return a?{[`--mantine-color-${r}-0`]:t.colors[n][0],[`--mantine-color-${r}-1`]:t.colors[n][1],[`--mantine-color-${r}-2`]:t.colors[n][2],[`--mantine-color-${r}-3`]:t.colors[n][3],[`--mantine-color-${r}-4`]:t.colors[n][4],[`--mantine-color-${r}-5`]:t.colors[n][5],[`--mantine-color-${r}-6`]:t.colors[n][6],[`--mantine-color-${r}-7`]:t.colors[n][7],[`--mantine-color-${r}-8`]:t.colors[n][8],[`--mantine-color-${r}-9`]:t.colors[n][9],...d}:d}function nb(t){return!!t&&typeof t=="object"&&"mantine-virtual-color"in t}function Bn(t,n,s){pe(n).forEach(r=>Object.assign(t,{[`--mantine-${s}-${r}`]:n[r]}))}const Cg=t=>{const n=zs(t,"light"),s=t.defaultRadius in t.radius?t.radius[t.defaultRadius]:E(t.defaultRadius),r={variables:{"--mantine-scale":t.scale.toString(),"--mantine-cursor-type":t.cursorType,"--mantine-color-scheme":"light dark","--mantine-webkit-font-smoothing":t.fontSmoothing?"antialiased":"unset","--mantine-moz-font-smoothing":t.fontSmoothing?"grayscale":"unset","--mantine-color-white":t.white,"--mantine-color-black":t.black,"--mantine-line-height":t.lineHeights.md,"--mantine-font-family":t.fontFamily,"--mantine-font-family-monospace":t.fontFamilyMonospace,"--mantine-font-family-headings":t.headings.fontFamily,"--mantine-heading-font-weight":t.headings.fontWeight,"--mantine-heading-text-wrap":t.headings.textWrap,"--mantine-radius-default":s,"--mantine-primary-color-filled":`var(--mantine-color-${t.primaryColor}-filled)`,"--mantine-primary-color-filled-hover":`var(--mantine-color-${t.primaryColor}-filled-hover)`,"--mantine-primary-color-light":`var(--mantine-color-${t.primaryColor}-light)`,"--mantine-primary-color-light-hover":`var(--mantine-color-${t.primaryColor}-light-hover)`,"--mantine-primary-color-light-color":`var(--mantine-color-${t.primaryColor}-light-color)`},light:{"--mantine-primary-color-contrast":fh(t,"light"),"--mantine-color-bright":"var(--mantine-color-black)","--mantine-color-text":t.black,"--mantine-color-body":t.white,"--mantine-color-error":"var(--mantine-color-red-6)","--mantine-color-placeholder":"var(--mantine-color-gray-5)","--mantine-color-anchor":`var(--mantine-color-${t.primaryColor}-${n})`,"--mantine-color-default":"var(--mantine-color-white)","--mantine-color-default-hover":"var(--mantine-color-gray-0)","--mantine-color-default-color":"var(--mantine-color-black)","--mantine-color-default-border":"var(--mantine-color-gray-4)","--mantine-color-dimmed":"var(--mantine-color-gray-6)"},dark:{"--mantine-primary-color-contrast":fh(t,"dark"),"--mantine-color-bright":"var(--mantine-color-white)","--mantine-color-text":"var(--mantine-color-dark-0)","--mantine-color-body":"var(--mantine-color-dark-7)","--mantine-color-error":"var(--mantine-color-red-8)","--mantine-color-placeholder":"var(--mantine-color-dark-3)","--mantine-color-anchor":`var(--mantine-color-${t.primaryColor}-4)`,"--mantine-color-default":"var(--mantine-color-dark-6)","--mantine-color-default-hover":"var(--mantine-color-dark-5)","--mantine-color-default-color":"var(--mantine-color-white)","--mantine-color-default-border":"var(--mantine-color-dark-4)","--mantine-color-dimmed":"var(--mantine-color-dark-2)"}};Bn(r.variables,t.breakpoints,"breakpoint"),Bn(r.variables,t.spacing,"spacing"),Bn(r.variables,t.fontSizes,"font-size"),Bn(r.variables,t.lineHeights,"line-height"),Bn(r.variables,t.shadows,"shadow"),Bn(r.variables,t.radius,"radius"),t.colors[t.primaryColor].forEach((o,d)=>{r.variables[`--mantine-primary-color-${d}`]=`var(--mantine-color-${t.primaryColor}-${d})`}),pe(t.colors).forEach(o=>{const d=t.colors[o];if(nb(d)){Object.assign(r.light,vr({theme:t,name:d.name,color:d.light,colorScheme:"light",withColorValues:!0})),Object.assign(r.dark,vr({theme:t,name:d.name,color:d.dark,colorScheme:"dark",withColorValues:!0}));return}d.forEach((u,h)=>{r.variables[`--mantine-color-${o}-${h}`]=u}),Object.assign(r.light,vr({theme:t,color:o,colorScheme:"light",withColorValues:!1})),Object.assign(r.dark,vr({theme:t,color:o,colorScheme:"dark",withColorValues:!1}))});const a=t.headings.sizes;return pe(a).forEach(o=>{r.variables[`--mantine-${o}-font-size`]=a[o].fontSize,r.variables[`--mantine-${o}-line-height`]=a[o].lineHeight,r.variables[`--mantine-${o}-font-weight`]=a[o].fontWeight||t.headings.fontWeight}),r};function ib({theme:t,generator:n}){const s=Cg(t),r=n==null?void 0:n(t);return r?Qc(s,r):s}const Fo=Cg(Jc);function sb(t){const n={variables:{},light:{},dark:{}};return pe(t.variables).forEach(s=>{Fo.variables[s]!==t.variables[s]&&(n.variables[s]=t.variables[s])}),pe(t.light).forEach(s=>{Fo.light[s]!==t.light[s]&&(n.light[s]=t.light[s])}),pe(t.dark).forEach(s=>{Fo.dark[s]!==t.dark[s]&&(n.dark[s]=t.dark[s])}),n}function rb(t){return`
  ${t}[data-mantine-color-scheme="dark"] { --mantine-color-scheme: dark; }
  ${t}[data-mantine-color-scheme="light"] { --mantine-color-scheme: light; }
`}function Tg({cssVariablesSelector:t,deduplicateCssVariables:n}){const s=Oe(),r=Xc(),a=_w(),o=ib({theme:s,generator:a}),d=t===":root"&&n,u=d?sb(o):o,h=tb(u,t);return h?e.jsx("style",{"data-mantine-styles":!0,nonce:r==null?void 0:r(),dangerouslySetInnerHTML:{__html:`${h}${d?"":rb(t)}`}}):null}Tg.displayName="@mantine/CssVariables";function ab(){const t=console.error;console.error=(...n)=>{n.length>1&&typeof n[0]=="string"&&n[0].toLowerCase().includes("extra attributes from the server")&&typeof n[1]=="string"&&n[1].toLowerCase().includes("data-mantine-color-scheme")||t(...n)}}function Hn(t,n){var a,o;const s=typeof window<"u"&&"matchMedia"in window&&((a=window.matchMedia("(prefers-color-scheme: dark)"))==null?void 0:a.matches),r=t!=="auto"?t:s?"dark":"light";(o=n())==null||o.setAttribute("data-mantine-color-scheme",r)}function ob({manager:t,defaultColorScheme:n,getRootElement:s,forceColorScheme:r}){const a=v.useRef(null),[o,d]=v.useState(()=>t.get(n)),u=r||o,h=v.useCallback(m=>{r||(Hn(m,s),d(m),t.set(m))},[t.set,u,r]),p=v.useCallback(()=>{d(n),Hn(n,s),t.clear()},[t.clear,n]);return v.useEffect(()=>(t.subscribe(h),t.unsubscribe),[t.subscribe,t.unsubscribe]),Ei(()=>{Hn(t.get(n),s)},[]),v.useEffect(()=>{var g;if(r)return Hn(r,s),()=>{};r===void 0&&Hn(o,s),typeof window<"u"&&"matchMedia"in window&&(a.current=window.matchMedia("(prefers-color-scheme: dark)"));const m=x=>{o==="auto"&&Hn(x.matches?"dark":"light",s)};return(g=a.current)==null||g.addEventListener("change",m),()=>{var x;return(x=a.current)==null?void 0:x.removeEventListener("change",m)}},[o,r]),{colorScheme:u,setColorScheme:h,clearColorScheme:p}}function lb({respectReducedMotion:t,getRootElement:n}){Ei(()=>{var s;t&&((s=n())==null||s.setAttribute("data-respect-reduced-motion","true"))},[t])}ab();function Rg({theme:t,children:n,getStyleNonce:s,withStaticClasses:r=!0,withGlobalClasses:a=!0,deduplicateCssVariables:o=!0,withCssVariables:d=!0,cssVariablesSelector:u=":root",classNamesPrefix:h="mantine",colorSchemeManager:p=Kw(),defaultColorScheme:m="light",getRootElement:g=()=>document.documentElement,cssVariablesResolver:x,forceColorScheme:j,stylesTransform:I,env:S}){const{colorScheme:T,setColorScheme:w,clearColorScheme:y}=ob({defaultColorScheme:m,forceColorScheme:j,manager:p,getRootElement:g});return lb({respectReducedMotion:(t==null?void 0:t.respectReducedMotion)||!1,getRootElement:g}),e.jsx(bg.Provider,{value:{colorScheme:T,setColorScheme:w,clearColorScheme:y,getRootElement:g,classNamesPrefix:h,getStyleNonce:s,cssVariablesResolver:x,cssVariablesSelector:u,withStaticClasses:r,stylesTransform:I,env:S},children:e.jsxs(Ig,{theme:t,children:[d&&e.jsx(Tg,{cssVariablesSelector:u,deduplicateCssVariables:o}),a&&e.jsx(eb,{}),n]})})}Rg.displayName="@mantine/core/MantineProvider";function cb({classNames:t,styles:n,props:s,stylesCtx:r}){const a=Oe();return{resolvedClassNames:Oa({theme:a,classNames:t,props:s,stylesCtx:r||void 0}),resolvedStyles:ga({theme:a,styles:n,props:s,stylesCtx:r||void 0})}}const db={always:"mantine-focus-always",auto:"mantine-focus-auto",never:"mantine-focus-never"};function ub({theme:t,options:n,unstyled:s}){return we((n==null?void 0:n.focusable)&&!s&&(t.focusClassName||db[t.focusRing]),(n==null?void 0:n.active)&&!s&&t.activeClassName)}function hb({selector:t,stylesCtx:n,options:s,props:r,theme:a}){return Oa({theme:a,classNames:s==null?void 0:s.classNames,props:(s==null?void 0:s.props)||r,stylesCtx:n})[t]}function ph({selector:t,stylesCtx:n,theme:s,classNames:r,props:a}){return Oa({theme:s,classNames:r,props:a,stylesCtx:n})[t]}function fb({rootSelector:t,selector:n,className:s}){return t===n?s:void 0}function pb({selector:t,classes:n,unstyled:s}){return s?void 0:n[t]}function mb({themeName:t,classNamesPrefix:n,selector:s,withStaticClass:r}){return r===!1?[]:t.map(a=>`${n}-${a}-${s}`)}function gb({themeName:t,theme:n,selector:s,props:r,stylesCtx:a}){return t.map(o=>{var d,u;return(u=Oa({theme:n,classNames:(d=n.components[o])==null?void 0:d.classNames,props:r,stylesCtx:a}))==null?void 0:u[s]})}function xb({options:t,classes:n,selector:s,unstyled:r}){return t!=null&&t.variant&&!r?n[`${s}--${t.variant}`]:void 0}function vb({theme:t,options:n,themeName:s,selector:r,classNamesPrefix:a,classNames:o,classes:d,unstyled:u,className:h,rootSelector:p,props:m,stylesCtx:g,withStaticClasses:x,headless:j,transformedStyles:I}){return we(ub({theme:t,options:n,unstyled:u||j}),gb({theme:t,themeName:s,selector:r,props:m,stylesCtx:g}),xb({options:n,classes:d,selector:r,unstyled:u}),ph({selector:r,stylesCtx:g,theme:t,classNames:o,props:m}),ph({selector:r,stylesCtx:g,theme:t,classNames:I,props:m}),hb({selector:r,stylesCtx:g,options:n,props:m,theme:t}),fb({rootSelector:p,selector:r,className:h}),pb({selector:r,classes:d,unstyled:u||j}),x&&!j&&mb({themeName:s,classNamesPrefix:a,selector:r,withStaticClass:n==null?void 0:n.withStaticClass}),n==null?void 0:n.className)}function yb({theme:t,themeName:n,props:s,stylesCtx:r,selector:a}){return n.map(o=>{var d;return ga({theme:t,styles:(d=t.components[o])==null?void 0:d.styles,props:s,stylesCtx:r})[a]}).reduce((o,d)=>({...o,...d}),{})}function Wl({style:t,theme:n}){return Array.isArray(t)?[...t].reduce((s,r)=>({...s,...Wl({style:r,theme:n})}),{}):typeof t=="function"?t(n):t??{}}function jb(t){return t.reduce((n,s)=>(s&&Object.keys(s).forEach(r=>{n[r]={...n[r],...Yc(s[r])}}),n),{})}function wb({vars:t,varsResolver:n,theme:s,props:r,stylesCtx:a,selector:o,themeName:d,headless:u}){var h;return(h=jb([u?{}:n==null?void 0:n(s,r,a),...d.map(p=>{var m,g,x;return(x=(g=(m=s.components)==null?void 0:m[p])==null?void 0:g.vars)==null?void 0:x.call(g,s,r,a)}),t==null?void 0:t(s,r,a)]))==null?void 0:h[o]}function bb({theme:t,themeName:n,selector:s,options:r,props:a,stylesCtx:o,rootSelector:d,styles:u,style:h,vars:p,varsResolver:m,headless:g,withStylesTransform:x}){return{...!x&&yb({theme:t,themeName:n,props:a,stylesCtx:o,selector:s}),...!x&&ga({theme:t,styles:u,props:a,stylesCtx:o})[s],...!x&&ga({theme:t,styles:r==null?void 0:r.styles,props:(r==null?void 0:r.props)||a,stylesCtx:o})[s],...wb({theme:t,props:a,stylesCtx:o,vars:p,varsResolver:m,selector:s,themeName:n,headless:g}),...d===s?Wl({style:h,theme:t}):null,...Wl({style:r==null?void 0:r.style,theme:t})}}function Sb({props:t,stylesCtx:n,themeName:s}){var d;const r=Oe(),a=(d=Bw())==null?void 0:d();return{getTransformedStyles:u=>a?[...u.map(p=>a(p,{props:t,theme:r,ctx:n})),...s.map(p=>{var m;return a((m=r.components[p])==null?void 0:m.styles,{props:t,theme:r,ctx:n})})].filter(Boolean):[],withStylesTransform:!!a}}function se({name:t,classes:n,props:s,stylesCtx:r,className:a,style:o,rootSelector:d="root",unstyled:u,classNames:h,styles:p,vars:m,varsResolver:g}){const x=Oe(),j=Lw(),I=Ow(),S=Fw(),T=(Array.isArray(t)?t:[t]).filter(b=>b),{withStylesTransform:w,getTransformedStyles:y}=Sb({props:s,stylesCtx:r,themeName:T});return(b,C)=>({className:vb({theme:x,options:C,themeName:T,selector:b,classNamesPrefix:j,classNames:h,classes:n,unstyled:u,className:a,rootSelector:d,props:s,stylesCtx:r,withStaticClasses:I,headless:S,transformedStyles:y([C==null?void 0:C.styles,p])}),style:bb({theme:x,themeName:T,selector:b,options:C,props:s,stylesCtx:r,rootSelector:d,styles:p,style:o,vars:m,varsResolver:g,headless:S,withStylesTransform:w})})}function kg(t,n){return typeof t=="boolean"?t:n.autoContrast}function F(t,n,s){var d;const r=Oe(),a=(d=r.components[t])==null?void 0:d.defaultProps,o=typeof a=="function"?a(r):a;return{...n,...o,...Yc(s)}}const Hr=["xs","sm","md","lg","xl"];function Ib(t,n){if(!n)return t.base;let s=Hr.indexOf(n);for(;s>=0;){if(Hr[s]in t)return t[Hr[s]];s-=1}return t.base}function Cb(t){return t.findLastIndex(n=>n)}function Tb(t,n){const s=Oe(),r=mn(`(min-width: ${s.breakpoints.xs})`,!1,n),a=mn(`(min-width: ${s.breakpoints.sm})`,!1,n),o=mn(`(min-width: ${s.breakpoints.md})`,!1,n),d=mn(`(min-width: ${s.breakpoints.lg})`,!1,n),u=mn(`(min-width: ${s.breakpoints.xl})`,!1,n),p=Cb([r,a,o,d,u]);return Ib(t,Hr[p])}function $o(t){return pe(t).reduce((n,s)=>t[s]!==void 0?`${n}${uw(s)}:${t[s]};`:n,"").trim()}function Rb({selector:t,styles:n,media:s,container:r}){const a=n?$o(n):"",o=Array.isArray(s)?s.map(u=>`@media${u.query}{${t}{${$o(u.styles)}}}`):[],d=Array.isArray(r)?r.map(u=>`@container ${u.query}{${t}{${$o(u.styles)}}}`):[];return`${a?`${t}{${a}}`:""}${o.join("")}${d.join("")}`.trim()}function Pg(t){const n=Xc();return e.jsx("style",{"data-mantine-styles":"inline",nonce:n==null?void 0:n(),dangerouslySetInnerHTML:{__html:Rb(t)}})}function kb(t){const{m:n,mx:s,my:r,mt:a,mb:o,ml:d,mr:u,me:h,ms:p,p:m,px:g,py:x,pt:j,pb:I,pl:S,pr:T,pe:w,ps:y,bd:b,bg:C,c:R,opacity:D,ff:k,fz:P,fw:z,lts:_,ta:q,lh:oe,fs:ge,tt:Ye,td:Ke,w:Xe,miw:jt,maw:A,h:O,mih:$,mah:X,bgsz:re,bgp:Nn,bgr:wt,bga:Li,pos:bt,top:_n,left:Gv,bottom:Uv,right:qv,inset:Wv,display:Qv,flex:Yv,hiddenFrom:Kv,visibleFrom:Xv,lightHidden:Zv,darkHidden:Jv,sx:e0,...t0}=t;return{styleProps:Yc({m:n,mx:s,my:r,mt:a,mb:o,ml:d,mr:u,me:h,ms:p,p:m,px:g,py:x,pt:j,pb:I,pl:S,pr:T,pe:w,ps:y,bd:b,bg:C,c:R,opacity:D,ff:k,fz:P,fw:z,lts:_,ta:q,lh:oe,fs:ge,tt:Ye,td:Ke,w:Xe,miw:jt,maw:A,h:O,mih:$,mah:X,bgsz:re,bgp:Nn,bgr:wt,bga:Li,pos:bt,top:_n,left:Gv,bottom:Uv,right:qv,inset:Wv,display:Qv,flex:Yv,hiddenFrom:Kv,visibleFrom:Xv,lightHidden:Zv,darkHidden:Jv,sx:e0}),rest:t0}}const Pb={m:{type:"spacing",property:"margin"},mt:{type:"spacing",property:"marginTop"},mb:{type:"spacing",property:"marginBottom"},ml:{type:"spacing",property:"marginLeft"},mr:{type:"spacing",property:"marginRight"},ms:{type:"spacing",property:"marginInlineStart"},me:{type:"spacing",property:"marginInlineEnd"},mx:{type:"spacing",property:"marginInline"},my:{type:"spacing",property:"marginBlock"},p:{type:"spacing",property:"padding"},pt:{type:"spacing",property:"paddingTop"},pb:{type:"spacing",property:"paddingBottom"},pl:{type:"spacing",property:"paddingLeft"},pr:{type:"spacing",property:"paddingRight"},ps:{type:"spacing",property:"paddingInlineStart"},pe:{type:"spacing",property:"paddingInlineEnd"},px:{type:"spacing",property:"paddingInline"},py:{type:"spacing",property:"paddingBlock"},bd:{type:"border",property:"border"},bg:{type:"color",property:"background"},c:{type:"textColor",property:"color"},opacity:{type:"identity",property:"opacity"},ff:{type:"fontFamily",property:"fontFamily"},fz:{type:"fontSize",property:"fontSize"},fw:{type:"identity",property:"fontWeight"},lts:{type:"size",property:"letterSpacing"},ta:{type:"identity",property:"textAlign"},lh:{type:"lineHeight",property:"lineHeight"},fs:{type:"identity",property:"fontStyle"},tt:{type:"identity",property:"textTransform"},td:{type:"identity",property:"textDecoration"},w:{type:"spacing",property:"width"},miw:{type:"spacing",property:"minWidth"},maw:{type:"spacing",property:"maxWidth"},h:{type:"spacing",property:"height"},mih:{type:"spacing",property:"minHeight"},mah:{type:"spacing",property:"maxHeight"},bgsz:{type:"size",property:"backgroundSize"},bgp:{type:"identity",property:"backgroundPosition"},bgr:{type:"identity",property:"backgroundRepeat"},bga:{type:"identity",property:"backgroundAttachment"},pos:{type:"identity",property:"position"},top:{type:"size",property:"top"},left:{type:"size",property:"left"},bottom:{type:"size",property:"bottom"},right:{type:"size",property:"right"},inset:{type:"size",property:"inset"},display:{type:"identity",property:"display"},flex:{type:"identity",property:"flex"}};function nd(t,n){const s=Bs({color:t,theme:n});return s.color==="dimmed"?"var(--mantine-color-dimmed)":s.color==="bright"?"var(--mantine-color-bright)":s.variable?`var(${s.variable})`:s.color}function Eb(t,n){const s=Bs({color:t,theme:n});return s.isThemeColor&&s.shade===void 0?`var(--mantine-color-${s.color}-text)`:nd(t,n)}function Db(t,n){if(typeof t=="number")return E(t);if(typeof t=="string"){const[s,r,...a]=t.split(" ").filter(d=>d.trim()!=="");let o=`${E(s)}`;return r&&(o+=` ${r}`),a.length>0&&(o+=` ${nd(a.join(" "),n)}`),o.trim()}return t}const mh={text:"var(--mantine-font-family)",mono:"var(--mantine-font-family-monospace)",monospace:"var(--mantine-font-family-monospace)",heading:"var(--mantine-font-family-headings)",headings:"var(--mantine-font-family-headings)"};function Mb(t){return typeof t=="string"&&t in mh?mh[t]:t}const Ab=["h1","h2","h3","h4","h5","h6"];function zb(t,n){return typeof t=="string"&&t in n.fontSizes?`var(--mantine-font-size-${t})`:typeof t=="string"&&Ab.includes(t)?`var(--mantine-${t}-font-size)`:typeof t=="number"||typeof t=="string"?E(t):t}function Nb(t){return t}const _b=["h1","h2","h3","h4","h5","h6"];function Lb(t,n){return typeof t=="string"&&t in n.lineHeights?`var(--mantine-line-height-${t})`:typeof t=="string"&&_b.includes(t)?`var(--mantine-${t}-line-height)`:t}function Ob(t){return typeof t=="number"?E(t):t}function Fb(t,n){if(typeof t=="number")return E(t);if(typeof t=="string"){const s=t.replace("-","");if(!(s in n.spacing))return E(t);const r=`--mantine-spacing-${s}`;return t.startsWith("-")?`calc(var(${r}) * -1)`:`var(${r})`}return t}const Bo={color:nd,textColor:Eb,fontSize:zb,spacing:Fb,identity:Nb,size:Ob,lineHeight:Lb,fontFamily:Mb,border:Db};function gh(t){return t.replace("(min-width: ","").replace("em)","")}function $b({media:t,...n}){const r=Object.keys(t).sort((a,o)=>Number(gh(a))-Number(gh(o))).map(a=>({query:a,styles:t[a]}));return{...n,media:r}}function Bb(t){if(typeof t!="object"||t===null)return!1;const n=Object.keys(t);return!(n.length===1&&n[0]==="base")}function Hb(t){return typeof t=="object"&&t!==null?"base"in t?t.base:void 0:t}function Vb(t){return typeof t=="object"&&t!==null?pe(t).filter(n=>n!=="base"):[]}function Gb(t,n){return typeof t=="object"&&t!==null&&n in t?t[n]:t}function Ub({styleProps:t,data:n,theme:s}){return $b(pe(t).reduce((r,a)=>{if(a==="hiddenFrom"||a==="visibleFrom"||a==="sx")return r;const o=n[a],d=Array.isArray(o.property)?o.property:[o.property],u=Hb(t[a]);if(!Bb(t[a]))return d.forEach(p=>{r.inlineStyles[p]=Bo[o.type](u,s)}),r;r.hasResponsiveStyles=!0;const h=Vb(t[a]);return d.forEach(p=>{u&&(r.styles[p]=Bo[o.type](u,s)),h.forEach(m=>{const g=`(min-width: ${s.breakpoints[m]})`;r.media[g]={...r.media[g],[p]:Bo[o.type](Gb(t[a],m),s)}})}),r},{hasResponsiveStyles:!1,styles:{},inlineStyles:{},media:{}}))}function qb(){return`__m__-${v.useId().replace(/:/g,"")}`}function Eg(t){return t.startsWith("data-")?t:`data-${t}`}function Wb(t){return Object.keys(t).reduce((n,s)=>{const r=t[s];return r===void 0||r===""||r===!1||r===null||(n[Eg(s)]=t[s]),n},{})}function Dg(t){return t?typeof t=="string"?{[Eg(t)]:!0}:Array.isArray(t)?[...t].reduce((n,s)=>({...n,...Dg(s)}),{}):Wb(t):null}function Ql(t,n){return Array.isArray(t)?[...t].reduce((s,r)=>({...s,...Ql(r,n)}),{}):typeof t=="function"?t(n):t??{}}function Qb({theme:t,style:n,vars:s,styleProps:r}){const a=Ql(n,t),o=Ql(s,t);return{...a,...o,...r}}const Mg=v.forwardRef(({component:t,style:n,__vars:s,className:r,variant:a,mod:o,size:d,hiddenFrom:u,visibleFrom:h,lightHidden:p,darkHidden:m,renderRoot:g,__size:x,...j},I)=>{var P;const S=Oe(),T=t||"div",{styleProps:w,rest:y}=kb(j),b=$w(),C=(P=b==null?void 0:b())==null?void 0:P(w.sx),R=qb(),D=Ub({styleProps:w,theme:S,data:Pb}),k={ref:I,style:Qb({theme:S,style:n,vars:s,styleProps:D.inlineStyles}),className:we(r,C,{[R]:D.hasResponsiveStyles,"mantine-light-hidden":p,"mantine-dark-hidden":m,[`mantine-hidden-from-${u}`]:u,[`mantine-visible-from-${h}`]:h}),"data-variant":a,"data-size":ug(d)?void 0:d||void 0,size:x,...Dg(o),...y};return e.jsxs(e.Fragment,{children:[D.hasResponsiveStyles&&e.jsx(Pg,{selector:`.${R}`,styles:D.styles,media:D.media}),typeof g=="function"?g(k):e.jsx(T,{...k})]})});Mg.displayName="@mantine/core/Box";const L=Mg;function Ag(t){return t}function H(t){const n=v.forwardRef(t);return n.extend=Ag,n.withProps=s=>{const r=v.forwardRef((a,o)=>e.jsx(n,{...s,...a,ref:o}));return r.extend=n.extend,r.displayName=`WithProps(${n.displayName})`,r},n}function xt(t){const n=v.forwardRef(t);return n.withProps=s=>{const r=v.forwardRef((a,o)=>e.jsx(n,{...s,...a,ref:o}));return r.extend=n.extend,r.displayName=`WithProps(${n.displayName})`,r},n.extend=Ag,n}const Yb=v.createContext({dir:"ltr",toggleDirection:()=>{},setDirection:()=>{}});function zg(){return v.useContext(Yb)}function Kb(t){return v.useMemo(()=>t.every(n=>n==null)?null:n=>{t.forEach(s=>{typeof s=="function"?s(n):s!=null&&(s.current=n)})},t)}const[Xb,We]=Nt("ScrollArea.Root component was not found in tree");function bi(t,n){const s=pn(n);Ei(()=>{let r=0;if(t){const a=new ResizeObserver(()=>{cancelAnimationFrame(r),r=window.requestAnimationFrame(s)});return a.observe(t),()=>{window.cancelAnimationFrame(r),a.unobserve(t)}}},[t,s])}const Zb=v.forwardRef((t,n)=>{const{style:s,...r}=t,a=We(),[o,d]=v.useState(0),[u,h]=v.useState(0),p=!!(o&&u);return bi(a.scrollbarX,()=>{var g;const m=((g=a.scrollbarX)==null?void 0:g.offsetHeight)||0;a.onCornerHeightChange(m),h(m)}),bi(a.scrollbarY,()=>{var g;const m=((g=a.scrollbarY)==null?void 0:g.offsetWidth)||0;a.onCornerWidthChange(m),d(m)}),p?e.jsx("div",{...r,ref:n,style:{...s,width:o,height:u}}):null}),Jb=v.forwardRef((t,n)=>{const s=We(),r=!!(s.scrollbarX&&s.scrollbarY);return s.type!=="scroll"&&r?e.jsx(Zb,{...t,ref:n}):null}),eS={scrollHideDelay:1e3,type:"hover"},Ng=v.forwardRef((t,n)=>{const s=F("ScrollAreaRoot",eS,t),{type:r,scrollHideDelay:a,scrollbars:o,...d}=s,[u,h]=v.useState(null),[p,m]=v.useState(null),[g,x]=v.useState(null),[j,I]=v.useState(null),[S,T]=v.useState(null),[w,y]=v.useState(0),[b,C]=v.useState(0),[R,D]=v.useState(!1),[k,P]=v.useState(!1),z=zn(n,_=>h(_));return e.jsx(Xb,{value:{type:r,scrollHideDelay:a,scrollArea:u,viewport:p,onViewportChange:m,content:g,onContentChange:x,scrollbarX:j,onScrollbarXChange:I,scrollbarXEnabled:R,onScrollbarXEnabledChange:D,scrollbarY:S,onScrollbarYChange:T,scrollbarYEnabled:k,onScrollbarYEnabledChange:P,onCornerWidthChange:y,onCornerHeightChange:C},children:e.jsx(L,{...d,ref:z,__vars:{"--sa-corner-width":o!=="xy"?"0px":`${w}px`,"--sa-corner-height":o!=="xy"?"0px":`${b}px`}})})});Ng.displayName="@mantine/core/ScrollAreaRoot";function _g(t,n){const s=t/n;return Number.isNaN(s)?0:s}function Fa(t){const n=_g(t.viewport,t.content),s=t.scrollbar.paddingStart+t.scrollbar.paddingEnd,r=(t.scrollbar.size-s)*n;return Math.max(r,18)}function Lg(t,n){return s=>{if(t[0]===t[1]||n[0]===n[1])return n[0];const r=(n[1]-n[0])/(t[1]-t[0]);return n[0]+r*(s-t[0])}}function tS(t,[n,s]){return Math.min(s,Math.max(n,t))}function xh(t,n,s="ltr"){const r=Fa(n),a=n.scrollbar.paddingStart+n.scrollbar.paddingEnd,o=n.scrollbar.size-a,d=n.content-n.viewport,u=o-r,h=s==="ltr"?[0,d]:[d*-1,0],p=tS(t,h);return Lg([0,d],[0,u])(p)}function nS(t,n,s,r="ltr"){const a=Fa(s),o=a/2,d=n||o,u=a-d,h=s.scrollbar.paddingStart+d,p=s.scrollbar.size-s.scrollbar.paddingEnd-u,m=s.content-s.viewport,g=r==="ltr"?[0,m]:[m*-1,0];return Lg([h,p],g)(t)}function Og(t,n){return t>0&&t<n}function xa(t){return t?parseInt(t,10):0}function bn(t,n,{checkForDefaultPrevented:s=!0}={}){return r=>{t==null||t(r),(s===!1||!r.defaultPrevented)&&(n==null||n(r))}}const[iS,Fg]=Nt("ScrollAreaScrollbar was not found in tree"),$g=v.forwardRef((t,n)=>{const{sizes:s,hasThumb:r,onThumbChange:a,onThumbPointerUp:o,onThumbPointerDown:d,onThumbPositionChange:u,onDragScroll:h,onWheelScroll:p,onResize:m,...g}=t,x=We(),[j,I]=v.useState(null),S=zn(n,P=>I(P)),T=v.useRef(null),w=v.useRef(""),{viewport:y}=x,b=s.content-s.viewport,C=pn(p),R=pn(u),D=La(m,10),k=P=>{if(T.current){const z=P.clientX-T.current.left,_=P.clientY-T.current.top;h({x:z,y:_})}};return v.useEffect(()=>{const P=z=>{const _=z.target;(j==null?void 0:j.contains(_))&&C(z,b)};return document.addEventListener("wheel",P,{passive:!1}),()=>document.removeEventListener("wheel",P,{passive:!1})},[y,j,b,C]),v.useEffect(R,[s,R]),bi(j,D),bi(x.content,D),e.jsx(iS,{value:{scrollbar:j,hasThumb:r,onThumbChange:pn(a),onThumbPointerUp:pn(o),onThumbPositionChange:R,onThumbPointerDown:pn(d)},children:e.jsx("div",{...g,ref:S,"data-mantine-scrollbar":!0,style:{position:"absolute",...g.style},onPointerDown:bn(t.onPointerDown,P=>{P.preventDefault(),P.button===0&&(P.target.setPointerCapture(P.pointerId),T.current=j.getBoundingClientRect(),w.current=document.body.style.webkitUserSelect,document.body.style.webkitUserSelect="none",k(P))}),onPointerMove:bn(t.onPointerMove,k),onPointerUp:bn(t.onPointerUp,P=>{const z=P.target;z.hasPointerCapture(P.pointerId)&&(P.preventDefault(),z.releasePointerCapture(P.pointerId))}),onLostPointerCapture:()=>{document.body.style.webkitUserSelect=w.current,T.current=null}})})}),Bg=v.forwardRef((t,n)=>{const{sizes:s,onSizesChange:r,style:a,...o}=t,d=We(),[u,h]=v.useState(),p=v.useRef(null),m=zn(n,p,d.onScrollbarXChange);return v.useEffect(()=>{p.current&&h(getComputedStyle(p.current))},[p]),e.jsx($g,{"data-orientation":"horizontal",...o,ref:m,sizes:s,style:{...a,"--sa-thumb-width":`${Fa(s)}px`},onThumbPointerDown:g=>t.onThumbPointerDown(g.x),onDragScroll:g=>t.onDragScroll(g.x),onWheelScroll:(g,x)=>{if(d.viewport){const j=d.viewport.scrollLeft+g.deltaX;t.onWheelScroll(j),Og(j,x)&&g.preventDefault()}},onResize:()=>{p.current&&d.viewport&&u&&r({content:d.viewport.scrollWidth,viewport:d.viewport.offsetWidth,scrollbar:{size:p.current.clientWidth,paddingStart:xa(u.paddingLeft),paddingEnd:xa(u.paddingRight)}})}})});Bg.displayName="@mantine/core/ScrollAreaScrollbarX";const Hg=v.forwardRef((t,n)=>{const{sizes:s,onSizesChange:r,style:a,...o}=t,d=We(),[u,h]=v.useState(),p=v.useRef(null),m=zn(n,p,d.onScrollbarYChange);return v.useEffect(()=>{p.current&&h(window.getComputedStyle(p.current))},[]),e.jsx($g,{...o,"data-orientation":"vertical",ref:m,sizes:s,style:{"--sa-thumb-height":`${Fa(s)}px`,...a},onThumbPointerDown:g=>t.onThumbPointerDown(g.y),onDragScroll:g=>t.onDragScroll(g.y),onWheelScroll:(g,x)=>{if(d.viewport){const j=d.viewport.scrollTop+g.deltaY;t.onWheelScroll(j),Og(j,x)&&g.preventDefault()}},onResize:()=>{p.current&&d.viewport&&u&&r({content:d.viewport.scrollHeight,viewport:d.viewport.offsetHeight,scrollbar:{size:p.current.clientHeight,paddingStart:xa(u.paddingTop),paddingEnd:xa(u.paddingBottom)}})}})});Hg.displayName="@mantine/core/ScrollAreaScrollbarY";const $a=v.forwardRef((t,n)=>{const{orientation:s="vertical",...r}=t,{dir:a}=zg(),o=We(),d=v.useRef(null),u=v.useRef(0),[h,p]=v.useState({content:0,viewport:0,scrollbar:{size:0,paddingStart:0,paddingEnd:0}}),m=_g(h.viewport,h.content),g={...r,sizes:h,onSizesChange:p,hasThumb:m>0&&m<1,onThumbChange:j=>{d.current=j},onThumbPointerUp:()=>{u.current=0},onThumbPointerDown:j=>{u.current=j}},x=(j,I)=>nS(j,u.current,h,I);return s==="horizontal"?e.jsx(Bg,{...g,ref:n,onThumbPositionChange:()=>{if(o.viewport&&d.current){const j=o.viewport.scrollLeft,I=xh(j,h,a);d.current.style.transform=`translate3d(${I}px, 0, 0)`}},onWheelScroll:j=>{o.viewport&&(o.viewport.scrollLeft=j)},onDragScroll:j=>{o.viewport&&(o.viewport.scrollLeft=x(j,a))}}):s==="vertical"?e.jsx(Hg,{...g,ref:n,onThumbPositionChange:()=>{if(o.viewport&&d.current){const j=o.viewport.scrollTop,I=xh(j,h);h.scrollbar.size===0?d.current.style.setProperty("--thumb-opacity","0"):d.current.style.setProperty("--thumb-opacity","1"),d.current.style.transform=`translate3d(0, ${I}px, 0)`}},onWheelScroll:j=>{o.viewport&&(o.viewport.scrollTop=j)},onDragScroll:j=>{o.viewport&&(o.viewport.scrollTop=x(j))}}):null});$a.displayName="@mantine/core/ScrollAreaScrollbarVisible";const id=v.forwardRef((t,n)=>{const s=We(),{forceMount:r,...a}=t,[o,d]=v.useState(!1),u=t.orientation==="horizontal",h=La(()=>{if(s.viewport){const p=s.viewport.offsetWidth<s.viewport.scrollWidth,m=s.viewport.offsetHeight<s.viewport.scrollHeight;d(u?p:m)}},10);return bi(s.viewport,h),bi(s.content,h),r||o?e.jsx($a,{"data-state":o?"visible":"hidden",...a,ref:n}):null});id.displayName="@mantine/core/ScrollAreaScrollbarAuto";const Vg=v.forwardRef((t,n)=>{const{forceMount:s,...r}=t,a=We(),[o,d]=v.useState(!1);return v.useEffect(()=>{const{scrollArea:u}=a;let h=0;if(u){const p=()=>{window.clearTimeout(h),d(!0)},m=()=>{h=window.setTimeout(()=>d(!1),a.scrollHideDelay)};return u.addEventListener("pointerenter",p),u.addEventListener("pointerleave",m),()=>{window.clearTimeout(h),u.removeEventListener("pointerenter",p),u.removeEventListener("pointerleave",m)}}},[a.scrollArea,a.scrollHideDelay]),s||o?e.jsx(id,{"data-state":o?"visible":"hidden",...r,ref:n}):null});Vg.displayName="@mantine/core/ScrollAreaScrollbarHover";const sS=v.forwardRef((t,n)=>{const{forceMount:s,...r}=t,a=We(),o=t.orientation==="horizontal",[d,u]=v.useState("hidden"),h=La(()=>u("idle"),100);return v.useEffect(()=>{if(d==="idle"){const p=window.setTimeout(()=>u("hidden"),a.scrollHideDelay);return()=>window.clearTimeout(p)}},[d,a.scrollHideDelay]),v.useEffect(()=>{const{viewport:p}=a,m=o?"scrollLeft":"scrollTop";if(p){let g=p[m];const x=()=>{const j=p[m];g!==j&&(u("scrolling"),h()),g=j};return p.addEventListener("scroll",x),()=>p.removeEventListener("scroll",x)}},[a.viewport,o,h]),s||d!=="hidden"?e.jsx($a,{"data-state":d==="hidden"?"hidden":"visible",...r,ref:n,onPointerEnter:bn(t.onPointerEnter,()=>u("interacting")),onPointerLeave:bn(t.onPointerLeave,()=>u("idle"))}):null}),Yl=v.forwardRef((t,n)=>{const{forceMount:s,...r}=t,a=We(),{onScrollbarXEnabledChange:o,onScrollbarYEnabledChange:d}=a,u=t.orientation==="horizontal";return v.useEffect(()=>(u?o(!0):d(!0),()=>{u?o(!1):d(!1)}),[u,o,d]),a.type==="hover"?e.jsx(Vg,{...r,ref:n,forceMount:s}):a.type==="scroll"?e.jsx(sS,{...r,ref:n,forceMount:s}):a.type==="auto"?e.jsx(id,{...r,ref:n,forceMount:s}):a.type==="always"?e.jsx($a,{...r,ref:n}):null});Yl.displayName="@mantine/core/ScrollAreaScrollbar";function rS(t,n=()=>{}){let s={left:t.scrollLeft,top:t.scrollTop},r=0;return function a(){const o={left:t.scrollLeft,top:t.scrollTop},d=s.left!==o.left,u=s.top!==o.top;(d||u)&&n(),s=o,r=window.requestAnimationFrame(a)}(),()=>window.cancelAnimationFrame(r)}const Gg=v.forwardRef((t,n)=>{const{style:s,...r}=t,a=We(),o=Fg(),{onThumbPositionChange:d}=o,u=zn(n,m=>o.onThumbChange(m)),h=v.useRef(void 0),p=La(()=>{h.current&&(h.current(),h.current=void 0)},100);return v.useEffect(()=>{const{viewport:m}=a;if(m){const g=()=>{if(p(),!h.current){const x=rS(m,d);h.current=x,d()}};return d(),m.addEventListener("scroll",g),()=>m.removeEventListener("scroll",g)}},[a.viewport,p,d]),e.jsx("div",{"data-state":o.hasThumb?"visible":"hidden",...r,ref:u,style:{width:"var(--sa-thumb-width)",height:"var(--sa-thumb-height)",...s},onPointerDownCapture:bn(t.onPointerDownCapture,m=>{const x=m.target.getBoundingClientRect(),j=m.clientX-x.left,I=m.clientY-x.top;o.onThumbPointerDown({x:j,y:I})}),onPointerUp:bn(t.onPointerUp,o.onThumbPointerUp)})});Gg.displayName="@mantine/core/ScrollAreaThumb";const Kl=v.forwardRef((t,n)=>{const{forceMount:s,...r}=t,a=Fg();return s||a.hasThumb?e.jsx(Gg,{ref:n,...r}):null});Kl.displayName="@mantine/core/ScrollAreaThumb";const Ug=v.forwardRef(({children:t,style:n,...s},r)=>{const a=We(),o=zn(r,a.onViewportChange);return e.jsx(L,{...s,ref:o,style:{overflowX:a.scrollbarXEnabled?"scroll":"hidden",overflowY:a.scrollbarYEnabled?"scroll":"hidden",...n},children:e.jsx("div",{style:{minWidth:"100%"},ref:a.onContentChange,children:t})})});Ug.displayName="@mantine/core/ScrollAreaViewport";var sd={root:"m_d57069b5",viewport:"m_c0783ff9",viewportInner:"m_f8f631dd",scrollbar:"m_c44ba933",thumb:"m_d8b5e363",corner:"m_21657268"};const qg={scrollHideDelay:1e3,type:"hover",scrollbars:"xy"},aS=(t,{scrollbarSize:n,overscrollBehavior:s})=>({root:{"--scrollarea-scrollbar-size":E(n),"--scrollarea-over-scroll-behavior":s}}),Hs=H((t,n)=>{const s=F("ScrollArea",qg,t),{classNames:r,className:a,style:o,styles:d,unstyled:u,scrollbarSize:h,vars:p,type:m,scrollHideDelay:g,viewportProps:x,viewportRef:j,onScrollPositionChange:I,children:S,offsetScrollbars:T,scrollbars:w,onBottomReached:y,onTopReached:b,overscrollBehavior:C,...R}=s,[D,k]=v.useState(!1),[P,z]=v.useState(!1),[_,q]=v.useState(!1),oe=se({name:"ScrollArea",props:s,classes:sd,className:a,style:o,classNames:r,styles:d,unstyled:u,vars:p,varsResolver:aS}),ge=v.useRef(null),Ye=Kb([j,ge]);return v.useEffect(()=>{if(!ge.current||T!=="present")return;const Ke=ge.current,Xe=new ResizeObserver(()=>{const{scrollHeight:jt,clientHeight:A,scrollWidth:O,clientWidth:$}=Ke;z(jt>A),q(O>$)});return Xe.observe(Ke),()=>Xe.disconnect()},[ge,T]),e.jsxs(Ng,{type:m==="never"?"always":m,scrollHideDelay:g,ref:n,scrollbars:w,...oe("root"),...R,children:[e.jsx(Ug,{...x,...oe("viewport",{style:x==null?void 0:x.style}),ref:Ye,"data-offset-scrollbars":T===!0?"xy":T||void 0,"data-scrollbars":w||void 0,"data-horizontal-hidden":T==="present"&&!_?"true":void 0,"data-vertical-hidden":T==="present"&&!P?"true":void 0,onScroll:Ke=>{var O;(O=x==null?void 0:x.onScroll)==null||O.call(x,Ke),I==null||I({x:Ke.currentTarget.scrollLeft,y:Ke.currentTarget.scrollTop});const{scrollTop:Xe,scrollHeight:jt,clientHeight:A}=Ke.currentTarget;Xe-(jt-A)>=-.6&&(y==null||y()),Xe===0&&(b==null||b())},children:S}),(w==="xy"||w==="x")&&e.jsx(Yl,{...oe("scrollbar"),orientation:"horizontal","data-hidden":m==="never"||T==="present"&&!_?!0:void 0,forceMount:!0,onMouseEnter:()=>k(!0),onMouseLeave:()=>k(!1),children:e.jsx(Kl,{...oe("thumb")})}),(w==="xy"||w==="y")&&e.jsx(Yl,{...oe("scrollbar"),orientation:"vertical","data-hidden":m==="never"||T==="present"&&!P?!0:void 0,forceMount:!0,onMouseEnter:()=>k(!0),onMouseLeave:()=>k(!1),children:e.jsx(Kl,{...oe("thumb")})}),e.jsx(Jb,{...oe("corner"),"data-hovered":D||void 0,"data-hidden":m==="never"||void 0})]})});Hs.displayName="@mantine/core/ScrollArea";const rd=H((t,n)=>{const{children:s,classNames:r,styles:a,scrollbarSize:o,scrollHideDelay:d,type:u,dir:h,offsetScrollbars:p,viewportRef:m,onScrollPositionChange:g,unstyled:x,variant:j,viewportProps:I,scrollbars:S,style:T,vars:w,onBottomReached:y,onTopReached:b,...C}=F("ScrollAreaAutosize",qg,t);return e.jsx(L,{...C,ref:n,style:[{display:"flex",overflow:"auto"},T],children:e.jsx(L,{style:{display:"flex",flexDirection:"column",flex:1},children:e.jsx(Hs,{classNames:r,styles:a,scrollHideDelay:d,scrollbarSize:o,type:u,dir:h,offsetScrollbars:p,viewportRef:m,onScrollPositionChange:g,unstyled:x,variant:j,viewportProps:I,vars:w,scrollbars:S,onBottomReached:y,onTopReached:b,children:s})})})});Hs.classes=sd;rd.displayName="@mantine/core/ScrollAreaAutosize";rd.classes=sd;Hs.Autosize=rd;var Wg={root:"m_87cf2631"};const oS={__staticSelector:"UnstyledButton"},Vs=xt((t,n)=>{const s=F("UnstyledButton",oS,t),{className:r,component:a="button",__staticSelector:o,unstyled:d,classNames:u,styles:h,style:p,...m}=s,g=se({name:o,props:s,classes:Wg,className:r,style:p,classNames:u,styles:h,unstyled:d});return e.jsx(L,{...g("root",{focusable:!0}),component:a,ref:n,type:a==="button"?"button":void 0,...m})});Vs.classes=Wg;Vs.displayName="@mantine/core/UnstyledButton";var Qg={root:"m_515a97f8"};const lS={},ad=H((t,n)=>{const s=F("VisuallyHidden",lS,t),{classNames:r,className:a,style:o,styles:d,unstyled:u,vars:h,...p}=s,m=se({name:"VisuallyHidden",classes:Qg,props:s,className:a,style:o,classNames:r,styles:d,unstyled:u});return e.jsx(L,{component:"span",ref:n,...m("root"),...p})});ad.classes=Qg;ad.displayName="@mantine/core/VisuallyHidden";var Yg={root:"m_1b7284a3"};const cS={},dS=(t,{radius:n,shadow:s})=>({root:{"--paper-radius":n===void 0?void 0:dn(n),"--paper-shadow":fg(s)}}),Ba=xt((t,n)=>{const s=F("Paper",cS,t),{classNames:r,className:a,style:o,styles:d,unstyled:u,withBorder:h,vars:p,radius:m,shadow:g,variant:x,mod:j,...I}=s,S=se({name:"Paper",props:s,classes:Yg,className:a,style:o,classNames:r,styles:d,unstyled:u,vars:p,varsResolver:dS});return e.jsx(L,{ref:n,mod:[{"data-with-border":h},j],...S("root"),variant:x,...I})});Ba.classes=Yg;Ba.displayName="@mantine/core/Paper";var Kg={root:"m_9814e45f"};const uS={zIndex:Mn("modal")},hS=(t,{gradient:n,color:s,backgroundOpacity:r,blur:a,radius:o,zIndex:d})=>({root:{"--overlay-bg":n||(s!==void 0||r!==void 0)&&ut(s||"#000",r??.6)||void 0,"--overlay-filter":a?`blur(${E(a)})`:void 0,"--overlay-radius":o===void 0?void 0:dn(o),"--overlay-z-index":d==null?void 0:d.toString()}}),od=xt((t,n)=>{const s=F("Overlay",uS,t),{classNames:r,className:a,style:o,styles:d,unstyled:u,vars:h,fixed:p,center:m,children:g,radius:x,zIndex:j,gradient:I,blur:S,color:T,backgroundOpacity:w,mod:y,...b}=s,C=se({name:"Overlay",props:s,classes:Kg,className:a,style:o,classNames:r,styles:d,unstyled:u,vars:h,varsResolver:hS});return e.jsx(L,{ref:n,...C("root"),mod:[{center:m,fixed:p},y],...b,children:g})});od.classes=Kg;od.displayName="@mantine/core/Overlay";function Ho(t){const n=document.createElement("div");return n.setAttribute("data-portal","true"),typeof t.className=="string"&&n.classList.add(...t.className.split(" ").filter(Boolean)),typeof t.style=="object"&&Object.assign(n.style,t.style),typeof t.id=="string"&&n.setAttribute("id",t.id),n}function fS({target:t,reuseTargetNode:n,...s}){if(t)return typeof t=="string"?document.querySelector(t)||Ho(s):t;if(n){const r=document.querySelector("[data-mantine-shared-portal-node]");if(r)return r;const a=Ho(s);return a.setAttribute("data-mantine-shared-portal-node","true"),document.body.appendChild(a),a}return Ho(s)}const pS={},Xg=H((t,n)=>{const{children:s,target:r,reuseTargetNode:a,...o}=F("Portal",pS,t),[d,u]=v.useState(!1),h=v.useRef(null);return Ei(()=>(u(!0),h.current=fS({target:r,reuseTargetNode:a,...o}),Ul(n,h.current),!r&&!a&&h.current&&document.body.appendChild(h.current),()=>{!r&&!a&&h.current&&document.body.removeChild(h.current)}),[r]),!d||!h.current?null:Wc.createPortal(e.jsx(e.Fragment,{children:s}),h.current)});Xg.displayName="@mantine/core/Portal";const Zg=H(({withinPortal:t=!0,children:n,...s},r)=>Sg()==="test"||!t?e.jsx(e.Fragment,{children:n}):e.jsx(Xg,{ref:r,...s,children:n}));Zg.displayName="@mantine/core/OptionalPortal";const Qi=t=>({in:{opacity:1,transform:"scale(1)"},out:{opacity:0,transform:`scale(.9) translateY(${t==="bottom"?10:-10}px)`},transitionProperty:"transform, opacity"}),yr={fade:{in:{opacity:1},out:{opacity:0},transitionProperty:"opacity"},"fade-up":{in:{opacity:1,transform:"translateY(0)"},out:{opacity:0,transform:"translateY(30px)"},transitionProperty:"opacity, transform"},"fade-down":{in:{opacity:1,transform:"translateY(0)"},out:{opacity:0,transform:"translateY(-30px)"},transitionProperty:"opacity, transform"},"fade-left":{in:{opacity:1,transform:"translateX(0)"},out:{opacity:0,transform:"translateX(30px)"},transitionProperty:"opacity, transform"},"fade-right":{in:{opacity:1,transform:"translateX(0)"},out:{opacity:0,transform:"translateX(-30px)"},transitionProperty:"opacity, transform"},scale:{in:{opacity:1,transform:"scale(1)"},out:{opacity:0,transform:"scale(0)"},common:{transformOrigin:"top"},transitionProperty:"transform, opacity"},"scale-y":{in:{opacity:1,transform:"scaleY(1)"},out:{opacity:0,transform:"scaleY(0)"},common:{transformOrigin:"top"},transitionProperty:"transform, opacity"},"scale-x":{in:{opacity:1,transform:"scaleX(1)"},out:{opacity:0,transform:"scaleX(0)"},common:{transformOrigin:"left"},transitionProperty:"transform, opacity"},"skew-up":{in:{opacity:1,transform:"translateY(0) skew(0deg, 0deg)"},out:{opacity:0,transform:"translateY(-20px) skew(-10deg, -5deg)"},common:{transformOrigin:"top"},transitionProperty:"transform, opacity"},"skew-down":{in:{opacity:1,transform:"translateY(0) skew(0deg, 0deg)"},out:{opacity:0,transform:"translateY(20px) skew(-10deg, -5deg)"},common:{transformOrigin:"bottom"},transitionProperty:"transform, opacity"},"rotate-left":{in:{opacity:1,transform:"translateY(0) rotate(0deg)"},out:{opacity:0,transform:"translateY(20px) rotate(-5deg)"},common:{transformOrigin:"bottom"},transitionProperty:"transform, opacity"},"rotate-right":{in:{opacity:1,transform:"translateY(0) rotate(0deg)"},out:{opacity:0,transform:"translateY(20px) rotate(5deg)"},common:{transformOrigin:"top"},transitionProperty:"transform, opacity"},"slide-down":{in:{opacity:1,transform:"translateY(0)"},out:{opacity:0,transform:"translateY(-100%)"},common:{transformOrigin:"top"},transitionProperty:"transform, opacity"},"slide-up":{in:{opacity:1,transform:"translateY(0)"},out:{opacity:0,transform:"translateY(100%)"},common:{transformOrigin:"bottom"},transitionProperty:"transform, opacity"},"slide-left":{in:{opacity:1,transform:"translateX(0)"},out:{opacity:0,transform:"translateX(100%)"},common:{transformOrigin:"left"},transitionProperty:"transform, opacity"},"slide-right":{in:{opacity:1,transform:"translateX(0)"},out:{opacity:0,transform:"translateX(-100%)"},common:{transformOrigin:"right"},transitionProperty:"transform, opacity"},pop:{...Qi("bottom"),common:{transformOrigin:"center center"}},"pop-bottom-left":{...Qi("bottom"),common:{transformOrigin:"bottom left"}},"pop-bottom-right":{...Qi("bottom"),common:{transformOrigin:"bottom right"}},"pop-top-left":{...Qi("top"),common:{transformOrigin:"top left"}},"pop-top-right":{...Qi("top"),common:{transformOrigin:"top right"}}},vh={entering:"in",entered:"in",exiting:"out",exited:"out","pre-exiting":"out","pre-entering":"out"};function mS({transition:t,state:n,duration:s,timingFunction:r}){const a={WebkitBackfaceVisibility:"hidden",willChange:"transform, opacity",transitionDuration:`${s}ms`,transitionTimingFunction:r};return typeof t=="string"?t in yr?{transitionProperty:yr[t].transitionProperty,...a,...yr[t].common,...yr[t][vh[n]]}:{}:{transitionProperty:t.transitionProperty,...a,...t.common,...t[vh[n]]}}function gS({duration:t,exitDuration:n,timingFunction:s,mounted:r,onEnter:a,onExit:o,onEntered:d,onExited:u,enterDelay:h,exitDelay:p}){const m=Oe(),g=jg(),x=m.respectReducedMotion?g:!1,[j,I]=v.useState(x?0:t),[S,T]=v.useState(r?"entered":"exited"),w=v.useRef(-1),y=v.useRef(-1),b=v.useRef(-1);function C(){window.clearTimeout(w.current),window.clearTimeout(y.current),cancelAnimationFrame(b.current)}const R=k=>{C();const P=k?a:o,z=k?d:u,_=x?0:k?t:n;I(_),_===0?(typeof P=="function"&&P(),typeof z=="function"&&z(),T(k?"entered":"exited")):b.current=requestAnimationFrame(()=>{kj.flushSync(()=>{T(k?"pre-entering":"pre-exiting")}),b.current=requestAnimationFrame(()=>{typeof P=="function"&&P(),T(k?"entering":"exiting"),w.current=window.setTimeout(()=>{typeof z=="function"&&z(),T(k?"entered":"exited")},_)})})},D=k=>{if(C(),typeof(k?h:p)!="number"){R(k);return}y.current=window.setTimeout(()=>{R(k)},k?h:p)};return pg(()=>{D(r)},[r]),v.useEffect(()=>()=>{C()},[]),{transitionDuration:j,transitionStatus:S,transitionTimingFunction:s||"ease"}}function Ha({keepMounted:t,transition:n="fade",duration:s=250,exitDuration:r=s,mounted:a,children:o,timingFunction:d="ease",onExit:u,onEntered:h,onEnter:p,onExited:m,enterDelay:g,exitDelay:x}){const j=Sg(),{transitionDuration:I,transitionStatus:S,transitionTimingFunction:T}=gS({mounted:a,exitDuration:r,duration:s,timingFunction:d,onExit:u,onEntered:h,onEnter:p,onExited:m,enterDelay:g,exitDelay:x});return I===0||j==="test"?a?e.jsx(e.Fragment,{children:o({})}):t?o({display:"none"}):null:S==="exited"?t?o({display:"none"}):null:e.jsx(e.Fragment,{children:o(mS({transition:n,duration:I,state:S,timingFunction:T}))})}Ha.displayName="@mantine/core/Transition";function ld({children:t,active:n=!0,refProp:s="ref",innerRef:r}){const a=Pw(n),o=zn(a,r);return fw(t)?v.cloneElement(t,{[s]:o}):t}function Jg(t){return e.jsx(ad,{tabIndex:-1,"data-autofocus":!0,...t})}ld.displayName="@mantine/core/FocusTrap";Jg.displayName="@mantine/core/FocusTrapInitialFocus";ld.InitialFocus=Jg;var st={root:"m_5ae2e3c",barsLoader:"m_7a2bd4cd",bar:"m_870bb79","bars-loader-animation":"m_5d2b3b9d",dotsLoader:"m_4e3f22d7",dot:"m_870c4af","loader-dots-animation":"m_aac34a1",ovalLoader:"m_b34414df","oval-loader-animation":"m_f8e89c4b"};const ex=v.forwardRef(({className:t,...n},s)=>e.jsxs(L,{component:"span",className:we(st.barsLoader,t),...n,ref:s,children:[e.jsx("span",{className:st.bar}),e.jsx("span",{className:st.bar}),e.jsx("span",{className:st.bar})]}));ex.displayName="@mantine/core/Bars";const tx=v.forwardRef(({className:t,...n},s)=>e.jsxs(L,{component:"span",className:we(st.dotsLoader,t),...n,ref:s,children:[e.jsx("span",{className:st.dot}),e.jsx("span",{className:st.dot}),e.jsx("span",{className:st.dot})]}));tx.displayName="@mantine/core/Dots";const nx=v.forwardRef(({className:t,...n},s)=>e.jsx(L,{component:"span",className:we(st.ovalLoader,t),...n,ref:s}));nx.displayName="@mantine/core/Oval";const ix={bars:ex,oval:nx,dots:tx},xS={loaders:ix,type:"oval"},vS=(t,{size:n,color:s})=>({root:{"--loader-size":De(n,"loader-size"),"--loader-color":s?an(s,t):void 0}}),Va=H((t,n)=>{const s=F("Loader",xS,t),{size:r,color:a,type:o,vars:d,className:u,style:h,classNames:p,styles:m,unstyled:g,loaders:x,variant:j,children:I,...S}=s,T=se({name:"Loader",props:s,classes:st,className:u,style:h,classNames:p,styles:m,unstyled:g,vars:d,varsResolver:vS});return I?e.jsx(L,{...T("root"),ref:n,...S,children:I}):e.jsx(L,{...T("root"),ref:n,component:x[o],variant:j,size:r,...S})});Va.defaultLoaders=ix;Va.classes=st;Va.displayName="@mantine/core/Loader";const sx=v.forwardRef(({size:t="var(--cb-icon-size, 70%)",style:n,...s},r)=>e.jsx("svg",{viewBox:"0 0 15 15",fill:"none",xmlns:"http://www.w3.org/2000/svg",style:{...n,width:t,height:t},ref:r,...s,children:e.jsx("path",{d:"M11.7816 4.03157C12.0062 3.80702 12.0062 3.44295 11.7816 3.2184C11.5571 2.99385 11.193 2.99385 10.9685 3.2184L7.50005 6.68682L4.03164 3.2184C3.80708 2.99385 3.44301 2.99385 3.21846 3.2184C2.99391 3.44295 2.99391 3.80702 3.21846 4.03157L6.68688 7.49999L3.21846 10.9684C2.99391 11.193 2.99391 11.557 3.21846 11.7816C3.44301 12.0061 3.80708 12.0061 4.03164 11.7816L7.50005 8.31316L10.9685 11.7816C11.193 12.0061 11.5571 12.0061 11.7816 11.7816C12.0062 11.557 12.0062 11.193 11.7816 10.9684L8.31322 7.49999L11.7816 4.03157Z",fill:"currentColor",fillRule:"evenodd",clipRule:"evenodd"})}));sx.displayName="@mantine/core/CloseIcon";var rx={root:"m_86a44da5","root--subtle":"m_220c80f2"};const yS={variant:"subtle"},jS=(t,{size:n,radius:s,iconSize:r})=>({root:{"--cb-size":De(n,"cb-size"),"--cb-radius":s===void 0?void 0:dn(s),"--cb-icon-size":E(r)}}),cd=xt((t,n)=>{const s=F("CloseButton",yS,t),{iconSize:r,children:a,vars:o,radius:d,className:u,classNames:h,style:p,styles:m,unstyled:g,"data-disabled":x,disabled:j,variant:I,icon:S,mod:T,__staticSelector:w,...y}=s,b=se({name:w||"CloseButton",props:s,className:u,style:p,classes:rx,classNames:h,styles:m,unstyled:g,vars:o,varsResolver:jS});return e.jsxs(Vs,{ref:n,...y,unstyled:g,variant:I,disabled:j,mod:[{disabled:j||x},T],...b("root",{variant:I,active:!j&&!x}),children:[S||e.jsx(sx,{}),a]})});cd.classes=rx;cd.displayName="@mantine/core/CloseButton";function wS(t){return v.Children.toArray(t).filter(Boolean)}var ax={root:"m_4081bf90"};const bS={preventGrowOverflow:!0,gap:"md",align:"center",justify:"flex-start",wrap:"wrap"},SS=(t,{grow:n,preventGrowOverflow:s,gap:r,align:a,justify:o,wrap:d},{childWidth:u})=>({root:{"--group-child-width":n&&s?u:void 0,"--group-gap":An(r),"--group-align":a,"--group-justify":o,"--group-wrap":d}}),nt=H((t,n)=>{const s=F("Group",bS,t),{classNames:r,className:a,style:o,styles:d,unstyled:u,children:h,gap:p,align:m,justify:g,wrap:x,grow:j,preventGrowOverflow:I,vars:S,variant:T,__size:w,mod:y,...b}=s,C=wS(h),R=C.length,D=An(p??"md"),P={childWidth:`calc(${100/R}% - (${D} - ${D} / ${R}))`},z=se({name:"Group",props:s,stylesCtx:P,className:a,style:o,classes:ax,classNames:r,styles:d,unstyled:u,vars:S,varsResolver:SS});return e.jsx(L,{...z("root"),ref:n,variant:T,mod:[{grow:j},y],size:w,...b,children:C})});nt.classes=ax;nt.displayName="@mantine/core/Group";const[IS,Lt]=Nt("ModalBase component was not found in tree");function CS({opened:t,transitionDuration:n}){const[s,r]=v.useState(t),a=v.useRef(-1),d=jg()?0:n;return v.useEffect(()=>(t?(r(!0),window.clearTimeout(a.current)):d===0?r(!1):a.current=window.setTimeout(()=>r(!1),d),()=>window.clearTimeout(a.current)),[t,d]),s}function TS({id:t,transitionProps:n,opened:s,trapFocus:r,closeOnEscape:a,onClose:o,returnFocus:d}){const u=vg(t),[h,p]=v.useState(!1),[m,g]=v.useState(!1),x=typeof(n==null?void 0:n.duration)=="number"?n==null?void 0:n.duration:200,j=CS({opened:s,transitionDuration:x});return yg("keydown",I=>{var S;I.key==="Escape"&&a&&!I.isComposing&&s&&((S=I.target)==null?void 0:S.getAttribute("data-mantine-stop-propagation"))!=="true"&&o()},{capture:!0}),Sw({opened:s,shouldReturnFocus:r&&d}),{_id:u,titleMounted:h,bodyMounted:m,shouldLockScroll:j,setTitleMounted:p,setBodyMounted:g}}const ox=v.forwardRef(({keepMounted:t,opened:n,onClose:s,id:r,transitionProps:a,onExitTransitionEnd:o,onEnterTransitionEnd:d,trapFocus:u,closeOnEscape:h,returnFocus:p,closeOnClickOutside:m,withinPortal:g,portalProps:x,lockScroll:j,children:I,zIndex:S,shadow:T,padding:w,__vars:y,unstyled:b,removeScrollProps:C,...R},D)=>{const{_id:k,titleMounted:P,bodyMounted:z,shouldLockScroll:_,setTitleMounted:q,setBodyMounted:oe}=TS({id:r,transitionProps:a,opened:n,trapFocus:u,closeOnEscape:h,onClose:s,returnFocus:p}),{key:ge,...Ye}=C||{};return e.jsx(Zg,{...x,withinPortal:g,children:e.jsx(IS,{value:{opened:n,onClose:s,closeOnClickOutside:m,onExitTransitionEnd:o,onEnterTransitionEnd:d,transitionProps:{...a,keepMounted:t},getTitleId:()=>`${k}-title`,getBodyId:()=>`${k}-body`,titleMounted:P,bodyMounted:z,setTitleMounted:q,setBodyMounted:oe,trapFocus:u,closeOnEscape:h,zIndex:S,unstyled:b},children:e.jsx(_a,{enabled:_&&j,...Ye,children:e.jsx(L,{ref:D,...R,__vars:{...y,"--mb-z-index":(S||Mn("modal")).toString(),"--mb-shadow":fg(T),"--mb-padding":An(w)},children:I})},ge)})})});ox.displayName="@mantine/core/ModalBase";function RS(){const t=Lt();return v.useEffect(()=>(t.setBodyMounted(!0),()=>t.setBodyMounted(!1)),[]),t.getBodyId()}var Si={title:"m_615af6c9",header:"m_b5489c3c",inner:"m_60c222c7",content:"m_fd1ab0aa",close:"m_606cb269",body:"m_5df29311"};const lx=v.forwardRef(({className:t,...n},s)=>{const r=RS(),a=Lt();return e.jsx(L,{ref:s,...n,id:r,className:we({[Si.body]:!a.unstyled},t)})});lx.displayName="@mantine/core/ModalBaseBody";const cx=v.forwardRef(({className:t,onClick:n,...s},r)=>{const a=Lt();return e.jsx(cd,{ref:r,...s,onClick:o=>{a.onClose(),n==null||n(o)},className:we({[Si.close]:!a.unstyled},t),unstyled:a.unstyled})});cx.displayName="@mantine/core/ModalBaseCloseButton";const dx=v.forwardRef(({transitionProps:t,className:n,innerProps:s,onKeyDown:r,style:a,...o},d)=>{const u=Lt();return e.jsx(Ha,{mounted:u.opened,transition:"pop",...u.transitionProps,onExited:()=>{var h,p,m;(h=u.onExitTransitionEnd)==null||h.call(u),(m=(p=u.transitionProps)==null?void 0:p.onExited)==null||m.call(p)},onEntered:()=>{var h,p,m;(h=u.onEnterTransitionEnd)==null||h.call(u),(m=(p=u.transitionProps)==null?void 0:p.onEntered)==null||m.call(p)},...t,children:h=>e.jsx("div",{...s,className:we({[Si.inner]:!u.unstyled},s.className),children:e.jsx(ld,{active:u.opened&&u.trapFocus,innerRef:d,children:e.jsx(Ba,{...o,component:"section",role:"dialog",tabIndex:-1,"aria-modal":!0,"aria-describedby":u.bodyMounted?u.getBodyId():void 0,"aria-labelledby":u.titleMounted?u.getTitleId():void 0,style:[a,h],className:we({[Si.content]:!u.unstyled},n),unstyled:u.unstyled,children:o.children})})})})});dx.displayName="@mantine/core/ModalBaseContent";const ux=v.forwardRef(({className:t,...n},s)=>{const r=Lt();return e.jsx(L,{component:"header",ref:s,className:we({[Si.header]:!r.unstyled},t),...n})});ux.displayName="@mantine/core/ModalBaseHeader";const kS={duration:200,timingFunction:"ease",transition:"fade"};function PS(t){const n=Lt();return{...kS,...n.transitionProps,...t}}const hx=v.forwardRef(({onClick:t,transitionProps:n,style:s,visible:r,...a},o)=>{const d=Lt(),u=PS(n);return e.jsx(Ha,{mounted:r!==void 0?r:d.opened,...u,transition:"fade",children:h=>e.jsx(od,{ref:o,fixed:!0,style:[s,h],zIndex:d.zIndex,unstyled:d.unstyled,onClick:p=>{t==null||t(p),d.closeOnClickOutside&&d.onClose()},...a})})});hx.displayName="@mantine/core/ModalBaseOverlay";function ES(){const t=Lt();return v.useEffect(()=>(t.setTitleMounted(!0),()=>t.setTitleMounted(!1)),[]),t.getTitleId()}const fx=v.forwardRef(({className:t,...n},s)=>{const r=ES(),a=Lt();return e.jsx(L,{component:"h2",ref:s,className:we({[Si.title]:!a.unstyled},t),...n,id:r})});fx.displayName="@mantine/core/ModalBaseTitle";function DS({children:t}){return e.jsx(e.Fragment,{children:t})}var px={root:"m_b6d8b162"};function MS(t){if(t==="start")return"start";if(t==="end"||t)return"end"}const AS={inherit:!1},zS=(t,{variant:n,lineClamp:s,gradient:r,size:a,color:o})=>({root:{"--text-fz":wi(a),"--text-lh":hg(a),"--text-gradient":n==="gradient"?ql(r,t):void 0,"--text-line-clamp":typeof s=="number"?s.toString():void 0,"--text-color":o?an(o,t):void 0}}),i=xt((t,n)=>{const s=F("Text",AS,t),{lineClamp:r,truncate:a,inline:o,inherit:d,gradient:u,span:h,__staticSelector:p,vars:m,className:g,style:x,classNames:j,styles:I,unstyled:S,variant:T,mod:w,size:y,...b}=s,C=se({name:["Text",p],props:s,classes:px,className:g,style:x,classNames:j,styles:I,unstyled:S,vars:m,varsResolver:zS});return e.jsx(L,{...C("root",{focusable:!0}),ref:n,component:h?"span":"p",variant:T,mod:[{"data-truncate":MS(a),"data-line-clamp":typeof r=="number","data-inline":o,"data-inherit":d},w],size:y,...b})});i.classes=px;i.displayName="@mantine/core/Text";var mx={root:"m_849cf0da"};const NS={underline:"hover"},dd=xt((t,n)=>{const{underline:s,className:r,unstyled:a,mod:o,...d}=F("Anchor",NS,t);return e.jsx(i,{component:"a",ref:n,className:we({[mx.root]:!a},r),...d,mod:[{underline:s},o],__staticSelector:"Anchor",unstyled:a})});dd.classes=mx;dd.displayName="@mantine/core/Anchor";const[_S,Di]=Nt("AppShell was not found in tree");var un={root:"m_89ab340",navbar:"m_45252eee",aside:"m_9cdde9a",header:"m_3b16f56b",main:"m_8983817",footer:"m_3840c879",section:"m_6dcfc7c7"};const LS={},ud=H((t,n)=>{const s=F("AppShellAside",LS,t),{classNames:r,className:a,style:o,styles:d,unstyled:u,vars:h,withBorder:p,zIndex:m,mod:g,...x}=s,j=Di();return j.disabled?null:e.jsx(L,{component:"aside",ref:n,mod:[{"with-border":p??j.withBorder},g],...j.getStyles("aside",{className:a,classNames:r,styles:d,style:o}),...x,__vars:{"--app-shell-aside-z-index":`calc(${m??j.zIndex} + 1)`}})});ud.classes=un;ud.displayName="@mantine/core/AppShellAside";const OS={},hd=H((t,n)=>{var I;const s=F("AppShellFooter",OS,t),{classNames:r,className:a,style:o,styles:d,unstyled:u,vars:h,withBorder:p,zIndex:m,mod:g,...x}=s,j=Di();return j.disabled?null:e.jsx(L,{component:"footer",ref:n,mod:[{"with-border":p??j.withBorder},g],...j.getStyles("footer",{className:we({[_a.classNames.zeroRight]:j.offsetScrollbars},a),classNames:r,styles:d,style:o}),...x,__vars:{"--app-shell-footer-z-index":(I=m??j.zIndex)==null?void 0:I.toString()}})});hd.classes=un;hd.displayName="@mantine/core/AppShellFooter";const FS={},fd=H((t,n)=>{var I;const s=F("AppShellHeader",FS,t),{classNames:r,className:a,style:o,styles:d,unstyled:u,vars:h,withBorder:p,zIndex:m,mod:g,...x}=s,j=Di();return j.disabled?null:e.jsx(L,{component:"header",ref:n,mod:[{"with-border":p??j.withBorder},g],...j.getStyles("header",{className:we({[_a.classNames.zeroRight]:j.offsetScrollbars},a),classNames:r,styles:d,style:o}),...x,__vars:{"--app-shell-header-z-index":(I=m??j.zIndex)==null?void 0:I.toString()}})});fd.classes=un;fd.displayName="@mantine/core/AppShellHeader";const $S={},pd=H((t,n)=>{const s=F("AppShellMain",$S,t),{classNames:r,className:a,style:o,styles:d,vars:u,...h}=s,p=Di();return e.jsx(L,{component:"main",ref:n,...p.getStyles("main",{className:a,style:o,classNames:r,styles:d}),...h})});pd.classes=un;pd.displayName="@mantine/core/AppShellMain";function Gs(t){return typeof t=="object"?t.base:t}function Us(t){const n=typeof t=="object"&&t!==null&&typeof t.base<"u"&&Object.keys(t).length===1;return typeof t=="number"||typeof t=="string"||n}function qs(t){return!(typeof t!="object"||t===null||Object.keys(t).length===1&&"base"in t)}function BS({baseStyles:t,minMediaStyles:n,maxMediaStyles:s,aside:r,theme:a}){var h,p,m;const o=r==null?void 0:r.width,d="translateX(var(--app-shell-aside-width))",u="translateX(calc(var(--app-shell-aside-width) * -1))";if(r!=null&&r.breakpoint&&!((h=r==null?void 0:r.collapsed)!=null&&h.mobile)&&(s[r==null?void 0:r.breakpoint]=s[r==null?void 0:r.breakpoint]||{},s[r==null?void 0:r.breakpoint]["--app-shell-aside-width"]="100%",s[r==null?void 0:r.breakpoint]["--app-shell-aside-offset"]="0px"),Us(o)){const g=E(Gs(o));t["--app-shell-aside-width"]=g,t["--app-shell-aside-offset"]=g}if(qs(o)&&(typeof o.base<"u"&&(t["--app-shell-aside-width"]=E(o.base),t["--app-shell-aside-offset"]=E(o.base)),pe(o).forEach(g=>{g!=="base"&&(n[g]=n[g]||{},n[g]["--app-shell-aside-width"]=E(o[g]),n[g]["--app-shell-aside-offset"]=E(o[g]))})),(p=r==null?void 0:r.collapsed)!=null&&p.desktop){const g=r.breakpoint;n[g]=n[g]||{},n[g]["--app-shell-aside-transform"]=d,n[g]["--app-shell-aside-transform-rtl"]=u,n[g]["--app-shell-aside-offset"]="0px !important"}if((m=r==null?void 0:r.collapsed)!=null&&m.mobile){const g=Kc(r.breakpoint,a.breakpoints)-.1;s[g]=s[g]||{},s[g]["--app-shell-aside-width"]="100%",s[g]["--app-shell-aside-offset"]="0px",s[g]["--app-shell-aside-transform"]=d,s[g]["--app-shell-aside-transform-rtl"]=u}}function HS({baseStyles:t,minMediaStyles:n,footer:s}){const r=s==null?void 0:s.height,a="translateY(var(--app-shell-footer-height))",o=(s==null?void 0:s.offset)??!0;if(Us(r)){const d=E(Gs(r));t["--app-shell-footer-height"]=d,o&&(t["--app-shell-footer-offset"]=d)}qs(r)&&(typeof r.base<"u"&&(t["--app-shell-footer-height"]=E(r.base),o&&(t["--app-shell-footer-offset"]=E(r.base))),pe(r).forEach(d=>{d!=="base"&&(n[d]=n[d]||{},n[d]["--app-shell-footer-height"]=E(r[d]),o&&(n[d]["--app-shell-footer-offset"]=E(r[d])))})),s!=null&&s.collapsed&&(t["--app-shell-footer-transform"]=a,t["--app-shell-footer-offset"]="0px !important")}function VS({baseStyles:t,minMediaStyles:n,header:s}){const r=s==null?void 0:s.height,a="translateY(calc(var(--app-shell-header-height) * -1))",o=(s==null?void 0:s.offset)??!0;if(Us(r)){const d=E(Gs(r));t["--app-shell-header-height"]=d,o&&(t["--app-shell-header-offset"]=d)}qs(r)&&(typeof r.base<"u"&&(t["--app-shell-header-height"]=E(r.base),o&&(t["--app-shell-header-offset"]=E(r.base))),pe(r).forEach(d=>{d!=="base"&&(n[d]=n[d]||{},n[d]["--app-shell-header-height"]=E(r[d]),o&&(n[d]["--app-shell-header-offset"]=E(r[d])))})),s!=null&&s.collapsed&&(t["--app-shell-header-transform"]=a,t["--app-shell-header-offset"]="0px !important")}function GS({baseStyles:t,minMediaStyles:n,maxMediaStyles:s,navbar:r,theme:a}){var h,p,m;const o=r==null?void 0:r.width,d="translateX(calc(var(--app-shell-navbar-width) * -1))",u="translateX(var(--app-shell-navbar-width))";if(r!=null&&r.breakpoint&&!((h=r==null?void 0:r.collapsed)!=null&&h.mobile)&&(s[r==null?void 0:r.breakpoint]=s[r==null?void 0:r.breakpoint]||{},s[r==null?void 0:r.breakpoint]["--app-shell-navbar-width"]="100%",s[r==null?void 0:r.breakpoint]["--app-shell-navbar-offset"]="0px"),Us(o)){const g=E(Gs(o));t["--app-shell-navbar-width"]=g,t["--app-shell-navbar-offset"]=g}if(qs(o)&&(typeof o.base<"u"&&(t["--app-shell-navbar-width"]=E(o.base),t["--app-shell-navbar-offset"]=E(o.base)),pe(o).forEach(g=>{g!=="base"&&(n[g]=n[g]||{},n[g]["--app-shell-navbar-width"]=E(o[g]),n[g]["--app-shell-navbar-offset"]=E(o[g]))})),(p=r==null?void 0:r.collapsed)!=null&&p.desktop){const g=r.breakpoint;n[g]=n[g]||{},n[g]["--app-shell-navbar-transform"]=d,n[g]["--app-shell-navbar-transform-rtl"]=u,n[g]["--app-shell-navbar-offset"]="0px !important"}if((m=r==null?void 0:r.collapsed)!=null&&m.mobile){const g=Kc(r.breakpoint,a.breakpoints)-.1;s[g]=s[g]||{},s[g]["--app-shell-navbar-width"]="100%",s[g]["--app-shell-navbar-offset"]="0px",s[g]["--app-shell-navbar-transform"]=d,s[g]["--app-shell-navbar-transform-rtl"]=u}}function Vo(t){return Number(t)===0?"0px":An(t)}function US({padding:t,baseStyles:n,minMediaStyles:s}){Us(t)&&(n["--app-shell-padding"]=Vo(Gs(t))),qs(t)&&(t.base&&(n["--app-shell-padding"]=Vo(t.base)),pe(t).forEach(r=>{r!=="base"&&(s[r]=s[r]||{},s[r]["--app-shell-padding"]=Vo(t[r]))}))}function qS({navbar:t,header:n,footer:s,aside:r,padding:a,theme:o}){const d={},u={},h={};GS({baseStyles:h,minMediaStyles:d,maxMediaStyles:u,navbar:t,theme:o}),BS({baseStyles:h,minMediaStyles:d,maxMediaStyles:u,aside:r,theme:o}),VS({baseStyles:h,minMediaStyles:d,header:n}),HS({baseStyles:h,minMediaStyles:d,footer:s}),US({baseStyles:h,minMediaStyles:d,padding:a});const p=lh(pe(d),o.breakpoints).map(x=>({query:`(min-width: ${ma(x.px)})`,styles:d[x.value]})),m=lh(pe(u),o.breakpoints).map(x=>({query:`(max-width: ${ma(x.px)})`,styles:u[x.value]})),g=[...p,...m];return{baseStyles:h,media:g}}function WS({navbar:t,header:n,aside:s,footer:r,padding:a}){const o=Oe(),d=_t(),{media:u,baseStyles:h}=qS({navbar:t,header:n,footer:r,aside:s,padding:a,theme:o});return e.jsx(Pg,{media:u,styles:h,selector:d.cssVariablesSelector})}const QS={},md=H((t,n)=>{const s=F("AppShellNavbar",QS,t),{classNames:r,className:a,style:o,styles:d,unstyled:u,vars:h,withBorder:p,zIndex:m,mod:g,...x}=s,j=Di();return j.disabled?null:e.jsx(L,{component:"nav",ref:n,mod:[{"with-border":p??j.withBorder},g],...j.getStyles("navbar",{className:a,classNames:r,styles:d,style:o}),...x,__vars:{"--app-shell-navbar-z-index":`calc(${m??j.zIndex} + 1)`}})});md.classes=un;md.displayName="@mantine/core/AppShellNavbar";const YS={},gd=xt((t,n)=>{const s=F("AppShellSection",YS,t),{classNames:r,className:a,style:o,styles:d,vars:u,grow:h,mod:p,...m}=s,g=Di();return e.jsx(L,{ref:n,mod:[{grow:h},p],...g.getStyles("section",{className:a,style:o,classNames:r,styles:d}),...m})});gd.classes=un;gd.displayName="@mantine/core/AppShellSection";function KS({transitionDuration:t,disabled:n}){const[s,r]=v.useState(!0),a=v.useRef(-1),o=v.useRef(-1);return yg("resize",()=>{r(!0),clearTimeout(a.current),a.current=window.setTimeout(()=>v.startTransition(()=>{r(!1)}),200)}),Ei(()=>{r(!0),clearTimeout(o.current),o.current=window.setTimeout(()=>v.startTransition(()=>{r(!1)}),t||0)},[n,t]),s}const XS={withBorder:!0,padding:0,transitionDuration:200,transitionTimingFunction:"ease",zIndex:Mn("app")},ZS=(t,{transitionDuration:n,transitionTimingFunction:s})=>({root:{"--app-shell-transition-duration":`${n}ms`,"--app-shell-transition-timing-function":s}}),ot=H((t,n)=>{const s=F("AppShell",XS,t),{classNames:r,className:a,style:o,styles:d,unstyled:u,vars:h,navbar:p,withBorder:m,padding:g,transitionDuration:x,transitionTimingFunction:j,header:I,zIndex:S,layout:T,disabled:w,aside:y,footer:b,offsetScrollbars:C=T!=="alt",mod:R,...D}=s,k=se({name:"AppShell",classes:un,props:s,className:a,style:o,classNames:r,styles:d,unstyled:u,vars:h,varsResolver:ZS}),P=KS({disabled:w,transitionDuration:x});return e.jsxs(_S,{value:{getStyles:k,withBorder:m,zIndex:S,disabled:w,offsetScrollbars:C},children:[e.jsx(WS,{navbar:p,header:I,aside:y,footer:b,padding:g}),e.jsx(L,{ref:n,...k("root"),mod:[{resizing:P,layout:T,disabled:w},R],...D})]})});ot.classes=un;ot.displayName="@mantine/core/AppShell";ot.Navbar=md;ot.Header=fd;ot.Main=pd;ot.Aside=ud;ot.Footer=hd;ot.Section=gd;var Mi={root:"m_77c9d27d",inner:"m_80f1301b",label:"m_811560b9",section:"m_a74036a",loader:"m_a25b86ee",group:"m_80d6d844",groupSection:"m_70be2a01"};const yh={orientation:"horizontal"},JS=(t,{borderWidth:n})=>({group:{"--button-border-width":E(n)}}),xd=H((t,n)=>{const s=F("ButtonGroup",yh,t),{className:r,style:a,classNames:o,styles:d,unstyled:u,orientation:h,vars:p,borderWidth:m,variant:g,mod:x,...j}=F("ButtonGroup",yh,t),I=se({name:"ButtonGroup",props:s,classes:Mi,className:r,style:a,classNames:o,styles:d,unstyled:u,vars:p,varsResolver:JS,rootSelector:"group"});return e.jsx(L,{...I("group"),ref:n,variant:g,mod:[{"data-orientation":h},x],role:"group",...j})});xd.classes=Mi;xd.displayName="@mantine/core/ButtonGroup";const jh={},eI=(t,{radius:n,color:s,gradient:r,variant:a,autoContrast:o,size:d})=>{const u=t.variantColorResolver({color:s||t.primaryColor,theme:t,gradient:r,variant:a||"filled",autoContrast:o});return{groupSection:{"--section-height":De(d,"section-height"),"--section-padding-x":De(d,"section-padding-x"),"--section-fz":d!=null&&d.includes("compact")?wi(d.replace("compact-","")):wi(d),"--section-radius":n===void 0?void 0:dn(n),"--section-bg":s||a?u.background:void 0,"--section-color":u.color,"--section-bd":s||a?u.border:void 0}}},vd=H((t,n)=>{const s=F("ButtonGroupSection",jh,t),{className:r,style:a,classNames:o,styles:d,unstyled:u,vars:h,variant:p,gradient:m,radius:g,autoContrast:x,...j}=F("ButtonGroupSection",jh,t),I=se({name:"ButtonGroupSection",props:s,classes:Mi,className:r,style:a,classNames:o,styles:d,unstyled:u,vars:h,varsResolver:eI,rootSelector:"groupSection"});return e.jsx(L,{...I("groupSection"),ref:n,variant:p,...j})});vd.classes=Mi;vd.displayName="@mantine/core/ButtonGroupSection";const tI={in:{opacity:1,transform:`translate(-50%, calc(-50% + ${E(1)}))`},out:{opacity:0,transform:"translate(-50%, -200%)"},common:{transformOrigin:"center"},transitionProperty:"transform, opacity"},nI={},iI=(t,{radius:n,color:s,gradient:r,variant:a,size:o,justify:d,autoContrast:u})=>{const h=t.variantColorResolver({color:s||t.primaryColor,theme:t,gradient:r,variant:a||"filled",autoContrast:u});return{root:{"--button-justify":d,"--button-height":De(o,"button-height"),"--button-padding-x":De(o,"button-padding-x"),"--button-fz":o!=null&&o.includes("compact")?wi(o.replace("compact-","")):wi(o),"--button-radius":n===void 0?void 0:dn(n),"--button-bg":s||a?h.background:void 0,"--button-hover":s||a?h.hover:void 0,"--button-color":h.color,"--button-bd":s||a?h.border:void 0,"--button-hover-color":s||a?h.hoverColor:void 0}}},it=xt((t,n)=>{const s=F("Button",nI,t),{style:r,vars:a,className:o,color:d,disabled:u,children:h,leftSection:p,rightSection:m,fullWidth:g,variant:x,radius:j,loading:I,loaderProps:S,gradient:T,classNames:w,styles:y,unstyled:b,"data-disabled":C,autoContrast:R,mod:D,...k}=s,P=se({name:"Button",props:s,classes:Mi,className:o,style:r,classNames:w,styles:y,unstyled:b,vars:a,varsResolver:iI}),z=!!p,_=!!m;return e.jsxs(Vs,{ref:n,...P("root",{active:!u&&!I&&!C}),unstyled:b,variant:x,disabled:u||I,mod:[{disabled:u||C,loading:I,block:g,"with-left-section":z,"with-right-section":_},D],...k,children:[e.jsx(Ha,{mounted:!!I,transition:tI,duration:150,children:q=>e.jsx(L,{component:"span",...P("loader",{style:q}),"aria-hidden":!0,children:e.jsx(Va,{color:"var(--button-color)",size:"calc(var(--button-height) / 1.8)",...S})})}),e.jsxs("span",{...P("inner"),children:[p&&e.jsx(L,{component:"span",...P("section"),mod:{position:"left"},children:p}),e.jsx(L,{component:"span",mod:{loading:I},...P("label"),children:h}),m&&e.jsx(L,{component:"span",...P("section"),mod:{position:"right"},children:m})]})]})});it.classes=Mi;it.displayName="@mantine/core/Button";it.Group=xd;it.GroupSection=vd;const[sI,rI]=Nt("Card component was not found in tree");var yd={root:"m_e615b15f",section:"m_599a2148"};const aI={},Ga=xt((t,n)=>{const s=F("CardSection",aI,t),{classNames:r,className:a,style:o,styles:d,vars:u,withBorder:h,inheritPadding:p,mod:m,...g}=s,x=rI();return e.jsx(L,{ref:n,mod:[{"with-border":h,"inherit-padding":p},m],...x.getStyles("section",{className:a,style:o,styles:d,classNames:r}),...g})});Ga.classes=yd;Ga.displayName="@mantine/core/CardSection";const oI={},lI=(t,{padding:n})=>({root:{"--card-padding":An(n)}}),kn=xt((t,n)=>{const s=F("Card",oI,t),{classNames:r,className:a,style:o,styles:d,unstyled:u,vars:h,children:p,padding:m,...g}=s,x=se({name:"Card",props:s,classes:yd,className:a,style:o,classNames:r,styles:d,unstyled:u,vars:h,varsResolver:lI}),j=v.Children.toArray(p),I=j.map((S,T)=>typeof S=="object"&&S&&"type"in S&&S.type===Ga?v.cloneElement(S,{"data-first-section":T===0||void 0,"data-last-section":T===j.length-1||void 0}):S);return e.jsx(sI,{value:{getStyles:x},children:e.jsx(Ba,{ref:n,unstyled:u,...x("root"),...g,children:I})})});kn.classes=yd;kn.displayName="@mantine/core/Card";kn.Section=Ga;var gx={root:"m_3eebeb36",label:"m_9e365f20"};const cI={orientation:"horizontal"},dI=(t,{color:n,variant:s,size:r})=>({root:{"--divider-color":n?an(n,t):void 0,"--divider-border-style":s,"--divider-size":De(r,"divider-size")}}),Ua=H((t,n)=>{const s=F("Divider",cI,t),{classNames:r,className:a,style:o,styles:d,unstyled:u,vars:h,color:p,orientation:m,label:g,labelPosition:x,mod:j,...I}=s,S=se({name:"Divider",classes:gx,props:s,className:a,style:o,classNames:r,styles:d,unstyled:u,vars:h,varsResolver:dI});return e.jsx(L,{ref:n,mod:[{orientation:m,"with-label":!!g},j],...S("root"),...I,role:"separator",children:g&&e.jsx(L,{component:"span",mod:{position:x},...S("label"),children:g})})});Ua.classes=gx;Ua.displayName="@mantine/core/Divider";const[uI,hI]=Nt("List component was not found in tree");var jd={root:"m_abbac491",item:"m_abb6bec2",itemWrapper:"m_75cd9f71",itemIcon:"m_60f83e5b"};const fI={},wd=H((t,n)=>{const s=F("ListItem",fI,t),{classNames:r,className:a,style:o,styles:d,vars:u,icon:h,children:p,mod:m,...g}=s,x=hI(),j=h||x.icon,I={classNames:r,styles:d};return e.jsx(L,{...x.getStyles("item",{...I,className:a,style:o}),component:"li",mod:[{"with-icon":!!j,centered:x.center},m],ref:n,...g,children:e.jsxs("div",{...x.getStyles("itemWrapper",I),children:[j&&e.jsx("span",{...x.getStyles("itemIcon",I),children:j}),e.jsx("span",{...x.getStyles("itemLabel",I),children:p})]})})});wd.classes=jd;wd.displayName="@mantine/core/ListItem";const pI={type:"unordered"},mI=(t,{size:n,spacing:s})=>({root:{"--list-fz":wi(n),"--list-lh":hg(n),"--list-spacing":An(s)}}),c=H((t,n)=>{const s=F("List",pI,t),{classNames:r,className:a,style:o,styles:d,unstyled:u,vars:h,children:p,type:m,withPadding:g,icon:x,spacing:j,center:I,listStyleType:S,mod:T,...w}=s,y=se({name:"List",classes:jd,props:s,className:a,style:o,classNames:r,styles:d,unstyled:u,vars:h,varsResolver:mI});return e.jsx(uI,{value:{center:I,icon:x,getStyles:y},children:e.jsx(L,{...y("root",{style:{listStyleType:S}}),component:m==="unordered"?"ul":"ol",mod:[{"with-padding":g},T],ref:n,...w,children:p})})});c.classes=jd;c.displayName="@mantine/core/List";c.Item=wd;const[gI,Ai]=Nt("Modal component was not found in tree");var Ot={root:"m_9df02822",content:"m_54c44539",inner:"m_1f958f16",header:"m_d0e2b9cd"};const xI={},qa=H((t,n)=>{const s=F("ModalBody",xI,t),{classNames:r,className:a,style:o,styles:d,vars:u,...h}=s,p=Ai();return e.jsx(lx,{ref:n,...p.getStyles("body",{classNames:r,style:o,styles:d,className:a}),...h})});qa.classes=Ot;qa.displayName="@mantine/core/ModalBody";const vI={},Wa=H((t,n)=>{const s=F("ModalCloseButton",vI,t),{classNames:r,className:a,style:o,styles:d,vars:u,...h}=s,p=Ai();return e.jsx(cx,{ref:n,...p.getStyles("close",{classNames:r,style:o,styles:d,className:a}),...h})});Wa.classes=Ot;Wa.displayName="@mantine/core/ModalCloseButton";const yI={},Qa=H((t,n)=>{const s=F("ModalContent",yI,t),{classNames:r,className:a,style:o,styles:d,vars:u,children:h,__hidden:p,...m}=s,g=Ai(),x=g.scrollAreaComponent||DS;return e.jsx(dx,{...g.getStyles("content",{className:a,style:o,styles:d,classNames:r}),innerProps:g.getStyles("inner",{className:a,style:o,styles:d,classNames:r}),"data-full-screen":g.fullScreen||void 0,"data-modal-content":!0,"data-hidden":p||void 0,ref:n,...m,children:e.jsx(x,{style:{maxHeight:g.fullScreen?"100dvh":`calc(100dvh - (${E(g.yOffset)} * 2))`},children:h})})});Qa.classes=Ot;Qa.displayName="@mantine/core/ModalContent";const jI={},Ya=H((t,n)=>{const s=F("ModalHeader",jI,t),{classNames:r,className:a,style:o,styles:d,vars:u,...h}=s,p=Ai();return e.jsx(ux,{ref:n,...p.getStyles("header",{classNames:r,style:o,styles:d,className:a}),...h})});Ya.classes=Ot;Ya.displayName="@mantine/core/ModalHeader";const wI={},Ka=H((t,n)=>{const s=F("ModalOverlay",wI,t),{classNames:r,className:a,style:o,styles:d,vars:u,...h}=s,p=Ai();return e.jsx(hx,{ref:n,...p.getStyles("overlay",{classNames:r,style:o,styles:d,className:a}),...h})});Ka.classes=Ot;Ka.displayName="@mantine/core/ModalOverlay";const bI={__staticSelector:"Modal",closeOnClickOutside:!0,withinPortal:!0,lockScroll:!0,trapFocus:!0,returnFocus:!0,closeOnEscape:!0,keepMounted:!1,zIndex:Mn("modal"),transitionProps:{duration:200,transition:"fade-down"},yOffset:"5dvh"},SI=(t,{radius:n,size:s,yOffset:r,xOffset:a})=>({root:{"--modal-radius":n===void 0?void 0:dn(n),"--modal-size":De(s,"modal-size"),"--modal-y-offset":E(r),"--modal-x-offset":E(a)}}),Xa=H((t,n)=>{const s=F("ModalRoot",bI,t),{classNames:r,className:a,style:o,styles:d,unstyled:u,vars:h,yOffset:p,scrollAreaComponent:m,radius:g,fullScreen:x,centered:j,xOffset:I,__staticSelector:S,...T}=s,w=se({name:S,classes:Ot,props:s,className:a,style:o,classNames:r,styles:d,unstyled:u,vars:h,varsResolver:SI});return e.jsx(gI,{value:{yOffset:p,scrollAreaComponent:m,getStyles:w,fullScreen:x},children:e.jsx(ox,{ref:n,...w("root"),"data-full-screen":x||void 0,"data-centered":j||void 0,"data-offset-scrollbars":m===Hs.Autosize||void 0,unstyled:u,...T})})});Xa.classes=Ot;Xa.displayName="@mantine/core/ModalRoot";const[II,CI]=pw();function xx({children:t}){const[n,s]=v.useState([]),[r,a]=v.useState(Mn("modal"));return e.jsx(II,{value:{stack:n,addModal:(o,d)=>{s(u=>[...new Set([...u,o])]),a(u=>typeof d=="number"&&typeof u=="number"?Math.max(u,d):u)},removeModal:o=>s(d=>d.filter(u=>u!==o)),getZIndex:o=>`calc(${r} + ${n.indexOf(o)} + 1)`,currentId:n[n.length-1],maxZIndex:r},children:t})}xx.displayName="@mantine/core/ModalStack";const TI={},Za=H((t,n)=>{const s=F("ModalTitle",TI,t),{classNames:r,className:a,style:o,styles:d,vars:u,...h}=s,p=Ai();return e.jsx(fx,{ref:n,...p.getStyles("title",{classNames:r,style:o,styles:d,className:a}),...h})});Za.classes=Ot;Za.displayName="@mantine/core/ModalTitle";const RI={closeOnClickOutside:!0,withinPortal:!0,lockScroll:!0,trapFocus:!0,returnFocus:!0,closeOnEscape:!0,keepMounted:!1,zIndex:Mn("modal"),transitionProps:{duration:200,transition:"fade-down"},withOverlay:!0,withCloseButton:!0},Qe=H((t,n)=>{const{title:s,withOverlay:r,overlayProps:a,withCloseButton:o,closeButtonProps:d,children:u,radius:h,opened:p,stackId:m,zIndex:g,...x}=F("Modal",RI,t),j=CI(),I=!!s||o,S=j&&m?{closeOnEscape:j.currentId===m,trapFocus:j.currentId===m,zIndex:j.getZIndex(m)}:{},T=r===!1?!1:m&&j?j.currentId===m:p;return v.useEffect(()=>{j&&m&&(p?j.addModal(m,g||Mn("modal")):j.removeModal(m))},[p,m,g]),e.jsxs(Xa,{ref:n,radius:h,opened:p,zIndex:j&&m?j.getZIndex(m):g,...x,...S,children:[r&&e.jsx(Ka,{visible:T,transitionProps:j&&m?{duration:0}:void 0,...a}),e.jsxs(Qa,{radius:h,__hidden:j&&m&&p?m!==j.currentId:!1,children:[I&&e.jsxs(Ya,{children:[s&&e.jsx(Za,{children:s}),o&&e.jsx(Wa,{...d})]}),e.jsx(qa,{children:u})]})]})});Qe.classes=Ot;Qe.displayName="@mantine/core/Modal";Qe.Root=Xa;Qe.Overlay=Ka;Qe.Content=Qa;Qe.Body=qa;Qe.Header=Ya;Qe.Title=Za;Qe.CloseButton=Wa;Qe.Stack=xx;const[kI,vx]=Nt("Progress.Root component was not found in tree");var Ws={root:"m_db6d6462",section:"m_2242eb65","stripes-animation":"m_81a374bd",label:"m_91e40b74"};const PI={},bd=H((t,n)=>{const{classNames:s,className:r,style:a,styles:o,vars:d,...u}=F("ProgressLabel",PI,t),h=vx();return e.jsx(L,{ref:n,...h.getStyles("label",{className:r,style:a,classNames:s,styles:o}),...u})});bd.classes=Ws;bd.displayName="@mantine/core/ProgressLabel";const EI={},DI=(t,{size:n,radius:s,transitionDuration:r})=>({root:{"--progress-size":De(n,"progress-size"),"--progress-radius":s===void 0?void 0:dn(s),"--progress-transition-duration":typeof r=="number"?`${r}ms`:void 0}}),Ja=H((t,n)=>{const s=F("ProgressRoot",EI,t),{classNames:r,className:a,style:o,styles:d,unstyled:u,vars:h,autoContrast:p,transitionDuration:m,...g}=s,x=se({name:"Progress",classes:Ws,props:s,className:a,style:o,classNames:r,styles:d,unstyled:u,vars:h,varsResolver:DI});return e.jsx(kI,{value:{getStyles:x,autoContrast:p},children:e.jsx(L,{ref:n,...x("root"),...g})})});Ja.classes=Ws;Ja.displayName="@mantine/core/ProgressRoot";const MI={withAria:!0},eo=H((t,n)=>{const{classNames:s,className:r,style:a,styles:o,vars:d,value:u,withAria:h,color:p,striped:m,animated:g,mod:x,...j}=F("ProgressSection",MI,t),I=vx(),S=Oe(),T=h?{role:"progressbar","aria-valuemax":100,"aria-valuemin":0,"aria-valuenow":u,"aria-valuetext":`${u}%`}:{};return e.jsx(L,{ref:n,...I.getStyles("section",{className:r,classNames:s,styles:o,style:a}),...j,...T,mod:[{striped:m||g,animated:g},x],__vars:{"--progress-section-width":`${u}%`,"--progress-section-color":an(p,S),"--progress-label-color":kg(I.autoContrast,S)?td({color:p,theme:S,autoContrast:I.autoContrast}):void 0}})});eo.classes=Ws;eo.displayName="@mantine/core/ProgressSection";const AI={},zi=H((t,n)=>{const s=F("Progress",AI,t),{value:r,classNames:a,styles:o,vars:d,color:u,striped:h,animated:p,"aria-label":m,...g}=s,{resolvedClassNames:x,resolvedStyles:j}=cb({classNames:a,styles:o,props:s});return e.jsx(Ja,{ref:n,classNames:x,styles:j,vars:d,...g,children:e.jsx(eo,{value:r,color:u,striped:h,animated:p,"aria-label":m})})});zi.classes=Ws;zi.displayName="@mantine/core/Progress";zi.Section=eo;zi.Root=Ja;zi.Label=bd;var yx={root:"m_6d731127"};const zI={gap:"md",align:"stretch",justify:"flex-start"},NI=(t,{gap:n,align:s,justify:r})=>({root:{"--stack-gap":An(n),"--stack-align":s,"--stack-justify":r}}),l=H((t,n)=>{const s=F("Stack",zI,t),{classNames:r,className:a,style:o,styles:d,unstyled:u,vars:h,align:p,justify:m,gap:g,variant:x,...j}=s,I=se({name:"Stack",props:s,classes:yx,className:a,style:o,classNames:r,styles:d,unstyled:u,vars:h,varsResolver:NI});return e.jsx(L,{ref:n,...I("root"),variant:x,...j})});l.classes=yx;l.displayName="@mantine/core/Stack";const[_I,Sd]=Nt("Tabs component was not found in the tree");var Qs={root:"m_89d60db1","list--default":"m_576c9d4",list:"m_89d33d6d",panel:"m_b0c91715",tab:"m_4ec4dce6",tabSection:"m_fc420b1f","tab--default":"m_539e827b","list--outline":"m_6772fbd5","tab--outline":"m_b59ab47c","tab--pills":"m_c3381914"};const LI={},Id=H((t,n)=>{const s=F("TabsList",LI,t),{children:r,className:a,grow:o,justify:d,classNames:u,styles:h,style:p,mod:m,...g}=s,x=Sd();return e.jsx(L,{...g,...x.getStyles("list",{className:a,style:p,classNames:u,styles:h,props:s,variant:x.variant}),ref:n,role:"tablist",variant:x.variant,mod:[{grow:o,orientation:x.orientation,placement:x.orientation==="vertical"&&x.placement,inverted:x.inverted},m],"aria-orientation":x.orientation,__vars:{"--tabs-justify":d},children:r})});Id.classes=Qs;Id.displayName="@mantine/core/TabsList";const OI={},Cd=H((t,n)=>{const s=F("TabsPanel",OI,t),{children:r,className:a,value:o,classNames:d,styles:u,style:h,mod:p,keepMounted:m,...g}=s,x=Sd(),j=x.value===o,I=x.keepMounted||m||j?r:null;return e.jsx(L,{...g,...x.getStyles("panel",{className:a,classNames:d,styles:u,style:[h,j?void 0:{display:"none"}],props:s}),ref:n,mod:[{orientation:x.orientation},p],role:"tabpanel",id:x.getPanelId(o),"aria-labelledby":x.getTabId(o),children:I})});Cd.classes=Qs;Cd.displayName="@mantine/core/TabsPanel";const FI={},Td=H((t,n)=>{const s=F("TabsTab",FI,t),{className:r,children:a,rightSection:o,leftSection:d,value:u,onClick:h,onKeyDown:p,disabled:m,color:g,style:x,classNames:j,styles:I,vars:S,mod:T,tabIndex:w,...y}=s,b=Oe(),{dir:C}=zg(),R=Sd(),D=u===R.value,k=z=>{R.onChange(R.allowTabDeactivation&&u===R.value?null:u),h==null||h(z)},P={classNames:j,styles:I,props:s};return e.jsxs(Vs,{...y,...R.getStyles("tab",{className:r,style:x,variant:R.variant,...P}),disabled:m,unstyled:R.unstyled,variant:R.variant,mod:[{active:D,disabled:m,orientation:R.orientation,inverted:R.inverted,placement:R.orientation==="vertical"&&R.placement},T],ref:n,role:"tab",id:R.getTabId(u),"aria-selected":D,tabIndex:w!==void 0?w:D||R.value===null?0:-1,"aria-controls":R.getPanelId(u),onClick:k,__vars:{"--tabs-color":g?an(g,b):void 0},onKeyDown:vw({siblingSelector:'[role="tab"]',parentSelector:'[role="tablist"]',activateOnFocus:R.activateTabWithKeyboard,loop:R.loop,orientation:R.orientation||"horizontal",dir:C,onKeyDown:p}),children:[d&&e.jsx("span",{...R.getStyles("tabSection",P),"data-position":"left",children:d}),a&&e.jsx("span",{...R.getStyles("tabLabel",P),children:a}),o&&e.jsx("span",{...R.getStyles("tabSection",P),"data-position":"right",children:o})]})});Td.classes=Qs;Td.displayName="@mantine/core/TabsTab";const wh="Tabs.Tab or Tabs.Panel component was rendered with invalid value or without value",$I={keepMounted:!0,orientation:"horizontal",loop:!0,activateTabWithKeyboard:!0,allowTabDeactivation:!1,unstyled:!1,inverted:!1,variant:"default",placement:"left"},BI=(t,{radius:n,color:s,autoContrast:r})=>({root:{"--tabs-radius":dn(n),"--tabs-color":an(s,t),"--tabs-text-color":kg(r,t)?td({color:s,theme:t,autoContrast:r}):void 0}}),f=H((t,n)=>{const s=F("Tabs",$I,t),{defaultValue:r,value:a,onChange:o,orientation:d,children:u,loop:h,id:p,activateTabWithKeyboard:m,allowTabDeactivation:g,variant:x,color:j,radius:I,inverted:S,placement:T,keepMounted:w,classNames:y,styles:b,unstyled:C,className:R,style:D,vars:k,autoContrast:P,mod:z,..._}=s,q=vg(p),[oe,ge]=Aw({value:a,defaultValue:r,finalValue:null,onChange:o}),Ye=se({name:"Tabs",props:s,classes:Qs,className:R,style:D,classNames:y,styles:b,unstyled:C,vars:k,varsResolver:BI});return e.jsx(_I,{value:{placement:T,value:oe,orientation:d,id:q,loop:h,activateTabWithKeyboard:m,getTabId:oh(`${q}-tab`,wh),getPanelId:oh(`${q}-panel`,wh),onChange:ge,allowTabDeactivation:g,variant:x,color:j,radius:I,inverted:S,keepMounted:w,unstyled:C,getStyles:Ye},children:e.jsx(L,{ref:n,id:q,variant:x,mod:[{orientation:d,inverted:d==="horizontal"&&S,placement:d==="vertical"&&T},z],...Ye("root"),..._,children:u})})});f.classes=Qs;f.displayName="@mantine/core/Tabs";f.Tab=Td;f.Panel=Cd;f.List=Id;const HI=["h1","h2","h3","h4","h5","h6"],VI=["xs","sm","md","lg","xl"];function GI(t,n){const s=n!==void 0?n:`h${t}`;return HI.includes(s)?{fontSize:`var(--mantine-${s}-font-size)`,fontWeight:`var(--mantine-${s}-font-weight)`,lineHeight:`var(--mantine-${s}-line-height)`}:VI.includes(s)?{fontSize:`var(--mantine-font-size-${s})`,fontWeight:`var(--mantine-h${t}-font-weight)`,lineHeight:`var(--mantine-h${t}-line-height)`}:{fontSize:E(s),fontWeight:`var(--mantine-h${t}-font-weight)`,lineHeight:`var(--mantine-h${t}-line-height)`}}var jx={root:"m_8a5d1357"};const UI={order:1},qI=(t,{order:n,size:s,lineClamp:r,textWrap:a})=>{const o=GI(n,s);return{root:{"--title-fw":o.fontWeight,"--title-lh":o.lineHeight,"--title-fz":o.fontSize,"--title-line-clamp":typeof r=="number"?r.toString():void 0,"--title-text-wrap":a}}},Pn=H((t,n)=>{const s=F("Title",UI,t),{classNames:r,className:a,style:o,styles:d,unstyled:u,order:h,vars:p,size:m,variant:g,lineClamp:x,textWrap:j,mod:I,...S}=s,T=se({name:"Title",props:s,classes:jx,className:a,style:o,classNames:r,styles:d,unstyled:u,vars:p,varsResolver:qI});return[1,2,3,4,5,6].includes(h)?e.jsx(L,{...T("root"),component:`h${h}`,variant:g,ref:n,mod:[{order:h,"data-line-clamp":typeof x=="number"},I],size:m,...S}):null});Pn.classes=jx;Pn.displayName="@mantine/core/Title";const Ii="assignExposures",qn="continuous",Wn="categorical",Qn="time_to_event",WI="Outcome Measure",QI=()=>e.jsx(i,{c:"dimmed",size:"md",children:"Select the type of outcome variable being analyzed or compared."}),Ci="Further adjustments",Ti=()=>e.jsx(i,{c:"dimmed",size:"md",children:"Select any further adjustments done during analysis, for example to remove confounding factors or refine overall model assumptions."}),Be="Appropriate Effect Size Measurements ",He=()=>e.jsx(i,{c:"dimmed",size:"md",children:"Based on the inputs you've given, consider the following as effect size measurements when reporting the results of your investigation."}),Rd="Focus of Analysis",kd=()=>e.jsx(i,{c:"dimmed",size:"md",children:"In statistical analysis, the focus of analysis depends on the research question being asked and the type of data being collected."}),Pd="Adjusted association with predictor",Ed="A characteristic used in regression models to describe the relationship between an independent (predictor) variable and an outcome variable after accounting for other covariates or predictor variables within the model.",Dd=`A characteristic used in regression models to describe the relationship between an independent (predictor) variable and an outcome variable after accounting for other covariates or predictor variables within the model.

By controlling for the potential effects of other covariates, the identified association purely reflects the unique influence of the selected predictor.

By incorporating this concept, we can isolate associations and remove potential confounders.`,Md="Overall model",Ad="A characteristic used in regression models to describe the combined influence of all independent (predictor) variables on an outcome variable.",zd=`A characteristic used in regression models to describe the combined influence of all independent (predictor) variables on an outcome variable.

Rather than focusing on individual predictors and isolated associations, the overall model captures the collective effect of all predictor variables.

By evaluating the overall model, researchers can determine how well the entire set of predictors can explain the variability in the outcome.`,Nd="Reporting pairwise differences",_d="Reporting pairwise differences is a detailed sub-method of analysis used in the comparison of three or more groups.",Ld=`Reporting pairwise differences is a detailed sub-method of analysis used in the comparison of three or more groups.

By comparing each group to every other group individually, one can make multiple comparisons to observe and quantify the differences between pairs of groups. This added information allows for the extended interpretation of the comparative and contrasting relationships among the groups.`,wx="Reporting overall effect",bx="Reporting the overall effect size is a comprehensive sub-method of analysis used in the comparison of three or more groups.",Sx=`Reporting the overall effect size is a comprehensive sub-method of analysis used in the comparison of three or more groups.

By considering all of the groups collectively instead of in pairs, one can compute an overarching metric to observe and quantify the summative differences among the groups. Using this method of analysis, more holistic and aggregate interpretations regarding the relationships among the groups can be deduced.`,Od="Quantifies the strength and direction of a relationship between two continuous variables.",Fd="Evaluates the presence and magnitude of the difference between two groups.",$d="Evaluates the presence and magnitude of the difference among three or more groups.",Bd="Quantifies the improvement of the model as compared with a null model (a model with only an intercept) for explaining the variance in the outcome variable.",YI="A continuous dependent variable is a numeric variable that has an infinite number of values within a given interval. Continuous variables are often used to represent ratio data such as height, weight, and blood pressure, as well as interval data such as temperature in Celsius or Fahrenheit.",KI=`A continuous dependent variable is a numeric variable that has an infinite number of values within a given interval. Continuous variables are often used to represent ratio data (the presence of an absolute zero) such as height, weight, and blood pressure as well as interval data (the absence of an absolute zero) such as temperature in Celsius or Fahrenheit.

The continuous effect estimate should always be reported with a measure of the precision of the estimate, which is usually defined by the 95% confidence interval. The continuous estimate and the 95% confidence interval should be interpreted in the light of clinical importance.`,XI="A categorical dependent variable takes on a limited number of discrete values or categories. Categorical variables are often used to represent qualitative or nominal data such as sex, race, disease severity, and treatment group.",ZI=`A categorical dependent variable takes on a limited number of discrete values or categories. Categorical variables are often used to represent qualitative or nominal data such as sex, race, disease severity, and treatment group.

The categorical effect estimate should always be reported with a measure of the precision of the estimate, which is usually defined by the 95% confidence interval. The categorical estimate and the 95% confidence interval should be interpreted in the light of clinical importance.`,JI="A time-to-event dependent variable is used to measure the time it takes for a specific event to occur. This type of variable is commonly employed in studies that investigate the time until the occurrence of certain events, such as time to death, time to relapse, or time to recovery.",e5=`A time-to-event dependent variable is used to measure the time it takes for a specific event to occur. This type of variable is commonly employed in studies that investigate the time until the occurrence of certain events, such as time to death, time to relapse, or time to recovery.

In time-to-event analysis, the dependent variable represents the duration from a defined starting point (often referred to as zero-time) to the occurrence of the event of interest. The event can be either a positive event (e.g., recovery from illness, survival after the diagnosis of cancer) or a negative event (e.g., disease relapse, death).

The time-to-event effect estimate should always be reported with a measure of the precision of the estimate, which is usually defined by the 95% confidence interval. The time-to-event estimate and the 95% confidence interval should be interpreted in the light of clinical importance.`;function G({explanationSections:t,example1:n,example2:s,explanationLabel:r="Explanation",example1Label:a="Example 1",example2Label:o="Example 2",defaultTab:d="explanation"}){return e.jsx(l,{gap:"lg",children:t.map((u,h)=>e.jsx("div",{children:u},h))})}function t5(){const t=[e.jsx(l,{gap:4,children:e.jsxs(i,{children:["The Pearson correlation coefficient (Pearson's"," ",e.jsx(i,{span:!0,fs:"italic",children:"r"}),") is used to quantify the linear relationship or association between two continuous variables. It measures both the direction and the strength of this linear relationship."]})}),e.jsxs(l,{gap:6,children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Range of Pearson's r"}),e.jsxs(i,{children:["Pearson's"," ",e.jsx(i,{span:!0,fs:"italic",children:"r"})," ","values range from -1 to +1, with the following meanings:"]})]}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"+1:"})," ","There is a perfect positive linear relationship. As one variable increases, the other variable increases proportionally."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0:"})," ","No linear relationship exists between the two variables."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"-1:"})," ","There is a perfect negative linear relationship. As one variable increases, the other variable decreases proportionally."]})})]})]}),e.jsxs(l,{gap:6,children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpreting the magnitude of Pearson's r"}),e.jsx(i,{children:"The interpretation of the Pearson correlation coefficient as an absolute value is as follows:"})]}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.00 to 0.19:"})," ","Very weak association"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.20 to 0.39:"})," ","Weak association"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.40 to 0.59:"})," ","Moderate association"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.60 to 0.79:"})," ","Strong association"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.80 to 1.00:"})," ","Very strong association"]})})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Important caveats"}),e.jsxs(i,{children:["While a significant Pearson's"," ",e.jsx(i,{span:!0,fs:"italic",children:"r"})," ","value indicates a linear relationship between variables, it does not imply causation. Furthermore, it is essential to check the assumptions of the Pearson correlation (e.g., linearity, no outliers) and to consider the broader context when interpreting its value. Nonlinear relationships might not be well represented by Pearson's"," ",e.jsx(i,{span:!0,fs:"italic",children:"r"}),"."]})]})];return e.jsx(G,{explanationSections:t,example1:e.jsx(i,{children:"Example 1 content will go here (e.g., a scatterplot, numerical example, or walkthrough)."})})}function Ix(){return e.jsxs(l,{gap:"md",children:[e.jsx(i,{fs:"italic",mt:0,children:"Among adults, what is the strength of association between blood glucose and BMI?"}),e.jsxs(f,{defaultValue:"studyDesign",children:[e.jsxs(f.List,{children:[e.jsx(f.Tab,{value:"studyDesign",children:"Study Design and Methods"}),e.jsx(f.Tab,{value:"effectSize",children:"Effect Size Measure & MCID"}),e.jsx(f.Tab,{value:"result",children:"Result"}),e.jsx(f.Tab,{value:"discussion",children:"Discussion and Future Research"})]}),e.jsx(f.Panel,{value:"studyDesign",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Clinical Research Study Design:"}),e.jsx(i,{children:"Cross-sectional study, collecting data from a diverse sample of adults (aged 18 to 65 years)."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Study Population:"}),e.jsx(i,{children:"1000 Veterans attending a general medical clinic in a large urban setting."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Variables under Study:"}),e.jsx(i,{children:"Participants undergo measurements of fasting blood glucose levels, weight (measured in kilograms) and height (measured in meters)."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Independent/Predictor/Exposure:"}),e.jsx(i,{children:"Pearson correlation is not directional therefore defining variables as independent and dependent is not necessary. Cross-sectional study design does not support defining variables as independent, predictor, or exposure."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Dependent Outcome:"}),e.jsx(i,{children:"Due to cross-sectional study design, there is no dependent or outcome measure."})]})]})}),e.jsx(f.Panel,{value:"effectSize",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Effect Size Measure used in the Analytical Approach"}),e.jsxs(i,{children:["The Pearson correlation coefficient (",e.jsx(i,{span:!0,fs:"italic",children:"r"}),") is calculated to measure the strength and direction of the association between blood glucose level and BMI."]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Minimal Clinically Important Difference for Strength of Association"}),e.jsx(i,{children:"The minimal clinically important difference (MCID) for the strength of association between blood glucose levels and BMI was not determined by the investigators nor has it been established in the literature. However, based on Cohen's guidelines a value of 0.4 (moderate association) might be considered a clinically meaningful association."})]})]})}),e.jsx(f.Panel,{value:"result",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Point Estimate:"}),e.jsxs(i,{children:["Pearson Correlation Coefficient (",e.jsx(i,{span:!0,fs:"italic",children:"r"}),") between Blood Glucose Levels and BMI = 0.70"]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Confidence Interval:"}),e.jsx(i,{children:"95% CI = 0.67-0.73"})]}),e.jsxs(l,{gap:0,children:[e.jsxs(i,{fw:500,children:["Probability Value (",e.jsx(i,{span:!0,fs:"italic",children:"p"}),"-value):"]}),e.jsxs(i,{children:[e.jsx(i,{span:!0,fs:"italic",children:"p"})," ","< 0.0001"]})]})]})}),e.jsx(f.Panel,{value:"discussion",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Discussion"}),e.jsxs(i,{children:["Using the interpretation guide, the Pearson correlation coefficient (",e.jsx(i,{span:!0,fs:"italic",children:"r"}),") of 0.70 indicates a strong positive correlation between blood glucose levels and BMI in the studied adult population  higher blood glucose levels are associated with higher BMI levels."]})]}),e.jsxs(i,{children:["The researchers can conclude with 95% confidence that the true value for the correlation coefficient (",e.jsx(i,{span:!0,fs:"italic",children:"r"}),") between blood glucose levels and BMI in the population could be as low as 0.67 and as high as 0.73. In this case, the 95% CI around the correlation coefficient is considered precise because all plausible values for the true correlation between blood glucose and BMI (i.e., 0.67 to 0.73) indicate a strong relationship."]}),e.jsxs(i,{children:["The probability value (",e.jsx(i,{span:!0,fs:"italic",children:"p"}),'-value) of "<0.0001" indicates that the likelihood of obtaining a Pearson correlation coefficient (',e.jsx(i,{span:!0,fs:"italic",children:"r"}),") of 0.70 or greater by chance alone, assuming there is no relationship between these two variables, is extremely unlikely. However, the"," ",e.jsx(i,{span:!0,fs:"italic",children:"p"}),"-value must be interpreted with caution, especially given the large sample size of 1000 in this study. Larger sample sizes can produce highly significant"," ",e.jsx(i,{span:!0,fs:"italic",children:"p"}),"-values for the correlation coefficient even for small or modest correlations, which may not be practically meaningful. Therefore, the strength of the association, as indicated by the correlation coefficient, should be considered more closely than the"," ",e.jsx(i,{span:!0,fs:"italic",children:"p"}),"-value alone to understand the practical significance of the results."]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Implications of Results"}),e.jsx(i,{children:"This study provides robust evidence of a strong correlation between blood glucose levels and BMI in adults."})]}),e.jsx(i,{children:"Higher blood glucose levels are associated with higher BMI levels, which is consistent with established knowledge regarding the risk of metabolic disorders, including diabetes, in individuals with obesity."}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Future Research"}),e.jsxs(c,{spacing:"xs",children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Longitudinal Studies:"})," ","Conduct longitudinal studies to explore how changes in BMI over time relate to changes in blood glucose levels and the development of metabolic disorders."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Subgroup Analyses:"})," ","To better understand the nature of the association, investigate whether the association varies by age, gender, and ethnic background."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Mechanistic Research:"})," ","Explore the underlying mechanisms driving the association between BMI and blood glucose levels, such as insulin resistance and adipokine secretion."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Intervention Studies:"})," ","Assess the impact of weight management interventions on blood glucose control to determine if reducing BMI can mitigate the risk of elevated blood glucose."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Dietary and Lifestyle Factors:"})," ","Investigate how dietary patterns and physical activity influence the relationship between BMI and blood glucose levels."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Genetic and Molecular Studies:"})," ","Explore genetic and molecular markers that may mediate or modify the association between BMI and blood glucose levels."]})})]})]})]})})]})]})}Ix.title="Association Between Blood Glucose Levels and Body Mass Index (BMI) in Adults: A Cross-Sectional Analysis";function Cx(){return e.jsxs(l,{gap:"md",children:[e.jsx(i,{fs:"italic",mt:0,children:"Among older adults without known cognitive impairments or sleep disorders, what is the strength of association between nightly sleep duration and cognitive performance?"}),e.jsxs(f,{defaultValue:"studyDesign",children:[e.jsxs(f.List,{children:[e.jsx(f.Tab,{value:"studyDesign",children:"Study Design and Methods"}),e.jsx(f.Tab,{value:"effectSize",children:"Effect Size Measure & MCID"}),e.jsx(f.Tab,{value:"result",children:"Result"}),e.jsx(f.Tab,{value:"discussion",children:"Discussion and Future Research"})]}),e.jsx(f.Panel,{value:"studyDesign",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Clinical Research Study Design:"}),e.jsx(i,{children:"Cross-sectional"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Study Population:"}),e.jsx(i,{children:"100 older adults (aged 60 years and older) recruited from community centers and senior living facilities."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Variables under Study:"}),e.jsx(i,{children:"Participants undergo assessments of sleep duration, measured objectively using actigraphy, and cognitive function using standardized neuropsychological tests assessing memory, attention, and executive function."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Independent/Predictor/Exposure:"}),e.jsx(i,{children:"Pearson correlation is not directional, therefore defining variables as independent and dependent is not necessary. A cross-sectional study design does not support defining variables as independent, predictor, or exposure."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Dependent Outcome:"}),e.jsx(i,{children:"Due to the cross-sectional study design, there is no dependent or outcome measure."})]})]})}),e.jsx(f.Panel,{value:"effectSize",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Effect Size Measure used in the Analytical Approach"}),e.jsxs(i,{children:["The Pearson correlation coefficient (",e.jsx(i,{span:!0,fs:"italic",children:"r"}),") is calculated to measure the strength and direction of the association between nightly sleep duration and cognitive performance. The 95% confidence interval (CI) is reported to indicate the precision of the estimates."]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Minimal Clinically Important Difference for Strength of Association"}),e.jsx(i,{children:"The minimal clinically important difference (MCID) for the strength of association between sleep duration and cognitive function was not determined by the investigators, nor has it been established in the literature. However, based on Cohen's guidelines, a value of 0.4 (moderate association) might be considered a clinically meaningful association."})]})]})}),e.jsx(f.Panel,{value:"result",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Point Estimate:"}),e.jsxs(i,{children:["Pearson Correlation Coefficient (",e.jsx(i,{span:!0,fs:"italic",children:"r"}),") between Sleep Duration and Cognitive Performance = 0.62"]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Confidence Interval:"}),e.jsx(i,{children:"95% CI = 0.32 to 0.92"})]}),e.jsxs(l,{gap:0,children:[e.jsxs(i,{fw:500,children:["Probability Value (",e.jsx(i,{span:!0,fs:"italic",children:"p"}),"-value):"]}),e.jsxs(i,{children:[e.jsx(i,{span:!0,fs:"italic",children:"p"})," ","= 0.4"]})]})]})}),e.jsx(f.Panel,{value:"discussion",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Results"}),e.jsxs(i,{children:["Using the interpretation guide, the Pearson correlation coefficient (",e.jsx(i,{span:!0,fs:"italic",children:"r"}),") of 0.62 indicates a moderate to strong positive correlation between nightly sleep duration and cognitive performance in older adults  longer sleep duration is associated with increased mental performance."]})]}),e.jsxs(i,{children:["The researchers can conclude with 95% confidence that the actual value for the correlation coefficient (",e.jsx(i,{span:!0,fs:"italic",children:"r"}),") between nightly sleep duration and cognitive performance in older adults in the population could range from 0.32 (weak association) to 0.92 (very strong association). In this case, the 95% confidence interval (CI) around the correlation coefficient is considered imprecise because the range includes values indicating weak, moderate, strong, and very strong associations. Thus, this study provides limited evidence about the true strength of the relationship."]}),e.jsxs(i,{children:["The probability value (",e.jsx(i,{span:!0,fs:"italic",children:"p"}),"-value) of 0.4 indicates that the likelihood of obtaining a Pearson correlation coefficient (",e.jsx(i,{span:!0,fs:"italic",children:"r"}),") of 0.62 or greater by chance alone, assuming there is no relationship between these two variables, is relatively high. Therefore, the investigators cannot reject the null hypothesis of no relationship. The strength of the association, as indicated by the correlation coefficient, should be considered more closely than the"," ",e.jsx(i,{span:!0,fs:"italic",children:"p"}),"-value alone to understand the practical significance of the results."]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Implications of Results"}),e.jsx(i,{children:"While the correlation coefficient value of 0.62 suggests a moderate to strong positive correlation, the imprecision in this estimate, as indicated by the wide confidence interval, provides limited evidence of the actual relationship between longer sleep duration and better cognitive function in older adults."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Future Research"}),e.jsxs(c,{spacing:"xs",children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Conduct Additional Research with Increased Sample Size:"})," ","To obtain more precise estimates of the effect size, conduct the study with a larger sample size. This approach enables authors and readers to be more certain of where the true effect size value lies and whether the results are compatible with clinically meaningful effects. However, it's important to consider that increasing sample size may not always be feasible in every research context. Resource constraints, such as funding, time, and participant availability, can significantly limit the ability to expand the study. Therefore, while planning to increase the sample size, researchers should also work to ensure that the study remains viable and efficient."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Improve Study Quality via Reduction of Error:"})," ","Enhance the reliability and precision of effect size estimates by reducing both random and systematic errors. Adherence to Good Clinical Practice (GCP) guidelines, as described in the FDA's Code of Federal Regulations, is one effective strategy. GCP promotes standardized processes, data quality, patient safety, and rigorous oversight, all contributing to improved clinical research and evidence-based medicine. However, it's also vital to acknowledge that the potential for error reduction is influenced by the specific nature and inherent variability of the study population, making a one-size-fits-all approach impractical."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Improve Methodological Quality and Rigor of Subsequent Studies:"})," ","Enhance the methodological quality of the study via control of confounding. In such studies, focusing on methodological improvements is essential for clarifying ambiguous findings. These enhancements are critical for reducing bias and increasing the reliability of results, providing clearer direction for future research. While pursuing these methodological ideals, researchers should also consider the practical challenges, such as logistical constraints and participant-related hurdles, to conduct feasible yet robust studies."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Reduce Variability in the Measurement of Key Variables:"})," ","To diminish variability and enhance precision, standardize measurements through methods like a Standard Operating Procedure (SOP) manual, validated assessments, and calibrated instruments. Additionally, evaluate the sensitivity and specificity of these measurement tools to ensure they can detect small but clinically significant changes. While promoting consistency is crucial, it's equally important to consider potential limitations of standardization, such as missing context-specific factors that might influence results. This comprehensive approach enables the accurate capture of the study's outcomes' nuances."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Utilize Technology-Assisted Data Collection:"})," ","Employ technologies such as wearables and mobile apps to provide real-time measurements of sleep duration that are more accurate than actigraphy, potentially refining data accuracy and making it crucial for re-examining indeterminate results. This approach minimizes errors and variability, potentially revealing subtle effects that were initially overlooked. Enhanced participant engagement through these technologies also contributes to higher-quality data, aiding in a deeper understanding and reassessment of the study's conclusions."]})})]})]})]})})]})]})}Cx.title="Association Between Sleep Duration and Cognitive Function in Older Adults: A Cross-Sectional Analysis";const n5=[Ix,Cx];function i5(){const t=[e.jsx(l,{gap:4,children:e.jsx(i,{children:"The coefficient of determination (R) is an effect size measure used in regression analysis. It quantifies the proportion of the total variance in the dependent variable that is explained by the independent variables included in the regression model. R is used to assess the goodness of fit of the model and the proportion of variance in the dependent variable that can be attributed to the predictors."})}),e.jsxs(l,{gap:6,children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Range of R"}),e.jsx(i,{children:"R values range from 0 to 1:"})]}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:["An R of"," ",e.jsx(i,{span:!0,fw:500,children:"0"})," ","indicates that the model explains none of the variance in the dependent variable."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:["An R of"," ",e.jsx(i,{span:!0,fw:500,children:"1.0"})," ","suggests that the model explains all of the variance, which means that the model perfectly predicts the dependent variable."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:["A"," ",e.jsx(i,{span:!0,fw:500,children:"higher R value"})," ","suggests that the model is better at explaining and predicting the dependent variable."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:["A"," ",e.jsx(i,{span:!0,fw:500,children:"lower R value"})," ","implies that there may be factors that are unaccounted for or a measurement error that affects the model's ability to explain the variance."]})})]})]}),e.jsxs(l,{gap:6,children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of R values"}),e.jsx(i,{children:"The interpretation of R values is as follows:"})]}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"<0.30:"})," ","Low R. This indicates that only a small proportion of the variance in the dependent variable is explained by the independent variables. The model may not fit the data well or may lack important predictors."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.30 to 0.70:"})," ","Moderate R. This indicates that a substantial proportion of the variance in the dependent variable is explained by the independent variables. The model provides a reasonable fit to the data, but there is still unexplained variance."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:">0.70:"})," ","High R. This indicates that a large proportion of the variance in the dependent variable is explained by the independent variables. The model provides a strong fit to the data, and the predictors have a substantial influence on the dependent variable."]})})]})]})];return e.jsx(G,{explanationSections:t,example1:e.jsx(i,{children:"Example 1 content will go here (e.g., a scatterplot, numerical example, or walkthrough)."})})}function Tx(){return e.jsxs(l,{gap:"md",children:[e.jsx(i,{fs:"italic",mt:0,children:"In adults diagnosed with hypertension, how well do lifestyle factors such as diet, exercise, and stress levels explain the variance in blood pressure?"}),e.jsxs(f,{defaultValue:"studyDesign",children:[e.jsxs(f.List,{children:[e.jsx(f.Tab,{value:"studyDesign",children:"Study Design and Methods"}),e.jsx(f.Tab,{value:"effectSize",children:"Effect Size Measure & MCID"}),e.jsx(f.Tab,{value:"result",children:"Result"}),e.jsx(f.Tab,{value:"discussion",children:"Discussion and Future Research"})]}),e.jsx(f.Panel,{value:"studyDesign",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Clinical Research Study Design:"}),e.jsx(i,{children:"Observational study"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Study Population:"}),e.jsx(i,{children:"85 adults diagnosed with hypertension, identified through electronic health records from a network of primary care clinics."})]}),e.jsx(i,{children:"Participants were included if they had a documented diagnosis of hypertension, complete records of lifestyle factors (diet, exercise, stress levels), and blood pressure measurements."}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Variables under Study:"}),e.jsx(i,{fw:500,children:"Independent/Predictor/Exposure:"}),e.jsxs(c,{spacing:"xs",children:[e.jsx(c.Item,{children:e.jsx(i,{children:"Diet (measured by dietary sodium intake and adherence to a DASH diet)"})}),e.jsx(c.Item,{children:e.jsx(i,{children:"Exercise (measured by frequency and duration of physical activity per week)"})}),e.jsx(c.Item,{children:e.jsx(i,{children:"Stress Levels (measured by a standardized stress questionnaire)"})})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Dependent/Outcome:"}),e.jsx(i,{children:"Blood Pressure (measured as systolic and diastolic blood pressure)"})]})]})}),e.jsx(f.Panel,{value:"effectSize",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Effect Size Measure used in the Analytical Approach"}),e.jsx(i,{children:"Coefficient of Determination (R) is commonly used to quantify how well the independent variables explain the variance in the dependent variable. In this study, R will be used to indicate the proportion of variance in blood pressure that can be explained by factors such as diet, exercise, and stress levels."})]}),e.jsx(i,{children:"95% confidence intervals (CI) are reported to indicate the precision of the estimates."}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Minimal Clinically Important Difference (MCID)"}),e.jsx(i,{children:"The investigators established an R value of 0.3 (30%) and above as clinically meaningful."})]})]})}),e.jsx(f.Panel,{value:"result",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Point Estimate:"}),e.jsx(i,{children:"R value = 0.45"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Confidence Interval:"}),e.jsx(i,{children:"95% confidence interval (CI) of 0.40 to 0.50"})]}),e.jsxs(l,{gap:0,children:[e.jsxs(i,{fw:500,children:["Probability Value (",e.jsx(i,{span:!0,fs:"italic",children:"p"}),"-value):"]}),e.jsxs(i,{children:[e.jsx(i,{span:!0,fs:"italic",children:"P"}),"=0.0004"]})]})]})}),e.jsx(f.Panel,{value:"discussion",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Results"}),e.jsx(i,{children:"The R value of 0.45 indicates that the combined effects of diet, exercise, and stress levels can explain 45% variance in blood pressure among the study population. The results demonstrate that lifestyle factors have a substantial impact on blood pressure levels in adults with hypertension."})]}),e.jsx(i,{children:"The 95% CI of [0.40, 0.50] suggests that the true proportion of variance explained by these lifestyle factors is likely between 40% and 50%. Since all plausible values for the true proportion of variance explained lie above the minimal clinically important difference (MCID) value of 0.30, the estimate is considered precise."}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Implications of Results"}),e.jsx(i,{children:"These findings underscore the importance of lifestyle modifications in the management of hypertension. Interventions focusing on dietary changes, increased physical activity, and stress reduction could significantly improve blood pressure control in hypertensive patients. Healthcare providers should consider incorporating these lifestyle factors into hypertension management plans."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Future Research"}),e.jsxs(c,{spacing:"xs",children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"The long-term effects of lifestyle modifications on blood pressure and overall cardiovascular health."})," ","Future research should investigate how sustained lifestyle changes, including diet, exercise, and stress management, influence not only blood pressure but also broader cardiovascular outcomes over extended periods. This longitudinal approach can provide insights into the durability and comprehensive health benefits of lifestyle interventions."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"The impact of specific dietary patterns, types of exercise, and stress management techniques on blood pressure."})," ","Studying the differential effects of varied dietary patterns (e.g., DASH diet, Mediterranean diet), types of exercise (e.g., aerobic vs. resistance training), and stress reduction strategies (e.g., mindfulness, yoga) on blood pressure can elucidate which interventions are most effective for different patient profiles. This research could inform personalized recommendations for hypertension management."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"The interaction between lifestyle factors and pharmacological treatments for hypertension."})," ","Investigating how lifestyle modifications interact with pharmacotherapy in lowering blood pressure could reveal synergistic effects or potential conflicts. Understanding these interactions is crucial for optimizing treatment strategies and enhancing therapeutic outcomes for hypertensive patients."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"The role of personalized lifestyle interventions based on genetic and individual variability in optimizing blood pressure control."})," ","Future studies should investigate how genetic factors and individual variability in lifestyle responsiveness impact the effectiveness of interventions targeting blood pressure control. This personalized approach could lead to tailored lifestyle recommendations that maximize benefits and improve adherence among diverse patient populations."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Progress to Dissemination & Implementation (D&I)."})," ","Move towards disseminating and implementing the intervention into real-world clinical practice. This involves translating research findings into practical applications and addressing the challenges associated with implementing evidence-based interventions in healthcare settings."]})})]})]})]})})]})]})}Tx.title="The Influence of Lifestyle Factors on Blood Pressure in Adults: An Observational Study";const s5=[Tx];function r5(){const t=[e.jsx(l,{gap:4,children:e.jsx(i,{children:"Spearman's rho () can be used to measure the strength and direction of monotonic associations between two ordinal or ranked variables. Spearman's  is especially suitable for data that does not meet the assumptions required for the Pearson correlation coefficient, such as data with nonlinear relationships or data that is ordinal in nature."})}),e.jsxs(l,{gap:6,children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Range of Spearman's "}),e.jsx(i,{children:"Spearman's  values range from -1 to +1, with the following meanings:"})]}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"+1:"})," ","There is a perfect positive monotonic relationship. As the rank of one variable increases, the rank of the other variable increases proportionally."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0:"})," ","No monotonic relationship exists between the two ranked variables."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"-1:"})," ","There is a perfect negative monotonic relationship. As the rank of one variable increases, the rank of the other variable decreases proportionally."]})})]})]}),e.jsxs(l,{gap:6,children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpreting the magnitude of Spearman's "}),e.jsx(i,{children:"The interpretation of Spearman's  as an absolute value is as follows:"})]}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.00 to 0.19:"})," ","Very weak association"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.20 to 0.39:"})," ","Weak association"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.40 to 0.59:"})," ","Moderate association"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.60 to 0.79:"})," ","Strong association"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.80 to 1.00:"})," ","Very strong association"]})})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Important caveats"}),e.jsxs(i,{children:["While a significant Spearman's  value indicates a monotonic relationship between variables, it does not imply causation. Spearman's  is particularly useful for ordinal data or when the relationship between variables is monotonic but not necessarily linear. It is less sensitive to outliers than Pearson's"," ",e.jsx(i,{span:!0,fs:"italic",children:"r"}),", but it is important to consider the broader context when interpreting its value."]})]})];return e.jsx(G,{explanationSections:t,example1:e.jsx(i,{children:"Example 1 content will go here (e.g., a scatterplot, numerical example, or walkthrough)."})})}function Rx(){return e.jsxs(l,{gap:"md",children:[e.jsx(i,{fs:"italic",mt:0,children:"Among adults diagnosed with cancer who have recently completed or are currently undergoing cancer treatment, how strong is the association between performance status and quality of life?"}),e.jsxs(f,{defaultValue:"studyDesign",children:[e.jsxs(f.List,{children:[e.jsx(f.Tab,{value:"studyDesign",children:"Study Design and Methods"}),e.jsx(f.Tab,{value:"effectSize",children:"Effect Size Measure & MCID"}),e.jsx(f.Tab,{value:"result",children:"Result"}),e.jsx(f.Tab,{value:"discussion",children:"Discussion and Future Research"})]}),e.jsx(f.Panel,{value:"studyDesign",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Clinical Research Study Design:"}),e.jsx(i,{children:"Cross-sectional study, collecting data from cancer patients at a single time point."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Study Population:"}),e.jsx(i,{children:"500 adults, aged 18-75 years, diagnosed with various stages of cancer, who have recently completed or are currently undergoing cancer treatment."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Variables under Study:"}),e.jsxs(c,{spacing:"xs",children:[e.jsx(c.Item,{children:e.jsx(i,{children:"Karnofsky Performance Status is a patient-based rating system used in oncology to assess functional status. The scale ranges from 10 (severe impairment) to 100 (normal health), with higher scores indicating better overall functioning and well-being."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"Participants complete the EORTC QLQ-C30 (European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30), a self-report questionnaire designed to assess quality of life in cancer patients."})})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Independent/Predictor/Exposure:"}),e.jsx(i,{children:"Spearman's rho is a non-directional measure of correlation, so defining variables as independent (predictor/exposure) or dependent is not necessary. Furthermore, the cross-sectional study design does not inherently support the classification of variables as independent, predictor, or exposure."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Dependent/Outcome:"}),e.jsx(i,{children:"Due to the cross-sectional study design, there is no dependent or outcome measure."})]})]})}),e.jsx(f.Panel,{value:"effectSize",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Effect Size Measure used in the Analytical Approach"}),e.jsx(i,{children:"Spearman's rho is calculated to evaluate the strength and direction of the association between the Karnofsky Performance Status and EORTC QLQ-C30."})]}),e.jsx(i,{children:"95% confidence interval (CI) is reported to indicate the precision of the estimate."}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Minimal Clinically Important Difference (MCID)"}),e.jsx(i,{children:"Before conducting the study, the investigators determined that a Spearman's rho of 0.40 or greater (moderate association) would be clinically important."})]})]})}),e.jsx(f.Panel,{value:"result",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Point Estimate:"}),e.jsx(i,{children:"Spearman's rho between performance status and quality of life is 0.65"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Confidence Interval:"}),e.jsx(i,{children:"95% CI = 0.60 to 0.70"})]}),e.jsxs(l,{gap:0,children:[e.jsxs(i,{fw:500,children:["Probability Value (",e.jsx(i,{span:!0,fs:"italic",children:"p"}),"-value):"]}),e.jsxs(i,{children:[e.jsx(i,{span:!0,fs:"italic",children:"P"})," ","< 0.0001"]})]})]})}),e.jsx(f.Panel,{value:"discussion",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Results"}),e.jsx(i,{children:"The Spearman's rho of 0.65 indicates a strong positive correlation between performance status and quality of life in cancer patients - as the patient's performance status increases the quality-of-life increases."})]}),e.jsx(i,{children:"The 95% CI suggests high precision in estimating the strength of this association, and thus the investigator can be confident about where the true value lies. Based on this study, the researchers can conclude with 95% confidence that the association between functional status and quality of life in the population of patients similar to those in the study falls between 0.60 and 0.70; thus, all plausible values for the true effect size lie within this range, which is considered a strong association according to the interpretation guidelines."}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Implications of Results"}),e.jsx(i,{children:"This cross-sectional study provides robust evidence that as cancer stage increases, the self-reported performance status in cancer patients decreases."})]}),e.jsx(i,{children:"The results emphasize the importance of addressing functional status concerns, particularly in patients with advanced-stage cancer."}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Future Research"}),e.jsxs(c,{spacing:"xs",children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Longitudinal Studies:"})," ","Conduct longitudinal studies to track changes in quality of life across different levels of functional performance and assess factors influencing these changes."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Interventional Studies:"})," ","Investigate the effectiveness of supportive interventions (e.g., psychosocial support, palliative care) in improving the quality of life for cancer patients."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Subgroup Analyses:"})," ","Explore whether the relationship between functional performance and quality of life differs by demographic factors, cancer type, or treatment modality."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Patient-Reported Outcomes:"})," ","Utilize additional patient-reported outcome measures to assess quality of life domains affected by cancer comprehensively."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Survivorship Care Plans:"})," ","Develop and evaluate survivorship care plans that address the unique needs of cancer survivors based on their functional performance and quality of life."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Qualitative Research:"})," ","Conduct qualitative research to gain deeper insights into the lived experiences and perspectives of cancer patients."]})})]})]})]})})]})]})}Rx.title="Association Between Karnofsky Performance Status and Quality of Life in Cancer Patients: A Cross-Sectional Analysis";function kx(){return e.jsxs(l,{gap:"md",children:[e.jsx(i,{fs:"italic",mt:0,children:"Among adults with asthma who are on a prescribed medication regimen, what is the strength of the association between medication adherence levels and disease control as measured by peak expiratory flow?"}),e.jsxs(f,{defaultValue:"studyDesign",children:[e.jsxs(f.List,{children:[e.jsx(f.Tab,{value:"studyDesign",children:"Study Design and Methods"}),e.jsx(f.Tab,{value:"effectSize",children:"Effect Size Measure & MCID"}),e.jsx(f.Tab,{value:"result",children:"Result"}),e.jsx(f.Tab,{value:"discussion",children:"Discussion and Future Research"})]}),e.jsx(f.Panel,{value:"studyDesign",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Clinical Research Study Design:"}),e.jsx(i,{children:"Cross-sectional study, collecting data from patients with asthma who are on a prescribed medication regimen at a single time point."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Study Population:"}),e.jsx(i,{children:"50 adults receiving care from a general medical clinic associated with an extensive urban multi-specialty group practice."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Variables under Study:"}),e.jsxs(c,{spacing:"xs",children:[e.jsx(c.Item,{children:e.jsx(i,{children:"Medication adherence levels (Excellent, Good, Adequate, Fair, Poor, Very Poor, Non-Adherent) are defined using pharmacy refill data."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"Peak expiratory flow is measured according to established clinical guidelines on a continuous scale."})})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Independent/Predictor/Exposure:"}),e.jsx(i,{children:"Spearman's rho is a non-directional measure of correlation, so defining variables as independent (predictor/exposure) or dependent is not necessary. Furthermore, the cross-sectional study design does not inherently support the classification of variables as independent, predictor, or exposure."})]})]})}),e.jsx(f.Panel,{value:"effectSize",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Effect Size Measure used in the Analytical Approach"}),e.jsx(i,{children:"Spearman's rho is calculated to evaluate the strength and direction of the association between medication adherence and peak expiratory flow."})]}),e.jsx(i,{children:"95% confidence interval (CI) is reported to indicate the precision of the estimate."}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Minimal Clinically Important Difference (MCID)"}),e.jsx(i,{children:"Before conducting the study, the investigators determined that a Spearman's rho of 0.40 or greater (moderate association) would be clinically important."})]})]})}),e.jsx(f.Panel,{value:"result",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Point Estimate:"}),e.jsx(i,{children:"Spearman's rho between medication adherence levels and disease control = -0.28"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Confidence Interval:"}),e.jsx(i,{children:"95% CI = -0.44 to -0.12"})]}),e.jsxs(l,{gap:0,children:[e.jsxs(i,{fw:500,children:["Probability Value (",e.jsx(i,{span:!0,fs:"italic",children:"p"}),"-value):"]}),e.jsxs(i,{children:[e.jsx(i,{span:!0,fs:"italic",children:"P"})," ","= 0.895"]})]})]})}),e.jsx(f.Panel,{value:"discussion",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Results"}),e.jsx(i,{children:"The Spearman's rho of -0.28 suggests a weak negative relationship between medication adherence levels and disease control in asthma."})]}),e.jsx(i,{children:"The researchers can conclude with 95% confidence that the actual value for the negative correlation coefficient () between medication adherence levels and disease control in the population could be moderate ( = -0.44) to very weak ( = -0.12). In this case, the 95% confidence interval (CI) around the correlation coefficient is considered imprecise because the range includes values indicating moderate, weak, and very weak associations. Thus, this study provides limited evidence about the true strength of the relationship."}),e.jsxs(i,{children:["The probability value (",e.jsx(i,{span:!0,fs:"italic",children:"p"}),"-value) of 0.895 indicates that the likelihood of obtaining a Spearman's rho () of -0.28 or greater by chance alone, assuming there is no relationship between these two variables, is exceptionally high. Therefore, the investigators cannot reject the null hypothesis of no relationship. The strength of the association, as indicated by the correlation coefficient, should be considered more closely than the"," ",e.jsx(i,{span:!0,fs:"italic",children:"p"}),"-value alone to understand the practical significance of the results."]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Implications of Results"}),e.jsx(i,{children:"This exploratory study provides initial evidence of a potential negative association between higher medication adherence levels and better disease control. However, the weak association and wide CI indicate considerable uncertainty."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Future Research"}),e.jsxs(c,{spacing:"xs",children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Larger Sample Size:"})," ","Conduct a larger-scale study to obtain more precise estimates of the correlation."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Reduce the Number of Chronic Diseases Studied:"})," ","The investigators did not exclude subjects with other chronic medical conditions and this likely introduced a large amount of variation that contributes to the imprecision of the estimate. The investigator may want to exclude subjects with multiple other chronic comorbid health conditions to more accurately explore the relationship between medication adherence and asthma control."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Reduce Variability in the Measurement of the Key Variables:"})," ","Variability and imprecision in the measurements can be reduced with attention to standardizing the measurements with a variety of different techniques, including creating a standard operating procedure (SOP) manual, standardize and validate the assessment of medication adherence levels, and calibrate the instruments used to measure the various measures of disease control."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Comprehensive Data Collection:"})," ","Collect additional data on potential confounding variables, such as severity of overall comorbid health conditions, socioeconomic status, healthcare access, and psychosocial factors."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Objective Adherence Measures:"})," ","Incorporate objective measures of medication adherence (e.g., electronic pill bottles, pharmacy records) to reduce self-report bias."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Patient Education and Support:"})," ","Develop and evaluate interventions that target improving medication adherence in patients with chronic conditions."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Health System Interventions:"})," ","Investigate the impact of healthcare system-level interventions (e.g., electronic reminders, pharmacist consultations) on medication adherence and disease control."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Subgroup Analyses:"})," ","Explore whether the relationship between medication adherence and disease control varies by severity of asthma or specific medication regimens."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Longitudinal Studies:"})," ","Conduct longitudinal studies to examine changes in medication adherence levels and disease control over time and assess causality."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Controlled Interventions:"})," ","Randomized controlled trials to investigate the impact of interventions (e.g., medication adherence interventions) on disease control outcomes would be the ideal way to assess the relationship. However, the current exploratory study showing a weak association is unlikely to be adequate evidence to support a proposed clinical trial. Additional observational studies with stronger methodology are required to explore a possible association before moving on to a controlled intervention trial."]})})]})]})]})})]})]})}kx.title="Medication Adherence Levels and Disease Control in Asthma: An Exploratory Analysis";const a5=[Rx,kx];function bh(){const t=[e.jsx(l,{gap:4,children:e.jsx(i,{children:"Mean difference measures the absolute difference between the means (averages of values) of two or more groups of interest."})}),e.jsxs(l,{gap:6,children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Range of Mean Difference"}),e.jsx(i,{children:"Mean difference values range from negative to positive, with the following meanings:"})]}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:["A"," ",e.jsx(i,{span:!0,fw:500,children:"positive value"})," ",'indicates that the mean of the first group (often referred to as the "treatment" or "experimental" group) is higher than the mean of the second group (often the "control" or "comparison" group).']})}),e.jsx(c.Item,{children:e.jsxs(i,{children:["A"," ",e.jsx(i,{span:!0,fw:500,children:"negative value"})," ","indicates that the mean of the first group is lower than that of the second group."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:["A"," ",e.jsx(i,{span:!0,fw:500,children:"value close to 0"})," ","suggests that there is little to no difference between the means of the two groups."]})})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation"}),e.jsx(i,{children:"The measured values for mean difference will vary for each specific outcome measure and thus do not have standardized values and interpretations."})]})];return e.jsx(G,{explanationSections:t,example1:e.jsx(i,{children:"Example 1 content will go here (e.g., a scatterplot, numerical example, or walkthrough)."})})}function Px(){return e.jsxs(l,{gap:"md",children:[e.jsx(i,{fs:"italic",mt:0,style:{lineHeight:1.3},children:"Among adults with generalized anxiety disorder, does participation in a mindfulness-based stress reduction therapy program result in a greater reduction in symptom severity when compared to a more traditional, relaxation-based therapy program?"}),e.jsxs(f,{defaultValue:"studyDesign",children:[e.jsxs(f.List,{children:[e.jsx(f.Tab,{value:"studyDesign",children:"Study Design and Methods"}),e.jsx(f.Tab,{value:"effectSize",children:"Effect Size Measure & MCID"}),e.jsx(f.Tab,{value:"result",children:"Result"}),e.jsx(f.Tab,{value:"discussion",children:"Discussion and Future Research"})]}),e.jsx(f.Panel,{value:"studyDesign",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Clinical Research Study Design:"}),e.jsx(i,{children:"Randomized controlled trial (RCT)"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Study Population:"}),e.jsx(i,{children:"250 adults with generalized anxiety disorder (GAD) recruited from an outpatient behavioral clinic in an academic medical center."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Variables under Study:"}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Independent/Predictor/Exposure:"}),e.jsx(i,{children:"Type of therapy program - mindfulness-based stress reduction therapy (MBSR) program or relaxation-based therapy."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Dependent/Outcome:"}),e.jsx(i,{children:"Hospital Anxiety and Depression Scale (HADS), a widely used patient-reported questionnaire to assess symptoms of anxiety and depression."})]})]})]})}),e.jsx(f.Panel,{value:"effectSize",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Effect Size Measure used in the Analytical Approach"}),e.jsx(i,{children:"The difference in the post-intervention mean HADS-A value for the subjects randomized to MBSR versus the mean HADS-A value for those who received relaxation therapy."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Minimal Clinically Important Difference (MCID)"}),e.jsx(i,{children:"The minimal clinically important difference (MCID) for HADS-A is 4.0, which means that if the difference is 4.0 points or greater, the patient would note the difference in their anxiety."})]})]})}),e.jsx(f.Panel,{value:"result",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Point Estimate:"}),e.jsx(i,{children:"The post-intervention mean (SD) HADS-A score for the 125 adults who were randomized to MBSR was 6.5 (1.0), while the mean HADS-A score for the 125 adults randomized to relaxation-based therapy was 11.0 (1.4), resulting in a mean difference of 4.5."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Confidence Interval:"}),e.jsx(i,{children:"95% confidence interval = 4.2 to 4.8"})]}),e.jsxs(l,{gap:0,children:[e.jsxs(i,{fw:500,children:["Probability Value (",e.jsx(i,{span:!0,fs:"italic",children:"p"}),"-value):"]}),e.jsx(i,{children:"< 0.001"})]})]})}),e.jsx(f.Panel,{value:"discussion",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Results"}),e.jsx(i,{children:"The mean difference between the two intervention arms in the HADS-A of 4.5 points, which exceeds the minimal clinically important difference, indicates a clinically important difference was observed in this study."})]}),e.jsx(i,{children:"The estimates of this study are precise (narrow range of 95% CI). The lower bound of the 95% CI of 4.2 is greater than the MCID for HADS-A, indicating that all the plausible differences in the population are clinically meaningful."}),e.jsxs(i,{children:["The probability value (",e.jsx(i,{span:!0,fs:"italic",children:"p"}),'-value) is <0.001 so the results from this study are considered "statistically significant."']}),e.jsx(i,{children:"This is a definitive study (both statistically significant and clinically meaningful) in favor of MBSR."}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Implication of Results"}),e.jsx(i,{children:"Based on these findings, this study provides strong evidence that MBSR is better at anxiety reduction, as defined by the HADS-A, than relaxation-based therapy."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Future Research"}),e.jsx(i,{children:"As this is a definitive study, additional trials are unlikely to produce different results. Therefore, the investigator should move on to translating the results from this study to clinical practice."}),e.jsxs(c,{spacing:"xs",children:[e.jsx(c.Item,{children:e.jsx(i,{children:"Investigating the specific mechanisms or components of MBSR to understand better why it is associated with reduced anxiety as compared to relaxation-based therapy."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"Long-term follow-up studies could assess the durability of MBSR beyond the short timeframe of this randomized trial and explore potential interventions to sustain mindfulness practice, if it wanes over time."})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Progress to Dissemination & Implementation (D&I)."})," ","Translate the research findings into clinical practice by bridging the gap between the development of effective interventions and their widespread adoption and use in real-world healthcare settings. D&I research aims to understand the factors that influence the adoption and utilization of evidence-based interventions, designs, and testing strategies to overcome identified barriers and enhance facilitators. Successful D&I research actively involves stakeholders, including clinicians, patients, policymakers, and administrators. Consider creating a multidisciplinary team of clinical psychologists and health service researchers with the broad range of expertise and perspectives needed to address the multifaceted challenges of implementation in real-world healthcare settings."]})})]})]})]})})]})]})}Px.title="Comparative Efficacy of Mindfulness-Based Therapy versus Relaxation-Based Therapy in Symptom Reduction Among Adults with Generalized Anxiety Disorder: A Randomized Controlled Trial";function Ex(){return e.jsxs(l,{gap:"md",children:[e.jsx(i,{fs:"italic",mt:0,children:"Among adults with generalized anxiety disorder, does participation in a mindfulness-based stress reduction therapy program result in a greater reduction in symptom severity when compared to a more traditional, relaxation-based therapy program?"}),e.jsxs(f,{defaultValue:"studyDesign",children:[e.jsxs(f.List,{children:[e.jsx(f.Tab,{value:"studyDesign",children:"Study Design and Methods"}),e.jsx(f.Tab,{value:"effectSize",children:"Effect Size Measure & MCID"}),e.jsx(f.Tab,{value:"result",children:"Result"}),e.jsx(f.Tab,{value:"discussion",children:"Discussion and Future Research"})]}),e.jsx(f.Panel,{value:"studyDesign",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Clinical Research Study Design:"}),e.jsx(i,{children:"Randomized Controlled Trial (RCT)"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Study Population:"}),e.jsx(i,{children:"250 adults with generalized anxiety disorder (GAD) recruited from an outpatient behavioral clinic in an academic medical center."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Variables under Study:"}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Independent/Predictor/Exposure:"}),e.jsx(i,{children:"Type of therapy program - mindfulness-based stress reduction therapy (MBSR) program or relaxation-based therapy."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Dependent/Outcome:"}),e.jsx(i,{children:"Hospital Anxiety and Depression Scale (HADS), a widely used patient-reported questionnaire to assess symptoms of anxiety and depression."})]})]})]})}),e.jsx(f.Panel,{value:"effectSize",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Effect Size Measure used in the Analytical Approach"}),e.jsx(i,{children:"The difference in the post-intervention mean HADS-A value for the subjects randomized to MBSR versus the mean HADS-A value for those who received relaxation therapy."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Minimal Clinically Important Difference (MCID)"}),e.jsx(i,{children:"The minimal clinically important difference (MCID) for HADS-A is 4.0, which means that if the difference is 4.0 points or greater, the patient would note the difference in their anxiety."})]})]})}),e.jsx(f.Panel,{value:"result",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Point Estimate:"}),e.jsx(i,{children:"The post-intervention mean (SD) HADS-A score for the 125 adults who were randomized to MBSR was 6.5 (4), while the mean (SD) HADS-A score for the 125 adults randomized to relaxation-based therapy was 11.0 (6), resulting in a mean difference of 4.5."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Confidence Interval:"}),e.jsx(i,{children:"95% confidence interval = 3.2 to 5.8"})]}),e.jsxs(l,{gap:0,children:[e.jsxs(i,{fw:500,children:["Probability Value (",e.jsx(i,{span:!0,fs:"italic",children:"p"}),"-value):"]}),e.jsx(i,{children:"< 0.001"})]})]})}),e.jsx(f.Panel,{value:"discussion",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Results"}),e.jsx(i,{children:"The mean difference of 4.5 points in the HADS-A between the two intervention arms suggests a clinically important difference."})]}),e.jsx(i,{children:"Although the confidence interval is relatively narrow, it is not considered precise because it includes both clinically meaningful and clinically meaningless results. The lower bound of the 95% CI is 3.2, which is smaller than the MCID for HADS-A (4.0), indicating that not all plausible differences in the population would be clinically important."}),e.jsxs(i,{children:["The probability value (",e.jsx(i,{span:!0,fs:"italic",children:"p"}),'-value) is <0.001, making the results statistically significant. However, despite this statistical significance, the imprecision around the clinically meaningful difference and the inclusion of clinically meaningless differences make the results of this study "indeterminate."']}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Implication of Results"}),e.jsx(i,{children:"Because the preponderance of the confidence interval is within the MCID effect size range, this study provides some evidence that MBSR is more effective at anxiety reduction than relaxation-based therapy. Still, no definitive conclusion can be made regarding whether the difference is clinically meaningful."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Future Research"}),e.jsxs(c,{spacing:"xs",children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Conduct Additional Research with Increased Sample Size:"})," ","To obtain more precise estimates of the effect size, conduct the study with a larger sample size. This approach enables authors and readers to be more certain of where the actual effect size value lies and whether the results are compatible with clinically meaningful effects. However, it's essential to consider that increasing sample size may not always be feasible in every research context. Resource constraints, such as funding, time, and participant availability, can significantly limit the ability to expand the study. Therefore, while planning to increase the sample size, researchers should also work to ensure that the study remains viable and efficient."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Improve Study Quality via Reduction of Error:"})," ","Enhance the reliability and precision of effect size estimates by reducing both random and systematic errors. Adherence to Good Clinical Practice (GCP) guidelines, as described in the FDA's Code of Federal Regulations, is one effective strategy. GCP promotes standardized processes, data quality, patient safety, and rigorous oversight, all contributing to improved clinical research and evidence-based medicine. However, it's also vital to acknowledge that the potential for error reduction is influenced by the specific nature and inherent variability of the study population, making a one-size-fits-all approach impractical."]})}),e.jsx(c.Item,{children:e.jsx(i,{children:"The investigator can implement strategies to reduce systematic error, such as ensuring each intervention is provided in a standardized way and with true fidelity to establish practice."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"Explore additional factors that may define unique prognostic subgroups for whom the chosen protocol is associated with better (or worse) anxiety reduction outcome."})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Improve Methodological Quality and Rigor of Subsequent Studies:"})," ","Enhance the study design, via randomization, blinding, and control of confounding variables, to address the uncertainties in indeterminate study outcomes. In such studies, focusing on methodological improvements is essential for clarifying ambiguous findings. These enhancements are critical for reducing bias and increasing the reliability of results, providing clearer direction for future research. While pursuing these methodological ideals, researchers should also consider the practical challenges, such as logistical constraints and participant-related hurdles, to conduct feasible yet robust studies."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Reduce Variability in the Measurement of Key Variables:"})," ","To diminish variability and enhance precision, standardize measurements through methods like a Standard Operating Procedure (SOP) manual, validated assessments, and calibrated instruments. Additionally, evaluate the sensitivity and specificity of these measurement tools to ensure they can detect small but clinically significant changes. While promoting consistency is crucial, it's equally important to consider potential limitations of standardization, such as missing context-specific factors that might influence results. This comprehensive approach enables the accurate capture of the study's outcomes' nuances."]})})]})]})]})})]})]})}Ex.title="Comparative Efficacy of Mindfulness-Based Therapy versus Relaxation-Based Therapy in Symptom Reduction Among Adults with Generalized Anxiety Disorder: A Randomized Controlled Trial";function Dx(){return e.jsxs(l,{gap:"md",children:[e.jsx(i,{fs:"italic",mt:0,children:"Among adults with generalized anxiety disorder, does participation in a mindfulness-based stress reduction therapy program result in a greater reduction in symptom severity when compared to a more traditional, relaxation-based therapy program?"}),e.jsxs(f,{defaultValue:"studyDesign",children:[e.jsxs(f.List,{children:[e.jsx(f.Tab,{value:"studyDesign",children:"Study Design and Methods"}),e.jsx(f.Tab,{value:"effectSize",children:"Effect Size Measure & MCID"}),e.jsx(f.Tab,{value:"result",children:"Result"}),e.jsx(f.Tab,{value:"discussion",children:"Discussion and Future Research"})]}),e.jsx(f.Panel,{value:"studyDesign",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Clinical Research Study Design:"}),e.jsx(i,{children:"Randomized Controlled Trial (RCT)"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Study Population:"}),e.jsx(i,{children:"250 adults with generalized anxiety disorder (GAD) recruited from an outpatient behavioral clinic in an academic medical center."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Variables under Study:"}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Independent/Predictor/Exposure:"}),e.jsx(i,{children:"Type of therapy program - mindfulness-based stress reduction therapy (MBSR) program or relaxation-based therapy."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Dependent/Outcome:"}),e.jsx(i,{children:"Hospital Anxiety and Depression Scale (HADS), a widely used patient-reported questionnaire to assess symptoms of anxiety and depression."})]})]})]})}),e.jsx(f.Panel,{value:"effectSize",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Effect Size Measure used in the Analytical Approach"}),e.jsx(i,{children:"The difference in the post-intervention mean HADS-A value for the subjects randomized to MBSR versus the mean HADS-A value for those who received relaxation therapy."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Minimal Clinically Important Difference (MCID)"}),e.jsx(i,{children:"The minimal clinically important difference (MCID) for HADS-A is 4.0, which means that if the difference is 4.0 points or greater the patient would note the difference in their anxiety."})]})]})}),e.jsx(f.Panel,{value:"result",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Point Estimate:"}),e.jsx(i,{children:"The post-intervention mean (SD) HADS-A score for the 125 adults who were randomized to MBSR was 6.5 (3.3), while the mean HADS-A score for the 125 adults randomized to relaxation-based therapy was 9.8 (3.0), resulting in a difference in the mean value of 3.3."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Confidence Interval:"}),e.jsx(i,{children:"95% confidence interval = 2.6 to 3.9"})]}),e.jsxs(l,{gap:0,children:[e.jsxs(i,{fw:500,children:["Probability Value (",e.jsx(i,{span:!0,fs:"italic",children:"p"}),"-value):"]}),e.jsx(i,{children:"< 0.001"})]})]})}),e.jsx(f.Panel,{value:"discussion",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Results"}),e.jsx(i,{children:"The mean difference of 3.3 points in the HADS-A between the two intervention arms indicates that the findings of this study are not clinically meaningful."})]}),e.jsx(i,{children:"The confidence interval is narrow, and all plausible values within the range are consistent with clinically meaningless results. Specifically, the upper bound of the 95% CI is 3.9, which is smaller than the MCID value of 4.0 for the HADS-A."}),e.jsxs(i,{children:["Despite the statistical significance of the difference (probability value"," ",e.jsx(i,{span:!0,fs:"italic",children:"p"}),"-value <0.001), the investigator can conclude that MBSR does not produce a clinically important reduction in anxiety compared to relaxation therapy, as a difference of 3.9 or greater is extremely unlikely based on the findings from this study."]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Implication of Results"}),e.jsx(i,{children:'Because the entirety of the confidence interval lies below the clinically important difference value, this study provides definitive evidence that MBSR is not more effective at reducing anxiety by a clinically important difference than relaxation-based therapy, despite the finding of "statistical significance".'})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Future Research"}),e.jsxs(c,{spacing:"xs",children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Do Not Repeat the Study:"})," ",'As judged by the fact that the upper bound of the CI rules out a clinically meaningful effect, this is a definitive clinically negative study despite the "statistical significance" (i.e.,'," ",e.jsx(i,{span:!0,fs:"italic",children:"p"}),"-value of <0.001). Further research is unlikely to find clinically meaningful results. Considering that the observed results are both precise and definitive, there is generally no need to conduct a repeat or similarly designed study, thus avoiding research waste. However, it's essential to acknowledge exceptions where replication studies can be particularly valuable, especially in diverse populations or settings, to validate the universality of findings. In most instances, prioritizing new research questions or unexplored avenues is more beneficial, ensuring efficient use of resources and the robustness of scientific inquiry."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Reduce Variability in the Measurement of Key Variables:"})," ","To diminish variability and enhance precision, standardize measurements through methods like a Standard Operating Procedure (SOP) manual, validated assessments, and calibrated instruments. Additionally, evaluate the sensitivity and specificity of these measurement tools to ensure they can detect small but clinically significant changes. While promoting consistency is crucial, it's equally important to consider potential limitations of standardization, such as missing context-specific factors that might influence results. This comprehensive approach helps in accurately capturing the nuances of the study's outcomes."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Improve Methodological Quality and Rigor of Subsequent Studies:"})," ","Strengthen the study design, through rigorous randomization, blinding, and controlling confounding variables, to confirm and validate the findings of definitive negative studies. In this context, enhancing methodological rigor is crucial to ensure that negative results are not a product of study design flaws but are indeed reflective of the intervention's ineffectiveness. Such improvements are key to minimizing bias and enhancing the validity of conclusions. Researchers must navigate the practical challenges of implementing these methodologies while ensuring the study remains feasible and accurate."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Perform Subgroup or Outlier Analyses:"})," ","Conduct detailed analyses on specific subsets of the study population, such as different age groups, genders, or comorbidities, to uncover variations in treatment effects. This statistical exploration helps identify which subgroups may benefit most or least from the intervention, enhancing personalized treatment approaches. Yet, with any subgroup analysis, it is crucial to be aware of the associated statistical power of each analysis and consider potential biases that may be present."]})})]})]})]})})]})]})}Dx.title="Comparative Efficacy of Mindfulness-Based Therapy versus Relaxation-Based Therapy in Symptom Reduction Among Adults with Generalized Anxiety Disorder: A Randomized Controlled Trial";function Mx(){return e.jsxs(l,{gap:"md",children:[e.jsx(i,{fs:"italic",mt:0,children:"Among adults with lower back pain, is there a difference in short-term outcomes defined by the Oswestry Disability Index between physical therapy, use of opioid medication, or a mindfulness-based stress reduction (MBSR) therapy program?"}),e.jsxs(f,{defaultValue:"studyDesign",children:[e.jsxs(f.List,{children:[e.jsx(f.Tab,{value:"studyDesign",children:"Study Design and Methods"}),e.jsx(f.Tab,{value:"effectSize",children:"Effect Size Measure & MCID"}),e.jsx(f.Tab,{value:"result",children:"Result"}),e.jsx(f.Tab,{value:"discussion",children:"Discussion and Future Research"})]}),e.jsx(f.Panel,{value:"studyDesign",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Clinical Research Study Design:"}),e.jsx(i,{children:"Randomized clinical trial"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Study Population:"}),e.jsx(i,{children:"300 adults with chronic lower back pain and moderate disability are recruited from an outpatient general medical clinic."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Variables under Study:"}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Independent/Predictor/Exposure:"}),e.jsx(i,{children:"Type of intervention - physical therapy (n=100), use of opioid medication (n=100), or a mindfulness-based stress reduction (MBSR) therapy program (n=100)."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Dependent/Outcome:"}),e.jsx(i,{children:"Oswestry Disability Index (ODI) The ODI is comprised of 10 questions that ask patients about their ability to manage everyday life, and covers intensity of pain, lifting, ability to care for oneself, ability to walk, ability to sit, sexual function, ability to stand, social life, sleep quality, and ability to travel. Each question contains 6 statements that correlate to a score of 0 through 5, where the patient is to choose the statement that best matches their ability."}),e.jsx(i,{children:"The final score/index ranges from 0-100, with 0 representing no disability and 100 representing total disability."})]})]})]})}),e.jsx(f.Panel,{value:"effectSize",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Effect Size Measure used in the Analytical Approach"}),e.jsxs(i,{children:["The overall effect size for the comparison of ODI between the three study groups would be eta squared, but since we are interested in quantifying the pairwise differences of ODI score in each group from the other two study groups, mean difference (unstandardized) or Cohen's"," ",e.jsx(i,{span:!0,fs:"italic",children:"d"})," ","(standardized) would be more informative and valuable."]}),e.jsx(i,{children:"The difference in the post-intervention means ODI for the subjects randomized to the different treatments."}),e.jsx(i,{children:"The 95% CI around the difference in the mean values will be calculated as a measure of the precision of the estimate and to interpret the results in the light of clinical importance."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Minimal Clinically Important Difference (MCID)"}),e.jsx(i,{children:"Minimal clinically important difference (MCID) has been evaluated across numerous types of interventions and has been shown to vary significantly. It is generally agreed that 10 to 12 points on the ODI results in meaningful patient improvement."})]})]})}),e.jsx(f.Panel,{value:"result",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Physical Therapy vs. Opioid Medication:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:"Mean ODI for Physical Therapy: 18.2 (SD = 11.3)"}),e.jsx(c.Item,{children:"Mean ODI for Opioid Medication: 24.5 (SD = 12.6)"}),e.jsx(c.Item,{children:"Difference in the means 6.3 (95% CI: 3.0 to 9.6)"}),e.jsxs(c.Item,{children:["Probability value (",e.jsx(i,{span:!0,fs:"italic",children:"p"}),"-value): <0.001"]})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Physical Therapy vs. MBSR:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:"Mean ODI for Physical Therapy: 18.2 (SD = 11.3)"}),e.jsx(c.Item,{children:"Mean ODI for MBSR: 15.8 (SD = 12.2)"}),e.jsx(c.Item,{children:"Difference in means 2.4 (95% CI: -0.88 to 5.7)"}),e.jsxs(c.Item,{children:["Probability value (",e.jsx(i,{span:!0,fs:"italic",children:"p"}),"-value): 0.151"]})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Opioid Medication vs. MBSR:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:"Mean ODI for Opioid Medication: 24.5 (SD = 12.6)"}),e.jsx(c.Item,{children:"Mean ODI for MBSR: 15.8 (SD = 12.2)"}),e.jsx(c.Item,{children:"Difference in means: 8.7 (95% CI: 5.2 to 12.2)"}),e.jsxs(c.Item,{children:["Probability value (",e.jsx(i,{span:!0,fs:"italic",children:"p"}),"-value): <0.001"]})]})]})]})}),e.jsx(f.Panel,{value:"discussion",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Results:"}),e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Physical Therapy vs. Opioid Medication:"})," ","The mean difference of 6.3 in favor of physical therapy is statistically significant (",e.jsx(i,{span:!0,fs:"italic",children:"p"}),"<0.001). However, all plausible population values (estimated by the 95% CI of 3.0 to 9.6) fall below the minimal clinically important difference (MCID) of 10-12 points. This indicates that while physical therapy produces statistically better outcomes than opioid medication, the difference does not reach the threshold for clinical importance."]}),e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Physical Therapy vs. MBSR:"})," ","The mean difference of 2.4 in favor of MBSR is not statistically significant (",e.jsx(i,{span:!0,fs:"italic",children:"p"}),"=0.151) and falls well below the MCID threshold. The 95% CI (-0.88 to 5.7) indicates imprecision in the estimate and includes zero, suggesting the possibility of no true difference between these interventions. All values within this range are below the MCID, indicating no clinically meaningful difference between physical therapy and MBSR."]}),e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Opioid Medication vs. MBSR:"})," ","The mean difference of 8.7 in favor of MBSR is statistically significant (",e.jsx(i,{span:!0,fs:"italic",children:"p"}),"<0.001). The 95% CI (5.2 to 12.2) includes values below the MCID threshold (5.2 to 10) as well as values that would be considered clinically meaningful (10 to 12.2). This imprecision prevents a definitive conclusion about whether the difference is clinically meaningful, despite statistical significance."]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Implications of Results:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:"MBSR appears to be the most effective short-term treatment for chronic low back pain, as it is associated with the lowest ODI scores."}),e.jsx(c.Item,{children:"Opioid medication is associated with the highest (worst) ODI scores, suggesting it may be less effective than the other treatments, although the differences do not consistently reach the threshold for clinical significance."}),e.jsx(c.Item,{children:"Physical therapy effectiveness falls between MBSR and opioid therapy."}),e.jsx(c.Item,{children:"Further research with larger sample sizes are needed to increase precision in estimating the true differences between these treatments. However, the 95% confidence intervals suggest that many of the observed differences, while statistically significant, may not reach the threshold for clinical importance (MCID of 10-12 points) and thus future studies of a similar design and study population are unlikely to be valuable."})]})]})]})})]})]})}Mx.title="Comparative Efficacy of Physical Therapy, Opioid Medication, and Mindfulness-Based Stress Reduction (MBSR) for Chronic Low Back Pain";const o5=[Px,Ex,Dx],l5=[Mx];function Sh(){const t=[e.jsx(l,{gap:4,children:e.jsx(i,{children:"Median difference measures the absolute difference between the medians (the middle value within a set of values when arranged in order) of two or more groups of interest. The median difference is especially valuable when data distributions are skewed or have notable outliers, as medians are less influenced by these factors as compared with means."})}),e.jsxs(l,{gap:6,children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Range of Median Difference"}),e.jsx(i,{children:"Median difference values range from negative to positive, with the following meanings:"})]}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:["A"," ",e.jsx(i,{span:!0,fw:500,children:"positive value"})," ",'indicates that the median of the first group (often referred to as the "treatment" or "experimental" group) is higher than the median of the second group (often the "control" or "comparison" group).']})}),e.jsx(c.Item,{children:e.jsxs(i,{children:["A"," ",e.jsx(i,{span:!0,fw:500,children:"negative value"})," ","indicates that the median of the first group is lower than that of the second group."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:["A"," ",e.jsx(i,{span:!0,fw:500,children:"value close to 0"})," ","suggests that there is little to no difference between the medians of the two groups."]})})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation"}),e.jsx(i,{children:"The measured values for median difference will vary for each specific outcome measure and thus do not have standardized values and interpretations."})]})];return e.jsx(G,{explanationSections:t,example1:e.jsx(i,{children:"Example 1 content will go here (e.g., a scatterplot, numerical example, or walkthrough)."})})}function Ax(){return e.jsxs(l,{gap:"md",children:[e.jsx(i,{fs:"italic",mt:0,children:"What is the difference in systolic blood pressure reduction between patients treated with HypoTensix and those treated with PressureEase?"}),e.jsxs(f,{defaultValue:"studyDesign",children:[e.jsxs(f.List,{children:[e.jsx(f.Tab,{value:"studyDesign",children:"Study Design and Methods"}),e.jsx(f.Tab,{value:"effectSize",children:"Effect Size Measure & MCID"}),e.jsx(f.Tab,{value:"result",children:"Result"}),e.jsx(f.Tab,{value:"discussion",children:"Discussion and Future Research"})]}),e.jsx(f.Panel,{value:"studyDesign",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Clinical Research Study Design:"}),e.jsx(i,{children:"Randomized clinical trial"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Study Population:"}),e.jsx(i,{children:"The study includes 200 hypertensive patients aged 40 to 70 recruited from a cardiology clinic."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Variables under Study:"}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Independent/Predictor/Exposure:"}),e.jsx(i,{children:"Patients are randomly assigned to receive either HypoTensix or PressureEase for hypertension management."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Dependent/Outcome:"}),e.jsx(i,{children:"The primary outcome is the difference in systolic blood pressure reduction (mm Hg) between the two groups after 12 weeks of treatment."})]})]})]})}),e.jsx(f.Panel,{value:"effectSize",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Effect Size Measure used in the Analytical Approach"}),e.jsx(i,{children:"Median Difference in systolic Blood Pressure Reduction (mm Hg)"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Minimal Clinically Important Difference (MCID)"}),e.jsx(i,{children:'A "clinically meaningful difference" in systolic blood pressure reduction can vary depending on individual patient characteristics, the severity of hypertension, and the overall treatment goals. However, in general, many doctors might consider a systolic blood pressure reduction of 10 mm Hg or more as a clinically meaningful difference in the context of antihypertensive treatment. This level of reduction is often associated with a decreased risk of cardiovascular events and improved health outcomes for patients with hypertension.'}),e.jsx(i,{children:"10 mm Hg is determined to be the minimal clinically important difference."})]})]})}),e.jsx(f.Panel,{value:"result",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Point Estimate:"}),e.jsx(i,{children:"The study finds that patients treated with HypoTensix experienced a median reduction in systolic blood pressure of 18 mm Hg (95% CI: 15-21 mm Hg), while patients treated with PressureEase had a median reduction of 5 mm Hg (95% CI: 1-9 mm Hg)."}),e.jsx(i,{children:"The median difference in systolic blood pressure reduction between the two groups is 13 mm Hg."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Confidence Interval:"}),e.jsx(i,{children:"95% CI: 11-15 mm Hg"})]}),e.jsxs(l,{gap:0,children:[e.jsxs(i,{fw:500,children:["Probability Value (",e.jsx(i,{span:!0,fs:"italic",children:"p"}),"-value):"]}),e.jsx(i,{children:"< 0.001"})]})]})}),e.jsx(f.Panel,{value:"discussion",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Results"}),e.jsx(i,{children:"The study defines a 13 mm difference in median systolic blood pressure reduction between participants treated with HypoTensix and PressureEase. Considering the MCID in blood pressure reduction is 10, this difference of 13 is considered a clinically meaningful difference."})]}),e.jsx(i,{children:"The width of the confidence interval is narrow, and the results are considered precise as all plausible values for the difference (i.e., 11 to 15) are greater than the MCID (10), and thus the investigator can conclude with confidence where the true value lies for the difference in blood pressure reduction based on the observed results from this study and that the true difference will be clinically meaningful."}),e.jsxs(i,{children:["Since the probability value (",e.jsx(i,{span:!0,fs:"italic",children:"p"}),'-value) is <0.001, the results from this study are determined to be "statistically significant".']}),e.jsx(i,{children:"This study is considered a definitive positive study - all plausible results defined by the range of the CI demonstrate that HypoTensix reduces systolic blood pressure to a clinically meaningful greater degree than PressureEase."}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Implications of Results"}),e.jsx(i,{children:"The study findings strongly suggest that HypoTensix reduces systolic blood pressure to a much larger amount and in clinically meaningful way than PressureEase."})]}),e.jsx(i,{children:"These results can guide treatment decisions and potentially improve the standard of care for patients with hypertension."}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Future Research"}),e.jsx(i,{children:"As this is a definitive study, additional trials are unlikely to produce different results. Therefore, the investigator should move on to translating the results from this study to clinical practice."}),e.jsxs(c,{spacing:"xs",children:[e.jsx(c.Item,{children:e.jsx(i,{children:"Conduct dissemination & implementation (D&I) research to translate the research findings into clinical practice by bridging the gap between the development of effective interventions and their widespread adoption and use in real-world healthcare settings. D&I research seeks to understand the factors that influence the adoption and utilization of evidence-based interventions, designs and tests strategies to overcome identified barriers and enhance facilitators; successful D&I research actively involves stakeholders such as clinicians, patients, policymakers, and administrators. Consider creating a multidisciplinary team of cardiologists and health service researchers with the broad range of expertise and perspectives needed to address the multifaceted challenges of implementation in real-world healthcare settings."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"Investigate the specific mechanisms or components of HypoTensix to better understand why it is associated with greater reduction in blood pressure than PressureEase."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"Long-term follow-up studies could assess the durability of blood pressure reduction with HypoTensix beyond the short timeframe of this randomized trial."})})]})]})]})})]})]})}Ax.title="Comparing Systolic Blood Pressure Reduction: HypoTensix vs. PressureEase";function zx(){return e.jsxs(l,{gap:"md",children:[e.jsx(i,{fs:"italic",mt:0,children:"What is the difference in systolic blood pressure reduction between patients treated with HypoTensix and those treated with PressureEase?"}),e.jsxs(f,{defaultValue:"studyDesign",children:[e.jsxs(f.List,{children:[e.jsx(f.Tab,{value:"studyDesign",children:"Study Design and Methods"}),e.jsx(f.Tab,{value:"effectSize",children:"Effect Size Measure & MCID"}),e.jsx(f.Tab,{value:"result",children:"Result"}),e.jsx(f.Tab,{value:"discussion",children:"Discussion and Future Research"})]}),e.jsx(f.Panel,{value:"studyDesign",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Clinical Research Study Design:"}),e.jsx(i,{children:"Randomized clinical trial"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Study Population:"}),e.jsx(i,{children:"The study includes 200 hypertensive patients aged 40 to 70 recruited from a cardiology clinic."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Variables under Study:"}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Independent/Predictor/Exposure:"}),e.jsx(i,{children:"Patients are randomly assigned to receive either HypoTensix or PressureEase for hypertension management."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Dependent/Outcome:"}),e.jsx(i,{children:"The primary outcome is the difference in systolic blood pressure reduction (mm Hg) between the two groups after 12 weeks of treatment."})]})]})]})}),e.jsx(f.Panel,{value:"effectSize",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Effect Size Measure used in the Analytical Approach"}),e.jsx(i,{children:"Median Difference in systolic Blood Pressure Reduction (mm Hg)"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Minimal Clinically Important Difference (MCID)"}),e.jsx(i,{children:'A "clinically meaningful difference" in systolic blood pressure reduction can vary depending on individual patient characteristics, the severity of hypertension, and the overall treatment goals. However, in general, many doctors might consider a systolic blood pressure reduction of 10 mm Hg or more as a clinically meaningful difference in the context of antihypertensive treatment. This level of reduction is often associated with a decreased risk of cardiovascular events and improved health outcomes for hypertensive patients.'}),e.jsx(i,{children:"10 mm Hg is determined to be the minimal clinically important difference."})]})]})}),e.jsx(f.Panel,{value:"result",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Point Estimate:"}),e.jsx(i,{children:"The study finds that patients treated with HypoTensix experienced a median reduction in systolic blood pressure of 18 mm Hg (95% CI: 10-26 mm Hg), while patients treated with PressureEase had a median reduction of 5 mm Hg (95% CI: -4 to 14 mm Hg)."}),e.jsx(i,{children:"The median difference in systolic blood pressure reduction between the two groups is 13 mm Hg."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Confidence Interval:"}),e.jsx(i,{children:"95% confidence interval = 5 to 21 mm Hg"})]}),e.jsxs(l,{gap:0,children:[e.jsxs(i,{fw:500,children:["Probability Value (",e.jsx(i,{span:!0,fs:"italic",children:"p"}),"-value):"]}),e.jsx(i,{children:"< 0.05"})]})]})}),e.jsx(f.Panel,{value:"discussion",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Results"}),e.jsx(i,{children:"The study defines a 13 mm difference in median systolic blood pressure reduction between participants treated with HypoTensix and PressureEase. Considering the MCID in blood pressure reduction is 10, this difference of 13 is considered a clinically meaningful difference."})]}),e.jsx(i,{children:"The width of the confidence interval is quite wide, and considered imprecise as the plausible values for the difference (i.e., 5 to 21) include values smaller and larger than the MCID (10), and thus the investigator cannot conclude with confidence from this study whether the true value for the difference in blood pressure will be clinically meaningful."}),e.jsxs(i,{children:["Since the probability value (",e.jsx(i,{span:!0,fs:"italic",children:"p"}),'-value) is <0.05, the results from this study are determined to be "statistically significant".']}),e.jsx(i,{children:"This study is considered an indeterminate positive study since clinically meaningful and meaningless values are compatible with the results as defined by the range of values contained within the confidence interval."}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Implications of Results"}),e.jsx(i,{children:"Despite the large difference in median systolic blood pressure reduction with HypoTensix as compared to PressureEase, the imprecision around the point estimate prevents making a definitive conclusion about whether HypoTensix is associated with a clinically meaningful reduction in blood pressure."})]}),e.jsx(i,{children:'Despite the statistical significance of the difference, the imprecision of the results and the possibility that clinically meaningless differences in systolic blood pressure reduction are plausible, the results of this study are referred to as "indeterminate".'}),e.jsx(i,{children:"Because the preponderance of the confidence interval is within the clinically meaningful effect size range, this study provides some evidence that HypoTensix is better at blood pressure reduction than PressureEase, but no definitive conclusion can be made."}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Future Research"}),e.jsxs(c,{spacing:"xs",children:[e.jsx(c.Item,{children:e.jsx(i,{children:"Conduct a follow-up study with a larger sample size to both confirm the clinically meaningful reduction and increase the precision of the estimate (i.e., decrease the width of the confidence interval)."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"The investigator can implement strategies to reduce systematic error, such as standardizing the measurement of blood pressure and validating the accuracy of blood pressure recordings, to increase the precision of the estimate."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"Conduct a meta-analysis, which is a quantitative approach to combine data from multiple studies, yielding summary effect estimates with increased statistical power."})})]})]})]})})]})]})}zx.title="Comparing Systolic Blood Pressure Reduction: HypoTensix vs. PressureEase";function Nx(){return e.jsxs(l,{gap:"md",children:[e.jsx(i,{fs:"italic",mt:0,children:"What is the difference in systolic blood pressure reduction between patients treated with HypoTensix and those treated with PressureEase?"}),e.jsxs(f,{defaultValue:"studyDesign",children:[e.jsxs(f.List,{children:[e.jsx(f.Tab,{value:"studyDesign",children:"Study Design and Methods"}),e.jsx(f.Tab,{value:"effectSize",children:"Effect Size Measure & MCID"}),e.jsx(f.Tab,{value:"result",children:"Result"}),e.jsx(f.Tab,{value:"discussion",children:"Discussion and Future Research"})]}),e.jsx(f.Panel,{value:"studyDesign",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Clinical Research Study Design:"}),e.jsx(i,{children:"Randomized clinical trial"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Study Population:"}),e.jsx(i,{children:"The study includes 200 hypertensive patients aged 40 to 70 recruited from a cardiology clinic."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Variables under Study:"}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Independent/Predictor/Exposure:"}),e.jsx(i,{children:"Patients are randomly assigned to receive either HypoTensix or PressureEase for hypertension management."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Dependent/Outcome:"}),e.jsx(i,{children:"The primary outcome is the difference in systolic blood pressure reduction (mm Hg) between the two groups after 12 weeks of treatment."})]})]})]})}),e.jsx(f.Panel,{value:"effectSize",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Effect Size Measure used in the Analytical Approach"}),e.jsx(i,{children:"Median Difference in systolic Blood Pressure Reduction (mm Hg)"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Minimal Clinically Important Difference (MCID)"}),e.jsx(i,{children:'A "clinically meaningful difference" in systolic blood pressure reduction can vary depending on individual patient characteristics, the severity of hypertension, and the overall treatment goals. However, in general, many doctors might consider a systolic blood pressure reduction of 10 mm Hg or more as a clinically meaningful difference in the context of antihypertensive treatment. This level of reduction is often associated with a decreased risk of cardiovascular events and improved health outcomes for hypertensive patients.'}),e.jsx(i,{children:"10 mm Hg is determined to be the minimal clinically important difference."})]})]})}),e.jsx(f.Panel,{value:"result",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Point Estimate:"}),e.jsx(i,{children:"The study finds that patients treated with HypoTensix experienced a median systolic reduction in blood pressure of 14 mm Hg (95% CI: 12-16 mm Hg), while patients treated with PressureEase had a median reduction of 9 mm Hg (95% CI: 8-10 mm Hg)."}),e.jsx(i,{children:"The median difference in systolic blood pressure reduction between the two groups is 5 mm Hg."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Confidence Interval:"}),e.jsx(i,{children:"95% confidence interval = 3 to 7 mm Hg"})]}),e.jsxs(l,{gap:0,children:[e.jsxs(i,{fw:500,children:["Probability Value (",e.jsx(i,{span:!0,fs:"italic",children:"p"}),"-value):"]}),e.jsx(i,{children:"< 0.05"})]})]})}),e.jsx(f.Panel,{value:"discussion",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Results"}),e.jsx(i,{children:"The study defines a difference of 5 mm in median systolic blood pressure reduction between participants treated with HypoTensix and PressureEase. Considering that the MCID for blood pressure reduction is 10, this difference of 5 mm is clinically meaningless."})]}),e.jsx(i,{children:"The confidence interval is narrow, ranging from 3 to 7, and is considered precise because all plausible values are below the MCID of 10. Therefore, the investigator can confidently conclude that the true difference in blood pressure reduction is clinically meaningless."}),e.jsxs(i,{children:["Although the probability value (",e.jsx(i,{span:!0,fs:"italic",children:"p"}),"-value) is <0.05, indicating statistical significance, the small difference in systolic blood pressure reduction and the precise confidence interval that excludes a clinically meaningful reduction confirm that this is a clinically negative study with no clinically meaningful benefit of one treatment over the other."]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Implications of Results"}),e.jsx(i,{children:"The small difference in systolic blood pressure reduction between the HypoTensix and PressureEase groups, combined with the narrow confidence interval that excludes a clinically meaningful reduction, indicates that there is no clinically meaningful benefit of one treatment over the other."})]}),e.jsx(i,{children:"Because the lower bound of the confidence interval does not cross 0, the investigator must conclude that the results are statistically significant. This example illustrates a situation where statistically significant results are clinically meaningless, a common occurrence in clinical research, particularly in industry-funded studies."}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Future Research"}),e.jsx(i,{children:"As this is a definitive negative study, further research is unlikely to find a clinically meaningful difference in blood pressure between these two medications."}),e.jsx(i,{children:"The investigator could choose to explore additional patient or clinical factors that may define unique prognostic subgroups for whom the chosen protocol is associated with greater blood pressure reduction."})]})]})})]})]})}Nx.title="Comparing Systolic Blood Pressure Reduction: HypoTensix vs. PressureEase";function _x(){return e.jsxs(l,{gap:"md",children:[e.jsx(i,{fs:"italic",mt:0,children:"What is the difference in systolic blood pressure reduction between patients treated with HypoTensix and those treated with PressureEase?"}),e.jsxs(f,{defaultValue:"studyDesign",children:[e.jsxs(f.List,{children:[e.jsx(f.Tab,{value:"studyDesign",children:"Study Design and Methods"}),e.jsx(f.Tab,{value:"effectSize",children:"Effect Size Measure & MCID"}),e.jsx(f.Tab,{value:"result",children:"Result"}),e.jsx(f.Tab,{value:"discussion",children:"Discussion and Future Research"})]}),e.jsx(f.Panel,{value:"studyDesign",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Clinical Research Study Design:"}),e.jsx(i,{children:"Randomized clinical trial"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Study Population:"}),e.jsx(i,{children:"The study includes 200 hypertensive patients aged 40 to 70 recruited from a cardiology clinic."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Variables under Study:"}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Independent/Predictor/Exposure:"}),e.jsx(i,{children:"Patients are randomly assigned to receive either HypoTensix or PressureEase for hypertension management."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Dependent/Outcome:"}),e.jsx(i,{children:"The primary outcome is the difference in systolic blood pressure reduction (mm Hg) between the two groups after 12 weeks of treatment."})]})]})]})}),e.jsx(f.Panel,{value:"effectSize",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Effect Size Measure used in the Analytical Approach"}),e.jsx(i,{children:"Median Difference in systolic Blood Pressure Reduction (mm Hg)"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Minimal Clinically Important Difference (MCID)"}),e.jsx(i,{children:'A "clinically meaningful difference" in systolic blood pressure reduction can vary depending on individual patient characteristics, the severity of hypertension, and the overall treatment goals. However, in general, many doctors might consider a systolic blood pressure reduction of 10 mm Hg or more as a clinically meaningful difference in the context of antihypertensive treatment. This level of reduction is often associated with a decreased risk of cardiovascular events and improved health outcomes for hypertensive patients.'}),e.jsx(i,{children:"10 mm Hg is determined to be the minimal clinically important difference."})]})]})}),e.jsx(f.Panel,{value:"result",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Point Estimate:"}),e.jsx(i,{children:"The study finds that patients treated with HypoTensix experienced a median reduction in systolic blood pressure of 12 mm Hg (95% CI: 3 - 21 mm Hg), while patients treated with PressureEase had a median reduction of 10 mm Hg (95% CI: 1 - 19 mm Hg)."}),e.jsx(i,{children:"The median difference in systolic blood pressure reduction between the two groups is 2 mm Hg."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Confidence Interval:"}),e.jsx(i,{children:"95% confidence interval = -8 to 12 mm Hg"})]}),e.jsxs(l,{gap:0,children:[e.jsxs(i,{fw:500,children:["Probability Value (",e.jsx(i,{span:!0,fs:"italic",children:"p"}),"-value):"]}),e.jsx(i,{children:"0.05"})]})]})}),e.jsx(f.Panel,{value:"discussion",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Results"}),e.jsx(i,{children:"The study defines a difference of 2 mm in median systolic blood pressure reduction between participants treated with HypoTensix and PressureEase. Considering that the MCID for blood pressure reduction is 10, this difference of 2 mm is clinically meaningless."})]}),e.jsx(i,{children:"The confidence interval is wide, ranging from -8 to 12, and is considered imprecise. This determination of imprecision is because the interval includes values suggesting no difference between the treatments, PressureEase being better than HypoTensix, HypoTensix being better than PressureEase, and HypoTensix offering a clinically meaningful improvement. Thus, the investigator cannot make a definitive conclusion about the comparative impact of these two treatments on blood pressure reduction."}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Implications of Results"}),e.jsx(i,{children:'The small difference in systolic blood pressure reduction between participants who received HypoTensix and those who received PressureEase, combined with the wide confidence interval and the upper bound of the CI that crosses the clinically meaningful threshold, prevents definitive conclusions about whether the intervention is associated with a clinically meaningful risk reduction. Therefore, the findings of this study on the effect of HypoTensix and PressureEase on blood pressure reduction are referred to as "indeterminate."'})]}),e.jsx(i,{children:"Even though the study results are deemed indeterminate regarding the benefit of HypoTensix and PressureEase on blood pressure reduction, much of the confidence interval lies within the clinically meaningless effect size range (<10 mm Hg). Thus, this study suggests that HypoTensix and PressureEase do not have clinically meaningful differences in blood pressure reduction. However, no definitive conclusion can be made."}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Future Research"}),e.jsx(i,{children:"As the results suggest there is only a very small probability of a clinically meaningful difference in systolic blood pressure reduction between HypoTensix and PressureEase, the investigator is unlikely to consider conducting additional studies with the same research question. The investigator would need special reasons to propose conducting a similar study again in hopes of finding clinically meaningful results."}),e.jsx(i,{children:"It may be beneficial to explore additional factors that may interact with medication and blood pressure control, such as diet modification, exercise, and sleep."})]})]})})]})]})}_x.title="Comparing Systolic Blood Pressure Reduction: HypoTensix vs. PressureEase";const Ih=[Ax,zx,Nx,_x];function Ch(){const t=[e.jsx(l,{gap:4,children:e.jsxs(i,{children:["Cohen's"," ",e.jsx(i,{span:!0,fs:"italic",children:"d"})," ","is a standardized measure that represents the magnitude of the difference between two groups by taking the difference between the means and dividing by the pooled standard deviation."]})}),e.jsxs(l,{gap:6,children:[e.jsxs(l,{gap:0,children:[e.jsxs(i,{fw:500,children:["Interpreting the magnitude of Cohen's"," ",e.jsx(i,{span:!0,fs:"italic",children:"d"})]}),e.jsxs(i,{children:["The interpretation of Cohen's"," ",e.jsx(i,{span:!0,fs:"italic",children:"d"})," ","as an absolute value is as follows:"]})]}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.00 to 0.19:"})," ","Negligible effect size"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.20 to 0.39:"})," ","Small effect size"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.40 to 0.59:"})," ","Medium effect size"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.60 to 0.79:"})," ","Large effect size"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.80 to 1.00:"})," ","Very large effect size"]})})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Standardized measure"}),e.jsxs(i,{children:["Cohen's"," ",e.jsx(i,{span:!0,fs:"italic",children:"d"})," ","will measure a standardized difference irrespective of sample size, thus making it a valuable tool for understanding the practical significance of results."]})]})];return e.jsx(G,{explanationSections:t,example1:e.jsx(i,{children:"Example 1 content will go here (e.g., a scatterplot, numerical example, or walkthrough)."})})}function Lx(){return e.jsxs(l,{gap:"md",children:[e.jsx(i,{fs:"italic",mt:0,children:"In patients undergoing knee replacement surgery, how does the post-operative day 1 pain score compare between those who receive traditional open knee replacement and those who receive minimally invasive knee replacement?"}),e.jsxs(f,{defaultValue:"studyDesign",children:[e.jsxs(f.List,{children:[e.jsx(f.Tab,{value:"studyDesign",children:"Study Design and Methods"}),e.jsx(f.Tab,{value:"effectSize",children:"Effect Size Measure & MCID"}),e.jsx(f.Tab,{value:"result",children:"Result"}),e.jsx(f.Tab,{value:"discussion",children:"Discussion and Future Research"})]}),e.jsx(f.Panel,{value:"studyDesign",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Clinical Research Study Design:"}),e.jsx(i,{children:"Cross-sectional"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Study Population:"}),e.jsx(i,{children:"40 adults undergoing knee replacement surgery; recruited from a multi-center orthopedic surgery department."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Variables under Study:"}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Independent/Predictor/Exposure:"}),e.jsx(i,{children:"Type of knee replacement surgery (Traditional open, minimally invasive)."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Dependent/Outcome:"}),e.jsx(i,{children:"Post-operative day 1 (POD 1) pain score using the Visual Analog Scale (VAS) where 0 indicates no pain and 10 indicates the worst pain imaginable."})]})]})]})}),e.jsx(f.Panel,{value:"effectSize",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Effect Size Measure used in the Analytical Approach"}),e.jsxs(i,{children:["Cohen's"," ",e.jsx(i,{span:!0,fs:"italic",children:"d"})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Minimal Clinically Important Difference (MCID)"}),e.jsx(i,{children:"The minimal clinically important difference (MCID) (smallest difference that a patient would notice) was determined pre-study through a discussion with experts of an absolute difference of 0.45 points or greater on the VAS scale."})]})]})}),e.jsx(f.Panel,{value:"result",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Point Estimate:"}),e.jsxs(l,{gap:5,children:[e.jsx(i,{children:"Of the 20 adults undergoing traditional open knee replacement, the mean (SD) VAS score was 5 (1.5) and for the 20 adults undergoing minimally invasive knee replacement the mean (SD) VAS score was 4 (1.0)."}),e.jsx(i,{children:"The difference in means is 1 (95% CI: 0.64 to 1.4)"}),e.jsxs(i,{children:["The Cohen's"," ",e.jsx(i,{span:!0,fs:"italic",children:"d"})," ","value is 0.78"]})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Confidence Interval:"}),e.jsxs(i,{children:["95% confidence interval around the Cohen's"," ",e.jsx(i,{span:!0,fs:"italic",children:"d"})," ","= 0.13 to 1.41"]})]}),e.jsxs(l,{gap:0,children:[e.jsxs(i,{fw:500,children:["Probability Value (",e.jsx(i,{span:!0,fs:"italic",children:"p"}),"-value):"]}),e.jsx(i,{children:"0.018"})]})]})}),e.jsx(f.Panel,{value:"discussion",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Results"}),e.jsx(i,{children:"The investigators found a 1-point difference on the VAS between subjects undergoing traditional open knee replacement and those undergoing minimally invasive knee replacement, favoring the minimally invasive procedure. Considering the MCID of an absolute difference of 0.45 points or greater on the VAS scale, the observed difference of 1 is considered a clinically meaningful difference. The width of the confidence interval and thus the imprecision of the estimate prevents making a definitive conclusion about whether the true difference exceeds the minimal clinically important difference, as the lower bound of the CI (0.64) is below 1."})]}),e.jsxs(i,{children:["The value for Cohen's"," ",e.jsx(i,{span:!0,fs:"italic",children:"d"})," ","of 0.78 is consistent with a large effect size. Unfortunately, the width of the confidence interval around the Cohen's"," ",e.jsx(i,{span:!0,fs:"italic",children:"d"})," ","estimate and resultant imprecision in the estimate of the true value prevent making a definitive conclusion. Based on the range of the CI around the Cohen's"," ",e.jsx(i,{span:!0,fs:"italic",children:"d"})," ","estimate, the true value for the Cohen's"," ",e.jsx(i,{span:!0,fs:"italic",children:"d"})," ","could be as small as 0.13, interpreted as a negligible effect, all the way to 1.41, which represents a very large effect."]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Implications of Results"}),e.jsx(i,{children:"The magnitude of the difference in pain scores highlights the potential advantage of minimally invasive procedures in immediate post-operative pain management. The imprecision in the effect size estimate, however, prevents making definitive conclusions. Furthermore, as this was a cross-sectional study and treatment was not randomly assigned, no causal inference can be made regarding the effect of the type of knee replacement on post-operative pain."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Future Research"}),e.jsx(i,{children:"Given the notable difference in POD 1 pain scores, additional research, including the possible pursuit of an experimental study where the investigator randomly assigns patients to minimally invasive knee replacement or traditional replacement, on immediate post-operative pain, other post-operative complications, and long-term outcomes between the two surgical approaches is warranted."})]})]})})]})]})}Lx.title="Minimally Invasive vs. Traditional Knee Replacement: A Cross-Sectional Analysis of Immediate Post-Operative Pain";const Th=[Lx];function Rh(){const t=[e.jsx(l,{gap:4,children:e.jsxs(i,{children:["Glass's delta () is a standardized measure that represents the magnitude of the difference between two groups, similar to Cohen's"," ",e.jsx(i,{span:!0,fs:"italic",children:"d"}),". However, unlike Cohen's"," ",e.jsx(i,{span:!0,fs:"italic",children:"d"}),", Glass's  is computed by taking the difference between two means and dividing by the standard deviation of just one group, typically the control or baseline group."]})}),e.jsxs(l,{gap:6,children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpreting the magnitude of Glass's "}),e.jsx(i,{children:"The interpretation of Glass's  as an absolute value is as follows:"})]}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.00 to 0.19:"})," ","Negligible effect size"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.20 to 0.39:"})," ","Small effect size"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.40 to 0.59:"})," ","Medium effect size"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.60 to 0.79:"})," ","Large effect size"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.80 to 1.00:"})," ","Very large effect size"]})})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"When to use Glass's "}),e.jsx(i,{children:"Glass's  is particularly useful when the groups being compared have different standard deviations or when the researcher wants to standardize the mean difference using the variability of a specific reference group."})]})];return e.jsx(G,{explanationSections:t,example1:e.jsx(i,{children:"Example 1 content will go here (e.g., a scatterplot, numerical example, or walkthrough)."})})}function Ox(){return e.jsxs(l,{gap:"md",children:[e.jsx(i,{fs:"italic",mt:0,children:"Among adults with moderate acne vulgaris, does the application of benzoyl peroxide gel compared to salicylic acid result in a greater reduction in the number of inflammatory acne lesions?"}),e.jsxs(f,{defaultValue:"studyDesign",children:[e.jsxs(f.List,{children:[e.jsx(f.Tab,{value:"studyDesign",children:"Study Design and Methods"}),e.jsx(f.Tab,{value:"effectSize",children:"Effect Size Measure & MCID"}),e.jsx(f.Tab,{value:"result",children:"Result"}),e.jsx(f.Tab,{value:"discussion",children:"Discussion and Future Research"})]}),e.jsx(f.Panel,{value:"studyDesign",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Clinical Research Study Design:"}),e.jsx(i,{children:"Randomized controlled trial (RCT)"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Study Population:"}),e.jsx(i,{children:"30 adults with moderate acne vulgaris; recruited from a dermatological outpatient clinic in an academic medical center"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Variables under Study:"}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Independent/Predictor/Exposure:"}),e.jsx(i,{children:"Type of acne treatment (benzoyl peroxide gel (n=18) or salicylic acid (n=13))"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Dependent/Outcome:"}),e.jsx(i,{children:"Reduction in the number of inflammatory acne lesions."})]})]})]})}),e.jsx(f.Panel,{value:"effectSize",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Effect Size Measure used in the Analytical Approach"}),e.jsx(i,{children:"Glass's delta will be used to compare the difference in the mean number of inflammatory acne lesions among participants using salicylic acid or benzoyl peroxide gel."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Minimal Clinically Important Difference (MCID)"}),e.jsx(i,{children:"The minimal clinically important difference (MCID) was determined pre-study by an expert panel of dermatologists and is a difference of 2 in the mean number of inflammatory acne lesions."})]})]})}),e.jsx(f.Panel,{value:"result",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Values represent mean (SD) number of inflammatory acne lesions"}),e.jsx(i,{children:"Salicylic acid: 5.9 (0.9) Benzoyl peroxide gel: 5.7 (0.6) Mean difference: 0.2 (95% CI: -0.39 to 0.79)"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Point Estimate:"}),e.jsx(i,{children:"Glass'  = 0.33"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Confidence Interval:"}),e.jsx(i,{children:"95% confidence interval = -0.98 to 0.46"})]}),e.jsxs(l,{gap:0,children:[e.jsxs(i,{fw:500,children:["Probability Value (",e.jsx(i,{span:!0,fs:"italic",children:"p"}),"-value):"]}),e.jsxs(i,{children:[e.jsx(i,{span:!0,fs:"italic",children:"p"}),"-value = 0.464"]})]})]})}),e.jsx(f.Panel,{value:"discussion",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Results"}),e.jsx(i,{children:"The mean difference of 0.2 and Glass's Delta of 0.33 suggests a small difference in the magnitude of the change in the number of inflammatory acne lesions based on treatment. The 95% CI around the mean difference is wide (-0.39 to 0.79) and thus the observed result from this study provides an imprecise estimate of the true value for the difference."})]}),e.jsx(i,{children:"The upper bound of the 95% CI for the difference in the number of inflammatory lesions is 0.79, which is well below the minimal clinically important difference (MCID) value of 2 or greater acne lesions. In fact, of the 30 participants, only 4 (13%) had a reduction of more than 2 inflammatory acne lesions."}),e.jsxs(i,{children:["The probability value (",e.jsx(i,{span:!0,fs:"italic",children:"p"}),'-value) indicates that the likelihood that the observed value for the mean difference of 0.2 is different from 0, assuming there is no difference, is 0.464, which is higher than 0.05 and thus the difference is classified as "not significant".']}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Implication of Results"}),e.jsx(i,{children:"Based on these findings, this study concludes that the difference between benzoyl peroxide gel and salicylic acid in reducing inflammatory acne lesions is very minor. However, the exact magnitude of the difference cannot be determined due to the imprecise estimates from this study."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Future Research"}),e.jsxs(c,{spacing:"xs",children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Do Not Repeat the Study:"})," ","Despite the wide confidence intervals, there is no need to conduct a repeat or similarly designed study as the upper bound of the CI is well below the clinically meaningful difference in the number of acne lesions of 2. However, it's important to recognize exceptions where replication studies can be valuable, especially in diverse populations or settings, to verify the universality of findings. In most instances, prioritizing new research questions or unexplored avenues is more beneficial, ensuring efficient use of resources and the robustness of scientific inquiry."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Reduce Variability in the Measurement of Key Variables:"})," ","To diminish variability and enhance precision, standardize measurements through methods like a Standard Operating Procedure (SOP) manual, validated assessments, and calibrated instruments. Additionally, evaluate the sensitivity and specificity of these measurement tools to ensure they can detect small but clinically significant changes. While promoting consistency is crucial, it's equally important to consider potential limitations of standardization, such as missing context-specific factors that might influence results. This comprehensive approach helps in accurately capturing the nuances of the study's outcomes."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Improve Methodological Quality and Rigor of Subsequent Studies:"})," ","Enhancing methodological rigor is crucial to ensure that negative results are not a product of study design flaws but are indeed reflective of the intervention's ineffectiveness. Such improvements are key to minimizing bias and enhancing the validity of conclusions. Researchers must navigate the practical challenges of implementing these methodologies while ensuring the study remains feasible and accurate."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Utilize Technology-Assisted Data Collection:"})," ","Employ technologies to refine data accuracy, crucial for re-examining negative results. This approach minimizes errors and variability, potentially revealing subtle effects that were initially overlooked. Enhanced participant engagement through these technologies also contributes to higher quality data, aiding in a deeper understanding and reassessment of the study's conclusions."]})})]})]})]})})]})]})}Ox.title="Efficiency of Benzoyl Peroxide Gel vs. Salicylic Acid in Reducing Inflammatory Acne Lesions: An RCT Perspective on Treatment Outcomes";function Fx(){return e.jsxs(l,{gap:"md",children:[e.jsx(i,{fs:"italic",mt:0,children:"Among adults with moderate acne vulgaris, does the application of benzoyl peroxide gel, salicylic acid, or topical retinoid result in a greater reduction in the number of inflammatory acne lesions?"}),e.jsxs(f,{defaultValue:"studyDesign",children:[e.jsxs(f.List,{children:[e.jsx(f.Tab,{value:"studyDesign",children:"Study Design and Methods"}),e.jsx(f.Tab,{value:"effectSize",children:"Effect Size Measure & MCID"}),e.jsx(f.Tab,{value:"result",children:"Result"}),e.jsx(f.Tab,{value:"discussion",children:"Discussion and Future Research"})]}),e.jsx(f.Panel,{value:"studyDesign",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Clinical Research Study Design:"}),e.jsx(i,{children:"Randomized Controlled Trial (RCT)"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Study Population:"}),e.jsx(i,{children:"Adults with moderate acne vulgaris; recruited from a dermatological outpatient clinic in an academic medical center."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Variables under Study:"}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Independent/Predictor/Exposure:"}),e.jsx(i,{children:"Type of acne treatment - benzoyl peroxide gel (n=18), salicylic acid (n=13), topical retinoid (n=21)"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Dependent/Outcome:"}),e.jsx(i,{children:"Reduction in the number of inflammatory acne lesions."})]})]})]})}),e.jsx(f.Panel,{value:"effectSize",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Effect Size Measure used in the Analytical Approach"}),e.jsx(i,{children:"Glass's delta will be used to compare the difference in the mean number of inflammatory acne lesions among participants using benzoyl peroxide gel, salicylic acid, and topical retinoid."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Minimal Clinically Important Difference (MCID)"}),e.jsx(i,{children:"The MCID was determined pre-study by an expert panel of dermatologists and is a difference of 1 or greater in the mean number of inflammatory acne lesions."})]})]})}),e.jsx(f.Panel,{value:"result",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsx(i,{fw:500,children:"Values represent the mean (SD) number of inflammatory acne lesions"}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Benzoyl Peroxide vs Salicylic Acid"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:"Benzoyl peroxide gel: 5.7 (0.6)"}),e.jsx(c.Item,{children:"Salicylic acid: 5.9 (0.9)"}),e.jsx(c.Item,{children:"Mean difference: 0.2 (95% CI: -0.39 to 0.79)"}),e.jsxs(c.Item,{children:["Probability value (",e.jsx(i,{span:!0,fs:"italic",children:"p"}),"-value): 0.464"]}),e.jsx(c.Item,{children:"Effect Size: Glass'  0.33"}),e.jsx(c.Item,{children:"95% Confidence Interval: -0.98 to 0.46"})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Benzoyl Peroxide vs Topical Retinoid"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:"Benzoyl peroxide gel: 5.7 (0.6)"}),e.jsx(c.Item,{children:"Topical Retinoid: 4.9 (0.9)"}),e.jsx(c.Item,{children:"Mean difference: 0.8 (95% CI: 0.29 to 1.30)"}),e.jsxs(c.Item,{children:["Probability value (",e.jsx(i,{span:!0,fs:"italic",children:"p"}),"-value): 0.002"]}),e.jsx(c.Item,{children:"Point Estimate: Glass'  1.33"}),e.jsx(c.Item,{children:"95% CI: 0.38 to 1.72"})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Salicylic Acid vs Topical Retinoid"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:"Salicylic acid: 5.9 (0.9)"}),e.jsx(c.Item,{children:"Topical Retinoid: 4.9 (0.9)"}),e.jsx(c.Item,{children:"Mean Difference: 1.0 (95% CI 0.35 to 1.65)"}),e.jsxs(c.Item,{children:["Probability value (",e.jsx(i,{span:!0,fs:"italic",children:"p"}),"-value): 0.004"]}),e.jsx(c.Item,{children:"Point Estimate: Glass'  1.11"}),e.jsx(c.Item,{children:"95% CI: 0.39 to 1.83"})]})]})]})}),e.jsx(f.Panel,{value:"discussion",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Results"}),e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Benzoyl Peroxide vs Salicylic Acid:"})," ","The mean difference of 0.2 and Glass's Delta of 0.33 indicate a small difference in the change in the number of inflammatory acne lesions based on treatment. However, the wide 95% confidence interval (-0.39 to 0.79) suggests that the observed result from this study provides an imprecise estimate of the true difference."]}),e.jsx(i,{children:"The upper bound of the 95% confidence interval for the difference in inflammatory lesions is 0.79, which is below the minimal clinically important difference (MCID) of 1 or greater acne lesions."}),e.jsxs(i,{children:["With a"," ",e.jsx(i,{span:!0,fs:"italic",children:"p"}),'-value of 0.464, there is a high probability that the observed mean difference of 0.2 is not significantly different from 0, assuming no actual difference. Therefore, the difference between the two treatments is considered "not significant" using a commonly used significance level of 0.05.']}),e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Benzoyl Peroxide vs Topical Retinoid:"})," ","The mean difference of 0.8 and Glass's Delta of 1.33 indicate a very large difference in the number of inflammatory acne lesions based on treatment. However, the wide 95% confidence interval (0.29 to 1.30) shows imprecision in estimating the true difference. Importantly, the upper bound of the 95% confidence interval exceeds the threshold value of 1 for minimal clinically important difference (MCID), suggesting that clinically meaningful differences may be present."]}),e.jsxs(i,{children:["With a"," ",e.jsx(i,{span:!0,fs:"italic",children:"p"}),'-value of 0.002, there is a low probability that the observed mean difference of 0.8 is due to chance alone, assuming no actual difference. Therefore, the difference is considered "significant" using a commonly used significance level of 0.05.']}),e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Salicylic Acid vs Topical Retinoid:"})," ","The mean difference of 1.0 and Glass's Delta of 1.11 suggest a very large difference in the number of inflammatory acne lesions based on treatment. However, the wide 95% confidence interval (0.35 to 1.65) shows imprecision in estimating the true difference. It is important to note that the wide range of the confidence interval encompasses both clinically meaningful and meaningless values. Although the observed result indicates a substantial difference and includes clinically meaningful differences in its plausible range, the imprecise estimate arising from the wide confidence interval introduces uncertainty."]}),e.jsxs(i,{children:["The"," ",e.jsx(i,{span:!0,fs:"italic",children:"p"}),'-value of 0.004 indicates a low probability that the observed mean difference of 1.0 is due to chance alone, assuming no actual difference. This classifies the difference as "significant" using a commonly used significance level of 0.05.']})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Implication of Results"}),e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Benzoyl Peroxide vs Salicylic Acid:"})," ","Based on these findings, the investigators conclude that there is only a minor difference between benzoyl peroxide gel and salicylic acid in reducing inflammatory acne lesions and that this difference is not clinically meaningful. However, due to imprecise estimates, the exact magnitude of the difference cannot be determined from this study."]}),e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Benzoyl Peroxide vs Topical Retinoid:"})," ","This study is indeterminate due to the imprecision of the results, which prevents the investigator from reaching a definitive conclusion. The 95% confidence interval includes a range of values that encompass both clinically meaningful and meaningless differences."]}),e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Salicylic Acid vs Topical Retinoid:"})," ",'Despite the "statistically significant" finding, this study is still considered indeterminate due to the imprecision of the results. The wide confidence interval prevents the investigator from reaching a definitive conclusion. Within the plausible range defined by the 95% confidence interval, both clinically meaningful and meaningless differences exist.']})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Future Research"}),e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Benzoyl Peroxide vs Salicylic Acid:"})," ","Given the small difference in the number of inflammatory lesions between the two treatments and the fact that the range of the confidence interval rules out a clinically meaningful difference, additional studies with these two drugs may not be warranted."]}),e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Benzoyl Peroxide vs Topical Retinoid:"})," ","Since these results demonstrate a large reduction in the number of inflammatory acne lesions with topical retinoid, but a wide confidence interval with an imprecise estimate, additional studies with a larger sample size and adherence to strict research methodology to reduce systematic bias seem warranted."]}),e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Salicylic Acid vs Topical Retinoid:"})," ","Since these results demonstrate a large reduction in the number of inflammatory acne lesions with topical retinoid, but a wide confidence interval with an imprecise estimate, additional studies with a larger sample size and adherence to strict research methodology to reduce systematic bias seem warranted."]})]})]})})]})]})}Fx.title="Efficiency of Benzoyl Peroxide Gel, Salicylic Acid, and Topical Retinoid in Reducing Inflammatory Acne Lesions: An RCT Perspective on Treatment Outcomes";const c5=[Ox],d5=[Fx];function kh(){const t=[e.jsx(l,{gap:4,children:e.jsxs(i,{children:["Hedge's"," ",e.jsx(i,{span:!0,fs:"italic",children:"g"})," ","is a standardized measure that represents the magnitude of the difference between two groups in terms of standard deviations, similar to Cohen's"," ",e.jsx(i,{span:!0,fs:"italic",children:"d"})," ","and Glass's . The difference is its incorporated correction of biases in small sample sizes, thus making it an unbiased estimator of the population effect size."]})}),e.jsxs(l,{gap:6,children:[e.jsxs(l,{gap:0,children:[e.jsxs(i,{fw:500,children:["Interpreting the magnitude of Hedge's"," ",e.jsx(i,{span:!0,fs:"italic",children:"g"})]}),e.jsxs(i,{children:["The interpretation of Hedge's"," ",e.jsx(i,{span:!0,fs:"italic",children:"g"})," ","as an absolute value is as follows:"]})]}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.00 to 0.19:"})," ","Negligible effect size"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.20 to 0.39:"})," ","Small effect size"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.40 to 0.59:"})," ","Medium effect size"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.60 to 0.79:"})," ","Large effect size"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.80 to 1.00:"})," ","Very large effect size"]})})]})]}),e.jsxs(l,{gap:0,children:[e.jsxs(i,{fw:500,children:["When to use Hedge's"," ",e.jsx(i,{span:!0,fs:"italic",children:"g"})]}),e.jsxs(i,{children:["Hedge's"," ",e.jsx(i,{span:!0,fs:"italic",children:"g"})," ","is particularly useful when dealing with small sample sizes due to its bias correction."]})]})];return e.jsx(G,{explanationSections:t,example1:e.jsx(i,{children:"Example 1 content will go here (e.g., a scatterplot, numerical example, or walkthrough)."})})}function $x(){return e.jsxs(l,{gap:"md",children:[e.jsx(i,{fs:"italic",mt:0,children:"Is there a difference in mean hemoglobin value after 6 weeks of therapy between adult patients with end-stage kidney disease and anemia who receive epoetin alfa or darbepoetin alfa?"}),e.jsxs(f,{defaultValue:"studyDesign",children:[e.jsxs(f.List,{children:[e.jsx(f.Tab,{value:"studyDesign",children:"Study Design and Methods"}),e.jsx(f.Tab,{value:"effectSize",children:"Effect Size Measure & MCID"}),e.jsx(f.Tab,{value:"result",children:"Result"}),e.jsx(f.Tab,{value:"discussion",children:"Discussion and Future Research"})]}),e.jsx(f.Panel,{value:"studyDesign",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Clinical Research Study Design:"}),e.jsx(i,{children:"Randomized clinical trial"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Study Population:"}),e.jsx(i,{children:"The study population consists of 30 adult patients with end-stage kidney disease and anemia. They were identified from a pool of patients at a healthcare institution specializing in kidney disease treatment."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Variables Under Study:"}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Independent/Predictor/Exposure:"}),e.jsx(i,{children:"The independent/predictor/exposure variable is the administration of two different erythropoietin-stimulating agents (ESA) protocols - epoetin alfa (n=15) and darbepoetin alfa (n=15)."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Dependent/Outcome:"}),e.jsx(i,{children:"The dependent variable is the mean hemoglobin value after 6 weeks of therapy."})]})]})]})}),e.jsx(f.Panel,{value:"effectSize",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Effect Size Measure used in the Analytical Approach"}),e.jsx(i,{children:"Hedge's g will be used as the effect size measure to demonstrate the magnitude of the difference in hemoglobin value between the two groups."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Minimal Clinically Important Difference (MCID)"}),e.jsx(i,{children:"The minimal clinically important difference (MCID) was not defined in this situation."})]})]})}),e.jsx(f.Panel,{value:"result",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Point Estimate:"}),e.jsx(i,{children:"The mean pre-study hemoglobin value for the 30 participants is 8.6 g/dl. The post-intervention mean (SD) hemoglobin value for the epoetin alfa group is 10.0 (1.1) g/dL, while for the darbepoetin alfa group it is 10.3 (1.2) g/dL, for a difference (95% CI) of 0.3 g/dL (-0.56 to 1.2)"}),e.jsxs(i,{children:["The Hedge's"," ",e.jsx(i,{span:!0,fs:"italic",children:"g"})," ","value is 0.25."]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Confidence Interval:"}),e.jsxs(i,{children:["The 95% confidence interval for Hedge's"," ",e.jsx(i,{span:!0,fs:"italic",children:"g"})," ","is narrow, ranging from 0.05 to 0.45."]})]}),e.jsxs(l,{gap:0,children:[e.jsxs(i,{fw:500,children:["Probability Value (",e.jsx(i,{span:!0,fs:"italic",children:"p"}),"-value):"]}),e.jsxs(i,{children:[e.jsx(i,{span:!0,fs:"italic",children:"p"}),"-value = 0.48"]})]})]})}),e.jsx(f.Panel,{value:"discussion",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Results:"}),e.jsxs(i,{children:["The difference in hemoglobin is only 0.3 g/dL, which is small in favor of darbepoetin alfa. However, the confidence interval is wide, and the probability value (",e.jsx(i,{span:!0,fs:"italic",children:"p"}),"-value) is 0.48. Thus, the results are imprecise and neither statistically significant nor clinically meaningful."]})]}),e.jsxs(i,{children:["The Hedge's"," ",e.jsx(i,{span:!0,fs:"italic",children:"g"})," ","value of 0.25, indicates a small effect size and the upper bound of the confidence interval suggest the largest effect consistent with the study results (0.45) is barely large enough to be considered a medium effect."]}),e.jsx(i,{children:"The results of the study suggest that there is a small difference in mean hemoglobin value after 6 weeks of therapy between patients receiving epoetin alfa and darbepoetin alfa but the difference is neither statistically nor clinically meaningful."}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Implications of Results:"}),e.jsx(i,{children:"This difference may not have significant clinical implications."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Future Research"}),e.jsxs(c,{spacing:"xs",children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Reduce Variability in the Measurement of Key Variables:"})," ","To minimize variability and enhance precision, standardize measurements through methods such as a Standard Operating Procedure (SOP) manual, validated assessments, and calibrated instruments, as seen in the measurement of hemoglobin. Additionally, evaluate the sensitivity and specificity of these measurement tools to ensure they can detect small but clinically significant changes. While promoting consistency is crucial, it's equally important to consider potential limitations of standardization, such as missing context-specific factors that might influence results. This comprehensive approach enables the accurate capture of the study's outcomes' nuances."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Conduct Additional Research with Increased Sample Size:"})," ","To obtain more precise estimates of the effect size, conduct the study with a larger sample size. This approach enables authors and readers to be more certain of where the actual effect size value lies and whether the results are compatible with clinically meaningful effects. However, it's essential to consider that increasing sample size may not always be feasible in every research context. Resource constraints, such as funding, time, and participant availability, can limit the ability to significantly expand the study. Therefore, while planning to increase the sample size, researchers should also work to ensure that the study remains viable and efficient."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Improve Study Quality via Reduction of Error:"})," ","Enhance the reliability and precision of effect size estimates by reducing both random and systematic errors. Adherence to Good Clinical Practice (GCP) guidelines, as described in the FDA's Code of Federal Regulations, is one effective strategy. GCP promotes standardized processes, data quality, patient safety, and rigorous oversight, all contributing to improved clinical research and evidence-based medicine. However, it's also vital to acknowledge that the potential for error reduction is influenced by the specific nature and inherent variability of the study population, making a one-size-fits-all approach impractical."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Improve Methodological Quality and Rigor of Subsequent Studies:"})," ","Enhance the study design, via randomization, blinding, and control of confounding variables, to address the uncertainties in indeterminate study outcomes. In such studies, focusing on methodological improvements is essential for clarifying ambiguous findings. These enhancements are critical for reducing bias and increasing the reliability of results, providing clearer direction for future research. While pursuing these methodological ideals, researchers should also consider the practical challenges, such as logistical constraints and participant-related hurdles, to conduct feasible yet robust studies."]})})]})]})]})})]})]})}$x.title="A Randomized Clinical Trial Comparing the Efficacy of Epoetin Alfa and Darbepoetin Alfa in Adult Patients with End-Stage Kidney Disease and Anemia";function Bx(){return e.jsxs(l,{gap:"md",children:[e.jsx(i,{fs:"italic",mt:0,children:"Is there a difference in the mean hemoglobin value after 6 weeks of therapy among adult patients with end-stage kidney disease and anemia who receive different erythropoietin-stimulating agents (ESA) - epoetin alfa, darbepoetin alfa, or methoxy polyethylene glycol-epoetin beta?"}),e.jsxs(f,{defaultValue:"studyDesign",children:[e.jsxs(f.List,{children:[e.jsx(f.Tab,{value:"studyDesign",children:"Study Design and Methods"}),e.jsx(f.Tab,{value:"effectSize",children:"Effect Size Measure & MCID"}),e.jsx(f.Tab,{value:"result",children:"Result"}),e.jsx(f.Tab,{value:"discussion",children:"Discussion and Future Research"})]}),e.jsx(f.Panel,{value:"studyDesign",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Clinical Research Study Design:"}),e.jsx(i,{children:"Randomized clinical trial"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Study Population:"}),e.jsx(i,{children:"The study population consists of 45 adult patients with end-stage kidney disease and anemia. They were identified from a pool of patients at a healthcare institution specializing in kidney disease treatment."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Variables Under Study:"}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Independent/predictor/exposure:"}),e.jsx(i,{children:"The independent/predictor/exposure variable is the administration of three different erythropoietin-stimulating agents (ESA) protocols - epoetin alfa (n=15), darbepoetin alfa (n=15), or methoxy polyethylene glycol-epoetin beta (n=15)."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Dependent/outcome:"}),e.jsx(i,{children:"The dependent variable is the mean hemoglobin value after 6 weeks of therapy."})]})]})]})}),e.jsx(f.Panel,{value:"effectSize",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Effect Size Measure used in the Analytical Approach"}),e.jsxs(i,{children:["Hedge's"," ",e.jsx(i,{span:!0,fs:"italic",children:"g"})," ","will be used as the effect size measure to demonstrate the magnitude of the difference in hemoglobin values between the pairwise comparisons of the three drug interventions."]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Minimal Clinically Important Difference (MCID)"}),e.jsx(i,{children:"Not defined in this situation."})]}),e.jsxs(l,{gap:0,children:[e.jsxs(i,{fw:500,children:["Effect Size Measure Definition: Hedge's"," ",e.jsx(i,{span:!0,fs:"italic",children:"g"})]}),e.jsxs(i,{children:["Hedge's"," ",e.jsx(i,{span:!0,fs:"italic",children:"g"})," ","is a standardized measure that represents the magnitude of the difference between two groups in terms of standard deviations, similar to Cohen's"," ",e.jsx(i,{span:!0,fs:"italic",children:"d"})," ","and Glass's . The difference is that it incorporates the correction of biases in small sample sizes, thus making it an unbiased estimator of the population effect size."]}),e.jsxs(i,{children:["Hedge's"," ",e.jsx(i,{span:!0,fs:"italic",children:"g"})," ","is particularly useful when dealing with small sample sizes due to its bias correction."]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation"}),e.jsxs(i,{children:["The interpretation of Hedge's"," ",e.jsx(i,{span:!0,fs:"italic",children:"g"})," ","as an absolute value is as follows:"]}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.00 to 0.19:"})," ","Negligible effect size"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.20 to 0.39:"})," ","Small effect size"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.40 to 0.59:"})," ","Medium effect size"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.60 to 0.79:"})," ","Large effect size"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.80 to 1.00:"})," ","Very large effect size"]})})]})]})]})}),e.jsx(f.Panel,{value:"result",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Point Estimate"}),e.jsx(i,{children:"The mean pre-study hemoglobin value for all three groups is 8.5 g/dL."}),e.jsx(i,{children:"After 6 weeks of therapy, the mean (SD) hemoglobin values for the three groups are as follows: darbepoetin alfa - 10.3 (1.2) g/dL, methoxy polyethylene glycol-epoetin beta - 10.1 (1.3) g/dL, and epoetin alfa - 10.0 (1.1) g/dL."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Pairwise Comparisons"}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"1. Epoetin alfa vs. darbepoetin alfa"}),e.jsx(i,{children:"Darbepoetin associated with increase of 0.3 g/dl hemoglobin as compared to epoetin alfa"}),e.jsxs(c,{spacing:2,children:[e.jsxs(c.Item,{children:["Hedge's"," ",e.jsx(i,{span:!0,fs:"italic",children:"g"})," ","= 0.26"]}),e.jsx(c.Item,{children:"95% CI = 0.15 to 0.35"})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"2. Epoetin alfa vs. methoxy polyethylene glycol-epoetin beta"}),e.jsx(i,{children:"Methoxy polyethylene glycol-epoetin is associated with an increase of 0.1 g/dl hemoglobin as compared to epoetin alfa."}),e.jsxs(c,{spacing:2,children:[e.jsxs(c.Item,{children:["Hedge's"," ",e.jsx(i,{span:!0,fs:"italic",children:"g"})," ","= 0.08"]}),e.jsx(c.Item,{children:"95% CI = 0.01 to 0.15"})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"3. Darbepoetin alfa vs. methoxy polyethylene glycol-epoetin beta"}),e.jsx(i,{children:"Darbepoetin alfa is associated with an increase of 0.2 g/dl hemoglobin as compared to methoxy polyethylene glycol-epoetin beta."}),e.jsxs(c,{spacing:2,children:[e.jsxs(c.Item,{children:["Hedge's"," ",e.jsx(i,{span:!0,fs:"italic",children:"g"})," ","= 0.16"]}),e.jsx(c.Item,{children:"95% CI = 0.06 to 0.26"})]})]})]})]})}),e.jsx(f.Panel,{value:"discussion",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Results"}),e.jsx(i,{children:"The results of the study suggest that there is a small difference in mean hemoglobin value after 6 weeks of therapy among the three different erythropoietin-stimulating agents. Darbepoetin alfa appears to have the largest increase in hemoglobin while methoxy polyethylene glycol-epoetin beta has the smallest increase. The upper bound of the confidence intervals suggest that no pairwise difference is greater than a small effect."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Implications of Results"}),e.jsx(i,{children:"The clinical significance of these differences needs to be further explored, but it seems unlikely to be clinically meaningful."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Future Research"}),e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Do Not Repeat the Study:"})," ","Considering that the observed results are both precise and definitive, there generally is no need to conduct a repeat or similarly designed study, thus avoiding research waste. However, it's essential to acknowledge exceptions where replication studies can be particularly valuable, especially in diverse populations or settings, to validate the universality of findings. In most instances, prioritizing new research questions or unexplored avenues is more beneficial, ensuring efficient use of resources and the robustness of scientific inquiry."]}),e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Explore Other Clinical and Patient-Reported Outcomes:"})," ","Exploring other clinical outcomes and patient-reported outcomes may provide a comprehensive understanding of the benefits and risks associated with each drug intervention."]}),e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Reduce Variability in the Measurement of Key Variables:"})," ","To diminish variability and enhance precision, standardize measurements through methods like a Standard Operating Procedure (SOP) manual, validated assessments, and calibrated instruments. Additionally, evaluate the sensitivity and specificity of these measurement tools to ensure they can detect small but clinically significant changes. While promoting consistency is crucial, it's equally important to consider potential limitations of standardization, such as missing context-specific factors that might influence results. This comprehensive approach helps in accurately capturing the nuances of the study's outcomes."]}),e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Improve Methodological Quality and Rigor of Subsequent Studies:"})," ","Strengthen the study design, through rigorous randomization, blinding, and controlling confounding variables, to confirm and validate the findings of definitive negative studies. In this context, enhancing methodological rigor is crucial to ensure that negative results are not a product of study design flaws but are indeed reflective of the intervention's ineffectiveness. Such improvements are key to minimizing bias and enhancing the validity of conclusions. Researchers must navigate the practical challenges of implementing these methodologies while ensuring the study remains feasible and accurate."]}),e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Utilize Technology-Assisted Data Collection:"})," ","Employ technologies like wearables and mobile apps to provide real-time measurements and possibly refine data accuracy, crucial for re-examining negative results. This approach minimizes errors and variability, potentially revealing subtle effects that were initially overlooked. Enhanced data precision through technological assistance can provide deeper insights into treatment efficacy and help distinguish between true negative results and measurement limitations."]})]})]})})]})]})}Bx.title="A Randomized Clinical Trial Comparing the Effect of Three Different Erythropoietin-Stimulating Agents on Hemoglobin Levels in Adult Patients with End-Stage Kidney Disease and Anemia";const u5=[$x],h5=[Bx];function Ph(){const t=[e.jsx(l,{gap:4,children:e.jsxs(i,{children:["The"," ",e.jsx(i,{span:!0,fs:"italic",children:"r"})," ","correlation coefficient is a standardized measure that represents the strength and direction of a linear relationship between two ordinal or ranked variables without making assumptions about the distribution of the variables. In the context of nonparametric statistics, it refers to measures like Spearman's ."]})}),e.jsxs(l,{gap:6,children:[e.jsxs(l,{gap:0,children:[e.jsxs(i,{fw:500,children:["Range of"," ",e.jsx(i,{span:!0,fs:"italic",children:"r"})," ","correlation coefficient"]}),e.jsxs(i,{children:["The"," ",e.jsx(i,{span:!0,fs:"italic",children:"r"})," ","correlation coefficient values range from -1 to +1, with the following meanings:"]})]}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0 to +1:"})," ","There is a positive association. As the values of one variable increase, the values of the other variable tend to increase as well."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0 to -1:"})," ","There is a negative association. As the values of one variable increase, the values of the other variable tend to decrease."]})})]})]}),e.jsxs(l,{gap:6,children:[e.jsxs(l,{gap:0,children:[e.jsxs(i,{fw:500,children:["Interpreting the magnitude of"," ",e.jsx(i,{span:!0,fs:"italic",children:"r"})]}),e.jsxs(i,{children:["The interpretation of the"," ",e.jsx(i,{span:!0,fs:"italic",children:"r"})," ","correlation coefficient as an absolute value is as follows:"]})]}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.00 to 0.19:"})," ","Negligible effect size"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.20 to 0.39:"})," ","Small effect size"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.40 to 0.59:"})," ","Medium effect size"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.60 to 0.79:"})," ","Large effect size"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.80 to 1.00:"})," ","Very large effect size"]})})]})]}),e.jsxs(l,{gap:0,children:[e.jsxs(i,{fw:500,children:["When to use"," ",e.jsx(i,{span:!0,fs:"italic",children:"r"})]}),e.jsxs(i,{children:["The"," ",e.jsx(i,{span:!0,fs:"italic",children:"r"})," ","value is particularly useful when dealing with data that do not meet the assumptions of parametric tests, such as data that are not normally distributed or that have outliers."]})]})];return e.jsx(G,{explanationSections:t,example1:e.jsx(i,{children:"Example 1 content will go here (e.g., a scatterplot, numerical example, or walkthrough)."})})}function Hx(){return e.jsxs(l,{gap:"md",children:[e.jsx(i,{fs:"italic",mt:0,children:"What is the strength of association between CFTR gene mutations and disease severity, as defined by results of pulmonary function tests (PFTs), in adolescents with Cystic Fibrosis (CF)?"}),e.jsxs(f,{defaultValue:"studyDesign",children:[e.jsxs(f.List,{children:[e.jsx(f.Tab,{value:"studyDesign",children:"Study Design and Methods"}),e.jsx(f.Tab,{value:"effectSize",children:"Effect Size Measure & MCID"}),e.jsx(f.Tab,{value:"result",children:"Result"}),e.jsx(f.Tab,{value:"discussion",children:"Discussion and Future Research"})]}),e.jsx(f.Panel,{value:"studyDesign",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Clinical Research Study Design:"}),e.jsx(i,{children:"Cross-sectional"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Study Population:"}),e.jsx(i,{children:"200 adolescents with diagnosed Cystic Fibrosis (CF) who were identified and recruited from a CF specialty clinic or CF research database. They were selected based on their availability and willingness to participate in the study."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Variables under Study:"}),e.jsx(i,{children:"As this is a cross-sectional study, there are no independent or dependent variables. The two variables analyzed are the cystic fibrosis transmembrane conductance regulator (CFTR) gene mutation and results of pulmonary function test. CFTR is a well-known genetic biomarker used to assess the severity of the disease. PFTs assess lung function and provide objective measures of respiratory impairment in CF patients."})]})]})}),e.jsx(f.Panel,{value:"effectSize",pt:"md",children:e.jsx(l,{gap:"md",children:e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Effect Size Measure used in the Analytical Approach"}),e.jsxs(i,{children:[e.jsx(i,{span:!0,fs:"italic",children:"r"})," ","correlation coefficient (nonparametric)"]})]})})}),e.jsx(f.Panel,{value:"result",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Point Estimate:"}),e.jsx(i,{children:"0.50"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Confidence Interval:"}),e.jsx(i,{children:"95% confidence interval = 0.38 to 0.62"})]}),e.jsxs(l,{gap:0,children:[e.jsxs(i,{fw:500,children:["Probability Value (",e.jsx(i,{span:!0,fs:"italic",children:"p"}),"-value):"]}),e.jsx(i,{children:"< 0.00001"})]})]})}),e.jsx(f.Panel,{value:"discussion",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Results:"}),e.jsxs(i,{children:["The findings of the study suggest a moderate association between CFTR gene mutations and disease severity in adolescents with CF. Specifically, certain CFTR gene mutations are moderately linked to the observed airflow obstruction severity in pulmonary function tests (PFTs). The extremely low probability value (",e.jsx(i,{span:!0,fs:"italic",children:"p"}),"-value) (<0.00001) indicates a highly improbable chance of obtaining these results by random variation alone, therefore demonstrating statistical significance."]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Implication of Results:"}),e.jsx(i,{children:"CFTR gene mutations can provide valuable insights into disease prognosis and guide treatment decisions, particularly for adolescents with CF. However, it is important to consider that other factors may also contribute to disease severity, and CFTR gene mutations may not fully account for all variations observed in PFT results."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Future Research:"}),e.jsx(i,{children:"It is recommended for further investigations to explore the interplay between CFTR gene mutations and other potential determinants of disease severity, including patient-reported outcome measures. Additionally, larger sample sizes and more diverse populations can enhance the generalizability of these findings and provide more precise estimates of the association."})]})]})})]})]})}Hx.title="The Association between CFTR Gene Mutations and Disease Severity Measured by Pulmonary Function Tests in Adolescents with Cystic Fibrosis: A Cross-sectional Study";function Vx(){return e.jsxs(l,{gap:"md",children:[e.jsx(i,{fs:"italic",mt:0,children:"What is the strength of association between CFTR gene mutations and measures of disease severity (PFT, sweat chloride test, and CFQ-R) in adolescents with Cystic Fibrosis?"}),e.jsxs(f,{defaultValue:"studyDesign",children:[e.jsxs(f.List,{children:[e.jsx(f.Tab,{value:"studyDesign",children:"Study Design and Methods"}),e.jsx(f.Tab,{value:"effectSize",children:"Effect Size Measure & MCID"}),e.jsx(f.Tab,{value:"result",children:"Result"}),e.jsx(f.Tab,{value:"discussion",children:"Discussion and Future Research"})]}),e.jsx(f.Panel,{value:"studyDesign",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Clinical Research Study Design:"}),e.jsx(i,{children:"Cross-sectional"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Study Population:"}),e.jsx(i,{children:"20 adolescents with diagnosed Cystic Fibrosis (CF) who were identified and recruited from a CF specialty clinic or CF research database. They were selected based on their availability and willingness to participate in the study."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Variables under Study"}),e.jsx(i,{children:"As this is a cross-sectional study, there are no independent or dependent variables. The variables analyzed are the cystic fibrosis transmembrane conductance regulator (CFTR) gene mutation, pulmonary function test, sweat chloride test, and the Cystic Fibrosis Questionnaire-Revised (CFQ-R) is a validated and widely used questionnaire designed to assess the health-related quality of life (HRQoL) in individuals with cystic fibrosis (CF)."})]})]})}),e.jsx(f.Panel,{value:"effectSize",pt:"md",children:e.jsx(l,{gap:"md",children:e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Effect Size Measure used in the Analytical Approach"}),e.jsxs(i,{children:[e.jsx(i,{span:!0,fs:"italic",children:"r"})," ","correlation coefficient (non-parametric) for the pairwise comparisons of CFTR and PFT, CFTR and Sweat Chloride Test, and CFTR and CFQ-R."]})]})})}),e.jsx(f.Panel,{value:"result",pt:"md",children:e.jsx(l,{gap:"md",children:e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Pairwise Strength of Association"}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"1. CFTR gene mutations and PFT"}),e.jsxs(c,{spacing:2,children:[e.jsxs(c.Item,{children:["Point Estimate (",e.jsx(i,{span:!0,fs:"italic",children:"r"})," ","non-parametric): 0.40"]}),e.jsx(c.Item,{children:"95% Confidence Interval (CI): 0.20 to 0.60 (moderately precise estimate)"})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"2. CFTR gene mutations and sweat chloride test"}),e.jsxs(c,{spacing:2,children:[e.jsxs(c.Item,{children:["Point Estimate (",e.jsx(i,{span:!0,fs:"italic",children:"r"})," ","non-parametric): 0.60"]}),e.jsx(c.Item,{children:"95% Confidence Interval (CI): 0.50 to 0.70 (precise estimate)"})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"3. CFTR gene mutations and CFQ-R"}),e.jsxs(c,{spacing:2,children:[e.jsxs(c.Item,{children:["Point Estimate (",e.jsx(i,{span:!0,fs:"italic",children:"r"})," ","non-parametric): 0.20"]}),e.jsx(c.Item,{children:"95% Confidence Interval (CI): 0.10 to 0.30 (imprecise estimate)"})]})]})]})})}),e.jsx(f.Panel,{value:"discussion",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Results"}),e.jsx(i,{children:"The study results indicate varying strengths of association between CFTR gene mutations and different measures. The strongest association is observed between CFTR gene mutations and sweat chloride test, suggesting a clear relationship between genetic mutations and the results of this test. Conversely, the association between CFTR gene mutations and CFQ-R patient-reported outcome measures is weaker, suggesting that factors other than CFTR gene mutations influence patient-reported outcomes. The strength of association between CFTR gene mutations and PFT results falls in the medium range."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Implication of Results"}),e.jsx(i,{children:"The findings emphasize the significance of genetic biomarkers, particularly CFTR gene mutations, in assessing disease severity in CF patients. The strong association between CFTR gene mutations and sweat chloride test results indicates that the extent of gene mutation can serve as a reliable and informative indicator of disease severity. However, the weaker association between CFTR gene mutations and CFQ-R scores highlights the importance of considering other factors that contribute to patient-reported outcomes in CF."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Future Research"}),e.jsx(i,{children:"For future investigations, it is recommended to identify additional relevant biomarkers that can further enhance the understanding of disease severity in CF. Incorporating additional patient-reported outcome measures can also provide a more comprehensive assessment of the disease's impact on quality of life. Such efforts will contribute to a deeper understanding of CF and help improve patient care."})]})]})})]})]})}Vx.title="The Association between CFTR Gene Mutations and Measures of Disease Severity in Adolescents with Cystic Fibrosis: A Cross-sectional Study";const f5=[Hx],p5=[Vx];function m5(){const t=[e.jsx(l,{gap:4,children:e.jsx(i,{children:"Eta-squared () is used to assess the strength of association between multiple groups and a dependent variable; it is commonly used in analysis of variance. It helps researchers to gauge the practical significance of group differences, and it provides a quantitative measure of the impact of the independent variable on the dependent variable."})}),e.jsxs(l,{gap:6,children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Range of "}),e.jsx(i,{children:" values range from 0 to 1, with the following meanings:"})]}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0"})," ","indicates that the independent variable has no effect on the dependent variable (no variance explained)."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"1"})," ","indicates that the independent variable completely accounts for all of the variance in the dependent variable (full variance explained)."]})})]})]}),e.jsxs(l,{gap:6,children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of "}),e.jsx(i,{children:"Interpretation of  is as follows:"})]}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:" 0.01:"})," ","Small effect size. A value such as this suggests that the independent variable accounts for a very small proportion of the total variance in the dependent variable. This indicates a weak or negligible relationship."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:" 0.06:"})," ","Medium effect size. A value such as this suggests that the independent variable accounts for a moderate proportion of the total variance in the dependent variable. This indicates a moderate or intermediate relationship."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:" 0.14:"})," ","Large effect size. A value such as this suggests that the independent variable accounts for a substantial proportion of the total variance in the dependent variable. This indicates a strong and meaningful relationship."]})})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Important considerations"}),e.jsx(i,{children:"Although  provides valuable insights into the strength of relationships, it is essential to be aware that it can be biased, especially with smaller sample sizes, where it tends to overestimate the population effect size. In such cases, omega-squared may be a more appropriate measure."})]})];return e.jsx(G,{explanationSections:t,example1:e.jsx(i,{children:"Example 1 content will go here (e.g., a scatterplot, numerical example, or walkthrough)."})})}function Gx(){return e.jsxs(l,{gap:"md",children:[e.jsx(i,{fs:"italic",mt:0,children:"How strong is the association between overall severity of comorbid ailments and control of diabetes?"}),e.jsxs(f,{defaultValue:"studyDesign",children:[e.jsxs(f.List,{children:[e.jsx(f.Tab,{value:"studyDesign",children:"Study Design and Methods"}),e.jsx(f.Tab,{value:"effectSize",children:"Effect Size Measure & MCID"}),e.jsx(f.Tab,{value:"result",children:"Result"}),e.jsx(f.Tab,{value:"discussion",children:"Discussion and Future Research"})]}),e.jsx(f.Panel,{value:"studyDesign",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Clinical Research Study Design:"}),e.jsx(i,{children:"Observational study"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Study Population:"}),e.jsx(i,{children:"150 adult patients, aged 30 and above, diagnosed with diabetes mellitus and from diverse demographic and socioeconomic backgrounds. Subjects were recruited from a multispecialty group in a suburban area."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Variables under Study:"}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Independent/Predictor/Exposure:"}),e.jsx(i,{children:"Patients are classified into one of four groups based on the overall severity of comorbidities as defined on the Adult Comorbidity Evaluation-27 (ACE-27) index. The Adult Comorbidity Evaluation 27 (ACE-27) is a validated instrument that reflects the number and severity of medical comorbidity. ACE-27 grades individual comorbid ailments into 1 of 4 comorbidity classes: none, mild, moderate, or severe."}),e.jsx(i,{children:"The overall ACE-27 score can be None (0), Mild (1), Moderate (2) or Severe (3) and is defined according to the highest scored ailment. In cases with two or more grade 1 ailments, a final score of 1 assigned. In cases with two or more grade 2 ailments in different organ systems, a final score of 3 is assigned."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Dependent/Outcome:"}),e.jsx(i,{children:"The primary outcome is the control of diabetes, as measured by glycated hemoglobin (HbA1c) levels over a one-year follow-up period."})]})]})]})}),e.jsx(f.Panel,{value:"effectSize",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Effect Size Measure used in the Analytical Approach"}),e.jsx(i,{children:"The study uses eta-squared () as the effect size measure to quantify the proportion of variance in glycated hemoglobin (HbA1c) diabetes control explained by the overall severity of comorbidity."}),e.jsx(i,{children:"95% CI indicate the precision of the estimate of the strength of the association between presence and severity of comorbidity and control of diabetes."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Minimal Clinically Important Difference (MCID)"}),e.jsx(i,{children:"Not applicable"})]})]})}),e.jsx(f.Panel,{value:"result",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Point Estimate"}),e.jsx(i,{children:"Average Hemoglobin A1c value for each comorbidity severity grouping:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:"None: 5.8%"}),e.jsx(c.Item,{children:"Mild: 6.5%"}),e.jsx(c.Item,{children:"Moderate: 7.8%"}),e.jsx(c.Item,{children:"Severe: 8.8%"})]}),e.jsx(i,{children:"eta-squared () value of 0.023"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Confidence Interval"}),e.jsx(i,{children:"95% CI = 0.018 to 0.029"})]})]})}),e.jsx(f.Panel,{value:"discussion",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Results"}),e.jsx(i,{children:"The study provides strong evidence that diabetes control is strongly associated with the overall severity of comorbidity."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Implications of Results"}),e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Clinical Practice:"})," ","Healthcare providers should consider the overall burden of comorbidity when managing diabetes patients, as diabetes control is strongly associated with the severity of comorbidities."]}),e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Patient Education:"})," ","Patients with high comorbidity burden may benefit from targeted education and management strategies to improve diabetes control."]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Future Research"}),e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Further Exploration:"})," ","Investigate the mechanisms by which overall comorbidity burden affects diabetes control, enabling more tailored interventions."]}),e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Longitudinal Studies:"})," ","Conduct long-term studies to assess the persistence of the association between comorbidity severity and diabetes control over time."]}),e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Intervention Studies:"})," ","Evaluate the effectiveness of interventions targeting both diabetes and the specific comorbidity to optimize diabetes control."]})]})]})})]})]})}Gx.title="Impact of Comorbidities on Diabetes Control: An Observational Analysis";const g5=[Gx];function x5(){const t=[e.jsx(l,{gap:4,children:e.jsx(i,{children:"Omega-squared () is used to assess the strength of association between multiple groups and a dependent variable; it is commonly used in analysis of variance. It helps researchers to gauge the practical significance of group differences, and it provides a quantitative measure of the impact of the independent variable on the dependent variable."})}),e.jsxs(l,{gap:6,children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Range of "}),e.jsx(i,{children:" values range from 0 to 1, with the following meanings:"})]}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0"})," ","indicates that the independent variable has no effect on the dependent variable (no variance explained)."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"1"})," ","indicates that the independent variable completely accounts for all of the variance in the dependent variable (full variance explained)."]})})]})]}),e.jsxs(l,{gap:6,children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of "}),e.jsx(i,{children:"Interpretation of  is as follows:"})]}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"<0.01:"})," ","Small effect size. This value suggests that the independent variable(s) have a small effect on the dependent variable. Only a tiny portion of the variance in the dependent variable can be attributed to the independent variable(s)."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.01 to 0.06:"})," ","Medium effect size. This value suggests that the independent variable(s) have a moderate effect on the dependent variable. A moderate portion of the variance in the dependent variable can be attributed to the independent variable(s)."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:">0.06:"})," ","Large effect size. This value suggests that the independent variable(s) have a substantial effect on the dependent variable. A significant portion of the variance in the dependent variable can be attributed to the independent variable(s)."]})})]})]})];return e.jsx(G,{explanationSections:t,example1:e.jsx(i,{children:"Example 1 content will go here (e.g., a scatterplot, numerical example, or walkthrough)."})})}function Ux(){return e.jsxs(l,{gap:"md",children:[e.jsx(i,{fs:"italic",mt:0,children:"What is the overall effect of different pain management interventions (standard opioid therapy, multimodal analgesia, and nerve block technique) on post-operative pain scores in patients undergoing knee replacement surgery?"}),e.jsxs(f,{defaultValue:"studyDesign",children:[e.jsxs(f.List,{children:[e.jsx(f.Tab,{value:"studyDesign",children:"Study Design and Methods"}),e.jsx(f.Tab,{value:"effectSize",children:"Effect Size Measure & MCID"}),e.jsx(f.Tab,{value:"result",children:"Result"}),e.jsx(f.Tab,{value:"discussion",children:"Discussion and Future Research"})]}),e.jsx(f.Panel,{value:"studyDesign",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Clinical Research Study Design:"}),e.jsx(i,{children:"Randomized Controlled Trial"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Study Population:"}),e.jsx(i,{children:"The study population comprises 150 adult patients aged 50-80 years who are scheduled for elective knee replacement surgery. They were recruited from orthopedic surgery departments at three academic medical centers. Patients were randomized into three equal groups of 50 participants each."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Variables under Study:"}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Independent/Predictor/Exposure:"}),e.jsx(i,{children:"Pain management intervention type:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:"Group 1: Standard opioid therapy (morphine-based protocol)"}),e.jsx(c.Item,{children:"Group 2: Multimodal analgesia (combination of acetaminophen, NSAIDs, and reduced opioids)"}),e.jsx(c.Item,{children:"Group 3: Nerve block technique (regional anesthesia with femoral nerve block)"})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Dependent/Outcome:"}),e.jsx(i,{children:"Post-operative pain scores measured using Visual Analog Scale (VAS) at 24 hours post-surgery (0-10 scale, where 0 = no pain and 10 = worst pain imaginable)"})]})]})]})}),e.jsx(f.Panel,{value:"effectSize",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Effect Size Measure used in the Analytical Approach"}),e.jsx(i,{children:"omega squared () as the effect size measure to quantify the proportion of the total variance in post-operative pain scores that can be attributed to the overall effect of pain management intervention type. This analysis focuses on understanding how much of the variability in pain outcomes can be explained by the choice of pain management approach across all three groups collectively."}),e.jsx(i,{children:"95% CI to indicate the precision of the estimate of the strength of the association."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Minimal Clinically Important Difference (MCID)"}),e.jsx(i,{children:"A difference of 1.0 point or greater on the VAS pain scale is considered clinically meaningful."})]})]})}),e.jsx(f.Panel,{value:"result",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Point Estimate"}),e.jsx(i,{children:"Mean (SD) VAS pain scores by group:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:"Standard opioid therapy: 6.2 (1.8)"}),e.jsx(c.Item,{children:"Multimodal analgesia: 4.1 (1.5)"}),e.jsx(c.Item,{children:"Nerve block technique: 3.8 (1.3)"})]}),e.jsx(i,{children:"Omega squared () value of 0.18"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Confidence Interval"}),e.jsx(i,{children:"95% CI 0.12 to 0.24"})]})]})}),e.jsx(f.Panel,{value:"discussion",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Results"}),e.jsx(i,{children:"The study provides evidence that the overall effect of pain management intervention type accounts for 18% of the variance in postoperative pain scores. This represents a large effect size, indicating that the choice of pain management approach has a substantial impact on patient pain outcomes."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Implications of Results"}),e.jsx(i,{children:"The results demonstrate that the type of pain management intervention has a clinically meaningful impact on postoperative pain control. The nerve block technique and multimodal analgesia both showed superior pain control compared to standard opioid therapy. The large omega-squared value indicates that the intervention accounts for a substantial portion of the variance in pain outcomes, suggesting that clinical decision-making regarding pain management approach can significantly influence patient experience."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Future Research"}),e.jsx(i,{children:"Future research should investigate the long-term effects of these interventions on functional recovery and patient satisfaction. Additionally, cost-effectiveness analyses comparing these three approaches would inform healthcare policy decisions. Studies examining patient-specific factors that predict optimal response to each intervention type support personalized pain management strategies."})]})]})})]})]})}Ux.title="Effectiveness of Three Pain Management Interventions on Post-Operative Pain Scores: A Randomized Controlled Trial";const v5=[Ux];function y5(){const t=[e.jsxs(l,{gap:6,children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Standardized Beta () Coefficient"}),e.jsx(i,{children:"The standardized beta () coefficient represents the change in the dependent variable (Y) in standard deviation units (z-scores) for a one-standard-deviation change in the predictor variable (X), while holding all other predictor variables constant. Standardized betas allow for a direct comparison of the magnitude of the effects of different predictors in the model, regardless of the units of measurement, which makes it easier to identify which predictor variable has a stronger or weaker impact on the dependent variable in terms of standard deviations."})]}),e.jsxs(l,{gap:4,mt:4,children:[e.jsx(i,{fw:500,children:"Standardized beta coefficients can be positive, negative, or equivalent to 0:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Positive :"})," ","This indicates a positive association between the predictor and the outcome. An increase of one standard deviation in the predictor is associated with an increase in the dependent variable by the magnitude of the standardized beta, assuming all other variables remain constant."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Negative :"})," ","This suggests a negative association. An increase of one standard deviation in the predictor is associated with a decrease in the dependent variable by the magnitude of the standardized beta, given all other variables stay the same."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:" close to 0:"})," ","This implies a weak or no association between the predictor and the outcome when considering other predictors in the model."]})})]}),e.jsx(i,{fw:500,mt:4,children:"The interpretation of a standardized beta coefficient as an absolute value is as follows:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"1.0:"})," ","This suggests that a one-standard-deviation change in the predictor variable corresponds to a one-standard-deviation change in the dependent variable."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"<1.0:"})," ","This suggests that a less than one-standard-deviation (or smaller) change in the predictor variable corresponds to a less than one-standard-deviation change in the dependent variable."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:">1.0:"})," ","This suggests that a more than one-standard-deviation (or larger) change in the predictor variable corresponds to a more than one-standard-deviation change in the dependent variable."]})})]}),e.jsx(i,{mt:4,children:"The magnitude of the beta value reflects the strength of the association. Larger beta values indicate a stronger relationship."})]})]}),e.jsxs(l,{gap:6,children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Unstandardized Beta () Coefficient"}),e.jsx(i,{children:"The unstandardized beta () coefficient represents the change in the dependent variable (Y) for a one-unit change in the predictor variable (X), while holding all other predictor variables constant. The unstandardized beta coefficient provides the specific effect size in the original units of the dependent variable, and it is particularly useful when the predictor variables are measured in different units or have different scales."})]}),e.jsxs(l,{gap:4,mt:4,children:[e.jsx(i,{fw:500,children:"Unstandardized beta coefficients can be positive, negative, or equivalent to 0:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Positive :"})," ","This indicates that, as the independent variable increases by one unit, the dependent variable is expected to increase by the value of the beta coefficient, assuming all other variables remain constant."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Negative :"})," ","This suggests that, as the independent variable increases by one unit, the dependent variable is expected to decrease by the value of the beta coefficient, given all other variables stay the same."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:" = 0:"})," ","This implies that there is no effect of the independent variable on the dependent variable, holding all other predictors constant."]})})]}),e.jsx(i,{mt:4,children:"The magnitude of the beta value reflects the strength of the association. Larger beta values indicate a stronger relationship."})]})]})];return e.jsx(G,{explanationSections:t,example1:e.jsx(i,{children:"Example 1 content will go here (e.g., a scatterplot, numerical example, or walkthrough)."})})}function qx(){return e.jsxs(l,{gap:"md",children:[e.jsx(i,{fs:"italic",mt:0,children:"What is the impact of various demographic (age, gender) and clinical factors (visual acuity, hearing, olfaction, and comorbidity burden) on long-term cognitive performance in elderly adults?"}),e.jsxs(f,{defaultValue:"studyDesign",children:[e.jsxs(f.List,{children:[e.jsx(f.Tab,{value:"studyDesign",children:"Study Design and Methods"}),e.jsx(f.Tab,{value:"effectSize",children:"Effect Size Measure & MCID"}),e.jsx(f.Tab,{value:"result",children:"Result"}),e.jsx(f.Tab,{value:"discussion",children:"Discussion and Future Research"})]}),e.jsx(f.Panel,{value:"studyDesign",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Clinical Research Study Design:"}),e.jsx(i,{children:"Observational"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Study Population:"}),e.jsx(i,{children:"Elderly patients (age > 65 years) with no signs of cognitive impairment."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Variables under Study:"}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Independent/Predictor/Exposure:"}),e.jsx(i,{children:"Age, gender, visual acuity, hearing level, olfaction, and overall severity of comorbidity"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Dependent/Outcome:"}),e.jsx(i,{children:"Cognitive performance as assessed by the Montreal Cognitive Assessment (MoCA)."})]})]})]})}),e.jsx(f.Panel,{value:"effectSize",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Effect Size Measure used in the Analytical Approach"}),e.jsx(i,{children:"Standardized beta coefficients will be used as the effect size measure to assess the independent impact of each independent variable on cognitive performance while controlling for other factors. To analyze the data, a multiple linear regression model is employed, which enables the researcher to quantify the strength of association between each independent variable and cognitive performance while considering the potential confounding effects of other variables."}),e.jsx(i,{children:"The width of the confidence intervals associated with the standardized beta estimates reflects the precision of these estimates."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Minimal Clinically Important Difference (MCID)"}),e.jsx(i,{children:"Not applicable"})]})]})}),e.jsx(f.Panel,{value:"result",pt:"md",children:e.jsxs(l,{gap:"sm",children:[e.jsx(i,{fw:500,children:"Point Estimate and 95% CI"}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Age (in years):"}),e.jsx(i,{children:"The standardized beta coefficient for age is -0.30. This suggests that, on average, a one-year increase in age is associated with a 0.30 standard deviation decrease in cognitive performance after adjusting for other factors."}),e.jsx(i,{children:"The 95% confidence interval for this coefficient (-0.22 to -0.38) suggests that the estimate is imprecise."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Gender:"}),e.jsx(i,{children:"The standardized beta coefficient for gender is 0.05. This indicates that gender has a very small impact on cognitive performance."}),e.jsx(i,{children:"The wide confidence interval (-0.03 to 0.13) suggests weak precision."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Baseline Visual Acuity:"}),e.jsx(i,{children:"The standardized beta coefficient for baseline visual acuity is 0.06. This demonstrates a weak positive association, where patients with better baseline visual acuity tend to have better cognitive performance."}),e.jsx(i,{children:"The 95% confidence interval (-0.01 to 0.13) indicates relatively modest imprecision."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Hearing Level:"}),e.jsx(i,{children:"The standardized beta coefficient for hearing level is 0.18. This demonstrates a strong positive association, where patients with better baseline hearing level tend to have better long-term cognitive performance."}),e.jsx(i,{children:"The 95% confidence interval (0.12 to 0.24) suggests relatively modest precision."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Olfaction:"}),e.jsx(i,{children:"The standardized beta coefficient for olfaction is 0.20. This demonstrates a strong positive association, where patients with better olfaction tend to have better long-term cognitive performance."}),e.jsx(i,{children:"The 95% confidence interval (0.15 to 0.28) suggests relatively modest precision."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Comorbidity Burden (None, Mild, Moderate, or Severe):"}),e.jsx(i,{children:"The standardized beta coefficient for comorbidity burden is -0.10. For each increase in comorbidity severity, patients tend to have worse cognitive performance."}),e.jsx(i,{children:"The 95% confidence interval (-0.25 to 0.05) suggests moderate precision."})]})]})}),e.jsx(f.Panel,{value:"discussion",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Results"}),e.jsx(i,{children:"These findings provide insights into the impact of various demographic and clinical factors on long-term cognitive performance in elderly adults. Age, hearing level, olfaction, and comorbidity burden all show significant associations with cognitive performance."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Implications of Results"}),e.jsx(i,{children:"These findings can help clinicians identify elderly patients at higher risk for cognitive decline."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Future Research"}),e.jsx(i,{children:"Future studies could consider evaluating additional factors that may influence cognitive performance, such as lifestyle factors (e.g., physical activity, education), genetic factors, and social determinants of health. Overall, these findings contribute to the understanding of factors influencing cognitive performance in the elderly population and inform potential interventions and directions for further research in this field."})]})]})})]})]})}qx.title="Impact of Demographic and Clinical Factors on Long-Term Cognitive Performance in Elderly Adult Patients";function Wx(){return e.jsxs(l,{gap:"md",children:[e.jsx(i,{fs:"italic",mt:0,children:"What is the relationship between weekly exercise duration, dietary adherence, and baseline BMI on weight loss outcomes in adults participating in a structured weight management program?"}),e.jsxs(f,{defaultValue:"studyDesign",children:[e.jsxs(f.List,{children:[e.jsx(f.Tab,{value:"studyDesign",children:"Study Design and Methods"}),e.jsx(f.Tab,{value:"effectSize",children:"Effect Size Measure & MCID"}),e.jsx(f.Tab,{value:"result",children:"Result"}),e.jsx(f.Tab,{value:"discussion",children:"Discussion and Future Research"})]}),e.jsx(f.Panel,{value:"studyDesign",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Clinical Research Study Design:"}),e.jsx(i,{children:"Prospective cohort study"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Study Population:"}),e.jsx(i,{children:"200 adults aged 25-55 years enrolled in a 12-week structured weight management program at a community health center. Participants had baseline BMI between 25-40 kg/m and no contraindications to moderate exercise."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Variables under Study:"}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Independent/Predictor/Exposure:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:"Weekly exercise duration (measured in hours per week)"}),e.jsx(c.Item,{children:"Dietary adherence score (measured as percentage adherence to prescribed meal plan, 0-100%)"}),e.jsx(c.Item,{children:"Baseline BMI (measured in kg/m)"})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Dependent/Outcome:"}),e.jsx(i,{children:"Weight loss (measured in kilograms) at 12 weeks"})]})]})]})}),e.jsx(f.Panel,{value:"effectSize",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Effect Size Measure used in the Analytical Approach"}),e.jsx(i,{children:"Unstandardized beta coefficients will be used as the effect size measure to assess the independent impact of each predictor variable on weight loss while controlling for other factors. Multiple linear regression analysis will quantify the expected change in weight loss (in kilograms) for each unit change in the predictor variables."}),e.jsx(i,{children:"The unstandardized beta coefficients will provide clinically meaningful estimates that can be directly applied to patient counseling and program planning."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Minimal Clinically Important Difference (MCID)"}),e.jsx(i,{children:"A weight loss of 2.0 kg or greater is considered clinically meaningful for health benefits."})]})]})}),e.jsx(f.Panel,{value:"result",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsx(i,{fw:500,children:"Point Estimate and 95% CI"}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Weekly Exercise Duration (hours per week):"}),e.jsx(i,{children:"The unstandardized beta coefficient is -1.2 kg/h. This indicates that for each additional hour of exercise per week, participants lost an average of 1.2 kg, controlling for other factors."}),e.jsx(i,{children:"95% CI: -1.5 to -0.9 kg per hour"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Dietary Adherence Score (percentage):"}),e.jsx(i,{children:"The unstandardized beta coefficient is -0.08 kg per percentage point. This suggests that for each 1% increase in dietary adherence, participants lost an additional 0.08 kg on average."}),e.jsx(i,{children:"95% CI: -0.12 to -0.04 kg per percentage point"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Baseline BMI (kg/m):"}),e.jsx(i,{children:"The unstandardized beta coefficient is -0.3 kg per unit increase in BMI. This indicates that for each unit increase in baseline BMI, participants lost an additional 0.3 kilograms on average, suggesting that individuals with higher starting BMI experienced greater absolute weight loss."}),e.jsx(i,{children:"95% CI: -0.5 to -0.1 kg per BMI unit"})]})]})}),e.jsx(f.Panel,{value:"discussion",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Results"}),e.jsx(i,{children:"The unstandardized beta coefficients provide practical, clinically relevant information about weight loss expectations. Exercise duration showed the strongest association with weight loss, with each additional hour of weekly exercise associated with 1.2 kg of additional weight loss over the 12 weeks."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Implications of Results"}),e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Clinical Practice:"})," ","Healthcare providers can use these estimates to set realistic expectations with patients. For example, a patient who increases exercise from 2 to 5 hours per week (a 3-hour increase) could expect approximately 3.6 kg (3  1.2 kg) of additional weight loss, assuming other factors remain constant."]}),e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Program Planning:"})," ","The results suggest that exercise duration is the most modifiable factor for achieving clinically meaningful weight loss. Increasing weekly exercise by just 2 hours would be expected to produce 2.4 kg additional weight loss, exceeding the MCID threshold."]}),e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Patient Counseling:"})," ","The dietary adherence coefficient indicates that achieving 100% adherence (versus 75% adherence) would result in an additional 2.0 kg weight loss (25%  0.08 kg), which meets the clinical significance threshold."]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Future Research"}),e.jsx(i,{children:"Future studies should investigate dose-response relationships for different types of exercise and examine whether the effects of exercise duration and dietary adherence are sustained beyond the initial 12-week intervention period. Long-term follow-up studies would help determine whether these relationships persist in maintaining weight."})]})]})})]})]})}Wx.title="Impact of Exercise Duration on Weight Loss in Adult Participants: A 12-Week Intervention Study";const j5=[qx,Wx];function w5(){const t=[e.jsxs(l,{gap:6,children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Part Correlation"}),e.jsx(i,{children:"Part correlation (also known as semipartial correlation) measures the unique contribution of one predictor variable to the variance in the dependent variable, while controlling for the effects of other predictor variables. It quantifies the relationship between a predictor and the outcome that is not shared with other predictors in the model."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Partial Correlation"}),e.jsx(i,{children:"Partial correlation measures the relationship between two variables while controlling for the effects of one or more other variables. It quantifies the association between a predictor and the outcome after removing the variance that is shared with the control variables."})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation"}),e.jsx(i,{children:"Both part and partial correlations range from -1 to +1, with values closer to 1 indicating stronger relationships. Positive values indicate positive associations, while negative values indicate negative associations. These measures help researchers understand the unique contribution of each predictor variable in a multiple regression model."})]})];return e.jsx(G,{explanationSections:t,example1:e.jsx(i,{children:"Example 1 content will go here (e.g., a scatterplot, numerical example, or walkthrough)."})})}function Qx(){return e.jsxs(l,{gap:"md",children:[e.jsx(i,{fs:"italic",mt:0,children:"Among individuals diagnosed with generalized anxiety disorder (GAD), does participation in a 12-week aerobic exercise program lead to a greater reduction in anxiety levels compared to standard care without exercise?"}),e.jsxs(f,{defaultValue:"studyDesign",children:[e.jsxs(f.List,{children:[e.jsx(f.Tab,{value:"studyDesign",children:"Study Design and Methods"}),e.jsx(f.Tab,{value:"effectSize",children:"Effect Size Measure & MCID"}),e.jsx(f.Tab,{value:"result",children:"Result"}),e.jsx(f.Tab,{value:"discussion",children:"Discussion and Future Research"})]}),e.jsx(f.Panel,{value:"studyDesign",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Clinical Research Study Design:"}),e.jsx(i,{children:"Randomized clinical trial"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Study Population:"}),e.jsx(i,{children:"The study population consists of 200 adults diagnosed with generalized anxiety disorder (GAD). These participants were identified through clinical settings, such as mental health clinics or hospitals, where they received a diagnosis based on standardized criteria for GAD."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Variables under Study:"}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Independent/Predictor/Exposure:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:"Primary Independent Variable: Exercise participation (exercise group vs. control group)."}),e.jsx(c.Item,{children:"Confounding Variables: Age, gender, medication use."})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Dependent/Outcome:"}),e.jsx(i,{children:"Change in anxiety scores, measured by the Hamilton Anxiety Rating Scale (HARS)."})]})]})]})}),e.jsx(f.Panel,{value:"effectSize",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Effect Size Measure used in the Analytical Approach"}),e.jsx(i,{children:"Part correlation is used as the effect size measure to quantify the unique contribution of exercise participation to the reduction in anxiety levels among individuals with generalized anxiety disorder (GAD), while controlling for the effects of other potential confounding variables such as age, gender, and medication use. By controlling for the effects of age, gender, and medication use, part correlation helps isolate the specific impact of exercise on anxiety reduction, ensuring that these other variables do not confound the observed effect."}),e.jsx(i,{children:"The 95% confidence interval (CI) around the part correlation coefficient provides a range within which the true value of the part correlation is expected to lie with 95% confidence. This interval offers additional context to the point estimate, indicating the precision and reliability of the measured effect size."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Minimal Clinically Important Difference (MCID)"}),e.jsx(i,{children:"Not applicable"})]})]})}),e.jsx(f.Panel,{value:"result",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Point Estimate"}),e.jsxs(i,{children:["The part correlation coefficient (",e.jsx(i,{span:!0,fs:"italic",children:"r"}),"_part) for anxiety was found to be -0.40 (",e.jsx(i,{span:!0,fs:"italic",children:"p"})," ","< 0.01)"]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Confidence Interval"}),e.jsx(i,{children:"95% CI = -0.55 to -0.25"})]})]})}),e.jsx(f.Panel,{value:"discussion",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Results"}),e.jsx(i,{children:"The results of the study suggest that there is a moderate negative association between exercise participation and the reduction in anxiety levels among individuals with GAD, even when controlling for the effects of age, gender, and medication use. Specifically, the part correlation of -0.40 indicates that participants in the 12-week exercise program experienced a significant reduction in their anxiety levels compared to those who did not engage in the exercise program. This significant reduction in anxiety, as measured by the HARS, highlights the therapeutic potential of exercise as an adjunctive treatment for GAD."}),e.jsx(i,{children:"The 95% confidence interval (CI) around this point estimate is very precise, meaning the true value of the effect is confidently estimated to be close to -0.40. The consistent negative values within the CI imply that exercise has a reliably negative association with anxiety levels. Even the lower bound of -0.25 still suggests a meaningful reduction in anxiety due to exercise."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Implications of Results"}),e.jsx(i,{children:"The findings imply that incorporating regular aerobic exercise into the treatment regimen for individuals with GAD can be beneficial in reducing anxiety levels. Given the moderate effect size and the precision of the results, healthcare providers might consider recommending exercise as part of a comprehensive treatment plan for GAD."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Future Research"}),e.jsx(i,{children:"Future research should investigate whether the anxiety-reducing benefits of exercise are sustained over extended periods beyond the initial 12 weeks. Additional studies could explore the effects of various forms of exercise, such as strength training and yoga, on anxiety to identify specific activities that are particularly effective for anxiety reduction."})]})]})})]})]})}Qx.title="The Impact of Exercise on Anxiety Levels: A Randomized Controlled Trial";function Yx(){return e.jsxs(l,{gap:"md",children:[e.jsx(i,{fs:"italic",mt:0,children:"What is the unique contribution of a low-sodium diet in reducing blood pressure among individuals with hypertension, while controlling for the effects of physical activity, age, and medication use?"}),e.jsxs(f,{defaultValue:"studyDesign",children:[e.jsxs(f.List,{children:[e.jsx(f.Tab,{value:"studyDesign",children:"Study Design and Methods"}),e.jsx(f.Tab,{value:"effectSize",children:"Effect Size Measure & MCID"}),e.jsx(f.Tab,{value:"result",children:"Result"}),e.jsx(f.Tab,{value:"discussion",children:"Discussion and Future Research"})]}),e.jsx(f.Panel,{value:"studyDesign",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Clinical Research Study Design:"}),e.jsx(i,{children:"Randomized Clinical Trial"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Study Population:"}),e.jsx(i,{children:"225 adults diagnosed with hypertension. These participants were identified through clinical settings, such as primary care clinics or hospitals, where they received a diagnosis based on standardized criteria for hypertension."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Variables under Study:"}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Independent/Predictor/Exposure:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:"Primary Independent Variable: Low-sodium diet adherence (low-sodium diet group vs. control group)."}),e.jsx(c.Item,{children:"Confounding variables include physical activity levels, age, and medication use."})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Dependent/Outcome:"}),e.jsx(i,{children:"Change in blood pressure levels."})]})]})]})}),e.jsx(f.Panel,{value:"effectSize",pt:"md",children:e.jsx(l,{gap:"md",children:e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Effect Size Measure used in the Analytical Approach"}),e.jsx(i,{children:"Partial correlation coefficients are used to quantify the unique contribution of low-sodium diet adherence to blood pressure reduction while controlling for the effects of physical activity, age, and medication use. Multiple regression analysis will build a predictive model for treatment response, with partial coefficients calculated for each predictor variable to assess their individual contributions while accounting for the effects of other variables in the model."}),e.jsx(i,{children:"95% confidence intervals around each partial coefficient will assess the precision of the estimates."})]})})}),e.jsx(f.Panel,{value:"result",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Point Estimate"}),e.jsxs(i,{children:["The partial correlation coefficient (",e.jsx(i,{span:!0,fs:"italic",children:"r"}),"_partial) for blood pressure was found to be -0.35 (",e.jsx(i,{span:!0,fs:"italic",children:"p"}),"-value < 0.01)"]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Confidence Interval"}),e.jsx(i,{children:"The 95% CI ranges from -0.45 to -0.25."})]})]})}),e.jsx(f.Panel,{value:"discussion",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Results"}),e.jsx(i,{children:"The results suggest that there is a moderate negative association between low-sodium diet adherence and the reduction in blood pressure levels among individuals with hypertension, even when controlling for the effects of physical activity, age, and medication use. Specifically, the partial correlation of -0.35 indicates that those who adhered to the low-sodium diet experienced a significant reduction in their blood pressure levels compared to those who did not, independent of the effects of physical activity, age, and medication use."}),e.jsx(i,{children:"The 95% confidence interval (CI) around this point estimate is very precise, meaning the true value of the effect is confidently estimated to be close to -0.35."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Implications of Results"}),e.jsx(i,{children:"The findings imply that incorporating a low-sodium diet into the treatment regimen for individuals with hypertension can be beneficial in reducing blood pressure levels. Given the moderate effect size and the precision of the results, healthcare providers might consider recommending dietary interventions as part of a comprehensive treatment plan for hypertension."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Future Research"}),e.jsx(i,{children:"Future research should examine whether the blood pressure-lowering effects of a low-sodium diet are maintained over longer periods, such as six months or a year. Additional studies could investigate the effects of various dietary interventions, such as the DASH diet, Mediterranean diet, or plant-based diets, on blood pressure to identify which dietary patterns are most effective."})]})]})})]})]})}Yx.title="The Impact of Dietary Interventions on Blood Pressure: A Randomized Controlled Trial";const b5=[Qx,Yx];function S5(){const t=[e.jsx(l,{gap:4,children:e.jsx(i,{children:"Least square (LS) means are used to estimate and compare group means in a regression model, particularly in the context of analysis of variance or linear regression. LS means are useful when dealing with complex models involving multiple predictors, including categorical variables or interactions. The LS means represent the average predicted values of the outcome variable for each level of the categorical predictor when considering the model's full set of predictors and covariates. In simpler terms, LS means offer a way to estimate what the group means would be if all groups had the same covariate values; this allows for a fairer comparison between groups."})}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation"}),e.jsx(i,{children:"For interpretation of the precision of LS means, consider the associated confidence intervals (CIs). Narrower CIs indicate more precise estimates, whereas wider CIs suggest greater uncertainty. In addition, interpretation depends on the context of the study itself. In the case of a treatment or intervention study, differences in LS means can suggest the effectiveness of one treatment over another after accounting for other variables. In observational studies, they can show differences between groups when other factors are held constant."})]})];return e.jsx(G,{explanationSections:t,example1:e.jsx(i,{children:"Example 1 content will go here (e.g., a scatterplot, numerical example, or walkthrough)."})})}function Kx(){return e.jsxs(l,{gap:"md",children:[e.jsx(i,{fs:"italic",mt:0,children:"Among adults between the ages of 65 and 80 who are interested in improving cardiovascular fitness, what is the impact of three different types of exercise  Aerobic, Strength, and Flexibility on improvement in cardiovascular fitness as measured by increased VO2 max (a common measure of cardiovascular endurance)?"}),e.jsxs(f,{defaultValue:"studyDesign",children:[e.jsxs(f.List,{children:[e.jsx(f.Tab,{value:"studyDesign",children:"Study Design and Methods"}),e.jsx(f.Tab,{value:"effectSize",children:"Effect Size Measure & MCID"}),e.jsx(f.Tab,{value:"result",children:"Result"}),e.jsx(f.Tab,{value:"discussion",children:"Discussion and Future Research"})]}),e.jsx(f.Panel,{value:"studyDesign",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Clinical Research Study Design:"}),e.jsx(i,{children:"Randomized clinical trial"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Study Population:"}),e.jsx(i,{children:"Participants were recruited from the local community, and a total of 150 adults (75 male and 75 female) were included."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Variables under Study:"}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Independent/Predictor/Exposure:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:"Aerobic Exercise Group: Engaged in supervised aerobic exercises (e.g., running, cycling) for 45 minutes, three times a week."}),e.jsx(c.Item,{children:"Strength Exercise Group: Participated in strength training (e.g., weightlifting) for 45 minutes, three times a week."}),e.jsx(c.Item,{children:"Flexibility Exercise Group: Focused on flexibility exercises (e.g., yoga, stretching) for 45 minutes, three times a week."})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Dependent/Outcome:"}),e.jsx(i,{children:"Improvement in cardiovascular fitness was assessed by measuring the change in participants' VO2 max before and after the 12-week exercise program."})]})]})]})}),e.jsx(f.Panel,{value:"effectSize",pt:"md",children:e.jsx(l,{gap:"md",children:e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Effect Size Measure used in the Analytical Approach"}),e.jsx(i,{children:"A linear regression model was used to analyze the data, with exercise type (categorical: Aerobic, Strength, Flexibility), age (continuous), and gender (categorical: Male, Female) as predictor variables. Least Square Means (LS Means) were calculated to estimate the average predicted values of VO2 max improvement for each exercise group while controlling for age and gender."}),e.jsx(i,{children:"95% confidence intervals (CIs) were generated around the LS Means as a measure of the precision of the estimates."})]})})}),e.jsx(f.Panel,{value:"result",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Point Estimate"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:"Aerobic Exercise Group: LS Mean: 8.7 ml/kg/min (95% CI [7.8 to 9.6])"}),e.jsx(c.Item,{children:"Strength Exercise Group: LS Mean: 7.9 ml/kg/min (95% CI [6.9 to 8.9])"}),e.jsx(c.Item,{children:"Flexibility Exercise Group: LS Mean: 7.5 ml/kg/min (95% CI [6.6 to 8.4])"})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Confidence Interval"}),e.jsx(i,{children:"All three LS Means have wide 95% CIs, indicating low precision in the estimates. Hence, no definitive conclusions can be made about the true benefit of the three different types of exercise."})]})]})}),e.jsx(f.Panel,{value:"discussion",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Results"}),e.jsx(i,{children:"Although the study suggests some potential effects of aerobic exercise on improving cardiovascular fitness when compared to the strength and flexibility exercises, the imprecision of the estimates prevents making definitive conclusions."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Implications of Results"}),e.jsx(i,{children:"At this time, no specific recommendation about a particular training program should be made based on the results from this study."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Future Research"}),e.jsx(i,{children:"Given the observed magnitude of the difference in the change in participants' VO2 max before and after the 12-week exercise program among the three different exercise groups, which appears to be substantial and potentially clinically significant, it is recommended that further studies with larger sample sizes be considered to enhance the precision of the estimate."})]})]})})]})]})}Kx.title="Impact of Three Exercise Types on Cardiovascular Fitness in Older Adults";function Xx(){return e.jsxs(l,{gap:"md",children:[e.jsx(i,{fs:"italic",mt:0,children:"Among adults between the ages of 40 and 65, what is the impact of cigarette smoking on lung function?"}),e.jsxs(f,{defaultValue:"studyDesign",children:[e.jsxs(f.List,{children:[e.jsx(f.Tab,{value:"studyDesign",children:"Study Design and Methods"}),e.jsx(f.Tab,{value:"effectSize",children:"Effect Size Measure & MCID"}),e.jsx(f.Tab,{value:"result",children:"Result"}),e.jsx(f.Tab,{value:"discussion",children:"Discussion and Future Research"})]}),e.jsx(f.Panel,{value:"studyDesign",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Clinical Research Study Design:"}),e.jsx(i,{children:"Observational cohort"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Study Population:"}),e.jsx(i,{children:"Cohort of 1,000 adults aged 40-65 recruited from the general population."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Variables under Study:"}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Independent/Predictor/Exposure:"}),e.jsx(i,{children:"Smoking Status: Participants are categorized into three groups based on their smoking status:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:"Non-Smokers"}),e.jsx(c.Item,{children:"Current Smokers"}),e.jsx(c.Item,{children:"Former Smokers"})]}),e.jsx(i,{children:"Potential Confounding Variables:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:"Age"}),e.jsx(c.Item,{children:"Gender"}),e.jsx(c.Item,{children:"Body Mass Index (BMI)"}),e.jsx(c.Item,{children:"Occupational Exposure to Lung Irritants (e.g., occupational dust or fumes)"}),e.jsx(c.Item,{children:"Socioeconomic Status (e.g., income, education)"})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Dependent/Outcome:"}),e.jsx(i,{children:"Lung function as measured by Forced Expiratory Volume in one second (FEV1), a common marker of lung health."})]})]})]})}),e.jsx(f.Panel,{value:"effectSize",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Effect Size Measure used in the Analytical Approach"}),e.jsx(i,{children:"A multiple linear regression model is used to examine the relationship between smoking status and lung function (FEV1), while controlling for potential confounding variables. LS Means are calculated for each smoking status group (Non-Smokers, Current Smokers, Former Smokers) to estimate the adjusted means of FEV1, considering the influence of age, gender, BMI, occupational exposure, and socioeconomic status. 95% confidence intervals (CIs) are reported around the LS Means, indicating precise estimates."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Minimal Clinically Important Difference"}),e.jsx(i,{children:"In general, a difference in FEV1 of at least 150 milliliters (0.15 liters) or more has been suggested as a clinically meaningful difference."})]})]})}),e.jsx(f.Panel,{value:"result",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Point Estimate"}),e.jsx(i,{children:"The study reports the following LS Means for FEV1, along with 95% CIs:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:"Non-Smokers: LS Mean FEV1 = 2.94 L (95% CI [2.92, 2.96])"}),e.jsx(c.Item,{children:"Former Smokers: LS Mean FEV1 = 2.78 L (95% CI [2.77, 2.79])"}),e.jsx(c.Item,{children:"Current Smokers: LS Mean FEV1 = 2.60 L (95% CI [2.58, 2.62])"})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Confidence Interval"}),e.jsx(i,{children:"The confidence intervals are quite narrow, indicating precise estimates."})]})]})}),e.jsx(f.Panel,{value:"discussion",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Results"}),e.jsx(i,{children:"Non-Smokers have the highest adjusted LS Mean FEV1 (2.94 L) followed by Former Smokers (2.78 L). Current Smokers have the lowest adjusted LS Mean FEV1 (2.60 L). The differences between Non-Smokers and Former Smokers (0.16 L) and Former Smokers and Current Smokers (0.18 L) are considered clinically meaningful."}),e.jsx(i,{children:"These LS Means are adjusted for potential confounding variables."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Implications of Results"}),e.jsx(i,{children:"Controlling for confounding variables in the analysis enables the researcher to estimate the true impact of smoking on lung function, independent of factors such as age, gender, BMI, occupational exposure, and socioeconomic status. The precise LS Means (as demonstrated by the narrow CIs) enhance the reliability of the estimates, providing more confidence in the observed associations and their clinical significance."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Future Research"}),e.jsx(i,{children:"Future studies could include longitudinal follow-up to assess the trajectory of lung function decline in smokers over several decades, a comparative analysis of various smoking patterns, including intensity and duration, an exploration of behavioral and psychosocial factors, and an investigation of genetic factors that may influence individual susceptibility to lung function decline due to smoking."})]})]})})]})]})}Xx.title="Impact of Cigarette Smoking on Lung Function in Middle-Aged Adults";const I5=[Kx,Xx];function C5(){const t=[e.jsx(l,{gap:4,children:e.jsx(i,{children:"The coefficient of determination (R) is an effect size measure used in regression analysis. It quantifies the proportion of the total variance in the dependent variable that is explained by the independent variables included in the regression model. R is used to assess the goodness of fit of the model and the proportion of variance in the dependent variable that can be attributed to the predictors."})}),e.jsxs(l,{gap:6,children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Range of R"}),e.jsx(i,{children:"R values range from 0 to 1:"})]}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:["An R of"," ",e.jsx(i,{span:!0,fw:500,children:"0"})," ","indicates that the model explains none of the variance in the dependent variable."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:["An R of"," ",e.jsx(i,{span:!0,fw:500,children:"1.0"})," ","suggests that the model explains all of the variance, which means that the model perfectly predicts the dependent variable."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:["A"," ",e.jsx(i,{span:!0,fw:500,children:"higher R value"})," ","suggests that the model is better at explaining and predicting the dependent variable."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:["A"," ",e.jsx(i,{span:!0,fw:500,children:"lower R value"})," ","implies that there may be factors that are unaccounted for or a measurement error that affects the model's ability to explain the variance."]})})]})]}),e.jsxs(l,{gap:6,children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of R values"}),e.jsx(i,{children:"The interpretation of R values is as follows:"})]}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"<0.30:"})," ","Low R. This indicates that only a small proportion of the variance in the dependent variable is explained by the independent variables. The model may not fit the data well or may lack important predictors."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.30 to 0.70:"})," ","Moderate R. This indicates that a substantial proportion of the variance in the dependent variable is explained by the independent variables. The model provides a reasonable fit to the data, but there is still unexplained variance."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:">0.70:"})," ","High R. This indicates that a large proportion of the variance in the dependent variable is explained by the independent variables. The model provides a strong fit to the data, and the predictors have a substantial influence on the dependent variable."]})})]})]})];return e.jsx(G,{explanationSections:t,example1:e.jsx(i,{children:"Example 1 content will go here (e.g., a scatterplot, numerical example, or walkthrough)."})})}function Zx(){return e.jsxs(l,{gap:"md",children:[e.jsx(i,{fs:"italic",mt:0,children:"How much of the variance in medication adherence for rheumatoid arthritis can be explained by patient characteristics (age, gender, education level, work status), social support, and medication regimen complexity?"}),e.jsxs(f,{defaultValue:"studyDesign",children:[e.jsxs(f.List,{children:[e.jsx(f.Tab,{value:"studyDesign",children:"Study Design and Methods"}),e.jsx(f.Tab,{value:"effectSize",children:"Effect Size Measure & MCID"}),e.jsx(f.Tab,{value:"result",children:"Result"}),e.jsx(f.Tab,{value:"discussion",children:"Discussion and Future Research"})]}),e.jsx(f.Panel,{value:"studyDesign",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Clinical Research Study Design:"}),e.jsx(i,{children:"Observational study"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Study Population:"}),e.jsx(i,{children:"250 adults with rheumatoid arthritis were identified and recruited from a general medical clinic with rheumatoid arthritis."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Variables under Study:"}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Independent/Predictor/Exposure:"}),e.jsx(i,{children:"Patient characteristics (age, gender, educational level), social support, and medication regimen complexity"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Dependent/Outcome:"}),e.jsx(i,{children:"Medication adherence defined as the percentage of days per month the participant uses medication."})]})]})]})}),e.jsx(f.Panel,{value:"effectSize",pt:"md",children:e.jsx(l,{gap:"md",children:e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Effect Size Measure used in the Analytical Approach"}),e.jsx(i,{children:"The R-squared (R) will be used as the effect size measure to quantify the proportion of variance in medication adherence explained by the independent variables included in the regression model."}),e.jsx(i,{children:"R-squared, also known as the coefficient of determination, ranges from 0 to 1."})]})})}),e.jsx(f.Panel,{value:"result",pt:"md",children:e.jsx(l,{gap:"md",children:e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Point Estimate"}),e.jsx(i,{children:"The R-squared value for this study is 0.50, indicating that approximately 50% of the variance in medication adherence can be explained by the variables included in the model."})]})})}),e.jsx(f.Panel,{value:"discussion",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Results"}),e.jsx(i,{children:"The R-squared value of 0.50 indicates that the independent variables account for a substantial portion of the variance in medication adherence among individuals with rheumatoid arthritis. This indicates a reasonable fit of the model to the data; however, there is still unexplained variance, suggesting the presence of other factors that influence medication adherence."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Implications of Results"}),e.jsx(i,{children:"The R-squared value of 0.50 indicates a moderate level of goodness of fit, where 50% of the variance in medication adherence is accounted for by the variables considered in the model. It suggests that the model can reasonably explain adherence behaviors but acknowledges the presence of factors not included in the model that may also impact medication adherence."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Future Research"}),e.jsx(i,{children:"The study findings highlight the importance of patient characteristics, social support, and medication regimen complexity in explaining medication adherence among patients with rheumatoid arthritis. Future research could focus on identifying additional factors that contribute to adherence, such as psychological factors, healthcare provider-patient communication, or treatment-related barriers. Moreover, interventions targeting the identified factors could be explored to improve medication adherence among individuals with rheumatoid arthritis."})]})]})})]})]})}Zx.title="Exploring the Influence of Patient Characteristics, Social Support, and Medication Regimen Complexity on Medication Adherence in a Cohort of Individuals with Rheumatoid Arthritis";const T5=[Zx];function R5(){const t=[e.jsx(l,{gap:4,children:e.jsx(i,{children:"Adjusted R-squared (R) is a statistical metric used to measure the proportion of variance in the dependent variable that is explained by the independent variables in a regression model. It is a modified version of the traditional R (coefficient of determination) that takes into account the number of predictors in the model. The adjusted R provides a more realistic and conservative estimate of the model's goodness of fit as compared with the traditional R."})}),e.jsxs(l,{gap:6,children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Range of adjusted R"}),e.jsx(i,{children:"The values for the adjusted R range from 0 to 1:"})]}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"High adjusted R:"})," ","A value closer to 1 indicates that a large proportion of the variance in the dependent variable is explained by the independent variables in the model, after accounting for the number of predictors and the sample size. This suggests that the model is a good fit for the data."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Low adjusted R:"})," ","A value closer to 0 suggests that the model is not explaining much of the variance in the dependent variable, considering the number of predictors and sample size. It may indicate that the model needs improvement or that there are factors that have not been accounted for that are affecting the outcome."]})})]})]}),e.jsxs(l,{gap:6,children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of adjusted R values"}),e.jsx(i,{children:"The interpretation of adjusted R values is as follows:"})]}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.00 to 0.19:"})," ","Very weak explanatory power"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.20 to 0.39:"})," ","Weak explanatory power"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.40 to 0.59:"})," ","Moderate explanatory power"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.60 to 0.79:"})," ","Strong explanatory power"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.80 to 1.00:"})," ","Very strong explanatory power"]})})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Comparing Models"}),e.jsx(i,{children:"The adjusted R is useful for comparing different regression models. When comparing models with similar numbers of predictors, a higher adjusted R indicates a better fit."})]}),e.jsxs(l,{gap:0,mt:4,children:[e.jsx(i,{fw:500,children:"Model Parsimony"}),e.jsx(i,{children:"The adjusted R penalizes the inclusion of additional predictors that do not contribute significantly to explaining the variance in the outcome. Therefore, it encourages model parsimony by favoring models with fewer predictors that still provide a good fit."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Summary"}),e.jsx(i,{children:"In summary, the adjusted R is a valuable metric for assessing the goodness of fit of a regression model while considering model complexity. It provides a more balanced perspective on model performance than the traditional R, as it adjusts for the number of predictors and sample size. It is important to remember that a high adjusted R does not necessarily mean that the model is the best one, and it does not indicate causality."})]})];return e.jsx(G,{explanationSections:t,example1:e.jsx(i,{children:"Example 1 content will go here (e.g., a scatterplot, numerical example, or walkthrough)."})})}function Jx(){return e.jsxs(l,{gap:"md",children:[e.jsx(i,{fs:"italic",mt:0,children:"How much variation in 5-year mortality for older adults can be defined by demographic data, lifestyle factors, and genetic markers."}),e.jsxs(f,{defaultValue:"studyDesign",children:[e.jsxs(f.List,{children:[e.jsx(f.Tab,{value:"studyDesign",children:"Study Design and Methods"}),e.jsx(f.Tab,{value:"effectSize",children:"Effect Size Measure & MCID"}),e.jsx(f.Tab,{value:"result",children:"Result"}),e.jsx(f.Tab,{value:"discussion",children:"Discussion and Future Research"})]}),e.jsx(f.Panel,{value:"studyDesign",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Clinical Research Study Design:"}),e.jsx(i,{children:"Cohort study"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Study Population:"}),e.jsx(i,{children:"1000 adults recruited from a large urban healthcare center."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Variables under Study:"}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Independent / Predictor/Exposure:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:"Demographic data (age, gender, race/ethnicity, socioeconomic status)"}),e.jsx(c.Item,{children:"Lifestyle factors (smoking status, physical activity, diet)"}),e.jsx(c.Item,{children:"Genetic markers (identified through genotyping)."})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Dependent/ Outcome"}),e.jsx(i,{children:"The primary outcome is mortality, measured as the occurrence of death within the 5-year follow-up period after baseline assessment."})]})]})]})}),e.jsx(f.Panel,{value:"effectSize",pt:"md",children:e.jsx(l,{gap:"md",children:e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Effect size Measure used in the Analytical Approach"}),e.jsx(i,{children:"Conduct a multiple regression analysis where mortality is the dependent variable, and demographics, lifestyle factors, and genetic markers are independent variables. Calculate the adjusted R-squared value from the multiple regression model. Account for potential confounding variables such as baseline health status, comorbidities (e.g., diabetes, hypertension), and access to healthcare."})]})})}),e.jsx(f.Panel,{value:"result",pt:"md",children:e.jsx(l,{gap:"md",children:e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Point Estimate"}),e.jsx(i,{children:"Adjusted R-squared: 0.55."})]})})}),e.jsx(f.Panel,{value:"discussion",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Results"}),e.jsx(i,{children:"The adjusted R-squared value of 0.55 indicates that approximately 55% of the variance in mortality can be explained by the predictors  demographics, lifestyle factors, and genetic markers, while adjusting for confounding variables. This suggests that the model has substantial explanatory power. Demographic characteristics, lifestyle choices, and genetic markers collectively provide valuable information for predicting mortality in this population."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Implications of Results"}),e.jsx(i,{children:"The study suggests that a combination of factors, including demographics, lifestyle, and genetics, plays a significant role in predicting mortality. Understanding these predictors can help identify individuals at higher risk and potentially inform targeted preventive strategies. The results could guide the development of personalized healthcare interventions tailored to an individual's risk profile, including lifestyle modifications and genetic counseling."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Future Research"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:"Conduct longitudinal studies to assess the predictive value of these factors over longer periods and explore potential changes in the significance of predictors over time."}),e.jsx(c.Item,{children:"Validate the predictive model in different populations to assess its generalizability and robustness."}),e.jsx(c.Item,{children:"Investigate the biological mechanisms through which genetic markers interact with demographic and lifestyle factors to influence mortality risk."}),e.jsx(c.Item,{children:"Design and test interventions based on identified risk profiles to assess their effectiveness in reducing mortality."}),e.jsx(c.Item,{children:"Explore ethical implications, such as issues related to genetic data privacy and informed consent, in implementing predictive models in healthcare."})]})]})]})})]})]})}Jx.title="Integrated Predictors of Mortality: Demographics, Lifestyle Factors, and Genetic Markers in an Urban Healthcare Cohort";const k5=[Jx],Yi="correlation-with-continuous-measure",Eh="pearson-r",Dh="spearman-rho",Mh="r2",Bt="comparison-of-two-groups",Ah="mean-difference",zh="median-difference",Nh="cohens-d",_h="glass-delta",Lh="hedges-g",Oh="r-nonparametric",jr="comparison-of-three-or-more-groups",Ht="reporting-pairwise-differences",wr="reporting-overall-effect",Fh="eta-squared",$h="omega-squared",Bh="mean-difference-3groups",Hh="median-difference-3groups",Vh="cohens-d-3groups",Gh="glass-delta-3groups",Uh="hedges-g-3groups",qh="r-nonparametric-3groups",br="regression-model",Ki="adjusted-association-continuous",Sr="overall-model",Wh="beta-coefficient",Qh="part-partial-correlations",Yh="ls-mean-difference",Kh="r2-regression",Xh="adjusted-r2",P5={[qn]:{type:"question",title:Rd,component:kd,inputs:[Ii],choices:[{answer:"Correlation with continuous measure",next:Yi,option_description:Od},{answer:"Comparison of 2 groups",next:Bt,option_description:Fd},{answer:"Comparison of 3 or more groups",next:jr,option_description:$d},{answer:"Regression model",next:br,option_description:Bd}]},[Yi]:{type:"question",title:Be,component:He,color:"teal-darken-2",inputs:[qn],choices:[{answer:"Pearson Correlation Coefficient r",next:Eh,option_description:"Used to quantify the linear relationship or association between two continuous variables."},{answer:"Spearman's rho (non-parametric)",next:Dh,option_description:"Can be used to measure the strength and direction of monotonic associations between two ordinal or ranked variables."},{answer:"Coefficient of Determination R",next:Mh,option_description:"Quantifies the proportion of the total variance in the dependent variable that is explained by the independent variables included in the regression model."}]},[Eh]:{type:"statement",title:"Pearson correlation coefficient (Pearson's r)",flowChartTitle:"Pearson r",component:t5,color:"teal-darken-2",inputs:[Yi],examples:n5},[Dh]:{type:"statement",title:"Spearman's rho (non-parametric)",flowChartTitle:"Spearman's rho",component:r5,color:"teal-darken-2",inputs:[Yi],examples:a5},[Mh]:{type:"statement",title:"Coefficient of Determination R",flowChartTitle:"R2",component:i5,color:"teal-darken-2",inputs:[Yi],examples:s5},[Bt]:{type:"question",title:Be,component:He,color:"indigo-darken-2",inputs:[qn],choices:[{answer:"Mean Difference",next:Ah,option_description:"Measures the absolute difference between the means of two or more groups of interest.",group:"Simple Measures"},{answer:"Median Difference (non-parametric)",next:zh,option_description:"Measures the absolute difference between the medians of two or more groups of interest.",group:"Simple Measures"},{answer:"Cohen's d",next:Nh,option_description:"A standardized measure that represents the magnitude of the difference between two groups by taking the difference between the means and dividing by the pooled standard deviation.",group:"Standardized Measures"},{answer:"Glass's ",next:_h,option_description:"A standardized measure representing the magnitude of the difference between two groups, similar to Cohen's d.",group:"Standardized Measures"},{answer:"Hedges' g",next:Lh,option_description:"Represents the magnitude of the difference between two groups in terms of standard deviations, similar to Cohen's d and Glass's .",group:"Standardized Measures"},{answer:"r (non-parametric)",next:Oh,option_description:"A standardized measure that represents the strength and direction of a linear relationship between two ordinal or ranked variables without making assumptions about the distribution of the variables.",group:"Standardized Measures"}]},[Ah]:{type:"statement",title:"Mean Difference",flowChartTitle:"Mean Difference",component:bh,color:"indigo-darken-2",inputs:[Bt],examples:o5},[zh]:{type:"statement",title:"Median Difference (non-parametric)",flowChartTitle:"Median Difference",component:Sh,color:"indigo-darken-2",inputs:[Bt],examples:Ih},[Nh]:{type:"statement",title:"Cohen's d",flowChartTitle:"Cohen's d",component:Ch,color:"indigo-darken-2",inputs:[Bt],examples:Th},[_h]:{type:"statement",title:"Glass's ",flowChartTitle:"Glass's ",component:Rh,color:"indigo-darken-2",inputs:[Bt],examples:c5},[Lh]:{type:"statement",title:"Hedges' g",flowChartTitle:"Hedges' g",component:kh,color:"indigo-darken-2",inputs:[Bt],examples:u5},[Oh]:{type:"statement",title:"r (non-parametric)",flowChartTitle:"r (non-parametric)",component:Ph,color:"indigo-darken-2",inputs:[Bt],examples:f5},[jr]:{type:"question",title:Ci,component:Ti,color:"orange-darken-2",inputs:[qn],choices:[{answer:Nd,next:Ht,option_description:{short:_d,long:Ld}},{answer:wx,next:wr,option_description:{short:bx,long:Sx}}]},[Ht]:{type:"question",title:Be,component:He,color:"orange-darken-2",inputs:[jr],choices:[{answer:"Mean Difference",next:Bh,option_description:"Measures the absolute difference between the means of two or more groups of interest.",group:"Simple Measures"},{answer:"Median Difference (non-parametric)",next:Hh,option_description:"Measures the absolute difference between the medians of two or more groups of interest.",group:"Simple Measures"},{answer:"Cohen's d",next:Vh,option_description:"Represents the magnitude of the difference between two groups by taking the difference between the means and dividing by the pooled standard deviation.",group:"Standardized Measures"},{answer:"Glass's ",next:Gh,option_description:"Represents the magnitude of the difference between two groups, similar to Cohen's d.",group:"Standardized Measures"},{answer:"Hedges' g",next:Uh,option_description:"Represents the magnitude of the difference between two groups in terms of standard deviations, similar to Cohen's d and Glass's .",group:"Standardized Measures"},{answer:"r (non-parametric)",next:qh,option_description:"Represents the strength and direction of a linear relationship between two ordinal or ranked variables without making assumptions about the distribution of the variables.",group:"Standardized Measures"}]},[Bh]:{type:"statement",title:"Mean Difference",flowChartTitle:"Mean Difference",component:bh,color:"indigo-darken-2",inputs:[Ht],examples:l5},[Hh]:{type:"statement",title:"Median Difference (non-parametric)",flowChartTitle:"Median Difference",component:Sh,color:"indigo-darken-2",inputs:[Ht],examples:Ih},[Vh]:{type:"statement",title:"Cohen's d",flowChartTitle:"Cohen's d",component:Ch,color:"indigo-darken-2",inputs:[Ht],examples:Th},[Gh]:{type:"statement",title:"Glass's ",flowChartTitle:"Glass's ",component:Rh,color:"indigo-darken-2",inputs:[Ht],examples:d5},[Uh]:{type:"statement",title:"Hedges' g",flowChartTitle:"Hedges' g",component:kh,color:"indigo-darken-2",inputs:[Ht],examples:h5},[qh]:{type:"statement",title:"r (non-parametric)",flowChartTitle:"r (non-parametric)",component:Ph,color:"indigo-darken-2",inputs:[Ht],examples:p5},[wr]:{type:"question",title:Be,component:He,color:"orange-darken-2",inputs:[jr],choices:[{answer:"Eta Squared ()",next:Fh,option_description:"Used to assess the strength of association between multiple groups and a dependent variable; it is commonly used in analysis of variance."},{answer:"Omega Squared ()",next:$h,option_description:"Used to assess the strength of association between multiple groups and a dependent variable; it is commonly used in analysis of variance."}]},[Fh]:{type:"statement",title:"Eta Squared ()",flowChartTitle:"",component:m5,color:"orange-darken-2",inputs:[wr],examples:g5},[$h]:{type:"statement",title:"Omega Squared ()",flowChartTitle:"",component:x5,color:"orange-darken-2",inputs:[wr],examples:v5},[br]:{type:"question",title:Ci,component:Ti,color:"purple-darken-2",inputs:[qn],choices:[{answer:Pd,next:Ki,option_description:{short:Ed,long:Dd}},{answer:Md,next:Sr,option_description:{short:Ad,long:zd}}]},[Ki]:{type:"question",title:Be,component:He,color:"purple-darken-2",inputs:[br],choices:[{answer:"Beta coefficient (standardized or unstandardized)",next:Wh,option_description:"Represents the change in the dependent variable in standard deviation units for a one-standard-deviation change in the predictor variable, while holding all other predictor variables constant."},{answer:"Part and partial correlations",next:Qh,option_description:"Measures the unique contribution of one predictor variable to the variance in the dependent variable, while controlling for the effects of other predictor variables."},{answer:"Least Squared Mean Difference",next:Yh,option_description:"Used to estimate and compare group means in a regression model, particularly in the context of analysis of variance or linear regression."}]},[Sr]:{type:"question",title:Be,component:He,color:"purple-darken-2",inputs:[br],choices:[{answer:"R",next:Kh,option_description:"Quantifies the proportion of the total variance in the dependent variable that is explained by the independent variables included in the regression model."},{answer:"Adjusted R",next:Xh,option_description:"A statistical metric used to measure the proportion of variance in the dependent variable that is explained by the independent variables in a regression model."}]},[Wh]:{type:"statement",title:"Beta Coefficient (standardized / unstandardized)",flowChartTitle:" Coefficient",component:y5,color:"purple-darken-2",inputs:[Ki],examples:j5},[Qh]:{type:"statement",title:"Part and partial correlations",flowChartTitle:"Part and partial Correlation",component:w5,color:"purple-darken-2",inputs:[Ki],examples:b5},[Yh]:{type:"statement",title:"LS Mean Difference",flowChartTitle:"LS Mean Difference",component:S5,color:"purple-darken-2",inputs:[Ki],examples:I5},[Kh]:{type:"statement",title:"R",flowChartTitle:"R",component:C5,color:"purple-darken-2",inputs:[Sr],examples:T5},[Xh]:{type:"statement",title:"Adjusted R",flowChartTitle:"Adjusted R",component:R5,color:"purple-darken-2",inputs:[Sr],examples:k5}};function E5(){const t=[e.jsx(l,{gap:4,children:e.jsx(i,{children:"The point-biserial correlation (r_pb) quantifies the strength and direction of the association between a continuous variable and a dichotomous variable. Specifically, it determines the degree of relationship between two variables when one is continuous and the other is binary in nature. This measure is a special case of the Pearson correlation coefficient."})}),e.jsxs(l,{gap:6,children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Range of point-biserial correlation"}),e.jsx(i,{children:"The values for the point-biserial correlation range from -1 to +1:"})]}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Positive r_pb (0 to +1):"})," ","This indicates a positive association between the variables. As the values of the continuous variable increase, the likelihood of the dichotomous variable taking a particular value (e.g., 1) also tends to increase."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"r_pb close to 0:"})," ","This suggests minimal or no association between the two variables."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Negative r_pb (0 to -1):"})," ","This indicates a negative association between the variables. As the values of the continuous variable increase, the likelihood of the dichotomous variable taking a particular value (e.g., 1) tends to decrease."]})})]})]}),e.jsxs(l,{gap:6,children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpreting the magnitude of point-biserial correlation"}),e.jsx(i,{children:"The interpretation of the point-biserial correlation as an absolute value is as follows:"})]}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.00 to 0.19:"})," ","Very weak association"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.20 to 0.39:"})," ","Weak association"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.40 to 0.59:"})," ","Moderate association"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.60 to 0.79:"})," ","Strong association"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.80 to 1.00:"})," ","Very strong association"]})})]})]})];return e.jsx(G,{explanationSections:t,example1:e.jsx(i,{children:"Example 1 content will go here (e.g., a scatterplot, numerical example, or walkthrough)."})})}function Zh(){const t=[e.jsx(l,{gap:4,children:e.jsx(i,{children:"Risk ratio (RR; also known as rate ratio or relative risk) is a measure used to quantify the association between an exposure and an outcome. Specifically, it measures the magnitude of the difference of the probability of an event or outcome occurring in the exposed group(s) as compared with the probability of the outcome occurring in the unexposed group(s). It is particularly insightful in epidemiology to determine the relative increase or decrease in risk after exposure to a particular factor."})}),e.jsxs(l,{gap:6,children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Range of RR"}),e.jsx(i,{children:"RR values can range from 0 to positive infinity:"})]}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"RR = 1:"})," ","This indicates that there is no association between the exposure and the outcome, which suggests that the risk of the event is the same in both the exposed and nonexposed groups."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"RR > 1:"})," ","This shows that there is a higher risk of the event in the exposed group as compared with the nonexposed group."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"RR < 1:"})," ","This implies that there is a lower risk of the event in the exposed group as compared with the nonexposed group."]})})]}),e.jsx(i,{mt:4,children:"Note that the RR value cannot be negative."})]}),e.jsxs(l,{gap:6,children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation"}),e.jsx(i,{children:"Interpreting the exact values of RRs is largely context-dependent and involves consideration of the specific domain, dataset, or health outcome being investigated. Although higher RR values indicate a greater risk and lower RR values indicate reduced risk, the exact thresholds for what is considered significant or clinically relevant can vary."})]}),e.jsxs(l,{gap:0,mt:4,children:[e.jsx(i,{fw:500,children:"Clinical Pearl"}),e.jsx(i,{children:"Remember that the RR calculates a relative risk. It is always important to consider what the base rate is when interpreting the clinical significance of the relative risk. For example, a relative risk of 2 has a very different interpretation when the base rate is 1% (risk increase to 2%; still quite low) versus 15% (risk increase to 30%; clinically important)."})]})]})];return e.jsx(G,{explanationSections:t,example1:e.jsx(i,{children:"Example 1 content will go here (e.g., a scatterplot, numerical example, or walkthrough)."})})}function ev(){return e.jsxs(l,{gap:"md",children:[e.jsx(i,{fs:"italic",mt:0,children:"Among adults who suffer a myocardial infarction and are placed on standard antithrombotic treatment (i.e., aspirin, clopidogrel, or a vitamin K antagonist), what is the risk of subsequent gastrointestinal bleeding among adults who also receive a non-steroidal anti-inflammatory drug?"}),e.jsxs(f,{defaultValue:"studyDesign",children:[e.jsxs(f.List,{children:[e.jsx(f.Tab,{value:"studyDesign",children:"Study Design and Methods"}),e.jsx(f.Tab,{value:"effectSize",children:"Effect Size Measure & MCID"}),e.jsx(f.Tab,{value:"result",children:"Result"}),e.jsx(f.Tab,{value:"discussion",children:"Discussion and Future Research"})]}),e.jsx(f.Panel,{value:"studyDesign",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Clinical Research Study Design:"}),e.jsx(i,{children:"Cohort. This is a longitudinal observational study from a 10-year period, tracking a cohort of older adults who suffered their first myocardial infarction. The cohort was restricted to individuals alive 30 days after discharge, which was the date of study inclusion."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Study Population:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Number of participants:"})," ","62,125 patients aged 30 years or older."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Location of recruitment:"})," ","National registry"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Inclusion/exclusion criteria:"})," ","Inclusion: Adults who suffered first MI. Exclusion: Prior diagnosis of intracranial bleeding, gastrointestinal bleeding (bleeding ulcer, hematemesis, melena, and unspecified gastrointestinal bleeding), bleeding from the respiratory or urinary tract, and anemia caused by bleeding."]})})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Variables Under Study:"}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Independent/Predictor/Exposure:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsx(i,{children:"Antithrombotic therapy defined by prescription claims from the registry."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"Monotherapy defined by claimed prescriptions for aspirin, clopidogrel, or vitamin K antagonists alone."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"Dual therapy defined as the use of non-steroidal anti-inflammatory drug (NSAID) in addition to aspirin, clopidogrel, or vitamin K."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"Confounders: Overall burden of comorbidities (e.g., diabetes) as defined by the Adult Comorbidity Evaluation-27 were identified."})})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Dependent/Outcome:"}),e.jsx(i,{children:"The primary outcome of bleeding was defined as admission or death from diagnoses of intracranial bleeding, gastrointestinal bleeding (bleeding ulcer, hematemesis, melena, and unspecified gastrointestinal bleeding), bleeding from the respiratory or urinary tract, and anemia caused by bleeding."})]})]})]})}),e.jsx(f.Panel,{value:"effectSize",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Effect Size Measure used in the Analytical Approach:"}),e.jsx(i,{children:"Risk ratio (RR) was used to quantify the effect size."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Minimal Clinically Important Difference (MCID):"}),e.jsx(i,{children:"The MCID was defined as a 20% increase in bleeding risk (i.e., RR = 1.2)."})]})]})}),e.jsx(f.Panel,{value:"result",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Point Estimate:"}),e.jsx(i,{children:"The number of bleeding events among the 43,487 subjects treated with monotherapy was 539 for a risk of 1.24% (95% CI 1.14 to 1.35)."}),e.jsx(i,{children:"The number of bleeding events among the 18,638 subjects treated with dual therapy was 582 for a risk of 3.12% (95% CI 2.88 to 3.38)."}),e.jsx(i,{children:"The risk ratio or relative risk is 2.52."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Confidence Interval:"}),e.jsx(i,{children:"The 95% confidence interval for the RR ranges from 2.24 to 2.83, which is a precise estimate of the true value of the RR."})]}),e.jsxs(l,{gap:0,children:[e.jsxs(i,{fw:500,children:["Probability Value (",e.jsx(i,{span:!0,fs:"italic",children:"P"}),"-value):"]}),e.jsxs(i,{children:[e.jsx(i,{span:!0,fs:"italic",children:"P"})," ","< 0.0001"]})]})]})}),e.jsx(f.Panel,{value:"discussion",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Results:"}),e.jsx(i,{children:"The RR point estimate is 2.52, which corresponds to a 152% increase [(RR point estimate  1)*100] in the number of bleed events among those who were taking a non-steroidal anti-inflammatory drug in addition to aspirin, clopidogrel, or vitamin K."}),e.jsx(i,{children:"The 95% CI ranges from 2.24 to 2.83. This is a precise estimate of the true risk increase, indicating that the actual risk increase can range from 124% to 183%."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Implications of Results:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsx(i,{children:"The risk ratio or relative risk is 2.52, which greatly exceeds the MCID of 1.2, so the results are clinically meaningful."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"The relatively narrow confidence interval indicates a precise estimate of the true effect and all plausible results, defined by the range of the 95% CI, are clinically meaningful (i.e., the lower bound of the CI is 2.24)."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"This study is a definitively positive study. All plausible results are clinically meaningful, and the observed difference is statistically significant."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"This study provides strong evidence that adding a non-steroidal anti-inflammatory drug in addition to aspirin, clopidogrel, or vitamin K is associated with a clinically meaningful increase in bleeding events."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"Because this is an observational study, alternative explanations for the positive findings can include confounding (a third factor causes both increased use of NSAIDs and an increase in GI bleeding events), bias (a systematic error in one or more aspects of the conduct of the study), chance (a random effect), and effect-cause (a reversal of effect)."})})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Future Research:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsx(i,{children:"Conduct dissemination and implementation (D&I) research to translate the research findings into clinical practice by bridging the gap between the development of effective interventions and their widespread adoption and use in real-world health care settings. D&I research seeks to understand the factors that influence the adoption and utilization of evidence-based interventions, and it designs and tests strategies to overcome identified barriers and enhance facilitators. Successful D&I research actively involves stakeholders such as clinicians, patients, policy makers, and administrators. Consider creating a multidisciplinary team of scientists and health service researchers with the broad range of expertise and perspectives needed to address the multifaceted challenges of implementation in real-world health care settings."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"Further research could explore unique prognostic subgroups for whom the risk of NSAIDs is particularly elevated or reduced."})})]})]})]})})]})]})}ev.title="Association of Antithrombotic Treatment After Myocardial Infarction (MI) and Risk of Gastrointestinal Bleeding";function tv(){return e.jsxs(l,{gap:"md",children:[e.jsx(i,{fs:"italic",mt:0,children:"In adult patients with no history of hepatitis, what is the association between long-term use of acetaminophen, long-term use of ibuprofen, or no pain medication use and the development of liver failure?"}),e.jsxs(f,{defaultValue:"studyDesign",children:[e.jsxs(f.List,{children:[e.jsx(f.Tab,{value:"studyDesign",children:"Study Design and Methods"}),e.jsx(f.Tab,{value:"effectSize",children:"Effect Size Measure & MCID"}),e.jsx(f.Tab,{value:"result",children:"Result"}),e.jsx(f.Tab,{value:"discussion",children:"Discussion and Future Research"})]}),e.jsx(f.Panel,{value:"studyDesign",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Clinical Research Study Design:"}),e.jsx(i,{children:"Prospective cohort study"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Study Population:"}),e.jsx(i,{children:"The study sample consisted of 10,000 adult patients with no history of hepatitis or liver failure at baseline who were enrolled from a tertiary medical center between 2010 and 2012 and followed through 2020. Participants were divided into three groups based on their pain medication use patterns at enrollment. The cohort included 3,000 patients with long-term acetaminophen use (Group 1), 3,500 patients with long-term ibuprofen use (Group 2), and 3,500 patients with no long-term pain medication use (Group 3). All groups were balanced for history of alcohol consumption, age, sex, and history of hepatitis C."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Variables under Study:"}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Independent/Predictor/Exposure:"}),e.jsx(i,{children:"The independent variable is long-term pain medication exposure at baseline. Group 1 had long-term exposure to acetaminophen, defined as use of the recommended dosage of acetaminophen (325 mg every 3-4 hours) or higher every day for at least a month. Group 2 had long-term exposure to ibuprofen, defined as use of the recommended dosage of ibuprofen (200-400 mg every 4-6 hours) or higher every day for at least a month. Group 3 had no long-term pain medication use."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Dependent/Outcome:"}),e.jsx(i,{children:"The dependent variable is the development of liver failure during the follow-up period (yes/no)."})]})]})]})}),e.jsx(f.Panel,{value:"effectSize",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Effect Size Measure used in the Analytical Approach:"}),e.jsx(i,{children:"The effect size measure used in this study is the relative risk (RR). It quantifies the strength and direction of association between different pain medication exposures and the occurrence of liver failure."}),e.jsx(i,{children:"The relative risk and 95% confidence intervals can be calculated for the pair-wise comparisons between the three groups (Group 1 vs. Group 2, Group 1 vs. Group 3, Group 2 vs. Group 3). These values provide estimates of the effect size and the precision of the estimates between the exposure groups."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Minimal Clinically Important Difference (MCID):"}),e.jsx(i,{children:"Investigators determined that a relative risk of 2.0 or greater would be clinically meaningful for the association between pain medication use and liver failure."})]})]})}),e.jsx(f.Panel,{value:"result",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Point Estimate:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsx(i,{children:"Group 1 (Acetaminophen) vs. Group 3 (No pain medication): RR = 2.7, indicating that the risk of liver failure is 2.7 times higher in acetaminophen users compared to non-users."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"Group 2 (Ibuprofen) vs. Group 3 (No pain medication): RR = 1.4, indicating that the risk of liver failure is 1.4 times higher in ibuprofen users compared to non-users."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"Group 1 (Acetaminophen) vs. Group 2 (Ibuprofen): RR = 1.9, indicating that the risk of liver failure is 1.9 times higher in acetaminophen users compared to ibuprofen users."})})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Confidence Interval:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsx(i,{children:"Group 1 (Acetaminophen) vs. Group 3 (No pain medication): 95% CI [2.4, 3.0], indicating a precise estimate."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"Group 2 (Ibuprofen) vs. Group 3 (No pain medication): 95% CI [1.2, 1.7], indicating a precise estimate."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"Group 1 (Acetaminophen) vs. Group 2 (Ibuprofen): 95% CI [1.6, 2.3], indicating a precise estimate."})})]})]}),e.jsxs(l,{gap:0,children:[e.jsxs(i,{fw:500,children:["Probability Value (",e.jsx(i,{span:!0,fs:"italic",children:"P"}),"-value):"]}),e.jsxs(i,{children:["All comparisons:"," ",e.jsx(i,{span:!0,fs:"italic",children:"p"})," ","< 0.0001, indicating statistically significant results."]})]})]})}),e.jsx(f.Panel,{value:"discussion",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Results:"}),e.jsx(i,{children:"These results suggest that long-term acetaminophen use has the strongest association with liver failure, with risk 2.7 times higher compared to no pain medication use. Long-term ibuprofen use also shows an association with liver failure, though weaker, with risk 1.4 times higher compared to no pain medication use. When comparing the two medications directly, acetaminophen users have 1.9 times higher risk of liver failure compared to ibuprofen users."}),e.jsx(i,{children:"The effect sizes indicate a clinically meaningful difference between acetaminophen use and no medication use (RR = 2.7, exceeding the MCID of 2.0), a smaller but still significant difference between ibuprofen use and no medication use (RR = 1.4, below the MCID), and a borderline clinically meaningful difference between acetaminophen and ibuprofen use (RR = 1.9, approaching the MCID)."}),e.jsx(i,{children:"All confidence intervals are narrow and indicate precise estimates. The confidence interval for acetaminophen versus no medication (2.4 to 3.0) is entirely above the MCID of 2.0, confirming both statistical and clinical significance for this comparison."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Implications of Results:"}),e.jsx(i,{children:"These findings indicate clinically meaningful associations between long-term pain medication use and increased risk of liver failure, with acetaminophen showing the strongest association. Healthcare providers should be aware of these associations when considering recommending long-term pain medication use for their patients. For patients with the need for long-term pain relief, these results suggest that ibuprofen may present a lower risk for liver failure compared to acetaminophen, though both medications show elevated risk compared to no medication use. Alternative pain relief options or careful monitoring for liver function should be considered, particularly for patients requiring long-term acetaminophen."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Future Research:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Dose-response relationship:"})," ","Investigate whether there is a threshold dose below which acetaminophen or ibuprofen use might be considered safer for long-term use. Establishing safe dosage guidelines could help clinicians balance pain management needs with liver safety."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Interaction effects:"})," ","Examine the potential interaction of acetaminophen and ibuprofen with other risk factors for liver failure, such as alcohol consumption patterns, concurrent medication use, nutritional status, and genetic predispositions. Understanding these interactions could help identify particularly vulnerable patient populations."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Comparative effectiveness of alternative pain management:"})," ","Evaluate the effectiveness and safety profiles of other pain relief options, including other NSAIDs, opioid medications, topical analgesics, and non-pharmacological interventions. This research would provide healthcare providers with a broader evidence base for informed decision-making regarding long-term pain management."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Subgroup and stratification analyses:"})," ","Conduct detailed analyses on specific subsets of the study population, such as different age groups, genders, body mass indices, or comorbidities, to uncover variations in medication-related liver failure risk. This prognostic stratification approach enhances personalized treatment approaches. Yet, with any subgroup analysis, it is crucial to be aware of the associated statistical power of each analysis and consider potential biases that may be present."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Extended follow-up studies:"})," ","While the current cohort study provides valuable longitudinal data over 8-10 years, longer follow-up periods could reveal late-onset effects and assess cumulative exposure impacts. Such studies could also examine whether changes in medication use patterns over time affect liver failure risk."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Mechanistic studies:"})," ","Explore the biological mechanisms by which acetaminophen and ibuprofen contribute to liver failure, including metabolic pathways, oxidative stress, and cellular damage patterns. Understanding these mechanisms could lead to preventive strategies or protective interventions."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Cost-effectiveness analysis:"})," ","Evaluate the cost-effectiveness of different pain management strategies, including monitoring protocols, when accounting for the risk of liver failure. Understanding the economic implications alongside clinical outcomes can assist in healthcare resource allocation and policy development."]})})]})]})]})})]})]})}tv.title="Association Between Long-Term Acetaminophen Use, Ibuprofen Use, and Liver Failure: A Multi-Group Comparison";const D5=[ev],M5=[tv];function Jh(){const t=[e.jsx(l,{gap:4,children:e.jsx(i,{children:"Risk difference (RD) is used to determine the magnitude of the difference in the risk of an outcome of interest occurring in two or more groups. Specifically, it computes the difference in probabilities of an event occurring between the exposed and nonexposed groups. It is frequently used in epidemiology to assess the absolute effect of an exposure or intervention."})}),e.jsxs(l,{gap:6,children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Range of RD"}),e.jsx(i,{children:"RD values can range from -1 to +1:"})]}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"RD = 0:"})," ","This suggests that there is no difference in risk between the exposed and nonexposed groups."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"RD > 0:"})," ","This indicates that the exposed group has a higher risk of the event as compared with the nonexposed group."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"RD < 0:"})," ","This implies that the exposed group has a lower risk of the event as compared with the nonexposed group."]})})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation"}),e.jsx(i,{children:"Interpreting the exact values of RDs is context-dependent and relies heavily on the specific domain, dataset, or health outcome being examined. Although positive values show an increased risk due to exposure and negative values suggest a reduced risk, the specific thresholds for what is considered a significant or clinically meaningful difference can vary."})]})];return e.jsx(G,{explanationSections:t,example1:e.jsx(i,{children:"Example 1 content will go here (e.g., a scatterplot, numerical example, or walkthrough)."})})}function nv(){return e.jsxs(l,{gap:"md",children:[e.jsx(i,{fs:"italic",mt:0,children:"In patients with primary open-angle glaucoma, does medication A reduce the risk of developing glaucoma progression compared to medication B?"}),e.jsxs(f,{defaultValue:"studyDesign",children:[e.jsxs(f.List,{children:[e.jsx(f.Tab,{value:"studyDesign",children:"Study Design and Methods"}),e.jsx(f.Tab,{value:"effectSize",children:"Effect Size Measure & MCID"}),e.jsx(f.Tab,{value:"result",children:"Result"}),e.jsx(f.Tab,{value:"discussion",children:"Discussion and Future Research"})]}),e.jsx(f.Panel,{value:"studyDesign",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Clinical Research Study Design:"}),e.jsx(i,{children:"This study is a randomized controlled trial (RCT). The study followed participants over 2 years, utilizing regular follow-up visits, visual field tests, and optic nerve evaluations to assess glaucoma progression."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Study Population:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Number of participants:"})," ","The study population consists of 500 individuals aged 40 and above who have been diagnosed with primary open-angle glaucoma."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Location of recruitment:"})," ","Participants were recruited from ophthalmology clinics in a tertiary care center."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Inclusion/exclusion criteria:"})," ","New diagnosis of primary open-angle glaucoma without previous medical treatment."]})})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Variables Under Study:"}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Independent variable (exposure):"}),e.jsx(i,{children:"The intervention group (n=250) received medication A, while the control group (n=250) received medication B."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Dependent variable (outcome):"}),e.jsx(i,{children:"The dependent variable is the risk of developing glaucoma progression."})]})]})]})}),e.jsx(f.Panel,{value:"effectSize",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Effect size measure:"}),e.jsx(i,{children:"Risk difference in developing glaucoma progression."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Minimal Clinically Important Difference (MCID):"}),e.jsx(i,{children:"Before the study, the investigators surveyed a group of expert ophthalmologists and determined that a risk difference of 10% or more in the rate of glaucoma progression is considered clinically meaningful. Thus, the investigators declared the MCID for the risk difference for this study to be 10% or greater."})]})]})}),e.jsx(f.Panel,{value:"result",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Point Estimate"}),e.jsx(i,{children:"In the intervention group (medication A), the risk of glaucoma progression was 20% (50/250), while in the control group (medication B), the risk was 35% (88/250). Thus, the risk difference in developing glaucoma progression was 15% (a reduction)."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"95% Confidence Interval:"}),e.jsx(i,{children:"8% to 22%"})]}),e.jsxs(l,{gap:0,children:[e.jsxs(i,{fw:500,children:["Probability Value (",e.jsx(i,{span:!0,fs:"italic",children:"p"}),"-Value):"]}),e.jsxs(i,{children:[e.jsx(i,{span:!0,fs:"italic",children:"p"})," ","< 0.001"]})]})]})}),e.jsx(f.Panel,{value:"discussion",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Results"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsx(i,{children:"The results of this study indicate that medication A is associated with a significantly lower risk of glaucoma progression compared to medication B. The 15% absolute risk reduction in glaucoma progression is noteworthy and clinically relevant."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"The confidence interval (8% to 22%) suggests that the estimate is reasonably precise."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"The lower bound of the CI (8%) is slightly less than the MCID value of 10%. Thus, the investigators cannot conclude with certainty that medication A is definitively clinically superior to medication B. However, the preponderance of values for the risk difference, contained within the lower and upper bounds of the 95% CI, does suggest that medication A is better than medication B by an amount considered clinically meaningful."})})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Implications of Results"}),e.jsx(i,{children:"Assuming there is no significant difference in cost or adverse effects, medication A should be considered over medication B for the treatment of patients with newly diagnosed open-angle glaucoma, to prevent glaucoma progression."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Recommendations for Future Research"}),e.jsx(i,{children:"While the lower bound of the confidence interval (8%) is slightly less than the MCID value of 10%, most values within the 95% CI suggest that Medication A is clinically better than Medication B. If the investigators interpret these results as indeterminate or require further validation, the following strategies can strengthen evidence:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Conduct Additional Research with Increased Sample Size:"})," ","To obtain more precise estimates of the effect size, conduct the study with a larger sample size. This approach enables authors and readers to be more certain of where the actual effect size value lies and whether the results are compatible with clinically meaningful effects. However, resource constraints, such as funding, time, and participant availability, should be considered."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Improve Study Quality by Reducing Error:"})," ","Enhance the reliability and precision of effect size estimates by minimizing both random and systematic errors. Adherence to Good Clinical Practice (GCP) guidelines is a highly effective strategy for promoting standardized processes, ensuring data quality, enhancing patient safety, and ensuring rigorous oversight."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Improve Methodological Quality and Rigor:"})," ","Enhance the study design via randomization, blinding, and control of confounding variables to address uncertainties in indeterminate study outcomes. These enhancements are critical for reducing bias and increasing the reliability of results."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Reduce Variability in Measurement:"})," ","Standardize measurements through methods like Standard Operating Procedure (SOP) manuals, validated assessments, and calibrated instruments. Additionally, evaluate the sensitivity and specificity of measurement tools to ensure they can detect clinically significant changes."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Pursue an Adaptive Trial Design:"})," ","Adaptive trial designs allow for modifications to the study protocol based on interim data analysis, providing a flexible approach to refining research as it progresses and potentially resolving areas of uncertainty."]})})]}),e.jsx(i,{children:"Else if the investigators interpret these results as definitive, where the overall difference between groups is large, and the confidence interval around the effect size is narrow and nearly all is above the MCID, the following strategies should be considered:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Progress to Dissemination & Implementation (D&I):"})," ","Move towards disseminating and implementing the intervention into real-world clinical practice. This involves translating research findings into practical applications and addressing the challenges associated with the adoption of evidence-based interventions in healthcare settings."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Create a Multidisciplinary Team:"})," ","Assemble a multidisciplinary team of investigators and health-service researchers with diverse expertise to comprehensively address the multifaceted challenges of dissemination and implementation. This may include clinicians, implementation scientists, health economists, and other relevant stakeholders. Although facilitating the coordination and communication across various professions can be challenging, the end results obtained by a heterogenous team can be deeply informative."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Implement Health System-Level Interventions:"})," ","Explore interventions at the health system level to facilitate the integration of the successful intervention into routine clinical practice. This involves collaborating with healthcare administrators and policymakers at an organizational level as well as addressing potential resistance (established practices, cultural norms) to change."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Adapt and Tailor:"})," ","Refine the process of customizing interventions to different populations by systematically developing, testing, and refining adaptations. Document how each modification is made to maintain the core elements of the intervention while ensuring its effectiveness across diverse settings and populations."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Investigate Alternative Delivery Modes:"})," ","Explore the feasibility and effectiveness of delivering the intervention through alternative modes such as telehealth, digital platforms, or mobile applications. This can expand the reach of the intervention and increase accessibility for a larger population."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Pursue Policy Impact Studies:"})," ","Investigate how your findings can inform and influence healthcare policy and practice at a systemic level. For positive results, this involves analyzing how the effective intervention can be integrated into existing healthcare systems, potentially leading to the development of new guidelines or the enhancement of current practices. Engage with policymakers to advocate for evidence-based changes that leverage your findings to improve patient outcomes and system efficiency. Examine the broader implications of adopting this intervention in practice, considering aspects like healthcare access, quality, and economic impacts."]})})]})]})]})})]})]})}nv.title="Optimal Medication for Glaucoma Intervention in Comparative Analysis (OPTIMA)";function iv(){return e.jsxs(l,{gap:"md",children:[e.jsx(i,{fs:"italic",mt:0,children:"In patients with primary open-angle glaucoma, what is the effect of medication A, medication B, or medication C on the risk of developing glaucoma progression?"}),e.jsxs(f,{defaultValue:"studyDesign",children:[e.jsxs(f.List,{children:[e.jsx(f.Tab,{value:"studyDesign",children:"Study Design and Methods"}),e.jsx(f.Tab,{value:"effectSize",children:"Effect Size Measure & MCID"}),e.jsx(f.Tab,{value:"result",children:"Result"}),e.jsx(f.Tab,{value:"discussion",children:"Discussion and Future Research"})]}),e.jsx(f.Panel,{value:"studyDesign",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Clinical Research Study Design:"}),e.jsx(i,{children:"This study is a randomized controlled trial (RCT). The study followed participants over 2 years, utilizing regular follow-up visits, visual field tests, and optic nerve evaluations to assess glaucoma progression."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Study Population:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Number of participants:"})," ","The study population consists of 750 individuals aged 40 and above who have been diagnosed with primary open-angle glaucoma."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Location of recruitment:"})," ","Participants were recruited from ophthalmology clinics in a tertiary care center."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Inclusion/exclusion criteria:"})," ","New diagnosis of primary open-angle glaucoma without previous medical treatment."]})})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Variables Under Study:"}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Independent/Predictor/Exposure:"}),e.jsx(i,{children:"The independent variable is the type of medication intervention. Group 1 (n=250) received medication A, Group 2 (n=250) received medication B, and Group 3 (n=250) received medication C."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Dependent/Outcome:"}),e.jsx(i,{children:"The dependent variable is the risk of developing glaucoma progression (yes/no)."})]})]})]})}),e.jsx(f.Panel,{value:"effectSize",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Effect Size Measure used in the Analytical Approach:"}),e.jsx(i,{children:"The effect size measure used in this study is the risk difference (RD). It quantifies the absolute difference in risk of glaucoma progression between different medication groups."}),e.jsx(i,{children:"The risk difference and 95% confidence intervals can be calculated for the pair-wise comparisons between the three groups (Group 1 vs. Group 2, Group 1 vs. Group 3, Group 2 vs. Group 3). These values provide estimates of the effect size and the precision of the estimates between the intervention groups."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Minimal Clinically Important Difference (MCID):"}),e.jsx(i,{children:"Before the study, the investigators surveyed a group of expert ophthalmologists and determined that a risk difference of 10% or more in the rate of glaucoma progression is considered clinically meaningful. Thus, the investigators declared the MCID for the risk difference for this study to be 10% or greater."})]})]})}),e.jsx(f.Panel,{value:"result",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Point Estimate:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:"Group 1 (Medication A): Risk of glaucoma progression was 20% (50/250)"}),e.jsx(c.Item,{children:"Group 2 (Medication B): Risk of glaucoma progression was 35% (88/250)"}),e.jsx(c.Item,{children:"Group 3 (Medication C): Risk of glaucoma progression was 28% (70/250)"})]}),e.jsxs(i,{mt:"sm",children:[e.jsx(i,{span:!0,fw:500,children:"Group 1 (Medication A) vs. Group 2 (Medication B):"})," ","Risk difference = 15% reduction (Medication A has 15% lower absolute risk than Medication B)"]}),e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Group 1 (Medication A) vs. Group 3 (Medication C):"})," ","Risk difference = 8% reduction (Medication A has 8% lower absolute risk than Medication C)"]}),e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Group 3 (Medication C) vs. Group 2 (Medication B):"})," ","Risk difference = 7% reduction (Medication C has 7% lower absolute risk than Medication B)"]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Confidence Interval:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsx(i,{children:"Group 1 (Medication A) vs. Group 2 (Medication B): 95% CI [8%, 22%], indicating a reasonably precise estimate."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"Group 1 (Medication A) vs. Group 3 (Medication C): 95% CI [1%, 15%], indicating a reasonably precise estimate."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"Group 3 (Medication C) vs. Group 2 (Medication B): 95% CI [0%, 14%], indicating a reasonably precise estimate."})})]})]}),e.jsxs(l,{gap:0,children:[e.jsxs(i,{fw:500,children:["Probability Value (",e.jsx(i,{span:!0,fs:"italic",children:"P"}),"-value):"]}),e.jsxs(c,{spacing:2,children:[e.jsxs(c.Item,{children:["Group 1 (Medication A) vs. Group 2 (Medication B):"," ",e.jsx(i,{span:!0,fs:"italic",children:"p"})," ","< 0.001"]}),e.jsxs(c.Item,{children:["Group 1 (Medication A) vs. Group 3 (Medication C):"," ",e.jsx(i,{span:!0,fs:"italic",children:"p"})," ","= 0.02"]}),e.jsxs(c.Item,{children:["Group 3 (Medication C) vs. Group 2 (Medication B):"," ",e.jsx(i,{span:!0,fs:"italic",children:"p"})," ","= 0.048"]})]})]})]})}),e.jsx(f.Panel,{value:"discussion",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Results:"}),e.jsx(i,{children:"These results suggest that Medication A demonstrates the lowest risk of glaucoma progression (20%), followed by Medication C (28%), and then Medication B (35%)."}),e.jsx(i,{children:"The comparison between Medication A and Medication B shows a 15% absolute risk reduction, which exceeds the MCID of 10%. The confidence interval (8% to 22%) is reasonably precise, and the lower bound (8%) is slightly less than the MCID value of 10%. Thus, the investigators cannot conclude with certainty that Medication A is definitively clinically superior to Medication B. However, the preponderance of values for the risk difference, contained within the lower and upper bounds of the 95% CI, does suggest that Medication A is better than Medication B by an amount considered clinically meaningful."}),e.jsx(i,{children:"The comparison between Medication A and Medication C shows an 8% absolute risk reduction, which is below the MCID of 10%. The confidence interval (1% to 15%) crosses the MCID threshold, indicating uncertainty about whether this difference is clinically meaningful. While statistically significant, the clinical significance remains indeterminate."}),e.jsx(i,{children:"The comparison between Medication C and Medication B shows a 7% absolute risk reduction, which is below the MCID of 10%. The confidence interval (0% to 14%) crosses both the null value and the MCID threshold, indicating substantial uncertainty about both statistical and clinical significance."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Implications of Results:"}),e.jsx(i,{children:"Assuming there is no significant difference in cost or adverse effects among the three medications, Medication A should be considered as the preferred treatment option for patients with newly diagnosed open-angle glaucoma to prevent glaucoma progression. The comparison of Medication A to Medication B provides the strongest evidence, with a clinically meaningful risk reduction suggested by most values within the confidence interval."}),e.jsx(i,{children:"The relative positioning of Medication C compared to both Medication A and Medication B is less clear, with risk differences that do not consistently exceed the MCID threshold. Additional research may be needed to clarify the clinical significance of differences involving Medication C."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Recommendations for Future Research:"}),e.jsx(i,{children:"Based on the results of the pairwise comparisons between the three groups, the following research strategies are recommended:"}),e.jsx(i,{children:e.jsx(i,{span:!0,fw:500,children:"For comparisons where results are indeterminate or require further validation (particularly Medication A vs. Medication C and Medication C vs. Medication B):"})}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Conduct Additional Research with Increased Sample Size:"})," ","To obtain more precise estimates of the effect size, conduct the study with a larger sample size. This approach enables authors and readers to be more certain of where the actual effect size value lies and whether the results are compatible with clinically meaningful effects. However, resource constraints, such as funding, time, and participant availability, should be considered."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Improve Study Quality by Reducing Error:"})," ","Enhance the reliability and precision of effect size estimates by minimizing both random and systematic errors. Adherence to Good Clinical Practice (GCP) guidelines is a highly effective strategy for promoting standardized processes, ensuring data quality, enhancing patient safety, and ensuring rigorous oversight."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Improve Methodological Quality and Rigor:"})," ","Enhance the study design via randomization, blinding, and control of confounding variables to address uncertainties in indeterminate study outcomes. These enhancements are critical for reducing bias and increasing the reliability of results."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Reduce Variability in Measurement:"})," ","Standardize measurements through methods like Standard Operating Procedure (SOP) manuals, validated assessments, and calibrated instruments. Additionally, evaluate the sensitivity and specificity of measurement tools to ensure they can detect clinically significant changes."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Pursue an Adaptive Trial Design:"})," ","Adaptive trial designs allow for modifications to the study protocol based on interim data analysis, providing a flexible approach to refining research as it progresses and potentially resolving areas of uncertainty."]})})]}),e.jsx(i,{children:e.jsx(i,{span:!0,fw:500,children:"For the comparison where results suggest clinical superiority (Medication A vs. Medication B):"})}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Progress to Dissemination & Implementation (D&I):"})," ","Move towards disseminating and implementing Medication A as a preferred intervention into real-world clinical practice. This involves translating research findings into practical applications and addressing the challenges associated with the adoption of evidence-based interventions in healthcare settings."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Create a Multidisciplinary Team:"})," ","Assemble a multidisciplinary team of investigators and health-service researchers with diverse expertise to comprehensively address the multifaceted challenges of dissemination and implementation. This may include ophthalmologists, implementation scientists, health economists, and other relevant stakeholders. Although facilitating the coordination and communication across various professions can be challenging, the end results obtained by a heterogenous team can be deeply informative."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Implement Health System-Level Interventions:"})," ","Explore interventions at the health system level to facilitate the integration of Medication A into routine clinical practice as a first-line treatment. This involves collaborating with healthcare administrators and policymakers at an organizational level as well as addressing potential resistance (established practices, cultural norms, medication formulary constraints) to change."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Adapt and Tailor:"})," ","Refine the process of customizing the intervention to different populations by systematically developing, testing, and refining adaptations. Document how each modification is made to maintain the core elements of the intervention while ensuring its effectiveness across diverse settings and populations."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Investigate Cost-Effectiveness:"})," ","Conduct economic analyses comparing the three medications to determine the cost-effectiveness of Medication A relative to alternatives. This information is crucial for healthcare policy decisions and resource allocation."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Subgroup Analyses:"})," ","Investigate whether treatment effects vary across patient subgroups defined by age, disease severity, comorbidities, or genetic factors. This could identify patients who benefit most from each medication and support personalized treatment approaches."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Long-term Follow-up Studies:"})," ","Extend the follow-up period beyond 2 years to assess the durability of treatment effects and identify any long-term differences in progression rates or adverse events among the three medications."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Pursue Policy Impact Studies:"})," ","Investigate how your findings can inform and influence healthcare policy and practice at a systemic level. Engage with policymakers to advocate for evidence-based changes in glaucoma treatment guidelines that leverage your findings to improve patient outcomes and system efficiency."]})})]})]})]})})]})]})}iv.title="Comparative Effectiveness of Three Medications for Glaucoma Progression Prevention: A Randomized Controlled Trial (TRIPLE-G)";const A5=[nv],z5=[iv];function ef(){const t=[e.jsx(l,{gap:4,children:e.jsx(i,{children:"The phi coefficient () is a measure used to express the degree of association between two dichotomous variables. Specifically, it quantifies the correlation in a 2 x 2 contingency table. Derived from the Pearson correlation coefficient, the phi coefficient is particularly effective when exploring the relationship between two binary variables."})}),e.jsxs(l,{gap:6,children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Range of phi coefficient"}),e.jsx(i,{children:"Phi coefficient values can range from -1 to +1:"})]}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Positive  (0 to +1):"})," ","This indicates a positive association between the variables. If one variable takes a particular value, the other variable is more likely to take a specific value as well."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:" close to 0:"})," ","This suggests minimal or no association between the two variables, implying that the variables are independent of each other."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Negative  (0 to -1):"})," ","This implies a negative association between the variables. If one variable takes a particular value, the other variable is less likely to take a specific value."]})})]})]}),e.jsxs(l,{gap:6,children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of phi coefficient values"}),e.jsx(i,{children:"The interpretation of phi coefficient values is as follows:"})]}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.1 to 0.3:"})," ","Small effect size"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.3 to 0.5:"})," ","Medium effect size"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:">0.5:"})," ","Large effect size"]})})]}),e.jsx(i,{mt:4,children:"The interpretation of the phi coefficient is context-dependent, and the above thresholds are general guidelines. For some applications, even smaller values might indicate meaningful associations, especially if sample sizes are large."})]})];return e.jsx(G,{explanationSections:t,example1:e.jsx(i,{children:"Example 1 content will go here (e.g., a scatterplot, numerical example, or walkthrough)."})})}function sv(){return e.jsxs(l,{gap:"md",children:[e.jsx(i,{fs:"italic",mt:0,children:"In children with croup, does the administration of corticosteroids reduce the rate of hospitalization compared to a placebo?"}),e.jsxs(f,{defaultValue:"studyDesign",children:[e.jsxs(f.List,{children:[e.jsx(f.Tab,{value:"studyDesign",children:"Study Design and Methods"}),e.jsx(f.Tab,{value:"effectSize",children:"Effect Size Measure & MCID"}),e.jsx(f.Tab,{value:"result",children:"Result"}),e.jsx(f.Tab,{value:"discussion",children:"Discussion and Future Research"})]}),e.jsx(f.Panel,{value:"studyDesign",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Clinical Research Study Design:"}),e.jsx(i,{children:"Randomized clinical trial"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Study Population:"}),e.jsx(i,{children:"The study population consists of 150 children diagnosed with croup. They were identified through collaboration with pediatric clinics, hospitals, and primary care providers."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Variables under Study:"}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Independent/Predictor/Exposure:"}),e.jsx(i,{children:"The independent variable in this study is the administration of corticosteroids, specifically dexamethasone. The experimental group receives dexamethasone, while the control group receives a placebo."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Dependent/Outcome:"}),e.jsx(i,{children:'The dependent variable is the rate of hospitalization, categorized as "hospitalized" or "not hospitalized", indicating whether the child was hospitalized for the management of croup.'})]})]})]})}),e.jsx(f.Panel,{value:"effectSize",pt:"md",children:e.jsx(l,{gap:"md",children:e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Effect Size Measure used in the Analytical Approach:"}),e.jsx(i,{children:"The effect size measure used in this study is the Phi Coefficient. It quantifies the strength and direction of association between the administration of corticosteroids and the rate of hospitalization."}),e.jsx(i,{children:"The 95% confidence interval provides a range within which the true effect size is likely to fall with 95% confidence."})]})})}),e.jsx(f.Panel,{value:"result",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Point Estimate"}),e.jsx(i,{children:"Phi coefficient () = 0.40"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Confidence Interval"}),e.jsx(i,{children:"95% CI [0.3, 0.5]"})]})]})}),e.jsx(f.Panel,{value:"discussion",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Results"}),e.jsx(i,{children:"A Phi Coefficient of 0.40 suggests a moderate association between the administration of corticosteroids and the rate of hospitalization in children with croup. The narrow confidence interval provides the investigator and reader with the understanding that all plausible results are compatible with a medium effect."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Implications of Results"}),e.jsx(i,{children:"This indicates that the corticosteroid intervention has a non-negligible impact on reducing the likelihood of hospitalization for these patients."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Future Research"}),e.jsx(i,{children:"While the study demonstrates a moderate effect size, further research is recommended to enhance knowledge in this area. Here are some suggestions for future research:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Subgroup Analysis:"})," ","Explore whether the effect of corticosteroids on hospitalization rates varies among different subgroups, such as age, severity of illness, or specific viral strains causing croup. This could provide valuable insights into tailoring treatment strategies based on individual patient characteristics."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Optimal Dosage and Duration:"})," ","Determine the optimal dosage and duration of corticosteroid therapy for croup treatment. By establishing the most effective regimen, clinical guidelines could be refined to optimize patient outcomes."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Adverse Events:"})," ","Conduct further investigation into potential adverse events associated with corticosteroid administration in children with croup. Understanding the safety profile of these interventions is essential for weighing the benefits against potential risks."]})})]})]})]})})]})]})}sv.title="A Randomized Clinical Trial Assessing the Impact of Corticosteroids on the Rate of Hospitalization in Children with Croup";function rv(){return e.jsxs(l,{gap:"md",children:[e.jsx(i,{fs:"italic",mt:0,children:"In children with acute peritonsillar abscess, what is the effect of antibiotics only, incision and drainage with antibiotics, or tonsillectomy on the rate of recurrence of peritonsillar abscess within the next 24 months?"}),e.jsxs(f,{defaultValue:"studyDesign",children:[e.jsxs(f.List,{children:[e.jsx(f.Tab,{value:"studyDesign",children:"Study Design and Methods"}),e.jsx(f.Tab,{value:"effectSize",children:"Effect Size Measure & MCID"}),e.jsx(f.Tab,{value:"result",children:"Result"}),e.jsx(f.Tab,{value:"discussion",children:"Discussion and Future Research"})]}),e.jsx(f.Panel,{value:"studyDesign",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Clinical Research Study Design:"}),e.jsx(i,{children:"Randomized Clinical Trial"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Study Population:"}),e.jsx(i,{children:"The study population consists of children diagnosed with acute peritonsillar abscess. Participants are identified through collaboration with pediatric clinics, hospitals, and otolaryngology departments."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Variables under Study:"}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Independent/Predictor/Exposure:"}),e.jsx(i,{children:"The independent variable in this study is the type of intervention. The experimental group 1 receives antibiotics only, the experimental group 2 undergoes incision and drainage with antibiotics, and the experimental group 3 undergoes tonsillectomy."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Dependent/Outcome:"}),e.jsx(i,{children:'The dependent variable is the rate of recurrence of peritonsillar abscess, categorized as "Yes" or "No", indicating whether the child experiences another episode within the next 24 months.'})]})]})]})}),e.jsx(f.Panel,{value:"effectSize",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Effect Size Measure used in the Analytical Approach:"}),e.jsx(i,{children:"The effect size measure used in this study is the Phi Coefficient. It quantifies the strength and direction of association between the different interventions and the rate of recurrence of peritonsillar abscess."}),e.jsx(i,{children:"The Phi Coefficient and 95% confidence intervals can be calculated for the pair-wise comparisons between the three interventions (Group 1 vs. Group 2, Group 1 vs. Group 3, Group 2 vs. Group 3). These values provide estimates of the effect size and the precision of the estimates between the interventions."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Minimal Clinically Important Difference (MCID):"}),e.jsx(i,{children:"Not applicable in this situation"})]})]})}),e.jsx(f.Panel,{value:"result",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Point Estimate:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsx(i,{children:"Group 1 (Antibiotics only) vs. Group 2 (Incision and drainage with antibiotics): Phi Coefficient = 0.11, indicating a small effect size."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"Group 1 (Antibiotics only) vs. Group 3 (Tonsillectomy): Phi Coefficient = 0.34, indicating a medium effect size."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"Group 2 (Incision and drainage with antibiotics) vs. Group 3 (Tonsillectomy): Phi Coefficient = 0.09, indicating a small effect size."})})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Confidence Interval:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsx(i,{children:"Group 1 (Antibiotics only) vs. Group 2 (Incision and drainage with antibiotics): 95% CI [0.08, 0.14], indicating a precise estimate."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"Group 1 (Antibiotics only) vs. Group 3 (Tonsillectomy): 95% CI [0.32, 0.36], indicating a precise estimate."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"Group 2 (Incision and drainage with antibiotics) vs. Group 3 (Tonsillectomy): 95% CI [0.06, 0.12], indicating a precise estimate."})})]})]})]})}),e.jsx(f.Panel,{value:"discussion",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Results"}),e.jsx(i,{children:"These results suggest that the lowest rate of recurrence is observed after tonsillectomy (Group 3), while the highest rate is associated with antibiotics only (Group 1). The effect sizes indicate a smaller difference between Group 1 and Group 2 (Antibiotics vs. Incision and drainage with antibiotics), a medium difference between Group 1 and Group 3 (Antibiotics vs. Tonsillectomy), and a smaller difference between Group 2 and Group 3 (Incision and drainage with antibiotics vs. Tonsillectomy)."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Implications of Results"}),e.jsx(i,{children:"The results of this study can elucidate the effectiveness of different interventions for preventing the recurrence of peritonsillar abscess in children. It can guide clinicians in making evidence-based decisions regarding the optimal management strategy for this condition."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Future Research"}),e.jsx(i,{children:"Based on the results of the pairwise comparisons between the three groups, there are a few potential areas for future research in this field:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Long-term follow-up:"})," ","Conducting a study with a longer follow-up period could provide insights into the durability of the interventions and their impact on recurrence rates over time. This would help determine whether the observed differences in recurrence rates persist in the long term."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Patient characteristics:"})," ","Investigate the influence of patient-specific factors on treatment outcomes. Factors such as age, comorbidities, severity of the abscess, and anatomical considerations may play a role in the effectiveness of different interventions. Analyzing these variables may help inform treatment decisions and identify patient subgroups that may benefit more from specific interventions."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Cost-effectiveness analysis:"})," ","Evaluate the cost-effectiveness of each intervention to help guide healthcare decision-makers in allocating resources. Understanding the economic implications of each treatment option can assist in determining the most efficient use of healthcare resources while considering the clinical benefits."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Patient-centered outcomes:"})," ","Expand the research to incorporate patient-centered outcomes, such as quality-of-life measurements, pain levels, and patient satisfaction. This would provide a more comprehensive understanding of the impact of different interventions on the overall well-being and experience of the patients."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Comparative effectiveness studies:"})," ","Conduct these studies to compare not only the interventions used in this study but also other potential treatment options, such as minimally invasive procedures or alternative antibiotic regimens. Comparing these interventions head-to-head can provide additional insights into their relative effectiveness and guide treatment decisions."]})})]})]})]})})]})]})}rv.title="Assessing Interventions for Peritonsillar Abscess Recurrence in Children: Antibiotics, Drainage, or Tonsillectomy?";const N5=[sv],_5=[rv];function L5(){const t=[e.jsx(l,{gap:4,children:e.jsx(i,{children:"The pseudo R-squared (R) measures the goodness-of-fit for models that do not inherently provide a traditional pseudo R value, like logistic regression. Specifically, it provides an indication of how well the chosen model explains the variation in the response variable. While it borrows its name from the pseudo R of linear regression, it is important to understand that these two values are not directly comparable."})}),e.jsxs(l,{gap:6,children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Range of pseudo R"}),e.jsx(i,{children:"Values for pseudo R can range between 0 and 1, but the interpretation is not always as straightforward as that of the traditional R:"})]}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Closer to 1:"})," ","This means that the model provides a better fit to the data as compared with a null model (i.e., a model without predictors). The closer the pseudo R is to 1, the stronger the model's explanatory power."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Around 0.5:"})," ","The model's fit is comparable to that of a null model, which suggests that the predictors in the model are not contributing much to explaining the variance in the dependent variable."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Closer to 0, but not 0:"})," ","This implies that the model provides some explanatory power, but it may still be weak. It suggests that the predictors have some influence, but the overall fit is not strong."]})})]})]}),e.jsxs(l,{gap:6,children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of pseudo R values"}),e.jsx(i,{children:"The interpretation of pseudo R values between variables is as follows:"})]}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"<0.10:"})," ","Low. These values suggest a weak association between the predictors and the outcome. The predictors collectively explain a small proportion of the variance in the outcome."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.10 to 0.30:"})," ","Moderate. These values suggest that the predictors contribute a moderate proportion of the variance in the outcome."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:">0.30:"})," ","High. These values suggest that the predictors collectively explain a substantial proportion of the variance in the outcome."]})})]}),e.jsx(i,{mt:4,children:"Keep in mind that several versions of the pseudo R exist (e.g., McFadden's, Nagelkerke's)."})]})];return e.jsx(G,{explanationSections:t,example1:e.jsx(i,{children:"Example 1 content will go here (e.g., a scatterplot, numerical example, or walkthrough)."})})}function av(){return e.jsxs(l,{gap:"md",children:[e.jsx(i,{fs:"italic",mt:0,children:"In patients followed for 2 years or more, what is the association between age, sex, race, cigarette smoking, BMI, exercise, and severity of comorbid ailments with the occurrence of a heart attack?"}),e.jsxs(f,{defaultValue:"studyDesign",children:[e.jsxs(f.List,{children:[e.jsx(f.Tab,{value:"studyDesign",children:"Study Design and Methods"}),e.jsx(f.Tab,{value:"effectSize",children:"Effect Size Measure & MCID"}),e.jsx(f.Tab,{value:"result",children:"Result"}),e.jsx(f.Tab,{value:"discussion",children:"Discussion and Future Research"})]}),e.jsx(f.Panel,{value:"studyDesign",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Clinical Research Study Design:"}),e.jsx(i,{children:"Prospective longitudinal cohort study"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Study Population:"}),e.jsx(i,{children:"The study population consists of individuals who were identified from a primary care database within a specific geographic region, ensuring representativeness of the general population. Participants were enrolled at baseline and followed prospectively for a minimum of 2 years. Inclusion criteria include adults aged 18 years and older with no history of previous heart attack at baseline and willingness to participate in regular follow-up assessments. Exclusion criteria include current acute cardiovascular disease at enrollment, terminal illness with a life expectancy of less than 2 years, and inability to provide informed consent or complete baseline assessments."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Variables under Study:"}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Independent/Predictor/Exposure:"}),e.jsx(i,{children:"The independent variables include age (continuous), sex (male/female), race (categorical: White, Black, Hispanic, Asian, Other), cigarette smoking status (categorical: current smoker, former smoker, never smoker), BMI (continuous), exercise level (categorical: sedentary, moderate, active), and the severity of comorbid ailments (measured using a validated comorbidity index). These variables were assessed at baseline."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Dependent/Outcome:"}),e.jsx(i,{children:"The outcome of interest is the occurrence of a heart attack (myocardial infarction) over the course of the 2-year follow-up period. A heart attack was defined according to standard diagnostic criteria, including cardiac biomarker elevation, electrocardiographic changes, and clinical symptoms, and was confirmed through medical record review."})]})]})]})}),e.jsx(f.Panel,{value:"effectSize",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Effect Size Measure used in the Analytical Approach:"}),e.jsx(i,{children:"Logistic regression analysis will be used to examine the associations between risk factors and the occurrence of a heart attack. The overall model performance will be assessed using the Pseudo R-squared effect size measure. The pseudo R-squared, also known as a goodness-of-fit measure, provides insight into how well the model fits the observed data and quantifies the improvement of the model over a null model (a model with only an intercept) in explaining the variance in the outcome variable."}),e.jsx(i,{children:"Pseudo R-squared values vary between 0 and 1, where 0 indicates that the predictors do not explain any variance in the outcome, and 1 indicates that the predictors perfectly explain the variance."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Minimal Clinically Important Difference (MCID):"}),e.jsx(i,{children:"Not applicable for Pseudo R-squared as it measures overall model fit and explained variance rather than a specific threshold difference."})]})]})}),e.jsx(f.Panel,{value:"result",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Point Estimate:"}),e.jsx(i,{children:"The Pseudo R-squared value is 0.45, indicating that the model explains a substantial proportion of the variance in heart attack occurrence."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Confidence Interval:"}),e.jsx(i,{children:"95% CI [0.38, 0.52], indicating a precise estimate."})]}),e.jsxs(l,{gap:0,children:[e.jsxs(i,{fw:500,children:["Probability Value (",e.jsx(i,{span:!0,fs:"italic",children:"P"}),"-value):"]}),e.jsxs(i,{children:[e.jsx(i,{span:!0,fs:"italic",children:"p"})," ","< 0.001, indicating that the overall model is statistically significant."]})]})]})}),e.jsx(f.Panel,{value:"discussion",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Results:"}),e.jsx(i,{children:"The Pseudo R-squared value of 0.45 indicates a high level of model fit, suggesting that the included risk factors collectively explain a substantial proportion (45%) of the variation in heart attack occurrence. This indicates that age, sex, race, cigarette smoking, BMI, exercise, and severity of comorbid ailments together have a strong association with the development of heart attacks."}),e.jsx(i,{children:`The 95% confidence interval (0.38 to 0.52) is relatively narrow, suggesting that the investigator and readers can be confident that the actual value for the model's explanatory power is close to the point estimate. The entire confidence interval falls within the "high association" range (0.30), indicating that the model consistently demonstrates strong predictive performance.`}),e.jsx(i,{children:"This high Pseudo R-squared value suggests that the selected risk factors are significant predictors of heart attack risk and that the model captures much of the variation in heart attack occurrence within this population. However, it also indicates that approximately 55% of the variance remains unexplained, suggesting that other factors not included in the model (such as genetic predispositions, psychosocial stress, diet quality, specific lipid profiles, inflammatory markers, or unmeasured lifestyle factors) may also contribute to heart attack risk."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Implications of Results:"}),e.jsx(i,{children:"Identifying these risk factors and their collective association with heart attacks can contribute to enhanced risk stratification and targeted preventive interventions. The strong model performance (Pseudo R = 0.45) demonstrates that these commonly measured clinical and demographic variables provide substantial predictive value for heart attack risk, which has several important implications:"}),e.jsx(i,{children:"Healthcare providers can utilize this knowledge to guide patient education and intervention strategies to reduce the risk of heart attacks. The model could be implemented as a risk assessment tool in primary care settings to identify high-risk individuals who would benefit from intensive preventive interventions such as smoking cessation programs, exercise prescriptions, weight management support, and closer monitoring for cardiovascular disease."}),e.jsx(i,{children:"Public health initiatives can focus on the modifiable risk factors identified in this modelparticularly cigarette smoking, BMI, and exerciseas targets for population-level prevention strategies. Health systems and policymakers can allocate resources toward programs addressing these factors to reduce the overall burden of heart attacks."}),e.jsx(i,{children:"The strong model performance validates the importance of comprehensive cardiovascular risk assessment that considers multiple factors simultaneously rather than focusing on single risk factors in isolation. This supports guideline recommendations for multifactorial risk assessment in cardiovascular disease prevention."}),e.jsx(i,{children:"The model could potentially be refined and validated for use in clinical decision support systems, helping clinicians identify patients who would benefit most from primary prevention strategies such as statin therapy, antihypertensive medications, or aspirin prophylaxis."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Future Research:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"External validation:"})," ","Validate the study findings and model performance in larger and more diverse populations across different geographic regions, healthcare systems, and racial/ethnic groups to assess generalizability and identify any population-specific factors that might affect model performance."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Interaction effects:"})," ","Investigate the interactions between different risk factors to understand synergistic effects. For example, explore whether the effect of smoking on heart attack risk differs by age group, sex, or presence of comorbidities, or whether certain combinations of risk factors confer particularly high or low risk."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Mechanistic pathways:"})," ","Conduct research to understand the biological mechanisms underlying how these risk factors influence heart attack development. This could include studies of inflammatory pathways, endothelial dysfunction, plaque formation, and thrombosis to provide insights into effective prevention strategies targeting specific pathways."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Additional risk factors:"})," ","Expand the model to include additional variables not examined in this study, such as detailed lipid profiles (LDL, HDL, triglycerides), blood pressure measurements, fasting glucose or HbA1c levels, family history of cardiovascular disease, psychosocial stress measures, diet quality scores, sleep patterns, and novel biomarkers (C-reactive protein, troponins, natriuretic peptides). This could potentially improve model performance beyond the current Pseudo R of 0.45."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Machine learning approaches:"})," ","Apply advanced machine learning algorithms (random forests, neural networks, gradient boosting) to identify non-linear relationships and complex interactions that traditional logistic regression may not capture. Compare the performance of these approaches to the traditional regression model."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Intervention studies:"})," ","Design and implement randomized controlled trials targeting the modifiable risk factors identified in this model (smoking cessation, weight reduction, exercise promotion) to demonstrate whether modifying these factors actually reduces heart attack incidence and to quantify the magnitude of risk reduction achievable through intervention."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Risk score development:"})," ","Develop and validate a simple clinical risk score based on this model that can be easily calculated and implemented in clinical practice for point-of-care risk assessment."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Temporal dynamics:"})," ","Investigate how changes in risk factors over time affect heart attack risk. Conduct analyses examining whether improvements in modifiable risk factors (quitting smoking, increasing exercise, losing weight) lead to corresponding reductions in heart attack risk."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Healthcare utilization and outcomes:"})," ","Assess whether implementing risk stratification based on this model leads to improved healthcare delivery, more appropriate preventive treatment allocation, reduced cardiovascular events, and cost-effective resource utilization."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Subgroup-specific models:"})," ","Develop and validate separate prediction models for specific subpopulations (e.g., by age group, sex, or racial/ethnic group) to determine whether customized models improve prediction accuracy compared to a one-size-fits-all approach."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Competing risks analysis:"})," ","Conduct competing risks analyses to account for other causes of morbidity and mortality that may prevent heart attacks from occurring, providing a more nuanced understanding of cardiovascular risk in the context of overall health."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Long-term follow-up:"})," ","Extend the follow-up period beyond 2 years to assess whether the identified risk factors predict heart attack risk over longer time horizons (5, 10, or 20 years) and whether the relative importance of different risk factors changes over time."]})})]})]})]})})]})]})}av.title="Prospective Longitudinal Cohort Study Investigating Risk Factors for the Development of Heart Attack";const O5=[av];function F5(){const t=[e.jsx(l,{gap:4,children:e.jsx(i,{children:"The concordance index (C-index), which is also known as the area under the receiver operating characteristic curve (AUC-ROC), is a performance measure used to evaluate the discriminatory power and predictive accuracy of a regression model, particularly in binary classification tasks. The C-index measures the ability of a predictive model to correctly rank pairs of observations: one with the event of interest (e.g., disease occurrence) and the other without."})}),e.jsxs(l,{gap:6,children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Range of C-index"}),e.jsx(i,{children:"C-index values range from 0.5 to 1. The interpretation revolves around the model's ability to correctly rank subjects based on their risk scores:"})]}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Closer to 1:"})," ","This indicates strong predictive accuracy and suggests that the model has a high probability of correctly ranking pairs of subjects in order of their event times."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Around 0.5:"})," ","This implies that the model has no better discriminatory power than random chance."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Closer to 0:"})," ","This suggests that the model consistently predicts in the opposite direction, thus implying poor predictive accuracy."]})})]})]}),e.jsxs(l,{gap:6,children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of C-index values"}),e.jsx(i,{children:"The interpretation of C-index values between variables is as follows:"})]}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.5:"})," ","Random performance or no discrimination (equivalent to flipping a coin)"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.7 to 0.8:"})," ","Acceptable discrimination, suggesting some ability to distinguish between event and nonevent cases"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.8 to 0.9:"})," ","Good discrimination, indicating a strong ability to distinguish between event and nonevent cases"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.9 to 1.0:"})," ","Excellent discrimination, suggesting a near-perfect ability to discriminate between event and nonevent cases"]})})]})]})];return e.jsx(G,{explanationSections:t,example1:e.jsx(i,{children:"Example 1 content will go here (e.g., a scatterplot, numerical example, or walkthrough)."})})}function ov(){return e.jsxs(l,{gap:"md",children:[e.jsx(i,{fs:"italic",mt:0,children:"In patients with rheumatic diseases, does a regression model incorporating various independent variables accurately predict the occurrence of disease exacerbations?"}),e.jsxs(f,{defaultValue:"studyDesign",children:[e.jsxs(f.List,{children:[e.jsx(f.Tab,{value:"studyDesign",children:"Study Design and Methods"}),e.jsx(f.Tab,{value:"effectSize",children:"Effect Size Measure & MCID"}),e.jsx(f.Tab,{value:"result",children:"Result"}),e.jsx(f.Tab,{value:"discussion",children:"Discussion and Future Research"})]}),e.jsx(f.Panel,{value:"studyDesign",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Clinical Research Study Design:"}),e.jsx(i,{children:"Prospective longitudinal cohort study"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Study Population:"}),e.jsx(i,{children:"The study population consists of patients diagnosed with rheumatic diseases, such as rheumatoid arthritis, systemic lupus erythematosus, or psoriatic arthritis, who are recruited from rheumatology clinics in a specific geographic area. Participants were enrolled at baseline and followed prospectively for 12 months to monitor for disease exacerbations. Inclusion criteria include adults aged 18 years and older with a confirmed diagnosis of a rheumatic disease for at least 6 months, stable disease activity at enrollment, and willingness to participate in regular follow-up assessments. Exclusion criteria include other major comorbidities that could confound disease exacerbation assessment (such as active malignancy or severe uncontrolled infections), inability to attend follow-up visits, and inability to provide informed consent."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Variables under Study:"}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Independent/Predictor/Exposure:"}),e.jsx(i,{children:"The independent variables include demographic characteristics (age, sex), disease-specific factors (disease duration, baseline disease severity measured by validated disease activity scores), treatment modalities (medication use including disease-modifying antirheumatic drugs, biologic agents, corticosteroids; physical therapy participation), and lifestyle factors (smoking status categorized as current/former/never, physical activity level categorized as sedentary/moderate/active, body mass index). These variables were assessed at baseline."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Dependent/Outcome:"}),e.jsx(i,{children:"The dependent measure is the occurrence of disease exacerbation during the follow-up period, which is classified as a binary outcome (present/absent). Disease exacerbation was defined as a clinically significant worsening of disease activity requiring escalation of therapy, hospitalization, or meeting validated criteria for disease flare specific to each rheumatic condition."})]})]})]})}),e.jsx(f.Panel,{value:"effectSize",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Effect Size Measure used in the Analytical Approach:"}),e.jsx(i,{children:"A logistic regression model will be constructed using the independent variables, and the performance of the model will be evaluated using the c-statistic (area under the receiver operating characteristic curve, AUC-ROC) as the effect size measure. The c-statistic, also known as the C-index or concordance index, is a performance measure used to evaluate the discriminatory power and predictive accuracy of a regression model, particularly in binary classification tasks. The c-index measures the ability of a predictive model to correctly rank pairs of observations, one with the event of interest (disease exacerbation) and the other without. It ranges from 0 to 1, where 0.5 indicates random performance (like chance), and 1 indicates perfect discrimination."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Minimal Clinically Important Difference (MCID):"}),e.jsx(i,{children:"Not applicable for the c-statistic as it measures overall model discrimination rather than a specific threshold difference. However, a c-statistic 0.70 is generally considered clinically useful for prediction models."})]})]})}),e.jsx(f.Panel,{value:"result",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Point Estimate:"}),e.jsx(i,{children:"The c-statistic (AUC-ROC) is 0.78, indicating acceptable discrimination."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Confidence Interval:"}),e.jsx(i,{children:"95% CI [0.72, 0.84], indicating a reasonably precise estimate."})]})]})}),e.jsx(f.Panel,{value:"discussion",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Results:"}),e.jsx(i,{children:"The c-statistic of 0.78 suggests that the regression model has acceptable discrimination, or the ability to correctly rank pairs of observations, with one having a disease exacerbation and the other without. This indicates that the included independent variables contribute meaningfully to the predictive capacity of the model for disease exacerbations in rheumatic patients."}),e.jsx(i,{children:`The 95% confidence interval (0.72 to 0.84) is reasonably narrow and entirely falls within the "acceptable to good discrimination" range, suggesting that the model's discriminatory performance is consistent and reliable. The entire confidence interval is above 0.70, which is generally considered the threshold for clinically useful prediction models, providing confidence that the model has meaningful predictive utility.`}),e.jsx(i,{children:"A c-statistic of 0.78 means that if we randomly select one patient who experienced a disease exacerbation and one patient who did not, there is a 78% probability that the model will assign a higher predicted risk to the patient who experienced the exacerbation. This represents a substantial improvement over random chance (which would be 50%) and indicates that the model can meaningfully stratify patients by their risk of disease exacerbation."}),e.jsx(i,{children:"While the model demonstrates acceptable discrimination, the c-statistic of 0.78 also indicates room for improvement. Approximately 22% of the time, the model may incorrectly rank patient pairs, suggesting that additional factors not captured by the current variables may influence disease exacerbation risk."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Implications of Results:"}),e.jsx(i,{children:"The results suggest that the regression model incorporating the identified independent variables can potentially help clinicians in rheumatology clinics identify patients at higher risk of experiencing disease exacerbations. This knowledge can aid in implementing preventive measures, adjusting treatment strategies, and providing personalized care to improve patient outcomes."}),e.jsx(i,{children:"The acceptable discriminatory performance (c-statistic = 0.78) indicates that this risk prediction model could be implemented as a clinical decision support tool in rheumatology practice. Clinicians could use the model to:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsx(i,{children:"Identify high-risk patients who may benefit from more intensive monitoring, earlier treatment escalation, or proactive preventive interventions before exacerbations occur."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"Stratify patients for different management pathways, with high-risk patients receiving closer follow-up (e.g., monthly visits) and low-risk patients potentially suitable for less frequent monitoring."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"Support shared decision-making discussions with patients about their individual exacerbation risk and the potential benefits of various treatment intensification strategies or lifestyle modifications."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"Optimize resource allocation by targeting intensive interventions to patients most likely to benefit based on their predicted risk profile."})})]}),e.jsx(i,{children:"The model's performance suggests that readily measurable clinical and demographic factors can provide meaningful prognostic information, making the tool practical for implementation in routine clinical practice without requiring expensive or invasive testing."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Future Research:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"External validation:"})," ","Validate the discriminatory power of the regression model in larger populations, diverse geographic settings, different healthcare systems, and across various subtypes of rheumatic diseases to assess generalizability and identify any population-specific factors that might affect model performance."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Model refinement:"})," ","Investigate the inclusion of additional factors that could improve the predictive accuracy and enhance the clinical utility of the model. Potential additions include: genetic markers (e.g., HLA alleles, specific single-nucleotide polymorphisms associated with disease severity), biomarkers (e.g., inflammatory markers like C-reactive protein, erythrocyte sedimentation rate, specific autoantibodies, cytokine profiles), patient-reported outcomes (pain scores, fatigue levels, quality of life measures), medication adherence measures, psychosocial factors (stress levels, depression, anxiety, social support), environmental exposures, and comorbidity burden measured by validated indices, like the Adult Comorbidity Evaluation-27."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Model calibration assessment:"})," ","Evaluate not only discrimination (assessed by c-statistic) but also calibrationhow well predicted probabilities match observed exacerbation rates. Calibration plots and Hosmer-Lemeshow tests should be performed to assess whether the model provides accurate absolute risk estimates."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Clinical utility studies:"})," ","Conduct prospective implementation studies to assess whether using the prediction model in clinical practice actually improves patient outcomes, reduces exacerbations, enhances quality of life, or improves cost-effectiveness compared to standard care without risk stratification."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Dynamic prediction models:"})," ","Develop and validate dynamic prediction models that incorporate longitudinal changes in risk factors over time, as disease characteristics, treatment responses, and other factors evolve during follow-up. Time-varying covariates may improve prediction accuracy."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Subgroup-specific models:"})," ","Investigate whether separate prediction models for specific rheumatic disease subtypes (rheumatoid arthritis-specific, lupus-specific, etc.) provide better discrimination than a general model across all rheumatic diseases."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Machine learning approaches:"})," ","Apply advanced machine learning algorithms (random forests, gradient boosting, neural networks) to identify non-linear relationships and complex interactions that traditional logistic regression may not capture. Compare the performance of these approaches to the current model."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Decision curve analysis:"})," ","Perform decision curve analysis to determine the net benefit of using the prediction model across different risk thresholds and to identify the optimal risk threshold for clinical decision-making."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Implementation science research:"})," ","Study the barriers and facilitators to implementing the risk prediction model in routine clinical practice, including clinician acceptance, workflow integration, electronic health record compatibility, and patient perspectives on risk-based care."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Cost-effectiveness analysis:"})," ","Assess the value of implementing risk-based care using the prediction model, weighing monitoring costs, preventive measures, and exacerbation management against potential benefits like fewer disease flares and complications."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Prediction of specific exacerbation types:"})," ","Investigate whether the model can predict specific types of exacerbations (e.g., severe vs. mild, organ-specific manifestations, treatment-requiring vs. self-limiting) to enable even more targeted preventive strategies."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Integration with other prediction tools:"})," ","Assess whether combining this exacerbation risk model with other validated risk prediction tools (e.g., cardiovascular risk calculators, infection risk scores) provides a more comprehensive risk profile for patients with rheumatic diseases who face multiple health threats."]})})]})]})]})})]})]})}ov.title="Identification of Risk Factors Associated with Disease Exacerbation in Patients with Various Rheumatic Diseases";const $5=[ov];function B5(){const t=[e.jsx(l,{gap:4,children:e.jsx(i,{children:"Percent correctly classified is a statistic used to quantify the accuracy of classification models. Specifically, it measures the proportion of observations that are accurately predicted by the model. It is particularly useful for evaluating the performance of models in categorical outcome scenarios, such as binary or multinomial classification tasks."})}),e.jsxs(l,{gap:6,children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Range of percent correctly classified"}),e.jsx(i,{children:"Percent correctly classified values range from 0% to 100%. The interpretation revolves around the model's ability to predict the correct categories:"})]}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Closer to 100%:"})," ","This indicates a high level of accuracy, with a larger proportion of observations correctly classified by the model."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Around 50% (for binary classification):"})," ","This implies that the model performs no better than random guessing."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Closer to 0%:"})," ","This suggests a low level of accuracy, with a larger proportion of observations misclassified by the model."]})})]})]}),e.jsxs(l,{gap:6,children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of percent correctly classified"}),e.jsx(i,{children:"The interpretation of the percent correctly classified between variables is as follows:"})]}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"<60%:"})," ","Very low percent correctly classified. The model's predictive accuracy is minimal, and its ability implies near-random performance."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"60% to 69%:"})," ","Low percent correctly classified. The model's predictive accuracy is limited, and its performance may not be reliable or satisfactory."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"70% to 89%:"})," ","Moderate percent correctly classified. The model demonstrates reasonable predictive accuracy, but there is room for improvement."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:">90%:"})," ","High percent correctly classified. The model has a strong ability to accurately classify cases, thus indicating good predictive performance."]})})]})]})];return e.jsx(G,{explanationSections:t,example1:e.jsx(i,{children:"Example 1 content will go here (e.g., a scatterplot, numerical example, or walkthrough)."})})}function lv(){return e.jsxs(l,{gap:"md",children:[e.jsx(i,{fs:"italic",mt:0,children:"In pediatric patients with orbital cellulitis receiving intravenous antibiotics, what factors are associated with treatment response, defined as the resolution of orbital cellulitis without surgical intervention?"}),e.jsxs(f,{defaultValue:"studyDesign",children:[e.jsxs(f.List,{children:[e.jsx(f.Tab,{value:"studyDesign",children:"Study Design and Methods"}),e.jsx(f.Tab,{value:"effectSize",children:"Effect Size Measure & MCID"}),e.jsx(f.Tab,{value:"result",children:"Result"}),e.jsx(f.Tab,{value:"discussion",children:"Discussion and Future Research"})]}),e.jsx(f.Panel,{value:"studyDesign",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Clinical Research Study Design:"}),e.jsx(i,{children:"Prospective cohort study"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Study Population:"}),e.jsx(i,{children:"The study includes pediatric patients (ages 2-18 years) diagnosed with orbital cellulitis and admitted to a pediatric hospital, with consultations from ophthalmology and otolaryngology departments. Participants were enrolled upon hospital admission and monitored until the treatment outcome was reached. Inclusion criteria consist of children aged 2-18 years with radiographically confirmed orbital cellulitis (defined as inflammation of orbital tissues posterior to the orbital septum) who received intravenous antibiotic therapy. Exclusion criteria include prior surgical intervention before enrollment, orbital trauma, orbital tumors, previous orbital surgery, and incomplete treatment data."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Variables under Study:"}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Independent/Predictor/Exposure:"}),e.jsx(i,{children:"The independent variables consist of demographic factors (age, sex), clinical characteristics (duration of symptoms before presentation, presence and severity of signs of systemic illness including fever and elevated white blood cell count), imaging findings (extent of orbital involvement on CT or MRI, presence and size of abscess formation, involvement of specific orbital structures), laboratory results (inflammatory markers such as C-reactive protein and erythrocyte sedimentation rate, white blood cell count), and comorbidities (such as immunosuppression, chronic or acute sinusitis, diabetes). All variables were evaluated at baseline during the initial hospital admission."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Dependent/Outcome:"}),e.jsx(i,{children:'The dependent variable is treatment response, categorized as "Responder" (resolution of orbital cellulitis without surgical intervention, defined as clinical improvement with resolution of orbital signs and symptoms on antibiotics alone) or "Non-responder" (received surgical intervention due to failure to resolve with antibiotics, including procedures such as abscess drainage or orbital decompression).'})]})]})]})}),e.jsx(f.Panel,{value:"effectSize",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Effect Size Measure used in the Analytical Approach:"}),e.jsx(i,{children:`Logistic regression analysis will be used to assess the association between the independent variables and treatment response. The overall performance of the model will be evaluated using the "Percent Correctly Classified" (also called overall classification accuracy) effect size measure. This measure quantifies the proportion of cases or observations that the statistical model correctly classifies or predicts. It directly reflects the model's ability to assign observations to their true categories accurately and is presented as a percentage ranging from 0% (no correct classifications) to 100% (all classifications are correct).`})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Minimal Clinically Important Difference (MCID):"}),e.jsx(i,{children:"Not applicable for percent correctly classified since it measures overall model accuracy rather than a specific threshold difference. However, classification accuracy 70% is generally considered acceptable for clinical prediction models in pediatric infectious disease contexts."})]})]})}),e.jsx(f.Panel,{value:"result",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Point Estimate:"}),e.jsx(i,{children:"The model exhibits an overall predictive accuracy of 75%, correctly identifying the treatment response category in 75% of the pediatric patients with orbital cellulitis."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Confidence Interval:"}),e.jsx(i,{children:"95% CI [68%, 82%], indicating a reasonably precise estimate of the model's predictive accuracy."})]}),e.jsxs(l,{gap:0,children:[e.jsxs(i,{fw:500,children:["Probability Value (",e.jsx(i,{span:!0,fs:"italic",children:"P"}),"-value):"]}),e.jsxs(i,{children:[e.jsx(i,{span:!0,fs:"italic",children:"p"})," ","< 0.001, indicating that the model's classification accuracy is significantly better than chance (which would be approximately 50% for a binary outcome)."]})]})]})}),e.jsx(f.Panel,{value:"discussion",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Results:"}),e.jsx(i,{children:"The Percent Correctly Classified effect size of 75% indicates that the regression model has a moderate ability to accurately categorize pediatric patients with orbital cellulitis into responders and non-responders based on the included independent variables. This means that when predicting treatment response, the model correctly determines the actual outcome (whether the patient will respond to antibiotics alone or need surgery) in three out of four cases."}),e.jsx(i,{children:`The 95% confidence interval (68% to 82%) is fairly narrow, indicating a precise estimate of the model's predictive accuracy. The entire interval falls within the "moderate predictive accuracy" range (70% to 89%), showing consistent performance. The lower bound of 68% nears the acceptable threshold for clinical utility, while the upper bound of 82% suggests the model could perform quite well in certain populations.`}),e.jsx(i,{children:"The model's performance shows that the chosen predictorsdemographic factors, clinical characteristics, imaging findings, laboratory results, and comorbiditiescollectively offer useful information for predicting treatment outcomes. However, the 75% accuracy also means that 25% of cases are misclassified, indicating the model does not correctly predict the treatment outcome in one out of four patients. This suggests that additional factors not included in the current model may also affect treatment response, or that some inherent unpredictability exists in the clinical course of orbital cellulitis."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Implications of Results:"}),e.jsx(i,{children:"The findings indicate that the identified predictors have moderate discriminatory power in determining the likelihood of treatment success without surgical intervention for pediatric patients with orbital cellulitis. This information can aid clinicians in several important ways:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Risk stratification:"})," ","The model can help identify patients at higher risk of treatment failure who may benefit from earlier surgical consultation, closer monitoring, or more aggressive initial management strategies."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Treatment decision-making:"})," ","Clinicians can use the model to facilitate shared decision-making with families regarding the likelihood of antibiotic success versus the potential need for surgical intervention, helping establish realistic expectations."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Resource allocation:"})," ","Healthcare systems can use the model to help allocate resources effectively, such as identifying patients who require intensive monitoring, earlier imaging follow-up, or faster access to the surgical team."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Clinical pathway development:"})," ","The predictive model could be incorporated into standardized clinical pathways for managing pediatric orbital cellulitis, guiding escalation of care decisions based on individual patient risk profiles."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Patient counseling:"})," ","The model provides objective data to help families understand their child's prognosis and prepare for potential outcomes, including the possibility of surgical intervention."]})})]}),e.jsx(i,{children:"However, clinicians should interpret the model's predictions in the context of its 75% accuracy and recognize that individual clinical judgment remains essential. The model should serve as a decision support tool rather than a definitive predictor, and clinical deterioration should always prompt reassessment regardless of the initial prediction."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Future Research:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"External validation:"})," ","Confirm these findings in larger and more diverse groups of pediatric patients with orbital cellulitis across multiple institutions, geographic regions, and healthcare settings to evaluate generalizability and identify any population-specific factors that might influence model performance."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Model refinement and enhancement:"})," ","Investigate the incorporation of additional factors that may improve predictive accuracy, including: microbiological data (specific pathogens identified from blood cultures, sinus aspirates, or abscess cultures; antibiotic sensitivities), response to initial antibiotic therapy (clinical improvement within first 24-48 hours, change in inflammatory markers), specific antibiotic regimens used, abscess characteristics (precise location, volume, multilocularity), additional biomarkers (procalcitonin, specific cytokines), orbital compartment pressure measurements, and visual function parameters (visual acuity, extraocular motility, pupillary responses)."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Machine learning approaches:"})," ","Apply advanced machine learning algorithms (random forests, support vector machines, neural networks) to identify non-linear relationships and complex interactions that traditional logistic regression may not capture. Compare performance to the current model."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Time-series modeling:"})," ","Develop dynamic prediction models that incorporate changes in clinical parameters over time (such as temperature trends, inflammatory marker trajectories, imaging changes on serial scans) rather than relying solely on baseline characteristics. This could improve prediction accuracy by accounting for treatment response patterns."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Sensitivity and specificity analysis:"})," ","Perform a detailed evaluation of the model's sensitivity (ability to accurately identify non-responders who will need surgery) and specificity (ability to correctly identify responders who will improve with antibiotics alone). Recognizing which type of misclassification occurs more frequently can help guide model improvements and clinical use."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Decision threshold optimization:"})," ","Explore various probability thresholds to classify patients as responders or non-responders, aiming to find the best balance between sensitivity and specificity based on clinical priorities (such as reducing unnecessary surgeries or preventing delayed surgical intervention)."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Subgroup analyses:"})," ","Determine whether model performance differs across patient age groups, specific comorbidities, causative organisms, or initial disease severity. Subgroup-specific models may offer improved predictions for certain patient populations."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Clinical impact studies:"})," ","Perform prospective implementation studies to determine whether using the prediction model in clinical practice truly enhances patient outcomes, shortens time to appropriate treatment (antibiotics vs. surgery), reduces hospital length of stay, or improves resource utilization compared to standard care without the model."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Cost-effectiveness analysis:"})," ","Assess the value of implementing the prediction model by considering the costs of model development and deployment, the benefits of earlier appropriate surgical intervention in high-risk patients, and the potential to avoid unnecessary surgeries in low-risk patients."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Longitudinal outcome tracking:"})," ","Follow patients over the long term to evaluate outcomes beyond the initial hospitalization, including rates of recurrent orbital cellulitis, chronic sinus disease, visual complications, and quality of life measures. This can help determine if certain predictors also indicate long-term results."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Comparison with clinician judgment:"})," ","Evaluate the model's predictive accuracy against experienced clinicians' predictions to determine if the model provides additional value beyond clinical judgment and to identify cases where the model and clinical judgment contrast."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Development of clinical decision support tools:"})," ","If successfully validated, create user-friendly tools such as web-based calculators, mobile apps, and electronic health record integrations that enable clinicians to quickly input patient data and receive risk predictions during patient care."]})})]})]})]})})]})]})}lv.title="Pediatric Study on Predictors of Treatment Response in Orbital Cellulitis";const H5=[lv];function Go(){const t=[e.jsx(l,{gap:4,children:e.jsx(i,{children:"The odds ratio (OR) is used to analyze results from case-control studies. Due to its suitability for comparing the odds of an outcome between two groups, it can also be used in other clinical research circumstances. The OR quantifies how much larger the odds for exposure (risk factor) are among cases as compared with controls."})}),e.jsxs(l,{gap:6,children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Range of OR"}),e.jsx(i,{children:"OR values can range from 0 to positive infinity:"})]}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"OR = 1:"})," ","This indicates that there is no association between the exposure and the outcome, which suggests that the odds of the event are the same in both the exposed and nonexposed groups."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"OR > 1:"})," ","This shows that the odds of the event are higher in the exposed group as compared with the nonexposed group."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"OR < 1:"})," ","This implies that the odds of the event are lower in the exposed group as compared with the nonexposed group."]})})]}),e.jsx(i,{mt:4,children:"Note that the OR value cannot be negative."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation"}),e.jsx(i,{children:"Interpreting the exact values of ORs is context-dependent and involves consideration of the specific domain, dataset, or health outcome being assessed. Although OR values greater than 1 indicate increased odds due to exposure and those less than 1 indicate decreased odds, the specific thresholds for what is considered significant or clinically relevant can vary."})]})];return e.jsx(G,{explanationSections:t,example1:e.jsx(i,{children:"Example 1 content will go here (e.g., a scatterplot, numerical example, or walkthrough)."})})}function cv(){return e.jsxs(l,{gap:"md",children:[e.jsx(i,{fs:"italic",mt:0,children:"In adult patients, is there an association between long-term use of acetaminophen, long-term use of ibuprofen, or no pain medication use and the development of liver failure?"}),e.jsxs(f,{defaultValue:"studyDesign",children:[e.jsxs(f.List,{children:[e.jsx(f.Tab,{value:"studyDesign",children:"Study Design and Methods"}),e.jsx(f.Tab,{value:"effectSize",children:"Effect Size Measure & MCID"}),e.jsx(f.Tab,{value:"result",children:"Result"}),e.jsx(f.Tab,{value:"discussion",children:"Discussion and Future Research"})]}),e.jsx(f.Panel,{value:"studyDesign",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Clinical Research Study Design:"}),e.jsx(i,{children:"Case-control study"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Study Population:"}),e.jsx(i,{children:"The study sample consisted of 1,500 adult patients with no history of hepatitis who were seen at a tertiary medical center between 2010 and 2020. The cases were 500 patients diagnosed with liver failure. The controls were 1,000 patients without liver failure who were matched with cases based on history of alcohol consumption, age, sex, and history of hepatitis C. Participants were categorized into three groups based on their pain medication use history: Group 1 (long-term acetaminophen use), Group 2 (long-term ibuprofen use), and Group 3 (no long-term pain medication use)."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Variables under Study:"}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Independent/Predictor/Exposure:"}),e.jsx(i,{children:"The independent variable is long-term pain medication exposure history. Group 1 had long-term exposure to acetaminophen, defined as use of the recommended dosage of acetaminophen (325 mg every 3-4 hours) or higher every day for at least a month. Group 2 had long-term exposure to ibuprofen, defined as use of the recommended dosage of ibuprofen (200-400 mg every 4-6 hours) or higher every day for at least a month. Group 3 had no long-term pain medication use."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Dependent/Outcome:"}),e.jsx(i,{children:"The dependent variable is the occurrence of liver failure (yes/no)."})]})]})]})}),e.jsx(f.Panel,{value:"effectSize",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Effect Size Measure used in the Analytical Approach:"}),e.jsx(i,{children:"The effect size measure used in this study is the odds ratio (OR). It quantifies the strength and direction of association between different pain medication exposures and the occurrence of liver failure."}),e.jsx(i,{children:"The odds ratio and 95% confidence intervals can be calculated for the pair-wise comparisons between the three groups (Group 1 vs. Group 2, Group 1 vs. Group 3, Group 2 vs. Group 3). These values provide estimates of the effect size and the precision of the estimates between the exposure groups."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Minimal Clinically Important Difference (MCID):"}),e.jsx(i,{children:"Investigators determined that an odds ratio of 2.0 or greater would be clinically meaningful for the association between pain medication use and liver failure."})]})]})}),e.jsx(f.Panel,{value:"result",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Point Estimate:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsx(i,{children:"Group 1 (Acetaminophen) vs. Group 3 (No pain medication): OR = 2.7, indicating that the odds of liver failure are 2.7 times higher in acetaminophen users compared to non-users."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"Group 2 (Ibuprofen) vs. Group 3 (No pain medication): OR = 1.5, indicating that the odds of liver failure are 1.5 times higher in ibuprofen users compared to non-users."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"Group 1 (Acetaminophen) vs. Group 2 (Ibuprofen): OR = 1.8, indicating that the odds of liver failure are 1.8 times higher in acetaminophen users compared to ibuprofen users."})})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Confidence Interval:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsx(i,{children:"Group 1 (Acetaminophen) vs. Group 3 (No pain medication): 95% CI [1.9, 3.7], indicating a relatively narrow confidence interval and a precise estimate."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"Group 2 (Ibuprofen) vs. Group 3 (No pain medication): 95% CI [1.1, 2.1], indicating a relatively narrow confidence interval and a precise estimate."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"Group 1 (Acetaminophen) vs. Group 2 (Ibuprofen): 95% CI [1.3, 2.5], indicating a relatively narrow confidence interval and a precise estimate."})})]})]}),e.jsxs(l,{gap:0,children:[e.jsxs(i,{fw:500,children:["Probability Value (",e.jsx(i,{span:!0,fs:"italic",children:"P"}),"-value):"]}),e.jsxs(i,{children:["All comparisons:"," ",e.jsx(i,{span:!0,fs:"italic",children:"p"})," ","< 0.0001, indicating statistically significant results."]})]})]})}),e.jsx(f.Panel,{value:"discussion",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Results:"}),e.jsx(i,{children:"These results suggest that long-term acetaminophen use has the strongest association with liver failure, with odds 2.7 times higher compared to no pain medication use. Long-term ibuprofen use also shows an association with liver failure, though weaker, with odds 1.5 times higher compared to no pain medication use. When comparing the two medications directly, acetaminophen users have 1.8 times higher odds of liver failure compared to ibuprofen users."}),e.jsx(i,{children:"The effect sizes indicate a clinically meaningful difference between acetaminophen use and no medication use (OR = 2.7, exceeding the MCID of 2.0). The comparison between ibuprofen use and no medication use shows a smaller difference (OR = 1.5, below the MCID), though the lower bound of the confidence interval (1.1) is close to 1.0, suggesting some uncertainty about clinical meaningfulness. The comparison between acetaminophen and ibuprofen use shows a borderline clinically meaningful difference (OR = 1.8, approaching the MCID)."}),e.jsx(i,{children:"All confidence intervals are relatively narrow and indicate precise estimates. The confidence interval for acetaminophen versus no medication (1.9 to 3.7) has a lower bound just barely below the MCID of 2.0, meaning it is possible that long-term acetaminophen exposure is not associated with a clinically meaningful increase in liver failure, although the vast majority of the confidence interval is above the MCID of 2.0. The confidence interval for ibuprofen versus no medication (1.1 to 2.1) crosses the MCID, indicating uncertainty about whether this association is clinically meaningful, though it remains statistically significant."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Implications of Results:"}),e.jsx(i,{children:"These findings indicate clinically meaningful associations between long-term pain medication use and increased risk of liver failure, with acetaminophen showing the strongest association. Healthcare providers should exercise caution when recommending long-term pain medication use, particularly acetaminophen, and consider alternative pain relief options, especially for individuals at risk of liver disease. For patients with the need for long-term pain relief, these results suggest that ibuprofen may present a lower risk for liver failure compared to acetaminophen. However, both medications show an elevated risk compared to no medication use. Further research with larger sample sizes is needed to more conclusively determine if these associations represent clinically significant relationships, particularly for the ibuprofen comparison."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Future Research:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Larger sample size studies:"})," ","Conduct studies with larger sample sizes to narrow the confidence intervals and more definitively determine if these associations represent clinically meaningful relationships, particularly for the comparisons that approach or cross the MCID threshold."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Dose-response relationship:"})," ","Investigate whether there is a threshold dose below which acetaminophen or ibuprofen use might be considered safer for long-term use. Establishing safe dosage guidelines could help clinicians balance pain management needs with liver safety."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Interaction effects:"})," ","Examine the potential interaction of acetaminophen and ibuprofen with other risk factors for liver failure, such as alcohol consumption patterns, concurrent medication use, nutritional status, and genetic predispositions. Understanding these interactions could help identify particularly vulnerable patient populations."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Comparative effectiveness of alternative pain management:"})," ","Evaluate the effectiveness and safety profiles of other pain relief options, including other NSAIDs, opioid medications, topical analgesics, and non-pharmacological interventions. This research would provide healthcare providers with a broader evidence base for informed decision-making regarding long-term pain management."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Subgroup and stratification analyses:"})," ","Conduct detailed analyses on specific subsets of the study population (i.e., prognostic stratification), such as different age groups, genders, body mass indices, or comorbidities, to uncover variations in medication-related liver failure risk. This statistical exploration helps identify which subgroups may be at elevated (or reduced) risk of liver failure, and thus, alternative therapies should be (or not) explored. This prognostic stratification approach enhances personalized treatment approaches. Yet, with any subgroup analysis, it is crucial to be aware of the associated statistical power of each analysis and consider potential biases that may be present."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Prospective cohort studies:"})," ","While the current case-control design provides valuable association data, prospective cohort studies could establish temporal relationships more definitively and reduce potential recall bias regarding medication use history."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Mechanistic studies:"})," ","Explore the biological mechanisms by which acetaminophen and ibuprofen contribute to liver failure, including metabolic pathways, oxidative stress, and cellular damage patterns. Understanding these mechanisms could lead to preventive strategies or protective interventions."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Comparative Effectiveness Research (CER):"})," ","Compare the effectiveness of these pain medications with alternative treatments or strategies to provide healthcare providers with evidence for informed decision-making. In CER, it's crucial to address biases specific to comparative studies, such as ensuring comparability between study groups and choosing relevant comparators and endpoints."]})})]})]})]})})]})]})}cv.title="Association Between Long-Term Pain Medication Use and Liver Failure: A Multi-Group Case-Control Analysis";function dv(){return e.jsxs(l,{gap:"md",children:[e.jsx(i,{fs:"italic",mt:0,children:"In adults undergoing abdominal surgery, does minimally invasive surgery compared to open surgery affect the complication rate, after adjusting for age, comorbidity index, BMI, surgical indication, surgeon experience, and hospital volume?"}),e.jsxs(f,{defaultValue:"studyDesign",children:[e.jsxs(f.List,{children:[e.jsx(f.Tab,{value:"studyDesign",children:"Study Design and Methods"}),e.jsx(f.Tab,{value:"effectSize",children:"Effect Size Measure & MCID"}),e.jsx(f.Tab,{value:"result",children:"Result"}),e.jsx(f.Tab,{value:"discussion",children:"Discussion and Future Research"})]}),e.jsx(f.Panel,{value:"studyDesign",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Clinical Research Study Design:"}),e.jsx(i,{children:"Retrospective cohort study"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Study Population:"}),e.jsx(i,{children:"Adults undergoing abdominal surgery were identified from hospital databases and surgical registries. Participants were identified through electronic health record review at tertiary and community hospitals. Inclusion criteria include adults aged 18 years and older undergoing elective or urgent abdominal surgery for benign or malignant conditions. Exclusion criteria include emergency surgery, previous abdominal surgery within 30 days, and incomplete medical records."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Variables under Study:"}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Independent/Predictor/Exposure:"}),e.jsx(i,{children:"Surgical technique: Minimally Invasive Surgery (MIS) or Open Surgery (OS)"}),e.jsx(i,{children:"Covariates: Age, Adult Comorbidity Evaluation-27 (ACE-27) comorbidity index, body mass index (BMI), surgical indication, surgeon experience (measured in years of practice and annual surgical volume), and hospital volume (annual number of abdominal surgeries performed)."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Dependent/Outcome:"}),e.jsx(i,{children:"Complication rate (Complications Present or Absent). Complications were defined as any adverse event occurring within 30 days of surgery, including surgical site infections, anastomotic leaks, bleeding requiring transfusion, ileus, pneumonia, urinary tract infection, wound dehiscence, or readmission."})]})]})]})}),e.jsx(f.Panel,{value:"effectSize",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Effect Size Measure used in the Analytical Approach:"}),e.jsx(i,{children:"Adjusted odds ratio (aOR) analysis is performed to quantify the magnitude of the difference in complications between MIS and OS, while controlling for covariates. The adjusted odds ratio provides insight into how the surgical technique affects the odds of complications while controlling for the influence of other variables."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Minimal Clinically Important Difference (MCID):"}),e.jsx(i,{children:"Not applicable for adjusted odds ratios as they measure the strength of association rather than a specific threshold difference. However, for context, any reduction in complication rates is considered clinically meaningful given the impact on patient outcomes, length of stay, and healthcare costs."})]})]})}),e.jsx(f.Panel,{value:"result",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Results:"}),e.jsx(i,{children:"Complication rate with MIS (Minimally Invasive Surgery): 15%"}),e.jsx(i,{children:"Complication rate with OS (Open Surgery): 21%"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Point Estimate:"}),e.jsx(i,{children:"Adjusted odds ratio (aOR): 0.70"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Confidence Interval:"}),e.jsx(i,{children:"95% CI [0.52, 0.92]"})]}),e.jsxs(l,{gap:0,children:[e.jsxs(i,{fw:500,children:["Probability Value (",e.jsx(i,{span:!0,fs:"italic",children:"P"}),"-value):"]}),e.jsxs(i,{children:[e.jsx(i,{span:!0,fs:"italic",children:"p"})," ","= 0.012, indicating a statistically significant difference."]})]})]})}),e.jsx(f.Panel,{value:"discussion",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Results:"}),e.jsx(i,{children:"Patients undergoing MIS have 30% lower odds of experiencing complications compared to those undergoing OS, after adjusting for age, comorbidity index, BMI, surgical indication, surgeon experience, and hospital volume. The adjusted odds ratio of 0.70 (less than 1) indicates a protective effect of minimally invasive surgery, suggesting that this surgical approach is associated with reduced complication risk."}),e.jsx(i,{children:"The 95% confidence interval (0.52 to 0.92) is entirely below 1.0, indicating that the association consistently suggests lower odds of complications with MIS. However, the width of the confidence interval (spanning from 48% to 8% reduction in odds) prevents making definitive conclusions about the precise magnitude of the reduction in complications. The lower bound suggests at least an 8% reduction in odds, while the upper bound suggests up to a 48% reduction in odds."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Implications of Results:"}),e.jsx(i,{children:"The findings suggest that Minimally Invasive Surgery (MIS) may be a preferable surgical technique compared to Open Surgery (OS) when it comes to reducing the risk of complications in abdominal surgery. The 30% reduction in odds of complications, after controlling for important confounding variables, represents a clinically meaningful benefit that could translate to improved patient outcomes, shorter hospital stays, reduced healthcare costs, and faster return to normal activities."}),e.jsx(i,{children:"However, it's important to consider the limitations of the study, such as the retrospective cohort design and the relatively wide confidence interval. The retrospective nature of the study means that unmeasured confounding variables may exist, and treatment allocation was not randomized, which could introduce selection bias. These limitations imply that further research is needed to confirm and refine these findings."}),e.jsx(i,{children:"Clinical decision-making should integrate these findings with consideration of patient-specific factors, surgical complexity, surgeon expertise with MIS techniques, available resources, and patient preferences. Not all patients or surgical conditions may be suitable for MIS, and the benefits must be weighed against potential limitations such as longer operative time in some cases and the learning curve associated with minimally invasive techniques."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Future Research:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Prospective randomized controlled trials:"})," ","Conduct prospective studies with larger sample sizes and randomized treatment allocation to provide more robust evidence and eliminate selection bias. If appropriate, use of a randomized trial design would strengthen the evidence regarding the relationship between type of surgical approach and complications."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Specific complication analysis:"})," ","Investigate specific complications and their severity in relation to different surgical techniques. This could help identify the specific areas where MIS provides the greatest advantage (e.g., wound infections, ileus, pneumonia) and further refine patient selection criteria and surgical planning."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Additional confounding variables:"})," ","Explore additional variables that might affect complication rates, such as specific preoperative patient characteristics (nutritional status, functional status, frailty scores), intraoperative factors (operative time, blood loss, type of anesthesia), and postoperative care protocols (early mobilization, enhanced recovery pathways). Understanding these factors could provide valuable insights into optimizing surgical outcomes and improving patient care."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Cost-effectiveness analysis:"})," ","Conduct comprehensive economic analyses comparing MIS and OS, including direct costs (equipment, operative time, hospital stay), indirect costs (time to return to work, long-term complications), and quality-adjusted life years to inform healthcare resource allocation decisions."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Long-term outcome assessment:"})," ","Evaluate long-term outcomes beyond 30-day complications, including quality of life, functional recovery, incisional hernia rates, chronic pain, and long-term survival in oncologic cases."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Subgroup analyses:"})," ","Perform subgroup analyses based on surgical indication (benign vs. malignant disease), procedure complexity, patient age groups, comorbidity burden, and BMI categories to identify which patient populations benefit most from MIS and which may require open surgery."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Learning curve and surgeon experience:"})," ","Investigate the impact of surgeon experience and case volume with MIS techniques on complication rates to inform training programs and credentialing requirements. Determine the minimum case volume needed to achieve optimal outcomes with MIS."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Hospital and system factors:"})," ","Examine the role of hospital characteristics (teaching status, case volume, availability of specialized equipment, and support staff) in determining the success of MIS programs and complication rates."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Patient-reported outcomes:"})," ","Incorporate patient-reported outcome measures such as pain scores, satisfaction with cosmetic results, quality of life assessments, and return to normal activities to provide a more comprehensive evaluation of the patient experience with different surgical approaches."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Minimizing residual confounding:"})," ","Use advanced statistical techniques such as propensity score matching, instrumental variable analysis, or marginal structural models to reduce potential confounding in observational studies further when randomized trials are not feasible."]})})]})]})]})})]})]})}dv.title="Impact of Surgical Techniques on Complication Rates in Abdominal Surgery";const V5=[cv],G5=[dv];function U5(){const t=[e.jsx(l,{gap:4,children:e.jsx(i,{children:"Cramer's  is a statistical measure used as an effect size for categorical data, particularly in the context of analyzing the strength and association between two categorical variables. Derived from the chi-square statistical test, Cramer's  provides a standardized measure of the degree of association between the categorical variables. Cramer's  values range from 0 to 1. A larger value of Cramer's V indicates a stronger association between the categorical variables."})}),e.jsxs(l,{gap:6,children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Range of Cramer's "}),e.jsx(i,{children:"Cramer's  values can range from 0 to 1:"})]}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Closer to 1:"})," ","This indicates a strong association between the two variables, which implies that knowing the category of one variable can predict the category of the other variable with high accuracy."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Close to 0:"})," ","This suggests that there is little to no association between the two variables, which implies that the variables are independent of each other."]})})]})]}),e.jsxs(l,{gap:6,children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Cramer's  values"}),e.jsx(i,{children:"The interpretation of Cramer's  values is as follows:"})]}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.00 to 0.19:"})," ","Very weak association"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.20 to 0.39:"})," ","Weak association"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.40 to 0.59:"})," ","Moderate association"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.60 to 0.79:"})," ","Strong association"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.80 to 1.00:"})," ","Very strong association"]})})]}),e.jsx(i,{mt:4,children:"The maximum possible value for Cramer's  (approaching 1) is influenced by the number of rows and columns in the contingency table; hence, it is essential to consider this factor when interpreting the Cramer's  value."})]})];return e.jsx(G,{explanationSections:t,example1:e.jsx(i,{children:"Example 1 content will go here (e.g., a scatterplot, numerical example, or walkthrough)."})})}function uv(){return e.jsxs(l,{gap:"md",children:[e.jsx(i,{fs:"italic",mt:0,children:"In adults with Zenker's diverticulum, does the choice of surgical technique (transcervical, transoral stapling, or mixed endoscopic) significantly impact the rate of reoperation to treat recurrent or persistent Zenker's diverticulum within 24 months after the initial episode?"}),e.jsxs(f,{defaultValue:"studyDesign",children:[e.jsxs(f.List,{children:[e.jsx(f.Tab,{value:"studyDesign",children:"Study Design and Methods"}),e.jsx(f.Tab,{value:"effectSize",children:"Effect Size Measure & MCID"}),e.jsx(f.Tab,{value:"result",children:"Result"}),e.jsx(f.Tab,{value:"discussion",children:"Discussion and Future Research"})]}),e.jsx(f.Panel,{value:"studyDesign",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Clinical Research Study Design:"}),e.jsx(i,{children:"Randomized clinical trial"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Study Population:"}),e.jsx(i,{children:"The study population consists of 125 adults diagnosed with Zenker's diverticulum who were identified and recruited from a tertiary referral center specializing in upper gastrointestinal disorders."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Variables under Study:"}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Independent/Predictor/Exposure:"}),e.jsx(i,{children:"The independent variable is the choice of surgical technique, categorized into three groups: transcervical, transoral stapling, and mixed endoscopic."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Dependent/Outcome:"}),e.jsx(i,{children:"The dependent variable is the rate of reoperation (yes/no) within 24 months after the initial episode of Zenker's diverticulum."})]})]})]})}),e.jsx(f.Panel,{value:"effectSize",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Effect Size Measure used in the Analytical Approach:"}),e.jsx(i,{children:"Cramer's  is used as the effect size measure. Cramer's  is a statistical measure used as an effect size for nominal categorical data, particularly in the context of analyzing the strength of association between two categorical variables. Cramer's  provides a standardized measure of the degree of association between the categorical variables and ranges from 0 to 1."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Minimal Clinically Important Difference (MCID):"}),e.jsx(i,{children:"Not applicable for Cramer's  as it measures the overall association strength rather than a specific threshold difference."})]})]})}),e.jsx(f.Panel,{value:"result",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Results:"}),e.jsx(i,{children:"The rate of reoperation for the three techniques is: Transcervical 4 out of 42 (9%), Transoral stapling 8 out of 44 (18%), and Mixed endoscopic 2 out of 39 (4%)."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Point Estimate:"}),e.jsx(i,{children:"The Cramer's  for the overall effect of surgical technique on reoperation is 0.179, indicating a small association between surgical technique choice and reoperation rate."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Confidence Interval:"}),e.jsx(i,{children:"95% CI [0.129, 0.232], indicating a reasonably precise estimate."})]}),e.jsxs(l,{gap:0,children:[e.jsxs(i,{fw:500,children:["Probability Value (",e.jsx(i,{span:!0,fs:"italic",children:"P"}),"-value):"]}),e.jsxs(i,{children:[e.jsx(i,{span:!0,fs:"italic",children:"p"})," ","< 0.05, indicating a statistically significant association."]})]})]})}),e.jsx(f.Panel,{value:"discussion",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Results:"}),e.jsx(i,{children:"The Cramer's  effect size measure of 0.179 suggests a small association between the choice of surgical technique and the rate of reoperation for Zenker's diverticulum. While the confidence interval (0.129 to 0.232) indicates precision in the estimate and remains within the small association range (0.1 to 0.2), the effect is modest. The mixed endoscopic technique demonstrated the lowest reoperation rate (4%), followed by transcervical (9%), and transoral stapling (18%), suggesting some clinically meaningful differences among the techniques despite the overall small association measure."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Implications of Results:"}),e.jsx(i,{children:"The study provides evidence that the choice of surgical technique is associated with the rate of reoperation for Zenker's diverticulum, though the overall association strength is small. The notably lower reoperation rate with the mixed endoscopic technique (4%) compared to transoral stapling (18%) may have practical clinical significance for surgical decision-making. Clinicians should consider these differences when selecting the most appropriate surgical approach for individual patients, while recognizing that other factors such as technical expertise, patient anatomy, and comorbidities may also influence treatment selection."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Future Research:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Pairwise comparisons:"})," ","Conduct detailed pairwise analyses between the three surgical techniques using appropriate effect size measures (such as phi coefficient or odds ratios) to understand better which specific technique comparisons drive the observed differences in reoperation rates."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Mechanism exploration:"})," ","Investigate specific factors that explain the differences in reoperation rates, such as technical challenges, anatomical considerations, surgeon experience, or patient-specific factors. Understanding why mixed endoscopic techniques show lower reoperation rates could inform technical refinements."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Long-term follow-up studies:"})," ","Extend the follow-up period beyond 24 months to assess the durability of treatment outcomes and evaluate the impact of surgical technique on long-term postoperative complications and patient quality of life."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Subgroup analyses:"})," ","Examine whether the association between surgical technique and reoperation varies across patient subgroups defined by age, diverticulum size, symptom severity, or comorbidities. This could help identify which patients benefit most from specific surgical approaches."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Multi-center trials:"})," ","Conduct larger, multi-center studies to increase sample size and improve precision of effect size estimates. This would also help assess generalizability across different practice settings and surgeon expertise levels."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Patient-centered outcomes:"})," ","Expand outcome assessment beyond reoperation rates to include quality of life measurements, symptom resolution, procedural complications, recovery time, and patient satisfaction to provide a more comprehensive evaluation of treatment effectiveness."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Cost-effectiveness analysis:"})," ","Evaluate the economic implications of each surgical technique, considering initial procedure costs, reoperation rates, and long-term healthcare utilization to inform resource allocation decisions."]})})]})]})]})})]})]})}uv.title="Comparative Analysis of Transcervical, Transoral Stapling, and Mixed Endoscopic Techniques for Zenker's Diverticulum: A Randomized Clinical Trial";const q5=[uv];function W5(){const t=[e.jsx(l,{gap:4,children:e.jsx(i,{children:"Goodman and Kruskal's lambda () measures the strength of association between two nominal or categorical variables in a contingency table. It is particularly useful when dealing with multivariate categorical data, such as when examining relationships between multiple categories or groups within a dataset. It is especially useful for demonstrating how well one categorical variable predicts another."})}),e.jsxs(l,{gap:6,children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Range of Goodman and Kruskal's lambda"}),e.jsx(i,{children:"The values for Goodman and Kruskal's lambda range from 0 to 1. The interpretation revolves around the predictive power of one variable over another:"})]}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Closer to 1:"})," ","This indicates strong predictive power and suggests that knowing the categories of one variable substantially improves the ability to predict the categories of the other variable."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Close to 0:"})," ","This implies minimal or no predictive power and suggests that the two variables have little to no association in terms of prediction."]})})]})]}),e.jsxs(l,{gap:6,children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Goodman and Kruskal's lambda values"}),e.jsx(i,{children:"The interpretation of Goodman and Kruskal's lambda values between variables is as follows:"})]}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0:"})," ","No association"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.01 to 0.10:"})," ","Small association"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.11 to 0.30:"})," ","Moderate association"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.31 to 0.50:"})," ","Medium association"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.51 to 0.70:"})," ","Large association"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.71 to 0.99:"})," ","Very large association"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"1:"})," ","Perfect association"]})})]})]})];return e.jsx(G,{explanationSections:t,example1:e.jsx(i,{children:"Example 1 content will go here (e.g., a scatterplot, numerical example, or walkthrough)."})})}function hv(){return e.jsxs(l,{gap:"md",children:[e.jsx(i,{fs:"italic",mt:0,children:"In patients presenting with movement-related symptoms suggestive of Parkinson's disease, is the XYZ test more accurate in detecting stage-specific (none, early, or late) Parkinson's disease compared to standard clinical assessment, as measured by diagnostic accuracy parameters including sensitivity, specificity, and AUC-ROC?"}),e.jsxs(f,{defaultValue:"studyDesign",children:[e.jsxs(f.List,{children:[e.jsx(f.Tab,{value:"studyDesign",children:"Study Design and Methods"}),e.jsx(f.Tab,{value:"effectSize",children:"Effect Size Measure & MCID"}),e.jsx(f.Tab,{value:"result",children:"Result"}),e.jsx(f.Tab,{value:"discussion",children:"Discussion and Future Research"})]}),e.jsx(f.Panel,{value:"studyDesign",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Clinical Research Study Design:"}),e.jsx(i,{children:"This is a randomized clinical trial comparing the diagnostic accuracy of the XYZ test versus standard clinical assessment for detecting stage-specific Parkinson's disease."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Study Population:"}),e.jsx(i,{children:"Patients recruited from a tertiary referral center specializing in movement disorders. Participants are identified through outpatient clinic referrals, advertisements, and electronic medical record screening. Inclusion criteria include being over 40 years old, having at least two cardinal signs of Parkinsonism, lacking secondary Parkinsonism causes, and being willing to undergo both the XYZ test and standard clinical assessment. Exclusion criteria include a known Parkinson's disease diagnosis, other significant neurological or psychiatric disorders, and inability to provide informed consent."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Variables under Study:"}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Independent/Predictor/Exposure:"}),e.jsx(i,{children:"Participants undergo both the XYZ test and standard clinical assessment within a predefined timeframe. The XYZ test results are interpreted by blinded radiologists or neurologists who are not involved in the clinical evaluation."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Dependent/Outcome:"}),e.jsx(i,{children:"The reference standard for diagnosing stage-specific (none, early, or late) Parkinson's disease is a comprehensive clinical assessment conducted by movement disorder specialists, including medical history review, physical examination, and standardized rating scales such as the Unified Parkinson's Disease Rating Scale (UPDRS)."})]})]})]})}),e.jsx(f.Panel,{value:"effectSize",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Effect Size Measure used in the Analytical Approach:"}),e.jsx(i,{children:"Goodman and Kruskal's Lambda () is used as a measure of the strength of the association between the results of the XYZ tests and the diagnostic severity category of Parkinson's disease. Goodman and Kruskal's Lambda () measures the strength of association between two nominal or categorical variables in a contingency table. It is beneficial when dealing with multivariate categorical data, such as when examining relationships between multiple categories or groups within a dataset. Goodman and Kruskal's Lambda ranges from 0 to 1, with a larger value indicating a stronger association between the categorical variables."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Minimal Clinically Important Difference (MCID):"}),e.jsx(i,{children:"Not applicable for Goodman and Kruskal's Lambda, as it measures the overall association strength rather than a specific threshold difference."})]})]})}),e.jsx(f.Panel,{value:"result",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Point Estimate:"}),e.jsx(i,{children:"Goodman and Kruskal's Lambda ():  = 0.80, indicating a very large association between the XYZ test results and the diagnostic severity category of Parkinson's disease."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Confidence Interval:"}),e.jsx(i,{children:"95% CI [0.70, 0.90], indicating a precise estimate of the actual effect size value."})]}),e.jsxs(l,{gap:0,children:[e.jsxs(i,{fw:500,children:["Probability Value (",e.jsx(i,{span:!0,fs:"italic",children:"P"}),"-value):"]}),e.jsxs(i,{children:[e.jsx(i,{span:!0,fs:"italic",children:"p"})," ","< 0.001, indicating a statistically significant association."]})]})]})}),e.jsx(f.Panel,{value:"discussion",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Results:"}),e.jsx(i,{children:"The Goodman and Kruskal's Lambda value of 0.80 suggests a very large association between the results of the XYZ test and the diagnostic severity category of Parkinson's disease. This indicates that 80% of the agreement between the XYZ test results and the diagnostic severity category can be attributed to a true association beyond chance alone."}),e.jsx(i,{children:`With a 95% confidence level, we estimate that the actual value of Goodman and Kruskal's Lambda for the association between the XYZ test results and the diagnostic severity category of Parkinson's disease falls between 0.70 and 0.90. This range provides a precise estimate of the actual effect size value, indicating a very large association beyond chance alone. The entire confidence interval falls within the "very large association" range (0.71-0.99), though the lower bound (0.70) reaches into the "large association" range (0.51-0.70), suggesting consistently strong predictive utility of the XYZ test across the plausible range of true effect sizes.`})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Implications of Results:"}),e.jsx(i,{children:"The very large association observed between the XYZ test results and the diagnostic severity category of Parkinson's disease indicates the potential utility of the XYZ test as a reliable diagnostic tool for staging Parkinson's disease. The high Lambda value suggests that knowledge of the XYZ test results substantially improves the prediction of disease severity category compared to prediction without this information. This strong association supports the clinical implementation of the XYZ test as an adjunct to standard clinical assessment for more accurate staging of Parkinson's disease, which could facilitate earlier intervention and more tailored treatment approaches."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Future Research:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Multicenter validation:"})," ","Validate these findings in larger, multicenter cohorts to assess the generalizability of the XYZ test's diagnostic accuracy across different clinical settings, patient populations, and geographic regions."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Clinical impact assessment:"})," ","Evaluate the clinical impact of implementing the XYZ test in routine practice, including its effect on treatment decisions, patient outcomes, healthcare costs, and clinical workflow integration."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Mechanistic investigation:"})," ","Further investigate the mechanisms underlying the association between XYZ test results and disease severity to provide insights into the pathophysiology of Parkinson's disease progression. Understanding why the test correlates so strongly with disease staging could reveal new therapeutic targets."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Longitudinal studies:"})," ","Conduct longitudinal studies to assess whether the XYZ test can predict disease progression over time and whether early detection through this test leads to improved long-term outcomes with earlier intervention."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Comparative effectiveness:"})," ","Compare the XYZ test with other emerging diagnostic technologies for Parkinson's disease staging to determine relative advantages, cost-effectiveness, and optimal combinations of diagnostic approaches."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Subgroup analyses:"})," ","Examine whether the association between XYZ test results and disease severity varies across patient subgroups defined by age, sex, genetic factors, or disease subtypes. This could help identify populations where the test is most valuable."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Diagnostic algorithm development:"})," ","Develop and validate diagnostic algorithms that integrate XYZ test results with clinical assessment data to optimize diagnostic accuracy and create standardized protocols for clinical implementation."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Patient-centered outcomes:"})," ","Investigate how improved diagnostic accuracy through the XYZ test affects patient-reported outcomes, quality of life, treatment satisfaction, and psychological well-being, particularly in relation to diagnosis clarity and early intervention opportunities."]})})]})]})]})})]})]})}hv.title="Diagnostic Accuracy of XYZ Test for Early Detection of Parkinson's Disease: A Prospective Study";const Q5=[hv];function Y5(){const t=[e.jsx(l,{gap:4,children:e.jsx(i,{children:"Cliff's delta () is a nonparametric effect size measure used to describe the degree of overlap between two distributions. Specifically, it quantifies the difference between two groups in terms of the probability that a randomly selected value from one group will be greater than a randomly selected value from the other group, minus the reverse probability. It is particularly useful when comparing distributions that are not assumed to be normal or that have the same variance."})}),e.jsxs(l,{gap:6,children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Range of Cliff's delta"}),e.jsx(i,{children:"The values for Cliff's delta range from -1 to +1. The interpretation revolves around the difference in the distributions of the two groups being compared:"})]}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Positive  (0 to +1):"})," ","This indicates that a larger proportion of the scores in Group A are greater than the scores in Group B."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:" close to 0:"})," ","This implies substantial overlap between the two distributions, which suggests minimal or no difference."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Negative  (0 to -1):"})," ","This indicates that a larger proportion of the scores in Group B are greater than the scores in Group A."]})})]})]}),e.jsxs(l,{gap:6,children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Cliff's delta as absolute values"}),e.jsx(i,{children:"The interpretation of Cliff's delta as absolute values is as follows:"})]}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Close to 0:"})," ","Negligible effect size"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.14 to 0.32:"})," ","Small effect size"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.33 to 0.46:"})," ","Medium effect size"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.47 to 1.00:"})," ","Large effect size"]})})]})]})];return e.jsx(G,{explanationSections:t,example1:e.jsx(i,{children:"Example 1 content will go here (e.g., a scatterplot, numerical example, or walkthrough)."})})}function fv(){return e.jsxs(l,{gap:"md",children:[e.jsx(i,{fs:"italic",mt:0,children:"Does the type of feedback (None, Positive, Negative) provided by physical therapists have an impact on the DASH questionnaire scores at the end of 8 weeks for patients with rotator cuff injury, as measured by the Cliff's delta effect size?"}),e.jsxs(f,{defaultValue:"studyDesign",children:[e.jsxs(f.List,{children:[e.jsx(f.Tab,{value:"studyDesign",children:"Study Design and Methods"}),e.jsx(f.Tab,{value:"effectSize",children:"Effect Size Measure & MCID"}),e.jsx(f.Tab,{value:"result",children:"Result"}),e.jsx(f.Tab,{value:"discussion",children:"Discussion and Future Research"})]}),e.jsx(f.Panel,{value:"studyDesign",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Clinical Research Study Design:"}),e.jsx(i,{children:"Randomized clinical trial"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Study Population:"}),e.jsx(i,{children:"Patients with rotator cuff injury were identified and recruited from orthopedic clinics or physical therapy practices. Inclusion criteria include individuals with a diagnosed rotator cuff injury, aged 18-65, and without any severe comorbidities."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Variables under Study:"}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Independent/Predictor/Exposure:"}),e.jsx(i,{children:"Three different types of feedback provided by physical therapists: None (control group), Positive feedback, and Negative feedback."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Dependent/Outcome:"}),e.jsx(i,{children:"DASH questionnaire score at the end of 8 weeks. The DASH (Disabilities of the Arm, Shoulder, and Hand) questionnaire is an ordinal measure where lower scores indicate better function and fewer symptoms, and higher scores indicate worse function and more severe symptoms."})]})]})]})}),e.jsx(f.Panel,{value:"effectSize",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Effect Size Measure used in the Analytical Approach:"}),e.jsx(i,{children:"The effect size measure used is Cliff's delta (), which assesses the ordinal association between the predictor (feedback type) and the dependent variable (DASH score). Cliff's delta is a non-parametric measure of effect size that quantifies the difference in probability of one random variable (e.g., a measurement in one group) being larger than another random variable (e.g., a measurement in another group). It is beneficial when dealing with ordinal data or when the assumption of normality is violated. Cliff's delta ranges from -1 to +1, where negative values indicate that one group tends to have lower scores than another, positive values indicate higher scores, and 0 means no difference."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Minimal Clinically Important Difference (MCID):"}),e.jsx(i,{children:"Not applicable for Cliff's delta as it measures the overall effect magnitude rather than a specific threshold difference. However, for context, a minimal clinically important difference of 10 points on the DASH scale is often cited in the literature."})]})]})}),e.jsx(f.Panel,{value:"result",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"DASH score averages for the three feedback groups:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:"No feedback group: Average DASH score = 50"}),e.jsx(c.Item,{children:"Positive feedback group: Average DASH score = 30"}),e.jsx(c.Item,{children:"Negative feedback group: Average DASH score = 70"})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Point Estimate:"}),e.jsx(i,{children:"Cliff's Delta value:  = 0.70, indicating a large effect size."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Confidence Interval:"}),e.jsx(i,{children:"95% CI [0.40, 1.00], indicating a wide confidence interval."})]}),e.jsxs(l,{gap:0,children:[e.jsxs(i,{fw:500,children:["Probability Value (",e.jsx(i,{span:!0,fs:"italic",children:"P"}),"-value):"]}),e.jsxs(i,{children:[e.jsx(i,{span:!0,fs:"italic",children:"p"})," ","< 0.001, indicating a statistically significant difference."]})]})]})}),e.jsx(f.Panel,{value:"discussion",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Results:"}),e.jsx(i,{children:"The results suggest that patients who received positive feedback from physical therapists had the lowest average DASH scores (30), indicating better functional status and fewer symptoms associated with their rotator cuff injury. The negative feedback group had the highest average DASH scores (70), indicating poorer outcomes and greater functional limitations. The non-feedback group showed intermediate results (50)."}),e.jsx(i,{children:"The large Cliff's Delta value of 0.70 suggests a substantial difference in the DASH scores between the feedback groups, indicating that there is a 70% probability that a randomly selected patient from a more favorable feedback group will have a better (lower) DASH score than a randomly selected patient from a less favorable feedback group. This represents a large effect according to standard interpretation guidelines (  0.33)."}),e.jsx(i,{children:"However, the wide confidence interval (0.40 to 1.00) indicates considerable uncertainty about the precise magnitude of the effect. While the lower bound (0.40) still falls within the large effect range, and the entire interval excludes small effects, the wide range prevents definitive conclusions about the exact effect size based on this single study. The upper bound reaching 1.00 (the maximum possible value) suggests the study may have been underpowered to estimate the effect precisely."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Implications of Results:"}),e.jsx(i,{children:"The results from this study imply that the type of feedback provided by physical therapists has a clinically meaningful impact on the functional limitations and symptoms experienced by patients with rotator cuff injuries. Specifically, positive feedback appears to enhance patient outcomes considerably, while negative feedback may be detrimental to recovery."}),e.jsx(i,{children:"These findings have important clinical implications for physical therapy practice. Physical therapists should be trained to provide predominantly positive, encouraging feedback to patients during rehabilitation for rotator cuff injuries. Healthcare organizations should consider implementing feedback training programs for physical therapists, emphasizing the therapeutic value of positive reinforcement and the potential harm of negative feedback."}),e.jsx(i,{children:"The substantial effect size suggests that feedback type is not merely a minor factor but rather a major determinant of rehabilitation outcomes. This highlights the importance of the therapist-patient relationship and communication style in achieving optimal functional recovery."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Future Research:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Increased sample size studies:"})," ","Conduct studies with larger sample sizes to narrow the confidence interval and obtain more precise estimates of the effect size, allowing for more definitive conclusions about the magnitude of the feedback effect."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Mechanism exploration:"})," ","Investigate the specific mechanisms or aspects of positive feedback that contribute to better results. This could include examining whether the effects are mediated by increased patient motivation, improved self-efficacy, better adherence to exercises, reduced pain catastrophizing, or enhanced neuroplasticity."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Feedback content analysis:"})," ","Analyze the specific content, frequency, timing, and delivery methods of positive versus negative feedback to identify the most effective feedback strategies. This could involve coding and categorizing actual therapist-patient interactions."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Individual differences:"})," ","Examine individual patient characteristics such as personality traits, baseline psychological status, coping styles, or response patterns to different feedback types to identify who benefits most from specific feedback approaches. This could enable personalized feedback strategies."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Long-term outcomes:"})," ","Explore long-term effects and sustainability of the observed differences in DASH scores at 6 months, 1 year, and beyond to determine whether feedback effects persist or diminish over time."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Dose-response relationships:"})," ","Investigate whether there is a dose-response relationship between the frequency or intensity of positive feedback and patient outcomes."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Comparative studies across conditions:"})," ","Replicate this study design with other musculoskeletal conditions or injury types to assess the generalizability of feedback effects beyond rotator cuff injuries."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Training interventions:"})," ","Develop and evaluate training programs for physical therapists focused on providing effective positive feedback, and assess whether such training improves patient outcomes in real-world clinical settings."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Mixed feedback approaches:"})," ","Investigate whether certain combinations of feedback types (e.g., predominantly positive with strategic corrective feedback) might be more effective than purely positive feedback alone."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Mediator and moderator analyses:"})," ","Conduct statistical analyses to identify potential mediators (mechanisms through which feedback affects outcomes) and moderators (factors that influence the strength of feedback effects) of the relationship between feedback type and functional outcomes."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Cost-effectiveness analysis:"})," ","Evaluate the cost-effectiveness of implementing feedback training programs for physical therapists, considering the potential for improved patient outcomes and reduced need for extended rehabilitation."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Patient perspectives:"})," ","Conduct qualitative research to understand patients' perceptions and experiences of different types of feedback, including how feedback influences their engagement, motivation, and confidence during rehabilitation."]})})]})]})]})})]})]})}fv.title="Impact of Feedback from Physical Therapists on DASH Scores in Patients with Rotator Cuff Injury: A Longitudinal Study Assessing Different Feedback Types";const K5=[fv];function X5(){const t=[e.jsx(l,{gap:4,children:e.jsx(i,{children:"Kendall's tau () is a nonparametric correlation coefficient used to quantify the strength and direction of the relationship between two ordinal or ranked variables. Specifically, it measures the degree of concordance or discordance between two variables. It is particularly useful when dealing with data that have ranks or categories, but the intervals between the ranks are not meaningful."})}),e.jsxs(l,{gap:6,children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Range of Kendall's tau"}),e.jsx(i,{children:"Kendall's tau values range from -1 to +1. The sign of the coefficient indicates the direction of the relationship, while the magnitude indicates the strength of the relationship:"})]}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Positive  (0 to +1):"})," ","This indicates a positive association between the variables. As the values of one variable increase, the ranks of the other variable tend to increase as well."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Negative  (0 to -1):"})," ","This indicates a negative association between the variables. As the values of one variable increase, the ranks of the other variable tend to decrease."]})})]})]}),e.jsxs(l,{gap:6,children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Kendall's tau as absolute values"}),e.jsx(i,{children:"The interpretation of Kendall's tau as absolute values between variables is as follows:"})]}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.00 to 0.19:"})," ","Very weak association"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.20 to 0.39:"})," ","Weak association"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.40 to 0.59:"})," ","Moderate association"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.60 to 0.79:"})," ","Strong association"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.80 to 1.00:"})," ","Very strong association"]})})]})]})];return e.jsx(G,{explanationSections:t,example1:e.jsx(i,{children:"Example 1 content will go here (e.g., a scatterplot, numerical example, or walkthrough)."})})}function pv(){return e.jsxs(l,{gap:"md",children:[e.jsx(i,{fs:"italic",mt:0,children:"In patients with psoriasis, what is the comparative efficacy and impact on patient-reported outcomes of topical corticosteroids, phototherapy (UVB Therapy), and systemic biologic medications?"}),e.jsxs(f,{defaultValue:"studyDesign",children:[e.jsxs(f.List,{children:[e.jsx(f.Tab,{value:"studyDesign",children:"Study Design and Methods"}),e.jsx(f.Tab,{value:"effectSize",children:"Effect Size Measure & MCID"}),e.jsx(f.Tab,{value:"result",children:"Result"}),e.jsx(f.Tab,{value:"discussion",children:"Discussion and Future Research"})]}),e.jsx(f.Panel,{value:"studyDesign",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Clinical Research Study Design:"}),e.jsx(i,{children:"Randomized clinical trial"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Study Population:"}),e.jsx(i,{children:"Patients with psoriasis recruited from dermatology clinics or specialized research centers in a large Midwestern city. Participants were identified through clinic referrals, dermatology department databases, and community outreach. Inclusion criteria include adults aged 18-75 years with moderate to severe plaque psoriasis, stable disease for at least 3 months, and willingness to undergo treatment for the study duration. Exclusion criteria include pregnancy, active malignancy, uncontrolled infections, previous biologic therapy within 6 months, and contraindications to any of the study treatments."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Variables under Study:"}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Independent/Predictor/Exposure:"}),e.jsx(i,{children:"Three different treatment modalities: Group A received topical corticosteroids, Group B received phototherapy (UVB therapy), and Group C received systemic biologic medications."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Dependent/Outcome:"}),e.jsx(i,{children:"Dermatology Life Quality Index (DLQI). The DLQI is a validated questionnaire that evaluates the impact of a skin condition on a patient's quality of life. It assesses aspects such as symptoms and feelings, daily activities, leisure, work/education, personal relationships, and treatment burden."}),e.jsx(i,{children:"The total DLQI score ranges from 0 to 30, representing an ordinal scale. The higher the score, the greater the impact of the skin condition on the patient's quality of life."}),e.jsx(i,{children:"Interpretation of DLQI scores:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:"0-1: No effect on the patient's life"}),e.jsx(c.Item,{children:"2-5: Small impact on the patient's life"}),e.jsx(c.Item,{children:"6-10: Moderate impact on the patient's life"}),e.jsx(c.Item,{children:"11-20: Huge effect on the patient's life"}),e.jsx(c.Item,{children:"21-30: Huge impact on the patient's life"})]})]})]})]})}),e.jsx(f.Panel,{value:"effectSize",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Effect Size Measure used in the Analytical Approach:"}),e.jsx(i,{children:"Kendall's Tau () is used to assess the strength and direction of the association between treatment group and change in DLQI scores. Kendall's Tau () is a non-parametric correlation coefficient used to quantify the strength and direction of the relationship between two ordinal or ranked variables. Specifically, it measures the degree of concordance or discordance between two variables. It is beneficial when dealing with data that has ranks or categories, but the intervals between the ranks are not meaningful."}),e.jsx(i,{children:"Kendall's Tau ranges from -1 to +1. The sign of the coefficient indicates the direction of the relationship, while the magnitude indicates the strength of the relationship. A positive  (0 to +1) indicates a positive association between the variables, where as the values of one variable increase, the ranks of the other variable tend to increase as well. A negative  (0 to -1) indicates a negative association between the variables, where as the values of one variable increase, the ranks of the other variable tend to decrease."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Minimal Clinically Important Difference (MCID):"}),e.jsx(i,{children:"The MCID for DLQI is a difference in score of 4 or greater."})]})]})}),e.jsx(f.Panel,{value:"result",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Average change in DLQI scores (within subject pre- to post-intervention):"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:"Group A (Topical corticosteroids): 3-point reduction"}),e.jsx(c.Item,{children:"Group B (Phototherapy UVB): 7-point reduction"}),e.jsx(c.Item,{children:"Group C (Systemic biologic medications): 9-point reduction"})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Point Estimate:"}),e.jsx(i,{children:"Kendall's Tau () = 0.49, indicating a moderate positive association between treatment group and improvement in DLQI scores."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Confidence Interval:"}),e.jsx(i,{children:"95% CI [0.40, 0.59], demonstrating a precise estimate of the actual value for tau."})]}),e.jsxs(l,{gap:0,children:[e.jsxs(i,{fw:500,children:["Probability Value (",e.jsx(i,{span:!0,fs:"italic",children:"P"}),"-value):"]}),e.jsxs(i,{children:[e.jsx(i,{span:!0,fs:"italic",children:"p"})," ","< 0.001, indicating a statistically significant association."]})]})]})}),e.jsx(f.Panel,{value:"discussion",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Results:"}),e.jsx(i,{children:"The Kendall's Tau value of 0.49 indicates a moderate positive association between the treatment group and the change in DLQI scores. This suggests a meaningful ordered relationship between the type of treatment received and the degree of improvement in quality of life, with more intensive therapies generally associated with greater improvements."}),e.jsx(i,{children:"The 95% confidence interval (0.40 to 0.59) demonstrates a precise estimate of the actual value for tau, with the entire interval falling within the moderate association range. This narrow confidence interval provides confidence that the actual effect size is indeed in the moderate range."}),e.jsx(i,{children:"Examining the average changes in DLQI scores reveals a clear pattern: Group C (systemic biologic medications) achieved the greatest improvement with a 9-point reduction, Group B (phototherapy UVB) achieved a 7-point reduction, and Group A (topical corticosteroids) achieved the smallest improvement with a 3-point reduction. Notably, only Groups B and C exceeded the MCID of 4 points, indicating that phototherapy and systemic biologics achieved clinically meaningful improvements in quality of life. At the same time, topical corticosteroids alone did not reach this threshold."}),e.jsx(i,{children:"The ordered nature of these improvements (Group A < Group B < Group C) supports the moderate positive Kendall's Tau value, indicating that treatment intensity is associated with greater quality of life improvements in psoriasis patients."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Implications of Results:"}),e.jsx(i,{children:"These findings suggest that there is a significant relationship between the treatment modality and the improvement in DLQI scores for psoriasis patients. The larger change in DLQI scores in Group C compared to Groups A and B indicates that systemic biologic medications may be the most effective treatment option among the three interventions studied for achieving clinically meaningful improvements in quality of life."}),e.jsx(i,{children:"However, considering the moderate association observed ( = 0.49), it is essential to note that other factors, such as individual patient characteristics, disease severity, comorbidities, treatment adherence, and psychosocial factors, may also influence treatment outcomes. Treatment selection should consider not only efficacy but also factors such as cost, accessibility, safety profile, patient preferences, and practical considerations like frequency of administration and monitoring requirements."}),e.jsx(i,{children:"For patients with moderate to severe psoriasis, these results suggest a stepped approach may be appropriate: starting with topical corticosteroids for milder cases or as adjunctive therapy, progressing to phototherapy for patients requiring greater efficacy, and reserving systemic biologic medications for those needing the most substantial quality of life improvements or those who have failed other treatments. However, for patients with severe disease and significant quality of life impairment, earlier initiation of systemic biologics may be warranted given their superior efficacy."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Future Research:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Geographic generalizability:"})," ","Increase the number of recruitment sites to include participants from across the entire country, not just the Midwest. This will enhance the generalizability of the findings across diverse populations, healthcare settings, and geographic regions with varying climate conditions that may affect psoriasis severity."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Long-term follow-up:"})," ","Assess the long-term effects and sustainability of treatment outcomes over 1, 2, and 5 years. This would provide valuable insights into the durability of therapeutic responses, maintenance of quality of life improvements, relapse rates after treatment discontinuation, and long-term safety profiles."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Combination therapy investigations:"})," ","Investigate the potential synergistic effects of combining treatments from different modalities (e.g., topical corticosteroids plus phototherapy, or phototherapy plus biologics). This may lead to improved therapeutic strategies that maximize efficacy while potentially reducing doses and costs."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Cost-effectiveness analysis:"})," ","Conduct comprehensive economic evaluations comparing the cost-effectiveness of each treatment modality, considering direct medical costs, indirect costs (work productivity, quality-adjusted life years), and the value of quality of life improvements achieved."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Patient-reported outcomes expansion:"})," ","Expand the assessment of patient-reported outcomes beyond DLQI to include other relevant measures such as the Psoriasis Area and Severity Index (PASI), pruritus severity scales, pain assessments, treatment satisfaction, adherence measures, and general health-related quality of life instruments. This would provide a more comprehensive understanding of treatment effectiveness."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Predictive biomarkers:"})," ","Identify clinical, genetic, or biomarker predictors of treatment response to enable personalized treatment selection. This could include investigating whether baseline disease characteristics, inflammatory markers, genetic polymorphisms, or patient demographics predict differential responses to specific treatments."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Subgroup analyses:"})," ","Conduct detailed subgroup analyses examining whether treatment effects vary by patient characteristics such as age, sex, body mass index, disease duration, baseline disease severity, presence of psoriatic arthritis, or comorbid conditions like metabolic syndrome or depression."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Safety and tolerability assessment:"})," ","Systematically evaluate and compare the safety profiles, adverse event rates, and tolerability of the three treatment modalities to provide a balanced risk-benefit analysis for clinical decision-making."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Treatment sequencing studies:"})," ","Investigate optimal treatment sequencing strategies, including when to escalate therapy, whether specific sequences are more effective than others, and how to manage patients who fail initial treatments."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Patient preference and shared decision-making:"})," ","Explore patient preferences for different treatment modalities, considering factors such as treatment burden, route of administration, monitoring requirements, and lifestyle impacts. Develop decision aids to facilitate shared decision-making between patients and providers."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Mechanism of action studies:"})," ","Investigate the biological mechanisms underlying the differential effectiveness of these treatments, including their effects on inflammatory pathways, immune cell populations, and skin barrier function, which could inform the development of novel therapeutic approaches."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Domain-specific analyses:"})," ","Analyze which specific domains of the DLQI (symptoms, daily activities, leisure, work, personal relationships) are most improved by each treatment modality to understand better their differential impacts on various aspects of patients' lives."]})})]})]})]})})]})]})}pv.title="Comparative Study of Topical Corticosteroids, Phototherapy, and Systemic Biologic Medications in the Treatment of Psoriasis: Assessing Efficacy and Patient-Reported Outcomes";const Z5=[pv],tf="point-biserial",Vn="two-groups-effect-sizes-cat",nf="odds-ratio",sf="risk-ratio",rf="risk-difference",af="phi-coefficient",of="odds-ratio-3groups",lf="risk-ratio-3groups",cf="risk-difference-3groups",df="phi-coefficient-3groups",uf="odds-ratio-regression",Ir="comparison-of-three-or-more-groups-cat",Gn="pairwise-effect-sizes-cat",Un="overall-effect-sizes-cat",hf="cramers-v",ff="goodman-kruskal-lambda",pf="cliffs-delta",mf="kendalls-tau",Cr="regression-model-cat",Xi="regression-overall-effect-sizes-cat",gf="pseudo-r2",xf="c-statistic",vf="percent-correctly-classified",yf=`The phi coefficient () is a measure of the strength of association between two dichotomous variables.

Phi coefficient has a range from 01 with 0 value displaying no correlation between the two variables.

A value of 0.1 is considered a small effect, 0.3 medium effect, and 0.5 large effect.`,jf="The magnitude of the difference between the risk of an outcome of interest occurring in two or more groups.",J5=`The Risk Ratio (also known as Relative Risk) is a measure of the strength of association between 2 categorical variables calculated as the ratio of the probability of the outcome occurring in one group (exposed group) compared to the probability of the outcome occurring in the other (not exposed) group(s).

RR = 1 indicates that the probability of the outcome is the same in the 2 groups being compared, and there is no association between the 2 variables.

RR > 1 indicates that the probability or risk for the outcome is higher in the exposed group.

RR < 1 indicates that the probability or risk for the outcome is lower in the exposed group.`,Uo=`Odds Ratio (OR) is a measure of effect size used in case-control studies. OR quantifies how much higher are the odds for exposure (risk factor) among cases as compared to controls.

OR = 1 indicates that odds are the same for cases and controls, and there is no association between the 2 variables.

OR > 1, the odds for the event of interest are higher for cases as compared to controls.

OR < 1, the odds for the event of interest are lower for cases as compared to controls.`,eC={[Wn]:{type:"question",title:Rd,component:kd,inputs:[Ii],choices:[{answer:"Correlation with continuous measure",next:tf,option_description:Od},{answer:"Comparison of 2 groups",next:Vn,option_description:Fd},{answer:"Comparison of 3 or more groups",next:Ir,option_description:$d},{answer:"Regression model",next:Cr,option_description:Bd}]},[tf]:{type:"statement",title:"Point Bi-serial correlation",flowChartTitle:"Point Bi-serial",component:E5,color:"teal-darken-2",inputs:[Wn]},[Vn]:{type:"question",title:Be,component:He,inputs:[Wn],choices:[{answer:"Odds Ratio (OR)",next:nf,option_description:Uo},{answer:"Risk Ratio (RR)",next:sf,option_description:J5},{answer:"Risk Difference",next:rf,option_description:jf},{answer:"Phi coefficient ()",next:af,option_description:yf}]},[nf]:{type:"statement",title:"Odds Ratio (OR)",flowChartTitle:"Odds Ratio",component:Go,color:"indigo-darken-2",inputs:[Vn]},[sf]:{type:"statement",title:"Risk Ratio (RR)",flowChartTitle:"Risk Ratio",component:Zh,color:"indigo-darken-2",inputs:[Vn],examples:D5},[rf]:{type:"statement",title:"Risk Difference",flowChartTitle:"Risk Difference",component:Jh,color:"indigo-darken-2",inputs:[Vn],examples:A5},[af]:{type:"statement",title:"Phi coefficient ()",flowChartTitle:"Phi ()",component:ef,color:"indigo-darken-2",inputs:[Vn],examples:N5},[Ir]:{type:"question",title:Ci,component:Ti,inputs:[Wn],choices:[{answer:Nd,next:Gn,option_description:{short:_d,long:Ld}},{answer:wx,next:Un,option_description:{short:bx,long:Sx}}]},[Gn]:{type:"question",title:Be,component:He,inputs:[Ir],choices:[{answer:"Odds Ratio (OR)",next:of,option_description:Uo},{answer:"Risk Ratio (RR)",next:lf,option_description:Uo},{answer:"Risk Difference",next:cf,option_description:jf},{answer:"Phi coefficient ()",next:df,option_description:yf}]},[of]:{type:"statement",title:"Odds Ratio (OR)",flowChartTitle:"Odds Ratio",component:Go,color:"indigo-darken-2",inputs:[Gn],examples:V5},[lf]:{type:"statement",title:"Risk Ratio (RR)",flowChartTitle:"Risk Ratio",component:Zh,color:"indigo-darken-2",inputs:[Gn],examples:M5},[cf]:{type:"statement",title:"Risk Difference",flowChartTitle:"Risk Difference",component:Jh,color:"indigo-darken-2",inputs:[Gn],examples:z5},[df]:{type:"statement",title:"Phi coefficient ()",flowChartTitle:"Phi ()",component:ef,color:"indigo-darken-2",inputs:[Gn],examples:_5},[Un]:{type:"question",title:Be,component:He,inputs:[Ir],choices:[{answer:"Cramer's ",next:hf,option_description:"Used as an effect size for categorical data, particularly in the context of analyzing the strength and association between two categorical variables.",group:"Nominal"},{answer:"GoodmanKruskal ",next:ff,option_description:"Measures the strength of association between two nominal or categorical variables in a contingency table.",group:"Nominal"},{answer:"Cliff's ",next:pf,option_description:"A nonparametric effect size measure used to describe the degree of overlap between two distributions.",group:"Ordinal"},{answer:"Kendall's ",next:mf,option_description:"A nonparametric correlation coefficient used to quantify the strength and direction of the relationship between two ordinal or ranked variables.",group:"Ordinal"}]},[hf]:{type:"statement",title:"Cramer's ",flowChartTitle:"Cramer's ",component:U5,color:"orange-darken-2",inputs:[Un],examples:q5},[ff]:{type:"statement",title:"GoodmanKruskal ",flowChartTitle:"GK ",component:W5,color:"orange-darken-2",inputs:[Un],examples:Q5},[pf]:{type:"statement",title:"Cliff's ",flowChartTitle:"Cliff's ",component:Y5,color:"orange-darken-2",inputs:[Un],examples:K5},[mf]:{type:"statement",title:"Kendall's ",flowChartTitle:"Kendall's ",component:X5,color:"orange-darken-2",inputs:[Un],examples:Z5},[Cr]:{type:"question",title:Ci,component:Ti,inputs:[Wn],choices:[{answer:Pd,next:uf,option_description:{short:Ed,long:Dd}},{answer:Md,next:Xi,option_description:{short:Ad,long:zd}}]},[uf]:{type:"statement",title:"Odds Ratio (OR)",flowChartTitle:"Odds Ratio",component:Go,color:"indigo-darken-2",inputs:[Cr],examples:G5},[Xi]:{type:"question",title:Be,component:He,inputs:[Cr],choices:[{answer:"Pseudo R",next:gf,option_description:"Measures the goodness-of-fit for models that do not inherently provide a traditional pseudo R value, like logistic regression."},{answer:"C-Statistic",next:xf,option_description:"A performance measure used to evaluate the discriminatory power and predictive accuracy of a regression model, particularly in binary classification tasks."},{answer:"Percent correctly classified",next:vf,option_description:"A statistic used to quantify the accuracy of classification models."}]},[gf]:{type:"statement",title:"Pseudo R",flowChartTitle:"Pseudo R",component:L5,color:"purple-darken-2",inputs:[Xi],examples:O5},[xf]:{type:"statement",title:"C-Statistic",flowChartTitle:"C-Statistic",component:F5,color:"purple-darken-2",inputs:[Xi],examples:$5},[vf]:{type:"statement",title:"Percent correctly classified",flowChartTitle:"% Correctly Classified",component:B5,color:"purple-darken-2",inputs:[Xi],examples:H5}};function wf(){const t=[e.jsx(l,{gap:4,children:e.jsx(i,{children:"The hazard ratio (HR) is used to quantify the relative risk of experiencing an event between two groups over time. Specifically, it measures the rate at which events happen in one group as compared with another group. It is particularly useful in survival analysis and for time-to-event data to compare the efficacy of different treatments or exposures."})}),e.jsxs(l,{gap:6,children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Range of HR"}),e.jsx(i,{children:"HR values typically start from 0 and can theoretically extend to infinity. The interpretation revolves around the comparison of event rates between two groups:"})]}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"HR = 1:"})," ","This indicates no difference in the hazard rates between the two groups."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"HR > 1:"})," ","This implies that the event rate is higher in Group A as compared with Group B. For example, an HR of 2 suggests that Group A has twice the risk of experiencing the event over time as compared with Group B."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"HR < 1:"})," ","This suggests that the event rate is lower in Group A as compared with Group B. For example, an HR of 0.5 suggests that Group A has half the risk of experiencing the event over time as compared with Group B."]})})]})]})];return e.jsx(G,{explanationSections:t,example1:e.jsx(i,{children:"Example 1 content will go here (e.g., a scatterplot, numerical example, or walkthrough)."})})}function mv(){return e.jsxs(l,{gap:"md",children:[e.jsx(i,{fs:"italic",mt:0,children:"Is increased physical activity among older adults associated with time to first hip fracture?"}),e.jsxs(f,{defaultValue:"studyDesign",children:[e.jsxs(f.List,{children:[e.jsx(f.Tab,{value:"studyDesign",children:"Study Design and Methods"}),e.jsx(f.Tab,{value:"effectSize",children:"Effect Size Measure & MCID"}),e.jsx(f.Tab,{value:"result",children:"Result"}),e.jsx(f.Tab,{value:"discussion",children:"Discussion and Future Research"})]}),e.jsx(f.Panel,{value:"studyDesign",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Clinical Research Study Design:"}),e.jsx(i,{children:"Cohort. This is a longitudinal study conducted over several years, tracking a cohort of older adults."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Study Population:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Number of participants:"})," ","200"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Location of recruitment:"})," ","Community health centers across several regions"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Inclusion/exclusion criteria:"})," ","Older adults aged 65 and above"]})})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Variables Under Study:"}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Independent/predictor/exposure:"}),e.jsx(i,{children:"Physical activity level (measured continuously)"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Dependent/outcome:"}),e.jsx(i,{children:"Time to the first hip fracture event (time-to-event)"})]})]})]})}),e.jsx(f.Panel,{value:"effectSize",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Effect size measure used in the analytical approach:"}),e.jsx(i,{children:"Hazard ratio (HR) was used to quantify the effect size"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Minimal clinically important difference (MCID):"}),e.jsx(i,{children:"The MCID was defined as a 10% reduction in hip fracture risk (i.e., HR = 0.90)"})]})]})}),e.jsx(f.Panel,{value:"result",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Point Estimate:"}),e.jsx(i,{children:"The HR point estimate is 0.80."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Confidence Interval:"}),e.jsx(i,{children:"The 95% confidence interval (CI) for the HR ranges from 0.75 to 0.85, which is a precise estimate of the actual value of the HR."})]})]})}),e.jsx(f.Panel,{value:"discussion",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Results:"}),e.jsx(i,{children:"The HR point estimate is 0.80, which corresponds to a 20% reduction in hip fracture risk among those with increased physical activity."}),e.jsx(i,{children:"The 95% CI ranges from 0.75 to 0.85. This provides a precise estimate of the actual risk reduction, showing that the true difference in the population could be as small as 15% or as large as 25%."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Implications of Results:"}),e.jsx(i,{children:"The narrow CI and the accurate estimate of the true effect indicate that the actual impact of increased physical activity is likely to be clinically significant, as all plausible results within the range of the 95% CI are greater than the clinically meaningful difference of 10%."}),e.jsx(i,{children:"Because the upper bound of the CI (HR = 0.85) does not cross unity (HR = 1), the results of this study are statistically significant."}),e.jsx(i,{children:"This study is a definitively positive study. All plausible results are clinically meaningful, and the observed difference is statistically significant."}),e.jsx(i,{children:"This study provides strong evidence that increasing physical activity among older adults is associated with a clinically meaningful reduction in the risk of hip fractures."}),e.jsx(i,{children:"Because this is an observational study, alternative explanations for the positive findings can include confounding (a third factor causes both increased physical activity and a reduction in hip fracture), bias (a systematic error in one or more aspects of the conduct of the study), chance (a random effect), and effect-cause (a reversal of effect)."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Future Research:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Conduct a randomized controlled trial (RCT) to validate these findings."})," ","RCTs are regarded as the gold standard for establishing causality because they involve random assignment, which reduces selection bias, control over the independent variable (treatment or exposure), and help minimize potential confounding factors."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Conduct a systematic review"})," ","to thoroughly assess the existing literature on the topic, including various studies that may offer different perspectives."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Conduct a meta-analysis,"})," ","which is a quantitative approach to combine data from multiple studies that yields summary effect estimates with increased statistical power."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Conduct dissemination and implementation (D&I) research"})," ","to translate research findings into clinical practice by bridging the gap between developing effective interventions and their widespread adoption in real-world health care settings. D&I research aims to understand the factors that influence the adoption and use of evidence-based interventions. It also designs and tests strategies to overcome barriers and boost facilitators. Successful D&I research actively involves stakeholders such as clinicians, patients, policymakers, and administrators. Consider assembling a multidisciplinary team of scientists and health service researchers with diverse expertise and perspectives to address the complex challenges of implementation in real-world health care settings."]})})]})]})]})})]})]})}mv.title="Impact of Physical Activity on Hip Fracture Risk in Older Adults";function gv(){return e.jsxs(l,{gap:"md",children:[e.jsx(i,{fs:"italic",mt:0,children:"What is the independent association of age, race, TNM stage, and comorbidity burden with overall survival in patients with head and neck squamous cell carcinoma?"}),e.jsxs(f,{defaultValue:"studyDesign",children:[e.jsxs(f.List,{children:[e.jsx(f.Tab,{value:"studyDesign",children:"Study Design and Methods"}),e.jsx(f.Tab,{value:"effectSize",children:"Effect Size Measure & MCID"}),e.jsx(f.Tab,{value:"result",children:"Result"}),e.jsx(f.Tab,{value:"discussion",children:"Discussion and Future Research"})]}),e.jsx(f.Panel,{value:"studyDesign",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Clinical Research Study Design:"}),e.jsx(i,{children:"Retrospective observational cohort study"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Study Population:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Number of participants:"})," ","1,245"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Location of recruitment:"})," ","Patients were identified from a multi-institutional cancer registry, including academic medical centers and community hospitals"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Inclusion/exclusion criteria:"})," ","Adults (18 years) diagnosed with primary head and neck squamous cell carcinoma between 2015 and 2020, with complete staging information and comorbidity assessment. Exclusion criteria included prior head and neck cancer, metastatic disease at diagnosis, and incomplete follow-up data"]})})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Variables Under Study:"}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Independent/predictor/exposure variables:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:"Age (continuous variable, per 10-year increase)"}),e.jsx(c.Item,{children:"Race (categorical: White, Black, Hispanic, Asian/Other)"}),e.jsx(c.Item,{children:"TNM stage (categorical: Stage I, Stage II, Stage III, Stage IV)"}),e.jsx(c.Item,{children:"Adult Comorbidity Evaluation-27 (ACE-27) score (categorical: None, Mild, Moderate, Severe)"})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Dependent/outcome:"}),e.jsx(i,{children:"Overall survival (time from diagnosis to death from any cause)"})]})]})]})}),e.jsx(f.Panel,{value:"effectSize",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Focus of analysis:"}),e.jsx(i,{children:"Regression model (multivariable Cox proportional hazards regression)"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Effect size measures used in the analytical approach:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:"Adjusted Hazard Ratio (HR) for each predictor variable (adjusted association with predictor)"}),e.jsx(c.Item,{children:"Harrell's C-index for overall model performance"})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Minimal clinically important difference (MCID):"}),e.jsx(i,{children:"A priori, the research team defined a clinically meaningful HR as 1.30 or 0.77 (representing a 30% or greater change in risk), consistent with oncology literature standards"})]})]})}),e.jsx(f.Panel,{value:"result",pt:"md",children:e.jsx(l,{gap:"md",children:e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Adjusted Hazard Ratios for Individual Predictors:"}),e.jsx(i,{children:e.jsx(i,{span:!0,fw:500,children:"Age:"})}),e.jsxs(i,{children:["HR = 1.18 per 10-year increase (95% CI: 1.091.28;"," ",e.jsx(i,{span:!0,fs:"italic",children:"p"})," ","< 0.001)"]}),e.jsx(i,{children:"For every 10-year increase in age, patients had an 18% higher hazard of death after adjusting for race, TNM stage, and comorbidity burden"}),e.jsx(i,{children:e.jsx(i,{span:!0,fw:500,children:"Race (Reference: White):"})}),e.jsxs(c,{spacing:2,children:[e.jsxs(c.Item,{children:["Black: HR = 1.24 (95% CI: 1.021.51;"," ",e.jsx(i,{span:!0,fs:"italic",children:"p"})," ","= 0.03)"]}),e.jsxs(c.Item,{children:["Hispanic: HR = 0.89 (95% CI: 0.691.15;"," ",e.jsx(i,{span:!0,fs:"italic",children:"p"})," ","= 0.37)"]}),e.jsxs(c.Item,{children:["Asian/Other: HR = 0.82 (95% CI: 0.611.10;"," ",e.jsx(i,{span:!0,fs:"italic",children:"p"})," ","= 0.18)"]})]}),e.jsx(i,{children:"Black patients had a 24% higher hazard of death compared with White patients after adjusting for other variables. Hispanic and Asian/Other patients have a lower hazard of death compared to White patients, but the confidence interval includes values both below and above 1, so no definitive conclusion can be drawn about the actual relationship."}),e.jsx(i,{children:e.jsx(i,{span:!0,fw:500,children:"TNM Stage (Reference: Stage I):"})}),e.jsxs(c,{spacing:2,children:[e.jsxs(c.Item,{children:["Stage II: HR = 1.45 (95% CI: 1.081.95;"," ",e.jsx(i,{span:!0,fs:"italic",children:"p"})," ","= 0.01)"]}),e.jsxs(c.Item,{children:["Stage III: HR = 2.12 (95% CI: 1.612.79;"," ",e.jsx(i,{span:!0,fs:"italic",children:"p"})," ","< 0.001)"]}),e.jsxs(c.Item,{children:["Stage IV: HR = 3.58 (95% CI: 2.784.61;"," ",e.jsx(i,{span:!0,fs:"italic",children:"p"})," ","< 0.001)"]})]}),e.jsx(i,{children:"Compared with Stage I disease, patients with Stage II, III, and IV disease had progressively higher hazards of death. Stage IV patients had a 258% higher hazard (HR - 1 = 2.58) compared with Stage I patients after adjusting for other factors"}),e.jsx(i,{children:e.jsx(i,{span:!0,fw:500,children:"ACE-27 Comorbidity Score (Reference: None):"})}),e.jsxs(c,{spacing:2,children:[e.jsxs(c.Item,{children:["Mild: HR = 1.31 (95% CI: 1.051.64;"," ",e.jsx(i,{span:!0,fs:"italic",children:"p"})," ","= 0.02)"]}),e.jsxs(c.Item,{children:["Moderate: HR = 1.67 (95% CI: 1.342.08;"," ",e.jsx(i,{span:!0,fs:"italic",children:"p"})," ","< 0.001)"]}),e.jsxs(c.Item,{children:["Severe: HR = 2.41 (95% CI: 1.893.07;"," ",e.jsx(i,{span:!0,fs:"italic",children:"p"})," ","< 0.001)"]})]}),e.jsx(i,{children:"Patients with increasing comorbidity burden had progressively higher hazards of death. Those with severe comorbidity had a 141% higher hazard of death (HR - 1 = 1.41) compared with patients without comorbidity after adjusting for other variables."})]})})}),e.jsx(f.Panel,{value:"discussion",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Results:"}),e.jsx(i,{children:e.jsx(i,{span:!0,fw:500,children:"Individual Predictor Variables:"})}),e.jsx(i,{children:"Age demonstrated a clinically meaningful association with survival, with each decade of life increasing mortality risk by 18%"}),e.jsx(i,{children:"Race showed disparities in survival, with Black patients experiencing significantly worse outcomes even after controlling for tumor stage and comorbidity. The wide confidence interval and inclusion of 1.0 for the hazard ratio for Hispanic and Asian/Other groups suggest these findings require cautious interpretation."}),e.jsx(i,{children:"TNM stage emerged as the strongest predictor of survival, with advanced-stage disease showing progressively worse outcomes. All stage comparisons exceeded the pre-defined MCID threshold of HR 1.30, indicating clinically meaningful differences."}),e.jsx(i,{children:"Comorbidity burden showed a clear dose-response relationship with survival, where greater severity of comorbidity was associated with higher mortality risk. Moderate and severe comorbidity categories surpassed the clinically meaningful threshold."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Implications of Results:"}),e.jsx(i,{children:e.jsx(i,{span:!0,fw:500,children:"Clinical Practice:"})}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsx(i,{children:"This multivariable prognostic model helps clinicians with risk assessment and treatment planning for patients with head and neck squamous cell carcinoma."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"The significant effect of comorbidity burden on survival emphasizes the need for thorough geriatric and medical evaluations in cancer care planning."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"Racial disparities in outcomes warrant investigation into possible differences in treatment access, treatment tolerance, or biological factors."})})]}),e.jsx(i,{children:e.jsx(i,{span:!0,fw:500,children:"Patient Counseling:"})}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsx(i,{children:"The model offers quantitative estimates of survival risk that can help guide shared decision-making discussions with patients and families."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"Patients with severe comorbidity might benefit from discussions about treatment intensity, care goals, and supportive options."})})]}),e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Health Equity:"})," ","The persistent survival disadvantage for Black patients after adjusting for clinical factors suggests the need for interventions addressing social determinants of health, healthcare access, and treatment delivery"]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Future Research:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Model Validation and Refinement:"})," ","External validation of the model in independent cohorts is necessary to evaluate its generalizability and calibration. Including additional predictors such as treatment modality, performance status, smoking status, and molecular markers may enhance model discrimination. Investigation of potential interactions between predictors (e.g., age  comorbidity, race  stage) could offer more detailed risk stratification."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Disparity Research:"})," ","Conduct studies to explore the mechanisms behind racial disparities in survival, including analyses of treatment patterns, treatment completion rates, and access to multidisciplinary care. Assess whether the observed disparities continue in healthcare systems with universal access to care."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Comorbidity Management:"})," ","Prospective studies assessing interventions to improve comorbidity management during cancer treatment. Development of integrated care models that address both cancer treatment and management of concurrent medical conditions."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Clinical Trial Design:"})," ","Use the prognostic model to classify patients in clinical trials to ensure balanced randomization across risk groups. Consider using adaptive trial designs that include baseline risk when evaluating new therapeutic interventions."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Advanced Modeling:"})," ","Explore the use of machine learning techniques to identify complex non-linear relationships and interactions among predictors. Develop dynamic prediction models that include time-varying covariates and landmark analyses."]})})]})]})]})})]})]})}gv.title="Multivariable Prognostic Model for Overall Survival in Patients with Head and Neck Squamous Cell Carcinoma: The Role of Demographics, Tumor Stage, and Comorbidity";const tC=[mv],nC=[gv];function bf(){const t=[e.jsx(l,{gap:4,children:e.jsx(i,{children:"Survival rate difference is a nonparametric statistic used to quantify the difference in survival probabilities between two groups at a specific time point. Specifically, it measures the absolute difference in the proportion of subjects who are event-free in one group as compared with another. It is particularly useful when assessing the comparative effectiveness of two treatments or interventions on survival."})}),e.jsxs(l,{gap:6,children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Range of survival rate difference"}),e.jsx(i,{children:"Survival rate difference values are expressed as percentages, typically ranging from -100% to 100%. The interpretation revolves around the comparison of survival rates between two groups:"})]}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Positive survival rate difference:"})," ","This indicates that Group A has a higher proportion of subjects who are event-free as compared with Group B."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"No survival rate difference (0%):"})," ","This implies that both groups have a similar proportion of subjects who are event-free."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Negative survival rate difference:"})," ","This indicates that Group A has a lower proportion of subjects who are event-free as compared with Group B."]})})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation"}),e.jsx(i,{children:'Because the survival rate difference is a percentage-based measurement and does not fall within a standardized numeric range (e.g., -1 to +1, 0 to 1), there are no fixed value categories like "weak" or "strong." However, the significance or importance of the survival rate difference can be assessed based on clinical or practical significance, background knowledge, or other contextual factors.'})]})];return e.jsx(G,{explanationSections:t,example1:e.jsx(i,{children:"Example 1 content will go here (e.g., a scatterplot, numerical example, or walkthrough)."})})}function xv(){return e.jsxs(l,{gap:"md",children:[e.jsx(i,{fs:"italic",mt:0,children:"Among pediatric patients diagnosed with acute lymphoblastic leukemia (ALL), does one chemotherapy protocol lead to a significantly higher survival rate at 5 years as compared with another chemotherapy protocol?"}),e.jsxs(f,{defaultValue:"studyDesign",children:[e.jsxs(f.List,{children:[e.jsx(f.Tab,{value:"studyDesign",children:"Study Design and Methods"}),e.jsx(f.Tab,{value:"effectSize",children:"Effect Size Measure & MCID"}),e.jsx(f.Tab,{value:"result",children:"Result"}),e.jsx(f.Tab,{value:"discussion",children:"Discussion and Future Research"})]}),e.jsx(f.Panel,{value:"studyDesign",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Clinical Research Study Design:"}),e.jsx(i,{children:"Randomized controlled trial."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Study Population:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Number of participants:"})," ","260"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Location of recruitment:"})," ","Patients were identified through a nationwide registry of pediatric cancer cases and enrolled in the study at the time of their diagnosis"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Inclusion/exclusion criteria:"})," ","Pediatric patients diagnosed with ALL"]})})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Variables Under Study:"}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Independent/predictor/exposure:"}),e.jsx(i,{children:"The choice of chemotherapy protocol, Protocol A and Protocol B, is compared"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Dependent/outcome:"}),e.jsx(i,{children:"Patients' vital status (alive or dead) at 5 years after chemotherapy."})]})]})]})}),e.jsx(f.Panel,{value:"effectSize",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Effect size measure used in the analytical approach:"}),e.jsx(i,{children:"Survival rate difference was employed to compare the two chemotherapy protocols."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Minimal clinically important difference (MCID):"}),e.jsx(i,{children:"Before the study, a physician group associated with the National Cancer Institute defined the MCID as a survival rate difference of 0.25 (25%) or greater"})]})]})}),e.jsx(f.Panel,{value:"result",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Point Estimate:"}),e.jsx(i,{children:e.jsx(i,{span:!0,fw:500,children:"5-Year Survival Rate:"})}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:"Protocol A: 55%"}),e.jsx(c.Item,{children:"Protocol B: 25%"})]}),e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Survival Difference:"})," ","The survival rate difference point estimate is 30%, which indicates a large effect size."]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Confidence Interval:"}),e.jsx(i,{children:"The 95% confidence interval (CI) for the survival rate difference is moderately wide and ranges from 20% to 40%. The range of the CI allows for a moderately precise estimate of the true value of the effect of the chemotherapy."})]}),e.jsxs(l,{gap:0,children:[e.jsxs(i,{fw:500,children:["Probability Value (",e.jsx(i,{span:!0,fs:"italic",children:"P"}),"-Value):"]}),e.jsxs(i,{children:[e.jsx(i,{span:!0,fs:"italic",children:"P"})," ","< 0.001"]})]})]})}),e.jsx(f.Panel,{value:"discussion",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Results:"}),e.jsx(i,{children:"The survival rate difference of 30% derived from a randomized controlled trial illustrates a cause-and-effect relationship. This demonstrates that the choice of Protocol A results in a remarkable 30% increase in the 5-year survival rate as compared with Protocol B."}),e.jsx(i,{children:"The lower bound of the 95% CI (20%) suggests that a survival difference as small as 20% is compatible with the results. This difference of 20% is less than the 25% identified by the physician group associated with the National Cancer Institute as clinically important and meaningful."}),e.jsx(i,{children:"Since the lower bound of the CI does not cross 0, the results from this study are statistically significant."}),e.jsx(i,{children:'Despite the statistical significance, the results are imprecise, and the lower bound of the confidence interval of 20% suggests that the true difference may be clinically meaningless since 20% is less than the value of 25% deemed MCID. Thus, the results of this study are referred to as "indeterminate."'}),e.jsx(i,{children:"Because the preponderance of the CI is within the clinically meaningful effect range, this study provides some evidence that the use of Protocol A results in a clinically meaningful difference in survival duration. However, no definitive conclusion can be drawn."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Implications of Results:"}),e.jsx(i,{children:"Despite a 30% difference in survival rates between the two chemotherapy protocols, the uncertainty around the true extent of this differenceranging from as high as 40% to as low as 20%prevents definitive conclusions about whether Protocol A offers a clinically meaningful survival benefit."}),e.jsx(i,{children:"This study provides some evidence supporting the use of Protocol A, but further research with increased precision is needed to draw definitive conclusions."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Future Research:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Larger Sample Size."})," ","Conduct a larger study to achieve more accurate estimates of the effect of the selected protocol on survival. A bigger sample size will improve the estimate's accuracy by narrowing the CI. The investigator can adopt strategies to minimize systematic error, such as standardizing treatment protocols and follow-up procedures."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Identify Additional Factor."})," ","Explore additional factors that may define unique prognostic subgroups for whom the chosen protocol is associated with better (or worse) survival outcomes."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Long-Term Follow-up."})," ","Consider long-term follow-up studies to assess survival outcomes beyond 5 years and evaluate quality of life measures in survivors."]})})]})]})]})})]})]})}xv.title="Efficacy of Two Chemotherapy Protocols in Pediatric Acute Lymphoblastic Leukemia: A 5-Year Survival Analysis";function vv(){return e.jsxs(l,{gap:"md",children:[e.jsx(i,{fs:"italic",mt:0,children:"Among pediatric patients diagnosed with acute lymphoblastic leukemia (ALL), do the three chemotherapy protocols (Protocol A, Protocol B, and Protocol C) lead to significantly different survival rates at 5 years?"}),e.jsxs(f,{defaultValue:"studyDesign",children:[e.jsxs(f.List,{children:[e.jsx(f.Tab,{value:"studyDesign",children:"Study Design and Methods"}),e.jsx(f.Tab,{value:"effectSize",children:"Effect Size Measure & MCID"}),e.jsx(f.Tab,{value:"result",children:"Result"}),e.jsx(f.Tab,{value:"discussion",children:"Discussion and Future Research"})]}),e.jsx(f.Panel,{value:"studyDesign",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Clinical Research Study Design:"}),e.jsx(i,{children:"Randomized controlled trial."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Study Population:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Number of participants:"})," ","390 (130 per protocol)"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Location of recruitment:"})," ","Patients were identified through a nationwide registry of pediatric cancer cases and enrolled in the study at the time of their diagnosis"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Inclusion/exclusion criteria:"})," ","Pediatric patients diagnosed with ALL"]})})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Variables Under Study:"}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Independent/predictor/exposure:"}),e.jsx(i,{children:"The choice of chemotherapy protocol: Protocol A, Protocol B, or Protocol C"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Dependent/outcome:"}),e.jsx(i,{children:"Vital status (alive/dead) of patients at 5 years after receiving chemotherapy"})]})]})]})}),e.jsx(f.Panel,{value:"effectSize",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Effect size measure used in the analytical approach:"}),e.jsx(i,{children:"Survival rate difference was used to compare the three chemotherapy protocols through pairwise comparisons"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Minimal clinically important difference (MCID):"}),e.jsx(i,{children:"Before the study, a physician group associated with the National Cancer Institute defined the MCID as a survival rate difference of 25% or greater"})]})]})}),e.jsx(f.Panel,{value:"result",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Point Estimate:"}),e.jsx(i,{children:e.jsx(i,{span:!0,fw:500,children:"5-Year Survival Rates:"})}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:"Protocol A: 55%"}),e.jsx(c.Item,{children:"Protocol B: 45%"}),e.jsx(c.Item,{children:"Protocol C: 25%"})]}),e.jsx(i,{children:e.jsx(i,{span:!0,fw:500,children:"Pairwise Survival Rate Differences:"})}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:"Protocol A vs. Protocol B: 10% (55% - 45%)"}),e.jsx(c.Item,{children:"Protocol A vs. Protocol C: 30% (55% - 25%)"}),e.jsx(c.Item,{children:"Protocol B vs. Protocol C: 20% (45% - 25%)"})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Confidence Intervals:"}),e.jsx(i,{children:e.jsx(i,{span:!0,fw:500,children:"95% Confidence Intervals for Pairwise Differences:"})}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:"Protocol A vs. Protocol B: -5% to 25%"}),e.jsx(c.Item,{children:"Protocol A vs. Protocol C: 20% to 40%"}),e.jsx(c.Item,{children:"Protocol B vs. Protocol C: 5% to 35%"})]})]}),e.jsxs(l,{gap:0,children:[e.jsxs(i,{fw:500,children:["Probability Values (",e.jsx(i,{span:!0,fs:"italic",children:"P"}),"-Values):"]}),e.jsx(i,{children:e.jsx(i,{span:!0,fw:500,children:"Pairwise Comparisons:"})}),e.jsxs(c,{spacing:2,children:[e.jsxs(c.Item,{children:["Protocol A vs. Protocol B:"," ",e.jsx(i,{span:!0,fs:"italic",children:"P"})," ","= 0.18"]}),e.jsxs(c.Item,{children:["Protocol A vs. Protocol C:"," ",e.jsx(i,{span:!0,fs:"italic",children:"P"})," ","< 0.001"]}),e.jsxs(c.Item,{children:["Protocol B vs. Protocol C:"," ",e.jsx(i,{span:!0,fs:"italic",children:"P"})," ","= 0.02"]})]})]})]})}),e.jsx(f.Panel,{value:"discussion",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Results:"}),e.jsx(i,{children:e.jsx(i,{span:!0,fw:500,children:"Protocol A vs. Protocol B:"})}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsx(i,{children:"The survival rate difference of 10% suggests a modest improvement with Protocol A compared to Protocol B."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"The CI includes both negative values (favoring Protocol B) and positive values up to 25% (approaching clinical significance). This wide CI indicates considerable uncertainty about the true difference."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"The results are indeterminate. No definitive conclusion can be drawn about whether Protocol A offers a clinically meaningful advantage over Protocol B."})})]}),e.jsx(i,{children:e.jsx(i,{span:!0,fw:500,children:"Protocol A vs. Protocol C:"})}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsx(i,{children:"The survival rate difference of 30% derived from a randomized controlled trial illustrates a cause-and-effect relationship. This demonstrates that Protocol A results in a remarkable 30% increase in the 5-year survival rate compared to Protocol C."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"The 95% CI (20% to 40%) is moderately wide."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"The lower bound of the CI (20%) is less than the MCID of 25%, while the upper bound (40%) substantially exceeds it."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"The results are uncertain. While the point estimate indicates a potentially significant, clinically meaningful difference, the lower bound of the CI is below the MCID threshold. However, since most of the CI falls within the range of a clinically meaningful effect, this study provides strong evidence that Protocol A results in a meaningful difference in survival compared to Protocol C."})})]}),e.jsx(i,{children:e.jsx(i,{span:!0,fw:500,children:"Protocol B vs. Protocol C:"})}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsx(i,{children:"The 20% difference in survival rates indicates a significant improvement with Protocol B over Protocol C."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"The 95% CI (5% to 35%) is quite wide, making the estimate of the actual effect imprecise."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"The lower bound of the CI (5%) is significantly below the MCID of 25%, while the upper bound (35%) surpasses it, indicating considerable uncertainty about the true value."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"The results are inconclusive. The wide confidence interval includes values both below and above the clinically significant threshold, which prevents firm conclusions about clinical importance."})})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Implications of Results:"}),e.jsx(i,{children:e.jsx(i,{span:!0,fw:500,children:"Overall Findings:"})}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsx(i,{children:"Protocol A demonstrates the highest 5-year survival rate (55%), followed by Protocol B (45%) and Protocol C (25%)."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"The comparison between Protocol A and Protocol C provides the strongest evidence, with both statistical significance and a point estimate indicating substantial clinical benefit. However, the imprecision in the estimate (CI: 20% to 40%) means that while the preponderance of evidence supports clinical meaningfulness, definitive conclusions cannot be drawn."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"The comparison between Protocol A and Protocol B is inconclusive due to lack of statistical significance and a wide confidence interval."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"The comparison between Protocol B and Protocol C shows statistical significance but remains unclear about clinical significance because of the wide confidence interval."})})]}),e.jsx(i,{children:e.jsx(i,{span:!0,fw:500,children:"Clinical Application:"})}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsx(i,{children:"Clinicians can be fairly confident that Protocol A provides better outcomes than Protocol C, supported by strong evidence indicating a significant survival benefit."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"The decision between Protocol A and Protocol B is still unclear and needs further study."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"Protocol B seems to provide some benefit over Protocol C, although the clinical significance of this difference remains uncertain."})})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Future Research:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Larger Study."})," ","Conduct a larger study with a bigger sample size to gain more accurate estimates of the pairwise differences. Increasing the sample size will improve the precision of the estimates by reducing the width of the CIs."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Reduce systematic error."})," ","Implement strategies, like standardizing the delivery and monitoring of chemotherapy protocols, across treatment sites."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Additional Factors."})," ","Investigate other factors that could identify unique prognostic groups for whom certain protocols lead to better or worse survival outcomes."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Subgroup Analysis."})," ","Consider performing subgroup analyses based on patient characteristics (age, disease stage, genetic markers) to determine which patients are most likely to benefit from each protocol."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Additional Outcomes."})," ","Examine quality-of-life results and treatment-related adverse events alongside survival outcomes to offer a complete comparison of the three protocols."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Long-term follow-up."})," ","Conduct studies beyond 5 years to determine if survival differences remain or change over time."]})})]})]})]})})]})]})}vv.title="Efficacy of Three Chemotherapy Protocols in Pediatric Acute Lymphoblastic Leukemia: A 5-Year Survival Analysis";const iC=[xv],sC=[vv];function Sf(){const t=[e.jsx(l,{gap:4,children:e.jsx(i,{children:"Median survival time is a nonparametric statistic used to quantify the time at which half of the study population is still event-free. Specifically, it measures the time by which 50% of the subjects have experienced the event. It is particularly useful when summarizing the central tendency of survival time data."})}),e.jsxs(l,{gap:6,children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Range of median survival time"}),e.jsx(i,{children:"Median survival time values are also time-based measurements (like months or years). The interpretation revolves around the comparison of median survival time values between two groups:"})]}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Higher median survival time for Group A vs. Group B:"})," ","This indicates that the time at which 50% of Group A experiences the event is later than that of Group B."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Equivalent median survival time values for both groups:"})," ","This implies that both groups have a similar amount of time until 50% of their subjects experience the event."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Lower median survival time for Group A vs. Group B:"})," ","This suggests that the time at which 50% of Group A experiences the event is earlier than that of Group B."]})})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation"}),e.jsx(i,{children:'Because the median survival time is a time-based measurement and does not fall within a standardized numeric range (e.g., -1 to +1, 0 to 1), there are no fixed value categories like "weak" or "strong." However, the significance or importance of differences in median survival time can be assessed based on clinical or practical significance, background knowledge, or other contextual factors.'})]})];return e.jsx(G,{explanationSections:t,example1:e.jsx(i,{children:"Example 1 content will go here (e.g., a scatterplot, numerical example, or walkthrough)."})})}function yv(){return e.jsxs(l,{gap:"md",children:[e.jsx(i,{fs:"italic",mt:0,children:"Among patients diagnosed with glioblastoma multiforme (GBM), does the use of an experimental immunotherapy approach lead to a significant difference in median survival time over the study period as compared with standard therapy?"}),e.jsxs(f,{defaultValue:"studyDesign",children:[e.jsxs(f.List,{children:[e.jsx(f.Tab,{value:"studyDesign",children:"Study Design and Methods"}),e.jsx(f.Tab,{value:"effectSize",children:"Effect Size Measure & MCID"}),e.jsx(f.Tab,{value:"result",children:"Result"}),e.jsx(f.Tab,{value:"discussion",children:"Discussion and Future Research"})]}),e.jsx(f.Panel,{value:"studyDesign",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Clinical Research Study Design:"}),e.jsx(i,{children:"Randomized controlled trial."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Study Population:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Number of participants:"})," ","450"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Location of recruitment:"})," ","Patients were identified through collaboration with multiple cancer centers and hospitals specializing in neuro-oncology"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Inclusion/exclusion criteria:"})," ","Patients diagnosed with GBM"]})})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Variables Under Study:"}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Independent/predictor/exposure:"}),e.jsx(i,{children:"Treatment approach: standard therapy vs. experimental immunotherapy"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Dependent/outcome:"}),e.jsx(i,{children:"Median survival time (in months) after receiving either immunotherapy or standard chemotherapy"})]})]})]})}),e.jsx(f.Panel,{value:"effectSize",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Effect size measure used in the analytical approach:"}),e.jsx(i,{children:"Median survival time was used to compare the two treatment protocols"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Minimal clinically important difference (MCID):"}),e.jsx(i,{children:"Before the study, members of the National Brain Tumor Study defined the MCID as a difference in median survival time of 6 months or more"})]})]})}),e.jsx(f.Panel,{value:"result",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Point Estimate:"}),e.jsx(i,{children:"The median survival time for the experimental immunotherapy is 22 months (i.e., at 22 months, half of the subjects who received this therapy died). The median survival time for the standard therapy approach is 12 months. The point estimate for the median survival time difference is 10 months, which indicates a large effect size."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Confidence Interval:"}),e.jsx(i,{children:"The 95% confidence interval (CI) for the median survival time difference is 7 months to 13 months. The narrow range of the CI allows for a precise estimate of the actual value of the effect of the experimental immunotherapy."})]}),e.jsxs(l,{gap:0,children:[e.jsxs(i,{fw:500,children:["Probability Value (",e.jsx(i,{span:!0,fs:"italic",children:"P"}),"-Value):"]}),e.jsxs(i,{children:[e.jsx(i,{span:!0,fs:"italic",children:"P"})," ","< 0.001"]})]})]})}),e.jsx(f.Panel,{value:"discussion",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Results:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsx(i,{children:"The study findings indicate a statistically significant and clinically meaningful difference in median survival time between patients treated with standard therapy and those treated with the experimental immunotherapy approach."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"The lower bound of the CI (7 months) exceeds the threshold value of 6 months identified by members of the National Brain Tumor Study as the MCID."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"Therefore, the results demonstrate statistical significance and highlight a substantial clinical benefit associated with the immunotherapy approach."})})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Implications of Results:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsx(i,{children:"These results have significant clinical implications, suggesting that the experimental immunotherapy approach offers a substantial increase in median survival time compared to standard therapy for patients with GBM."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"These findings have the potential to revolutionize the treatment of GBM and to improve patient outcomes significantly."})})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Future Research:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Dissemination & Implementation Research."})," ","Conduct dissemination and implementation (D&I) research to translate the research findings into clinical practice by bridging the gap between the development of effective interventions and their widespread adoption and use in real-world health care settings. D&I research seeks to understand the factors that influence the adoption and utilization of evidence-based interventions. It also designs and tests strategies to overcome identified barriers and enhance facilitators. Successful D&I research actively involves stakeholders such as clinicians, patients, policy makers, and administrators. Consider creating a multidisciplinary team of scientists and health service researchers with the broad range of expertise and perspectives needed to address the multifaceted challenges of implementation in real-world health care settings."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Refine the Treatment Approach."})," ","Future research could focus on further refining the immunotherapy approach, identifying predictive biomarkers, and investigating potential combination therapies to enhance efficacy even further."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Long-Term Safety."})," ","Studies exploring the long-term safety profile of the immunotherapy protocol and quality-of-life outcomes for patients receiving this treatment would provide a comprehensive understanding of its overall impact."]})})]})]})]})})]})]})}yv.title="Comparing Median Survival Time Among Patients with Glioblastoma Multiforme: Immunotherapy vs. Standard Therapy";function jv(){return e.jsxs(l,{gap:"md",children:[e.jsx(i,{fs:"italic",mt:0,children:"Among patients diagnosed with glioblastoma multiforme (GBM), does the use of an experimental immunotherapy approach lead to a significant difference in median survival time over the study period as compared with standard therapy?"}),e.jsxs(f,{defaultValue:"studyDesign",children:[e.jsxs(f.List,{children:[e.jsx(f.Tab,{value:"studyDesign",children:"Study Design and Methods"}),e.jsx(f.Tab,{value:"effectSize",children:"Effect Size Measure & MCID"}),e.jsx(f.Tab,{value:"result",children:"Result"}),e.jsx(f.Tab,{value:"discussion",children:"Discussion and Future Research"})]}),e.jsx(f.Panel,{value:"studyDesign",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Clinical Research Study Design:"}),e.jsx(i,{children:"Randomized controlled trial."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Study Population:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Number of participants:"})," ","450"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Location of recruitment:"})," ","Patients were identified through collaboration with multiple cancer centers and hospitals specializing in neuro-oncology"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Inclusion/exclusion criteria:"})," ","Patients diagnosed with GBM"]})})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Variables Under Study:"}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Independent/predictor/exposure:"}),e.jsx(i,{children:"Treatment approach: standard therapy vs. experimental immunotherapy"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Dependent/outcome:"}),e.jsx(i,{children:"Median survival time (in months) after receiving either immunotherapy or standard chemotherapy"})]})]})]})}),e.jsx(f.Panel,{value:"effectSize",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Effect size measure used in the analytical approach:"}),e.jsx(i,{children:"Median survival time was used to compare the two treatment protocols"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Minimal clinically important difference (MCID):"}),e.jsx(i,{children:"Prior to the study, members of the National Brain Tumor Study defined the MCID as a difference in median survival time of 6 months or more"})]})]})}),e.jsx(f.Panel,{value:"result",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Point Estimate:"}),e.jsx(i,{children:"The median survival time for the experimental immunotherapy is 22 months (i.e., at 22 months, half of the subjects who received this therapy died). The median survival time for the standard therapy approach is 12 months. The point estimate for the median survival time difference is 10 months, which indicates a large effect size."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Confidence Interval:"}),e.jsx(i,{children:"The 95% confidence interval (CI) for the median survival time difference is -2 months to 22 months. The extremely wide range of the CI results in a high level of uncertainty about where the actual effect size value could lie."})]}),e.jsxs(l,{gap:0,children:[e.jsxs(i,{fw:500,children:["Probability Value (",e.jsx(i,{span:!0,fs:"italic",children:"P"}),"-Value):"]}),e.jsxs(i,{children:[e.jsx(i,{span:!0,fs:"italic",children:"P"})," ","= 0.456"]})]})]})}),e.jsx(f.Panel,{value:"discussion",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Results:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsx(i,{children:"The 10-month difference in median survival time derived from a randomized controlled trial illustrates a potential cause-and-effect relationship. This suggests that the use of immunotherapy results in a 10-month increase in median survival time compared to the standard therapy protocol."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"The results, as indicated by the confidence interval bounds, are consistent with a median survival time difference of up to 22 months for immunotherapy, as well as a survival benefit of 2 months for the standard chemotherapy protocol."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"The lower bound of the CI (-2 months) is significantly less than the 6 months recognized by the members of the National Brain Tumor Study as clinically important and meaningful."})}),e.jsx(c.Item,{children:e.jsx(i,{children:'Since the lower limit of the CI crosses 0, the results from this study are considered "not statistically significant."'})}),e.jsx(c.Item,{children:e.jsx(i,{children:`Because of the imprecision of the CI, the high uncertainty of the results, and the possibility that both clinically meaningless and meaningful differences are plausible, this study's results are called "indeterminate."`})})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Implications of Results:"}),e.jsx(i,{children:"Although there is a 10-month median survival difference between the two protocols, the uncertainty around the true survival time gap (which could be as large as 22 months in favor of immunotherapy or as small as 2 months in favor of standard chemotherapy) makes it impossible to definitively determine whether the intervention leads to a clinically meaningful survival difference."}),e.jsx(i,{children:"Since the majority of the CI falls below the clinically meaningful effect range, this study suggests that the immunotherapy protocol is unlikely to produce a clinically significant survival difference. However, a definitive conclusion cannot be drawn."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Future Research:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Perform a Follow-up Study."})," ","Perform a follow-up study to verify the clinically significant difference in median survival time. To improve the accuracy of the estimate, consider increasing the sample size and using techniques that enhance research quality."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Larger Sample Size."})," ","A larger sample size will improve the accuracy of the estimate by reducing the width of the CI."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Reduce Systematic Error."})," ","Implement strategies to reduce systematic error, such as standardizing the delivery of the immunotherapy and chemotherapy protocols."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Good Clinical Practice."})," ","Following good clinical practice guidelines as outlined in the FDA Code of Federal Regulations improves clinical research by encouraging standardized procedures, data integrity, patient safety, and strict oversight. By minimizing both random and systematic errors, good clinical practice increases the reliability and accuracy of effect size estimates, ultimately supporting the validity of clinical trial outcomes and the progress of evidence-based medicine."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Additional Factors."})," ","Explore additional factors that might identify unique prognostic subgroups where the selected protocol correlates with improved (or diminished) survival outcomes."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Replication Studies."})," ","Consider conducting replication studies with enhanced methodological rigor to achieve more accurate estimates of the treatment effect."]})})]})]})]})})]})]})}jv.title="Comparing Median Survival Time Among Patients with Glioblastoma Multiforme: Immunotherapy vs. Standard Therapy (Example B)";function wv(){return e.jsxs(l,{gap:"md",children:[e.jsx(i,{fs:"italic",mt:0,children:"Among patients diagnosed with glioblastoma multiforme (GBM), do three different treatment approaches (standard therapy, experimental immunotherapy, and combination therapy) lead to significantly different median survival times over the study period?"}),e.jsxs(f,{defaultValue:"studyDesign",children:[e.jsxs(f.List,{children:[e.jsx(f.Tab,{value:"studyDesign",children:"Study Design and Methods"}),e.jsx(f.Tab,{value:"effectSize",children:"Effect Size Measure & MCID"}),e.jsx(f.Tab,{value:"result",children:"Result"}),e.jsx(f.Tab,{value:"discussion",children:"Discussion and Future Research"})]}),e.jsx(f.Panel,{value:"studyDesign",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Clinical Research Study Design:"}),e.jsx(i,{children:"Randomized controlled trial."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Study Population:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Number of participants:"})," ","600 (200 per treatment group)"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Location of recruitment:"})," ","Patients were identified through collaboration with multiple cancer centers and hospitals specializing in neuro-oncology"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Inclusion/exclusion criteria:"})," ","Patients diagnosed with GBM"]})})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Variables Under Study:"}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Independent/predictor/exposure:"}),e.jsx(i,{children:"Treatment approach: standard therapy vs. experimental immunotherapy vs. combination therapy (immunotherapy plus standard therapy)"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Dependent/outcome:"}),e.jsx(i,{children:"Median survival time (in months) after receiving treatment"})]})]})]})}),e.jsx(f.Panel,{value:"effectSize",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Effect size measure used in the analytical approach:"}),e.jsx(i,{children:"Median survival time was used to compare the three treatment protocols through pairwise comparisons"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Minimal clinically important difference (MCID):"}),e.jsx(i,{children:"Prior to the study, members of the National Brain Tumor Study defined the MCID as a difference in median survival time of 6 months or more"})]})]})}),e.jsx(f.Panel,{value:"result",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Point Estimate:"}),e.jsx(i,{children:e.jsx(i,{span:!0,fw:500,children:"Median Survival Times:"})}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:"Standard Therapy: 12 months"}),e.jsx(c.Item,{children:"Experimental Immunotherapy: 22 months"}),e.jsx(c.Item,{children:"Combination Therapy: 26 months"})]}),e.jsx(i,{children:e.jsx(i,{span:!0,fw:500,children:"Pairwise Median Survival Time Differences:"})}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:"Immunotherapy vs. Standard Therapy: 10 months (22 - 12)"}),e.jsx(c.Item,{children:"Combination Therapy vs. Standard Therapy: 14 months (26 - 12)"}),e.jsx(c.Item,{children:"Combination Therapy vs. Immunotherapy: 4 months (26 - 22)"})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Confidence Intervals:"}),e.jsx(i,{children:e.jsx(i,{span:!0,fw:500,children:"95% Confidence Intervals for Pairwise Differences:"})}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:"Immunotherapy vs. Standard Therapy: 7 to 13 months"}),e.jsx(c.Item,{children:"Combination Therapy vs. Standard Therapy: 10 to 18 months"}),e.jsx(c.Item,{children:"Combination Therapy vs. Immunotherapy: 0 to 8 months"})]})]}),e.jsxs(l,{gap:0,children:[e.jsxs(i,{fw:500,children:["Probability Values (",e.jsx(i,{span:!0,fs:"italic",children:"P"}),"-Values):"]}),e.jsx(i,{children:e.jsx(i,{span:!0,fw:500,children:"Pairwise Comparisons:"})}),e.jsxs(c,{spacing:2,children:[e.jsxs(c.Item,{children:["Immunotherapy vs. Standard Therapy:"," ",e.jsx(i,{span:!0,fs:"italic",children:"P"})," ","< 0.001"]}),e.jsxs(c.Item,{children:["Combination Therapy vs. Standard Therapy:"," ",e.jsx(i,{span:!0,fs:"italic",children:"P"})," ","< 0.001"]}),e.jsxs(c.Item,{children:["Combination Therapy vs. Immunotherapy:"," ",e.jsx(i,{span:!0,fs:"italic",children:"P"})," ","= 0.048"]})]})]})]})}),e.jsx(f.Panel,{value:"discussion",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Results:"}),e.jsx(i,{children:e.jsx(i,{span:!0,fw:500,children:"Immunotherapy vs. Standard Therapy:"})}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsx(i,{children:"The 10-month difference in median survival time from a randomized controlled trial shows a cause-and-effect link. This indicates that experimental immunotherapy leads to a significant 10-month increase in median survival compared to standard treatment."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"The 95% CI (7 to 13 months) is narrow, showing a precise estimate of the true effect."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"The lower bound of the CI (7 months) surpasses the MCID threshold of 6 months, and the upper bound (13 months) significantly exceeds it."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"This is a definitely positive study. All plausible results, as defined by the range of the 95% CI, are clinically meaningful, and the observed difference is statistically significant."})})]}),e.jsx(i,{children:e.jsx(i,{span:!0,fw:500,children:"Combination Therapy vs. Standard Therapy:"})}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsx(i,{children:"The 14-month median survival time difference shows that combination therapy leads to a significant 14-month increase in median survival compared to standard therapy."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"The 95% CI (10 to 18 months) is narrow, showing a precise estimate of the actual effect."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"The lower bound of the CI (10 months) significantly surpasses the MCID threshold of 6 months."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"This is a definitively positive study. All plausible results are clinically meaningful, and the observed difference is statistically significant. Combination therapy provides the strongest evidence of clinical benefit compared to standard therapy."})})]}),e.jsx(i,{children:e.jsx(i,{span:!0,fw:500,children:"Combination Therapy vs. Immunotherapy:"})}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsx(i,{children:"The median survival time difference of 4 months indicates a modest benefit of combination therapy over immunotherapy alone."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"The 95% CI (0 to 8 months) is somewhat wide and imprecise."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"The lower bound of the CI (0 months) is well below the MCID threshold of 6 months, while the upper bound (8 months) slightly surpasses it."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"The results are inconclusive. Although the point estimate (4 months) and the lower bound of the confidence interval fall below the MCID threshold, the upper bound indicates the potential for a clinically significant benefit. The uncertainty in the estimate prevents firm conclusions about whether combination therapy provides a clinically meaningful improvement over immunotherapy alone."})})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Implications of Results:"}),e.jsx(i,{children:e.jsx(i,{span:!0,fw:500,children:"Overall Findings:"})}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsx(i,{children:"Combination therapy shows the longest median survival time (26 months), followed by experimental immunotherapy (22 months) and standard therapy (12 months)."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"Both immunotherapy alone and combination therapy show definitively positive results compared to standard therapy, with all plausible estimates indicating clinically meaningful survival benefits."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"Combination therapy seems more effective than standard therapy, with the biggest effect size of 14 months and high accuracy."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"The comparison between combination therapy and immunotherapy alone remains uncertain. While combination therapy shows a numerically longer median survival time, the clinical significance of this 4-month difference is unclear because it falls below the MCID threshold and the confidence interval includes both clinically insignificant and potentially significant values."})})]}),e.jsx(i,{children:e.jsx(i,{span:!0,fw:500,children:"Clinical Application:"})}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsx(i,{children:"These results have important clinical implications. Both experimental immunotherapy and combination therapy provide notable improvements in median survival time compared to standard treatment for patients with GBM."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"Clinicians can be very confident that either immunotherapy alone or combination therapy is a significant improvement over standard treatment."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"The choice between immunotherapy alone and combination therapy requires careful consideration. Although combination therapy offers the longest median survival, its additional benefit over immunotherapy alone might not be clinically significant. Factors such as treatment toxicity, quality of life, cost, and patient preferences should guide this decision."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"These findings could revolutionize GBM treatment and significantly improve patient outcomes."})})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Future Research:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Larger Study."})," ","Conduct a larger study focused specifically on comparing immunotherapy alone versus combination therapy to obtain more precise estimates of the difference between these two promising approaches. A larger sample size will increase the precision of the estimate by decreasing the width of the CI."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Benefit vs. Adverse Effects."})," ","Determine if the small additional survival benefit of combination therapy (4 months) is meaningful when weighed against potential increases in treatment-related side effects, costs, and effects on quality of life."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Dissemination & Implementation."})," ","Conduct dissemination and implementation (D&I) research to translate research findings into clinical practice by bridging the gap between developing effective interventions and their widespread adoption and use in real-world healthcare settings. D&I research aims to understand the factors that influence the adoption and utilization of evidence-based interventions, and it designs and tests strategies to overcome identified barriers and improve facilitators. Successful D&I research actively involves stakeholders such as clinicians, patients, policymakers, and administrators. Consider forming a multidisciplinary team of scientists and health services researchers with diverse expertise and perspectives needed to address the complex challenges of implementation in real-world healthcare settings."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Explore Biomarkers."})," ","Explore predictive biomarkers that can identify which patients are most likely to benefit from immunotherapy alone versus combination therapy."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Subgroup Analysis."})," ","Perform subgroup analyses based on patient characteristics (age, performance status, molecular markers) to identify if some populations gain more benefit from specific treatment approaches."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Long-Term Survival Outcomes."})," ","Examine long-term survival outcomes beyond the median survival point to determine whether survival curves continue to diverge or converge over time."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Long-Term Safety."})," ","Studies examining long-term safety, treatment-related toxicities, and quality-of-life outcomes for patients receiving these treatments would offer a comprehensive understanding of their overall impact and assist in guiding treatment choices."]})})]})]})]})})]})]})}wv.title="Comparing Median Survival Time Among Patients with Glioblastoma Multiforme: Three Treatment Approaches";const rC=[yv,jv],aC=[wv];function If(){const t=[e.jsx(l,{gap:4,children:e.jsx(i,{children:"Restricted mean survival time (RMST) is a nonparametric statistic used to quantify the expected time to an event under a survival curve up to a specified time point. Specifically, it measures the average event-free time up to a specified time horizon. It is particularly useful when comparing the survival experiences of two or more groups, especially when the proportional hazards assumption is not met."})}),e.jsxs(l,{gap:6,children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Range of RMST"}),e.jsx(i,{children:"RMST values are time-based measurements (like months or years). Unlike coefficients that range between specific numeric bounds, RMST provides an absolute difference or expected time. The interpretation revolves around the comparison of RMST values between two groups:"})]}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Higher RMST for Group A vs. Group B:"})," ","This indicates that Group A, on average, experiences the event later than Group B."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Equivalent RMST values for both groups:"})," ","This implies that both groups have a similar expected event-free time up to the specified time point."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Lower RMST for Group A vs. Group B:"})," ","This suggests that Group A, on average, experiences the event earlier than Group B."]})})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation"}),e.jsx(i,{children:'Because RMST is a time-based measurement and does not fall within a standardized numeric range (e.g., -1 to +1, 0 to 1), there are no fixed value categories like "weak" or "strong." However, the significance or importance of differences in RMST can be assessed based on clinical or practical significance, background knowledge, or other contextual factors.'})]})];return e.jsx(G,{explanationSections:t,example1:e.jsx(i,{children:"Example 1 content will go here (e.g., a scatterplot, numerical example, or walkthrough)."})})}function bv(){return e.jsxs(l,{gap:"md",children:[e.jsx(i,{fs:"italic",mt:0,children:"What is the difference in the restricted mean survival time (RMST) among patients with coronary artery disease (CAD) treated with Drug A as compared with those treated with Drug B over a 5-year follow-up period?"}),e.jsxs(f,{defaultValue:"studyDesign",children:[e.jsxs(f.List,{children:[e.jsx(f.Tab,{value:"studyDesign",children:"Study Design and Methods"}),e.jsx(f.Tab,{value:"effectSize",children:"Effect Size Measure & MCID"}),e.jsx(f.Tab,{value:"result",children:"Result"}),e.jsx(f.Tab,{value:"discussion",children:"Discussion and Future Research"})]}),e.jsx(f.Panel,{value:"studyDesign",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Clinical Research Study Design:"}),e.jsx(i,{children:"Randomized controlled trial."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Study Population:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Number of participants:"})," ","300"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Location of recruitment:"})," ","Patients were recruited from a cardiology clinic and identified through medical records and referrals"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Inclusion/exclusion criteria:"})," ","Patients diagnosed with CAD"]})})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Variables Under Study:"}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Independent/predictor/exposure:"}),e.jsx(i,{children:"Drug treatment assignment: Drug A vs. Drug B"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Dependent/outcome:"}),e.jsx(i,{children:"RMST over a 5-year follow-up period"})]})]})]})}),e.jsx(f.Panel,{value:"effectSize",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Effect size measure used in the analytical approach:"}),e.jsx(i,{children:"The difference in RMST was used to compare patients treated with Drug A and those treated with Drug B"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Minimal clinically important difference (MCID):"}),e.jsx(i,{children:"Before the study, experts defined the MCID as a difference in the RMST of 3 years or more"})]})]})}),e.jsx(f.Panel,{value:"result",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Point Estimate:"}),e.jsx(i,{children:"The study found a difference in RMST between patients treated with Drug A and those treated with Drug B of 1.5 years. Patients treated with Drug A survived an average of 1.5 years longer over the 5-year follow-up period as compared with the patients treated with Drug B."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Confidence Interval:"}),e.jsx(i,{children:"The 95% confidence interval (CI) for the RMST was 0.3 to 2.7 years."})]}),e.jsxs(l,{gap:0,children:[e.jsxs(i,{fw:500,children:["Probability Value (",e.jsx(i,{span:!0,fs:"italic",children:"P"}),"-Value):"]}),e.jsxs(i,{children:[e.jsx(i,{span:!0,fs:"italic",children:"P"})," ","= 0.035"]})]})]})}),e.jsx(f.Panel,{value:"discussion",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Results:"}),e.jsx(i,{children:"The point estimate for the difference in RMST (1.5 years) is smaller than the predetermined value for clinical significance (3 years)."}),e.jsx(i,{children:"The CI is narrow, which indicates that the study estimate is precise."}),e.jsx(i,{children:"All values in the CI are below the clinical significance threshold of 3 years, which suggests that there is no clinically important difference in RMST between Drug A and Drug B."}),e.jsxs(i,{children:["Since the"," ",e.jsx(i,{span:!0,fs:"italic",children:"P"})," ","value of 0.035 is less than 0.05, the results from this study are statistically significant."]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Implications of Results:"}),e.jsx(i,{children:e.jsx(i,{span:!0,fw:500,children:"Understanding Statistical Significance vs. Clinical Significance:"})}),e.jsxs(i,{children:["This study illustrates a critical distinction in research interpretation that students often find confusing. Although the results are statistically significant (",e.jsx(i,{span:!0,fs:"italic",children:"P"})," ",'= 0.035), the study is classified as "definitively negative." This apparent contradiction highlights the difference between statistical and clinical significance:']}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsxs(i,{span:!0,fw:500,children:["Statistical Significance (",e.jsx(i,{span:!0,fs:"italic",children:"P"})," ","< 0.05)"]})," ",'simply means that the observed difference is unlikely to be due to random chance alone. It answers the question: "Is there a real difference between the groups?"']})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Clinical Significance"})," ",'depends on whether the difference is large enough to matter in clinical practice. It answers the question: "Is this difference meaningful to patients and clinicians?"']})})]}),e.jsx(i,{children:"In this study:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:["The"," ",e.jsx(i,{span:!0,fs:"italic",children:"P"}),"-value of 0.035 indicates statistical significance, confirming that Drug A and Drug B likely produce different outcomesthis is not due to chance."]})}),e.jsx(c.Item,{children:e.jsx(i,{children:"However, the point estimate (1.5 years) and the entire 95% CI (0.3 to 2.7 years) fall below the predefined MCID of 3 years. This indicates that the results are not compatible with a clinically significant difference in long-term survival between patients with CAD treated with Drug A versus those treated with Drug B."})})]}),e.jsx(i,{children:e.jsx(i,{span:!0,fw:500,children:'Classification as "Definitively Negative":'})}),e.jsx(i,{children:'This study is classified as "definitively negative" because we can be confident (based on the narrow, precise confidence interval) that the true difference does not reach the threshold for clinical importance. All plausible results, as defined by the range of the 95% CI, are below the clinically meaningful threshold. While the difference is statistically significant, it is not clinically meaningful.'}),e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Clinical Application:"})," ","Cardiologists can be confident that the choice between Drug A and Drug B does not lead to a clinically important difference in RMST over a 5-year period, despite the statistical significance of the findings."]}),e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Key Takeaway:"})," ","This study definitively shows that while a difference exists (statistically significant), that difference is not large enough to be clinically important (definitively negative for clinical significance). This demonstrates why effect sizes, confidence intervals, and predetermined MCIDs are essential for interpreting research",e.jsx(i,{span:!0,fs:"italic",children:"P"}),"-values alone cannot tell us whether findings matter in clinical practice."]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Future Research:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Additional Outcomes."})," ","Future research could explore other outcomes (such as quality of life, adverse events, or cost-effectiveness) or subgroups of CAD patients to investigate the effectiveness of different drug treatments further."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Longer Follow-up."})," ","Long-term follow-up studies extending beyond 5 years may reveal survival differences that emerge over an even longer period."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Unique Patient Factors."})," ","Consider exploring whether particular patient traits or disease severity influence the treatment effect."]})})]})]})]})})]})]})}bv.title="Comparing Restricted Mean Survival Time Among Patients with Coronary Artery Disease: Drug A vs. Drug B";function Sv(){return e.jsxs(l,{gap:"md",children:[e.jsx(i,{fs:"italic",mt:0,children:"What are the differences in the restricted mean survival time (RMST) among patients with coronary artery disease (CAD) treated with Drug A, Drug B, or Drug C over a 5-year follow-up period?"}),e.jsxs(f,{defaultValue:"studyDesign",children:[e.jsxs(f.List,{children:[e.jsx(f.Tab,{value:"studyDesign",children:"Study Design and Methods"}),e.jsx(f.Tab,{value:"effectSize",children:"Effect Size Measure & MCID"}),e.jsx(f.Tab,{value:"result",children:"Result"}),e.jsx(f.Tab,{value:"discussion",children:"Discussion and Future Research"})]}),e.jsx(f.Panel,{value:"studyDesign",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Clinical Research Study Design:"}),e.jsx(i,{children:"Randomized controlled trial."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Study Population:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Number of participants:"})," ","450 (150 per treatment group)"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Location of recruitment:"})," ","Patients were recruited from multiple cardiology clinics and identified through medical records and referrals"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Inclusion/exclusion criteria:"})," ","Patients diagnosed with CAD"]})})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Variables Under Study:"}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Independent/predictor/exposure:"}),e.jsx(i,{children:"Drug treatment assignment: Drug A vs. Drug B vs. Drug C"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Dependent/outcome:"}),e.jsx(i,{children:"RMST over a 5-year follow-up period"})]})]})]})}),e.jsx(f.Panel,{value:"effectSize",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Effect size measure used in the analytical approach:"}),e.jsx(i,{children:"The difference in RMST was used to compare the three drug treatments through pairwise comparisons"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Minimal clinically important difference (MCID):"}),e.jsx(i,{children:"Prior to the study, experts defined the MCID as a difference in the RMST of 3 years or more"})]})]})}),e.jsx(f.Panel,{value:"result",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Point Estimate:"}),e.jsx(i,{children:e.jsx(i,{span:!0,fw:500,children:"Restricted Mean Survival Times (over 5 years):"})}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:"Drug A: 4.2 years"}),e.jsx(c.Item,{children:"Drug B: 3.5 years"}),e.jsx(c.Item,{children:"Drug C: 2.7 years"})]}),e.jsx(i,{children:e.jsx(i,{span:!0,fw:500,children:"Pairwise RMST Differences:"})}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:"Drug A vs. Drug B: 0.7 years (4.2 - 3.5)"}),e.jsx(c.Item,{children:"Drug A vs. Drug C: 1.5 years (4.2 - 2.7)"}),e.jsx(c.Item,{children:"Drug B vs. Drug C: 0.8 years (3.5 - 2.7)"})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Confidence Intervals:"}),e.jsx(i,{children:e.jsx(i,{span:!0,fw:500,children:"95% Confidence Intervals for Pairwise Differences:"})}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:"Drug A vs. Drug B: -0.1 to 1.5 years"}),e.jsx(c.Item,{children:"Drug A vs. Drug C: 0.3 to 2.7 years"}),e.jsx(c.Item,{children:"Drug B vs. Drug C: 0.1 to 1.5 years"})]})]}),e.jsxs(l,{gap:0,children:[e.jsxs(i,{fw:500,children:["Probability Values (",e.jsx(i,{span:!0,fs:"italic",children:"P"}),"-Values):"]}),e.jsx(i,{children:e.jsx(i,{span:!0,fw:500,children:"Pairwise Comparisons:"})}),e.jsxs(c,{spacing:2,children:[e.jsxs(c.Item,{children:["Drug A vs. Drug B:"," ",e.jsx(i,{span:!0,fs:"italic",children:"P"})," ","= 0.08"]}),e.jsxs(c.Item,{children:["Drug A vs. Drug C:"," ",e.jsx(i,{span:!0,fs:"italic",children:"P"})," ","= 0.015"]}),e.jsxs(c.Item,{children:["Drug B vs. Drug C:"," ",e.jsx(i,{span:!0,fs:"italic",children:"P"})," ","= 0.04"]})]})]})]})}),e.jsx(f.Panel,{value:"discussion",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Results:"}),e.jsx(i,{children:e.jsx(i,{span:!0,fw:500,children:"Drug A vs. Drug B:"})}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsx(i,{children:"The RMST difference of 0.7 years suggests a modest improvement with Drug A compared to Drug B. Patients treated with Drug A survived an average of 0.7 years longer over the 5-year follow-up period."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"The point estimate (0.7 years) is well below the predetermined MCID of 3 years."})}),e.jsx(c.Item,{children:e.jsxs(i,{children:["The 95% CI (-0.1 to 1.5 years) crosses 0, indicating the results are not statistically significant (",e.jsx(i,{span:!0,fs:"italic",children:"P"})," ","= 0.08)."]})}),e.jsx(c.Item,{children:e.jsx(i,{children:"All values in the CI are below the clinical significance threshold of 3 years, suggesting no clinically important difference in RMST between Drug A and Drug B."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"The results are indeterminate due to lack of statistical significance and the inclusion of both negative and positive values in the CI."})})]}),e.jsx(i,{children:e.jsx(i,{span:!0,fw:500,children:"Drug A vs. Drug C:"})}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsx(i,{children:"The RMST difference of 1.5 years demonstrates that Drug A provides longer average survival compared to Drug C. Patients treated with Drug A survived an average of 1.5 years longer over the 5-year follow-up period."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"The point estimate (1.5 years) is smaller than the predetermined MCID of 3 years."})}),e.jsx(c.Item,{children:e.jsxs(i,{children:["The 95% CI (0.3 to 2.7 years) is narrow and does not cross 0, indicating statistical significance (",e.jsx(i,{span:!0,fs:"italic",children:"P"})," ","= 0.015)."]})}),e.jsx(c.Item,{children:e.jsx(i,{children:"All values in the CI are below the clinical significance threshold of 3 years, suggesting that while the difference is statistically significant, it is not clinically meaningful."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"This is a definitively negative study. The results are statistically significant, but all plausible estimates fall below the MCID threshold."})})]}),e.jsx(i,{children:e.jsx(i,{span:!0,fw:500,children:"Drug B vs. Drug C:"})}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsx(i,{children:"The RMST difference of 0.8 years suggests a modest improvement with Drug B compared to Drug C. Patients treated with Drug B survived an average of 0.8 years longer over the 5-year follow-up period."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"The point estimate (0.8 years) is well below the predetermined MCID of 3 years."})}),e.jsx(c.Item,{children:e.jsxs(i,{children:["The 95% CI (0.1 to 1.5 years) is narrow and just barely does not cross 0, indicating marginal statistical significance (",e.jsx(i,{span:!0,fs:"italic",children:"P"})," ","= 0.04)."]})}),e.jsx(c.Item,{children:e.jsx(i,{children:"All values in the CI are below the clinical significance threshold of 3 years, suggesting no clinically important difference in RMST between Drug B and Drug C."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"This is a definitively negative study. While statistically significant, all plausible estimates are below the MCID threshold."})})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Implications of Results:"}),e.jsx(i,{children:e.jsx(i,{span:!0,fw:500,children:"Understanding Statistical Significance vs. Clinical Significance:"})}),e.jsx(i,{children:'This study illustrates an important distinction in research interpretation. Two comparisons (Drug A vs. Drug C and Drug B vs. Drug C) achieved statistical significance, yet the study conclusions for these comparisons are classified as "definitively negative." This highlights the critical difference between statistical and clinical significance:'}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsxs(i,{span:!0,fw:500,children:["Statistical Significance (",e.jsx(i,{span:!0,fs:"italic",children:"P"})," ","< 0.05)"]})," ",'simply means that the observed difference is unlikely to be due to random chance alone. It answers the question: "Is there a real difference between the groups?"']})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Clinical Significance"})," ",'depends on whether the difference is large enough to matter in clinical practice. It answers the question: "Is this difference meaningful to patients and clinicians?"']})})]}),e.jsx(i,{children:"In this study:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:["The comparisons of Drug A vs. Drug C (",e.jsx(i,{span:!0,fs:"italic",children:"P"})," ","= 0.015) and Drug B vs. Drug C (",e.jsx(i,{span:!0,fs:"italic",children:"P"})," ","= 0.04) show statistical significance, confirming that these drugs likely produce different outcomesthis is not due to chance."]})}),e.jsx(c.Item,{children:e.jsx(i,{children:"However, the point estimates (1.5 years and 0.8 years, respectively) and the entire confidence intervals for both comparisons fall below the predefined MCID of 3 years."})})]}),e.jsx(i,{children:e.jsx(i,{span:!0,fw:500,children:'Classification as "Definitively Negative":'})}),e.jsx(i,{children:'These comparisons are classified as "definitively negative" because we can be confident (based on the narrow, precise confidence intervals) that the true differences do not reach the threshold for clinical importance. All plausible values for the true effects are below what was predetermined to be clinically meaningful.'}),e.jsx(i,{children:e.jsx(i,{span:!0,fw:500,children:"Overall Findings:"})}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsx(i,{children:"Drug A demonstrates the longest RMST (4.2 years), followed by Drug B (3.5 years) and Drug C (2.7 years)."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"Despite numerical differences in survival times, none of the pairwise comparisons demonstrate clinically meaningful differences based on the predetermined MCID of 3 years."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"The comparison between Drug A and Drug C, while statistically significant, is definitively negative for clinical significance. All plausible estimates are below the MCID."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"The comparison between Drug B and Drug C is also definitively negative despite statistical significance."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"The comparison between Drug A and Drug B is not statistically significant and shows no clinically meaningful difference."})})]}),e.jsx(i,{children:e.jsx(i,{span:!0,fw:500,children:"Clinical Application:"})}),e.jsx(i,{children:"Cardiologists can be confident that the choice among Drug A, Drug B, or Drug C does not lead to clinically important differences in RMST over a 5-year period. While Drug A shows the highest average survival time, the differences are not large enough to be clinically meaningful according to the predetermined threshold."}),e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Key Takeaway:"})," ","This study definitively shows that while differences exist among the three drugs (particularly between Drug A and Drug C, and between Drug B and Drug C, which are statistically significant), these differences are not large enough to be clinically important (definitively negative for clinical significance). This demonstrates why effect sizes, confidence intervals, and predetermined MCIDs are essential for interpreting research",e.jsx(i,{span:!0,fs:"italic",children:"P"}),"-values alone cannot tell us whether findings matter in clinical practice."]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Future Research:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsx(i,{children:"Future research could explore other outcomes (such as quality of life, cardiovascular events, adverse effects, or cost-effectiveness) that may differ among the three drug treatments even if RMST differences are not clinically meaningful."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"Investigate subgroups of CAD patients (based on disease severity, comorbidities, age, or genetic factors) to determine whether certain populations may derive greater differential benefit from specific drugs."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"Long-term follow-up studies beyond 5 years may provide insights into survival differences that may become apparent over an even longer time frame, potentially reaching clinical significance."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"Consider conducting studies with larger sample sizes to increase precision, though given that the current confidence intervals are already narrow and entirely below the MCID, increased precision is unlikely to change the clinical interpretation."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"Explore combination therapies or novel treatment approaches that may achieve clinically meaningful improvements in RMST beyond what these three drugs individually provide."})})]})]})]})})]})]})}Sv.title="Comparing Restricted Mean Survival Time Among Patients with Coronary Artery Disease: Three Drug Treatments";const oC=[bv],lC=[Sv];function cC(){const t=[e.jsx(l,{gap:4,children:e.jsx(i,{children:"Harrell's C-index is a nonparametric statistic used to quantify the predictive accuracy of survival models. Specifically, it measures the discrimination ability of models for correctly ranking subjects based on their event times. It is particularly useful when assessing the performance of prognostic models in survival analysis."})}),e.jsxs(l,{gap:6,children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Range of Harrell's C-index"}),e.jsx(i,{children:"Harrell's C-index values range from 0 to 1. The value of the coefficient indicates the ability of the model to correctly rank pairs of subjects:"})]}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Value closer to 1:"})," ","This indicates a positive predictive accuracy. The model has a high probability of correctly ranking pairs of subjects in order of their event times."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Value closer to 0.5:"})," ","This implies no better accuracy than random chance."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Value closer to 0:"})," ","This suggests a negative predictive accuracy. The model consistently predicts in the opposite direction."]})})]})]}),e.jsxs(l,{gap:6,children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Harrell's C-index"}),e.jsx(i,{children:"An interpretation of Harrell's C-index in survival analysis is as follows:"})]}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"<0.5:"})," ","No discriminative ability and no better than chance"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.5 to 0.7:"})," ","Poor to moderate discriminative ability"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"0.7 to 0.8:"})," ","Good discriminative ability"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:">0.8:"})," ","Excellent discriminative ability"]})})]})]})];return e.jsx(G,{explanationSections:t,example1:e.jsx(i,{children:"Example 1 content will go here (e.g., a scatterplot, numerical example, or walkthrough)."})})}function Iv(){return e.jsxs(l,{gap:"md",children:[e.jsx(i,{fs:"italic",mt:0,children:"What is the predictive accuracy and discriminative ability of a model that includes a variety of demographic, clinical, treatment, and environmental factors to predict childhood asthma exacerbations?"}),e.jsxs(f,{defaultValue:"studyDesign",children:[e.jsxs(f.List,{children:[e.jsx(f.Tab,{value:"studyDesign",children:"Study Design and Methods"}),e.jsx(f.Tab,{value:"effectSize",children:"Effect Size Measure & MCID"}),e.jsx(f.Tab,{value:"result",children:"Result"}),e.jsx(f.Tab,{value:"discussion",children:"Discussion and Future Research"})]}),e.jsx(f.Panel,{value:"studyDesign",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Clinical Research Study Design:"}),e.jsx(i,{children:"Observational cohort"})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Study Population:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Number of participants:"})," ","1,100"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Location of recruitment:"})," ","Patients were recruited from pediatric clinics and hospitals"]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Inclusion/exclusion criteria:"})," ","Patients with asthma between the ages of 1 and 17 years"]})})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Variables Under Study:"}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Independent Variables (Predictors):"}),e.jsx(i,{children:e.jsx(i,{span:!0,fw:500,children:"Factor Group 1: Demographics"})}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:"Age: Continuous variable representing the age of the pediatric patient"}),e.jsx(c.Item,{children:"Gender: Categorical variable indicating the sex of the patient (male or female)"})]}),e.jsx(i,{children:e.jsx(i,{span:!0,fw:500,children:"Factor Group 2: Clinical-related"})}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:"Lung Function: Continuous variable signaling measurements of patient lung function (e.g., forced expiratory volume in 1 second)"}),e.jsx(c.Item,{children:"Allergy Status: Categorical variable disclosing the presence or absence of known allergies in the patient"})]}),e.jsx(i,{children:e.jsx(i,{span:!0,fw:500,children:"Factor Group 3: Treatment-related"})}),e.jsx(c,{spacing:2,children:e.jsx(c.Item,{children:"Medication Adherence: Continuous variable noting the patient's adherence level to prescribed asthma medications"})}),e.jsx(i,{children:e.jsx(i,{span:!0,fw:500,children:"Factor Group 4: Environmental-related"})}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:"Allergen Exposure: Categorical variable indicating the patient's level of exposure to common allergens (e.g., low, moderate, or high)"}),e.jsx(c.Item,{children:"Tobacco Smoke Exposure: Categorical variable indicating the patient's exposure to tobacco smoke (e.g., exposed or not exposed)"})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Dependent Variable (Outcome):"}),e.jsx(i,{children:"Childhood asthma exacerbations"})]})]})]})}),e.jsx(f.Panel,{value:"effectSize",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Analytical Approach:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:"Focus of Analysis: Regression Model - Overall Model"}),e.jsx(c.Item,{children:"Outcome Measure Type: Time-to-Event"}),e.jsx(c.Item,{children:"Effect Size Measure: Harrell's C-index was used to evaluate the survival model's performance"})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Minimal Clinically Important Difference (MCID):"}),e.jsx(i,{children:"Expert clinicians in this specialty deemed that a risk prediction model with a predictive ability of 0.75 or greater would be clinically meaningful in this disease/population"})]})]})}),e.jsx(f.Panel,{value:"result",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Point Estimate:"}),e.jsx(i,{children:"The Harrell's C-index value is 0.75, which represents good discriminative ability."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Confidence Interval:"}),e.jsx(i,{children:"The 95% confidence interval (CI) ranges from 0.73 to 0.77."})]})]})}),e.jsx(f.Panel,{value:"discussion",pt:"md",children:e.jsxs(l,{gap:"md",children:[e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Interpretation of Results:"}),e.jsx(i,{children:"The developed regression model demonstrates good predictive accuracy and discrimination, as suggested by Harrell's C-index value of 0.75. This value implies that the model is capable of correctly ranking pediatric patients with respect to their risk of developing asthma exacerbations 75% of the time."})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Implications of Results:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsx(i,{children:"The model's high Harrell's C-index shows its potential usefulness in clinical settings for identifying high-risk pediatric patients who might benefit from targeted treatments and personalized management strategies to prevent asthma exacerbations."})}),e.jsx(c.Item,{children:e.jsx(i,{children:"Early identification of at-risk children can improve asthma management and lower exacerbation rates."})})]})]}),e.jsxs(l,{gap:0,children:[e.jsx(i,{fw:500,children:"Future Research:"}),e.jsxs(c,{spacing:2,children:[e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Limitations to Consider:"})," ","Since this is an observational study, alternative explanations for the positive findings can include confounding (a third factor causes the observed results), bias (a systematic error in one or more aspects of the study's conduct), chance (a random effect), and effect-cause (a reversal of effect)."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Validate the Model:"})," ","Perform a follow-up study to evaluate and confirm the model's performance in a different cohort of patients, ensuring this new group represents diverse demographics and healthcare settings. This approach aims to compare the C-index from the original study with that of the new cohort, focusing on the model's consistency across various patient populations and identifying any biases or limitations."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Refine the Model:"})," ","Perform a follow-up study that includes additional factors such as genetic markers, new biomarkers, patient-reported outcomes, or social determinants of health. This step aims to further improve the model's predictive ability and increase its C-index. The addition of these variables should be balanced with the risk of overfitting and the model's clinical usefulness."]})}),e.jsx(c.Item,{children:e.jsxs(i,{children:[e.jsx(i,{span:!0,fw:500,children:"Assess the Model Over Time:"})," ","Use the model in studies with long-term follow-up, enabling evaluation of its performance over periods and its ability to adapt to changing patient features. This includes examining the C-index at various points and possibly updating the model with new patient data to maintain its accuracy and relevance in predicting outcomes."]})})]})]})]})})]})]})}Iv.title="Predictive Model for Childhood Asthma Exacerbations: A Multifactorial Approach";const dC=[Iv],Cf="hazard-ratio",Tf="hazard-ratio-regression",Rf="survival-rate-difference",kf="median-survival-time",Pf="restricted-mean-survival-time",Ef="survival-rate-difference-3groups",Df="median-survival-time-3groups",Mf="restricted-mean-survival-time-3groups",Zi="two-groups-effect-sizes-tte",qo="comparison-of-three-or-more-groups-tte",Ji="pairwise-effect-sizes-tte",Tr="regression-model-tte",Af="overall-model-tte",uC={[Qn]:{type:"question",title:Rd,component:kd,inputs:[Ii],choices:[{answer:"Correlation with continuous measure",next:Cf,option_description:Od},{answer:"Comparison of 2 groups",next:Zi,option_description:Fd},{answer:"Comparison of 3 or more groups",next:qo,option_description:$d},{answer:"Regression model",next:Tr,option_description:Bd}]},[Cf]:{type:"statement",title:"Hazard Ratio",flowChartTitle:"Hazard Ratio",component:wf,color:"teal-darken-2",inputs:[Qn],examples:tC},[Zi]:{type:"question",title:Be,component:He,inputs:[Qn],choices:[{answer:"Survival rate difference",next:Rf,option_description:"A nonparametric statistic used to quantify the difference in survival probabilities between two groups at a specific time point."},{answer:"Median survival time",next:kf,option_description:"A nonparametric statistic used to quantify the time at which half of the study population is still event-free."},{answer:"Restricted mean survival time",next:Pf,option_description:"A nonparametric statistic used to quantify the expected time to an event under a survival curve up to a specified time point."}]},[Rf]:{type:"statement",title:"Survival rate difference",flowChartTitle:"Survival Rate Difference",component:bf,color:"indigo-darken-2",inputs:[Zi],examples:iC},[kf]:{type:"statement",title:"Median survival time",flowChartTitle:"Median Survival Time",component:Sf,color:"indigo-darken-2",inputs:[Zi],examples:rC},[Pf]:{type:"statement",title:"Restricted mean survival time",flowChartTitle:"Restricted Mean Survival Time",component:If,color:"indigo-darken-2",inputs:[Zi],examples:oC},[qo]:{type:"question",title:Ci,component:Ti,inputs:[Qn],choices:[{answer:Nd,next:Ji,option_description:{short:_d,long:Ld}}]},[Ji]:{type:"question",title:Be,component:He,inputs:[qo],choices:[{answer:"Survival rate difference",next:Ef,option_description:"A nonparametric statistic used to quantify the difference in survival probabilities between two groups at a specific time point."},{answer:"Median survival time",next:Df,option_description:"A nonparametric statistic used to quantify the time at which half of the study population is still event-free."},{answer:"Restricted mean survival time",next:Mf,option_description:"A nonparametric statistic used to quantify the expected time to an event under a survival curve up to a specified time point."}]},[Ef]:{type:"statement",title:"Survival rate difference",flowChartTitle:"Survival Rate Difference",component:bf,color:"indigo-darken-2",inputs:[Ji],examples:sC},[Df]:{type:"statement",title:"Median survival time",flowChartTitle:"Median Survival Time",component:Sf,color:"indigo-darken-2",inputs:[Ji],examples:aC},[Mf]:{type:"statement",title:"Restricted mean survival time",flowChartTitle:"Restricted Mean Survival Time",component:If,color:"indigo-darken-2",inputs:[Ji],examples:lC},[Tr]:{type:"question",title:Ci,component:Ti,inputs:[Qn],choices:[{answer:Pd,next:Tf,option_description:{short:Ed,long:Dd}},{answer:Md,next:Af,option_description:{short:Ad,long:zd}}]},[Tf]:{type:"statement",title:"Hazard Ratio",flowChartTitle:"Hazard Ratio (HR)",component:wf,color:"purple-darken-2",inputs:[Tr],examples:nC},[Af]:{type:"statement",title:"Harrel's C-index",flowChartTitle:"Harrel's C-index",component:cC,color:"purple-darken-2",inputs:[Tr],examples:dC}},hC=t=>Object.entries(t).reduce((n,[s,r])=>(n[s]={...r,id:s},n),{}),fC={[Ii]:{title:WI,flowChartTitle:"Select the type of outcome variable being analyzed or compared.",component:QI,inputs:[],choices:[{answer:"Continous",next:qn,option_description:{short:YI,long:KI}},{answer:"Categorical",next:Wn,option_description:{short:XI,long:ZI}},{answer:"Time to Event",next:Qn,option_description:{short:JI,long:e5}}]},...P5,...eC,...uC},as=hC(fC),zf=({onClick:t,title:n,description:s,isSelected:r})=>{const a=Oe(),[o,d]=v.useState(!1),u=typeof s=="object",h=u?s.short:s,p=u?s.long:s,m=u&&s.long,g=x=>{x.stopPropagation(),d(!0)};return e.jsxs(e.Fragment,{children:[e.jsxs(kn,{variant:"light",shadow:"none",withBorder:!0,styles:{root:{borderColor:r?a.colors.green[5]:a.colors.gray[3]}},color:"gray",p:"xs",maw:350,onClick:t,bg:r?"green.1":"unset",children:[e.jsx(Pn,{c:r?"green.9":"gray.9",order:5,fw:500,children:n}),e.jsxs(i,{c:r?"green.9":"gray.9",style:{whiteSpace:"pre-wrap"},children:[h,m&&e.jsx(i,{fs:"italic",size:"sm",component:"span",c:r?"green.7":"blue.6",style:{cursor:"pointer",textDecoration:"underline"},onClick:g,ml:4,children:"(read more)"})]})]}),e.jsx(Qe,{opened:o,styles:{title:{fontSize:18,fontWeight:500,lineHeight:1.3,marginRight:5}},onClose:()=>d(!1),title:n,size:"md",children:e.jsx(l,{gap:"xs",children:p==null?void 0:p.split(`
`).map((x,j)=>e.jsx(i,{children:x},j))})})]})};/**
 * react-router v7.9.4
 *
 * Copyright (c) Remix Software Inc.
 *
 * This source code is licensed under the MIT license found in the
 * LICENSE.md file in the root directory of this source tree.
 *
 * @license MIT
 */var Nf="popstate";function pC(t={}){function n(r,a){let{pathname:o,search:d,hash:u}=r.location;return Xl("",{pathname:o,search:d,hash:u},a.state&&a.state.usr||null,a.state&&a.state.key||"default")}function s(r,a){return typeof a=="string"?a:Ns(a)}return gC(n,s,null,t)}function ee(t,n){if(t===!1||t===null||typeof t>"u")throw new Error(n)}function gt(t,n){if(!t){typeof console<"u"&&console.warn(n);try{throw new Error(n)}catch{}}}function mC(){return Math.random().toString(36).substring(2,10)}function _f(t,n){return{usr:t.state,key:t.key,idx:n}}function Xl(t,n,s=null,r){return{pathname:typeof t=="string"?t:t.pathname,search:"",hash:"",...typeof n=="string"?Ni(n):n,state:s,key:n&&n.key||r||mC()}}function Ns({pathname:t="/",search:n="",hash:s=""}){return n&&n!=="?"&&(t+=n.charAt(0)==="?"?n:"?"+n),s&&s!=="#"&&(t+=s.charAt(0)==="#"?s:"#"+s),t}function Ni(t){let n={};if(t){let s=t.indexOf("#");s>=0&&(n.hash=t.substring(s),t=t.substring(0,s));let r=t.indexOf("?");r>=0&&(n.search=t.substring(r),t=t.substring(0,r)),t&&(n.pathname=t)}return n}function gC(t,n,s,r={}){let{window:a=document.defaultView,v5Compat:o=!1}=r,d=a.history,u="POP",h=null,p=m();p==null&&(p=0,d.replaceState({...d.state,idx:p},""));function m(){return(d.state||{idx:null}).idx}function g(){u="POP";let T=m(),w=T==null?null:T-p;p=T,h&&h({action:u,location:S.location,delta:w})}function x(T,w){u="PUSH";let y=Xl(S.location,T,w);p=m()+1;let b=_f(y,p),C=S.createHref(y);try{d.pushState(b,"",C)}catch(R){if(R instanceof DOMException&&R.name==="DataCloneError")throw R;a.location.assign(C)}o&&h&&h({action:u,location:S.location,delta:1})}function j(T,w){u="REPLACE";let y=Xl(S.location,T,w);p=m();let b=_f(y,p),C=S.createHref(y);d.replaceState(b,"",C),o&&h&&h({action:u,location:S.location,delta:0})}function I(T){return xC(T)}let S={get action(){return u},get location(){return t(a,d)},listen(T){if(h)throw new Error("A history only accepts one active listener");return a.addEventListener(Nf,g),h=T,()=>{a.removeEventListener(Nf,g),h=null}},createHref(T){return n(a,T)},createURL:I,encodeLocation(T){let w=I(T);return{pathname:w.pathname,search:w.search,hash:w.hash}},push:x,replace:j,go(T){return d.go(T)}};return S}function xC(t,n=!1){let s="http://localhost";typeof window<"u"&&(s=window.location.origin!=="null"?window.location.origin:window.location.href),ee(s,"No window.location.(origin|href) available to create URL");let r=typeof t=="string"?t:Ns(t);return r=r.replace(/ $/,"%20"),!n&&r.startsWith("//")&&(r=s+r),new URL(r,s)}function Cv(t,n,s="/"){return vC(t,n,s,!1)}function vC(t,n,s,r){let a=typeof n=="string"?Ni(n):n,o=At(a.pathname||"/",s);if(o==null)return null;let d=Tv(t);yC(d);let u=null;for(let h=0;u==null&&h<d.length;++h){let p=EC(o);u=kC(d[h],p,r)}return u}function Tv(t,n=[],s=[],r="",a=!1){let o=(d,u,h=a,p)=>{let m={relativePath:p===void 0?d.path||"":p,caseSensitive:d.caseSensitive===!0,childrenIndex:u,route:d};if(m.relativePath.startsWith("/")){if(!m.relativePath.startsWith(r)&&h)return;ee(m.relativePath.startsWith(r),`Absolute route path "${m.relativePath}" nested under path "${r}" is not valid. An absolute child route path must start with the combined path of all its parent routes.`),m.relativePath=m.relativePath.slice(r.length)}let g=kt([r,m.relativePath]),x=s.concat(m);d.children&&d.children.length>0&&(ee(d.index!==!0,`Index routes must not have child routes. Please remove all child routes from route path "${g}".`),Tv(d.children,n,x,g,h)),!(d.path==null&&!d.index)&&n.push({path:g,score:TC(g,d.index),routesMeta:x})};return t.forEach((d,u)=>{var h;if(d.path===""||!((h=d.path)!=null&&h.includes("?")))o(d,u);else for(let p of Rv(d.path))o(d,u,!0,p)}),n}function Rv(t){let n=t.split("/");if(n.length===0)return[];let[s,...r]=n,a=s.endsWith("?"),o=s.replace(/\?$/,"");if(r.length===0)return a?[o,""]:[o];let d=Rv(r.join("/")),u=[];return u.push(...d.map(h=>h===""?o:[o,h].join("/"))),a&&u.push(...d),u.map(h=>t.startsWith("/")&&h===""?"/":h)}function yC(t){t.sort((n,s)=>n.score!==s.score?s.score-n.score:RC(n.routesMeta.map(r=>r.childrenIndex),s.routesMeta.map(r=>r.childrenIndex)))}var jC=/^:[\w-]+$/,wC=3,bC=2,SC=1,IC=10,CC=-2,Lf=t=>t==="*";function TC(t,n){let s=t.split("/"),r=s.length;return s.some(Lf)&&(r+=CC),n&&(r+=bC),s.filter(a=>!Lf(a)).reduce((a,o)=>a+(jC.test(o)?wC:o===""?SC:IC),r)}function RC(t,n){return t.length===n.length&&t.slice(0,-1).every((r,a)=>r===n[a])?t[t.length-1]-n[n.length-1]:0}function kC(t,n,s=!1){let{routesMeta:r}=t,a={},o="/",d=[];for(let u=0;u<r.length;++u){let h=r[u],p=u===r.length-1,m=o==="/"?n:n.slice(o.length)||"/",g=va({path:h.relativePath,caseSensitive:h.caseSensitive,end:p},m),x=h.route;if(!g&&p&&s&&!r[r.length-1].route.index&&(g=va({path:h.relativePath,caseSensitive:h.caseSensitive,end:!1},m)),!g)return null;Object.assign(a,g.params),d.push({params:a,pathname:kt([o,g.pathname]),pathnameBase:zC(kt([o,g.pathnameBase])),route:x}),g.pathnameBase!=="/"&&(o=kt([o,g.pathnameBase]))}return d}function va(t,n){typeof t=="string"&&(t={path:t,caseSensitive:!1,end:!0});let[s,r]=PC(t.path,t.caseSensitive,t.end),a=n.match(s);if(!a)return null;let o=a[0],d=o.replace(/(.)\/+$/,"$1"),u=a.slice(1);return{params:r.reduce((p,{paramName:m,isOptional:g},x)=>{if(m==="*"){let I=u[x]||"";d=o.slice(0,o.length-I.length).replace(/(.)\/+$/,"$1")}const j=u[x];return g&&!j?p[m]=void 0:p[m]=(j||"").replace(/%2F/g,"/"),p},{}),pathname:o,pathnameBase:d,pattern:t}}function PC(t,n=!1,s=!0){gt(t==="*"||!t.endsWith("*")||t.endsWith("/*"),`Route path "${t}" will be treated as if it were "${t.replace(/\*$/,"/*")}" because the \`*\` character must always follow a \`/\` in the pattern. To get rid of this warning, please change the route path to "${t.replace(/\*$/,"/*")}".`);let r=[],a="^"+t.replace(/\/*\*?$/,"").replace(/^\/*/,"/").replace(/[\\.*+^${}|()[\]]/g,"\\$&").replace(/\/:([\w-]+)(\?)?/g,(d,u,h)=>(r.push({paramName:u,isOptional:h!=null}),h?"/?([^\\/]+)?":"/([^\\/]+)")).replace(/\/([\w-]+)\?(\/|$)/g,"(/$1)?$2");return t.endsWith("*")?(r.push({paramName:"*"}),a+=t==="*"||t==="/*"?"(.*)$":"(?:\\/(.+)|\\/*)$"):s?a+="\\/*$":t!==""&&t!=="/"&&(a+="(?:(?=\\/|$))"),[new RegExp(a,n?void 0:"i"),r]}function EC(t){try{return t.split("/").map(n=>decodeURIComponent(n).replace(/\//g,"%2F")).join("/")}catch(n){return gt(!1,`The URL path "${t}" could not be decoded because it is a malformed URL segment. This is probably due to a bad percent encoding (${n}).`),t}}function At(t,n){if(n==="/")return t;if(!t.toLowerCase().startsWith(n.toLowerCase()))return null;let s=n.endsWith("/")?n.length-1:n.length,r=t.charAt(s);return r&&r!=="/"?null:t.slice(s)||"/"}function DC(t,n="/"){let{pathname:s,search:r="",hash:a=""}=typeof t=="string"?Ni(t):t;return{pathname:s?s.startsWith("/")?s:MC(s,n):n,search:NC(r),hash:_C(a)}}function MC(t,n){let s=n.replace(/\/+$/,"").split("/");return t.split("/").forEach(a=>{a===".."?s.length>1&&s.pop():a!=="."&&s.push(a)}),s.length>1?s.join("/"):"/"}function Wo(t,n,s,r){return`Cannot include a '${t}' character in a manually specified \`to.${n}\` field [${JSON.stringify(r)}].  Please separate it out to the \`to.${s}\` field. Alternatively you may provide the full path as a string in <Link to="..."> and the router will parse it for you.`}function AC(t){return t.filter((n,s)=>s===0||n.route.path&&n.route.path.length>0)}function kv(t){let n=AC(t);return n.map((s,r)=>r===n.length-1?s.pathname:s.pathnameBase)}function Pv(t,n,s,r=!1){let a;typeof t=="string"?a=Ni(t):(a={...t},ee(!a.pathname||!a.pathname.includes("?"),Wo("?","pathname","search",a)),ee(!a.pathname||!a.pathname.includes("#"),Wo("#","pathname","hash",a)),ee(!a.search||!a.search.includes("#"),Wo("#","search","hash",a)));let o=t===""||a.pathname==="",d=o?"/":a.pathname,u;if(d==null)u=s;else{let g=n.length-1;if(!r&&d.startsWith("..")){let x=d.split("/");for(;x[0]==="..";)x.shift(),g-=1;a.pathname=x.join("/")}u=g>=0?n[g]:"/"}let h=DC(a,u),p=d&&d!=="/"&&d.endsWith("/"),m=(o||d===".")&&s.endsWith("/");return!h.pathname.endsWith("/")&&(p||m)&&(h.pathname+="/"),h}var kt=t=>t.join("/").replace(/\/\/+/g,"/"),zC=t=>t.replace(/\/+$/,"").replace(/^\/*/,"/"),NC=t=>!t||t==="?"?"":t.startsWith("?")?t:"?"+t,_C=t=>!t||t==="#"?"":t.startsWith("#")?t:"#"+t;function LC(t){return t!=null&&typeof t.status=="number"&&typeof t.statusText=="string"&&typeof t.internal=="boolean"&&"data"in t}var Ev=["POST","PUT","PATCH","DELETE"];new Set(Ev);var OC=["GET",...Ev];new Set(OC);var _i=v.createContext(null);_i.displayName="DataRouter";var to=v.createContext(null);to.displayName="DataRouterState";v.createContext(!1);var Dv=v.createContext({isTransitioning:!1});Dv.displayName="ViewTransition";var FC=v.createContext(new Map);FC.displayName="Fetchers";var $C=v.createContext(null);$C.displayName="Await";var vt=v.createContext(null);vt.displayName="Navigation";var Ys=v.createContext(null);Ys.displayName="Location";var yt=v.createContext({outlet:null,matches:[],isDataRoute:!1});yt.displayName="Route";var Hd=v.createContext(null);Hd.displayName="RouteError";function BC(t,{relative:n}={}){ee(Ks(),"useHref() may be used only in the context of a <Router> component.");let{basename:s,navigator:r}=v.useContext(vt),{hash:a,pathname:o,search:d}=Xs(t,{relative:n}),u=o;return s!=="/"&&(u=o==="/"?s:kt([s,o])),r.createHref({pathname:u,search:d,hash:a})}function Ks(){return v.useContext(Ys)!=null}function Ft(){return ee(Ks(),"useLocation() may be used only in the context of a <Router> component."),v.useContext(Ys).location}var Mv="You should call navigate() in a React.useEffect(), not when your component is first rendered.";function Av(t){v.useContext(vt).static||v.useLayoutEffect(t)}function HC(){let{isDataRoute:t}=v.useContext(yt);return t?nT():VC()}function VC(){ee(Ks(),"useNavigate() may be used only in the context of a <Router> component.");let t=v.useContext(_i),{basename:n,navigator:s}=v.useContext(vt),{matches:r}=v.useContext(yt),{pathname:a}=Ft(),o=JSON.stringify(kv(r)),d=v.useRef(!1);return Av(()=>{d.current=!0}),v.useCallback((h,p={})=>{if(gt(d.current,Mv),!d.current)return;if(typeof h=="number"){s.go(h);return}let m=Pv(h,JSON.parse(o),a,p.relative==="path");t==null&&n!=="/"&&(m.pathname=m.pathname==="/"?n:kt([n,m.pathname])),(p.replace?s.replace:s.push)(m,p.state,p)},[n,s,o,a,t])}v.createContext(null);function GC(){let{matches:t}=v.useContext(yt),n=t[t.length-1];return n?n.params:{}}function Xs(t,{relative:n}={}){let{matches:s}=v.useContext(yt),{pathname:r}=Ft(),a=JSON.stringify(kv(s));return v.useMemo(()=>Pv(t,JSON.parse(a),r,n==="path"),[t,a,r,n])}function UC(t,n){return zv(t,n)}function zv(t,n,s,r,a){var y;ee(Ks(),"useRoutes() may be used only in the context of a <Router> component.");let{navigator:o}=v.useContext(vt),{matches:d}=v.useContext(yt),u=d[d.length-1],h=u?u.params:{},p=u?u.pathname:"/",m=u?u.pathnameBase:"/",g=u&&u.route;{let b=g&&g.path||"";Nv(p,!g||b.endsWith("*")||b.endsWith("*?"),`You rendered descendant <Routes> (or called \`useRoutes()\`) at "${p}" (under <Route path="${b}">) but the parent route path has no trailing "*". This means if you navigate deeper, the parent won't match anymore and therefore the child routes will never render.

Please change the parent <Route path="${b}"> to <Route path="${b==="/"?"*":`${b}/*`}">.`)}let x=Ft(),j;if(n){let b=typeof n=="string"?Ni(n):n;ee(m==="/"||((y=b.pathname)==null?void 0:y.startsWith(m)),`When overriding the location using \`<Routes location>\` or \`useRoutes(routes, location)\`, the location pathname must begin with the portion of the URL pathname that was matched by all parent routes. The current pathname base is "${m}" but pathname "${b.pathname}" was given in the \`location\` prop.`),j=b}else j=x;let I=j.pathname||"/",S=I;if(m!=="/"){let b=m.replace(/^\//,"").split("/");S="/"+I.replace(/^\//,"").split("/").slice(b.length).join("/")}let T=Cv(t,{pathname:S});gt(g||T!=null,`No routes matched location "${j.pathname}${j.search}${j.hash}" `),gt(T==null||T[T.length-1].route.element!==void 0||T[T.length-1].route.Component!==void 0||T[T.length-1].route.lazy!==void 0,`Matched leaf route at location "${j.pathname}${j.search}${j.hash}" does not have an element or Component. This means it will render an <Outlet /> with a null value by default resulting in an "empty" page.`);let w=KC(T&&T.map(b=>Object.assign({},b,{params:Object.assign({},h,b.params),pathname:kt([m,o.encodeLocation?o.encodeLocation(b.pathname.replace(/\?/g,"%3F").replace(/#/g,"%23")).pathname:b.pathname]),pathnameBase:b.pathnameBase==="/"?m:kt([m,o.encodeLocation?o.encodeLocation(b.pathnameBase.replace(/\?/g,"%3F").replace(/#/g,"%23")).pathname:b.pathnameBase])})),d,s,r,a);return n&&w?v.createElement(Ys.Provider,{value:{location:{pathname:"/",search:"",hash:"",state:null,key:"default",...j},navigationType:"POP"}},w):w}function qC(){let t=tT(),n=LC(t)?`${t.status} ${t.statusText}`:t instanceof Error?t.message:JSON.stringify(t),s=t instanceof Error?t.stack:null,r="rgba(200,200,200, 0.5)",a={padding:"0.5rem",backgroundColor:r},o={padding:"2px 4px",backgroundColor:r},d=null;return console.error("Error handled by React Router default ErrorBoundary:",t),d=v.createElement(v.Fragment,null,v.createElement("p",null," Hey developer "),v.createElement("p",null,"You can provide a way better UX than this when your app throws errors by providing your own ",v.createElement("code",{style:o},"ErrorBoundary")," or"," ",v.createElement("code",{style:o},"errorElement")," prop on your route.")),v.createElement(v.Fragment,null,v.createElement("h2",null,"Unexpected Application Error!"),v.createElement("h3",{style:{fontStyle:"italic"}},n),s?v.createElement("pre",{style:a},s):null,d)}var WC=v.createElement(qC,null),QC=class extends v.Component{constructor(t){super(t),this.state={location:t.location,revalidation:t.revalidation,error:t.error}}static getDerivedStateFromError(t){return{error:t}}static getDerivedStateFromProps(t,n){return n.location!==t.location||n.revalidation!=="idle"&&t.revalidation==="idle"?{error:t.error,location:t.location,revalidation:t.revalidation}:{error:t.error!==void 0?t.error:n.error,location:n.location,revalidation:t.revalidation||n.revalidation}}componentDidCatch(t,n){this.props.unstable_onError?this.props.unstable_onError(t,n):console.error("React Router caught the following error during render",t)}render(){return this.state.error!==void 0?v.createElement(yt.Provider,{value:this.props.routeContext},v.createElement(Hd.Provider,{value:this.state.error,children:this.props.component})):this.props.children}};function YC({routeContext:t,match:n,children:s}){let r=v.useContext(_i);return r&&r.static&&r.staticContext&&(n.route.errorElement||n.route.ErrorBoundary)&&(r.staticContext._deepestRenderedBoundaryId=n.route.id),v.createElement(yt.Provider,{value:t},s)}function KC(t,n=[],s=null,r=null,a=null){if(t==null){if(!s)return null;if(s.errors)t=s.matches;else if(n.length===0&&!s.initialized&&s.matches.length>0)t=s.matches;else return null}let o=t,d=s==null?void 0:s.errors;if(d!=null){let p=o.findIndex(m=>m.route.id&&(d==null?void 0:d[m.route.id])!==void 0);ee(p>=0,`Could not find a matching route for errors on route IDs: ${Object.keys(d).join(",")}`),o=o.slice(0,Math.min(o.length,p+1))}let u=!1,h=-1;if(s)for(let p=0;p<o.length;p++){let m=o[p];if((m.route.HydrateFallback||m.route.hydrateFallbackElement)&&(h=p),m.route.id){let{loaderData:g,errors:x}=s,j=m.route.loader&&!g.hasOwnProperty(m.route.id)&&(!x||x[m.route.id]===void 0);if(m.route.lazy||j){u=!0,h>=0?o=o.slice(0,h+1):o=[o[0]];break}}}return o.reduceRight((p,m,g)=>{let x,j=!1,I=null,S=null;s&&(x=d&&m.route.id?d[m.route.id]:void 0,I=m.route.errorElement||WC,u&&(h<0&&g===0?(Nv("route-fallback",!1,"No `HydrateFallback` element provided to render during initial hydration"),j=!0,S=null):h===g&&(j=!0,S=m.route.hydrateFallbackElement||null)));let T=n.concat(o.slice(0,g+1)),w=()=>{let y;return x?y=I:j?y=S:m.route.Component?y=v.createElement(m.route.Component,null):m.route.element?y=m.route.element:y=p,v.createElement(YC,{match:m,routeContext:{outlet:p,matches:T,isDataRoute:s!=null},children:y})};return s&&(m.route.ErrorBoundary||m.route.errorElement||g===0)?v.createElement(QC,{location:s.location,revalidation:s.revalidation,component:I,error:x,children:w(),routeContext:{outlet:null,matches:T,isDataRoute:!0},unstable_onError:r}):w()},null)}function Vd(t){return`${t} must be used within a data router.  See https://reactrouter.com/en/main/routers/picking-a-router.`}function XC(t){let n=v.useContext(_i);return ee(n,Vd(t)),n}function ZC(t){let n=v.useContext(to);return ee(n,Vd(t)),n}function JC(t){let n=v.useContext(yt);return ee(n,Vd(t)),n}function Gd(t){let n=JC(t),s=n.matches[n.matches.length-1];return ee(s.route.id,`${t} can only be used on routes that contain a unique "id"`),s.route.id}function eT(){return Gd("useRouteId")}function tT(){var r;let t=v.useContext(Hd),n=ZC("useRouteError"),s=Gd("useRouteError");return t!==void 0?t:(r=n.errors)==null?void 0:r[s]}function nT(){let{router:t}=XC("useNavigate"),n=Gd("useNavigate"),s=v.useRef(!1);return Av(()=>{s.current=!0}),v.useCallback(async(a,o={})=>{gt(s.current,Mv),s.current&&(typeof a=="number"?t.navigate(a):await t.navigate(a,{fromRouteId:n,...o}))},[t,n])}var Of={};function Nv(t,n,s){!n&&!Of[t]&&(Of[t]=!0,gt(!1,s))}v.memo(iT);function iT({routes:t,future:n,state:s,unstable_onError:r}){return zv(t,void 0,s,r,n)}function os(t){ee(!1,"A <Route> is only ever to be used as the child of <Routes> element, never rendered directly. Please wrap your <Route> in a <Routes>.")}function sT({basename:t="/",children:n=null,location:s,navigationType:r="POP",navigator:a,static:o=!1}){ee(!Ks(),"You cannot render a <Router> inside another <Router>. You should never have more than one in your app.");let d=t.replace(/^\/*/,"/"),u=v.useMemo(()=>({basename:d,navigator:a,static:o,future:{}}),[d,a,o]);typeof s=="string"&&(s=Ni(s));let{pathname:h="/",search:p="",hash:m="",state:g=null,key:x="default"}=s,j=v.useMemo(()=>{let I=At(h,d);return I==null?null:{location:{pathname:I,search:p,hash:m,state:g,key:x},navigationType:r}},[d,h,p,m,g,x,r]);return gt(j!=null,`<Router basename="${d}"> is not able to match the URL "${h}${p}${m}" because it does not start with the basename, so the <Router> won't render anything.`),j==null?null:v.createElement(vt.Provider,{value:u},v.createElement(Ys.Provider,{children:n,value:j}))}function rT({children:t,location:n}){return UC(Zl(t),n)}function Zl(t,n=[]){let s=[];return v.Children.forEach(t,(r,a)=>{if(!v.isValidElement(r))return;let o=[...n,a];if(r.type===v.Fragment){s.push.apply(s,Zl(r.props.children,o));return}ee(r.type===os,`[${typeof r.type=="string"?r.type:r.type.name}] is not a <Route> component. All component children of <Routes> must be a <Route> or <React.Fragment>`),ee(!r.props.index||!r.props.children,"An index route cannot have child routes.");let d={id:r.props.id||o.join("-"),caseSensitive:r.props.caseSensitive,element:r.props.element,Component:r.props.Component,index:r.props.index,path:r.props.path,middleware:r.props.middleware,loader:r.props.loader,action:r.props.action,hydrateFallbackElement:r.props.hydrateFallbackElement,HydrateFallback:r.props.HydrateFallback,errorElement:r.props.errorElement,ErrorBoundary:r.props.ErrorBoundary,hasErrorBoundary:r.props.hasErrorBoundary===!0||r.props.ErrorBoundary!=null||r.props.errorElement!=null,shouldRevalidate:r.props.shouldRevalidate,handle:r.props.handle,lazy:r.props.lazy};r.props.children&&(d.children=Zl(r.props.children,o)),s.push(d)}),s}var Vr="get",Gr="application/x-www-form-urlencoded";function no(t){return t!=null&&typeof t.tagName=="string"}function aT(t){return no(t)&&t.tagName.toLowerCase()==="button"}function oT(t){return no(t)&&t.tagName.toLowerCase()==="form"}function lT(t){return no(t)&&t.tagName.toLowerCase()==="input"}function cT(t){return!!(t.metaKey||t.altKey||t.ctrlKey||t.shiftKey)}function dT(t,n){return t.button===0&&(!n||n==="_self")&&!cT(t)}var Rr=null;function uT(){if(Rr===null)try{new FormData(document.createElement("form"),0),Rr=!1}catch{Rr=!0}return Rr}var hT=new Set(["application/x-www-form-urlencoded","multipart/form-data","text/plain"]);function Qo(t){return t!=null&&!hT.has(t)?(gt(!1,`"${t}" is not a valid \`encType\` for \`<Form>\`/\`<fetcher.Form>\` and will default to "${Gr}"`),null):t}function fT(t,n){let s,r,a,o,d;if(oT(t)){let u=t.getAttribute("action");r=u?At(u,n):null,s=t.getAttribute("method")||Vr,a=Qo(t.getAttribute("enctype"))||Gr,o=new FormData(t)}else if(aT(t)||lT(t)&&(t.type==="submit"||t.type==="image")){let u=t.form;if(u==null)throw new Error('Cannot submit a <button> or <input type="submit"> without a <form>');let h=t.getAttribute("formaction")||u.getAttribute("action");if(r=h?At(h,n):null,s=t.getAttribute("formmethod")||u.getAttribute("method")||Vr,a=Qo(t.getAttribute("formenctype"))||Qo(u.getAttribute("enctype"))||Gr,o=new FormData(u,t),!uT()){let{name:p,type:m,value:g}=t;if(m==="image"){let x=p?`${p}.`:"";o.append(`${x}x`,"0"),o.append(`${x}y`,"0")}else p&&o.append(p,g)}}else{if(no(t))throw new Error('Cannot submit element that is not <form>, <button>, or <input type="submit|image">');s=Vr,r=null,a=Gr,d=t}return o&&a==="text/plain"&&(d=o,o=void 0),{action:r,method:s.toLowerCase(),encType:a,formData:o,body:d}}Object.getOwnPropertyNames(Object.prototype).sort().join("\0");function Ud(t,n){if(t===!1||t===null||typeof t>"u")throw new Error(n)}function pT(t,n,s){let r=typeof t=="string"?new URL(t,typeof window>"u"?"server://singlefetch/":window.location.origin):t;return r.pathname==="/"?r.pathname=`_root.${s}`:n&&At(r.pathname,n)==="/"?r.pathname=`${n.replace(/\/$/,"")}/_root.${s}`:r.pathname=`${r.pathname.replace(/\/$/,"")}.${s}`,r}async function mT(t,n){if(t.id in n)return n[t.id];try{let s=await import(t.module);return n[t.id]=s,s}catch(s){return console.error(`Error loading route module \`${t.module}\`, reloading page...`),console.error(s),window.__reactRouterContext&&window.__reactRouterContext.isSpaMode,window.location.reload(),new Promise(()=>{})}}function gT(t){return t==null?!1:t.href==null?t.rel==="preload"&&typeof t.imageSrcSet=="string"&&typeof t.imageSizes=="string":typeof t.rel=="string"&&typeof t.href=="string"}async function xT(t,n,s){let r=await Promise.all(t.map(async a=>{let o=n.routes[a.route.id];if(o){let d=await mT(o,s);return d.links?d.links():[]}return[]}));return wT(r.flat(1).filter(gT).filter(a=>a.rel==="stylesheet"||a.rel==="preload").map(a=>a.rel==="stylesheet"?{...a,rel:"prefetch",as:"style"}:{...a,rel:"prefetch"}))}function Ff(t,n,s,r,a,o){let d=(h,p)=>s[p]?h.route.id!==s[p].route.id:!0,u=(h,p)=>{var m;return s[p].pathname!==h.pathname||((m=s[p].route.path)==null?void 0:m.endsWith("*"))&&s[p].params["*"]!==h.params["*"]};return o==="assets"?n.filter((h,p)=>d(h,p)||u(h,p)):o==="data"?n.filter((h,p)=>{var g;let m=r.routes[h.route.id];if(!m||!m.hasLoader)return!1;if(d(h,p)||u(h,p))return!0;if(h.route.shouldRevalidate){let x=h.route.shouldRevalidate({currentUrl:new URL(a.pathname+a.search+a.hash,window.origin),currentParams:((g=s[0])==null?void 0:g.params)||{},nextUrl:new URL(t,window.origin),nextParams:h.params,defaultShouldRevalidate:!0});if(typeof x=="boolean")return x}return!0}):[]}function vT(t,n,{includeHydrateFallback:s}={}){return yT(t.map(r=>{let a=n.routes[r.route.id];if(!a)return[];let o=[a.module];return a.clientActionModule&&(o=o.concat(a.clientActionModule)),a.clientLoaderModule&&(o=o.concat(a.clientLoaderModule)),s&&a.hydrateFallbackModule&&(o=o.concat(a.hydrateFallbackModule)),a.imports&&(o=o.concat(a.imports)),o}).flat(1))}function yT(t){return[...new Set(t)]}function jT(t){let n={},s=Object.keys(t).sort();for(let r of s)n[r]=t[r];return n}function wT(t,n){let s=new Set;return new Set(n),t.reduce((r,a)=>{let o=JSON.stringify(jT(a));return s.has(o)||(s.add(o),r.push({key:o,link:a})),r},[])}function _v(){let t=v.useContext(_i);return Ud(t,"You must render this element inside a <DataRouterContext.Provider> element"),t}function bT(){let t=v.useContext(to);return Ud(t,"You must render this element inside a <DataRouterStateContext.Provider> element"),t}var qd=v.createContext(void 0);qd.displayName="FrameworkContext";function Lv(){let t=v.useContext(qd);return Ud(t,"You must render this element inside a <HydratedRouter> element"),t}function ST(t,n){let s=v.useContext(qd),[r,a]=v.useState(!1),[o,d]=v.useState(!1),{onFocus:u,onBlur:h,onMouseEnter:p,onMouseLeave:m,onTouchStart:g}=n,x=v.useRef(null);v.useEffect(()=>{if(t==="render"&&d(!0),t==="viewport"){let S=w=>{w.forEach(y=>{d(y.isIntersecting)})},T=new IntersectionObserver(S,{threshold:.5});return x.current&&T.observe(x.current),()=>{T.disconnect()}}},[t]),v.useEffect(()=>{if(r){let S=setTimeout(()=>{d(!0)},100);return()=>{clearTimeout(S)}}},[r]);let j=()=>{a(!0)},I=()=>{a(!1),d(!1)};return s?t!=="intent"?[o,x,{}]:[o,x,{onFocus:es(u,j),onBlur:es(h,I),onMouseEnter:es(p,j),onMouseLeave:es(m,I),onTouchStart:es(g,j)}]:[!1,x,{}]}function es(t,n){return s=>{t&&t(s),s.defaultPrevented||n(s)}}function IT({page:t,...n}){let{router:s}=_v(),r=v.useMemo(()=>Cv(s.routes,t,s.basename),[s.routes,t,s.basename]);return r?v.createElement(TT,{page:t,matches:r,...n}):null}function CT(t){let{manifest:n,routeModules:s}=Lv(),[r,a]=v.useState([]);return v.useEffect(()=>{let o=!1;return xT(t,n,s).then(d=>{o||a(d)}),()=>{o=!0}},[t,n,s]),r}function TT({page:t,matches:n,...s}){let r=Ft(),{manifest:a,routeModules:o}=Lv(),{basename:d}=_v(),{loaderData:u,matches:h}=bT(),p=v.useMemo(()=>Ff(t,n,h,a,r,"data"),[t,n,h,a,r]),m=v.useMemo(()=>Ff(t,n,h,a,r,"assets"),[t,n,h,a,r]),g=v.useMemo(()=>{if(t===r.pathname+r.search+r.hash)return[];let I=new Set,S=!1;if(n.forEach(w=>{var b;let y=a.routes[w.route.id];!y||!y.hasLoader||(!p.some(C=>C.route.id===w.route.id)&&w.route.id in u&&((b=o[w.route.id])!=null&&b.shouldRevalidate)||y.hasClientLoader?S=!0:I.add(w.route.id))}),I.size===0)return[];let T=pT(t,d,"data");return S&&I.size>0&&T.searchParams.set("_routes",n.filter(w=>I.has(w.route.id)).map(w=>w.route.id).join(",")),[T.pathname+T.search]},[d,u,r,a,p,n,t,o]),x=v.useMemo(()=>vT(m,a),[m,a]),j=CT(m);return v.createElement(v.Fragment,null,g.map(I=>v.createElement("link",{key:I,rel:"prefetch",as:"fetch",href:I,...s})),x.map(I=>v.createElement("link",{key:I,rel:"modulepreload",href:I,...s})),j.map(({key:I,link:S})=>v.createElement("link",{key:I,nonce:s.nonce,...S})))}function RT(...t){return n=>{t.forEach(s=>{typeof s=="function"?s(n):s!=null&&(s.current=n)})}}var Ov=typeof window<"u"&&typeof window.document<"u"&&typeof window.document.createElement<"u";try{Ov&&(window.__reactRouterVersion="7.9.4")}catch{}function kT({basename:t,children:n,window:s}){let r=v.useRef();r.current==null&&(r.current=pC({window:s,v5Compat:!0}));let a=r.current,[o,d]=v.useState({action:a.action,location:a.location}),u=v.useCallback(h=>{v.startTransition(()=>d(h))},[d]);return v.useLayoutEffect(()=>a.listen(u),[a,u]),v.createElement(sT,{basename:t,children:n,location:o.location,navigationType:o.action,navigator:a})}var Fv=/^(?:[a-z][a-z0-9+.-]*:|\/\/)/i,gn=v.forwardRef(function({onClick:n,discover:s="render",prefetch:r="none",relative:a,reloadDocument:o,replace:d,state:u,target:h,to:p,preventScrollReset:m,viewTransition:g,...x},j){let{basename:I}=v.useContext(vt),S=typeof p=="string"&&Fv.test(p),T,w=!1;if(typeof p=="string"&&S&&(T=p,Ov))try{let z=new URL(window.location.href),_=p.startsWith("//")?new URL(z.protocol+p):new URL(p),q=At(_.pathname,I);_.origin===z.origin&&q!=null?p=q+_.search+_.hash:w=!0}catch{gt(!1,`<Link to="${p}"> contains an invalid URL which will probably break when clicked - please update to a valid URL path.`)}let y=BC(p,{relative:a}),[b,C,R]=ST(r,x),D=DT(p,{replace:d,state:u,target:h,preventScrollReset:m,relative:a,viewTransition:g});function k(z){n&&n(z),z.defaultPrevented||D(z)}let P=v.createElement("a",{...x,...R,href:T||y,onClick:w||o?n:k,ref:RT(j,C),target:h,"data-discover":!S&&s==="render"?"true":void 0});return b&&!S?v.createElement(v.Fragment,null,P,v.createElement(IT,{page:y})):P});gn.displayName="Link";var $v=v.forwardRef(function({"aria-current":n="page",caseSensitive:s=!1,className:r="",end:a=!1,style:o,to:d,viewTransition:u,children:h,...p},m){let g=Xs(d,{relative:p.relative}),x=Ft(),j=v.useContext(to),{navigator:I,basename:S}=v.useContext(vt),T=j!=null&&_T(g)&&u===!0,w=I.encodeLocation?I.encodeLocation(g).pathname:g.pathname,y=x.pathname,b=j&&j.navigation&&j.navigation.location?j.navigation.location.pathname:null;s||(y=y.toLowerCase(),b=b?b.toLowerCase():null,w=w.toLowerCase()),b&&S&&(b=At(b,S)||b);const C=w!=="/"&&w.endsWith("/")?w.length-1:w.length;let R=y===w||!a&&y.startsWith(w)&&y.charAt(C)==="/",D=b!=null&&(b===w||!a&&b.startsWith(w)&&b.charAt(w.length)==="/"),k={isActive:R,isPending:D,isTransitioning:T},P=R?n:void 0,z;typeof r=="function"?z=r(k):z=[r,R?"active":null,D?"pending":null,T?"transitioning":null].filter(Boolean).join(" ");let _=typeof o=="function"?o(k):o;return v.createElement(gn,{...p,"aria-current":P,className:z,ref:m,style:_,to:d,viewTransition:u},typeof h=="function"?h(k):h)});$v.displayName="NavLink";var PT=v.forwardRef(({discover:t="render",fetcherKey:n,navigate:s,reloadDocument:r,replace:a,state:o,method:d=Vr,action:u,onSubmit:h,relative:p,preventScrollReset:m,viewTransition:g,...x},j)=>{let I=zT(),S=NT(u,{relative:p}),T=d.toLowerCase()==="get"?"get":"post",w=typeof u=="string"&&Fv.test(u),y=b=>{if(h&&h(b),b.defaultPrevented)return;b.preventDefault();let C=b.nativeEvent.submitter,R=(C==null?void 0:C.getAttribute("formmethod"))||d;I(C||b.currentTarget,{fetcherKey:n,method:R,navigate:s,replace:a,state:o,relative:p,preventScrollReset:m,viewTransition:g})};return v.createElement("form",{ref:j,method:T,action:S,onSubmit:r?h:y,...x,"data-discover":!w&&t==="render"?"true":void 0})});PT.displayName="Form";function ET(t){return`${t} must be used within a data router.  See https://reactrouter.com/en/main/routers/picking-a-router.`}function Bv(t){let n=v.useContext(_i);return ee(n,ET(t)),n}function DT(t,{target:n,replace:s,state:r,preventScrollReset:a,relative:o,viewTransition:d}={}){let u=HC(),h=Ft(),p=Xs(t,{relative:o});return v.useCallback(m=>{if(dT(m,n)){m.preventDefault();let g=s!==void 0?s:Ns(h)===Ns(p);u(t,{replace:g,state:r,preventScrollReset:a,relative:o,viewTransition:d})}},[h,u,p,s,r,n,t,a,o,d])}var MT=0,AT=()=>`__${String(++MT)}__`;function zT(){let{router:t}=Bv("useSubmit"),{basename:n}=v.useContext(vt),s=eT();return v.useCallback(async(r,a={})=>{let{action:o,method:d,encType:u,formData:h,body:p}=fT(r,n);if(a.navigate===!1){let m=a.fetcherKey||AT();await t.fetch(m,s,a.action||o,{preventScrollReset:a.preventScrollReset,formData:h,body:p,formMethod:a.method||d,formEncType:a.encType||u,flushSync:a.flushSync})}else await t.navigate(a.action||o,{preventScrollReset:a.preventScrollReset,formData:h,body:p,formMethod:a.method||d,formEncType:a.encType||u,replace:a.replace,state:a.state,fromRouteId:s,flushSync:a.flushSync,viewTransition:a.viewTransition})},[t,n,s])}function NT(t,{relative:n}={}){let{basename:s}=v.useContext(vt),r=v.useContext(yt);ee(r,"useFormAction must be used inside a RouteContext");let[a]=r.matches.slice(-1),o={...Xs(t||".",{relative:n})},d=Ft();if(t==null){o.search=d.search;let u=new URLSearchParams(o.search),h=u.getAll("index");if(h.some(m=>m==="")){u.delete("index"),h.filter(g=>g).forEach(g=>u.append("index",g));let m=u.toString();o.search=m?`?${m}`:""}}return(!t||t===".")&&a.route.index&&(o.search=o.search?o.search.replace(/^\?/,"?index&"):"?index"),s!=="/"&&(o.pathname=o.pathname==="/"?s:kt([s,o.pathname])),Ns(o)}function _T(t,{relative:n}={}){let s=v.useContext(Dv);ee(s!=null,"`useViewTransitionState` must be used within `react-router-dom`'s `RouterProvider`.  Did you accidentally import `RouterProvider` from `react-router`?");let{basename:r}=Bv("useViewTransitionState"),a=Xs(t,{relative:n});if(!s.isTransitioning)return!1;let o=At(s.currentLocation.pathname,r)||s.currentLocation.pathname,d=At(s.nextLocation.pathname,r)||s.nextLocation.pathname;return va(a.pathname,d)!=null||va(a.pathname,o)!=null}function Hv(t,n){console.log({currentNode:t,steps:n});const s={...n[t]};if(!t||!s||s.leaf)return 0;let r=0;!s.choices&&s.type==="statement"&&(s.choices=[{next:s.next}]);for(const a of s.choices)if(a.next){const o=1+Hv(a.next,n);r=Math.max(r,o)}else r=Math.max(r,1);return r}function Vv(t){const n=as[t];return n?!n.inputs||n.inputs.length===0?[n.id]:[...n.inputs.flatMap(r=>Vv(r)),t]:(console.error("Invalid step name:",t),[])}const ts={variant:"subtle",color:"gray",tt:"uppercase"},$f=()=>{const[t,n]=v.useState(0),{step:s}=GC(),r=Ft(),[a,o]=v.useState([]),[d,u]=v.useState(),[h,p]=v.useState(as[s||Ii]),[m,g]=v.useState([]),[x,j]=v.useState(null),[I,S]=v.useState(!1),T=mn("(max-width: 768px)");v.useEffect(()=>{window.scrollTo({top:0,behavior:"instant"})},[r.pathname]),v.useEffect(()=>{const b=Object.keys(as).includes(s)?s:Ii,C=as[b],R=C.inputs.length?Vv(C.inputs[0]):[];u(void 0),p(C),o(R),j(null),S(!1),g(C.examples||[]);const k=Hv(b,as)-1+R.length,P=R.length;n(P/k*100)},[s,r.pathname]);function w(){return a.length>0?e.jsx(gn,{to:`/decision-tree/${a[a.length-1]}`,children:e.jsx(it,{...ts,children:"Back"})}):e.jsx(gn,{to:{pathname:"/intro"},children:e.jsx(it,{...ts,children:"Back to intro"})})}function y(){if(h.choices)return e.jsx(gn,{to:`/decision-tree/${d}`,children:e.jsx(it,{...ts,disabled:!d,children:"Next"})});if(!h.choices&&!h.next)return e.jsx(gn,{to:"/decision-tree",children:e.jsx(it,{...ts,children:"Start over"})});if(h.type==="statement"&&h.next)return e.jsx(gn,{to:`/decision-tree/${h.next}`,children:e.jsx(it,{...ts,children:"Continue"})})}if(h)return e.jsxs(kn,{shadow:"sm",padding:"lg",my:{base:"lg",md:"48px"},w:"100%",radius:"md",withBorder:!0,children:[e.jsx(kn.Section,{pb:"md",children:e.jsx(zi,{value:t,w:"100%",radius:0})}),e.jsx(nt,{justify:"center",w:"100%",children:e.jsxs(l,{w:"100%",children:[e.jsxs(nt,{justify:"space-between",w:"100%",align:"center",children:[e.jsx(Pn,{order:4,children:h.title}),m.length>0&&e.jsx(nt,{gap:"xs",children:m.map((b,C)=>e.jsxs(it,{size:"xs",variant:"outline",onClick:()=>{j({component:b,index:C+1}),S(!0)},children:["Example",C>0||m.length>1?` #${C+1}`:""]},C))})]}),e.jsx(Bf,{component:h.component}),h!=null&&h.choices?(()=>{const b=h.choices.reduce((R,D)=>{const k=D.group||"default";return R[k]||(R[k]=[]),R[k].push(D),R},{});return Object.keys(b).length>1||Object.keys(b).length===1&&Object.keys(b)[0]!=="default"?e.jsx(l,{gap:"lg",children:Object.entries(b).map(([R,D])=>e.jsxs(l,{gap:"md",children:[e.jsx(Ua,{mx:-20}),e.jsx(Pn,{order:5,c:"dimmed",fw:500,children:R}),e.jsx(nt,{justify:"center",children:D.map(k=>e.jsx(zf,{title:k.answer,description:k.option_description,isSelected:d===k.next,onClick:()=>{u(k.next)}},k.answer))})]},R))}):e.jsx(nt,{justify:"center",children:h.choices.map(R=>e.jsx(zf,{title:R.answer,description:R.option_description,isSelected:d===R.next,onClick:()=>{u(R.next)}},R.answer))})})():null,e.jsxs(nt,{justify:"space-between",w:"100%",children:[w(),y()]})]})}),x&&e.jsx(Qe,{opened:I,styles:{close:{marginBottom:"auto"},title:{fontSize:18,fontWeight:500,lineHeight:1.3,marginRight:5}},onClose:()=>{S(!1),j(null)},title:x.component.title||x.component.displayName||`Example ${x.index}`,size:T?"100%":1200,fullScreen:T,children:e.jsx(Bf,{component:x.component})})]})};function Bf(t){const{component:n,...s}=t;return e.jsx(n,{...s})}const io=({children:t,backgroundColor:n="white"})=>e.jsx(L,{w:"100%",bg:n,children:e.jsx(L,{w:"92%",mx:"auto",children:t})});function LT(){const t=Tb({base:!0,sm:!1},{getInitialValueInEffect:!1}),n=[{label:"title",value:"Department of Otolaryngology-Head & Neck Surgery"},{label:"email",value:"piccirij@wustl.edu"},{label:"campusBox",value:"Campus Box 8115"},{label:"address",value:"660 S. Euclid Ave."},{label:"cityStateZip",value:"St. Louis, MO, 63110"},{label:"phone",value:"314-362-8641"}];return e.jsx(io,{backgroundColor:"#3d3d3d",children:e.jsxs(l,{c:"white",py:"lg",children:[e.jsx(Pn,{order:4,size:"1.2rem",ff:"Libre Baskerville",fw:400,pb:0,mb:"-5px",ta:t?"center":"left",children:"Clinical Outcomes Research"}),e.jsx(l,{gap:5,align:t?"center":"left",children:n.map(({value:s,label:r})=>r==="email"?e.jsx(dd,{href:"mailto:piccirij@wustl.edu",size:"14px",c:"white",td:"underline",ff:"'Source Sans 3'",pb:0,mb:0,children:s},r):e.jsx(i,{size:"14px",ff:"'Source Sans 3'",pb:0,mb:0,children:s},r))}),e.jsx(L,{children:e.jsx(Ua,{})}),e.jsx(i,{size:"14px",ff:"'Source Sans 3'",pb:0,mb:0,children:"Copyright  2025 Washington University School of Medicine, St. Louis, Missouri"})]})})}const OT=()=>e.jsx(io,{children:e.jsxs(e.Fragment,{children:[e.jsx(i,{c:"red.9",span:!0,fw:600,ff:"'Source Sans 3'",tt:"uppercase",size:"14px",children:"Department of Otolaryngology"}),e.jsx(i,{c:"red.9",span:!0,fw:600,ff:"'Source Sans 3'",tt:"uppercase",size:"14px",children:"Clinical Outcomes Research"})]})}),FT="/correct-effect-size-dev/washuLogo.svg",$T=()=>e.jsx(io,{backgroundColor:"washu.9",children:e.jsx(L,{h:48,py:"sm",maw:"100%",children:e.jsx("img",{src:FT,style:{margin:"auto",height:"100%",maxWidth:"100%"}})})}),Hf=()=>e.jsx(kn,{shadow:"sm",padding:"lg",my:{base:"lg",md:"48px"},radius:"md",withBorder:!0,children:e.jsxs(l,{children:[e.jsx(nt,{justify:"space-between",children:e.jsx(Pn,{order:3,fw:400,children:"Selecting the Correct Effect Size Measurement"})}),e.jsxs(l,{children:[e.jsx(i,{c:"dark",children:"Effect size is a critical measurement used in clinical studies to evaluate the impact of an intervention on the outcome of interest. It quantifies the magnitude of the treatment effect, allowing researchers to determine whether the intervention is clinically significant or not. Choosing the correct effect size measurement is crucial as it directly impacts the power of the study, which in turn affects the study's ability to detect a true treatment effect."}),e.jsx(i,{c:"dark",children:"There are several effect size measurements available, each with its own strengths and weaknesses. Selecting the appropriate effect size measurement requires careful consideration of the study design, the research question, and the data being collected. The choice of effect size can have a significant impact on the study's interpretation, and incorrect selection can lead to underpowered studies or erroneous conclusions."}),e.jsx(i,{c:"dark",children:"This wizard-based web tool helps investigators select the appropriate effect size measurement for planning and reporting the results of their research."})]}),e.jsx($v,{to:"/decision-tree",style:{marginLeft:"auto"},children:e.jsx(it,{variant:"subtle",color:"gray",w:"max-content",tt:"uppercase",children:"Begin"})})]})});function BT(){const t=Ft();return v.useEffect(()=>{const n=window.location.href;let s=document.querySelector('meta[property="og:url"]');s||(s=document.createElement("meta"),s.setAttribute("property","og:url"),document.head.appendChild(s)),s.setAttribute("content",n);let r=document.querySelector('link[rel="canonical"]');r||(r=document.createElement("link"),r.setAttribute("rel","canonical"),document.head.appendChild(r)),r.setAttribute("href",n)},[t.pathname]),null}function HT(){const t={fontFamily:"Roboto, sans-serif",primaryColor:"washu",primaryShade:9,components:{Button:{styles:()=>({root:{fontFamily:"Roboto,sans-serif",fontWeight:500}})}},colors:{washu:["#fdeded","#f4d7d7","#edaaab","#e77a7b","#e25353","#e03b3a","#df2f2d","#c62421","#b11d1c","#9b1316"]}};return e.jsx(Rg,{theme:t,children:e.jsxs(ot,{header:{height:48},children:[e.jsx(ot.Header,{withBorder:!1,children:e.jsx($T,{})}),e.jsx(ot.Main,{w:"100vw",pl:0,pr:0,pb:0,h:"100%",children:e.jsxs(l,{pt:"sm",gap:0,mih:"100%",children:[e.jsx(OT,{}),e.jsx(nt,{styles:{root:{flexGrow:1}},align:"start",children:e.jsx(io,{children:e.jsx(nt,{maw:"1185px",mx:"auto",mt:0,justify:"center",children:e.jsxs(kT,{basename:"/correct-effect-size-dev/",children:[e.jsx(BT,{}),e.jsxs(rT,{children:[e.jsx(os,{path:"/intro",Component:Hf}),e.jsx(os,{path:"/decision-tree/:step",Component:$f}),e.jsx(os,{path:"/decision-tree/",Component:$f}),e.jsx(os,{path:"*",Component:Hf})]})]})})})}),e.jsx(LT,{})]})})]})})}ng(document.getElementById("root")).render(e.jsx(v.StrictMode,{children:e.jsx(HT,{})}));
